TTD - Therapeutic Targets Database Full Data Download File Title - TTD drugs information in raw format Version 8.1.01 (2021.11.08) Provided by IDRB Lab of Innovative Drug Reasearch and Bioinformatics College of Pharmaceutical Sciences Zhejiang University https://idrblab.org/ Provided by BIDD BioInformatic and Drug Design Group Department of Pharmacy National Unviersity of Singapore http://bidd.nus.edu.sg/ Any question about data provided here, please contact with: Dr. Zhou (zhou_ying@zju.edu.cn) and Dr. Zhang (zhangyintao@zju.edu.cn) _______________________________________________________________________ Abbreviations: DRUG__ID DRUG ID TRADNAME Trade Name DRUGCOMP Company THERCLAS Therapeutic Class DRUGTYPE Drug Type DRUGINCH InChI DRUGINKE InChIKey DRUGSMIL Canonical SMILES HIGHSTAT Highest status DRUGCLAS drug class DRUADIID ADI ID COMPCLAS Compound Class ________________________________________________________________________ D00AAN DRUG__ID D00AAN D00AAN DRUGCLAS Investigative Drug(s) D00AAN DRUGINCH 1S/C42H47ClN4O5S/c43-28-12-16-31(17-13-28)53(50,51)52-36-11-7-10-32-33-18-21-44-38(39(33)45-37(32)36)34-26-42(49)20-5-3-1-2-4-6-22-46-24-19-35(34)41(27-46)25-29-14-15-30(48)9-8-23-47(29)40(41)42/h1,3,7,10-13,16-18,21,26,29,35,40,45,49H,2,4-6,8-9,14-15,19-20,22-25,27H2/b3-1-/t29-,35?,40+,41-,42-/m0/s1 D00AAN DRUGINKE MSUMHGMGRZWLMN-WXPZYUJUSA-N D00AAN DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC5N4CCCC(=O)CC5)O)C6=NC=CC7=C6NC8=C7C=CC=C8OS(=O)(=O)C9=CC=C(C=C9)Cl D00AAN DRUGTYPE Small molecular drug D00AAN HIGHSTAT Investigative D00AAU DRUG__ID D00AAU D00AAU DRUGCLAS Investigative Drug(s) D00AAU DRUGINCH 1S/C18H22O2/c1-3-17(13-7-5-9-15(19)11-13)18(4-2)14-8-6-10-16(20)12-14/h5-12,17-20H,3-4H2,1-2H3 D00AAU DRUGINKE KUJAWCSIKNKXLL-UHFFFAOYSA-N D00AAU DRUGSMIL CCC(C1=CC(=CC=C1)O)C(CC)C2=CC(=CC=C2)O D00AAU DRUGTYPE Small molecular drug D00AAU HIGHSTAT Investigative D00ABE DRUG__ID D00ABE D00ABE DRUGCLAS Clinical Trial Drug(s) D00ABE DRUGCOMP Aldagen Durham, NC D00ABE HIGHSTAT Phase 2 D00ABO DRUG__ID D00ABO D00ABO DRUGCLAS Clinical Trial Drug(s) D00ABO DRUGCOMP Kyowa Hakko Kogyo Co Ltd D00ABO DRUGINCH 1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+ D00ABO DRUGINKE YYLKKYCXAOBSRM-JXMROGBWSA-N D00ABO DRUGSMIL C1CN(CCN1)C(=O)C2=CC=C(C=C2)C=CC3=NNC4=CC=CC=C43 D00ABO DRUGTYPE Small molecular drug D00ABO HIGHSTAT Phase 1 D00ABW DRUG__ID D00ABW D00ABW DRUGCLAS Discontinued Drug(s) D00ABW DRUGCOMP MacroChem Corporation D00ABW HIGHSTAT Discontinued in Phase 1 D00ACC DRUG__ID D00ACC D00ACC DRUGCLAS Discontinued Drug(s) D00ACC DRUGCOMP Neuro3d D00ACC DRUGINCH 1S/C26H31N3O/c30-25-26(29(18-27-25)21-9-2-1-3-10-21)14-16-28(17-15-26)23-13-12-20-7-4-6-19-8-5-11-22(23)24(19)20/h1-3,5,8-11,20,23H,4,6-7,12-18H2,(H,27,30)/t20-,23-/m0/s1 D00ACC DRUGINKE JLFMYEAXZNPWBK-REWPJTCUSA-N D00ACC DRUGSMIL C1CC2CCC(C3=CC=CC(=C23)C1)N4CCC5(CC4)C(=O)NCN5C6=CC=CC=C6 D00ACC DRUGTYPE Small molecular drug D00ACC HIGHSTAT Discontinued in Phase 1 D00ACH DRUG__ID D00ACH D00ACH DRUGCLAS Discontinued Drug(s) D00ACH DRUGCOMP Aventis Pharma AG D00ACH HIGHSTAT Terminated D00ACL DRUG__ID D00ACL D00ACL DRUGCLAS Patented Agent(s) D00ACL DRUGCOMP KARUS THERAPEUTICS LTD D00ACL DRUGINCH 1S/C16H13FN6O2/c17-13-7-11(16(24)22-25)1-2-12(13)10-23(14-8-18-3-5-20-14)15-9-19-4-6-21-15/h1-9,25H,10H2,(H,22,24) D00ACL DRUGINKE PLETUCDALFTIQN-UHFFFAOYSA-N D00ACL DRUGSMIL C1=CC(=C(C=C1C(=O)NO)F)CN(C2=NC=CN=C2)C3=NC=CN=C3 D00ACL DRUGTYPE Small molecular drug D00ACL HIGHSTAT Patented D00ACP DRUG__ID D00ACP D00ACP DRUGCLAS Investigative Drug(s) D00ACP DRUGCOMP Iterative Therapeutics Inc D00ACP DRUGTYPE Monoclonal antibody D00ACP HIGHSTAT Investigative D00ACX DRUG__ID D00ACX D00ACX DRUGCLAS Investigative Drug(s) D00ACX DRUGINCH 1S/C13H9ClN2O3/c14-12-7-6-10(16(18)19)8-11(12)13(17)15-9-4-2-1-3-5-9/h1-8H,(H,15,17) D00ACX DRUGINKE DNTSIBUQMRRYIU-UHFFFAOYSA-N D00ACX DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=C(C=CC(=C2)[N+](=O)[O-])Cl D00ACX DRUGTYPE Small molecular drug D00ACX HIGHSTAT Investigative D00ADV DRUG__ID D00ADV D00ADV DRUGCLAS Discontinued Drug(s) D00ADV DRUGCOMP Wyeth Research D00ADV HIGHSTAT Terminated D00AEQ DRUG__ID D00AEQ D00AEQ DRUADIID FDA-AP-BF04-00195 D00AEQ DRUGCLAS Approved Drug(s) D00AEQ DRUGCOMP Bristol Myers Squibb D00AEQ DRUGINCH 1S/C21H30O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h12,16-18,24H,4-11H2,1-3H3/t16-,17+,18+,19+,20+,21+/m1/s1 D00AEQ DRUGINKE DBPWSSGDRRHUNT-CEGNMAFCSA-N D00AEQ DRUGSMIL CC(=O)C1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O D00AEQ DRUGTYPE Small molecular drug D00AEQ HIGHSTAT Approved D00AES DRUG__ID D00AES D00AES DRUGCLAS Clinical Trial Drug(s) D00AES DRUGCOMP Cantex Pharmaceuticals Weston, FL D00AES HIGHSTAT Phase 2 D00AEV DRUG__ID D00AEV D00AEV DRUGCLAS Approved Drug(s) D00AEV HIGHSTAT Approved D00AEX DRUG__ID D00AEX D00AEX DRUGCLAS Investigative Drug(s) D00AEX DRUGINCH 1S/C14H19N3O/c1-2-3-4-5-10-18-14-7-6-13(11-16-14)17-9-8-15-12-17/h6-9,11-12H,2-5,10H2,1H3 D00AEX DRUGINKE DCDHWTNKKCKJLQ-UHFFFAOYSA-N D00AEX DRUGSMIL CCCCCCOC1=NC=C(C=C1)N2C=CN=C2 D00AEX DRUGTYPE Small molecular drug D00AEX HIGHSTAT Investigative D00AHD DRUG__ID D00AHD D00AHD DRUGCLAS Investigative Drug(s) D00AHD DRUGINCH 1S/C27H17NOS/c29-27(26-20-11-3-1-9-18(20)17-19-10-2-4-12-21(19)26)28-22-13-5-7-15-24(22)30-25-16-8-6-14-23(25)28/h1-17H D00AHD DRUGINKE GEDDVJWUHICGPI-UHFFFAOYSA-N D00AHD DRUGSMIL C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C(=O)N4C5=CC=CC=C5SC6=CC=CC=C64 D00AHD DRUGTYPE Small molecular drug D00AHD HIGHSTAT Investigative D00AHT DRUG__ID D00AHT D00AHT DRUGCLAS Clinical Trial Drug(s) D00AHT DRUGCOMP GlaxoSmithKline D00AHT HIGHSTAT Phase 1 D00AHV DRUG__ID D00AHV D00AHV DRUGCLAS Investigative Drug(s) D00AHV DRUGCOMP SK Life Science D00AHV HIGHSTAT Investigative D00AII DRUG__ID D00AII D00AII DRUGCLAS Investigative Drug(s) D00AII DRUGINCH 1S/C16H16O3/c1-18-15-9-13(10-16(11-15)19-2)4-3-12-5-7-14(17)8-6-12/h3-11,17H,1-2H3/b4-3+ D00AII DRUGINKE VLEUZFDZJKSGMX-ONEGZZNKSA-N D00AII DRUGSMIL COC1=CC(=CC(=C1)C=CC2=CC=C(C=C2)O)OC D00AII DRUGTYPE Small molecular drug D00AII HIGHSTAT Investigative D00AIO DRUG__ID D00AIO D00AIO COMPCLAS Pyridoindole derivatives D00AIO DRUGCLAS Patented Agent(s) D00AIO DRUGCOMP UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA UNIVERSITE DE GENEVE UNIVERSITE CLAUDE BERNARD LYON 1 D00AIO DRUGINCH 1S/C18H14N2O/c1-21-13-8-6-12(7-9-13)14-10-11-19-18-17(14)15-4-2-3-5-16(15)20-18/h2-11H,1H3,(H,19,20) D00AIO DRUGINKE PJJCQNCRSXRPLV-UHFFFAOYSA-N D00AIO DRUGSMIL COC1=CC=C(C=C1)C2=C3C4=CC=CC=C4NC3=NC=C2 D00AIO DRUGTYPE Small molecular drug D00AIO HIGHSTAT Patented D00AIS DRUG__ID D00AIS D00AIS DRUGCLAS Investigative Drug(s) D00AIS DRUGCOMP Antisense Pharma GmbH D00AIS HIGHSTAT Investigative D00AIZ DRUG__ID D00AIZ D00AIZ DRUGCLAS Investigative Drug(s) D00AIZ DRUGCOMP Snowdon Inc D00AIZ HIGHSTAT Investigative D00AJB DRUG__ID D00AJB D00AJB DRUGCLAS Investigative Drug(s) D00AJB DRUGINCH 1S/C22H28N2O3/c1-4-14-9-13-11-22(21(25)27-3)19-16(7-8-24(12-13)20(14)22)17-10-15(26-2)5-6-18(17)23-19/h5-6,10,13-14,20,23H,4,7-9,11-12H2,1-3H3/t13-,14-,20-,22+/m0/s1 D00AJB DRUGINKE MMAYTCMMKJYIAM-RUGRQLENSA-N D00AJB DRUGSMIL CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC D00AJB DRUGTYPE Small molecular drug D00AJB HIGHSTAT Investigative D00AJF DRUG__ID D00AJF D00AJF DRUGCLAS Investigative Drug(s) D00AJF DRUGCOMP Isis Pharmaceuticals D00AJF DRUGTYPE Antisense drug D00AJF HIGHSTAT Investigative D00AJI DRUG__ID D00AJI D00AJI DRUGCLAS Discontinued Drug(s) D00AJI DRUGCOMP Pfizer Inc D00AJI HIGHSTAT Discontinued in Phase 2 D00AJS DRUG__ID D00AJS D00AJS DRUGCLAS Investigative Drug(s) D00AJS DRUGCOMP Allinky Biopharma D00AJS HIGHSTAT Investigative D00AKL DRUG__ID D00AKL D00AKL DRUGCLAS Clinical Trial Drug(s) D00AKL DRUGCOMP Eurocine Vaccines AB D00AKL HIGHSTAT Phase 2 D00AKQ DRUG__ID D00AKQ D00AKQ DRUGCLAS Clinical Trial Drug(s) D00AKQ DRUGCOMP ParinGenix D00AKQ HIGHSTAT Phase 2 D00AKR DRUG__ID D00AKR D00AKR DRUGCLAS Clinical Trial Drug(s) D00AKR DRUGCOMP Amgen D00AKR HIGHSTAT Phase 2 D00AKV DRUG__ID D00AKV D00AKV DRUGCLAS Clinical Trial Drug(s) D00AKV DRUGCOMP GNI Ltd D00AKV DRUGINCH 1S/C12H11NO2/c1-9-2-7-12(15)13(8-9)10-3-5-11(14)6-4-10/h2-8,14H,1H3 D00AKV DRUGINKE NETTXQJYJRFTFS-UHFFFAOYSA-N D00AKV DRUGSMIL CC1=CN(C(=O)C=C1)C2=CC=C(C=C2)O D00AKV DRUGTYPE Small molecular drug D00AKV HIGHSTAT Phase 2 D00AKY DRUG__ID D00AKY D00AKY DRUGCLAS Discontinued Drug(s) D00AKY DRUGINCH 1S/C26H34O4S/c27-25(28)17-18-31-24(20-26(29)30)23-16-10-15-22(19-23)14-7-4-2-1-3-6-11-21-12-8-5-9-13-21/h5,8-10,12-13,15-16,19,24H,1-4,6-7,11,14,17-18,20H2,(H,27,28)(H,29,30)/t24-/m0/s1 D00AKY DRUGINKE IEOUXQMKLRALNJ-DEOSSOPVSA-N D00AKY DRUGSMIL C1=CC=C(C=C1)CCCCCCCCC2=CC(=CC=C2)C(CC(=O)O)SCCC(=O)O D00AKY HIGHSTAT Discontinued in Phase 2 D00ALE DRUG__ID D00ALE D00ALE DRUGCLAS Approved Drug(s) D00ALE DRUGCOMP Sanofi Pasteur D00ALE HIGHSTAT Approved D00ALJ DRUG__ID D00ALJ D00ALJ DRUGCLAS Clinical Trial Drug(s) D00ALJ DRUGCOMP Pervasis Therapeutics D00ALJ HIGHSTAT Phase 2 D00ALX DRUG__ID D00ALX D00ALX DRUGCLAS Patented Agent(s) D00ALX DRUGCOMP Merck Sharp & Dohme Corp D00ALX DRUGTYPE Small molecular drug D00ALX HIGHSTAT Patented D00AMQ DRUG__ID D00AMQ D00AMQ DRUGCLAS Approved Drug(s) D00AMQ DRUGINCH 1S/C2H6O/c1-2-3/h3H,2H2,1H3 D00AMQ DRUGINKE LFQSCWFLJHTTHZ-UHFFFAOYSA-N D00AMQ DRUGSMIL CCO D00AMQ DRUGTYPE Small molecular drug D00AMQ HIGHSTAT Approved D00AMQ THERCLAS Analgesics D00ANG DRUG__ID D00ANG D00ANG DRUGCLAS Clinical Trial Drug(s) D00ANG DRUGCOMP Medgenics D00ANG HIGHSTAT Phase 1/2 D00ANJ DRUG__ID D00ANJ D00ANJ DRUGCLAS Investigative Drug(s) D00ANJ DRUGINCH 1S/C20H29NO2/c1-2-3-4-5-6-7-8-9-10-13-16-21-18-15-12-11-14-17(18)19(22)20(21)23/h11-12,14-15H,2-10,13,16H2,1H3 D00ANJ DRUGINKE GQEQKTGRIPEAKW-UHFFFAOYSA-N D00ANJ DRUGSMIL CCCCCCCCCCCCN1C2=CC=CC=C2C(=O)C1=O D00ANJ DRUGTYPE Small molecular drug D00ANJ HIGHSTAT Investigative D00AOJ DRUG__ID D00AOJ D00AOJ DRUGCLAS Approved Drug(s) D00AOJ DRUGCOMP Avanir Pharmaceuticals D00AOJ DRUGINCH 1S/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H3 D00AOJ DRUGINKE NOPFSRXAKWQILS-UHFFFAOYSA-N D00AOJ DRUGSMIL CCCCCCCCCCCCCCCCCCCCCCO D00AOJ DRUGTYPE Small molecular drug D00AOJ HIGHSTAT Approved D00AOJ THERCLAS Antiviral Agents D00AON DRUG__ID D00AON D00AON DRUGCLAS Investigative Drug(s) D00AON DRUGINCH 1S/C18H25NO5S/c1-2-3-4-5-6-7-8-9-14-13-17(20)16-12-15(24-25(19,21)22)10-11-18(16)23-14/h10-13H,2-9H2,1H3,(H2,19,21,22) D00AON DRUGINKE ATSLCAISNROVSQ-UHFFFAOYSA-N D00AON DRUGSMIL CCCCCCCCCC1=CC(=O)C2=C(O1)C=CC(=C2)OS(=O)(=O)N D00AON DRUGTYPE Small molecular drug D00AON HIGHSTAT Investigative D00APD DRUG__ID D00APD D00APD DRUGCLAS Investigative Drug(s) D00APD DRUGINCH 1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-7-10(15)3-4-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3 D00APD DRUGINKE WUQMRWPLIMXBDX-UHFFFAOYSA-N D00APD DRUGSMIL CN(C)CCC1=CNC2=C1C=CC(=C2)O D00APD DRUGTYPE Small molecular drug D00APD HIGHSTAT Investigative D00AQP DRUG__ID D00AQP D00AQP DRUGCLAS Investigative Agents D00AQP DRUGTYPE Combination drug D00AQP HIGHSTAT Investigative D00AQP THERCLAS Antiviral Agents D00AQR DRUG__ID D00AQR D00AQR DRUGCLAS Investigative Drug(s) D00AQR DRUGINCH 1S/C17H12ClN5OS/c1-24-15(19)17-23-12-7-6-11-13(14(12)25-17)16(21-8-20-11)22-10-4-2-9(18)3-5-10/h2-8,19H,1H3,(H,20,21,22) D00AQR DRUGINKE BGXZIBSLBRKDTP-UHFFFAOYSA-N D00AQR DRUGSMIL COC(=N)C1=NC2=C(S1)C3=C(C=C2)N=CN=C3NC4=CC=C(C=C4)Cl D00AQR DRUGTYPE Small molecular drug D00AQR HIGHSTAT Investigative D00AQV DRUG__ID D00AQV D00AQV DRUGCLAS Investigative Drug(s) D00AQV DRUGCOMP Critical Outcome Technologies Inc D00AQV HIGHSTAT Investigative D00AQW DRUG__ID D00AQW D00AQW DRUGCLAS Patented Agent(s) D00AQW DRUGCOMP Zhejiang University D00AQW DRUGTYPE Small molecular drug D00AQW HIGHSTAT Patented D00AQY DRUG__ID D00AQY D00AQY DRUGCLAS Preclinical Drug(s) D00AQY DRUGCOMP Amgen D00AQY HIGHSTAT Preclinical D00ARM DRUG__ID D00ARM D00ARM DRUGCLAS Investigative Drug(s) D00ARM DRUGINCH 1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1 D00ARM DRUGINKE QZHBYNSSDLTCRG-LREBCSMRSA-N D00ARM DRUGSMIL C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O D00ARM DRUGTYPE Small molecular drug D00ARM HIGHSTAT Investigative D00ARN DRUG__ID D00ARN D00ARN DRUGCLAS Discontinued Drug(s) D00ARN DRUGCOMP Discovery Laboratories D00ARN DRUGINCH 1S/C14H22O.C2H4O.CH2O/c1-13(2,3)10-14(4,5)11-6-8-12(15)9-7-11;1-2-3-1;1-2/h6-9,15H,10H2,1-5H3;1-2H2;1H2 D00ARN DRUGINKE MDYZKJNTKZIUSK-UHFFFAOYSA-N D00ARN DRUGSMIL CC(C)(C)CC(C)(C)C1=CC=C(C=C1)O.C=O.C1CO1 D00ARN DRUGTYPE Small molecular drug D00ARN HIGHSTAT Terminated D00ARS DRUG__ID D00ARS D00ARS DRUGCLAS Clinical Trial Drug(s) D00ARS DRUGCOMP Mercia Pharma Inc D00ARS HIGHSTAT Phase 2 D00ASA DRUG__ID D00ASA D00ASA DRUGCLAS Investigative Drug(s) D00ASA DRUGINCH 1S/C15H9ClO2/c16-11-5-3-4-10(8-11)15-9-13(17)12-6-1-2-7-14(12)18-15/h1-9H D00ASA DRUGINKE JWTQJUQJIRWZLA-UHFFFAOYSA-N D00ASA DRUGSMIL C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC(=CC=C3)Cl D00ASA DRUGTYPE Small molecular drug D00ASA HIGHSTAT Investigative D00ASH DRUG__ID D00ASH D00ASH DRUGCLAS Investigative Drug(s) D00ASH DRUGINCH 1S/C12H15NO4/c1-12(13,11(15)16)7-10(14)8-4-3-5-9(6-8)17-2/h3-6H,7,13H2,1-2H3,(H,15,16) D00ASH DRUGINKE WRBHWPHQKJOLHX-UHFFFAOYSA-N D00ASH DRUGSMIL CC(CC(=O)C1=CC(=CC=C1)OC)(C(=O)O)N D00ASH DRUGTYPE Small molecular drug D00ASH HIGHSTAT Investigative D00ASJ DRUG__ID D00ASJ D00ASJ DRUGCLAS Approved Drug(s) D00ASJ DRUGCOMP SmithKline Beecham plc D00ASJ HIGHSTAT Approved D00ASL DRUG__ID D00ASL D00ASL DRUGCLAS Investigative Drug(s) D00ASL DRUGINCH 1S/C34H56O3/c1-9-10-19-37-28(36)34-17-15-29(2,3)22-25(34)24-11-12-27-31(6)21-23(35)20-30(4,5)26(31)13-14-33(27,8)32(24,7)16-18-34/h11,23,25-27,35H,9-10,12-22H2,1-8H3/t23-,25+,26+,27-,31+,32-,33-,34+/m1/s1 D00ASL DRUGINKE UZTYAEIRVQJQQC-XXJJMGNBSA-N D00ASL DRUGSMIL CCCCOC(=O)C12CCC(CC1C3=CCC4C(C3(CC2)C)(CCC5C4(CC(CC5(C)C)O)C)C)(C)C D00ASL DRUGTYPE Small molecular drug D00ASL HIGHSTAT Investigative D00ASX DRUG__ID D00ASX D00ASX DRUGCLAS Investigative Drug(s) D00ASX DRUGCOMP Chodang Pharm Co Ltd D00ASX HIGHSTAT Investigative D00ASZ DRUG__ID D00ASZ D00ASZ DRUGCLAS Investigative Drug(s) D00ASZ DRUGINCH 1S/C16H20N6O5/c17-13-10-14(21-16(20-13)26-4-2-8-1-3-18-5-8)22(7-19-10)15-12(25)11(24)9(6-23)27-15/h1,3,5,7,9,11-12,15,18,23-25H,2,4,6H2,(H2,17,20,21)/t9-,11-,12-,15-/m1/s1 D00ASZ DRUGINKE OBDCLFIHFXHMSJ-SDBHATRESA-N D00ASZ DRUGSMIL C1=CNC=C1CCOC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D00ASZ DRUGTYPE Small molecular drug D00ASZ HIGHSTAT Investigative D00ATA DRUG__ID D00ATA D00ATA DRUGCLAS Investigative Drug(s) D00ATA DRUGINCH 1S/C13H10N2O/c16-13-11(8-9-4-3-7-14-9)10-5-1-2-6-12(10)15-13/h1-8,14H,(H,15,16)/b11-8- D00ATA DRUGINKE SEZFNTZQMWJIAI-FLIBITNWSA-N D00ATA DRUGSMIL C1=CC=C2C(=C1)C(=CC3=CC=CN3)C(=O)N2 D00ATA DRUGTYPE Small molecular drug D00ATA HIGHSTAT Investigative D00AUC DRUG__ID D00AUC D00AUC DRUGCLAS Clinical Trial Drug(s) D00AUC DRUGINCH 1S/6C6H9NO2.Tc/c6*1-6(2,7-3)5(8)9-4;/h6*1-2,4H3;/i;;;;;;1+1 D00AUC DRUGINKE JECHAWIBZCKPHF-KTTJZPQESA-N D00AUC DRUGSMIL CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].[Tc] D00AUC DRUGTYPE Small molecular drug D00AUC HIGHSTAT Phase 2 D00AUM DRUG__ID D00AUM D00AUM DRUGCLAS Investigative Drug(s) D00AUM DRUGCOMP Aquilus Pharmaceuticals Inc D00AUM HIGHSTAT Investigative D00AUX DRUG__ID D00AUX D00AUX DRUGCLAS Clinical Trial Drug(s) D00AUX DRUGCOMP Metabolic Solutions Development D00AUX DRUGINCH 1S/C19H17NO5S/c1-24-15-4-2-3-13(10-15)16(21)11-25-14-7-5-12(6-8-14)9-17-18(22)20-19(23)26-17/h2-8,10,17H,9,11H2,1H3,(H,20,22,23) D00AUX DRUGINKE YAUMOGALQJYOJQ-UHFFFAOYSA-N D00AUX DRUGSMIL COC1=CC=CC(=C1)C(=O)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 D00AUX DRUGTYPE Small molecular drug D00AUX HIGHSTAT Phase 2 D00AUZ DRUG__ID D00AUZ D00AUZ DRUGCLAS Investigative Drug(s) D00AUZ DRUGCOMP TransGenex Nanobiotech Inc D00AUZ HIGHSTAT Investigative D00AVG DRUG__ID D00AVG D00AVG DRUGCLAS Investigative Drug(s) D00AVG DRUGCOMP Genexine Co Ltd D00AVG HIGHSTAT Investigative D00AVH DRUG__ID D00AVH D00AVH DRUGCLAS Clinical Trial Drug(s) D00AVH DRUGCOMP Ventria bioscience D00AVH HIGHSTAT Phase 2 D00AVR DRUG__ID D00AVR D00AVR DRUGCLAS Investigative Drug(s) D00AVR DRUGINCH 1S/C14H14N4O/c1-17-12(13(19)18(2)14(17)15)7-9-8-16-11-6-4-3-5-10(9)11/h3-8,15,19H,1-2H3/b9-7+,15-14? D00AVR DRUGINKE CYKDGQFRORUDQP-YHUDWFPJSA-N D00AVR DRUGSMIL CN1C(=C(N(C1=N)C)O)C=C2C=NC3=CC=CC=C32 D00AVR DRUGTYPE Small molecular drug D00AVR HIGHSTAT Investigative D00AVS DRUG__ID D00AVS D00AVS DRUGCLAS Investigative Drug(s) D00AVS HIGHSTAT Investigative D00AVT DRUG__ID D00AVT D00AVT DRUGCLAS Investigative Drug(s) D00AVT DRUGINCH 1S/C10H14O/c1-8(2)10-5-3-9(7-11)4-6-10/h3,7,10H,1,4-6H2,2H3 D00AVT DRUGINKE RUMOYJJNUMEFDD-UHFFFAOYSA-N D00AVT DRUGSMIL CC(=C)C1CCC(=CC1)C=O D00AVT DRUGTYPE Small molecular drug D00AVT HIGHSTAT Investigative D00AWA DRUG__ID D00AWA D00AWA DRUGCLAS Discontinued Drug(s) D00AWA DRUGCOMP Sterling Winthrop Group Ltd D00AWA DRUGINCH 1S/C25H28Cl2N2O8S/c1-15(2)17-12-16(34-3)13-20-21(17)24(30)29(38(20,32)33)14-37-25(31)22-18(26)4-5-19(23(22)27)36-11-8-28-6-9-35-10-7-28/h4-5,12-13,15H,6-11,14H2,1-3H3 D00AWA DRUGINKE AGROLWZEYXFDEB-UHFFFAOYSA-N D00AWA DRUGSMIL CC(C)C1=C2C(=CC(=C1)OC)S(=O)(=O)N(C2=O)COC(=O)C3=C(C=CC(=C3Cl)OCCN4CCOCC4)Cl D00AWA DRUGTYPE Small molecular drug D00AWA HIGHSTAT Terminated D00AWM DRUG__ID D00AWM D00AWM DRUGCLAS Investigative Drug(s) D00AWM DRUGINCH 1S/C25H24ClN3O3S/c1-31-22-14-19(8-9-21(22)32-13-12-28-10-2-3-11-28)29-16-27-20-15-23(33-24(20)25(29)30)17-4-6-18(26)7-5-17/h4-9,14-16H,2-3,10-13H2,1H3 D00AWM DRUGINKE MWULMTACIBZPGN-UHFFFAOYSA-N D00AWM DRUGSMIL COC1=C(C=CC(=C1)N2C=NC3=C(C2=O)SC(=C3)C4=CC=C(C=C4)Cl)OCCN5CCCC5 D00AWM DRUGTYPE Small molecular drug D00AWM HIGHSTAT Investigative D00AWT DRUG__ID D00AWT D00AWT DRUGCLAS Approved Drug(s) D00AWT DRUGCOMP Sanofi-Aventis D00AWT DRUGINCH 1S/C21H23N3OS/c22-15-16-6-7-21-19(14-16)24(18-4-1-2-5-20(18)26-21)11-3-10-23-12-8-17(25)9-13-23/h1-2,4-7,14,17,25H,3,8-13H2 D00AWT DRUGINKE LUALIOATIOESLM-UHFFFAOYSA-N D00AWT DRUGSMIL C1CN(CCC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C#N D00AWT DRUGTYPE Small molecular drug D00AWT HIGHSTAT Approved D00AWT THERCLAS Antipsychotic Agents D00AXG DRUG__ID D00AXG D00AXG DRUGCLAS Investigative Drug(s) D00AXG DRUGCOMP Summit Corp plc D00AXG HIGHSTAT Investigative D00AXJ DRUG__ID D00AXJ D00AXJ DRUGCLAS Approved Drug(s) D00AXJ DRUGCOMP Janssen Pharmaceutica D00AXJ DRUGINCH 1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2 D00AXJ DRUGINKE BYBLEWFAAKGYCD-UHFFFAOYSA-N D00AXJ DRUGSMIL C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl D00AXJ DRUGTYPE Small molecular drug D00AXJ HIGHSTAT Approved D00AXJ THERCLAS Antifungal Agents D00AXT DRUG__ID D00AXT D00AXT DRUGCLAS Investigative Drug(s) D00AXT DRUGCOMP State University of New York Stony Brook D00AXT HIGHSTAT Investigative D00AXZ DRUG__ID D00AXZ D00AXZ DRUGCLAS Investigative Drug(s) D00AXZ DRUGCOMP Glycadia Inc D00AXZ HIGHSTAT Investigative D00AYA DRUG__ID D00AYA D00AYA DRUGCLAS Clinical Trial Drug(s) D00AYA DRUGINCH 1S/C47H51NO15/c1-25-30(61-42(55)35(51)34(27-16-10-7-11-17-27)48-40(53)28-18-12-8-13-19-28)23-47(57)39(62-41(54)29-20-14-9-15-21-29)37-45(5,38(52)36(60-26(2)49)33(25)44(47,3)4)31(50)22-32-46(37,24-59-32)63-43(56)58-6/h7-21,30-32,34-37,39,50-51,57H,22-24H2,1-6H3,(H,48,53)/t30-,31-,32+,34-,35+,36+,37-,39-,45+,46-,47+/m0/s1 D00AYA DRUGINKE GMJWGJSDPOAZTP-MIDYMNAOSA-N D00AYA DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)OC)O)C)OC(=O)C D00AYA DRUGTYPE Small molecular drug D00AYA HIGHSTAT Phase 2 D00AYW DRUG__ID D00AYW D00AYW DRUGCLAS Clinical Trial Drug(s) D00AYW DRUGCOMP Hua Medicine Shanghai, China D00AYW DRUGINCH 1S/C22H27ClN4O5/c1-14(2)9-18(22(31)24-20-7-8-26(25-20)11-15(29)13-28)27-12-16(10-21(27)30)32-19-6-4-3-5-17(19)23/h3-8,10,14-15,18,28-29H,9,11-13H2,1-2H3,(H,24,25,31)/t15-,18+/m1/s1 D00AYW DRUGINKE HMUMWSORCUWQJO-QAPCUYQASA-N D00AYW DRUGSMIL CC(C)CC(C(=O)NC1=NN(C=C1)CC(CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl D00AYW HIGHSTAT Phase 1 D00BAJ DRUG__ID D00BAJ D00BAJ DRUGCLAS Investigative Drug(s) D00BAJ DRUGINCH 1S/C15H13Cl2N3O2/c1-3-22-15(21)14-11(8(6-18)7-19)9-4-5-10(16)12(17)13(9)20(14)2/h4-6H,3,18H2,1-2H3/b8-6- D00BAJ DRUGINKE CXJCGSPAPOTTSF-VURMDHGXSA-N D00BAJ DRUGSMIL CCOC(=O)C1=C(C2=C(N1C)C(=C(C=C2)Cl)Cl)C(=CN)C#N D00BAJ DRUGTYPE Small molecular drug D00BAJ HIGHSTAT Investigative D00BBB DRUG__ID D00BBB D00BBB DRUGCLAS Investigative Drug(s) D00BBB DRUGCOMP MicroDose Therapeutx Inc D00BBB HIGHSTAT Investigative D00BCG DRUG__ID D00BCG D00BCG DRUADIID FDA-AP-BF04-00184 D00BCG DRUGCLAS Approved Drug(s) D00BCG DRUGCOMP Zeneca Pharmaceuticals D00BCG DRUGINCH 1S/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-/m0/s1 D00BCG DRUGINKE BLCLNMBMMGCOAS-URPVMXJPSA-N D00BCG DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6 D00BCG DRUGTYPE Small molecular drug D00BCG HIGHSTAT Approved D00BCG THERCLAS Anticancer Agents D00BCO DRUG__ID D00BCO D00BCO DRUGCLAS Investigative Drug(s) D00BCO DRUGINCH 1S/C71H98N20O19S3/c1-9-34(4)56(81-37(7)93)66(106)87-50-31-113-112-30-49(65(105)90-57(36(6)92)68(108)109)86-60(100)44(18-14-22-76-70(73)74)82-62(102)47(24-39-27-75-32-79-39)83-58(98)35(5)80-53(95)28-78-59(99)46(23-38-26-77-43-17-12-10-15-40(38)43)84-63(103)48(25-54(96)97)85-61(101)45(20-21-52(72)94)88-69(110)71(8,42-29-111-51-19-13-11-16-41(42)51)91-67(107)55(33(2)3)89-64(50)104/h10-13,15-17,19,26-27,29,32-36,44-50,55-57,77,92H,9,14,18,20-25,28,30-31H2,1-8H3,(H2,72,94)(H,75,79)(H,78,99)(H,80,95)(H,81,93)(H,82,102)(H,83,98)(H,84,103)(H,85,101)(H,86,100)(H,87,106)(H,88,110)(H,89,104)(H,90,105)(H,91,107)(H,96,97)(H,108,109)(H4,73,74,76)/t34-,35-,36+,44-,45-,46-,47+,48+,49-,50-,55-,56-,57-,71-/m0/s1 D00BCO DRUGINKE JSPKWLRQUPIDRS-NWJDZPOUSA-N D00BCO DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)(C)C2=CSC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D00BCO HIGHSTAT Investigative D00BCP DRUG__ID D00BCP D00BCP DRUGCLAS Approved Drug(s) D00BCP DRUGINCH 1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14) D00BCP DRUGINKE RKWGIWYCVPQPMF-UHFFFAOYSA-N D00BCP DRUGSMIL CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl D00BCP DRUGTYPE Small molecular drug D00BCP HIGHSTAT Approved D00BCP THERCLAS Hypoglycemic Agents D00BCS DRUG__ID D00BCS D00BCS DRUGCLAS Investigative Drug(s) D00BCS DRUGCOMP IntelGenx Corp D00BCS HIGHSTAT Investigative D00BCZ DRUG__ID D00BCZ D00BCZ DRUGCLAS Investigative Drug(s) D00BCZ DRUGCOMP Xaragen Pharma Ltd D00BCZ HIGHSTAT Investigative D00BDC DRUG__ID D00BDC D00BDC DRUGCLAS Approved Drug(s) D00BDC DRUGINCH 1S/C19H20F3N3O3/c20-19(21,22)14-3-1-4-15(13-14)24-17-16(5-2-6-23-17)18(26)28-12-9-25-7-10-27-11-8-25/h1-6,13H,7-12H2,(H,23,24) D00BDC DRUGINKE LDXSPUSKBDTEKA-UHFFFAOYSA-N D00BDC DRUGSMIL C1COCCN1CCOC(=O)C2=C(N=CC=C2)NC3=CC=CC(=C3)C(F)(F)F D00BDC DRUGTYPE Small molecular drug D00BDC HIGHSTAT Approved D00BEA DRUG__ID D00BEA D00BEA DRUGCLAS Investigative Drug(s) D00BEA DRUGINCH 1S/C22H34O5/c1-8-20(5)12-14(24)16-21(6)11-9-10-19(3,4)17(21)15(25)18(26-13(2)23)22(16,7)27-20/h8,15-18,25H,1,9-12H2,2-7H3/t15-,16+,17-,18-,20-,21+,22-/m0/s1 D00BEA DRUGINKE ZKZMDXUDDJYAIB-SUCLLAFCSA-N D00BEA DRUGSMIL CC(=O)OC1C(C2C(CCCC2(C3C1(OC(CC3=O)(C)C=C)C)C)(C)C)O D00BEA DRUGTYPE Small molecular drug D00BEA HIGHSTAT Investigative D00BEJ DRUG__ID D00BEJ D00BEJ DRUGCLAS Patented Agent(s) D00BEJ DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHGIAN NIKOLOVSKA-COLESKA, Zaneta SHOWALTER, Hollis D. LIAO, Chenzhong MOHAMMAD, Ramzi ABULWERDI, Fardokht WAYNE STATE UNIVERSITY D00BEJ DRUGTYPE Small molecular drug D00BEJ HIGHSTAT Patented D00BEM DRUG__ID D00BEM D00BEM DRUGCLAS Investigative Drug(s) D00BEM DRUGINCH 1S/C15H12N2O/c1-10-4-2-5-11(8-10)13-9-14(18)12-6-3-7-16-15(12)17-13/h2-9H,1H3,(H,16,17,18) D00BEM DRUGINKE IZFIIAGLKAXALT-UHFFFAOYSA-N D00BEM DRUGSMIL CC1=CC(=CC=C1)C2=CC(=O)C3=C(N2)N=CC=C3 D00BEM DRUGTYPE Small molecular drug D00BEM HIGHSTAT Investigative D00BFF DRUG__ID D00BFF D00BFF COMPCLAS Benzothiazine derivatives D00BFF DRUGCLAS Patented Agent(s) D00BFF DRUGINCH 1S/C22H14Cl2N2O6S2/c23-15-2-1-3-16(24)14(15)11-34(31,32)13-5-7-20-17(10-13)25-22(28)21(33-20)9-12-4-6-19(27)18(8-12)26(29)30/h1-10,27H,11H2,(H,25,28)/b21-9- D00BFF DRUGINKE DOMBZVXKSRQDOJ-NKVSQWTQSA-N D00BFF DRUGSMIL C1=CC(=C(C(=C1)Cl)CS(=O)(=O)C2=CC3=C(C=C2)SC(=CC4=CC(=C(C=C4)O)[N+](=O)[O-])C(=O)N3)Cl D00BFF DRUGTYPE Small molecular drug D00BFF HIGHSTAT Patented D00BFT DRUG__ID D00BFT D00BFT DRUGCLAS Investigative Drug(s) D00BFT DRUGINCH 1S/C4H7NO2/c6-4(7)3-1-2-5-3/h3,5H,1-2H2,(H,6,7)/t3-/m0/s1 D00BFT DRUGINKE IADUEWIQBXOCDZ-VKHMYHEASA-N D00BFT DRUGSMIL C1CNC1C(=O)O D00BFT DRUGTYPE Small molecular drug D00BFT HIGHSTAT Investigative D00BGN DRUG__ID D00BGN D00BGN DRUGCLAS Investigative Drug(s) D00BGN DRUGINCH 1S/C9H8N2O2/c12-7-2-1-3-8(13)9(7)6-4-10-5-11-6/h1-5,12-13H,(H,10,11) D00BGN DRUGINKE VMNQZTQDHXFNPD-UHFFFAOYSA-N D00BGN DRUGSMIL C1=CC(=C(C(=C1)O)C2=CN=CN2)O D00BGN DRUGTYPE Small molecular drug D00BGN HIGHSTAT Investigative D00BHL DRUG__ID D00BHL D00BHL DRUGCLAS Clinical Trial Drug(s) D00BHL DRUGCOMP Endocyte D00BHL DRUGINCH 1S/C29H35N11O11S/c30-15(24(45)37-17(7-20(42)43)25(46)38-18(11-52)28(50)51)10-33-19(41)6-5-16(27(48)49)36-23(44)12-1-3-13(4-2-12)32-8-14-9-34-22-21(35-14)26(47)40-29(31)39-22/h1-4,9,15-18,32,52H,5-8,10-11,30H2,(H,33,41)(H,36,44)(H,37,45)(H,38,46)(H,42,43)(H,48,49)(H,50,51)(H3,31,34,39,40,47)/t15-,16+,17-,18-/m0/s1 D00BHL DRUGINKE RKGPQAGUQDVJHG-MHORFTMASA-N D00BHL DRUGSMIL C1=CC(=CC=C1C(=O)NC(CCC(=O)NCC(C(=O)NC(CC(=O)O)C(=O)NC(CS)C(=O)O)N)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N D00BHL DRUGTYPE Small molecular drug D00BHL HIGHSTAT Phase 3 D00BIE DRUG__ID D00BIE D00BIE DRUGCLAS Investigative Drug(s) D00BIE DRUGINCH 1S/C66H107N23O15/c1-37(55(95)84-46(25-16-30-76-65(71)72)59(99)83-43(54(70)94)22-10-13-27-67)80-58(98)44-24-12-15-29-75-50(91)34-49(62(102)81-38(2)56(96)85-47(26-17-31-77-66(73)74)61(101)87-45(60(100)86-44)23-11-14-28-68)88-64(104)53(39(3)90)89-63(103)48(33-41-20-8-5-9-21-41)82-52(93)36-78-51(92)35-79-57(97)42(69)32-40-18-6-4-7-19-40/h4-9,18-21,37-39,42-49,53,90H,10-17,22-36,67-69H2,1-3H3,(H2,70,94)(H,75,91)(H,78,92)(H,79,97)(H,80,98)(H,81,102)(H,82,93)(H,83,99)(H,84,95)(H,85,96)(H,86,100)(H,87,101)(H,88,104)(H,89,103)(H4,71,72,76)(H4,73,74,77)/t37-,38-,39+,42-,43-,44-,45-,46-,47-,48-,49-,53-/m0/s1 D00BIE DRUGINKE QRTPPIOAYQKBJN-WYNMOEERSA-N D00BIE DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(CCCCNC(=O)CC(C(=O)N1)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)CCCCN)CCCN=C(N)N D00BIE HIGHSTAT Investigative D00BIY DRUG__ID D00BIY D00BIY DRUGCLAS Discontinued Drug(s) D00BIY DRUGCOMP Novartis AG D00BIY DRUGINCH 1S/C26H30N6O/c1-3-5-11-23-22(26(33)28-24(27-23)12-6-4-2)17-18-13-15-19(16-14-18)20-9-7-8-10-21(20)25-29-31-32-30-25/h7-10,13-16H,3-6,11-12,17H2,1-2H3,(H,27,28,33)(H,29,30,31,32) D00BIY DRUGINKE UKEZYWUWLICNPR-UHFFFAOYSA-N D00BIY DRUGSMIL CCCCC1=C(C(=O)NC(=N1)CCCC)CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4 D00BIY DRUGTYPE Small molecular drug D00BIY HIGHSTAT Discontinued in Phase 1 D00BJV DRUG__ID D00BJV D00BJV DRUGCLAS Clinical Trial Drug(s) D00BJV DRUGCOMP Bristol-Myers Squibb Princeton, NJ D00BJV HIGHSTAT Phase 1/2 D00BKV DRUG__ID D00BKV D00BKV DRUGCLAS Discontinued Drug(s) D00BKV DRUGCOMP Asahi Kasei Pharma D00BKV HIGHSTAT Discontinued in Phase 1 D00BLD DRUG__ID D00BLD D00BLD DRUGCLAS Investigative Drug(s) D00BLD DRUGINCH 1S/C41H32O26/c42-17-1-12(2-18(43)28(17)52)36(57)62-11-27-33(64-37(58)13-3-19(44)29(53)20(45)4-13)34(65-38(59)14-5-21(46)30(54)22(47)6-14)35(66-39(60)15-7-23(48)31(55)24(49)8-15)41(63-27)67-40(61)16-9-25(50)32(56)26(51)10-16/h1-10,27,33-35,41-56H,11H2/t27-,33-,34+,35-,41?/m1/s1/i1D,3D,5D,7D,9D D00BLD DRUGINKE QJYNZEYHSMRWBK-GYNONJAESA-N D00BLD DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O D00BLD DRUGTYPE Small molecular drug D00BLD HIGHSTAT Investigative D00BLL DRUG__ID D00BLL D00BLL DRUGCLAS Approved Drug(s) D00BLL DRUGCOMP Pfizer D00BLL DRUGINCH 1S/C26H37NO3.C4H4O4/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6;5-3(6)1-2-4(7)8/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t23-;/m1./s1 D00BLL DRUGINKE MWHXMIASLKXGBU-RNCYCKTQSA-N D00BLL DRUGSMIL CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=CC(=O)O)C(=O)O D00BLL DRUGTYPE Small molecular drug D00BLL HIGHSTAT Approved D00BLS DRUG__ID D00BLS D00BLS DRUGCLAS Clinical Trial Drug(s) D00BLS DRUGCOMP AstraZeneca Wilmington, DE D00BLS HIGHSTAT Phase 1 D00BLY DRUG__ID D00BLY D00BLY DRUGCLAS Investigative Drug(s) D00BLY DRUGINCH 1S/C11H13NOS/c1-8(2)14-10-5-4-9(7-12)11(6-10)13-3/h4-6,8H,1-3H3 D00BLY DRUGINKE MIAOMCWVGGHYSA-UHFFFAOYSA-N D00BLY DRUGSMIL CC(C)SC1=CC(=C(C=C1)C#N)OC D00BLY DRUGTYPE Small molecular drug D00BLY HIGHSTAT Investigative D00BMF DRUG__ID D00BMF D00BMF DRUGCLAS Clinical Trial Drug(s) D00BMF DRUGCOMP Merck D00BMF DRUGINCH 1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1 D00BMF DRUGINKE PCHKPVIQAHNQLW-CQSZACIVSA-N D00BMF DRUGSMIL C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N D00BMF DRUGTYPE Small molecular drug D00BMF HIGHSTAT Phase 3 D00BMI DRUG__ID D00BMI D00BMI DRUGCLAS Investigative Drug(s) D00BMI DRUGINCH 1S/C2H4N4O2S2/c3-10(7,8)6-2-5-4-1-9-2/h1H,(H,5,6)(H2,3,7,8) D00BMI DRUGINKE TXIIDPYBTNXTDC-UHFFFAOYSA-N D00BMI DRUGSMIL C1=NN=C(S1)NS(=O)(=O)N D00BMI DRUGTYPE Small molecular drug D00BMI HIGHSTAT Investigative D00BMM DRUG__ID D00BMM D00BMM DRUGCLAS Investigative Drug(s) D00BMM DRUGCOMP Galera Therapeutics LLC D00BMM HIGHSTAT Investigative D00BND DRUG__ID D00BND D00BND DRUGCLAS Clinical Trial Drug(s) D00BND DRUGCOMP Biofrontera D00BND DRUGINCH 1S/C22H25NO2S/c1-4-25-16-8-9-17-20(14-16)26-19-7-5-6-18(24-3)22(19)21(17)15-10-12-23(2)13-11-15/h5-9,14H,4,10-13H2,1-3H3 D00BND DRUGINKE ANZVBVKYXOGOQC-UHFFFAOYSA-N D00BND DRUGSMIL CCOC1=CC2=C(C=C1)C(=C3CCN(CC3)C)C4=C(C=CC=C4S2)OC D00BND DRUGTYPE Small molecular drug D00BND HIGHSTAT Phase 1 D00BNE DRUG__ID D00BNE D00BNE DRUGCLAS Investigative Drug(s) D00BNE DRUGINCH 1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11-,12-/m0/s1 D00BNE DRUGINKE MSTNYGQPCMXVAQ-RYUDHWBXSA-N D00BNE DRUGSMIL C1C(NC2=C(N1)N=C(NC2=O)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D00BNE DRUGTYPE Small molecular drug D00BNE HIGHSTAT Investigative D00BOY DRUG__ID D00BOY D00BOY DRUGCLAS Clinical Trial Drug(s) D00BOY DRUGCOMP Cephalon D00BOY DRUGINCH 1S/C21H28BN3O5/c1-13(2)12-18(22(29)30)24-21(28)19(14(3)26)25-20(27)17-11-7-10-16(23-17)15-8-5-4-6-9-15/h4-11,13-14,18-19,26,29-30H,12H2,1-3H3,(H,24,28)(H,25,27)/t14?,18-,19-/m0/s1 D00BOY DRUGINKE SJFBTAPEPRWNKH-SQJZIBIZSA-N D00BOY DRUGSMIL B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O D00BOY DRUGTYPE Small molecular drug D00BOY HIGHSTAT Phase 2 D00BPA DRUG__ID D00BPA D00BPA DRUGCLAS Discontinued Drug(s) D00BPA DRUGINCH 1S/C15H18N6O/c1-21-10-18-12-13(17-9-11-5-3-2-4-6-11)19-15(16-7-8-22)20-14(12)21/h2-6,10,22H,7-9H2,1H3,(H2,16,17,19,20) D00BPA DRUGINKE GTVPOLSIJWJJNY-UHFFFAOYSA-N D00BPA DRUGSMIL CN1C=NC2=C(N=C(N=C21)NCCO)NCC3=CC=CC=C3 D00BPA DRUGTYPE Small molecular drug D00BPA HIGHSTAT Terminated D00BPE DRUG__ID D00BPE D00BPE DRUGCLAS Discontinued Drug(s) D00BPE DRUGCOMP ImmunoGen Inc D00BPE DRUGTYPE Antibody D00BPE HIGHSTAT Discontinued in Phase 2 D00BPH DRUG__ID D00BPH D00BPH DRUGCLAS Clinical Trial Drug(s) D00BPH DRUGCOMP Covagen/Johnson & Johnson D00BPH DRUGTYPE Monoclonal antibody D00BPH HIGHSTAT Phase 1/2a D00BQR DRUG__ID D00BQR D00BQR DRUGCLAS Patented Agent(s) D00BQR DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D00BQR DRUGINCH 1S/C11H12ClFN4O3/c12-11-15-8(14)4-1-2-17(9(4)16-11)10-6(13)7(19)5(3-18)20-10/h1-2,5-7,10,18-19H,3H2,(H2,14,15,16)/t5-,6+,7-,10-/m1/s1 D00BQR DRUGINKE VLXMLGCQJSJFSY-JTGULSINSA-N D00BQR DRUGSMIL C1=CN(C2=NC(=NC(=C21)N)Cl)C3C(C(C(O3)CO)O)F D00BQR DRUGTYPE Small molecular drug D00BQR HIGHSTAT Patented D00BRD DRUG__ID D00BRD D00BRD DRUGCLAS Patented Agent(s) D00BRD DRUGINCH 1S/C7H6O2/c8-5-6-1-3-7(9)4-2-6/h1-5,9H D00BRD DRUGINKE RGHHSNMVTDWUBI-UHFFFAOYSA-N D00BRD DRUGSMIL C1=CC(=CC=C1C=O)O D00BRD DRUGTYPE Small molecular drug D00BRD HIGHSTAT Patented D00BSX DRUG__ID D00BSX D00BSX DRUGCLAS Investigative Drug(s) D00BSX DRUGINCH 1S/C15H12O4/c1-7-2-8-4-9-5-10(16)6-12(18)14(9)15(19)13(8)11(17)3-7/h2-3,5-6,16-18H,4H2,1H3 D00BSX DRUGINKE LAJSXCAVRQXZIO-UHFFFAOYSA-N D00BSX DRUGSMIL CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2)C=C(C=C3O)O D00BSX DRUGTYPE Small molecular drug D00BSX HIGHSTAT Investigative D00BTW DRUG__ID D00BTW D00BTW DRUGCLAS Clinical Trial Drug(s) D00BTW DRUGCOMP Biosyn D00BTW DRUGINCH 1S/C17H18ClNO2S/c1-11(2)6-8-21-16-10-13(4-5-15(16)18)19-17(22)14-7-9-20-12(14)3/h4-7,9-10H,8H2,1-3H3,(H,19,22) D00BTW DRUGINKE YZHIXLCGPOTQNB-UHFFFAOYSA-N D00BTW DRUGSMIL CC1=C(C=CO1)C(=S)NC2=CC(=C(C=C2)Cl)OCC=C(C)C D00BTW DRUGTYPE Small molecular drug D00BTW HIGHSTAT Phase 1 D00BTZ DRUG__ID D00BTZ D00BTZ DRUGCLAS Investigative Drug(s) D00BTZ DRUGCOMP Cognition Therapeutics Inc D00BTZ HIGHSTAT Investigative D00BUO DRUG__ID D00BUO D00BUO DRUGCLAS Clinical Trial Drug(s) D00BUO HIGHSTAT Phase 2 D00BUR DRUG__ID D00BUR D00BUR DRUGCLAS Clinical Trial Drug(s) D00BUR DRUGCOMP Icagen D00BUR DRUGINCH 1S/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24) D00BUR DRUGINKE SCTZUZTYRMOMKT-UHFFFAOYSA-N D00BUR DRUGSMIL C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N D00BUR DRUGTYPE Small molecular drug D00BUR HIGHSTAT Phase 2 D00BVB DRUG__ID D00BVB D00BVB DRUGCLAS Clinical Trial Drug(s) D00BVB DRUGCOMP Sanofi Pasteur Swiftwater, PA D00BVB HIGHSTAT Phase 3 D00BVF DRUG__ID D00BVF D00BVF DRUGCLAS Discontinued Drug(s) D00BVF DRUGCOMP Iroko Pharmaceuticals D00BVF HIGHSTAT Discontinued in Phase 3 D00BVJ DRUG__ID D00BVJ D00BVJ DRUGCLAS Clinical Trial Drug(s) D00BVJ DRUGCOMP Emd serono; national cancer institute D00BVJ HIGHSTAT Phase 1 D00BVP DRUG__ID D00BVP D00BVP DRUGCLAS Investigative Drug(s) D00BVP DRUGINCH 1S/C20H16N2O3/c1-24-15-8-6-14(7-9-15)20-17(12-22-11-10-21-13-22)19(23)16-4-2-3-5-18(16)25-20/h2-11,13H,12H2,1H3 D00BVP DRUGINKE GMZSVBKZQWIFKJ-UHFFFAOYSA-N D00BVP DRUGSMIL COC1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)CN4C=CN=C4 D00BVP DRUGTYPE Small molecular drug D00BVP HIGHSTAT Investigative D00BVS DRUG__ID D00BVS D00BVS DRUGCLAS Clinical Trial Drug(s) D00BVS DRUGCOMP Pfizer New York, NY D00BVS DRUGTYPE Monoclonal antibody D00BVS HIGHSTAT Phase 3 D00BWF DRUG__ID D00BWF D00BWF DRUGCLAS Clinical Trial Drug(s) D00BWF DRUGCOMP ACADIA Pharmaceuticals D00BWF DRUGINCH 1S/C13H16N2S/c1-8-5-4-6-11(9(8)2)10(3)12-7-14-13(16)15-12/h4-7,10H,1-3H3,(H2,14,15,16)/t10-/m0/s1 D00BWF DRUGINKE WQXVKEDUCPMRRI-JTQLQIEISA-N D00BWF DRUGSMIL CC1=C(C(=CC=C1)C(C)C2=CNC(=S)N2)C D00BWF DRUGTYPE Small molecular drug D00BWF HIGHSTAT Phase 2 D00BWZ DRUG__ID D00BWZ D00BWZ DRUGCLAS Investigative Drug(s) D00BWZ DRUGINCH 1S/C14H13N3O/c18-14(16-12-5-3-8-15-10-12)17-9-7-11-4-1-2-6-13(11)17/h1-6,8,10H,7,9H2,(H,16,18) D00BWZ DRUGINKE ODXHNGJYIWHPAG-UHFFFAOYSA-N D00BWZ DRUGSMIL C1CN(C2=CC=CC=C21)C(=O)NC3=CN=CC=C3 D00BWZ DRUGTYPE Small molecular drug D00BWZ HIGHSTAT Investigative D00BXG DRUG__ID D00BXG D00BXG DRUGCLAS Investigative Drug(s) D00BXG DRUGINCH 1S/C37H40N4O5/c38-32(19-27-15-17-31(42)18-16-27)36(44)41-24-29-14-8-7-13-28(29)22-30(41)23-39-33(20-25-9-3-1-4-10-25)35(43)40-34(37(45)46)21-26-11-5-2-6-12-26/h1-18,30,32-34,39,42H,19-24,38H2,(H,40,43)(H,45,46)/t30-,32-,33-,34-/m0/s1 D00BXG DRUGINKE RPKMHCAOERKVEC-DYTOPAQESA-N D00BXG DRUGSMIL C1C(N(CC2=CC=CC=C21)C(=O)C(CC3=CC=C(C=C3)O)N)CNC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)O D00BXG DRUGTYPE Small molecular drug D00BXG HIGHSTAT Investigative D00BXK DRUG__ID D00BXK D00BXK COMPCLAS Pyrazole derivatives D00BXK DRUGCLAS Patented Agent(s) D00BXK DRUGCOMP 7TM PHARMA A/S RECEVEUR, Jean-Marie NIELSEN, Peter, Aadal HOEGBERG, Thomas LINGET, Jean-Michel COOPER, Martin NOERREGAARD, Pia, Karina D00BXK DRUGINCH 1S/C24H18Cl2FN5O/c25-15-7-5-14(6-8-15)23-18(13-21(28)29)22(24(33)30-17-11-9-16(27)10-12-17)31-32(23)20-4-2-1-3-19(20)26/h1-12H,13H2,(H3,28,29)(H,30,33) D00BXK DRUGINKE QWOVGBHZFLBBHN-UHFFFAOYSA-N D00BXK DRUGSMIL C1=CC=C(C(=C1)N2C(=C(C(=N2)C(=O)NC3=CC=C(C=C3)F)CC(=N)N)C4=CC=C(C=C4)Cl)Cl D00BXK DRUGTYPE Small molecular drug D00BXK HIGHSTAT Patented D00BXZ DRUG__ID D00BXZ D00BXZ DRUGCLAS Investigative Drug(s) D00BXZ DRUGCOMP Momenta Pharmaceuticals Inc D00BXZ HIGHSTAT Investigative D00BYK DRUG__ID D00BYK D00BYK DRUGCLAS Patented Agent(s) D00BYK DRUGCOMP BEIJING HANMI PHARMACEUTICAL CO., LTD D00BYK DRUGTYPE Small molecular drug D00BYK HIGHSTAT Patented D00BYM DRUG__ID D00BYM D00BYM DRUGCLAS Clinical Trial Drug(s) D00BYM DRUGCOMP Boehringer Ingelheim D00BYM DRUGINCH 1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25?,26?,28-/m1/s1 D00BYM DRUGINKE SXNJFOWDRLKDSF-XKHVUIRMSA-N D00BYM DRUGSMIL CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C D00BYM DRUGTYPE Small molecular drug D00BYM HIGHSTAT Phase 3 D00BZJ DRUG__ID D00BZJ D00BZJ DRUGCLAS Approved Drug(s) D00BZJ DRUGCOMP Wyeth; pfizer D00BZJ DRUGTYPE Vaccine D00BZJ HIGHSTAT Approved D00BZO DRUG__ID D00BZO D00BZO DRUGCLAS Investigative Drug(s) D00BZO DRUGCOMP HanAll Biopharma Co Ltd D00BZO HIGHSTAT Investigative D00BZS DRUG__ID D00BZS D00BZS DRUGCLAS Clinical Trial Drug(s) D00BZS DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D00BZS DRUGINCH 1S/C25H25N3O5/c1-5-25(31)18-10-20-21-16(12-28(20)22(29)17(18)13-32-23(25)30)15(11-26-33-24(2,3)4)14-8-6-7-9-19(14)27-21/h6-11,31H,5,12-13H2,1-4H3/b26-11+/t25-/m0/s1 D00BZS DRUGINKE UIVFUQKYVFCEKJ-OPTOVBNMSA-N D00BZS DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)C=NOC(C)(C)C)O D00BZS DRUGTYPE Small molecular drug D00BZS HIGHSTAT Phase 2 D00BZZ DRUG__ID D00BZZ D00BZZ DRUGCLAS Clinical Trial Drug(s) D00BZZ DRUGCOMP Biorexis Pharmaceutical Corp D00BZZ HIGHSTAT Phase 1 D00CAF DRUG__ID D00CAF D00CAF DRUGCLAS Investigative Drug(s) D00CAF DRUGINCH 1S/C12H14N2/c1-13-7-3-11(4-8-13)12-5-9-14(2)10-6-12/h3-10H,1-2H3/q+2 D00CAF DRUGINKE INFDPOAKFNIJBF-UHFFFAOYSA-N D00CAF DRUGSMIL C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C D00CAF DRUGTYPE Small molecular drug D00CAF HIGHSTAT Investigative D00CAO DRUG__ID D00CAO D00CAO DRUGCLAS Patented Agent(s) D00CAO DRUGINCH 1S/C21H18F3N3O6/c22-21(23,24)13-3-6-16(25-9-13)33-14-4-1-12(2-5-14)11-27-8-7-15(28)18(20(27)32)19(31)26-10-17(29)30/h1-6,9,28H,7-8,10-11H2,(H,26,31)(H,29,30) D00CAO DRUGINKE OAYSSFWXQZDVKQ-UHFFFAOYSA-N D00CAO DRUGSMIL C1CN(C(=O)C(=C1O)C(=O)NCC(=O)O)CC2=CC=C(C=C2)OC3=NC=C(C=C3)C(F)(F)F D00CAO DRUGTYPE Small molecular drug D00CAO HIGHSTAT Patented D00CAU DRUG__ID D00CAU D00CAU DRUGCLAS Investigative Drug(s) D00CAU DRUGINCH 1S/C20H31NO2/c1-4-5-6-7-14-23-18-10-8-16(9-11-18)19(22)21-17-12-13-20(2,3)15-17/h8-11,17H,4-7,12-15H2,1-3H3,(H,21,22) D00CAU DRUGINKE SPDGMSMRHOXECU-UHFFFAOYSA-N D00CAU DRUGSMIL CCCCCCOC1=CC=C(C=C1)C(=O)NC2CCC(C2)(C)C D00CAU DRUGTYPE Small molecular drug D00CAU HIGHSTAT Investigative D00CBP DRUG__ID D00CBP D00CBP DRUGCLAS Clinical Trial Drug(s) D00CBP DRUGCOMP SmithKline Beecham plc D00CBP HIGHSTAT Phase 3 D00CBY DRUG__ID D00CBY D00CBY DRUGCLAS Investigative Drug(s) D00CBY DRUGCOMP Celek Pharmaceuticals LLC D00CBY HIGHSTAT Investigative D00CCI DRUG__ID D00CCI D00CCI DRUGCLAS Discontinued Drug(s) D00CCI DRUGCOMP Eli Lilly D00CCI DRUGINCH 1S/C16H12ClNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20) D00CCI DRUGINKE MITFXPHMIHQXPI-UHFFFAOYSA-N D00CCI DRUGSMIL CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O D00CCI DRUGTYPE Small molecular drug D00CCI HIGHSTAT Withdrawn from market D00CCV DRUG__ID D00CCV D00CCV DRUGCLAS Investigative Drug(s) D00CCV DRUGINCH 1S/C28H42N4/c1-25-9-7-11-27(23-25)31-19-15-29(16-20-31)13-5-3-4-6-14-30-17-21-32(22-18-30)28-12-8-10-26(2)24-28/h7-12,23-24H,3-6,13-22H2,1-2H3 D00CCV DRUGINKE CQEUVRXXXLSTIL-UHFFFAOYSA-N D00CCV DRUGSMIL CC1=CC(=CC=C1)N2CCN(CC2)CCCCCCN3CCN(CC3)C4=CC=CC(=C4)C D00CCV DRUGTYPE Small molecular drug D00CCV HIGHSTAT Investigative D00CDF DRUG__ID D00CDF D00CDF DRUGCLAS Investigative Drug(s) D00CDF DRUGINCH 1S/C19H18F3N3O6/c1-11(26)23-12-3-6-14(7-4-12)31-10-18(2,28)17(27)24-13-5-8-16(25(29)30)15(9-13)19(20,21)22/h3-9,28H,10H2,1-2H3,(H,23,26)(H,24,27)/t18-/m0/s1 D00CDF DRUGINKE YVXVTLGIDOACBJ-SFHVURJKSA-N D00CDF DRUGSMIL CC(=O)NC1=CC=C(C=C1)OCC(C)(C(=O)NC2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)O D00CDF DRUGTYPE Small molecular drug D00CDF HIGHSTAT Investigative D00CDI DRUG__ID D00CDI D00CDI DRUGCLAS Patented Agent(s) D00CDI DRUGTYPE Peptide D00CDI HIGHSTAT Patented D00CDM DRUG__ID D00CDM D00CDM DRUGCLAS Investigative Drug(s) D00CDM DRUGINCH 1S/C14H19NO3/c1-2-5-15-6-7-17-14-11-8-10(16)3-4-13(11)18-9-12(14)15/h3-4,8,12,14,16H,2,5-7,9H2,1H3/t12-,14-/m0/s1 D00CDM DRUGINKE YOILXOMTHPUMRG-JSGCOSHPSA-N D00CDM DRUGSMIL CCCN1CCOC2C1COC3=C2C=C(C=C3)O D00CDM DRUGTYPE Small molecular drug D00CDM HIGHSTAT Investigative D00CED DRUG__ID D00CED D00CED DRUGCLAS Investigative Drug(s) D00CED DRUGCOMP Human Genome Sciences Inc D00CED HIGHSTAT Investigative D00CEE DRUG__ID D00CEE D00CEE DRUGCLAS Approved Drug(s) D00CEE DRUGCOMP Sanofi Pasteur MSD D00CEE HIGHSTAT Approved D00CEG DRUG__ID D00CEG D00CEG DRUGCLAS Discontinued Drug(s) D00CEG DRUGINCH 1S/C38H44N4O8/c1-38(2,3)50-37(47)42-30-20-11-9-17-27(30)23-32(42)34(44)41-29-19-10-8-16-26(29)22-31(41)33(43)40-28(35(45)48-4)18-12-13-21-39-36(46)49-24-25-14-6-5-7-15-25/h5-11,14-17,19-20,28,31-32H,12-13,18,21-24H2,1-4H3,(H,39,46)(H,40,43)/t28-,31-,32-/m0/s1 D00CEG DRUGINKE GKYGBJABPHBINI-MHDHXZMLSA-N D00CEG DRUGSMIL CC(C)(C)OC(=O)N1C(CC2=CC=CC=C21)C(=O)N3C(CC4=CC=CC=C43)C(=O)NC(CCCCNC(=O)OCC5=CC=CC=C5)C(=O)OC D00CEG DRUGTYPE Small molecular drug D00CEG HIGHSTAT Terminated D00CEI DRUG__ID D00CEI D00CEI DRUGCLAS Preclinical Drug(s) D00CEI DRUGCOMP Georgia Institute of Technology D00CEI HIGHSTAT Preclinical D00CEN DRUG__ID D00CEN D00CEN DRUGCLAS Investigative Drug(s) D00CEN DRUGINCH 1S/C38H48O12/c1-25(16-13-21-27-17-5-3-6-18-27)14-9-10-22-29(39)48-31-30(40)36(23-12-11-15-26(2)24-28-19-7-4-8-20-28)49-32(33(41)42)37(47,34(43)44)38(31,50-36)35(45)46/h3-9,14,17-20,25-26,30-32,40,47H,10-13,15-16,21-24H2,1-2H3,(H,41,42)(H,43,44)(H,45,46)/b14-9+/t25?,26?,30-,31-,32?,36?,37?,38?/m1/s1 D00CEN DRUGINKE ZOTNYZYRJOAANS-OIAIRNFISA-N D00CEN DRUGSMIL CC(CCCCC12C(C(C(O1)(C(C(O2)C(=O)O)(C(=O)O)O)C(=O)O)OC(=O)CCC=CC(C)CCCC3=CC=CC=C3)O)CC4=CC=CC=C4 D00CEN DRUGTYPE Small molecular drug D00CEN HIGHSTAT Investigative D00CEO DRUG__ID D00CEO D00CEO DRUGCLAS Investigative Drug(s) D00CEO DRUGINCH 1S/C8H12N2O3/c1-5-6(3-2-4-11)9-8(13)10-7(5)12/h11H,2-4H2,1H3,(H2,9,10,12,13) D00CEO DRUGINKE OIEJBPVNLZZLGQ-UHFFFAOYSA-N D00CEO DRUGSMIL CC1=C(NC(=O)NC1=O)CCCO D00CEO DRUGTYPE Small molecular drug D00CEO HIGHSTAT Investigative D00CFB DRUG__ID D00CFB D00CFB DRUGCLAS Discontinued Drug(s) D00CFB DRUGCOMP Lederle Laboratories D00CFB DRUGINCH 1S/C6H8O4.C5H12N2O2.Pt/c7-4(8)6(5(9)10)2-1-3-6;6-1-5(2-7,3-8)4-9;/h1-3H2,(H,7,8)(H,9,10);6-9H,1-4H2;/q;-2;+4/p-2 D00CFB DRUGINKE QPWBZVAOCWJTFK-UHFFFAOYSA-L D00CFB DRUGSMIL C1CC(C1)(C(=O)[O-])C(=O)[O-].C(C(C[NH-])(CO)CO)[NH-].[Pt+4] D00CFB DRUGTYPE Small molecular drug D00CFB HIGHSTAT Discontinued in Phase 2 D00CFU DRUG__ID D00CFU D00CFU DRUGCLAS Investigative Drug(s) D00CFU DRUGCOMP Roche Holding AG D00CFU HIGHSTAT Investigative D00CGH DRUG__ID D00CGH D00CGH DRUGCLAS Clinical Trial Drug(s) D00CGH DRUGINCH 1S/C27H38O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-12,18,22,24-25,28-30H,2,7-9,13,15-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,24+,25+,27-/m1/s1 D00CGH DRUGINKE JKFZMIQMKFWJAY-RQJQXFIZSA-N D00CGH DRUGSMIL CC(CC#CC(C)(C)O)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C D00CGH DRUGTYPE Small molecular drug D00CGH HIGHSTAT Phase 1 D00CGJ DRUG__ID D00CGJ D00CGJ DRUGCLAS Investigative Drug(s) D00CGJ DRUGINCH 1S/C10H14BrNO/c1-7(12)5-8-3-4-9(11)6-10(8)13-2/h3-4,6-7H,5,12H2,1-2H3 D00CGJ DRUGINKE YWONMRKCBJPFCM-UHFFFAOYSA-N D00CGJ DRUGSMIL CC(CC1=C(C=C(C=C1)Br)OC)N D00CGJ DRUGTYPE Small molecular drug D00CGJ HIGHSTAT Investigative D00CGU DRUG__ID D00CGU D00CGU DRUGCLAS Discontinued Drug(s) D00CGU DRUGCOMP Inotek Pharmaceuticals D00CGU DRUGINCH 1S/C4H10O3S/c1-4(2)7-8(3,5)6/h4H,1-3H3 D00CGU DRUGINKE SWWHCQCMVCPLEQ-UHFFFAOYSA-N D00CGU DRUGSMIL CC(C)OS(=O)(=O)C D00CGU DRUGTYPE Small molecular drug D00CGU HIGHSTAT Discontinued in Phase 1 D00CGX DRUG__ID D00CGX D00CGX DRUGCLAS Clinical Trial Drug(s) D00CGX DRUGCOMP Dynavax Technologies D00CGX HIGHSTAT Phase 1 D00CHD DRUG__ID D00CHD D00CHD DRUGCLAS Investigative Drug(s) D00CHD DRUGINCH 1S/C20H37NO3/c1-2-3-4-13-16-19(22)21-18-15-12-10-8-6-5-7-9-11-14-17-20(23)24/h6,8H,2-5,7,9-18H2,1H3,(H,21,22)(H,23,24)/b8-6- D00CHD DRUGINKE QCBRCTHDMJHJJU-VURMDHGXSA-N D00CHD DRUGSMIL CCCCCCC(=O)NCCCCC=CCCCCCCC(=O)O D00CHD DRUGTYPE Small molecular drug D00CHD HIGHSTAT Investigative D00CIF DRUG__ID D00CIF D00CIF DRUGCLAS Discontinued Drug(s) D00CIF DRUGCOMP Merck KGaA D00CIF DRUGINCH 1S/C22H23ClN4O5/c23-14-1-3-16(4-2-14)25-22(31)27-12-18(28)11-19(27)21(30)24-15-5-7-17(8-6-15)26-9-10-32-13-20(26)29/h1-8,18-19,28H,9-13H2,(H,24,30)(H,25,31)/t18-,19-/m1/s1 D00CIF DRUGINKE DMYZJLOWGSRVKP-RTBURBONSA-N D00CIF DRUGSMIL C1COCC(=O)N1C2=CC=C(C=C2)NC(=O)C3CC(CN3C(=O)NC4=CC=C(C=C4)Cl)O D00CIF HIGHSTAT Discontinued in Phase 1 D00CIT DRUG__ID D00CIT D00CIT DRUGCLAS Discontinued Drug(s) D00CIT DRUGCOMP Teijin Ltd D00CIT DRUGTYPE Monoclonal antibody D00CIT HIGHSTAT Discontinued in Preregistration D00CIW DRUG__ID D00CIW D00CIW DRUGCLAS Investigative Drug(s) D00CIW DRUGINCH 1S/C6H7O3P/c7-10(8,9)6-4-2-1-3-5-6/h1-5H,(H2,7,8,9) D00CIW DRUGINKE QLZHNIAADXEJJP-UHFFFAOYSA-N D00CIW DRUGSMIL C1=CC=C(C=C1)P(=O)(O)O D00CIW DRUGTYPE Small molecular drug D00CIW HIGHSTAT Investigative D00CJJ DRUG__ID D00CJJ D00CJJ DRUGCLAS Investigative Drug(s) D00CJJ DRUGINCH 1S/C13H12BrN5/c14-13-18-10-11(15)16-8-17-12(10)19(13)7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H2,15,16,17) D00CJJ DRUGINKE LQIMXMMBTNEKMZ-UHFFFAOYSA-N D00CJJ DRUGSMIL C1=CC=C(C=C1)CCN2C3=NC=NC(=C3N=C2Br)N D00CJJ DRUGTYPE Small molecular drug D00CJJ HIGHSTAT Investigative D00CKV DRUG__ID D00CKV D00CKV COMPCLAS Indolizine derivatives D00CKV DRUGCLAS Patented Agent(s) D00CKV DRUGINCH 1S/C24H16F3NO2/c1-15(29)22-20(16-7-3-2-4-8-16)21(19-9-5-6-14-28(19)22)23(30)17-10-12-18(13-11-17)24(25,26)27/h2-14H,1H3 D00CKV DRUGINKE GLIRMGCILWOVQU-UHFFFAOYSA-N D00CKV DRUGSMIL CC(=O)C1=C(C(=C2N1C=CC=C2)C(=O)C3=CC=C(C=C3)C(F)(F)F)C4=CC=CC=C4 D00CKV DRUGTYPE Small molecular drug D00CKV HIGHSTAT Patented D00CKY DRUG__ID D00CKY D00CKY DRUGCLAS Investigative Drug(s) D00CKY DRUGINCH 1S/C15H18N2OS/c18-14(15-17-16-12-19-15)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D00CKY DRUGINKE QUVXRHLPGVMXRU-UHFFFAOYSA-N D00CKY DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NN=CS2 D00CKY DRUGTYPE Small molecular drug D00CKY HIGHSTAT Investigative D00CLB DRUG__ID D00CLB D00CLB DRUGCLAS Investigative Drug(s) D00CLB DRUGINCH 1S/C31H42N4O3S/c1-22(2)18-27(33-31(37)29-19-24-8-5-6-9-28(24)39-29)30(36)32-25-14-16-35(21-25)20-23-10-12-26(13-11-23)38-17-7-15-34(3)4/h5-6,8-13,19,22,25,27H,7,14-18,20-21H2,1-4H3,(H,32,36)(H,33,37)/t25-,27-/m0/s1 D00CLB DRUGINKE HLMWNBIZKQIDFC-BDYUSTAISA-N D00CLB DRUGSMIL CC(C)CC(C(=O)NC1CCN(C1)CC2=CC=C(C=C2)OCCCN(C)C)NC(=O)C3=CC4=CC=CC=C4S3 D00CLB DRUGTYPE Small molecular drug D00CLB HIGHSTAT Investigative D00CLC DRUG__ID D00CLC D00CLC DRUGCLAS Clinical Trial Drug(s) D00CLC DRUGCOMP Solvay SA D00CLC HIGHSTAT Phase 1 D00CLK DRUG__ID D00CLK D00CLK DRUGCLAS Patented Agent(s) D00CLK DRUGCOMP THE UNIVERSITY OF HONG KON D00CLK DRUGTYPE Small molecular drug D00CLK HIGHSTAT Patented D00CLM DRUG__ID D00CLM D00CLM DRUGCLAS Clinical Trial Drug(s) D00CLM DRUGCOMP Nissan Chemical Industries Ltd D00CLM DRUGINCH 1S/C18H12Cl2N2O4S2/c1-8(21-22-17(24)13-4-5-14(28-13)18(25)26)10-7-27-16(15(10)23)9-2-3-11(19)12(20)6-9/h2-7,23H,1H3,(H,22,24)(H,25,26)/b21-8- D00CLM DRUGINKE JYODIYJKYDDIDN-WNFQYIGGSA-N D00CLM DRUGSMIL CC(=NNC(=O)C1=CC=C(S1)C(=O)O)C2=CSC(=C2O)C3=CC(=C(C=C3)Cl)Cl D00CLM HIGHSTAT Phase 1 D00CMA DRUG__ID D00CMA D00CMA DRUGCLAS Investigative Drug(s) D00CMA DRUGCOMP Vivozon Inc D00CMA HIGHSTAT Investigative D00CMC DRUG__ID D00CMC D00CMC DRUGCLAS Investigative Drug(s) D00CMC DRUGCOMP Beijing Pason Pharmaceuticals Inc D00CMC HIGHSTAT Investigative D00CMV DRUG__ID D00CMV D00CMV DRUGCLAS Clinical Trial Drug(s) D00CMV DRUGCOMP Abbott D00CMV DRUGINCH 1S/C21H24N4O/c1-21(2,3)14-8-9-15-13(11-14)7-10-18(15)24-20(26)23-17-5-4-6-19-16(17)12-22-25-19/h4-6,8-9,11-12,18H,7,10H2,1-3H3,(H,22,25)(H2,23,24,26)/t18-/m1/s1 D00CMV DRUGINKE TYOYXJNGINZFET-GOSISDBHSA-N D00CMV DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)C(CC2)NC(=O)NC3=CC=CC4=C3C=NN4 D00CMV DRUGTYPE Small molecular drug D00CMV HIGHSTAT Phase 1 D00CMV THERCLAS Analgesics D00CMX DRUG__ID D00CMX D00CMX DRUGCLAS Patented Agent(s) D00CMX DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D00CMX DRUGTYPE Small molecular drug D00CMX HIGHSTAT Patented D00COB DRUG__ID D00COB D00COB DRUGCLAS Discontinued Drug(s) D00COB DRUGINCH 1S/C35H40N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-12,19,21-22,24-25,29,32,36H,13-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/b12-11+/t21?,22?,24?,25?,29-,32?,35+/m0/s1 D00COB DRUGINKE REMAMJQTIPBFTH-MYJPUEAFSA-N D00COB DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NCC(C3=CC=CC=C3)NC(=O)C=CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D00COB DRUGTYPE Small molecular drug D00COB HIGHSTAT Terminated D00COH DRUG__ID D00COH D00COH COMPCLAS Biaryl mannoside derivatives D00COH DRUGCLAS Patented Agent(s) D00COH DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D00COH DRUGTYPE Carbohydrates D00COH HIGHSTAT Patented D00COJ DRUG__ID D00COJ D00COJ DRUGCLAS Clinical Trial Drug(s) D00COJ DRUGCOMP The Medicines Company Parsippany, NJ D00COJ HIGHSTAT Phase 3 D00CPI DRUG__ID D00CPI D00CPI DRUGCLAS Investigative Drug(s) D00CPI DRUGINCH 1S/C13H20N2O/c1-2-6-14-7-9-15(10-8-14)12-4-3-5-13(16)11-12/h3-5,11,16H,2,6-10H2,1H3 D00CPI DRUGINKE AWROKCIGUWAVRF-UHFFFAOYSA-N D00CPI DRUGSMIL CCCN1CCN(CC1)C2=CC(=CC=C2)O D00CPI DRUGTYPE Small molecular drug D00CPI HIGHSTAT Investigative D00CPM DRUG__ID D00CPM D00CPM DRUGCLAS Investigative Drug(s) D00CPM DRUGINCH 1S/C16H13NO2/c1-19-12-8-6-11(7-9-12)16-14(10-18)13-4-2-3-5-15(13)17-16/h2-10,17H,1H3 D00CPM DRUGINKE QIMWZVMNUAWWSJ-UHFFFAOYSA-N D00CPM DRUGSMIL COC1=CC=C(C=C1)C2=C(C3=CC=CC=C3N2)C=O D00CPM DRUGTYPE Small molecular drug D00CPM HIGHSTAT Investigative D00CPQ DRUG__ID D00CPQ D00CPQ DRUGCLAS Clinical Trial Drug(s) D00CPQ DRUGCOMP United Therapeutics Silver Spring, MD D00CPQ HIGHSTAT Phase 2 D00CQB DRUG__ID D00CQB D00CQB DRUGCLAS Discontinued Drug(s) D00CQB DRUGINCH 1S/C30H29N3O4/c1-20(21-10-4-3-5-11-21)32-28(34)30(2,17-23-18-31-26-14-8-7-13-25(23)26)33-29(35)36-19-24-16-22-12-6-9-15-27(22)37-24/h3-16,18,20,31H,17,19H2,1-2H3,(H,32,34)(H,33,35)/t20-,30+/m0/s1 D00CQB DRUGINKE IVIQHHCTWSXXCT-WENCNXQZSA-N D00CQB DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C(C)(CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC5=CC=CC=C5O4 D00CQB DRUGTYPE Small molecular drug D00CQB HIGHSTAT Terminated D00CQI DRUG__ID D00CQI D00CQI DRUGCLAS Clinical Trial Drug(s) D00CQI DRUGCOMP Biotest D00CQI DRUGTYPE Monoclonal antibody D00CQI HIGHSTAT Phase 2 D00CQL DRUG__ID D00CQL D00CQL DRUGCLAS Clinical Trial Drug(s) D00CQL DRUGCOMP Dynavax Technologies Corp D00CQL DRUGTYPE Vaccine D00CQL HIGHSTAT Phase 1 D00CQQ DRUG__ID D00CQQ D00CQQ DRUGCLAS Clinical Trial Drug(s) D00CQQ DRUGCOMP Fabre Kramer Pharmaceuticals Inc D00CQQ HIGHSTAT Phase 2 D00CQR DRUG__ID D00CQR D00CQR DRUGCLAS Investigative Drug(s) D00CQR DRUGINCH 1S/C9H14O2/c1-7-3-2-4-9(7)5-6-11-8(9)10/h7H,2-6H2,1H3 D00CQR DRUGINKE IDYXKZWAEUMDEE-UHFFFAOYSA-N D00CQR DRUGSMIL CC1CCCC12CCOC2=O D00CQR DRUGTYPE Small molecular drug D00CQR HIGHSTAT Investigative D00CQT DRUG__ID D00CQT D00CQT DRUGCLAS Investigative Drug(s) D00CQT DRUGINCH 1S/C13H8Cl2O3/c14-10(15)6-5-9-11(16)7-3-1-2-4-8(7)12(17)13(9)18/h1-4,6,16H,5H2 D00CQT DRUGINKE LWQZLQISFLBSGW-UHFFFAOYSA-N D00CQT DRUGSMIL C1=CC=C2C(=C1)C(=C(C(=O)C2=O)CC=C(Cl)Cl)O D00CQT DRUGTYPE Small molecular drug D00CQT HIGHSTAT Investigative D00CQW DRUG__ID D00CQW D00CQW DRUGCLAS Discontinued Drug(s) D00CQW DRUGINCH 1S/C21H24N6O5/c22-17-16-13(10-24-18(16)27-21(23)26-17)3-1-2-11-4-6-12(7-5-11)19(30)25-14(20(31)32)8-9-15(28)29/h4-7,10,14H,1-3,8-9H2,(H,25,30)(H,28,29)(H,31,32)(H5,22,23,24,26,27)/t14-/m0/s1 D00CQW DRUGINKE WLGCEMWNUHSIIS-AWEZNQCLSA-N D00CQW DRUGSMIL C1=CC(=CC=C1CCCC2=CNC3=NC(=NC(=C23)N)N)C(=O)NC(CCC(=O)O)C(=O)O D00CQW DRUGTYPE Small molecular drug D00CQW HIGHSTAT Discontinued in Phase 2 D00CRA DRUG__ID D00CRA D00CRA DRUGCLAS Investigative Drug(s) D00CRA DRUGINCH 1S/C11H14N2O/c1-7-9(4-5-12)10-6-8(14)2-3-11(10)13-7/h2-3,6,13-14H,4-5,12H2,1H3 D00CRA DRUGINKE WYWNEDARFVJQSG-UHFFFAOYSA-N D00CRA DRUGSMIL CC1=C(C2=C(N1)C=CC(=C2)O)CCN D00CRA DRUGTYPE Small molecular drug D00CRA HIGHSTAT Investigative D00CRQ DRUG__ID D00CRQ D00CRQ COMPCLAS Phenylate derivatives D00CRQ DRUGCLAS Patented Agent(s) D00CRQ DRUGCOMP INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES [CN] D00CRQ DRUGINCH 1S/C28H29BrClNO5/c1-18(2)11-12-35-25-14-26(23(30)13-21(25)15-31-24(16-32)28(33)34)36-17-20-9-6-10-22(27(20)29)19-7-4-3-5-8-19/h3-11,13-14,24,31-32H,12,15-17H2,1-2H3,(H,33,34) D00CRQ DRUGINKE HXFYELRCMXNMTR-UHFFFAOYSA-N D00CRQ DRUGSMIL CC(=CCOC1=CC(=C(C=C1CNC(CO)C(=O)O)Cl)OCC2=C(C(=CC=C2)C3=CC=CC=C3)Br)C D00CRQ DRUGTYPE Small molecule immunotherapy D00CRQ HIGHSTAT Patented D00CSA DRUG__ID D00CSA D00CSA DRUGCLAS Clinical Trial Drug(s) D00CSA DRUGCOMP Novartis pharmaceuticals D00CSA HIGHSTAT Phase 2 D00CSQ DRUG__ID D00CSQ D00CSQ DRUGCLAS Approved Drug(s) D00CSQ DRUGINCH 1S/C12H7Cl3O2/c13-7-1-3-11(9(15)5-7)17-12-4-2-8(14)6-10(12)16/h1-6,16H D00CSQ DRUGINKE XEFQLINVKFYRCS-UHFFFAOYSA-N D00CSQ DRUGSMIL C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl D00CSQ DRUGTYPE Small molecular drug D00CSQ HIGHSTAT Approved D00CSQ THERCLAS Antibiotics D00CTS DRUG__ID D00CTS D00CTS DRUGCLAS Approved Drug(s) D00CTS DRUGCOMP Takeda D00CTS DRUGINCH 1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15-,17-,20-/m1/s1 D00CTS DRUGINKE WGFOBBZOWHGYQH-MXHNKVEKSA-N D00CTS DRUGSMIL CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F D00CTS DRUGTYPE Small molecular drug D00CTS HIGHSTAT Approved D00CTS THERCLAS Anticonstipation Agents D00CTZ DRUG__ID D00CTZ D00CTZ DRUGCLAS Clinical Trial Drug(s) D00CTZ DRUGCOMP AstraZeneca D00CTZ HIGHSTAT Phase 2 D00CUZ DRUG__ID D00CUZ D00CUZ DRUGCLAS Investigative Drug(s) D00CUZ DRUGINCH 1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)/i1T3 D00CUZ DRUGINKE RMHMFHUVIITRHF-RLXJOQACSA-N D00CUZ DRUGSMIL CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4 D00CUZ DRUGTYPE Small molecular drug D00CUZ HIGHSTAT Investigative D00CVB DRUG__ID D00CVB D00CVB DRUGCLAS Investigative Drug(s) D00CVB DRUGINCH 1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1 D00CVB DRUGINKE MXHRCPNRJAMMIM-SHYZEUOFSA-N D00CVB DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)CO)O D00CVB DRUGTYPE Small molecular drug D00CVB HIGHSTAT Investigative D00CVD DRUG__ID D00CVD D00CVD DRUGCLAS Investigative Drug(s) D00CVD DRUGINCH 1S/C19H16Cl2O3/c1-10(2)23-16-8-11(3)4-6-13(16)19-17(21)18(22)14-9-12(20)5-7-15(14)24-19/h4-10H,1-3H3 D00CVD DRUGINKE PWGZOUCWGRTPSM-UHFFFAOYSA-N D00CVD DRUGSMIL CC1=CC(=C(C=C1)C2=C(C(=O)C3=C(O2)C=CC(=C3)Cl)Cl)OC(C)C D00CVD DRUGTYPE Small molecular drug D00CVD HIGHSTAT Investigative D00CVJ DRUG__ID D00CVJ D00CVJ DRUGCLAS Clinical Trial Drug(s) D00CVJ DRUGCOMP Neurim Pharmaceuticals D00CVJ DRUGINCH 1S/C17H16N2O4/c1-22-13-2-3-15-14(9-13)11(10-19-15)4-6-18-17(21)16-8-12(20)5-7-23-16/h2-3,5,7-10,19H,4,6H2,1H3,(H,18,21) D00CVJ DRUGINKE PNTNBIHOAPJYDB-UHFFFAOYSA-N D00CVJ DRUGSMIL COC1=CC2=C(C=C1)NC=C2CCNC(=O)C3=CC(=O)C=CO3 D00CVJ DRUGTYPE Small molecular drug D00CVJ HIGHSTAT Phase 2 D00CVT DRUG__ID D00CVT D00CVT DRUGCLAS Discontinued Drug(s) D00CVT DRUGCOMP Theravance Inc D00CVT HIGHSTAT Discontinued in Phase 1 D00CWH DRUG__ID D00CWH D00CWH DRUGCLAS Investigative Drug(s) D00CWH DRUGINCH 1S/C7H16N2O/c1-7(2,3)5(8)6(10)9-4/h5H,8H2,1-4H3,(H,9,10) D00CWH DRUGINKE BPKJNEIOHOEWLO-UHFFFAOYSA-N D00CWH DRUGSMIL CC(C)(C)C(C(=O)NC)N D00CWH DRUGTYPE Small molecular drug D00CWH HIGHSTAT Investigative D00CWJ DRUG__ID D00CWJ D00CWJ DRUGCLAS Investigative Drug(s) D00CWJ DRUGCOMP Isis Pharmaceuticals D00CWJ DRUGTYPE Antisense drug D00CWJ HIGHSTAT Investigative D00CWN DRUG__ID D00CWN D00CWN DRUGCLAS Investigative Drug(s) D00CWN DRUGINCH 1S/C15H11NO2/c17-12-4-1-10(2-5-12)14-7-3-11-9-13(18)6-8-15(11)16-14/h1-9,17-18H D00CWN DRUGINKE SEKOFPJLRLFURL-UHFFFAOYSA-N D00CWN DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=C2)C=C(C=C3)O)O D00CWN DRUGTYPE Small molecular drug D00CWN HIGHSTAT Investigative D00CYF DRUG__ID D00CYF D00CYF DRUGCLAS Investigative Drug(s) D00CYF DRUGINCH 1S/C79H105N23O18S2/c1-7-39(4)65(91-41(6)104)78(120)100-60-36-122-121-35-59(76(118)102-66(40(5)103)67(81)109)99-69(111)52(21-14-24-85-79(82)83)93-73(115)57(28-45-33-84-37-90-45)96-71(113)55(26-43-31-87-50-19-12-9-16-47(43)50)92-62(106)34-89-68(110)54(25-42-30-86-49-18-11-8-15-46(42)49)95-74(116)58(29-63(107)108)97-70(112)53(22-23-61(80)105)94-72(114)56(98-77(119)64(38(2)3)101-75(60)117)27-44-32-88-51-20-13-10-17-48(44)51/h8-13,15-20,30-33,37-40,52-60,64-66,86-88,103H,7,14,21-29,34-36H2,1-6H3,(H2,80,105)(H2,81,109)(H,84,90)(H,89,110)(H,91,104)(H,92,106)(H,93,115)(H,94,114)(H,95,116)(H,96,113)(H,97,112)(H,98,119)(H,99,111)(H,100,120)(H,101,117)(H,102,118)(H,107,108)(H4,82,83,85)/t39-,40+,52-,53-,54-,55-,56+,57+,58+,59-,60-,64-,65-,66-/m0/s1 D00CYF DRUGINKE FLYCCQRIADFTOH-RHIYSSTNSA-N D00CYF DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CNC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)CC6=CNC7=CC=CC=C76)CC8=CN=CN8)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D00CYF HIGHSTAT Investigative D00CYX DRUG__ID D00CYX D00CYX DRUGCLAS Investigative Drug(s) D00CYX DRUGINCH 1S/C45H70N8O16/c1-22(2)17-29(49-43(66)31(20-36(59)60)51-42(65)30(18-23(3)4)50-40(63)27(46)13-15-34(55)56)38(61)33(54)21-47-25(7)39(62)53-37(24(5)6)44(67)48-28(14-16-35(57)58)41(64)52-32(45(68)69)19-26-11-9-8-10-12-26/h8-12,22-25,27-33,37,47,54H,13-21,46H2,1-7H3,(H,48,67)(H,49,66)(H,50,63)(H,51,65)(H,52,64)(H,53,62)(H,55,56)(H,57,58)(H,59,60)(H,68,69)/t25-,27-,28-,29-,30-,31-,32-,33?,37-/m0/s1 D00CYX DRUGINKE WAHCXYBUKGOGCQ-SHELQGHFSA-N D00CYX DRUGSMIL CC(C)CC(C(=O)C(CNC(C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)N D00CYX DRUGTYPE Small molecular drug D00CYX HIGHSTAT Investigative D00CZT DRUG__ID D00CZT D00CZT DRUGCLAS Clinical Trial Drug(s) D00CZT DRUGCOMP Eli Lilly D00CZT DRUGTYPE Monoclonal antibody D00CZT HIGHSTAT Phase 3 D00DAE DRUG__ID D00DAE D00DAE DRUGCLAS Clinical Trial Drug(s) D00DAE DRUGCOMP Tactical Therapeutics D00DAE DRUGINCH 1S/C17H12Cl3N5O2.C5H4N2O4/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25;8-3-1-2(4(9)10)6-5(11)7-3/h1-6H,7H2,(H4,21,22,24,27);1H,(H,9,10)(H2,6,7,8,11) D00DAE DRUGINKE WEUITFNOCGSIHW-UHFFFAOYSA-N D00DAE DRUGSMIL C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2Cl)C[N+]3=C(C(=NN3)C(=O)N)N)Cl)Cl.C1=C(NC(=O)NC1=O)C(=O)[O-] D00DAE HIGHSTAT Phase 2 D00DAU DRUG__ID D00DAU D00DAU DRUGCLAS Discontinued Drug(s) D00DAU DRUGCOMP Veloxis Pharmaceuticals A/S D00DAU HIGHSTAT Terminated D00DBE DRUG__ID D00DBE D00DBE DRUGCLAS Discontinued Drug(s) D00DBE DRUGINCH 1S/C24H20N4O2/c1-15-13-18-9-12-28-21(18)19(14-15)20(16-5-3-2-4-6-16)26-22(24(28)30)27-23(29)17-7-10-25-11-8-17/h2-8,10-11,13-14,22H,9,12H2,1H3,(H,27,29)/t22-/m0/s1 D00DBE DRUGINKE KYFWUBJMTHVBIF-QFIPXVFZSA-N D00DBE DRUGSMIL CC1=CC2=C3C(=C1)C(=NC(C(=O)N3CC2)NC(=O)C4=CC=NC=C4)C5=CC=CC=C5 D00DBE DRUGTYPE Small molecular drug D00DBE HIGHSTAT Discontinued in Phase 2 D00DBH DRUG__ID D00DBH D00DBH DRUGCLAS Discontinued Drug(s) D00DBH DRUGCOMP NPS Pharmaceuticals D00DBH DRUGINCH 1S/C5H11NO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H2,6,7) D00DBH DRUGINKE SANOUVWGPVYVAV-UHFFFAOYSA-N D00DBH DRUGSMIL CC(C)CC(=O)N D00DBH DRUGTYPE Small molecular drug D00DBH HIGHSTAT Discontinued in Phase 2 D00DBO DRUG__ID D00DBO D00DBO DRUGCLAS Clinical Trial Drug(s) D00DBO DRUGINCH 1S/C21H30FN3O2/c22-18-8-6-17(7-9-18)19(26)5-4-12-24-15-10-21(11-16-24,20(23)27)25-13-2-1-3-14-25/h6-9H,1-5,10-16H2,(H2,23,27) D00DBO DRUGINKE AXKPFOAXAHJUAG-UHFFFAOYSA-N D00DBO DRUGSMIL C1CCN(CC1)C2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)C(=O)N D00DBO DRUGTYPE Small molecular drug D00DBO HIGHSTAT Phase 1/2 D00DBR DRUG__ID D00DBR D00DBR DRUGCLAS Investigative Drug(s) D00DBR DRUGINCH 1S/C5H7N5O3/c1-7-3-2(10(12)13)4(11)9-5(6)8-3/h1H3,(H4,6,7,8,9,11) D00DBR DRUGINKE NMCMUSAXKISTKW-UHFFFAOYSA-N D00DBR DRUGSMIL CNC1=C(C(=O)NC(=N1)N)[N+](=O)[O-] D00DBR DRUGTYPE Small molecular drug D00DBR HIGHSTAT Investigative D00DBU DRUG__ID D00DBU D00DBU DRUGCLAS Discontinued Drug(s) D00DBU DRUGCOMP Inhibitex Inc D00DBU HIGHSTAT Discontinued in Phase 2 D00DBV DRUG__ID D00DBV D00DBV DRUGCLAS Investigative Drug(s) D00DBV DRUGINCH 1S/C2H6N2O/c1-4-2(3)5/h1H3,(H3,3,4,5) D00DBV DRUGINKE XGEGHDBEHXKFPX-UHFFFAOYSA-N D00DBV DRUGSMIL CNC(=O)N D00DBV DRUGTYPE Small molecular drug D00DBV HIGHSTAT Investigative D00DCY DRUG__ID D00DCY D00DCY DRUGCLAS Approved Drug(s) D00DCY DRUGCOMP Zila D00DCY HIGHSTAT Approved D00DDH DRUG__ID D00DDH D00DDH DRUGCLAS Investigative Drug(s) D00DDH DRUGINCH 1S/C14H27N3O2/c1-4-10(3)9-16-13(18)12-7-6-8-17(12)14(19)11(15)5-2/h10-12H,4-9,15H2,1-3H3,(H,16,18)/t10-,11-,12-/m0/s1 D00DDH DRUGINKE KKFKEHDSJNUMHG-SRVKXCTJSA-N D00DDH DRUGSMIL CCC(C)CNC(=O)C1CCCN1C(=O)C(CC)N D00DDH DRUGTYPE Small molecular drug D00DDH HIGHSTAT Investigative D00DDJ DRUG__ID D00DDJ D00DDJ DRUGCLAS Investigative Drug(s) D00DDJ DRUGINCH 1S/C15H24N2O/c18-14(17-3-1-16-2-4-17)15-8-11-5-12(9-15)7-13(6-11)10-15/h11-13,16H,1-10H2 D00DDJ DRUGINKE XAFSAELWLMDLKL-UHFFFAOYSA-N D00DDJ DRUGSMIL C1CN(CCN1)C(=O)C23CC4CC(C2)CC(C4)C3 D00DDJ DRUGTYPE Small molecular drug D00DDJ HIGHSTAT Investigative D00DDO DRUG__ID D00DDO D00DDO DRUGCLAS Investigative Drug(s) D00DDO DRUGINCH 1S/C13H9BrO3/c14-11-7-9(8-4-2-1-3-5-8)6-10(12(11)15)13(16)17/h1-7,15H,(H,16,17) D00DDO DRUGINKE XVZSXNULHSIRCQ-UHFFFAOYSA-N D00DDO DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C(=C2)Br)O)C(=O)O D00DDO DRUGTYPE Small molecular drug D00DDO HIGHSTAT Investigative D00DDR DRUG__ID D00DDR D00DDR DRUGCLAS Investigative Drug(s) D00DDR DRUGSMIL failed D00DDR DRUGTYPE Combination drug (Antisense drug) D00DDR HIGHSTAT Investigative D00DDR THERCLAS Antisense D00DDT DRUG__ID D00DDT D00DDT DRUGCLAS Investigative Drug(s) D00DDT DRUGINCH 1S/C12H19NS/c1-10(13(2)3)9-11-5-7-12(14-4)8-6-11/h5-8,10H,9H2,1-4H3 D00DDT DRUGINKE NFRBJBFYUNQIQP-UHFFFAOYSA-N D00DDT DRUGSMIL CC(CC1=CC=C(C=C1)SC)N(C)C D00DDT DRUGTYPE Small molecular drug D00DDT HIGHSTAT Investigative D00DDX DRUG__ID D00DDX D00DDX COMPCLAS N-(pyridin-2-yl)pyrimidin-4-amine derivatives D00DDX DRUGCLAS Patented Agent(s) D00DDX DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D00DDX DRUGINCH 1S/C19H16F4N4O3S/c1-30-15-7-12(20)3-4-13(15)14-8-17(25-10-24-14)27-18-6-11(9-31(2,28)29)5-16(26-18)19(21,22)23/h3-8,10H,9H2,1-2H3,(H,24,25,26,27) D00DDX DRUGINKE WUAZMKUDCHZMEP-UHFFFAOYSA-N D00DDX DRUGSMIL COC1=C(C=CC(=C1)F)C2=CC(=NC=N2)NC3=CC(=CC(=N3)C(F)(F)F)CS(=O)(=O)C D00DDX DRUGTYPE Small molecular drug D00DDX HIGHSTAT Patented D00DEF DRUG__ID D00DEF D00DEF DRUGCLAS Approved Drug(s) D00DEF DRUGCOMP New River Pharmaceuticals D00DEF DRUGINCH 1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1 D00DEF DRUGINKE VOBHXZCDAVEXEY-JSGCOSHPSA-N D00DEF DRUGSMIL CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N D00DEF DRUGTYPE Small molecular drug D00DEF HIGHSTAT Approved D00DEH DRUG__ID D00DEH D00DEH DRUGCLAS Investigative Drug(s) D00DEH DRUGINCH 1S/C17H18ClNO/c18-14-4-3-5-15(12-14)20-17-7-2-1-6-16(17)13-8-10-19-11-9-13/h1-7,12-13,19H,8-11H2 D00DEH DRUGINKE QHHWSRAVBLCPAI-UHFFFAOYSA-N D00DEH DRUGSMIL C1CNCCC1C2=CC=CC=C2OC3=CC(=CC=C3)Cl D00DEH DRUGTYPE Small molecular drug D00DEH HIGHSTAT Investigative D00DFK DRUG__ID D00DFK D00DFK COMPCLAS Heteroaryl-azepine derivatives D00DFK DRUGCLAS Patented Agent(s) D00DFK DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D00DFK DRUGTYPE Small molecular drug D00DFK HIGHSTAT Patented D00DFP DRUG__ID D00DFP D00DFP DRUGCLAS Clinical Trial Drug(s) D00DFP DRUGCOMP KBP Biosciences Princeton, NJ D00DFP DRUGINCH 1S/C28H30ClN5O2/c29-23-15-19(6-5-18(23)16-30)34-27(17-3-1-2-4-17)22-8-9-24-21(26(22)32-34)7-10-25(31-24)28(36)33-13-11-20(35)12-14-33/h5-7,10,15,17,20,22,27,35H,1-4,8-9,11-14H2/t22-,27+/m1/s1 D00DFP DRUGINKE UXHQLGLGLZKHTC-AMGIVPHBSA-N D00DFP DRUGSMIL C1CCC(C1)C2C3CCC4=C(C3=NN2C5=CC(=C(C=C5)C#N)Cl)C=CC(=N4)C(=O)N6CCC(CC6)O D00DFP HIGHSTAT Phase 1/2 D00DFR DRUG__ID D00DFR D00DFR DRUGCLAS Investigative Drug(s) D00DFR DRUGINCH 1S/C20H20O3/c21-18-12-7-13-19(22-14-16-8-3-1-4-9-16)20(18)23-15-17-10-5-2-6-11-17/h1-12,19-20H,13-15H2/t19-,20-/m1/s1 D00DFR DRUGINKE PHZAKVRYDXRMRQ-WOJBJXKFSA-N D00DFR DRUGSMIL C1C=CC(=O)C(C1OCC2=CC=CC=C2)OCC3=CC=CC=C3 D00DFR DRUGTYPE Small molecular drug D00DFR HIGHSTAT Investigative D00DHM DRUG__ID D00DHM D00DHM DRUGCLAS Investigative Drug(s) D00DHM DRUGINCH 1S/C21H29N3O/c1-12-15-10-18-16(14-7-6-8-17(22-12)19(14)15)9-13(11-24(18)5)23-20(25)21(2,3)4/h6-8,13,16,18,22H,9-11H2,1-5H3,(H,23,25) D00DHM DRUGINKE ZNMWUMGOSWLWOH-UHFFFAOYSA-N D00DHM DRUGSMIL CC1=C2CC3C(CC(CN3C)NC(=O)C(C)(C)C)C4=C2C(=CC=C4)N1 D00DHM DRUGTYPE Small molecular drug D00DHM HIGHSTAT Investigative D00DHT DRUG__ID D00DHT D00DHT DRUGCLAS Investigative Drug(s) D00DHT DRUGCOMP Vasade Biosciences Inc D00DHT HIGHSTAT Investigative D00DHV DRUG__ID D00DHV D00DHV DRUGCLAS Investigative Drug(s) D00DHV DRUGINCH 1S/C10H12N4S/c1-6-15-9-8(1)12-7-13-10(9)14-4-2-11-3-5-14/h1,6-7,11H,2-5H2 D00DHV DRUGINKE GVNSLBIXJYZCCB-UHFFFAOYSA-N D00DHV DRUGSMIL C1CN(CCN1)C2=NC=NC3=C2SC=C3 D00DHV DRUGTYPE Small molecular drug D00DHV HIGHSTAT Investigative D00DIB DRUG__ID D00DIB D00DIB DRUGCLAS Clinical Trial Drug(s) D00DIB DRUGCOMP Intrexon Germantown, MD ZIOPHARM Oncology Boston, MA D00DIB HIGHSTAT Phase 1 D00DIF DRUG__ID D00DIF D00DIF DRUGCLAS Investigative Drug(s) D00DIF DRUGINCH 1S/C16H23N5/c1-11-10-15(18-14-7-5-4-6-8-14)19-16(17-11)21-13(3)9-12(2)20-21/h9-10,14H,4-8H2,1-3H3,(H,17,18,19) D00DIF DRUGINKE USEMRPYUFJNFQN-UHFFFAOYSA-N D00DIF DRUGSMIL CC1=CC(=NC(=N1)N2C(=CC(=N2)C)C)NC3CCCCC3 D00DIF DRUGTYPE Small molecular drug D00DIF HIGHSTAT Investigative D00DIJ DRUG__ID D00DIJ D00DIJ DRUADIID CLI-01-ALDR-00616 D00DIJ DRUGCLAS Investigative Drug(s) D00DIJ HIGHSTAT Investigative D00DIM DRUG__ID D00DIM D00DIM DRUGCLAS Clinical Trial Drug(s) D00DIM DRUGCOMP Universiteit Maastricht D00DIM HIGHSTAT Phase 1 D00DIZ DRUG__ID D00DIZ D00DIZ COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D00DIZ DRUGCLAS Patented Agent(s) D00DIZ DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven S. CONDROSKI, Kevin Ronald HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy SEO, Jeongbeob D00DIZ DRUGINCH 1S/C23H26FN5O4/c24-15-8-14(9-18(10-15)33-13-17(31)12-30)20-2-1-6-28(20)21-5-7-29-22(27-21)19(11-25-29)23(32)26-16-3-4-16/h5,7-11,16-17,20,30-31H,1-4,6,12-13H2,(H,26,32)/t17?,20-/m1/s1 D00DIZ DRUGINKE YDZSAJWQPHVDHL-UUSAFJCLSA-N D00DIZ DRUGSMIL C1CC(N(C1)C2=NC3=C(C=NN3C=C2)C(=O)NC4CC4)C5=CC(=CC(=C5)F)OCC(CO)O D00DIZ DRUGTYPE Small molecular drug D00DIZ HIGHSTAT Patented D00DJC DRUG__ID D00DJC D00DJC DRUGCLAS Investigative Drug(s) D00DJC DRUGCOMP China Pharmaceutical University D00DJC DRUGINCH 1S/C23H31ClN4O5/c1-4-33-22(30)20-17(13-32-12-11-27-23-25-9-10-26-23)28-14(2)18(21(29)31-3)19(20)15-7-5-6-8-16(15)24/h5-8,17,19-20,28H,4,9-13H2,1-3H3,(H2,25,26,27) D00DJC DRUGINKE LXRRBJNJPCPMOH-UHFFFAOYSA-N D00DJC DRUGSMIL CCOC(=O)C1C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCNC3=NCCN3 D00DJC HIGHSTAT Investigative D00DJE DRUG__ID D00DJE D00DJE DRUGCLAS Investigative Drug(s) D00DJE DRUGINCH 1S/C17H15N3/c1-2-6-13-10-14(9-12(13)5-1)20-17-15-7-3-4-8-16(15)18-11-19-17/h1-8,11,14H,9-10H2,(H,18,19,20) D00DJE DRUGINKE CLVFUKGYGOFREN-UHFFFAOYSA-N D00DJE DRUGSMIL C1C(CC2=CC=CC=C21)NC3=NC=NC4=CC=CC=C43 D00DJE DRUGTYPE Small molecular drug D00DJE HIGHSTAT Investigative D00DJX DRUG__ID D00DJX D00DJX DRUGCLAS Investigative Drug(s) D00DJX DRUGINCH 1S/C30H31NO5/c32-21-7-11-26-27(18-21)35-16-12-25-24-10-6-22(33)19-28(24)36-30(29(25)26)20-4-8-23(9-5-20)34-17-15-31-13-2-1-3-14-31/h4-11,18-19,30,32-33H,1-3,12-17H2/t30-/m1/s1 D00DJX DRUGINKE OFYZVZJXVRFMIW-SSEXGKCCSA-N D00DJX DRUGSMIL C1CCN(CC1)CCOC2=CC=C(C=C2)C3C4=C(CCOC5=C4C=CC(=C5)O)C6=C(O3)C=C(C=C6)O D00DJX DRUGTYPE Small molecular drug D00DJX HIGHSTAT Investigative D00DKK DRUG__ID D00DKK D00DKK DRUGCLAS Approved Drug(s) D00DKK DRUGCOMP Roche Pharmaceuticals D00DKK DRUGINCH 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14- D00DKK DRUGINKE SHGAZHPCJJPHSC-XFYACQKRSA-N D00DKK DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C D00DKK DRUGTYPE Small molecular drug D00DKK HIGHSTAT Approved D00DKK THERCLAS Antiacne Agents D00DLU DRUG__ID D00DLU D00DLU DRUGCLAS Investigative Drug(s) D00DLU DRUGINCH 1S/C20H19Cl2F6NO2/c1-2-3-8-29(11-12-9-15(21)17(30)16(22)10-12)14-6-4-13(5-7-14)18(31,19(23,24)25)20(26,27)28/h4-7,9-10,30-31H,2-3,8,11H2,1H3 D00DLU DRUGINKE TYYLMKBOWXDDCT-UHFFFAOYSA-N D00DLU DRUGSMIL CCCCN(CC1=CC(=C(C(=C1)Cl)O)Cl)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O D00DLU DRUGTYPE Small molecular drug D00DLU HIGHSTAT Investigative D00DNT DRUG__ID D00DNT D00DNT DRUGCLAS Investigative Drug(s) D00DNT DRUGINCH 1S/C20H32O/c1-4-5-6-14-20(2,3)18-12-10-16(11-13-18)17-8-7-9-19(21)15-17/h10-13,17,19,21H,4-9,14-15H2,1-3H3/t17-,19-/m1/s1 D00DNT DRUGINKE RGRMJFXCHLLHAS-IEBWSBKVSA-N D00DNT DRUGSMIL CCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D00DNT DRUGTYPE Small molecular drug D00DNT HIGHSTAT Investigative D00DNY DRUG__ID D00DNY D00DNY DRUGCLAS Investigative Drug(s) D00DNY DRUGINCH 1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3 D00DNY DRUGINKE CTSPAMFJBXKSOY-UHFFFAOYSA-N D00DNY DRUGSMIL CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)C D00DNY DRUGTYPE Small molecular drug D00DNY HIGHSTAT Investigative D00DPJ DRUG__ID D00DPJ D00DPJ DRUGCLAS Approved Drug(s) D00DPJ DRUGINCH 1S/C11H11N3O/c1-15-11-7-9(12)8-13-14(11)10-5-3-2-4-6-10/h2-8,12H,1H3/p+1 D00DPJ DRUGINKE VXROHTDSRBRJLN-UHFFFAOYSA-O D00DPJ DRUGSMIL COC1=[N+](N=CC(=C1)N)C2=CC=CC=C2 D00DPJ DRUGTYPE Small molecular drug D00DPJ HIGHSTAT Approved D00DPP DRUG__ID D00DPP D00DPP DRUGCLAS Clinical Trial Drug(s) D00DPP DRUGINCH 1S/C5H11N.C4H6O5.H3N.Pt/c6-5-3-1-2-4-5;5-2(4(8)9)1-3(6)7;;/h5H,1-4,6H2;2,5H,1H2,(H,6,7)(H,8,9);1H3;/q;;;+2/p-2 D00DPP DRUGINKE OPWOOOGFNULJAQ-UHFFFAOYSA-L D00DPP DRUGSMIL C1CCC(C1)N.C(C(C(=O)[O-])O)C(=O)[O-].N.[Pt+2] D00DPP DRUGTYPE Small molecular drug D00DPP HIGHSTAT Phase 2 D00DPX DRUG__ID D00DPX D00DPX DRUGCLAS Investigative Drug(s) D00DPX DRUGINCH 1S/C30H32N6O3/c1-38-18-17-36-29(32-33-34-36)28(26-20-24-19-25(39-2)13-14-27(24)31-30(26)37)35(21-23-11-7-4-8-12-23)16-15-22-9-5-3-6-10-22/h3-14,19-20,28H,15-18,21H2,1-2H3,(H,31,37) D00DPX DRUGINKE JKKKHIBCTKIWFJ-UHFFFAOYSA-N D00DPX DRUGSMIL COCCN1C(=NN=N1)C(C2=CC3=C(C=CC(=C3)OC)NC2=O)N(CCC4=CC=CC=C4)CC5=CC=CC=C5 D00DPX DRUGTYPE Small molecular drug D00DPX HIGHSTAT Investigative D00DQX DRUG__ID D00DQX D00DQX DRUGCLAS Discontinued Drug(s) D00DQX DRUGCOMP Amgen D00DQX DRUGINCH 1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28) D00DQX DRUGINKE RAHBGWKEPAQNFF-UHFFFAOYSA-N D00DQX DRUGSMIL CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C D00DQX DRUGTYPE Small molecular drug D00DQX HIGHSTAT Discontinued in Phase 3 D00DQZ DRUG__ID D00DQZ D00DQZ DRUGCLAS Investigative Drug(s) D00DQZ DRUGINCH 1S/C17H23NO3S/c1-14(19)22-13-16(20)11-7-2-3-8-12-17(21)18-15-9-5-4-6-10-15/h4-6,9-10H,2-3,7-8,11-13H2,1H3,(H,18,21) D00DQZ DRUGINKE OCDCFMXSXAYLLI-UHFFFAOYSA-N D00DQZ DRUGSMIL CC(=O)SCC(=O)CCCCCCC(=O)NC1=CC=CC=C1 D00DQZ DRUGTYPE Small molecular drug D00DQZ HIGHSTAT Investigative D00DRA DRUG__ID D00DRA D00DRA DRUGCLAS Investigative Drug(s) D00DRA DRUGCOMP Wuhan Katygen Pharmaceuticals Inc D00DRA HIGHSTAT Investigative D00DRL DRUG__ID D00DRL D00DRL DRUGCLAS Clinical Trial Drug(s) D00DRL DRUGINCH 1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1 D00DRL DRUGINKE JGEBLDKNWBUGRZ-HXUWFJFHSA-N D00DRL DRUGSMIL CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)NS(=O)(=O)N(C)CC5COCCO5)N=C2 D00DRL DRUGTYPE Small molecular drug D00DRL HIGHSTAT Phase 1/2 D00DRY DRUG__ID D00DRY D00DRY DRUGCLAS Investigative Drug(s) D00DRY DRUGCOMP Isis Pharmaceuticals D00DRY DRUGTYPE Antisense drug D00DRY HIGHSTAT Investigative D00DSD DRUG__ID D00DSD D00DSD DRUGCLAS Discontinued Drug(s) D00DSD DRUGCOMP Galileo Pharmaceuticals Inc D00DSD HIGHSTAT Terminated D00DSE DRUG__ID D00DSE D00DSE DRUGCLAS Investigative Drug(s) D00DSE DRUGINCH 1S/C18H14FN/c19-18-3-1-2-17(13-18)16-6-4-14(5-7-16)12-15-8-10-20-11-9-15/h1-11,13H,12H2 D00DSE DRUGINKE NDUUGOAGHNLAIZ-UHFFFAOYSA-N D00DSE DRUGSMIL C1=CC(=CC(=C1)F)C2=CC=C(C=C2)CC3=CC=NC=C3 D00DSE DRUGTYPE Small molecular drug D00DSE HIGHSTAT Investigative D00DSG DRUG__ID D00DSG D00DSG DRUGCLAS Investigative Drug(s) D00DSG DRUGCOMP Pfizer Inc D00DSG HIGHSTAT Investigative D00DSN DRUG__ID D00DSN D00DSN DRUGCLAS Investigative Drug(s) D00DSN DRUGCOMP NexBio Inc D00DSN HIGHSTAT Investigative D00DSQ DRUG__ID D00DSQ D00DSQ DRUGCLAS Investigative Drug(s) D00DSQ DRUGINCH 1S/C14H14BrN3OS/c15-11-3-6-13(17-9-11)18-14(20)16-8-7-10-1-4-12(19)5-2-10/h1-6,9,19H,7-8H2,(H2,16,17,18,20) D00DSQ DRUGINKE UAUYJJLEWDLTLK-UHFFFAOYSA-N D00DSQ DRUGSMIL C1=CC(=CC=C1CCNC(=S)NC2=NC=C(C=C2)Br)O D00DSQ DRUGTYPE Small molecular drug D00DSQ HIGHSTAT Investigative D00DSV DRUG__ID D00DSV D00DSV DRUGCLAS Clinical Trial Drug(s) D00DSV DRUGCOMP Vaccinoma Inc D00DSV DRUGTYPE Vaccine D00DSV HIGHSTAT Phase 2 D00DSW DRUG__ID D00DSW D00DSW DRUGCLAS Investigative Drug(s) D00DSW DRUGINCH 1S/C28H20N4O3S/c1-19-27(26(33)16-15-20-9-8-14-23(17-20)32(34)35)36-28(29-19)31-25(22-12-6-3-7-13-22)18-24(30-31)21-10-4-2-5-11-21/h2-18H,1H3/b16-15+ D00DSW DRUGINKE CJUKTJXWIFOPJJ-FOCLMDBBSA-N D00DSW DRUGSMIL CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C=CC5=CC(=CC=C5)[N+](=O)[O-] D00DSW DRUGTYPE Small molecular drug D00DSW HIGHSTAT Investigative D00DTP DRUG__ID D00DTP D00DTP DRUGCLAS Investigative Drug(s) D00DTP DRUGCOMP Zambon Co SpA D00DTP HIGHSTAT Investigative D00DUJ DRUG__ID D00DUJ D00DUJ DRUGCLAS Investigative Drug(s) D00DUJ DRUGINCH 1S/C19H13N/c1-2-8-16-14(6-1)12-19(15-7-5-11-20-13-15)18-10-4-3-9-17(16)18/h1-13H D00DUJ DRUGINKE PNVGXPZDAYDCKZ-UHFFFAOYSA-N D00DUJ DRUGSMIL C1=CC=C2C(=C1)C=C(C3=CC=CC=C23)C4=CN=CC=C4 D00DUJ DRUGTYPE Small molecular drug D00DUJ HIGHSTAT Investigative D00DXB DRUG__ID D00DXB D00DXB DRUGCLAS Investigative Drug(s) D00DXB DRUGINCH 1S/C8H15NO2S/c10-8(11)7(5-12)6-2-1-3-9-4-6/h6-7,9,12H,1-5H2,(H,10,11) D00DXB DRUGINKE ZEKJYPSRDZCIDP-UHFFFAOYSA-N D00DXB DRUGSMIL C1CC(CNC1)C(CS)C(=O)O D00DXB DRUGTYPE Small molecular drug D00DXB HIGHSTAT Investigative D00DXC DRUG__ID D00DXC D00DXC DRUGCLAS Patented Agent(s) D00DXC DRUGCOMP CS THERAPEUTICS INC D00DXC DRUGINCH 1S/C20H18FN5O3/c1-11-14-8-13(21)3-4-16(14)27-5-6-28-20-18(15(9-22)26(2)25-20)12-7-17(29-11)19(23)24-10-12/h3-4,7-8,10-11H,5-6H2,1-2H3,(H2,23,24) D00DXC DRUGINKE IAURDDBZTWBKOT-UHFFFAOYSA-N D00DXC DRUGSMIL CC1C2=C(C=CC(=C2)F)OCCOC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C D00DXC DRUGTYPE Small molecular drug D00DXC HIGHSTAT Patented D00DXH DRUG__ID D00DXH D00DXH DRUGCLAS Clinical Trial Drug(s) D00DXH DRUGCOMP Eli Lilly & Co D00DXH HIGHSTAT Phase 1 D00DXI DRUG__ID D00DXI D00DXI DRUGCLAS Investigative Drug(s) D00DXI DRUGINCH 1S/C15H17N3O4S/c1-8-4-10(3)15(23(20,21)22)7-12(8)17-18-13-5-9(2)14(19)6-11(13)16/h4-7,19H,16H2,1-3H3,(H,20,21,22) D00DXI DRUGINKE UUECJWRVDTUDCB-UHFFFAOYSA-N D00DXI DRUGSMIL CC1=CC(=C(C=C1N=NC2=C(C=C(C(=C2)C)O)N)S(=O)(=O)O)C D00DXI DRUGTYPE Small molecular drug D00DXI HIGHSTAT Investigative D00DXV DRUG__ID D00DXV D00DXV DRUGCLAS Investigative Drug(s) D00DXV DRUGINCH 1S/C24H23BrN4O8S2/c1-34-19-9-18(30)15(20(21(19)25)23(31)35-2)10-38-11-17(22-28-37-8-7-36-22)27-24-26-16(12-39-24)13-3-5-14(6-4-13)29(32)33/h3-6,9,12,17,30H,7-8,10-11H2,1-2H3,(H,26,27)/t17-/m0/s1 D00DXV DRUGINKE MRGBDARDZKENAD-KRWDZBQOSA-N D00DXV DRUGSMIL COC1=C(C(=C(C(=C1)O)CSCC(C2=NOCCO2)NC3=NC(=CS3)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)OC)Br D00DXV DRUGTYPE Small molecular drug D00DXV HIGHSTAT Investigative D00DYI DRUG__ID D00DYI D00DYI COMPCLAS Benzothiazole analogs D00DYI DRUGCLAS Patented Agent(s) D00DYI DRUGINCH 1S/C13H9NOS/c15-10-7-5-9(6-8-10)13-14-11-3-1-2-4-12(11)16-13/h1-8,15H D00DYI DRUGINKE ODMDLCWSMSFWCW-UHFFFAOYSA-N D00DYI DRUGSMIL C1=CC=C2C(=C1)N=C(S2)C3=CC=C(C=C3)O D00DYI DRUGTYPE Small molecular drug D00DYI HIGHSTAT Patented D00DYK DRUG__ID D00DYK D00DYK DRUGCLAS Clinical Trial Drug(s) D00DYK DRUGCOMP Johns Hopkins University D00DYK DRUGINCH 1S/C28H42O4S/c1-19(9-8-16-33(31,32)27(3,4)5)24-13-14-25-21(10-7-15-28(24,25)6)11-12-22-17-23(29)18-26(30)20(22)2/h8,11-13,16,19,23,25-26,29-30H,2,7,9-10,14-15,17-18H2,1,3-6H3/b16-8+,21-11+,22-12-/t19-,23-,25+,26+,28-/m1/s1 D00DYK DRUGINKE RFQHCLMGLJGZNV-UXXOMSPDSA-N D00DYK DRUGSMIL CC(CC=CS(=O)(=O)C(C)(C)C)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C D00DYK DRUGTYPE Small molecular drug D00DYK HIGHSTAT Phase 2 D00DYN DRUG__ID D00DYN D00DYN DRUGCLAS Clinical Trial Drug(s) D00DYN DRUGCOMP DynPort Vaccine Company D00DYN HIGHSTAT Phase 1 D00DYQ DRUG__ID D00DYQ D00DYQ DRUGCLAS Investigative Drug(s) D00DYQ DRUGCOMP Isis Pharmaceuticals D00DYQ DRUGTYPE Antisense drug D00DYQ HIGHSTAT Investigative D00DZN DRUG__ID D00DZN D00DZN DRUGCLAS Approved Drug(s) D00DZN DRUGINCH 1S/C10H12ClNO/c11-7-6-10(13)12-8-9-4-2-1-3-5-9/h1-5H,6-8H2,(H,12,13) D00DZN DRUGINKE JPYQFYIEOUVJDU-UHFFFAOYSA-N D00DZN DRUGSMIL C1=CC=C(C=C1)CNC(=O)CCCl D00DZN DRUGTYPE Small molecular drug D00DZN HIGHSTAT Approved D00DZY DRUG__ID D00DZY D00DZY DRUGCLAS Investigative Drug(s) D00DZY DRUGINCH 1S/C16H18N2O2S/c19-21(20,14-6-2-1-3-7-14)16-9-5-4-8-15(16)18-12-10-17-11-13-18/h1-9,17H,10-13H2 D00DZY DRUGINKE QHMSQHVDMJCBCI-UHFFFAOYSA-N D00DZY DRUGSMIL C1CN(CCN1)C2=CC=CC=C2S(=O)(=O)C3=CC=CC=C3 D00DZY DRUGTYPE Small molecular drug D00DZY HIGHSTAT Investigative D00EBH DRUG__ID D00EBH D00EBH DRUGCLAS Discontinued Drug(s) D00EBH DRUGCOMP Zeneca Group plc D00EBH DRUGINCH 1S/C21H24N2S.ClH/c1-21(2,23(3)4)15-24-20-18(16-10-6-5-7-11-16)14-17-12-8-9-13-19(17)22-20;/h5-14H,15H2,1-4H3;1H D00EBH DRUGINKE HVIXPSLXHVWFAU-UHFFFAOYSA-N D00EBH DRUGSMIL CC(C)(CSC1=NC2=CC=CC=C2C=C1C3=CC=CC=C3)N(C)C.Cl D00EBH DRUGTYPE Small molecular drug D00EBH HIGHSTAT Discontinued in Phase 2 D00EBN DRUG__ID D00EBN D00EBN COMPCLAS Imidazopyridine acetamide analogs D00EBN DRUGCLAS Patented Agent(s) D00EBN DRUGTYPE Small molecular drug D00EBN HIGHSTAT Patented D00ECB DRUG__ID D00ECB D00ECB DRUGCLAS Discontinued Drug(s) D00ECB DRUGCOMP Taisho Pharmaceutical Co Ltd D00ECB DRUGINCH 1S/C21H24N4O12/c1-12(37-25(32)33)11-35-21(27)18-14(3)22-13(2)17(20(26)34-8-5-9-36-24(30)31)19(18)15-6-4-7-16(10-15)23(28)29/h4,6-7,10,12,19,22H,5,8-9,11H2,1-3H3 D00ECB DRUGINKE QSTCLWROWBZZLA-UHFFFAOYSA-N D00ECB DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC(C)O[N+](=O)[O-])C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCCO[N+](=O)[O-] D00ECB DRUGTYPE Small molecular drug D00ECB HIGHSTAT Discontinued in Phase 2 D00ECO DRUG__ID D00ECO D00ECO DRUGCLAS Discontinued Drug(s) D00ECO DRUGINCH 1S/C13H19NOS/c1-14-9-2-3-11(14)8-10-16-13-6-4-12(15)5-7-13/h4-7,11,15H,2-3,8-10H2,1H3 D00ECO DRUGINKE NVZGJSVPOOILDI-UHFFFAOYSA-N D00ECO DRUGSMIL CN1CCCC1CCSC2=CC=C(C=C2)O D00ECO DRUGTYPE Small molecular drug D00ECO HIGHSTAT Discontinued in Phase 2 D00ECV DRUG__ID D00ECV D00ECV DRUGCLAS Investigative Drug(s) D00ECV DRUGINCH 1S/C23H25NO8S3/c1-16(24-33(4,25)26)17-5-10-20(11-6-17)34(27,28)22-14-9-19(32-3)15-23(22)35(29,30)21-12-7-18(31-2)8-13-21/h5-16,24H,1-4H3/i2-1 D00ECV DRUGINKE NXODIUKWAVUFGF-JVVVGQRLSA-N D00ECV DRUGSMIL CC(C1=CC=C(C=C1)S(=O)(=O)C2=C(C=C(C=C2)OC)S(=O)(=O)C3=CC=C(C=C3)OC)NS(=O)(=O)C D00ECV DRUGTYPE Small molecular drug D00ECV HIGHSTAT Investigative D00ECX DRUG__ID D00ECX D00ECX DRUGCLAS Patented Agent(s) D00ECX DRUGINCH 1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-2-4-11(16)5-3-9/h2-7,19H,8H2,1H3,(H,18,21) D00ECX DRUGINKE BYGKIXAXITXFDW-UHFFFAOYSA-N D00ECX DRUGSMIL COC(=O)CNC(=O)C1=C(C=C(C=N1)C2=CC=C(C=C2)Cl)O D00ECX DRUGTYPE Small molecular drug D00ECX HIGHSTAT Patented D00EEL DRUG__ID D00EEL D00EEL DRUGCLAS Approved Drug(s) D00EEL DRUGCOMP Merck & Co D00EEL DRUGINCH 1S/C6H8N2O2/c9-6-4-1-2-7-3-5(4)10-8-6/h7H,1-3H2,(H,8,9) D00EEL DRUGINKE ZXRVKCBLGJOCEE-UHFFFAOYSA-N D00EEL DRUGSMIL C1CNCC2=C1C(=O)NO2 D00EEL DRUGTYPE Small molecular drug D00EEL HIGHSTAT Approved D00EEL THERCLAS Hypnotics and Sedatives D00EEP DRUG__ID D00EEP D00EEP DRUGCLAS Discontinued Drug(s) D00EEP DRUGCOMP Teikoku Chemical Industries Co Ltd D00EEP HIGHSTAT Discontinued in Phase 1 D00EEU DRUG__ID D00EEU D00EEU DRUGCLAS Investigative Drug(s) D00EEU DRUGINCH 1S/C59H92N16O12S/c1-35(2)30-42(52(81)69-40(49(62)78)24-29-88-4)68-48(77)33-66-51(80)43(31-37-16-7-5-8-17-37)71-53(82)44(32-38-18-9-6-10-19-38)72-54(83)45(34-76)73-50(79)36(3)67-55(84)46-22-15-28-75(46)58(87)41(21-11-12-25-60)70-56(85)47-23-14-27-74(47)57(86)39(61)20-13-26-65-59(63)64/h5-10,16-19,35-36,39-47,76H,11-15,20-34,60-61H2,1-4H3,(H2,62,78)(H,66,80)(H,67,84)(H,68,77)(H,69,81)(H,70,85)(H,71,82)(H,72,83)(H,73,79)(H4,63,64,65)/t36-,39-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1 D00EEU DRUGINKE HMZBUUAKDIVOFX-KWWDQKRUSA-N D00EEU DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(C)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D00EEU HIGHSTAT Investigative D00EFA DRUG__ID D00EFA D00EFA DRUGCLAS Investigative Drug(s) D00EFA DRUGINCH 1S/C20H22N4O2/c25-19(22-16-4-2-1-3-5-16)23-17-10-14-11-20(26-18(14)21-12-17)13-24-8-6-15(20)7-9-24/h1-5,10,12,15H,6-9,11,13H2,(H2,22,23,25)/t20-/m0/s1 D00EFA DRUGINKE BUOWEYLLAFLKCW-FQEVSTJZSA-N D00EFA DRUGSMIL C1CN2CCC1C3(C2)CC4=C(O3)N=CC(=C4)NC(=O)NC5=CC=CC=C5 D00EFA DRUGTYPE Small molecular drug D00EFA HIGHSTAT Investigative D00EFD DRUG__ID D00EFD D00EFD DRUGCLAS Investigative Drug(s) D00EFD DRUGCOMP CoNCERT Pharmaceuticals Inc D00EFD HIGHSTAT Investigative D00EFO DRUG__ID D00EFO D00EFO DRUGCLAS Clinical Trial Drug(s) D00EFO DRUGCOMP Hanall biopharma; medtronic D00EFO HIGHSTAT Phase 2 D00EFT DRUG__ID D00EFT D00EFT DRUGCLAS Clinical Trial Drug(s) D00EFT DRUGINCH 1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 D00EFT DRUGINKE LRQKBLKVPFOOQJ-YFKPBYRVSA-N D00EFT DRUGSMIL CCCCC(C(=O)O)N D00EFT DRUGTYPE Small molecular drug D00EFT HIGHSTAT Phase 1/2 D00EGN DRUG__ID D00EGN D00EGN DRUGCLAS Clinical Trial Drug(s) D00EGN DRUGCOMP E-Therapeutics Ltd D00EGN HIGHSTAT Phase 2 D00EGU DRUG__ID D00EGU D00EGU DRUGCLAS Clinical Trial Drug(s) D00EGU HIGHSTAT Phase 1 D00EGV DRUG__ID D00EGV D00EGV DRUGCLAS Patented Agent(s) D00EGV DRUGCOMP UNILEVER PLC UNILEVER N.V. HINDUSTAN UNILEVER LIMITED ROSA, Jose, Guillermo HARICHIAN, Bijan DRENNAN, Diana, Jean BAJOR, John, Steven BOSKO, Carol, Annette D00EGV DRUGINCH 1S/C21H21NO/c1-3-8-18(9-4-1)14-15-22-17-19-10-7-13-21(16-19)23-20-11-5-2-6-12-20/h1-13,16,22H,14-15,17H2 D00EGV DRUGINKE VXWOCJGIIONIQR-UHFFFAOYSA-N D00EGV DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC(=CC=C2)OC3=CC=CC=C3 D00EGV DRUGTYPE Small molecular drug D00EGV HIGHSTAT Patented D00EHP DRUG__ID D00EHP D00EHP DRUGCLAS Investigative Drug(s) D00EHP DRUGINCH 1S/C15H19NO2S/c1-10-6-12(3)15(13(4)7-10)19(17,18)16-9-11(2)8-14(16)5/h6-9H,1-5H3 D00EHP DRUGINKE AFZWZVLPIMHLSE-UHFFFAOYSA-N D00EHP DRUGSMIL CC1=CC(=C(C(=C1)C)S(=O)(=O)N2C=C(C=C2C)C)C D00EHP DRUGTYPE Small molecular drug D00EHP HIGHSTAT Investigative D00EHX DRUG__ID D00EHX D00EHX DRUGCLAS Clinical Trial Drug(s) D00EHX DRUGCOMP Northwestern University D00EHX DRUGINCH 1S/C23H21N7/c1-2-5-19(6-3-1)21-17-20(18-7-11-24-12-8-18)22(28-27-21)29-13-15-30(16-14-29)23-25-9-4-10-26-23/h1-12,17H,13-16H2 D00EHX DRUGINKE ZPJGUEPHFXPAQF-UHFFFAOYSA-N D00EHX DRUGSMIL C1CN(CCN1C2=NN=C(C=C2C3=CC=NC=C3)C4=CC=CC=C4)C5=NC=CC=N5 D00EHX HIGHSTAT Phase 1 D00EIB DRUG__ID D00EIB D00EIB DRUGCLAS Approved Drug(s) D00EIB HIGHSTAT Approved D00EIL DRUG__ID D00EIL D00EIL DRUGCLAS Investigative Drug(s) D00EIL DRUGCOMP CG Pharmaceuticals Inc D00EIL DRUGINCH 1S/C18H15N3O3S/c1-21-10-11(13-4-2-3-5-17(13)21)8-15-14-9-12(25(19,23)24)6-7-16(14)20-18(15)22/h2-10H,1H3,(H,20,22)(H2,19,23,24)/b15-8- D00EIL DRUGINKE MLKHXLFEYOOYEY-NVNXTCNLSA-N D00EIL DRUGSMIL CN1C=C(C2=CC=CC=C21)C=C3C4=C(C=CC(=C4)S(=O)(=O)N)NC3=O D00EIL DRUGTYPE Small molecular drug D00EIL HIGHSTAT Investigative D00EJP DRUG__ID D00EJP D00EJP DRUGCLAS Clinical Trial Drug(s) D00EJP DRUGCOMP GlaxoSmithKline D00EJP HIGHSTAT Phase 2 D00EJS DRUG__ID D00EJS D00EJS DRUGCLAS Investigative Drug(s) D00EJS DRUGINCH 1S/C8H7NO/c10-7-1-2-8-6(5-7)3-4-9-8/h1-5,9-10H D00EJS DRUGINKE LMIQERWZRIFWNZ-UHFFFAOYSA-N D00EJS DRUGSMIL C1=CC2=C(C=CN2)C=C1O D00EJS DRUGTYPE Small molecular drug D00EJS HIGHSTAT Investigative D00EKM DRUG__ID D00EKM D00EKM DRUGCLAS Investigative Drug(s) D00EKM DRUGCOMP Vision 7 GmbH D00EKM HIGHSTAT Investigative D00EMB DRUG__ID D00EMB D00EMB DRUGCLAS Clinical Trial Drug(s) D00EMB DRUGCOMP GlaxoSmithKline plc D00EMB HIGHSTAT Phase 2 D00EMF DRUG__ID D00EMF D00EMF DRUGCLAS Investigative Drug(s) D00EMF DRUGINCH 1S/C21H19ClN4O2/c1-13-10-15-7-9-26(18(15)11-17(13)22)21(27)25-16-5-6-20(24-12-16)28-19-4-3-8-23-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,25,27) D00EMF DRUGINKE GIUZEIJUFOPTMR-UHFFFAOYSA-N D00EMF DRUGSMIL CC1=CC2=C(C=C1Cl)N(CC2)C(=O)NC3=CN=C(C=C3)OC4=C(N=CC=C4)C D00EMF DRUGTYPE Small molecular drug D00EMF HIGHSTAT Investigative D00EMH DRUG__ID D00EMH D00EMH DRUGCLAS Investigative Drug(s) D00EMH DRUGINCH 1S/C29H32ClFN8O3/c1-29(2)14-22(36-28(42)39-11-4-5-12-39)26(41)35-21-13-16(9-10-18(21)29)34-27-33-15-19(30)24(38-27)37-23-17(25(40)32-3)7-6-8-20(23)31/h6-10,13,15,22H,4-5,11-12,14H2,1-3H3,(H,32,40)(H,35,41)(H,36,42)(H2,33,34,37,38)/t22-/m1/s1 D00EMH DRUGINKE HGSNUBHWAMMKIR-JOCHJYFZSA-N D00EMH DRUGSMIL CC1(CC(C(=O)NC2=C1C=CC(=C2)NC3=NC=C(C(=N3)NC4=C(C=CC=C4F)C(=O)NC)Cl)NC(=O)N5CCCC5)C D00EMH DRUGTYPE Small molecular drug D00EMH HIGHSTAT Investigative D00EML DRUG__ID D00EML D00EML DRUGCLAS Discontinued Drug(s) D00EML DRUGCOMP CSL Ltd D00EML HIGHSTAT Terminated D00ENC DRUG__ID D00ENC D00ENC DRUGCLAS Investigative Drug(s) D00ENC DRUGINCH 1S/C5H8O3/c1-4(6)2-3-5(7)8/h2-4,6H,1H3,(H,7,8)/b3-2+ D00ENC DRUGINKE YANJKPZKTWMMOF-NSCUHMNNSA-N D00ENC DRUGSMIL CC(C=CC(=O)O)O D00ENC DRUGTYPE Small molecular drug D00ENC HIGHSTAT Investigative D00ENR DRUG__ID D00ENR D00ENR DRUGCLAS Investigative Drug(s) D00ENR DRUGINCH 1S/C17H14O4/c1-2-12(18)11-7-6-10-8-9-4-3-5-13(19)14(9)17(21)15(10)16(11)20/h3-7,19-20H,2,8H2,1H3 D00ENR DRUGINKE KGAHUIIBPUKUER-UHFFFAOYSA-N D00ENR DRUGSMIL CCC(=O)C1=C(C2=C(CC3=C(C2=O)C(=CC=C3)O)C=C1)O D00ENR DRUGTYPE Small molecular drug D00ENR HIGHSTAT Investigative D00ENU DRUG__ID D00ENU D00ENU DRUGCLAS Investigative Drug(s) D00ENU DRUGCOMP Cellmid Ltd D00ENU HIGHSTAT Investigative D00ENY DRUG__ID D00ENY D00ENY DRUGCLAS Approved Drug(s) D00ENY DRUGINCH 1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 D00ENY DRUGINKE WHUUTDBJXJRKMK-VKHMYHEASA-N D00ENY DRUGSMIL C(CC(=O)O)C(C(=O)O)N D00ENY DRUGTYPE Small molecular drug D00ENY HIGHSTAT Approved D00ENY THERCLAS Dietary supplement D00EOD DRUG__ID D00EOD D00EOD DRUGCLAS Investigative Drug(s) D00EOD DRUGINCH 1S/C20H22O7/c1-5-10(2)18(23)26-15-8-20(4)16(22)7-13(27-20)12(9-21)6-14-17(15)11(3)19(24)25-14/h5-7,14-15,17,21H,3,8-9H2,1-2,4H3/b10-5-,12-6-/t14-,15+,17+,20-/m1/s1 D00EOD DRUGINKE BMVJFNLJSZHNNS-YUDFMKBLSA-N D00EOD DRUGSMIL CC=C(C)C(=O)OC1CC2(C(=O)C=C(O2)C(=CC3C1C(=C)C(=O)O3)CO)C D00EOD DRUGTYPE Small molecular drug D00EOD HIGHSTAT Investigative D00EOP DRUG__ID D00EOP D00EOP DRUGCLAS Investigative Drug(s) D00EOP DRUGINCH 1S/C22H20N2O4S/c1-14-18(23-21(28-14)16-5-3-2-4-6-16)11-12-27-17-9-7-15(8-10-17)13-19-20(25)24-22(26)29-19/h2-10,19H,11-13H2,1H3,(H,24,25,26) D00EOP DRUGINKE GUTCYOKMCPFRGH-UHFFFAOYSA-N D00EOP DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC4C(=O)NC(=O)S4 D00EOP DRUGTYPE Small molecular drug D00EOP HIGHSTAT Investigative D00EPB DRUG__ID D00EPB D00EPB DRUGCLAS Investigative Drug(s) D00EPB DRUGCOMP Isis Pharmaceuticals D00EPB DRUGTYPE Antisense drug D00EPB HIGHSTAT Investigative D00EPD DRUG__ID D00EPD D00EPD DRUGCLAS Investigative Drug(s) D00EPD DRUGINCH 1S/C10H7ClN2O3S/c11-7-3-1-2-4-8(7)17(15,16)10-6-5-9(14)12-13-10/h1-6H,(H,12,14) D00EPD DRUGINKE FTLDTGWMVVXYAM-UHFFFAOYSA-N D00EPD DRUGSMIL C1=CC=C(C(=C1)S(=O)(=O)C2=NNC(=O)C=C2)Cl D00EPD DRUGTYPE Small molecular drug D00EPD HIGHSTAT Investigative D00EPL DRUG__ID D00EPL D00EPL DRUGCLAS Investigative Drug(s) D00EPL DRUGINCH 1S/C19H19N5/c1-3-7-16-14(5-1)13-15-6-2-4-8-17(15)24-18(16)21-22-19(24)23-11-9-20-10-12-23/h1-8,20H,9-13H2 D00EPL DRUGINKE GXFWOMYQHNODFA-UHFFFAOYSA-N D00EPL DRUGSMIL C1CN(CCN1)C2=NN=C3N2C4=CC=CC=C4CC5=CC=CC=C53 D00EPL DRUGTYPE Small molecular drug D00EPL HIGHSTAT Investigative D00EPM DRUG__ID D00EPM D00EPM DRUGCLAS Investigative Drug(s) D00EPM DRUGINCH 1S/C13H8ClFN4O/c14-9-1-2-12(17-7-9)19-13(20)18-11-4-8(6-16)3-10(15)5-11/h1-5,7H,(H2,17,18,19,20) D00EPM DRUGINKE KDANLHLWAYNCMV-UHFFFAOYSA-N D00EPM DRUGSMIL C1=CC(=NC=C1Cl)NC(=O)NC2=CC(=CC(=C2)C#N)F D00EPM DRUGTYPE Small molecular drug D00EPM HIGHSTAT Investigative D00EPS DRUG__ID D00EPS D00EPS DRUGCLAS Clinical Trial Drug(s) D00EPS DRUGINCH 1S/C21H27N5O6S/c22-19(23)16-8-6-14(7-9-16)10-24-20(29)17(11-27)25-21(30)18(12-28)26-33(31,32)13-15-4-2-1-3-5-15/h1-9,17-18,26-28H,10-13H2,(H3,22,23)(H,24,29)(H,25,30)/t17-,18+/m0/s1 D00EPS DRUGINKE ZNOKJHWJKULOGM-ZWKOTPCHSA-N D00EPS DRUGSMIL C1=CC=C(C=C1)CS(=O)(=O)NC(CO)C(=O)NC(CO)C(=O)NCC2=CC=C(C=C2)C(=N)N D00EPS DRUGTYPE Small molecular drug D00EPS HIGHSTAT Clinical trial D00EPT DRUG__ID D00EPT D00EPT DRUGCLAS Clinical Trial Drug(s) D00EPT DRUGCOMP Eisai D00EPT DRUGINCH 1S/C15H18O3/c1-8-6-10-12(11(8)7-16)9(2)15(4-5-15)14(3,18)13(10)17/h6,16,18H,4-5,7H2,1-3H3/t14-/m0/s1 D00EPT DRUGINKE NICJCIQSJJKZAH-AWEZNQCLSA-N D00EPT DRUGSMIL CC1=C(C2=C(C3(CC3)C(C(=O)C2=C1)(C)O)C)CO D00EPT DRUGTYPE Small molecular drug D00EPT HIGHSTAT Phase 2 D00EQD DRUG__ID D00EQD D00EQD DRUGCLAS Investigative Drug(s) D00EQD DRUGCOMP Proneuron Biotechnologies Inc D00EQD HIGHSTAT Investigative D00EQL DRUG__ID D00EQL D00EQL DRUGCLAS Approved Drug(s) D00EQL DRUGCOMP Epizyme D00EQL DRUGINCH 1S/C34H44N4O4/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40) D00EQL DRUGINKE NSQSAUGJQHDYNO-UHFFFAOYSA-N D00EQL DRUGSMIL CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5 D00EQL DRUGTYPE Small molecular drug D00EQL HIGHSTAT Approved D00EQY DRUG__ID D00EQY D00EQY DRUGCLAS Clinical Trial Drug(s) D00EQY DRUGCOMP Kolltan pharmaceuticals D00EQY DRUGTYPE Antibody D00EQY HIGHSTAT Phase 1 D00ERI DRUG__ID D00ERI D00ERI DRUGCLAS Investigative Drug(s) D00ERI DRUGCOMP Isis Pharmaceuticals D00ERI DRUGTYPE Antisense drug D00ERI HIGHSTAT Investigative D00ERV DRUG__ID D00ERV D00ERV DRUGCLAS Clinical Trial Drug(s) D00ERV DRUGINCH 1S/C28H40N2O5/c1-20(2)28(19-29,22-17-25(33-6)27(35-8)26(18-22)34-7)13-9-14-30(3)15-12-21-10-11-23(31-4)24(16-21)32-5/h10-11,16-18,20H,9,12-15H2,1-8H3 D00ERV DRUGINKE XQLWNAFCTODIRK-UHFFFAOYSA-N D00ERV DRUGSMIL CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC D00ERV DRUGTYPE Small molecular drug D00ERV HIGHSTAT Phase 2 D00ERW DRUG__ID D00ERW D00ERW DRUGCLAS Investigative Drug(s) D00ERW DRUGINCH 1S/C20H18ClN7O3S/c21-13-5-15-17(6-14(13)24-9-12-8-23-11-32-12)30-3-1-2-4-31-19-16(7-22)25-10-18(27-19)28-20(29)26-15/h5-6,8,10-11,24H,1-4,9H2,(H2,26,27,28,29) D00ERW DRUGINKE AZTMYWWWILJAKW-UHFFFAOYSA-N D00ERW DRUGSMIL C1CCOC2=NC(=CN=C2C#N)NC(=O)NC3=CC(=C(C=C3OC1)NCC4=CN=CS4)Cl D00ERW DRUGTYPE Small molecular drug D00ERW HIGHSTAT Investigative D00ESG DRUG__ID D00ESG D00ESG DRUGCLAS Investigative Drug(s) D00ESG DRUGINCH 1S/C10H14N4O/c11-10(15)14-7-5-13(6-8-14)9-3-1-2-4-12-9/h1-4H,5-8H2,(H2,11,15) D00ESG DRUGINKE XYIDWLYTWKIZQC-UHFFFAOYSA-N D00ESG DRUGSMIL C1CN(CCN1C2=CC=CC=N2)C(=O)N D00ESG DRUGTYPE Small molecular drug D00ESG HIGHSTAT Investigative D00ESH DRUG__ID D00ESH D00ESH DRUGCLAS Clinical Trial Drug(s) D00ESH DRUGCOMP Northwest biotherapeutics D00ESH HIGHSTAT Phase 1/2 D00ETS DRUG__ID D00ETS D00ETS DRUGCLAS Approved Drug(s) D00ETS DRUGINCH 1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17) D00ETS DRUGINKE UYXAWHWODHRRMR-UHFFFAOYSA-N D00ETS DRUGSMIL CC1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2 D00ETS DRUGTYPE Small molecular drug D00ETS HIGHSTAT Approved D00ETS THERCLAS Hypnotics and Sedatives D00EUD DRUG__ID D00EUD D00EUD DRUGCLAS Investigative Drug(s) D00EUD DRUGINCH 1S/C11H17NS/c1-3-10(12)8-9-4-6-11(13-2)7-5-9/h4-7,10H,3,8,12H2,1-2H3 D00EUD DRUGINKE DTEDVKORISMLCH-UHFFFAOYSA-N D00EUD DRUGSMIL CCC(CC1=CC=C(C=C1)SC)N D00EUD DRUGTYPE Small molecular drug D00EUD HIGHSTAT Investigative D00EUE DRUG__ID D00EUE D00EUE DRUGCLAS Investigative Drug(s) D00EUE DRUGINCH 1S/C3H7NO5S2/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/t2-/m0/s1 D00EUE DRUGINKE NOKPBJYHPHHWAN-REOHCLBHSA-N D00EUE DRUGSMIL C(C(C(=O)O)N)SS(=O)(=O)O D00EUE DRUGTYPE Small molecular drug D00EUE HIGHSTAT Investigative D00EUL DRUG__ID D00EUL D00EUL DRUGCLAS Patented Agent(s) D00EUL DRUGCOMP MERCK SHARP & DOHME CORP D00EUL HIGHSTAT Patented D00EVC DRUG__ID D00EVC D00EVC DRUGCLAS Investigative Drug(s) D00EVC DRUGINCH 1S/C10H16N2/c1-7(2)4-9-5-8(3)6-10(11)12-9/h5-7H,4H2,1-3H3,(H2,11,12) D00EVC DRUGINKE VMTPVCVORKDABN-UHFFFAOYSA-N D00EVC DRUGSMIL CC1=CC(=NC(=C1)N)CC(C)C D00EVC DRUGTYPE Small molecular drug D00EVC HIGHSTAT Investigative D00EVP DRUG__ID D00EVP D00EVP DRUGCLAS Clinical Trial Drug(s) D00EVP DRUGCOMP Allergan Inc D00EVP DRUGINCH 1S/C26H35NO5S/c1-4-5-6-7-23(28)19-8-10-20(11-9-19)27-21(12-15-25(27)29)16-31-17-22-13-14-24(33-22)26(30)32-18(2)3/h8-11,13-14,18,21,23,28H,4-7,12,15-17H2,1-3H3/t21-,23+/m1/s1 D00EVP DRUGINKE MSIIJNOQQWRTFC-GGAORHGYSA-N D00EVP DRUGSMIL CCCCCC(C1=CC=C(C=C1)N2C(CCC2=O)COCC3=CC=C(S3)C(=O)OC(C)C)O D00EVP DRUGTYPE Small molecular drug D00EVP HIGHSTAT Phase 2 D00EWP DRUG__ID D00EWP D00EWP DRUGCLAS Investigative Drug(s) D00EWP DRUGINCH 1S/C18H14N2O4/c1-9(21)19-11-3-5-13-15(7-11)18(24)16-8-12(20-10(2)22)4-6-14(16)17(13)23/h3-8H,1-2H3,(H,19,21)(H,20,22) D00EWP DRUGINKE SNSGXIQBZKNIJT-UHFFFAOYSA-N D00EWP DRUGSMIL CC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)C D00EWP DRUGTYPE Small molecular drug D00EWP HIGHSTAT Investigative D00EWR DRUG__ID D00EWR D00EWR DRUGCLAS Clinical Trial Drug(s) D00EWR DRUGCOMP Sanwa Kagaku D00EWR DRUGINCH 1S/C12H10FN3O4/c13-5-1-2-7-6(3-5)12(4-8(20-7)9(14)17)10(18)15-11(19)16-12/h1-3,8H,4H2,(H2,14,17)(H2,15,16,18,19)/t8-,12-/m0/s1 D00EWR DRUGINKE WAAPEIZFCHNLKK-UFBFGSQYSA-N D00EWR DRUGSMIL C1C(OC2=C(C13C(=O)NC(=O)N3)C=C(C=C2)F)C(=O)N D00EWR DRUGTYPE Small molecular drug D00EWR HIGHSTAT Phase 3 D00EXZ DRUG__ID D00EXZ D00EXZ DRUGCLAS Clinical Trial Drug(s) D00EXZ HIGHSTAT Phase 1 D00EYC DRUG__ID D00EYC D00EYC DRUGCLAS Clinical Trial Drug(s) D00EYC DRUGCOMP Catalyst biosciences; pfizer D00EYC HIGHSTAT Phase 1 D00EYF DRUG__ID D00EYF D00EYF DRUGCLAS Investigative Drug(s) D00EYF DRUGCOMP Ambrx Inc D00EYF HIGHSTAT Investigative D00EYY DRUG__ID D00EYY D00EYY DRUGCLAS Investigative Drug(s) D00EYY DRUGINCH 1S/C33H41N5O3.ClH/c1-7-8-15-38-31-25(13-10-14-35-31)28(23-11-9-12-24(18-23)41-6)30(32(38)39)37-33(40)36-29-26(20(2)3)16-22(19-34)17-27(29)21(4)5;/h9-14,16-18,20-21H,7-8,15,19,34H2,1-6H3,(H2,36,37,40);1H D00EYY DRUGINKE SZCBDIVMCGFVPW-UHFFFAOYSA-N D00EYY DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)CN)C(C)C)C4=CC(=CC=C4)OC.Cl D00EYY DRUGTYPE Small molecular drug D00EYY HIGHSTAT Investigative D00EZE DRUG__ID D00EZE D00EZE DRUGCLAS Discontinued Drug(s) D00EZE DRUGCOMP Merck KGaA D00EZE DRUGINCH 1S/C23H26N2O6/c1-28-18-5-3-17(4-6-18)25-14-19(31-22(25)26)13-24-10-8-23(27,9-11-24)16-2-7-20-21(12-16)30-15-29-20/h2-7,12,19,27H,8-11,13-15H2,1H3/t19-/m0/s1 D00EZE DRUGINKE NINYZUDVKTUKIA-IBGZPJMESA-N D00EZE DRUGSMIL COC1=CC=C(C=C1)N2CC(OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O D00EZE DRUGTYPE Small molecular drug D00EZE HIGHSTAT Discontinued in Phase 2 D00EZO DRUG__ID D00EZO D00EZO DRUGCLAS Clinical Trial Drug(s) D00EZO DRUGCOMP Targacept D00EZO DRUGINCH 1S/C12H17N3/c1-3-11(9-13-6-1)15-8-5-12(10-15)4-2-7-14-12/h1,3,6,9,14H,2,4-5,7-8,10H2 D00EZO DRUGINKE NXIPMBQVNTWEEX-UHFFFAOYSA-N D00EZO DRUGSMIL C1CC2(CCN(C2)C3=CN=CC=C3)NC1 D00EZO DRUGTYPE Small molecular drug D00EZO HIGHSTAT Phase 1 D00FAE DRUG__ID D00FAE D00FAE DRUGCLAS Investigative Drug(s) D00FAE DRUGINCH 1S/C49H69N15O12S/c50-30(10-5-15-55-48(51)52)41(70)58-31(11-6-16-56-49(53)54)45(74)62-17-7-13-35(62)47(76)63-22-29(66)20-36(63)43(72)57-21-38(67)61-40(28-18-26-8-1-2-9-27(26)19-28)44(73)59-32(24-65)42(71)60-33-25-77-37-14-4-3-12-34(37)64(46(33)75)23-39(68)69/h1-4,8-9,12,14,28-33,35-36,40,65-66H,5-7,10-11,13,15-25,50H2,(H,57,72)(H,58,70)(H,59,73)(H,60,71)(H,61,67)(H,68,69)(H4,51,52,55)(H4,53,54,56)/t29?,30?,31-,32+,33-,35+,36+,40?/m1/s1 D00FAE DRUGINKE BBKUNIDRTSPPPW-XBNUIVHSSA-N D00FAE DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(C3CC4=CC=CC=C4C3)C(=O)NC(CO)C(=O)NC5CSC6=CC=CC=C6N(C5=O)CC(=O)O)O D00FAE HIGHSTAT Investigative D00FAL DRUG__ID D00FAL D00FAL DRUGCLAS Investigative Drug(s) D00FAL DRUGCOMP Isis Pharmaceuticals D00FAL DRUGTYPE Antisense drug D00FAL HIGHSTAT Investigative D00FAW DRUG__ID D00FAW D00FAW DRUGCLAS Investigative Drug(s) D00FAW DRUGCOMP Charleston Laboratories Inc D00FAW DRUGINCH 1S/C12H8F3N3O4S2/c13-12(14,15)22-7-3-1-2-6(4-7)9(21)16-10-17-18-11(24-10)23-5-8(19)20/h1-4H,5H2,(H,19,20)(H,16,17,21) D00FAW DRUGINKE RAIBXQFEDDRDPH-UHFFFAOYSA-N D00FAW DRUGSMIL C1=CC(=CC(=C1)OC(F)(F)F)C(=O)NC2=NN=C(S2)SCC(=O)O D00FAW DRUGTYPE Small molecular drug D00FAW HIGHSTAT Investigative D00FAY DRUG__ID D00FAY D00FAY DRUGCLAS Investigative Drug(s) D00FAY DRUGINCH 1S/C10H10N2S/c11-9-2-1-7(5-10(9)12)8-3-4-13-6-8/h1-6H,11-12H2 D00FAY DRUGINKE OZEWMDJTNVDPJN-UHFFFAOYSA-N D00FAY DRUGSMIL C1=CC(=C(C=C1C2=CSC=C2)N)N D00FAY DRUGTYPE Small molecular drug D00FAY HIGHSTAT Investigative D00FBC DRUG__ID D00FBC D00FBC DRUGCLAS Clinical Trial Drug(s) D00FBC DRUGCOMP Kyowa Hakko Kirin Co Ltd D00FBC HIGHSTAT Phase 2 D00FBM DRUG__ID D00FBM D00FBM DRUGCLAS Discontinued Drug(s) D00FBM DRUGCOMP Medical Biology Institute D00FBM HIGHSTAT Discontinued in Phase 2 D00FCF DRUG__ID D00FCF D00FCF DRUGCLAS Investigative Drug(s) D00FCF DRUGINCH 1S/C28H30N2O4/c31-25-21-13-11-19(29-27(33)17-7-3-1-4-8-17)15-23(21)26(32)24-16-20(12-14-22(24)25)30-28(34)18-9-5-2-6-10-18/h11-18H,1-10H2,(H,29,33)(H,30,34) D00FCF DRUGINKE ISUCEGSINPVOBA-UHFFFAOYSA-N D00FCF DRUGSMIL C1CCC(CC1)C(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)C5CCCCC5 D00FCF DRUGTYPE Small molecular drug D00FCF HIGHSTAT Investigative D00FCJ DRUG__ID D00FCJ D00FCJ DRUGCLAS Investigative Drug(s) D00FCJ DRUGINCH 1S/C18H21N3O3/c1-12-3-2-4-15(11-12)24-14-7-5-13(6-8-14)21-17(22)10-9-16(19)18(20)23/h2-8,11,16H,9-10,19H2,1H3,(H2,20,23)(H,21,22)/t16-/m0/s1 D00FCJ DRUGINKE JZBKUKPJKVOVGL-INIZCTEOSA-N D00FCJ DRUGSMIL CC1=CC(=CC=C1)OC2=CC=C(C=C2)NC(=O)CCC(C(=O)N)N D00FCJ DRUGTYPE Small molecular drug D00FCJ HIGHSTAT Investigative D00FCW DRUG__ID D00FCW D00FCW DRUGCLAS Discontinued Drug(s) D00FCW DRUGCOMP King Pharmaceuticals R&D Inc D00FCW HIGHSTAT Discontinued in Preregistration D00FDD DRUG__ID D00FDD D00FDD DRUGCLAS Clinical Trial Drug(s) D00FDD DRUGCOMP IntelGenx Corp D00FDD HIGHSTAT Phase 1 D00FDS DRUG__ID D00FDS D00FDS DRUGCLAS Investigative Drug(s) D00FDS DRUGINCH 1S/C18H21NO2/c1-2-7-17(8-3-1)21-18-11-9-16(10-12-18)20-14-15-6-4-5-13-19-15/h1-3,7-12,15,19H,4-6,13-14H2/t15-/m1/s1 D00FDS DRUGINKE CSJNBXMUZIPBKQ-OAHLLOKOSA-N D00FDS DRUGSMIL C1CCNC(C1)COC2=CC=C(C=C2)OC3=CC=CC=C3 D00FDS DRUGTYPE Small molecular drug D00FDS HIGHSTAT Investigative D00FEA DRUG__ID D00FEA D00FEA DRUGCLAS Investigative Drug(s) D00FEA DRUGCOMP Purdue University D00FEA DRUGINCH 1S/C29H40N2O7S2/c1-20(2)16-31(40(35,36)25-10-8-21(18-32)9-11-25)17-27(33)26(19-39-24-6-4-3-5-7-24)30-29(34)38-23-14-22-12-13-37-28(22)15-23/h3-11,20,22-23,26-28,32-33H,12-19H2,1-2H3,(H,30,34)/t22-,23+,26-,27+,28+/m0/s1 D00FEA DRUGINKE MNXUZAOQXFTGTG-GOIXWRCSSA-N D00FEA DRUGSMIL CC(C)CN(CC(C(CSC1=CC=CC=C1)NC(=O)OC2CC3CCOC3C2)O)S(=O)(=O)C4=CC=C(C=C4)CO D00FEA DRUGTYPE Small molecular drug D00FEA HIGHSTAT Investigative D00FEH DRUG__ID D00FEH D00FEH DRUGCLAS Investigative Drug(s) D00FEH DRUGINCH 1S/C30H36O6/c1-17(2)12-13-29(5,34)30(6)16-21-26(33)25(22(31)14-18(3)4)28-24(27(21)36-30)20(15-23(32)35-28)19-10-8-7-9-11-19/h7-11,15,17-18,33-34H,12-14,16H2,1-6H3 D00FEH DRUGINKE PABMLJMVAOFHKY-UHFFFAOYSA-N D00FEH DRUGSMIL CC(C)CCC(C)(C1(CC2=C(C(=C3C(=C2O1)C(=CC(=O)O3)C4=CC=CC=C4)C(=O)CC(C)C)O)C)O D00FEH DRUGTYPE Small molecular drug D00FEH HIGHSTAT Investigative D00FEY DRUG__ID D00FEY D00FEY DRUGCLAS Investigative Drug(s) D00FEY DRUGCOMP Isis Pharmaceuticals D00FEY DRUGTYPE Antisense drug D00FEY HIGHSTAT Investigative D00FGA DRUG__ID D00FGA D00FGA DRUGCLAS Investigative Drug(s) D00FGA DRUGINCH 1S/C5H8N2/c6-5-7-3-1-2-4-7/h1-4H2 D00FGA DRUGINKE QJRYYOWARFCJQZ-UHFFFAOYSA-N D00FGA DRUGSMIL C1CCN(C1)C#N D00FGA DRUGTYPE Small molecular drug D00FGA HIGHSTAT Investigative D00FGB DRUG__ID D00FGB D00FGB DRUGCLAS Investigative Drug(s) D00FGB DRUGINCH 1S/C11H14N2O3S/c1-7(14)13-10-4-8-2-3-11(17(12,15)16)6-9(8)5-10/h2-3,6,10H,4-5H2,1H3,(H,13,14)(H2,12,15,16) D00FGB DRUGINKE RVPDXKXWYPPTAL-UHFFFAOYSA-N D00FGB DRUGSMIL CC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N D00FGB DRUGTYPE Small molecular drug D00FGB HIGHSTAT Investigative D00FGO DRUG__ID D00FGO D00FGO DRUGCLAS Approved Drug(s) D00FGO DRUGINCH 1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1 D00FGO DRUGINKE SGDBTWWWUNNDEQ-LBPRGKRZSA-N D00FGO DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl D00FGO DRUGTYPE Small molecular drug D00FGO HIGHSTAT Approved D00FGO THERCLAS Anticancer Agents D00FGR DRUG__ID D00FGR D00FGR DRUGCLAS Approved Drug(s) D00FGR DRUGCOMP Aeterna Zentaris D00FGR DRUGINCH 1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3 D00FGR DRUGINKE PQLXHQMOHUQAKB-UHFFFAOYSA-N D00FGR DRUGSMIL CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C D00FGR DRUGTYPE Small molecular drug D00FGR HIGHSTAT Approved D00FGR THERCLAS Antifungal Agents D00FGV DRUG__ID D00FGV D00FGV DRUADIID FDA-AP-BF04-01547 D00FGV DRUGCLAS Approved Drug(s) D00FGV DRUGCOMP McNeil Laboratories D00FGV DRUGINCH 1S/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3 D00FGV DRUGINKE OJFSXZCBGQGRNV-UHFFFAOYSA-N D00FGV DRUGSMIL CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2 D00FGV DRUGTYPE Small molecular drug D00FGV HIGHSTAT Approved D00FGV THERCLAS Antihistamines D00FGW DRUG__ID D00FGW D00FGW DRUGCLAS Clinical Trial Drug(s) D00FGW DRUGCOMP Intercell USA D00FGW HIGHSTAT Phase 1 D00FGY DRUG__ID D00FGY D00FGY DRUGCLAS Discontinued Drug(s) D00FGY DRUGCOMP Pfizer Inc D00FGY HIGHSTAT Discontinued in Phase 1 D00FHI DRUG__ID D00FHI D00FHI DRUGCLAS Discontinued Drug(s) D00FHI DRUGCOMP Servier D00FHI DRUGINCH 1S/C21H28N2O5/c1-13(22-17(20(25)26)12-7-14-5-3-2-4-6-14)19(24)23-16-10-8-15(9-11-16)18(23)21(27)28/h2-6,13,15-18,22H,7-12H2,1H3,(H,25,26)(H,27,28)/t13-,15?,16?,17-,18-/m0/s1 D00FHI DRUGINKE HBZJVGFXZTUXNI-XMQLQKOFSA-N D00FHI DRUGSMIL CC(C(=O)N1C2CCC(C1C(=O)O)CC2)NC(CCC3=CC=CC=C3)C(=O)O D00FHI DRUGTYPE Small molecular drug D00FHI HIGHSTAT Discontinued in Phase 2 D00FHR DRUG__ID D00FHR D00FHR DRUGCLAS Clinical Trial Drug(s) D00FHR DRUGCOMP MethylGene Inc D00FHR DRUGINCH 1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29) D00FHR DRUGINKE HRNLUBSXIHFDHP-UHFFFAOYSA-N D00FHR DRUGSMIL C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4 D00FHR DRUGTYPE Small molecular drug D00FHR HIGHSTAT Phase 2 D00FHR THERCLAS Anticancer Agents D00FHV DRUG__ID D00FHV D00FHV DRUGCLAS Investigative Drug(s) D00FHV DRUGINCH 1S/C57H80N12O9/c1-35(2)23-44(53(74)66-43(52(58)73)26-38-17-10-6-11-18-38)63-51(72)30-49(70)42(25-37-15-8-5-9-16-37)65-55(76)46(28-40-31-59-33-61-40)67-54(75)45(27-39-19-12-7-13-20-39)68-56(77)48-21-14-22-69(48)57(78)47(29-41-32-60-34-62-41)64-50(71)24-36(3)4/h6-7,10-13,17-20,31-37,42-49,70H,5,8-9,14-16,21-30H2,1-4H3,(H2,58,73)(H,59,61)(H,60,62)(H,63,72)(H,64,71)(H,65,76)(H,66,74)(H,67,75)(H,68,77) D00FHV DRUGINKE ZOAVSRHEYNKAIW-UHFFFAOYSA-N D00FHV DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)CC(C(CC2CCCCC2)NC(=O)C(CC3=CN=CN3)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5CCCN5C(=O)C(CC6=CN=CN6)NC(=O)CC(C)C)O D00FHV HIGHSTAT Investigative D00FHZ DRUG__ID D00FHZ D00FHZ DRUGCLAS Investigative Drug(s) D00FHZ DRUGINCH 1S/C12H13N3O/c16-11-2-1-10-12(15-11)9(7-14-10)8-3-5-13-6-4-8/h1-3,7,13-14H,4-6H2,(H,15,16) D00FHZ DRUGINKE PJYVGMRFPFNZCT-UHFFFAOYSA-N D00FHZ DRUGSMIL C1CNCC=C1C2=CNC3=C2NC(=O)C=C3 D00FHZ DRUGTYPE Small molecular drug D00FHZ HIGHSTAT Investigative D00FIE DRUG__ID D00FIE D00FIE DRUGCLAS Investigative Drug(s) D00FIE DRUGINCH 1S/C16H12N2O2/c19-9-8-18-13-7-3-6-12-14(13)15(17-18)10-4-1-2-5-11(10)16(12)20/h1-7,19H,8-9H2 D00FIE DRUGINKE IWTWHJYONHLOQB-UHFFFAOYSA-N D00FIE DRUGSMIL C1=CC=C2C(=C1)C3=NN(C4=CC=CC(=C43)C2=O)CCO D00FIE DRUGTYPE Small molecular drug D00FIE HIGHSTAT Investigative D00FIO DRUG__ID D00FIO D00FIO DRUGCLAS Clinical Trial Drug(s) D00FIO DRUGCOMP Southwest Hospital, China D00FIO DRUGTYPE CAR T Cell Therapy D00FIO HIGHSTAT Phase 1/2 D00FIT DRUG__ID D00FIT D00FIT DRUGCLAS Investigative Drug(s) D00FIT DRUGINCH 1S/C17H21N5O/c1-12(23)14(9-5-8-13-6-3-2-4-7-13)22-11-21-15-16(18)19-10-20-17(15)22/h2-4,6-7,10-12,14,23H,5,8-9H2,1H3,(H2,18,19,20)/t12-,14+/m0/s1 D00FIT DRUGINKE KTRFRUCNFHFSAF-GXTWGEPZSA-N D00FIT DRUGSMIL CC(C(CCCC1=CC=CC=C1)N2C=NC3=C(N=CN=C32)N)O D00FIT DRUGTYPE Small molecular drug D00FIT HIGHSTAT Investigative D00FIV DRUG__ID D00FIV D00FIV DRUGCLAS Investigative Drug(s) D00FIV DRUGCOMP Actinobac Biomed Inc D00FIV DRUGINCH 1S/C18H34O4/c1-2-3-4-5-7-10-13-16(19)17(20)14-11-8-6-9-12-15-18(21)22/h7,10,16-17,19-20H,2-6,8-9,11-15H2,1H3,(H,21,22)/b10-7- D00FIV DRUGINKE XEBKSQSGNGRGDW-YFHOEESVSA-N D00FIV DRUGSMIL CCCCCC=CCC(C(CCCCCCCC(=O)O)O)O D00FIV DRUGTYPE Small molecular drug D00FIV HIGHSTAT Investigative D00FIX DRUG__ID D00FIX D00FIX DRUGCLAS Approved Drug(s) D00FIX DRUGCOMP Genzyme D00FIX HIGHSTAT Approved D00FJC DRUG__ID D00FJC D00FJC DRUGCLAS Discontinued Drug(s) D00FJC DRUGCOMP Procter & Gamble Pharmaceuticals Inc D00FJC HIGHSTAT Discontinued in Phase 2 D00FJH DRUG__ID D00FJH D00FJH COMPCLAS N-acylpiperidine ether derivatives D00FJH DRUGCLAS Patented Agent(s) D00FJH DRUGCOMP PFIZER LIMITED D00FJH HIGHSTAT Patented D00FJQ DRUG__ID D00FJQ D00FJQ DRUGCLAS Clinical Trial Drug(s) D00FJQ DRUGCOMP NuSirt Biopharma Nashville, TN D00FJQ HIGHSTAT Phase 2 D00FJS DRUG__ID D00FJS D00FJS DRUGCLAS Discontinued Drug(s) D00FJS DRUGCOMP Kureha D00FJS HIGHSTAT Terminated D00FJT DRUG__ID D00FJT D00FJT DRUGCLAS Investigative Drug(s) D00FJT DRUGINCH 1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1/i1-1 D00FJT DRUGINKE HXTGXYRHXAGCFP-AVUPQLEMSA-N D00FJT DRUGSMIL COC1=CC=CC(=C1OC)C(C2CCN(CC2)CCC3=CC=C(C=C3)F)O D00FJT DRUGTYPE Small molecular drug D00FJT HIGHSTAT Investigative D00FKF DRUG__ID D00FKF D00FKF COMPCLAS Pyrrolo-pyridine derivatives D00FKF DRUGCLAS Patented Agent(s) D00FKF DRUGCOMP H. LUNDBECK A/S VERNALIS (R&D) LTD D00FKF DRUGTYPE Small molecular drug D00FKF HIGHSTAT Patented D00FLQ DRUG__ID D00FLQ D00FLQ DRUGCLAS Investigative Drug(s) D00FLQ DRUGINCH 1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21?,22?,23?,24?,26-,30?,33-/m0/s1 D00FLQ DRUGINKE PGOLWKTUHWHYJS-VRJYPAKCSA-N D00FLQ DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D00FLQ DRUGTYPE Small molecular drug D00FLQ HIGHSTAT Investigative D00FLT DRUG__ID D00FLT D00FLT DRUGCLAS Investigative Drug(s) D00FLT DRUGINCH 1S/C15H23N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h4-8,10-11,14,23-24H,1-3,16-17H2,(H,25,26)(H2,18,19,20)/t6-,7-,8+,10+,11+,14+/m0/s1 D00FLT DRUGINKE LMXOHSDXUQEUSF-YECHIGJVSA-N D00FLT DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CC(CCC(C(=O)O)N)N)O)O)N D00FLT DRUGTYPE Small molecular drug D00FLT HIGHSTAT Investigative D00FLZ DRUG__ID D00FLZ D00FLZ DRUGCLAS Investigative Drug(s) D00FLZ HIGHSTAT Investigative D00FMK DRUG__ID D00FMK D00FMK DRUGCLAS Clinical Trial Drug(s) D00FMK HIGHSTAT Phase 1 D00FMQ DRUG__ID D00FMQ D00FMQ DRUGCLAS Investigative Drug(s) D00FMQ DRUGCOMP Fibrex Medical R&D GmbH D00FMQ HIGHSTAT Investigative D00FMV DRUG__ID D00FMV D00FMV DRUGCLAS Discontinued Drug(s) D00FMV DRUGINCH 1S/C4H12N2/c5-3-1-2-4-6/h1-6H2 D00FMV DRUGINKE KIDHWZJUCRJVML-UHFFFAOYSA-N D00FMV DRUGSMIL C(CCN)CN D00FMV DRUGTYPE Small molecular drug D00FMV HIGHSTAT Discontinued in Phase 2 D00FMW DRUG__ID D00FMW D00FMW DRUGCLAS Clinical Trial Drug(s) D00FMW DRUGCOMP Iomai D00FMW HIGHSTAT Phase 2 D00FMX DRUG__ID D00FMX D00FMX DRUGCLAS Investigative Drug(s) D00FMX DRUGINCH 1S/C17H20N2O/c1-13-5-2-3-7-16(13)20-17-15(6-4-10-19-17)14-8-11-18-12-9-14/h2-7,10,14,18H,8-9,11-12H2,1H3 D00FMX DRUGINKE BLKKGRNFYMEBJN-UHFFFAOYSA-N D00FMX DRUGSMIL CC1=CC=CC=C1OC2=C(C=CC=N2)C3CCNCC3 D00FMX DRUGTYPE Small molecular drug D00FMX HIGHSTAT Investigative D00FOE DRUG__ID D00FOE D00FOE DRUGCLAS Discontinued Drug(s) D00FOE DRUGINCH 1S/C45H60Cl2O6/c1-25(2)8-6-9-26(3)35-14-15-36-32-13-12-30-20-27(16-18-44(30,4)37(32)17-19-45(35,36)5)10-7-11-31(28-21-33(42(50)51)40(48)38(46)23-28)29-22-34(43(52)53)41(49)39(47)24-29/h11,21-27,30,32,35-37,48-49H,6-10,12-20H2,1-5H3,(H,50,51)(H,52,53)/t26-,27+,30+,32+,35-,36+,37+,44+,45-/m1/s1 D00FOE DRUGINKE VOJOOGPALCATLT-ZFQBPCNVSA-N D00FOE DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)CCC=C(C5=CC(=C(C(=C5)Cl)O)C(=O)O)C6=CC(=C(C(=C6)Cl)O)C(=O)O)C)C D00FOE DRUGTYPE Small molecular drug D00FOE HIGHSTAT Terminated D00FOR DRUG__ID D00FOR D00FOR DRUGCLAS Investigative Drug(s) D00FOR DRUGCOMP Almirall Prodesfarma SA D00FOR HIGHSTAT Investigative D00FOZ DRUG__ID D00FOZ D00FOZ DRUGCLAS Investigative Drug(s) D00FOZ DRUGINCH 1S/C14H20N2O3/c1-4-5-9-18-13-8-6-7-12(10-13)15-14(17)19-16-11(2)3/h6-8,10H,4-5,9H2,1-3H3,(H,15,17) D00FOZ DRUGINKE GNTLUXBWYDMBFL-UHFFFAOYSA-N D00FOZ DRUGSMIL CCCCOC1=CC=CC(=C1)NC(=O)ON=C(C)C D00FOZ DRUGTYPE Small molecular drug D00FOZ HIGHSTAT Investigative D00FPB DRUG__ID D00FPB D00FPB DRUGCLAS Investigative Drug(s) D00FPB DRUGINCH 1S/C5H10O3/c1-4(3-6)2-5(7)8/h4,6H,2-3H2,1H3,(H,7,8) D00FPB DRUGINKE ZGYGEPZZMAXSKH-UHFFFAOYSA-N D00FPB DRUGSMIL CC(CC(=O)O)CO D00FPB DRUGTYPE Small molecular drug D00FPB HIGHSTAT Investigative D00FPG DRUG__ID D00FPG D00FPG DRUGCLAS Investigative Drug(s) D00FPG DRUGINCH 1S/C10H10N2O/c1-12-6-8(10(11)13)7-4-2-3-5-9(7)12/h2-6H,1H3,(H2,11,13) D00FPG DRUGINKE UHQHFXKJFJHBAE-UHFFFAOYSA-N D00FPG DRUGSMIL CN1C=C(C2=CC=CC=C21)C(=O)N D00FPG DRUGTYPE Small molecular drug D00FPG HIGHSTAT Investigative D00FPI DRUG__ID D00FPI D00FPI DRUGCLAS Investigative Drug(s) D00FPI DRUGINCH 1S/C42H38N2O8/c1-45-35-7-5-25-15-33-29-19-39-37(49-23-51-39)17-27(29)9-11-43(33)21-31(25)41(35)47-13-3-4-14-48-42-32-22-44-12-10-28-18-38-40(52-24-50-38)20-30(28)34(44)16-26(32)6-8-36(42)46-2/h5-8,15-22H,3-4,9-14,23-24H2,1-2H3/q+2 D00FPI DRUGINKE SJALLAIALHPUMH-UHFFFAOYSA-N D00FPI DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCOC6=C(C=CC7=CC8=[N+](CCC9=CC1=C(C=C98)OCO1)C=C76)OC D00FPI DRUGTYPE Small molecular drug D00FPI HIGHSTAT Investigative D00FPJ DRUG__ID D00FPJ D00FPJ DRUGCLAS Investigative Drug(s) D00FPJ DRUGINCH 1S/C15H10O5/c16-8-3-1-7(2-4-8)12-14(19)10-5-9(17)6-11(18)13(10)15(12)20/h1-6,12,16-18H D00FPJ DRUGINKE GXKXWCKNQMYETG-UHFFFAOYSA-N D00FPJ DRUGSMIL C1=CC(=CC=C1C2C(=O)C3=C(C2=O)C(=CC(=C3)O)O)O D00FPJ DRUGTYPE Small molecular drug D00FPJ HIGHSTAT Investigative D00FPT DRUG__ID D00FPT D00FPT DRUGCLAS Investigative Drug(s) D00FPT DRUGINCH 1S/C11H18N5O14P3/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-4,6-7,10,17-18H,2H2,1H3,(H6-,12,13,14,19,20,21,22,23,24,25,26)/p+1/t4-,6-,7-,10-/m1/s1 D00FPT DRUGINKE DKVRNHPCAOHRSI-KQYNXXCUSA-O D00FPT DRUGSMIL CN1C=[N+](C2=C1C(=O)NC(=N2)N)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D00FPT DRUGTYPE Small molecular drug D00FPT HIGHSTAT Investigative D00FQP DRUG__ID D00FQP D00FQP DRUGCLAS Discontinued Drug(s) D00FQP DRUGINCH 1S/C33H58N10O9/c1-17(2)25(41-28(47)20-10-7-15-37-20)31(50)42-26(19(4)44)32(51)40-22(9-5-6-14-34)33(52)43-16-8-11-23(43)30(49)39-21(12-13-24(35)45)29(48)38-18(3)27(36)46/h17-23,25-26,37,44H,5-16,34H2,1-4H3,(H2,35,45)(H2,36,46)(H,38,48)(H,39,49)(H,40,51)(H,41,47)(H,42,50)/t18-,19-,20+,21+,22+,23+,25+,26+/m1/s1 D00FQP DRUGINKE WNDMGDURKQLJNM-DHCXFDNTSA-N D00FQP DRUGSMIL CC(C)C(C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)N)NC(=O)C2CCCN2 D00FQP DRUGTYPE Small molecular drug D00FQP HIGHSTAT Discontinued in Phase 2 D00FRX DRUG__ID D00FRX D00FRX DRUGCLAS Investigative Drug(s) D00FRX DRUGCOMP University of California Davis D00FRX HIGHSTAT Investigative D00FRY DRUG__ID D00FRY D00FRY DRUGCLAS Discontinued Drug(s) D00FRY DRUGCOMP Bio-Mega Research Division D00FRY DRUGINCH 1S/C39H68N4O7/c1-13-27(36(4,5)6)40-33(47)31(39(34(48)49)19-14-15-20-39)42-32(46)25(22-28(45)37(7,8)9)21-26(44)30(38(10,11)12)43-35(50)41-29-23(2)17-16-18-24(29)3/h23-25,27,29-31H,13-22H2,1-12H3,(H,40,47)(H,42,46)(H,48,49)(H2,41,43,50)/t23-,24+,25-,27+,29?,30+,31+/m0/s1 D00FRY DRUGINKE BICMJCLCIQRONK-CVXWQFLKSA-N D00FRY DRUGSMIL CCC(C(C)(C)C)NC(=O)C(C1(CCCC1)C(=O)O)NC(=O)C(CC(=O)C(C(C)(C)C)NC(=O)NC2C(CCCC2C)C)CC(=O)C(C)(C)C D00FRY DRUGTYPE Small molecular drug D00FRY HIGHSTAT Terminated D00FSB DRUG__ID D00FSB D00FSB DRUGCLAS Clinical Trial Drug(s) D00FSB DRUGCOMP Biogen D00FSB HIGHSTAT Phase 1 D00FSS DRUG__ID D00FSS D00FSS DRUGCLAS Discontinued Drug(s) D00FSS DRUGCOMP Shire plc D00FSS HIGHSTAT Terminated D00FSV DRUG__ID D00FSV D00FSV DRUGCLAS Approved Drug(s) D00FSV DRUGINCH 1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+/t23-,24-/m1/s1 D00FSV DRUGINKE MBWXNTAXLNYFJB-NKFFZRIASA-N D00FSV DRUGSMIL CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C D00FSV DRUGTYPE Small molecular drug D00FSV HIGHSTAT Approved D00FSV THERCLAS Vitamins D00FTQ DRUG__ID D00FTQ D00FTQ DRUGCLAS Investigative Drug(s) D00FTQ DRUGINCH 1S/C8H16O3/c1-2-3-4-5-7(9)6-8(10)11/h7,9H,2-6H2,1H3,(H,10,11) D00FTQ DRUGINKE NDPLAKGOSZHTPH-UHFFFAOYSA-N D00FTQ DRUGSMIL CCCCCC(CC(=O)O)O D00FTQ DRUGTYPE Small molecular drug D00FTQ HIGHSTAT Investigative D00FUD DRUG__ID D00FUD D00FUD DRUGCLAS Investigative Drug(s) D00FUD DRUGCOMP HRA Pharma D00FUD HIGHSTAT Investigative D00FUO DRUG__ID D00FUO D00FUO DRUGCLAS Investigative Drug(s) D00FUO DRUGINCH 1S/C29H31NO2/c1-31-26-14-16-28-24(21-26)11-15-27(22-7-3-2-4-8-22)29(28)23-9-12-25(13-10-23)32-20-19-30-17-5-6-18-30/h2-4,7-10,12-14,16,21H,5-6,11,15,17-20H2,1H3 D00FUO DRUGINKE JEYWNNAZDLFBFF-UHFFFAOYSA-N D00FUO DRUGSMIL COC1=CC2=C(C=C1)C(=C(CC2)C3=CC=CC=C3)C4=CC=C(C=C4)OCCN5CCCC5 D00FUO DRUGTYPE Small molecular drug D00FUO HIGHSTAT Investigative D00FUS DRUG__ID D00FUS D00FUS DRUGCLAS Investigative Drug(s) D00FUS DRUGINCH 1S/C10H15NO/c1-8(11)7-9-5-3-4-6-10(9)12-2/h3-6,8H,7,11H2,1-2H3 D00FUS DRUGINKE VBAHFEPKESUPDE-UHFFFAOYSA-N D00FUS DRUGSMIL CC(CC1=CC=CC=C1OC)N D00FUS DRUGTYPE Small molecular drug D00FUS HIGHSTAT Investigative D00FUT DRUG__ID D00FUT D00FUT DRUGCLAS Investigative Drug(s) D00FUT DRUGINCH 1S/C41H63N11O10/c1-24(2)20-28(40(61)62)48-36(57)31-14-8-17-50(31)38(59)29(23-53)49-34(55)27(21-25-10-4-3-5-11-25)47-33(54)22-46-35(56)30-13-7-18-51(30)39(60)32-15-9-19-52(32)37(58)26(42)12-6-16-45-41(43)44/h3-5,10-11,24,26-32,53H,6-9,12-23,42H2,1-2H3,(H,46,56)(H,47,54)(H,48,57)(H,49,55)(H,61,62)(H4,43,44,45)/t26-,27-,28-,29-,30-,31-,32-/m0/s1 D00FUT DRUGINKE BGAPYBBQGHUQNM-YYGRSCHNSA-N D00FUT DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C3CCCN3C(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D00FUT DRUGTYPE Small molecular drug D00FUT HIGHSTAT Investigative D00FUZ DRUG__ID D00FUZ D00FUZ COMPCLAS Quinoline carboxamide derivatives D00FUZ DRUGCLAS Patented Agent(s) D00FUZ DRUGCOMP Pharma. Ip. General, Inc. Mamoto Health Science University D00FUZ DRUGINCH 1S/C22H13ClN4O3/c23-14-8-9-17-15(11-14)16(12-18(24-17)13-5-2-1-3-6-13)20(28)25-22-27-26-21(30-22)19-7-4-10-29-19/h1-12H,(H,25,27,28) D00FUZ DRUGINKE GMIGNWBMEJMRDV-UHFFFAOYSA-N D00FUZ DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C=C(C=C3)Cl)C(=C2)C(=O)NC4=NN=C(O4)C5=CC=CO5 D00FUZ DRUGTYPE Small molecular drug D00FUZ HIGHSTAT Patented D00FWB DRUG__ID D00FWB D00FWB DRUGCLAS Discontinued Drug(s) D00FWB DRUGCOMP Merck & Co Inc D00FWB DRUGINCH 1S/C36H39N5O5S/c1-5-11-32-39-33-25(4)30(38-35(42)28-12-7-6-8-13-28)22-37-34(33)41(32)23-26-16-18-27(19-17-26)29-14-9-10-15-31(29)47(44,45)40-36(43)46-21-20-24(2)3/h6-10,12-19,22,24H,5,11,20-21,23H2,1-4H3,(H,38,42)(H,40,43) D00FWB DRUGINKE WGFOETKPMPCUOG-UHFFFAOYSA-N D00FWB DRUGSMIL CCCC1=NC2=C(C(=CN=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC(=O)OCCC(C)C)NC(=O)C5=CC=CC=C5)C D00FWB DRUGTYPE Small molecular drug D00FWB HIGHSTAT Terminated D00FXL DRUG__ID D00FXL D00FXL DRUGCLAS Investigative Drug(s) D00FXL DRUGINCH 1S/C34H46N8O9S/c1-17(2)11-23(32(49)42-28(18(3)44)33(50)51)39-31(48)24(13-19-7-5-4-6-8-19)38-27(45)15-37-30(47)25(16-43)40-29(46)21(35)12-20-9-10-22-26(14-20)52-34(36)41-22/h4-10,14,17-18,21,23-25,28,43-44H,11-13,15-16,35H2,1-3H3,(H2,36,41)(H,37,47)(H,38,45)(H,39,48)(H,40,46)(H,42,49)(H,50,51)/t18-,21+,23+,24+,25+,28+/m1/s1 D00FXL DRUGINKE XSYMBKQKMSKFJU-LEKCGIOJSA-N D00FXL DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(CO)NC(=O)C(CC2=CC3=C(C=C2)N=C(S3)N)N D00FXL DRUGTYPE Small molecular drug D00FXL HIGHSTAT Investigative D00FXQ DRUG__ID D00FXQ D00FXQ DRUGCLAS Investigative Drug(s) D00FXQ DRUGCOMP Indigene Pharmaceuticals Inc D00FXQ HIGHSTAT Investigative D00FYF DRUG__ID D00FYF D00FYF DRUGCLAS Discontinued Drug(s) D00FYF DRUGINCH 1S/C15H18N6O/c16-8-12-3-4-14(20-10-12)19-6-5-18-11-15(22)21-7-1-2-13(21)9-17/h3-4,10,13,18H,1-2,5-7,11H2,(H,19,20)/t13-/m0/s1 D00FYF DRUGINKE VFFZWMWTUSXDCB-ZDUSSCGKSA-N D00FYF DRUGSMIL C1CC(N(C1)C(=O)CNCCNC2=NC=C(C=C2)C#N)C#N D00FYF DRUGTYPE Small molecular drug D00FYF HIGHSTAT Discontinued in Phase 2 D00FYP DRUG__ID D00FYP D00FYP DRUGCLAS Discontinued Drug(s) D00FYP DRUGCOMP Pharmagenesis Inc D00FYP HIGHSTAT Terminated D00FZA DRUG__ID D00FZA D00FZA DRUGCLAS Investigative Drug(s) D00FZA DRUGCOMP Alder Biopharmaceuticals Inc D00FZA DRUGTYPE Antibody D00FZA HIGHSTAT Investigative D00FZH DRUG__ID D00FZH D00FZH DRUGCLAS Drugs in Phase 1 Trial D00FZH DRUGTYPE Cell therapy D00FZH HIGHSTAT Phase 1 Trial D00FZH THERCLAS Antiviral Agents D00FZN DRUG__ID D00FZN D00FZN DRUGCLAS Investigative Drug(s) D00FZN DRUGINCH 1S/C30H33N5O5/c31-24(14-20-10-12-23(36)13-11-20)29(39)34-26-16-21-8-4-5-9-22(21)17-35(30(26)40)18-27(37)33-25(28(32)38)15-19-6-2-1-3-7-19/h1-13,24-26,36H,14-18,31H2,(H2,32,38)(H,33,37)(H,34,39)/t24-,25-,26+/m0/s1 D00FZN DRUGINKE XIRBKSHTAOQLGM-KKUQBAQOSA-N D00FZN DRUGSMIL C1C(C(=O)N(CC2=CC=CC=C21)CC(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D00FZN DRUGTYPE Small molecular drug D00FZN HIGHSTAT Investigative D00FZZ DRUG__ID D00FZZ D00FZZ DRUGCLAS Clinical Trial Drug(s) D00FZZ DRUGCOMP Bristol-Myers Squibb D00FZZ HIGHSTAT Phase 2 D00GAM DRUG__ID D00GAM D00GAM DRUGCLAS Clinical Trial Drug(s) D00GAM DRUGCOMP Santaris Pharma A/S D00GAM DRUGTYPE Antisense drug D00GAM HIGHSTAT Phase 1/2 D00GAV DRUG__ID D00GAV D00GAV DRUGCLAS Discontinued Drug(s) D00GAV DRUGCOMP Evolva Holding SA D00GAV HIGHSTAT Terminated D00GBB DRUG__ID D00GBB D00GBB DRUGCLAS Investigative Drug(s) D00GBB DRUGINCH 1S/C14H19N3O4/c18-12(17-21)9-5-2-6-10-15-14(20)16-13(19)11-7-3-1-4-8-11/h1,3-4,7-8,21H,2,5-6,9-10H2,(H,17,18)(H2,15,16,19,20) D00GBB DRUGINKE VQLQZMGNGMOMPU-UHFFFAOYSA-N D00GBB DRUGSMIL C1=CC=C(C=C1)C(=O)NC(=O)NCCCCCC(=O)NO D00GBB DRUGTYPE Small molecular drug D00GBB HIGHSTAT Investigative D00GBG DRUG__ID D00GBG D00GBG DRUGCLAS Approved Drug(s) D00GBG HIGHSTAT Approved D00GBP DRUG__ID D00GBP D00GBP DRUGCLAS Investigative Drug(s) D00GBP HIGHSTAT Investigative D00GBX DRUG__ID D00GBX D00GBX DRUGCLAS Investigative Drug(s) D00GBX DRUGINCH 1S/C19H24O2S/c1-18(2,3)13-10-12(16(20)15-8-7-9-22-15)11-14(17(13)21)19(4,5)6/h7-11,21H,1-6H3 D00GBX DRUGINKE WAAVMZLJRXYRMA-UHFFFAOYSA-N D00GBX DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(=O)C2=CC=CS2 D00GBX DRUGTYPE Small molecular drug D00GBX HIGHSTAT Investigative D00GBZ DRUG__ID D00GBZ D00GBZ DRUGCLAS Clinical Trial Drug(s) D00GBZ DRUGCOMP Cequent Pharmaceuticals Inc D00GBZ DRUGTYPE siRNA drug D00GBZ HIGHSTAT Phase 1/2 D00GCA DRUG__ID D00GCA D00GCA DRUGCLAS Clinical Trial Drug(s) D00GCA DRUGCOMP Merck D00GCA HIGHSTAT Phase 1 D00GCC DRUG__ID D00GCC D00GCC DRUGCLAS Investigative Drug(s) D00GCC DRUGINCH 1S/C34H47FN4O/c1-27(2)38-22-24-39(25-23-38)33(29-11-14-30(35)15-12-29)26-37-20-18-36(19-21-37)17-7-6-10-32-31-9-5-4-8-28(31)13-16-34(32)40-3/h4-5,8-9,11-16,27,33H,6-7,10,17-26H2,1-3H3/t33-/m1/s1 D00GCC DRUGINKE SLGLZEJKMBCODK-MGBGTMOVSA-N D00GCC DRUGSMIL CC(C)N1CCN(CC1)C(CN2CCN(CC2)CCCCC3=C(C=CC4=CC=CC=C43)OC)C5=CC=C(C=C5)F D00GCC DRUGTYPE Small molecular drug D00GCC HIGHSTAT Investigative D00GCK DRUG__ID D00GCK D00GCK DRUGCLAS Investigative Drug(s) D00GCK DRUGINCH 1S/2C19H13N/c2*1-3-9-17-15(7-1)16-8-2-4-10-18(16)19(17)12-14-6-5-11-20-13-14/h2*1-13H D00GCK DRUGINKE QQJHSQKNTSNWIQ-UHFFFAOYSA-N D00GCK DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3C2=CC4=CN=CC=C4.C1=CC=C2C(=C1)C3=CC=CC=C3C2=CC4=CN=CC=C4 D00GCK DRUGTYPE Small molecular drug D00GCK HIGHSTAT Investigative D00GCN DRUG__ID D00GCN D00GCN DRUGCLAS Investigative Drug(s) D00GCN DRUGINCH 1S/C18H12N2O/c21-17-11-16(20-18-15(17)6-3-9-19-18)14-8-7-12-4-1-2-5-13(12)10-14/h1-11H,(H,19,20,21) D00GCN DRUGINKE SIAZQYUZGIPPRX-UHFFFAOYSA-N D00GCN DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CC(=O)C4=C(N3)N=CC=C4 D00GCN DRUGTYPE Small molecular drug D00GCN HIGHSTAT Investigative D00GDI DRUG__ID D00GDI D00GDI DRUGCLAS Investigative Drug(s) D00GDI DRUGINCH 1S/C13H17Cl2NO/c1-8(16-13(2,3)4)12(17)9-5-6-10(14)11(15)7-9/h5-8,16H,1-4H3 D00GDI DRUGINKE MXUDEADPGZWZCH-UHFFFAOYSA-N D00GDI DRUGSMIL CC(C(=O)C1=CC(=C(C=C1)Cl)Cl)NC(C)(C)C D00GDI DRUGTYPE Small molecular drug D00GDI HIGHSTAT Investigative D00GDN DRUG__ID D00GDN D00GDN DRUGCLAS Discontinued Drug(s) D00GDN DRUGCOMP Milkhaus Laboratory Inc D00GDN HIGHSTAT Terminated D00GEE DRUG__ID D00GEE D00GEE DRUGCLAS Investigative Drug(s) D00GEE DRUGINCH 1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19-/m0/s1 D00GEE DRUGINKE BLGXFZZNTVWLAY-DKJBZYCGSA-N D00GEE DRUGSMIL COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O D00GEE DRUGTYPE Small molecular drug D00GEE HIGHSTAT Investigative D00GEG DRUG__ID D00GEG D00GEG DRUGCLAS Clinical Trial Drug(s) D00GEG DRUGCOMP Newron D00GEG DRUGINCH 1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1 D00GEG DRUGINKE BHJIBOFHEFDSAU-LBPRGKRZSA-N D00GEG DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F D00GEG DRUGTYPE Small molecular drug D00GEG HIGHSTAT Phase 3 D00GEG THERCLAS Analgesics D00GES DRUG__ID D00GES D00GES DRUGCLAS Preclinical Drug(s) D00GES DRUGCOMP Jenrin Discovery Inc. D00GES DRUGINCH 1S/C27H27Cl2N5O3S/c1-17(2)24(26(30)35)31-27(33-38(36,37)22-14-12-21(29)13-15-22)34-16-23(18-6-4-3-5-7-18)25(32-34)19-8-10-20(28)11-9-19/h3-15,17,23-24H,16H2,1-2H3,(H2,30,35)(H,31,33)/t23-,24+/m1/s1 D00GES DRUGINKE GTCSIQFTNPTSLO-RPWUZVMVSA-N D00GES DRUGSMIL CC(C)C(C(=O)N)N=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4 D00GES HIGHSTAT Preclinical D00GFU DRUG__ID D00GFU D00GFU DRUGCLAS Investigative Drug(s) D00GFU DRUGCOMP Receptagen Corp D00GFU HIGHSTAT Investigative D00GFV DRUG__ID D00GFV D00GFV DRUGCLAS Clinical Trial Drug(s) D00GFV DRUGCOMP GD Searle & Co D00GFV HIGHSTAT Phase 2 D00GGB DRUG__ID D00GGB D00GGB DRUGCLAS Patented Agent(s) D00GGB DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY D00GGB DRUGTYPE Small molecular drug D00GGB HIGHSTAT Patented D00GHB DRUG__ID D00GHB D00GHB DRUGCLAS Investigative Drug(s) D00GHB DRUGINCH 1S/C6H15O13P3/c7-5-3(2-17-20(9,10)11)1-4(6(5)8)18-22(15,16)19-21(12,13)14/h3-8H,1-2H2,(H,15,16)(H2,9,10,11)(H2,12,13,14)/t3-,4+,5-,6+/m1/s1 D00GHB DRUGINKE OICBXEWBKALHHB-MOJAZDJTSA-N D00GHB DRUGSMIL C1C(C(C(C1OP(=O)(O)OP(=O)(O)O)O)O)COP(=O)(O)O D00GHB DRUGTYPE Small molecular drug D00GHB HIGHSTAT Investigative D00GHG DRUG__ID D00GHG D00GHG DRUGCLAS Clinical Trial Drug(s) D00GHG DRUGCOMP VaxInnate D00GHG HIGHSTAT Phase 2 D00GHK DRUG__ID D00GHK D00GHK DRUGCLAS Investigative Drug(s) D00GHK DRUGINCH 1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,16-18,22H,2-3,5-6,8-14H2,1H3,(H,24,25)/b7-4-/t16-,17-,18+/m1/s1 D00GHK DRUGINKE VSRXYLYXIXYEST-KZTWKYQFSA-N D00GHK DRUGSMIL CCCCCC(=O)CCC1C(C(CC1=O)O)CC=CCCCC(=O)O D00GHK DRUGTYPE Small molecular drug D00GHK HIGHSTAT Investigative D00GIB DRUG__ID D00GIB D00GIB DRUGCLAS Investigative Drug(s) D00GIB DRUGINCH 1S/C20H14BrNO4/c21-16-11-10-13(12-18(16)26-14-6-2-1-3-7-14)19(23)22-17-9-5-4-8-15(17)20(24)25/h1-12H,(H,22,23)(H,24,25) D00GIB DRUGINKE XOENRMSDPFHAEO-UHFFFAOYSA-N D00GIB DRUGSMIL C1=CC=C(C=C1)OC2=C(C=CC(=C2)C(=O)NC3=CC=CC=C3C(=O)O)Br D00GIB DRUGTYPE Small molecular drug D00GIB HIGHSTAT Investigative D00GII DRUG__ID D00GII D00GII DRUGCLAS Investigative Drug(s) D00GII DRUGINCH 1S/C37H49N11O6/c1-48-30(9-5-17-43-37(40)41)34(53)46-27(8-4-16-42-36(38)39)33(52)47-28(19-22-11-14-26(49)15-12-22)32(51)44-21-31(50)45-29(35(48)54)20-23-10-13-24-6-2-3-7-25(24)18-23/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,51)(H,45,50)(H,46,53)(H,47,52)(H4,38,39,42)(H4,40,41,43)/t27-,28+,29-,30-/m0/s1 D00GII DRUGINKE UYLRGPNGYHIOPK-XJYHXZFBSA-N D00GII DRUGSMIL CN1C(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C1=O)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O)CCCN=C(N)N)CCCN=C(N)N D00GII DRUGTYPE Small molecular drug D00GII HIGHSTAT Investigative D00GIK DRUG__ID D00GIK D00GIK DRUGCLAS Investigative Drug(s) D00GIK DRUGINCH 1S/C12H13ClN2/c13-12-5-3-11(4-6-12)2-1-8-15-9-7-14-10-15/h3-7,9-10H,1-2,8H2 D00GIK DRUGINKE CLJJKXWBLJQDDT-UHFFFAOYSA-N D00GIK DRUGSMIL C1=CC(=CC=C1CCCN2C=CN=C2)Cl D00GIK DRUGTYPE Small molecular drug D00GIK HIGHSTAT Investigative D00GIR DRUG__ID D00GIR D00GIR DRUGCLAS Clinical Trial Drug(s) D00GIR DRUGCOMP DAC Srl D00GIR HIGHSTAT Phase 2 D00GIU DRUG__ID D00GIU D00GIU DRUGCLAS Investigative Drug(s) D00GIU DRUGINCH 1S/C26H32N6.C2H4O2/c1-17-13-25(21-15-19(27)7-9-23(21)31-17)29-11-5-3-4-6-12-30-26-14-18(2)32-24-10-8-20(28)16-22(24)26;1-2(3)4/h7-10,13-16H,3-6,11-12,27-28H2,1-2H3,(H,29,31)(H,30,32);1H3,(H,3,4) D00GIU DRUGINKE LSRAVPLRIOILDT-UHFFFAOYSA-N D00GIU DRUGSMIL CC1=CC(=C2C=C(C=CC2=N1)N)NCCCCCCNC3=C4C=C(C=CC4=NC(=C3)C)N.CC(=O)O D00GIU DRUGTYPE Small molecular drug D00GIU HIGHSTAT Investigative D00GIW DRUG__ID D00GIW D00GIW DRUGCLAS Investigative Drug(s) D00GIW DRUGINCH 1S/C10H8Br2N2/c11-9-3-8(4-10(12)5-9)6-14-2-1-13-7-14/h1-5,7H,6H2 D00GIW DRUGINKE QXITVPZFTOHIGY-UHFFFAOYSA-N D00GIW DRUGSMIL C1=CN(C=N1)CC2=CC(=CC(=C2)Br)Br D00GIW DRUGTYPE Small molecular drug D00GIW HIGHSTAT Investigative D00GJK DRUG__ID D00GJK D00GJK DRUGCLAS Clinical Trial Drug(s) D00GJK DRUGCOMP Laboratorios Leti SL D00GJK HIGHSTAT Phase 2 D00GJY DRUG__ID D00GJY D00GJY COMPCLAS Cyclohexyl azetidine derivatives D00GJY DRUGCLAS Patented Agent(s) D00GJY DRUGCOMP INCYTE CORPORATION RODGERS, James D. ARVANITIS, Argyrios G D00GJY DRUGTYPE Small molecular drug D00GJY HIGHSTAT Patented D00GJZ DRUG__ID D00GJZ D00GJZ DRUGCLAS Investigative Drug(s) D00GJZ DRUGINCH 1S/C35H40N4O4.Cu/c1-8-22-18(3)28-17-33-23(9-2)21(6)32(39(33)7)16-27-20(5)25(11-13-35(42)43)31(38-27)15-30-24(10-12-34(40)41)19(4)26(36-30)14-29(22)37-28;/h14-17H,8-13H2,1-7H3,(H3,36,37,38,40,41,42,43);/q;+2/p-1 D00GJZ DRUGINKE WLMGFVUEDVZKTK-UHFFFAOYSA-M D00GJZ DRUGSMIL CCC1=C(C2=CC3=C(C(=C(N3C)C=C4C(=C(C(=N4)C=C5C(=C(C(=CC1=N2)[N-]5)C)CCC(=O)O)CCC(=O)O)C)C)CC)C.[Cu+2] D00GJZ DRUGTYPE Small molecular drug D00GJZ HIGHSTAT Investigative D00GKE DRUG__ID D00GKE D00GKE DRUGCLAS Investigative Drug(s) D00GKE DRUGCOMP Isis Pharmaceuticals D00GKE DRUGTYPE Antisense drug D00GKE HIGHSTAT Investigative D00GKH DRUG__ID D00GKH D00GKH DRUGCLAS Investigative Drug(s) D00GKH DRUGCOMP Human Genome Sciences Inc D00GKH HIGHSTAT Investigative D00GLJ DRUG__ID D00GLJ D00GLJ DRUGCLAS Patented Agent(s) D00GLJ DRUGCOMP KARUS THERAPEUTICS LTD D00GLJ DRUGTYPE Small molecular drug D00GLJ HIGHSTAT Patented D00GLQ DRUG__ID D00GLQ D00GLQ DRUGCLAS Investigative Drug(s) D00GLQ DRUGCOMP Pfizer Inc D00GLQ HIGHSTAT Investigative D00GLW DRUG__ID D00GLW D00GLW DRUGCLAS Investigative Drug(s) D00GLW DRUGCOMP OM Pharma D00GLW HIGHSTAT Investigative D00GMI DRUG__ID D00GMI D00GMI DRUGCLAS Patented Agent(s) D00GMI DRUGTYPE Small molecular drug D00GMI HIGHSTAT Patented D00GMJ DRUG__ID D00GMJ D00GMJ COMPCLAS Azaindole derivatives D00GMJ DRUGCLAS Patented Agent(s) D00GMJ DRUGCOMP Kissei Pharmaceutical Co. Ltd D00GMJ DRUGINCH 1S/C15H9N3O3/c16-8-10-6-13(18-12(10)2-1-5-17-18)9-3-4-11(15(20)21)14(19)7-9/h1-7,19H,(H,20,21) D00GMJ DRUGINKE NSOWXVMDKNRRTI-UHFFFAOYSA-N D00GMJ DRUGSMIL C1=CC2=C(C=C(N2N=C1)C3=CC(=C(C=C3)C(=O)O)O)C#N D00GMJ DRUGTYPE Small molecular drug D00GMJ HIGHSTAT Patented D00GNI DRUG__ID D00GNI D00GNI DRUGCLAS Approved Drug(s) D00GNI DRUGCOMP Sanofi; Novo Nordisk D00GNI DRUGTYPE Antibody D00GNI HIGHSTAT Approved D00GNJ DRUG__ID D00GNJ D00GNJ DRUGCLAS Approved Drug(s) D00GNJ DRUGCOMP Microbia D00GNJ DRUGINCH 1S/C59H79N15O21S6/c1-26-47(82)69-41-25-101-99-22-38-52(87)65-33(13-14-45(80)81)49(84)66-34(16-28-5-9-30(76)10-6-28)50(85)71-40(54(89)72-39(23-97-96-20-32(60)48(83)70-38)53(88)67-35(18-43(61)78)58(93)74-15-3-4-42(74)56(91)63-26)24-100-98-21-37(64-44(79)19-62-57(92)46(27(2)75)73-55(41)90)51(86)68-36(59(94)95)17-29-7-11-31(77)12-8-29/h5-12,26-27,32-42,46,75-77H,3-4,13-25,60H2,1-2H3,(H2,61,78)(H,62,92)(H,63,91)(H,64,79)(H,65,87)(H,66,84)(H,67,88)(H,68,86)(H,69,82)(H,70,83)(H,71,85)(H,72,89)(H,73,90)(H,80,81)(H,94,95)/t26-,27+,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,46-/m0/s1 D00GNJ DRUGINKE KXGCNMMJRFDFNR-WDRJZQOASA-N D00GNJ DRUGSMIL CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O D00GNJ DRUGTYPE Small molecular drug D00GNJ HIGHSTAT Approved D00GNK DRUG__ID D00GNK D00GNK DRUGCLAS Discontinued Drug(s) D00GNK DRUGCOMP Sawyer & Brooks D00GNK DRUGINCH 1S/C33H33FO6/c1-3-9-25-29(12-7-13-30(25)40-31-11-6-5-10-26(31)33(36)37)38-18-8-19-39-32-21-28(35)27(20-22(32)4-2)23-14-16-24(34)17-15-23/h5-7,10-17,20-21,35H,3-4,8-9,18-19H2,1-2H3,(H,36,37) D00GNK DRUGINKE YFIZRWPXUYFCSN-UHFFFAOYSA-N D00GNK DRUGSMIL CCCC1=C(C=CC=C1OC2=CC=CC=C2C(=O)O)OCCCOC3=CC(=C(C=C3CC)C4=CC=C(C=C4)F)O D00GNK DRUGTYPE Small molecular drug D00GNK HIGHSTAT Discontinued in Phase 2 D00GNK THERCLAS Anticancer Agents D00GNN DRUG__ID D00GNN D00GNN DRUGCLAS Investigative Drug(s) D00GNN DRUGCOMP State University of New York D00GNN HIGHSTAT Investigative D00GNP DRUG__ID D00GNP D00GNP COMPCLAS Triazole piperazine derivatives D00GNP DRUGCLAS Patented Agent(s) D00GNP DRUGTYPE Small molecular drug D00GNP HIGHSTAT Patented D00GNW DRUG__ID D00GNW D00GNW DRUGCLAS Investigative Drug(s) D00GNW DRUGINCH 1S/C23H23N3/c1-3-16(4-2)22-25-21-19(17-11-7-5-8-12-17)15-20(24-23(21)26-22)18-13-9-6-10-14-18/h5-16H,3-4H2,1-2H3,(H,24,25,26) D00GNW DRUGINKE GPQRSDCKVYJMOH-UHFFFAOYSA-N D00GNW DRUGSMIL CCC(CC)C1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D00GNW DRUGTYPE Small molecular drug D00GNW HIGHSTAT Investigative D00GOC DRUG__ID D00GOC D00GOC DRUGCLAS Investigative Drug(s) D00GOC DRUGINCH 1S/C9H13N3O6/c10-9(17)4-6(15)3(11-12-4)8-7(16)5(14)2(1-13)18-8/h2,5,7-8,13-16H,1H2,(H2,10,17)(H,11,12)/t2-,5-,7-,8+/m1/s1 D00GOC DRUGINKE XESARGFCSKSFID-FLLFQEBCSA-N D00GOC DRUGSMIL C(C1C(C(C(O1)C2=NNC(=C2O)C(=O)N)O)O)O D00GOC DRUGTYPE Small molecular drug D00GOC HIGHSTAT Investigative D00GOD DRUG__ID D00GOD D00GOD DRUGCLAS Investigative Drug(s) D00GOD DRUGINCH 1S/C9H15N3O2/c10-4-2-1-3-7(9(13)14)8-5-11-6-12-8/h5-7H,1-4,10H2,(H,11,12)(H,13,14) D00GOD DRUGINKE ATNHCKIPIWIEGH-UHFFFAOYSA-N D00GOD DRUGSMIL C1=C(NC=N1)C(CCCCN)C(=O)O D00GOD DRUGTYPE Small molecular drug D00GOD HIGHSTAT Investigative D00GOH DRUG__ID D00GOH D00GOH DRUGCLAS Clinical Trial Drug(s) D00GOH DRUGCOMP XTL Biopharmaceuticals D00GOH HIGHSTAT Phase 2 D00GOM DRUG__ID D00GOM D00GOM COMPCLAS 2,2-dimethylbenzopyran derivatives D00GOM DRUGCLAS Patented Agent(s) D00GOM DRUGCOMP SNU R&DB Foundation, S. Korea D00GOM DRUGINCH 1S/C22H24O5/c1-22(2)11-10-16-18(27-22)9-7-15(21(16)26-5)17(23)12-14-6-8-19(24-3)20(13-14)25-4/h6-11,13H,12H2,1-5H3 D00GOM DRUGINKE TZRPLTHVBYHDBJ-UHFFFAOYSA-N D00GOM DRUGSMIL CC1(C=CC2=C(O1)C=CC(=C2OC)C(=O)CC3=CC(=C(C=C3)OC)OC)C D00GOM DRUGTYPE Small molecular drug D00GOM HIGHSTAT Patented D00GOQ DRUG__ID D00GOQ D00GOQ DRUGCLAS Investigative Drug(s) D00GOQ DRUGINCH 1S/C21H22O6/c1-22-21-16(7-14-3-5-18-20(9-14)27-12-25-18)15(10-23-21)6-13-2-4-17-19(8-13)26-11-24-17/h2-5,8-9,15-16,21H,6-7,10-12H2,1H3/t15-,16+,21+/m0/s1 D00GOQ DRUGINKE UUUXPUGZNDRYSV-GCKMJXCFSA-N D00GOQ DRUGSMIL COC1C(C(CO1)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5 D00GOQ DRUGTYPE Small molecular drug D00GOQ HIGHSTAT Investigative D00GOS DRUG__ID D00GOS D00GOS DRUADIID FDA-AP-BF04-01444 D00GOS DRUGCLAS Approved Drug(s) D00GOS DRUGCOMP Promius Pharma Llc D00GOS DRUGINCH 1S/C22H28ClFO4/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-21(15,3)22(14,23)18(28)9-20(13,2)19(11)17(27)10-25/h4-5,7,11,13-14,16,18-19,25,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,18+,19-,20+,21+,22+/m1/s1 D00GOS DRUGINKE YMTMADLUXIRMGX-RFPWEZLHSA-N D00GOS DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)Cl)C)F D00GOS DRUGTYPE Small molecular drug D00GOS HIGHSTAT Approved D00GOV DRUG__ID D00GOV D00GOV DRUGCLAS Approved Drug(s) D00GOV DRUGCOMP Bristol-Myers Squibb D00GOV DRUGTYPE Monoclonal antibody D00GOV HIGHSTAT Approved D00GOY DRUG__ID D00GOY D00GOY DRUGCLAS Investigative Drug(s) D00GOY DRUGINCH 1S/C11H15BrN2/c1-8(13)7-14-5-4-9-2-3-10(12)6-11(9)14/h2-3,6,8H,4-5,7,13H2,1H3/t8-/m0/s1 D00GOY DRUGINKE QGRQJMXAQYGAKK-QMMMGPOBSA-N D00GOY DRUGSMIL CC(CN1CCC2=C1C=C(C=C2)Br)N D00GOY DRUGTYPE Small molecular drug D00GOY HIGHSTAT Investigative D00GPQ DRUG__ID D00GPQ D00GPQ DRUGCLAS Clinical Trial Drug(s) D00GPQ DRUGCOMP Pfizer D00GPQ DRUGINCH 1S/C27H41F2N5O/c1-7-8-23(32-20-10-9-18-11-19(28)12-22(29)21(18)13-20)25(35)33-24-14-34(17-31-24)27(5,6)16-30-15-26(2,3)4/h11-12,14,17,20,23,30,32H,7-10,13,15-16H2,1-6H3,(H,33,35)/t20-,23-/m0/s1 D00GPQ DRUGINKE VFCRKLWBYMDAED-REWPJTCUSA-N D00GPQ DRUGSMIL CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F D00GPQ DRUGTYPE Small molecular drug D00GPQ HIGHSTAT Phase 3 D00GPY DRUG__ID D00GPY D00GPY DRUGCLAS Clinical Trial Drug(s) D00GPY DRUGCOMP Oncomed pharmaceuticals; Bayer HealthCare Pharmaceuticals; OncoMed Pharmaceuticals D00GPY HIGHSTAT Phase 1 D00GQC DRUG__ID D00GQC D00GQC DRUGCLAS Investigative Drug(s) D00GQC DRUGINCH 1S/C19H34O2/c1-2-3-4-5-7-10-13-17-16-18(17)14-11-8-6-9-12-15-19(20)21/h2-16H2,1H3,(H,20,21) D00GQC DRUGINKE PQRKPYLNZGDCFH-UHFFFAOYSA-N D00GQC DRUGSMIL CCCCCCCCC1=C(C1)CCCCCCCC(=O)O D00GQC DRUGTYPE Small molecular drug D00GQC HIGHSTAT Investigative D00GQI DRUG__ID D00GQI D00GQI DRUGCLAS Investigative Drug(s) D00GQI DRUGINCH 1S/C20H19N3O/c1-14(2)20(24)23-18-13-17(15-9-5-3-6-10-15)21-19(22-18)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,21,22,23,24) D00GQI DRUGINKE ONJOWWUQGQUDTK-UHFFFAOYSA-N D00GQI DRUGSMIL CC(C)C(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D00GQI DRUGTYPE Small molecular drug D00GQI HIGHSTAT Investigative D00GQM DRUG__ID D00GQM D00GQM DRUGCLAS Investigative Drug(s) D00GQM DRUGINCH 1S/C16H17N5O2/c22-9-11-1-3-12(4-2-11)14-19-15-13(17-10-18-15)16(20-14)21-5-7-23-8-6-21/h1-4,10,22H,5-9H2,(H,17,18,19,20) D00GQM DRUGINKE GSYUMLARWMDMOF-UHFFFAOYSA-N D00GQM DRUGSMIL C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=C(C=C4)CO D00GQM DRUGTYPE Small molecular drug D00GQM HIGHSTAT Investigative D00GQP DRUG__ID D00GQP D00GQP DRUGCLAS Investigative Drug(s) D00GQP DRUGINCH 1S/C21H39NO4/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-20(25)21(26)22-17-14-15-19(24)18-23/h23H,2-18H2,1H3,(H,22,26) D00GQP DRUGINKE JVJFDPHNZMYFII-UHFFFAOYSA-N D00GQP DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCCC(=O)CO D00GQP DRUGTYPE Small molecular drug D00GQP HIGHSTAT Investigative D00GRN DRUG__ID D00GRN D00GRN DRUGCLAS Investigative Drug(s) D00GRN DRUGINCH 1S/C11H16O3S/c1-2-3-4-5-15-8-9-6-10(12)11(13)7-14-9/h6-7,13H,2-5,8H2,1H3 D00GRN DRUGINKE BSUYJCKSLPFPSA-UHFFFAOYSA-N D00GRN DRUGSMIL CCCCCSCC1=CC(=O)C(=CO1)O D00GRN DRUGTYPE Small molecular drug D00GRN HIGHSTAT Investigative D00GSD DRUG__ID D00GSD D00GSD DRUGCLAS Investigative Drug(s) D00GSD DRUGINCH 1S/C30H34N4O/c31-23-25-14-16-26(17-15-25)24-32-30(35)13-5-2-8-18-33-19-21-34(22-20-33)29-12-7-6-11-28(29)27-9-3-1-4-10-27/h1,3-4,6-7,9-12,14-17H,2,5,8,13,18-22,24H2,(H,32,35) D00GSD DRUGINKE BQEDZLDNNBDKDS-UHFFFAOYSA-N D00GSD DRUGSMIL C1CN(CCN1CCCCCC(=O)NCC2=CC=C(C=C2)C#N)C3=CC=CC=C3C4=CC=CC=C4 D00GSD DRUGTYPE Small molecular drug D00GSD HIGHSTAT Investigative D00GSF DRUG__ID D00GSF D00GSF COMPCLAS Di-substituted piperidine derivatives D00GSF DRUGCLAS Patented Agent(s) D00GSF DRUGCOMP UNIVERZA V LJUBLJANI [SI] D00GSF DRUGTYPE Small molecular drug D00GSF HIGHSTAT Patented D00GTC DRUG__ID D00GTC D00GTC DRUGCLAS Investigative Drug(s) D00GTC DRUGINCH 1S/C13H14BrN3O/c1-9-8-12(15-6-7-18)17-13(16-9)10-2-4-11(14)5-3-10/h2-5,8,18H,6-7H2,1H3,(H,15,16,17) D00GTC DRUGINKE DUKPGOOUJNUIOI-UHFFFAOYSA-N D00GTC DRUGSMIL CC1=CC(=NC(=N1)C2=CC=C(C=C2)Br)NCCO D00GTC DRUGTYPE Small molecular drug D00GTC HIGHSTAT Investigative D00GTU DRUG__ID D00GTU D00GTU DRUGCLAS Investigative Drug(s) D00GTU DRUGINCH 1S/C21H34O3S/c1-2-3-6-9-17(22)13-12-16-14-18-15-20(25-18)19(16)10-7-4-5-8-11-21(23)24/h4,7,12-13,16-20,22H,2-3,5-6,8-11,14-15H2,1H3,(H,23,24)/b7-4-,13-12+/t16-,17+,18-,19+,20-/m0/s1 D00GTU DRUGINKE OVGWMUWIRHGGJP-WVDJAODQSA-N D00GTU DRUGSMIL CCCCCC(C=CC1CC2CC(C1CC=CCCCC(=O)O)S2)O D00GTU DRUGTYPE Small molecular drug D00GTU HIGHSTAT Investigative D00GTY DRUG__ID D00GTY D00GTY COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D00GTY DRUGCLAS Patented Agent(s) D00GTY DRUGCOMP MEDIVATION TECHNOLOGIES, INC D00GTY DRUGINCH 1S/C21H17FN4O/c22-15-5-14(8-17(27)9-15)18-10-26(21-19(18)20(23)24-11-25-21)16-6-12-3-1-2-4-13(12)7-16/h1-5,8-11,16,27H,6-7H2,(H2,23,24,25) D00GTY DRUGINKE FOYDQEHGCZAQII-UHFFFAOYSA-N D00GTY DRUGSMIL C1C(CC2=CC=CC=C21)N3C=C(C4=C(N=CN=C43)N)C5=CC(=CC(=C5)F)O D00GTY DRUGTYPE Small molecular drug D00GTY HIGHSTAT Patented D00GUE DRUG__ID D00GUE D00GUE DRUGCLAS Investigative Drug(s) D00GUE DRUGINCH 1S/C24H19NO2S/c26-21(27)16-20-23(19-14-8-3-9-15-19)25-24(28-20)22(17-10-4-1-5-11-17)18-12-6-2-7-13-18/h1-15,22H,16H2,(H,26,27) D00GUE DRUGINKE GSFLUFCQJVKCFD-UHFFFAOYSA-N D00GUE DRUGSMIL C1=CC=C(C=C1)C2=C(SC(=N2)C(C3=CC=CC=C3)C4=CC=CC=C4)CC(=O)O D00GUE DRUGTYPE Small molecular drug D00GUE HIGHSTAT Investigative D00GUG DRUG__ID D00GUG D00GUG DRUGCLAS Investigative Drug(s) D00GUG DRUGINCH 1S/C27H18N2O2/c30-29(31)23-15-11-19(12-16-23)10-13-22-18-26(21-7-2-1-3-8-21)28-25-17-14-20-6-4-5-9-24(20)27(22)25/h1-18H/b13-10+ D00GUG DRUGINKE TXOPJXIIAAMQKX-JLHYYAGUSA-N D00GUG DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C4=CC=CC=C4C=C3)C(=C2)C=CC5=CC=C(C=C5)[N+](=O)[O-] D00GUG DRUGTYPE Small molecular drug D00GUG HIGHSTAT Investigative D00GUM DRUG__ID D00GUM D00GUM DRUGCLAS Investigative Drug(s) D00GUM DRUGINCH 1S/C31H44N2O10/c1-36-24-18-22(19-25(37-2)28(24)40-5)30(34)42-16-8-12-32-10-7-11-33(15-14-32)13-9-17-43-31(35)23-20-26(38-3)29(41-6)27(21-23)39-4/h18-21H,7-17H2,1-6H3 D00GUM DRUGINKE QVZCXCJXTMIDME-UHFFFAOYSA-N D00GUM DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(=O)OCCCN2CCCN(CC2)CCCOC(=O)C3=CC(=C(C(=C3)OC)OC)OC D00GUM DRUGTYPE Small molecular drug D00GUM HIGHSTAT Investigative D00GVA DRUG__ID D00GVA D00GVA DRUGCLAS Investigative Drug(s) D00GVA DRUGINCH 1S/C13H13N3O3S/c14-20(18,19)12-3-1-11(2-4-12)16-13(17)9-10-5-7-15-8-6-10/h1-8H,9H2,(H,16,17)(H2,14,18,19) D00GVA DRUGINKE CXBVXOMVANONBT-UHFFFAOYSA-N D00GVA DRUGSMIL C1=CC(=CC=C1NC(=O)CC2=CC=NC=C2)S(=O)(=O)N D00GVA DRUGTYPE Small molecular drug D00GVA HIGHSTAT Investigative D00GVV DRUG__ID D00GVV D00GVV DRUGCLAS Investigative Drug(s) D00GVV DRUGINCH 1S/C17H15BrN2O/c18-11-5-6-16-13(8-11)14(17(21)20-16)9-12-7-10-3-1-2-4-15(10)19-12/h5-9,19H,1-4H2,(H,20,21)/b14-9- D00GVV DRUGINKE RFHPWPWVGFSLOP-ZROIWOOFSA-N D00GVV DRUGSMIL C1CCC2=C(C1)C=C(N2)C=C3C4=C(C=CC(=C4)Br)NC3=O D00GVV DRUGTYPE Small molecular drug D00GVV HIGHSTAT Investigative D00GWE DRUG__ID D00GWE D00GWE DRUGCLAS Patented Agent(s) D00GWE DRUGCOMP THE SCRIPPS RESEARCH INSTITUTE D00GWE DRUGTYPE Small molecular drug D00GWE HIGHSTAT Patented D00GWR DRUG__ID D00GWR D00GWR DRUGCLAS Investigative Drug(s) D00GWR HIGHSTAT Investigative D00GXL DRUG__ID D00GXL D00GXL DRUGCLAS Clinical Trial Drug(s) D00GXL DRUGCOMP Prana biotechnology D00GXL DRUGINCH 1S/C12H12Cl2N2O/c1-16(2)6-7-3-4-8-9(13)5-10(14)12(17)11(8)15-7/h3-5,17H,6H2,1-2H3 D00GXL DRUGINKE YZPOQCQXOSEMAZ-UHFFFAOYSA-N D00GXL DRUGSMIL CN(C)CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl D00GXL DRUGTYPE Small molecular drug D00GXL HIGHSTAT Phase 2 D00GYE DRUG__ID D00GYE D00GYE DRUGCLAS Investigative Drug(s) D00GYE DRUGINCH 1S/C10H15FN2/c1-8-6-9(4-2-3-5-11)13-10(12)7-8/h6-7H,2-5H2,1H3,(H2,12,13) D00GYE DRUGINKE OTKWRERYYAYGSY-UHFFFAOYSA-N D00GYE DRUGSMIL CC1=CC(=NC(=C1)N)CCCCF D00GYE DRUGTYPE Small molecular drug D00GYE HIGHSTAT Investigative D00GYX DRUG__ID D00GYX D00GYX DRUGCLAS Investigative Drug(s) D00GYX DRUGINCH 1S/C7H8S/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2 D00GYX DRUGINKE UENWRTRMUIOCKN-UHFFFAOYSA-N D00GYX DRUGSMIL C1=CC=C(C=C1)CS D00GYX DRUGTYPE Small molecular drug D00GYX HIGHSTAT Investigative D00GZW DRUG__ID D00GZW D00GZW DRUGCLAS Clinical Trial Drug(s) D00GZW DRUGCOMP Ono Pharmaceuticals D00GZW DRUGINCH 1S/C11H22O2/c1-3-5-6-7-9-10(8-4-2)11(12)13/h10H,3-9H2,1-2H3,(H,12,13)/t10-/m1/s1 D00GZW DRUGINKE YCYMCMYLORLIJX-SNVBAGLBSA-N D00GZW DRUGSMIL CCCCCCC(CCC)C(=O)O D00GZW DRUGTYPE Small molecular drug D00GZW HIGHSTAT Phase 2/3 D00GZY DRUG__ID D00GZY D00GZY DRUGCLAS Clinical Trial Drug(s) D00GZY DRUGINCH 1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46);1H3,(H,3,4)/t19-,20-,21-,26-,27-;/m0./s1 D00GZY DRUGINKE NYGCNONRVCGHAT-UFIKZEAMSA-N D00GZY DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN.CC(=O)O D00GZY DRUGTYPE Small molecular drug D00GZY HIGHSTAT Phase 3 D00HAJ DRUG__ID D00HAJ D00HAJ DRUGCLAS Investigative Drug(s) D00HAJ DRUGINCH 1S/C49H63FN10O9/c1-29(2)17-22-34(43(63)56-38(27-32-18-20-33(50)21-19-32)45(65)55-36(42(52)62)25-30-11-5-3-6-12-30)53-47(67)40-16-10-24-60(40)48(68)35(15-9-23-51)54-44(64)37(26-31-13-7-4-8-14-31)57-46(66)39-28-41(61)59-49(69)58-39/h3-8,11-14,18-21,29,34-40H,9-10,15-17,22-28,51H2,1-2H3,(H2,52,62)(H,53,67)(H,54,64)(H,55,65)(H,56,63)(H,57,66)(H2,58,59,61,69)/t34-,35-,36+,37-,38-,39-,40-/m0/s1 D00HAJ DRUGINKE HXKFHHNEFCZKPG-VEKZNEBUSA-N D00HAJ DRUGSMIL CC(C)CCC(C(=O)NC(CC1=CC=C(C=C1)F)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CCCN)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5CC(=O)NC(=O)N5 D00HAJ DRUGTYPE Small molecular drug D00HAJ HIGHSTAT Investigative D00HAM DRUG__ID D00HAM D00HAM DRUGCLAS Investigative Drug(s) D00HAM HIGHSTAT Investigative D00HAN DRUG__ID D00HAN D00HAN DRUGCLAS Clinical Trial Drug(s) D00HAN DRUGCOMP Beijing Immunochina Medical Science & Technology Co., Ltd. D00HAN DRUGTYPE CAR T Cell Therapy D00HAN HIGHSTAT Phase 1 D00HAP DRUG__ID D00HAP D00HAP DRUGCLAS Clinical Trial Drug(s) D00HAP DRUGCOMP AstraZeneca; Bristol-Myers Squibb D00HAP DRUGINCH 1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21?/m1/s1 D00HAP DRUGINKE JVHXJTBJCFBINQ-AWGDKMGJSA-N D00HAP DRUGSMIL CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl D00HAP DRUGTYPE Small molecular drug D00HAP HIGHSTAT Phase 3 D00HAZ DRUG__ID D00HAZ D00HAZ DRUGCLAS Investigative Drug(s) D00HAZ DRUGINCH 1S/C17H12N2O/c1-2-8-13-12(6-1)7-5-10-15(13)18-17-14-9-3-4-11-16(14)20-19-17/h1-11H,(H,18,19) D00HAZ DRUGINKE SOIDHQDYGYBXPJ-UHFFFAOYSA-N D00HAZ DRUGSMIL C1=CC=C2C(=C1)C=CC=C2NC3=NOC4=CC=CC=C43 D00HAZ DRUGTYPE Small molecular drug D00HAZ HIGHSTAT Investigative D00HBE DRUG__ID D00HBE D00HBE DRUGCLAS Clinical Trial Drug(s) D00HBE DRUGCOMP Astrazeneca D00HBE DRUGINCH 1S/C22H22FN5O7/c1-8-7-33-21(32)28(8)17-12-4-11-5-22(18(29)24-20(31)25-19(22)30)16-10(3)34-9(2)6-27(16)14(11)13(23)15(12)35-26-17/h4,8-10,16H,5-7H2,1-3H3,(H2,24,25,29,30,31)/t8-,9+,10-,16+/m0/s1 D00HBE DRUGINKE ZSWMIFNWDQEXDT-ZESJGQACSA-N D00HBE DRUGSMIL CC1CN2C(C(O1)C)C3(CC4=CC5=C(C(=C42)F)ON=C5N6C(COC6=O)C)C(=O)NC(=O)NC3=O D00HBE HIGHSTAT Phase 3 D00HBF DRUG__ID D00HBF D00HBF DRUGCLAS Investigative Drug(s) D00HBF DRUGCOMP Cell Signals Inc D00HBF HIGHSTAT Investigative D00HBJ DRUG__ID D00HBJ D00HBJ DRUGCLAS Patented Agent(s) D00HBJ DRUGINCH 1S/C20H21F3N6O3/c1-28-7-10-31-16-15(28)17(24-13-5-8-30-9-6-13)27-29-18(25-26-19(16)29)12-3-2-4-14(11-12)32-20(21,22)23/h2-4,11,13H,5-10H2,1H3,(H,24,27) D00HBJ DRUGINKE DKFWOQOORFAKNT-UHFFFAOYSA-N D00HBJ DRUGSMIL CN1CCOC2=C1C(=NN3C2=NN=C3C4=CC(=CC=C4)OC(F)(F)F)NC5CCOCC5 D00HBJ DRUGTYPE Small molecular drug D00HBJ HIGHSTAT Patented D00HBR DRUG__ID D00HBR D00HBR DRUGCLAS Clinical Trial Drug(s) D00HBR DRUGCOMP Aiko Biotechnology Inc D00HBR DRUGINCH 1S/C20H25NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,14-15,18,22-24H,1-2,5-10H2/t14-,15-,18+,19+,20-/m1/s1 D00HBR DRUGINKE JLVNEHKORQFVQJ-PYIJOLGTSA-N D00HBR DRUGSMIL C1CC1CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O D00HBR DRUGTYPE Small molecular drug D00HBR HIGHSTAT Phase 1 D00HCC DRUG__ID D00HCC D00HCC DRUGCLAS Investigative Drug(s) D00HCC DRUGINCH 1S/C16H18N2O/c1-2-6-14(7-3-1)19-16-9-5-4-8-15(16)18-12-10-17-11-13-18/h1-9,17H,10-13H2 D00HCC DRUGINKE VAXHGPCUAFNAQS-UHFFFAOYSA-N D00HCC DRUGSMIL C1CN(CCN1)C2=CC=CC=C2OC3=CC=CC=C3 D00HCC DRUGTYPE Small molecular drug D00HCC HIGHSTAT Investigative D00HCI DRUG__ID D00HCI D00HCI DRUGCLAS Investigative Drug(s) D00HCI DRUGINCH 1S/C14H16BNO/c16-11-12-17-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10H,11-12,16H2 D00HCI DRUGINKE BLZVCIGGICSWIG-UHFFFAOYSA-N D00HCI DRUGSMIL B(C1=CC=CC=C1)(C2=CC=CC=C2)OCCN D00HCI DRUGTYPE Small molecular drug D00HCI HIGHSTAT Investigative D00HCK DRUG__ID D00HCK D00HCK DRUGCLAS Investigative Drug(s) D00HCK DRUGTYPE Peptide D00HCK HIGHSTAT Investigative D00HCQ DRUG__ID D00HCQ D00HCQ DRUGCLAS Approved Drug(s) D00HCQ DRUGCOMP Roche D00HCQ DRUGINCH 1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1 D00HCQ DRUGINKE GAGWJHPBXLXJQN-UORFTKCHSA-N D00HCQ DRUGSMIL CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O D00HCQ DRUGTYPE Small molecular drug D00HCQ HIGHSTAT Approved D00HCQ THERCLAS Anticancer Agents D00HDB DRUG__ID D00HDB D00HDB DRUGCLAS Clinical Trial Drug(s) D00HDB DRUGCOMP Acorda therapeutics D00HDB HIGHSTAT Phase 2 D00HDC DRUG__ID D00HDC D00HDC DRUGCLAS Investigative Drug(s) D00HDC DRUGCOMP Mt Cook Pharma D00HDC HIGHSTAT Investigative D00HDH DRUG__ID D00HDH D00HDH DRUGCLAS Investigative Drug(s) D00HDH DRUGCOMP Merck & Co Inc D00HDH HIGHSTAT Investigative D00HDK DRUG__ID D00HDK D00HDK DRUGCLAS Preclinical Drug(s) D00HDK DRUGCOMP Psychiatric Genomics Inc D00HDK HIGHSTAT Preclinical D00HDU DRUG__ID D00HDU D00HDU DRUADIID FDA-AP-BF04-01522 D00HDU DRUGCLAS Approved Drug(s) D00HDU DRUGCOMP Ucb Inc D00HDU DRUGINCH 1S/C27H34N2O7/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32)/t17-,21-,22-/m0/s1 D00HDU DRUGINKE UWWDHYUMIORJTA-HSQYWUDLSA-N D00HDU DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC D00HDU DRUGTYPE Small molecular drug D00HDU HIGHSTAT Approved D00HDU THERCLAS Antihypertensive Agents D00HDZ DRUG__ID D00HDZ D00HDZ DRUGCLAS Drugs in Phase 1 Trial D00HDZ DRUGTYPE Cell therapy D00HDZ HIGHSTAT Phase 1/2 Trial D00HDZ THERCLAS Antiviral Agents D00HEA DRUG__ID D00HEA D00HEA DRUGCLAS Investigative Drug(s) D00HEA DRUGCOMP Kyto Biopharma Inc D00HEA HIGHSTAT Investigative D00HEN DRUG__ID D00HEN D00HEN DRUGCLAS Approved Drug(s) D00HEN DRUGCOMP Lanzhou Institute of Biological Products D00HEN HIGHSTAT Approved D00HET DRUG__ID D00HET D00HET DRUGCLAS Investigative Drug(s) D00HET DRUGINCH 1S/C21H18N2O2/c1-24-18-11-12-19-20(14-18)23-21(22-19)13-15-7-9-17(10-8-15)25-16-5-3-2-4-6-16/h2-12,14H,13H2,1H3,(H,22,23) D00HET DRUGINKE QXVTTYRBOJXPRC-UHFFFAOYSA-N D00HET DRUGSMIL COC1=CC2=C(C=C1)N=C(N2)CC3=CC=C(C=C3)OC4=CC=CC=C4 D00HET DRUGTYPE Small molecular drug D00HET HIGHSTAT Investigative D00HFD DRUG__ID D00HFD D00HFD DRUGCLAS Discontinued Drug(s) D00HFD DRUGCOMP Eisai Co Ltd D00HFD DRUGINCH 1S/C17H19N3O3S2.ClH/c1-9-10(2)15(21)11(3)16-14(9)20-17(24-16)19-8-12-4-6-13(7-5-12)25(18,22)23;/h4-7,21H,8H2,1-3H3,(H,19,20)(H2,18,22,23);1H D00HFD DRUGINKE WLODMDLNSQYBMG-UHFFFAOYSA-N D00HFD DRUGSMIL CC1=C(C(=C(C2=C1N=C(S2)NCC3=CC=C(C=C3)S(=O)(=O)N)C)O)C.Cl D00HFD DRUGTYPE Small molecular drug D00HFD HIGHSTAT Discontinued in Phase 2 D00HFS DRUG__ID D00HFS D00HFS DRUGCLAS Investigative Drug(s) D00HFS DRUGINCH 1S/C13H18N2O3/c1-10-6-8-11(9-7-10)14-12(16)4-2-3-5-13(17)15-18/h6-9,18H,2-5H2,1H3,(H,14,16)(H,15,17) D00HFS DRUGINKE VUUHXDZTBBCMIT-UHFFFAOYSA-N D00HFS DRUGSMIL CC1=CC=C(C=C1)NC(=O)CCCCC(=O)NO D00HFS DRUGTYPE Small molecular drug D00HFS HIGHSTAT Investigative D00HFT DRUG__ID D00HFT D00HFT DRUGCLAS Investigative Drug(s) D00HFT DRUGINCH 1S/C32H36N2O8/c1-7-18-16-34-26-14-21(18)30(29(36)40-6,17-41-28(35)19-8-11-24(38-4)25(12-19)39-5)31-15-27(34)42-32(26,31)33(2)23-10-9-20(37-3)13-22(23)31/h7-13,21,26-27H,14-17H2,1-6H3/b18-7-/t21-,26-,27-,30-,31-,32-/m0/s1 D00HFT DRUGINKE DTINADCHYFZWSG-BUVDGYSPSA-N D00HFT DRUGSMIL CC=C1CN2C3CC1C(C45C3(N(C6=C4C=C(C=C6)OC)C)OC2C5)(COC(=O)C7=CC(=C(C=C7)OC)OC)C(=O)OC D00HFT DRUGTYPE Small molecular drug D00HFT HIGHSTAT Investigative D00HFV DRUG__ID D00HFV D00HFV DRUGCLAS Investigative Drug(s) D00HFV DRUGINCH 1S/C14H11F3N2S/c15-14(16,17)11-5-1-9(2-6-11)10-3-7-12(8-4-10)19-13(18)20/h1-8H,(H3,18,19,20) D00HFV DRUGINKE VTGXCQVBAHHGLK-UHFFFAOYSA-N D00HFV DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)NC(=S)N)C(F)(F)F D00HFV DRUGTYPE Small molecular drug D00HFV HIGHSTAT Investigative D00HGB DRUG__ID D00HGB D00HGB DRUGCLAS Approved Drug(s) D00HGB DRUGINCH 1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20) D00HGB DRUGINKE JZFPYUNJRRFVQU-UHFFFAOYSA-N D00HGB DRUGSMIL C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F D00HGB DRUGTYPE Small molecular drug D00HGB HIGHSTAT Approved D00HGB THERCLAS Antiinflammatory Agents D00HGD DRUG__ID D00HGD D00HGD DRUGCLAS Patented Agent(s) D00HGD DRUGINCH 1S/C24H21ClN4O2/c25-20-4-2-1-3-19(20)21-15-16-9-10-26-24(30)22(16)23(28-21)27-17-5-7-18(8-6-17)29-11-13-31-14-12-29/h1-10,15H,11-14H2,(H,26,30)(H,27,28) D00HGD DRUGINKE BMPOWIIBXCMAFL-UHFFFAOYSA-N D00HGD DRUGSMIL C1COCCN1C2=CC=C(C=C2)NC3=C4C(=CC(=N3)C5=CC=CC=C5Cl)C=CNC4=O D00HGD DRUGTYPE Small molecular drug D00HGD HIGHSTAT Patented D00HGF DRUG__ID D00HGF D00HGF DRUGCLAS Clinical Trial Drug(s) D00HGF DRUGINCH 1S/C4H10O4/c5-1-3(7)4(8)2-6/h3-8H,1-2H2/t3-,4+ D00HGF DRUGINKE UNXHWFMMPAWVPI-ZXZARUISSA-N D00HGF DRUGSMIL C(C(C(CO)O)O)O D00HGF DRUGTYPE Small molecular drug D00HGF HIGHSTAT Phase 2/3 D00HGY DRUG__ID D00HGY D00HGY DRUGCLAS Clinical Trial Drug(s) D00HGY DRUGCOMP Orban Biotech LLC D00HGY HIGHSTAT Phase 1 D00HHK DRUG__ID D00HHK D00HHK DRUGCLAS Investigative Drug(s) D00HHK DRUGINCH 1S/C21H25N3/c1-2-6-18(7-3-1)19-9-11-20(12-10-19)23-14-16-24(17-15-23)21-8-4-5-13-22-21/h1-9,13,20H,10-12,14-17H2 D00HHK DRUGINKE MBOHGQXYZVXXQF-UHFFFAOYSA-N D00HHK DRUGSMIL C1CC(=CCC1N2CCN(CC2)C3=CC=CC=N3)C4=CC=CC=C4 D00HHK DRUGTYPE Small molecular drug D00HHK HIGHSTAT Investigative D00HHP DRUG__ID D00HHP D00HHP DRUGCLAS Discontinued Drug(s) D00HHP DRUGCOMP Pfizer Inc D00HHP DRUGINCH 1S/C20H25NO8/c1-3-6-27-13-5-4-11(8-12(13)22)7-10(2)20(26)21-14-15(23)17(25)19-18(16(14)24)28-9-29-19/h3-5,7-8,14-19,22-25H,1,6,9H2,2H3,(H,21,26)/b10-7+/t14-,15+,16-,17-,18+,19-/m1/s1 D00HHP DRUGINKE NGSRLTSVOTUMKD-ZKVKIDQDSA-N D00HHP DRUGSMIL CC(=CC1=CC(=C(C=C1)OCC=C)O)C(=O)NC2C(C(C3C(C2O)OCO3)O)O D00HHP HIGHSTAT Terminated D00HHS DRUG__ID D00HHS D00HHS DRUGCLAS Approved Drug(s) D00HHS DRUGCOMP Pfizer Pharmaceuticals D00HHS DRUGINCH 1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1 D00HHS DRUGINKE KWGRBVOPPLSCSI-WCBMZHEXSA-N D00HHS DRUGSMIL CC(C(C1=CC=CC=C1)O)NC D00HHS DRUGTYPE Small molecular drug D00HHS HIGHSTAT Approved D00HHU DRUG__ID D00HHU D00HHU DRUGCLAS Clinical Trial Drug(s) D00HHU DRUGCOMP Statens Serum Institut D00HHU DRUGTYPE Vaccine D00HHU HIGHSTAT Phase 1 D00HIC DRUG__ID D00HIC D00HIC DRUGCLAS Discontinued Drug(s) D00HIC DRUGCOMP Provalis plc D00HIC HIGHSTAT Discontinued in Phase 1 D00HIG DRUG__ID D00HIG D00HIG DRUGCLAS Investigative Drug(s) D00HIG DRUGINCH 1S/C21H28N2OS/c1-3-21(24)23(18-8-5-4-6-9-18)20-12-14-22(16-17(20)2)13-11-19-10-7-15-25-19/h4-10,15,17,20H,3,11-14,16H2,1-2H3 D00HIG DRUGINKE SRARDYUHGVMEQI-UHFFFAOYSA-N D00HIG DRUGSMIL CCC(=O)N(C1CCN(CC1C)CCC2=CC=CS2)C3=CC=CC=C3 D00HIG DRUGTYPE Small molecular drug D00HIG HIGHSTAT Investigative D00HIH DRUG__ID D00HIH D00HIH DRUGCLAS Investigative Drug(s) D00HIH DRUGINCH 1S/C18H20FN5O/c1-18(2,3)17-22-21-14-10-12(8-9-24(14)17)16-20-15(23-25-16)11-4-6-13(19)7-5-11/h4-7,12H,8-10H2,1-3H3/t12-/m0/s1 D00HIH DRUGINKE NPRJTKMKUYJGAL-LBPRGKRZSA-N D00HIH DRUGSMIL CC(C)(C)C1=NN=C2N1CCC(C2)C3=NC(=NO3)C4=CC=C(C=C4)F D00HIH DRUGTYPE Small molecular drug D00HIH HIGHSTAT Investigative D00HKQ DRUG__ID D00HKQ D00HKQ DRUGCLAS Investigative Drug(s) D00HKQ DRUGINCH 1S/C22H20FN3O2/c1-3-4-10-26-11-8-18(19(14-24)22(26)27)16-5-6-21(20(23)13-16)28-17-7-9-25-15(2)12-17/h5-9,11-13H,3-4,10H2,1-2H3 D00HKQ DRUGINKE IPTWXMISVLTMAV-UHFFFAOYSA-N D00HKQ DRUGSMIL CCCCN1C=CC(=C(C1=O)C#N)C2=CC(=C(C=C2)OC3=CC(=NC=C3)C)F D00HKQ DRUGTYPE Small molecular drug D00HKQ HIGHSTAT Investigative D00HLW DRUG__ID D00HLW D00HLW DRUGCLAS Investigative Drug(s) D00HLW DRUGINCH 1S/C25H29ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h5-9,14-16H,4,10-13H2,1-3H3,(H,28,33)(H,27,29,30) D00HLW DRUGINKE SDGJBAUIGHSMRI-UHFFFAOYSA-N D00HLW DRUGSMIL CCC(=O)NC1=CC(=CC=C1)OC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCN(CC4)C)OC D00HLW DRUGTYPE Small molecular drug D00HLW HIGHSTAT Investigative D00HMQ DRUG__ID D00HMQ D00HMQ DRUGCLAS Discontinued Drug(s) D00HMQ DRUGCOMP Pharmacia & Upjohn Co D00HMQ HIGHSTAT Discontinued in Phase 1 D00HMZ DRUG__ID D00HMZ D00HMZ DRUGCLAS Clinical Trial Drug(s) D00HMZ DRUGCOMP Tvax biomedical D00HMZ HIGHSTAT Phase 2 D00HNB DRUG__ID D00HNB D00HNB DRUGCLAS Approved Drug(s) D00HNB DRUGINCH 1S/CH4Cl2O6P2/c2-1(3,10(4,5)6)11(7,8)9/h(H2,4,5,6)(H2,7,8,9) D00HNB DRUGINKE ACSIXWWBWUQEHA-UHFFFAOYSA-N D00HNB DRUGSMIL C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl D00HNB DRUGTYPE Small molecular drug D00HNB HIGHSTAT Approved D00HNB THERCLAS Antihypocalcemic Agents D00HNG DRUG__ID D00HNG D00HNG DRUGCLAS Investigative Drug(s) D00HNG DRUGINCH 1S/C30H37NO5/c1-18-13-22-23(30(4,5)12-11-29(22,2)3)15-19(18)14-20-9-10-24(36-20)28(32)31-27-25(34-7)16-21(33-6)17-26(27)35-8/h9-10,13,15-17H,11-12,14H2,1-8H3,(H,31,32) D00HNG DRUGINKE IPEMCIBPDYCJLO-UHFFFAOYSA-N D00HNG DRUGSMIL CC1=CC2=C(C=C1CC3=CC=C(O3)C(=O)NC4=C(C=C(C=C4OC)OC)OC)C(CCC2(C)C)(C)C D00HNG DRUGTYPE Small molecular drug D00HNG HIGHSTAT Investigative D00HNK DRUG__ID D00HNK D00HNK DRUGCLAS Discontinued Drug(s) D00HNK DRUGCOMP Somatogen Inc D00HNK HIGHSTAT Terminated D00HNQ DRUG__ID D00HNQ D00HNQ DRUGCLAS Investigative Drug(s) D00HNQ DRUGCOMP ALS Therapy Development Foundation Inc D00HNQ HIGHSTAT Investigative D00HPD DRUG__ID D00HPD D00HPD DRUADIID 800026609 D00HPD DRUGCLAS Approved Drug(s) D00HPD DRUGCOMP AstraZeneca D00HPD DRUGTYPE Monoclonal antibody D00HPD HIGHSTAT Approved D00HPD THERCLAS Anticancer Agents D00HPD TRADNAME Lumoxiti D00HPK DRUG__ID D00HPK D00HPK DRUADIID FDA-AP-BF04-01323 D00HPK DRUGCLAS Approved Drug(s) D00HPK DRUGCOMP Merz Pharmaceuticals Llc D00HPK DRUGINCH 1S/C21H21N/c1-22(16-8-11-18-9-3-2-4-10-18)17-20-14-7-13-19-12-5-6-15-21(19)20/h2-15H,16-17H2,1H3/b11-8+ D00HPK DRUGINKE OZGNYLLQHRPOBR-DHZHZOJOSA-N D00HPK DRUGSMIL CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32 D00HPK DRUGTYPE Small molecular drug D00HPK HIGHSTAT Approved D00HPK THERCLAS Antifungal Agents D00HPX DRUG__ID D00HPX D00HPX DRUGCLAS Investigative Drug(s) D00HPX DRUGCOMP Onconova Therapeutics Inc D00HPX HIGHSTAT Investigative D00HQB DRUG__ID D00HQB D00HQB DRUGCLAS Investigative Drug(s) D00HQB DRUGCOMP TxCell SA D00HQB HIGHSTAT Investigative D00HQE DRUG__ID D00HQE D00HQE DRUGCLAS Clinical Trial Drug(s) D00HQE DRUGCOMP Avant Immunotherapeutics D00HQE HIGHSTAT Phase 2 D00HQJ DRUG__ID D00HQJ D00HQJ DRUGCLAS Patented Agent(s) D00HQJ DRUGINCH 1S/C23H23F2N7O2/c1-34-22-21(28-19-9-16(24)17(25)10-20(19)29-22)30-23(33)27-15-4-6-32(7-5-15)12-13-2-3-14-11-26-31-18(14)8-13/h2-3,8-11,15H,4-7,12H2,1H3,(H,26,31)(H2,27,28,30,33) D00HQJ DRUGINKE XSQADOWIAZCVIY-UHFFFAOYSA-N D00HQJ DRUGSMIL COC1=NC2=CC(=C(C=C2N=C1NC(=O)NC3CCN(CC3)CC4=CC5=C(C=C4)C=NN5)F)F D00HQJ DRUGTYPE Small molecular drug D00HQJ HIGHSTAT Patented D00HSG DRUG__ID D00HSG D00HSG DRUGCLAS Investigative Drug(s) D00HSG DRUGINCH 1S/C12H11ClN2/c13-11-6-2-1-5-10(11)12-9(8-14)4-3-7-15-12/h1-7H,8,14H2 D00HSG DRUGINKE FTTHUIFIPJIQEI-UHFFFAOYSA-N D00HSG DRUGSMIL C1=CC=C(C(=C1)C2=C(C=CC=N2)CN)Cl D00HSG DRUGTYPE Small molecular drug D00HSG HIGHSTAT Investigative D00HSJ DRUG__ID D00HSJ D00HSJ DRUGCLAS Investigative Drug(s) D00HSJ DRUGINCH 1S/C16H14BrN5O4S/c1-11-3-5-13(22(23)24)7-15(11)27(25,26)20(2)19-9-14-8-18-16-6-4-12(17)10-21(14)16/h3-10H,1-2H3/b19-9+ D00HSJ DRUGINKE QTHCAAFKVUWAFI-DJKKODMXSA-N D00HSJ DRUGSMIL CC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N(C)N=CC2=CN=C3N2C=C(C=C3)Br D00HSJ DRUGTYPE Small molecular drug D00HSJ HIGHSTAT Investigative D00HSK DRUG__ID D00HSK D00HSK DRUGCLAS Clinical Trial Drug(s) D00HSK DRUGCOMP NewLink Genetics D00HSK DRUGTYPE Vaccine D00HSK HIGHSTAT Phase 3 D00HTO DRUG__ID D00HTO D00HTO DRUGCLAS Clinical Trial Drug(s) D00HTO DRUGCOMP Genzyme D00HTO DRUGINCH 1S/C28H52O7P2/c1-18(2)32-36(30,33-19(3)4)25(37(31,34-20(5)6)35-21(7)8)17-22-15-23(27(9,10)11)26(29)24(16-22)28(12,13)14/h15-16,18-21,25,29H,17H2,1-14H3 D00HTO DRUGINKE YLJOVCWVJCDPLN-UHFFFAOYSA-N D00HTO DRUGSMIL CC(C)OP(=O)(C(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)P(=O)(OC(C)C)OC(C)C)OC(C)C D00HTO DRUGTYPE Small molecular drug D00HTO HIGHSTAT Phase 2 D00HTT DRUG__ID D00HTT D00HTT DRUGCLAS Discontinued Drug(s) D00HTT DRUGCOMP XenoStat Inc D00HTT HIGHSTAT Terminated D00HTY DRUG__ID D00HTY D00HTY DRUGCLAS Clinical Trial Drug(s) D00HTY DRUGINCH 1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 D00HTY DRUGINKE PXGPLTODNUVGFL-YNNPMVKQSA-N D00HTY DRUGSMIL CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O D00HTY DRUGTYPE Small molecular drug D00HTY HIGHSTAT Clinical trial D00HUB DRUG__ID D00HUB D00HUB DRUGCLAS Investigative Drug(s) D00HUB DRUGINCH 1S/C19H15NO/c21-20-14-15-11-12-18(16-7-3-1-4-8-16)19(13-15)17-9-5-2-6-10-17/h1-14,21H/b20-14+ D00HUB DRUGINKE XSIHFOOFJWBVHK-XSFVSMFZSA-N D00HUB DRUGSMIL C1=CC=C(C=C1)C2=C(C=C(C=C2)C=NO)C3=CC=CC=C3 D00HUB DRUGTYPE Small molecular drug D00HUB HIGHSTAT Investigative D00HUP DRUG__ID D00HUP D00HUP DRUGCLAS Investigative Drug(s) D00HUP DRUGINCH 1S/C17H13N5/c1-3-7-12(8-4-1)15-21-14-16(18-11-19-17(14)22-15)20-13-9-5-2-6-10-13/h1-11H,(H2,18,19,20,21,22) D00HUP DRUGINKE OKZNIBWRMMFNQY-UHFFFAOYSA-N D00HUP DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N2)C(=NC=N3)NC4=CC=CC=C4 D00HUP DRUGTYPE Small molecular drug D00HUP HIGHSTAT Investigative D00HUV DRUG__ID D00HUV D00HUV DRUGCLAS Investigative Drug(s) D00HUV DRUGINCH 1S/C16H17N3O/c1-2-5-13(6-3-1)11-17-9-10-20-15-8-4-7-14-16(15)19-12-18-14/h1-8,12,17H,9-11H2,(H,18,19) D00HUV DRUGINKE XQWCSGWUJUEAQM-UHFFFAOYSA-N D00HUV DRUGSMIL C1=CC=C(C=C1)CNCCOC2=CC=CC3=C2N=CN3 D00HUV DRUGTYPE Small molecular drug D00HUV HIGHSTAT Investigative D00HUY DRUG__ID D00HUY D00HUY DRUGCLAS Investigative Drug(s) D00HUY DRUGINCH 1S/C22H24N2O3/c1-14-8-15(2)10-17(9-14)13-27-22(26)21(24-16(3)25)11-18-12-23-20-7-5-4-6-19(18)20/h4-10,12,21,23H,11,13H2,1-3H3,(H,24,25)/t21-/m0/s1 D00HUY DRUGINKE YIHWPQQGVKFHTC-NRFANRHFSA-N D00HUY DRUGSMIL CC1=CC(=CC(=C1)COC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C)C D00HUY DRUGTYPE Small molecular drug D00HUY HIGHSTAT Investigative D00HUZ DRUG__ID D00HUZ D00HUZ DRUGCLAS Clinical Trial Drug(s) D00HUZ DRUGINCH 1S/2C10H20O2.C6H12N2.Pt/c2*1-10(2,3)8-6-4-5-7-9(11)12;7-5-3-1-2-4-6(5)8;/h2*4-8H2,1-3H3,(H,11,12);5-8H,1-4H2;/q;;-2;+4/p-2 D00HUZ DRUGINKE ALPHSAWEOKVWID-UHFFFAOYSA-L D00HUZ DRUGSMIL CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].C1CCC(C(C1)[NH-])[NH-].[Pt+4] D00HUZ DRUGTYPE Small molecular drug D00HUZ HIGHSTAT Phase 2 D00HVA DRUG__ID D00HVA D00HVA DRUGCLAS Investigative Drug(s) D00HVA DRUGINCH 1S/C18H20N4O4/c1-4-26-18-13(10-19)14(20)9-16(22-18)21-17(23)8-11-7-12(24-2)5-6-15(11)25-3/h5-7,9H,4,8H2,1-3H3,(H3,20,21,22,23) D00HVA DRUGINKE KQMPRSZTUSSXND-UHFFFAOYSA-N D00HVA DRUGSMIL CCOC1=C(C(=CC(=N1)NC(=O)CC2=C(C=CC(=C2)OC)OC)N)C#N D00HVA DRUGTYPE Small molecular drug D00HVA HIGHSTAT Investigative D00HVP DRUG__ID D00HVP D00HVP DRUGCLAS Investigative Drug(s) D00HVP DRUGINCH 1S/C28H24O4/c29-22-9-13-24-21(17-22)8-3-18-4-10-23(11-5-18)32-28-16-20(7-14-26(28)30)2-1-19-6-12-25(24)27(31)15-19/h4-7,9-17,29-31H,1-3,8H2 D00HVP DRUGINKE JMKSVONWZFVEAI-UHFFFAOYSA-N D00HVP DRUGSMIL C1CC2=C(C=CC(=C2)O)C3=C(C=C(CCC4=CC(=C(C=C4)O)OC5=CC=C1C=C5)C=C3)O D00HVP DRUGTYPE Small molecular drug D00HVP HIGHSTAT Investigative D00HVX DRUG__ID D00HVX D00HVX DRUGCLAS Investigative Drug(s) D00HVX DRUGINCH 1S/C9H6N4O/c14-9-8-10-5-11-13(8)7-4-2-1-3-6(7)12-9/h1-5H,(H,12,14) D00HVX DRUGINKE OEIMIUHARCZWJY-UHFFFAOYSA-N D00HVX DRUGSMIL C1=CC=C2C(=C1)NC(=O)C3=NC=NN23 D00HVX DRUGTYPE Small molecular drug D00HVX HIGHSTAT Investigative D00HVZ DRUG__ID D00HVZ D00HVZ DRUGCLAS Investigative Drug(s) D00HVZ DRUGINCH 1S/C17H16O4/c1-19-12-5-3-11(4-6-12)16-10-15(18)14-8-7-13(20-2)9-17(14)21-16/h3-9,16H,10H2,1-2H3 D00HVZ DRUGINKE YAEYGSBLDUIDTP-UHFFFAOYSA-N D00HVZ DRUGSMIL COC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)OC D00HVZ HIGHSTAT Investigative D00HWD DRUG__ID D00HWD D00HWD DRUGCLAS Investigative Drug(s) D00HWD DRUGINCH 1S/C3H5NO5/c5-2(6)1-4(9)3(7)8/h9H,1H2,(H,5,6)(H,7,8) D00HWD DRUGINKE LJSQPIOQKDFEKE-UHFFFAOYSA-N D00HWD DRUGSMIL C(C(=O)O)N(C(=O)O)O D00HWD DRUGTYPE Small molecular drug D00HWD HIGHSTAT Investigative D00HWF DRUG__ID D00HWF D00HWF DRUGCLAS Investigative Drug(s) D00HWF DRUGINCH 1S/C13H16N2O/c1-2-5-12(6-3-1)10-16-8-4-7-13-9-14-11-15-13/h1-3,5-6,9,11H,4,7-8,10H2,(H,14,15) D00HWF DRUGINKE WNWALBVQAAIULR-UHFFFAOYSA-N D00HWF DRUGSMIL C1=CC=C(C=C1)COCCCC2=CN=CN2 D00HWF DRUGTYPE Small molecular drug D00HWF HIGHSTAT Investigative D00HWJ DRUG__ID D00HWJ D00HWJ DRUGCLAS Investigative Drug(s) D00HWJ DRUGINCH 1S/C28H28N4O4S2/c1-36-22-9-7-20-8-11-24(16-21(20)15-22)38(34,35)32(17-19-5-3-2-4-6-19)25-13-14-31(28(25)33)18-23-10-12-26(37-23)27(29)30/h2-12,15-16,25H,13-14,17-18H2,1H3,(H3,29,30)/t25-/m0/s1 D00HWJ DRUGINKE KKFJNRXJRRYNRJ-VWLOTQADSA-N D00HWJ DRUGSMIL COC1=CC2=C(C=C1)C=CC(=C2)S(=O)(=O)N(CC3=CC=CC=C3)C4CCN(C4=O)CC5=CC=C(S5)C(=N)N D00HWJ DRUGTYPE Small molecular drug D00HWJ HIGHSTAT Investigative D00HWO DRUG__ID D00HWO D00HWO DRUGCLAS Approved Drug(s) D00HWO DRUGINCH 1S/C15H23N3O4S/c1-14(2)9(12(20)21)18-10(19)8(11(18)23-14)17-13(22)15(16)6-4-3-5-7-15/h8-9,11H,3-7,16H2,1-2H3,(H,17,22)(H,20,21)/t8-,9+,11-/m1/s1 D00HWO DRUGINKE HGBLNBBNRORJKI-WCABBAIRSA-N D00HWO DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C D00HWO DRUGTYPE Small molecular drug D00HWO HIGHSTAT Approved D00HWO THERCLAS Antibiotics D00HXJ DRUG__ID D00HXJ D00HXJ DRUGCLAS Patented Agent(s) D00HXJ DRUGCOMP UNIVERSIT T REGENSBURG [DEFRIEDRICH SCHILLER UNIVERSIT T JENA [DEUNIVERSIT TSKLINIKUM JENA [DE] D00HXJ DRUGINCH 1S/C22H20N4O4/c1-24-21(28)16-11-25(22(24)29)12-18-19(16)15-4-2-3-5-17(15)26(18)10-13-6-8-14(9-7-13)20(27)23-30/h2-9,16,30H,10-12H2,1H3,(H,23,27) D00HXJ DRUGINKE ZCAIUGLOTHAUQX-UHFFFAOYSA-N D00HXJ DRUGSMIL CN1C(=O)C2CN(C1=O)CC3=C2C4=CC=CC=C4N3CC5=CC=C(C=C5)C(=O)NO D00HXJ DRUGTYPE Small molecular drug D00HXJ HIGHSTAT Patented D00HXX DRUG__ID D00HXX D00HXX DRUGCLAS Investigative Drug(s) D00HXX DRUGINCH 1S/C21H19FN4O/c22-18-9-10-20(19(23)13-18)25-21(27)11-8-17-14-24-26(15-17)12-4-7-16-5-2-1-3-6-16/h1-11,13-15H,12,23H2,(H,25,27)/b7-4+,11-8+ D00HXX DRUGINKE BLVQHYHDYFTPDV-VCABWLAWSA-N D00HXX DRUGSMIL C1=CC=C(C=C1)C=CCN2C=C(C=N2)C=CC(=O)NC3=C(C=C(C=C3)F)N D00HXX DRUGTYPE Small molecular drug D00HXX HIGHSTAT Investigative D00HXZ DRUG__ID D00HXZ D00HXZ DRUGCLAS Investigative Drug(s) D00HXZ DRUGINCH 1S/C25H19NO3S2/c27-19-15-24(26-10-12-28-13-11-26)29-20-9-8-16(14-18(19)20)17-4-3-7-23-25(17)31-22-6-2-1-5-21(22)30-23/h1-9,14-15H,10-13H2 D00HXZ DRUGINKE NXGBJPCXFKHQKN-UHFFFAOYSA-N D00HXZ DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=C5C(=CC=C4)SC6=CC=CC=C6S5 D00HXZ DRUGTYPE Small molecular drug D00HXZ HIGHSTAT Investigative D00HYD DRUG__ID D00HYD D00HYD DRUGCLAS Clinical Trial Drug(s) D00HYD DRUGCOMP SCOLR Pharma D00HYD HIGHSTAT Phase 1 D00HYF DRUG__ID D00HYF D00HYF DRUGCLAS Clinical Trial Drug(s) D00HYF DRUGCOMP Denka Seiken Co Ltd D00HYF HIGHSTAT Phase 3 D00HYK DRUG__ID D00HYK D00HYK DRUGCLAS Clinical Trial Drug(s) D00HYK DRUGCOMP Affinium pharmaceuticals D00HYK DRUGINCH 1S/C22H21N3O3/c1-14-17-5-3-4-6-18(17)28-19(14)13-25(2)21(27)10-7-15-11-16-8-9-20(26)24-22(16)23-12-15/h3-7,10-12H,8-9,13H2,1-2H3,(H,23,24,26)/b10-7+ D00HYK DRUGINKE QXTWSUQCXCWEHF-JXMROGBWSA-N D00HYK DRUGSMIL CC1=C(OC2=CC=CC=C12)CN(C)C(=O)C=CC3=CC4=C(NC(=O)CC4)N=C3 D00HYK DRUGTYPE Small molecular drug D00HYK HIGHSTAT Phase 2 D00HYL DRUG__ID D00HYL D00HYL DRUGCLAS Investigative Drug(s) D00HYL DRUGINCH 1S/C80H132N28O21/c1-42(2)34-55(74(125)97-44(4)67(118)104-57(37-60(85)112)75(126)99-50(65(86)116)28-29-59(84)111)105-72(123)51(24-14-16-30-81)102-71(122)54(27-19-33-92-80(89)90)101-68(119)45(5)108(7)78(129)58(41-109)106-73(124)52(25-15-17-31-82)103-70(121)53(26-18-32-91-79(87)88)100-66(117)43(3)96-62(114)40-95-77(128)64(46(6)110)107-76(127)56(36-48-22-12-9-13-23-48)98-63(115)39-93-61(113)38-94-69(120)49(83)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64,109-110H,14-19,24-41,81-83H2,1-7H3,(H2,84,111)(H2,85,112)(H2,86,116)(H,93,113)(H,94,120)(H,95,128)(H,96,114)(H,97,125)(H,98,115)(H,99,126)(H,100,117)(H,101,119)(H,102,122)(H,103,121)(H,104,118)(H,105,123)(H,106,124)(H,107,127)(H4,87,88,91)(H4,89,90,92)/t43-,44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D00HYL DRUGINKE JRFVGOSSKZWBRX-FKPOJLNCSA-N D00HYL DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)N(C)C(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D00HYL HIGHSTAT Investigative D00HYO DRUG__ID D00HYO D00HYO DRUGCLAS Investigative Drug(s) D00HYO DRUGINCH 1S/C25H24N6O5/c1-29-17(9-15-5-7-19-21(11-15)36-13-34-19)16(8-14-4-6-18-20(10-14)35-12-33-18)27-25(29)28-22-23(32)31(3)24(26)30(22)2/h4-7,10-11,26H,8-9,12-13H2,1-3H3/b26-24?,28-22+ D00HYO DRUGINKE RZKRATQHPLTYSI-GQZUJQTPSA-N D00HYO DRUGSMIL CN1C(=C(N=C1N=C2C(=O)N(C(=N)N2C)C)CC3=CC4=C(C=C3)OCO4)CC5=CC6=C(C=C5)OCO6 D00HYO DRUGTYPE Small molecular drug D00HYO HIGHSTAT Investigative D00HYS DRUG__ID D00HYS D00HYS DRUGCLAS Investigative Drug(s) D00HYS DRUGINCH 1S/C17H12N4/c18-11-14-15(12-7-3-1-4-8-12)20-17(19)21-16(14)13-9-5-2-6-10-13/h1-10H,(H2,19,20,21) D00HYS DRUGINKE JMXZSEAMWCKILY-UHFFFAOYSA-N D00HYS DRUGSMIL C1=CC=C(C=C1)C2=C(C(=NC(=N2)N)C3=CC=CC=C3)C#N D00HYS DRUGTYPE Small molecular drug D00HYS HIGHSTAT Investigative D00HZA DRUG__ID D00HZA D00HZA DRUGCLAS Clinical Trial Drug(s) D00HZA DRUGCOMP Xiamen Amoytop Biotech Co Ltd D00HZA HIGHSTAT Phase 1 D00HZO DRUG__ID D00HZO D00HZO DRUGCLAS Investigative Drug(s) D00HZO DRUGCOMP Gene Signal SAS D00HZO HIGHSTAT Investigative D00HZT DRUG__ID D00HZT D00HZT DRUGCLAS Investigative Drug(s) D00HZT DRUGINCH 1S/C17H11NO3/c19-13-4-3-10-7-12(2-1-11(10)8-13)17-18-15-6-5-14(20)9-16(15)21-17/h1-9,19-20H D00HZT DRUGINKE PZIKVWJRAOMJDU-UHFFFAOYSA-N D00HZT DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=NC4=C(O3)C=C(C=C4)O D00HZT DRUGTYPE Small molecular drug D00HZT HIGHSTAT Investigative D00HZV DRUG__ID D00HZV D00HZV DRUADIID FDA-AP-BF04-01324 D00HZV DRUGCLAS Approved Drug(s) D00HZV DRUGCOMP Odyssey Pharmaceuticals Inc D00HZV DRUGINCH 1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3 D00HZV DRUGINKE ZSCDBOWYZJWBIY-UHFFFAOYSA-N D00HZV DRUGSMIL CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C D00HZV DRUGTYPE Small molecular drug D00HZV HIGHSTAT Approved D00HZV THERCLAS Antidepressants D00IAE DRUG__ID D00IAE D00IAE DRUGCLAS Investigative Drug(s) D00IAE DRUGINCH 1S/C10H9NO4S/c1-2-7-15-10(12)8-3-5-9(6-4-8)16(11,13)14/h1,3-6H,7H2,(H2,11,13,14) D00IAE DRUGINKE IORJVPBKDUGFOJ-UHFFFAOYSA-N D00IAE DRUGSMIL C#CCOC(=O)C1=CC=C(C=C1)S(=O)(=O)N D00IAE DRUGTYPE Small molecular drug D00IAE HIGHSTAT Investigative D00IAH DRUG__ID D00IAH D00IAH DRUGCLAS Approved Drug(s) D00IAH HIGHSTAT Approved D00IAK DRUG__ID D00IAK D00IAK DRUGCLAS Investigative Drug(s) D00IAK DRUGINCH 1S/C11H19F3O3S/c1-2-3-4-5-6-7-8-18(16,17)9-10(15)11(12,13)14/h2-9H2,1H3 D00IAK DRUGINKE LGBYSBJDEXOENJ-UHFFFAOYSA-N D00IAK DRUGSMIL CCCCCCCCS(=O)(=O)CC(=O)C(F)(F)F D00IAK DRUGTYPE Small molecular drug D00IAK HIGHSTAT Investigative D00IBG DRUG__ID D00IBG D00IBG DRUGCLAS Investigative Drug(s) D00IBG DRUGINCH 1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/t11-,12+,14-/m0/s1 D00IBG DRUGINKE FVTCRASFADXXNN-SCRDCRAPSA-N D00IBG DRUGSMIL CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)O)O)O)O D00IBG DRUGTYPE Small molecular drug D00IBG HIGHSTAT Investigative D00IBN DRUG__ID D00IBN D00IBN DRUGCLAS Approved Drug(s) D00IBN DRUGCOMP Pfizer Pharmaceuticals D00IBN DRUGINCH 1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20) D00IBN DRUGINKE QYSPLQLAKJAUJT-UHFFFAOYSA-N D00IBN DRUGSMIL CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3 D00IBN DRUGTYPE Small molecular drug D00IBN HIGHSTAT Approved D00IBN THERCLAS Analgesics D00ICA DRUG__ID D00ICA D00ICA DRUGCLAS Investigative Drug(s) D00ICA DRUGINCH 1S/C10H17N6O12P3/c11-8-5-9(13-2-12-8)16(3-14-5)10-7(18)6(17)4(27-10)1-26-31(24,25)28-30(22,23)15-29(19,20)21/h2-4,6-7,10,17-18H,1H2,(H,24,25)(H2,11,12,13)(H4,15,19,20,21,22,23)/t4-,6-,7-,10-/m1/s1 D00ICA DRUGINKE PVKSNHVPLWYQGJ-KQYNXXCUSA-N D00ICA DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)O)O)N D00ICA DRUGTYPE Small molecular drug D00ICA HIGHSTAT Investigative D00ICD DRUG__ID D00ICD D00ICD DRUGCLAS Clinical Trial Drug(s) D00ICD DRUGCOMP Bayer Schering Pharma AG; Novogen Ltd D00ICD HIGHSTAT Phase 2 D00ICM DRUG__ID D00ICM D00ICM DRUGCLAS Discontinued Drug(s) D00ICM DRUGINCH 1S/C26H28N2O4S.ClH/c1-17(29)32-23-24(19-9-12-20(31-4)13-10-19)33-25-21-8-6-5-7-18(21)11-14-22(25)28(26(23)30)16-15-27(2)3;/h5-14,23-24H,15-16H2,1-4H3;1H/t23-,24+;/m1./s1 D00ICM DRUGINKE SFTBZKFGODNAKF-ITNPDYSASA-N D00ICM DRUGSMIL CC(=O)OC1C(SC2=C(C=CC3=CC=CC=C32)N(C1=O)CCN(C)C)C4=CC=C(C=C4)OC.Cl D00ICM DRUGTYPE Small molecular drug D00ICM HIGHSTAT Terminated D00ICS DRUG__ID D00ICS D00ICS COMPCLAS Pyrrolidinyl urea derivatives D00ICS DRUGCLAS Patented Agent(s) D00ICS DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D00ICS DRUGINCH 1S/C23H27F2N7O2/c1-14-10-27-20(11-26-14)19-9-22(31(2)30-19)29-23(33)28-21-13-32(6-7-34-3)12-16(21)15-4-5-17(24)18(25)8-15/h4-5,8-11,16,21H,6-7,12-13H2,1-3H3,(H2,28,29,33)/t16-,21+/m0/s1 D00ICS DRUGINKE NPZQKAJVRDLUTI-HRAATJIYSA-N D00ICS DRUGSMIL CC1=CN=C(C=N1)C2=NN(C(=C2)NC(=O)NC3CN(CC3C4=CC(=C(C=C4)F)F)CCOC)C D00ICS DRUGTYPE Small molecular drug D00ICS HIGHSTAT Patented D00ICY DRUG__ID D00ICY D00ICY DRUGCLAS Clinical Trial Drug(s) D00ICY DRUGCOMP Forward Pharma A/S D00ICY HIGHSTAT Phase 2 D00IDP DRUG__ID D00IDP D00IDP DRUGCLAS Approved Drug(s) D00IDP DRUGCOMP Biora AB D00IDP HIGHSTAT Approved D00IDR DRUG__ID D00IDR D00IDR DRUGCLAS Clinical Trial Drug(s) D00IDR DRUGCOMP Biomarin pharmaceutical D00IDR HIGHSTAT Phase 2 D00IDV DRUG__ID D00IDV D00IDV DRUGCLAS Investigative Drug(s) D00IDV DRUGCOMP Cornerstone Therapeutics Inc D00IDV HIGHSTAT Investigative D00IEB DRUG__ID D00IEB D00IEB DRUGCLAS Investigative Drug(s) D00IEB DRUGCOMP Dr Reddy's Laboratories Ltd D00IEB HIGHSTAT Investigative D00IFH DRUG__ID D00IFH D00IFH DRUGCLAS Clinical Trial Drug(s) D00IFH DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D00IFH HIGHSTAT Phase 1 D00IFJ DRUG__ID D00IFJ D00IFJ DRUGCLAS Investigative Drug(s) D00IFJ DRUGINCH 1S/C13H13NO/c15-12-7-8-14-11(9-12)6-5-10-3-1-2-4-13(10)14/h1-4,9H,5-8H2 D00IFJ DRUGINKE OPJKPSOLCGGXEW-UHFFFAOYSA-N D00IFJ DRUGSMIL C1CC2=CC(=O)CCN2C3=CC=CC=C31 D00IFJ DRUGTYPE Small molecular drug D00IFJ HIGHSTAT Investigative D00IFQ DRUG__ID D00IFQ D00IFQ DRUGCLAS Clinical Trial Drug(s) D00IFQ DRUGCOMP MabVax Therapeutics San Diego, CA D00IFQ HIGHSTAT Phase 1 D00IFR DRUG__ID D00IFR D00IFR DRUGCLAS Clinical Trial Drug(s) D00IFR DRUGCOMP AstraZeneca D00IFR DRUGINCH 1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19-15(12-18-20(25)23-21(26)27-18)8-4-10-17(19)14-6-2-1-3-7-14/h1-4,6-8,10,12,16H,5,9,11,13,22H2,(H,23,25,26)/b18-12-/t16-/m1/s1 D00IFR DRUGINKE MCUJKPPARUPFJM-UWCCDQBKSA-N D00IFR DRUGSMIL C1CC(CN(C1)C2=C(C=CC=C2C3=CC=CC=C3)C=C4C(=O)NC(=O)S4)N D00IFR DRUGTYPE Small molecular drug D00IFR HIGHSTAT Phase 1 D00IGI DRUG__ID D00IGI D00IGI DRUGCLAS Investigative Drug(s) D00IGI DRUGINCH 1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10) D00IGI DRUGINKE DDOQBQRIEWHWBT-UHFFFAOYSA-N D00IGI DRUGSMIL C(CP(=O)(O)O)C(C(=O)O)N D00IGI DRUGTYPE Small molecular drug D00IGI HIGHSTAT Investigative D00IIQ DRUG__ID D00IIQ D00IIQ DRUGCLAS Investigative Drug(s) D00IIQ DRUGINCH 1S/C13H18N2O2/c1-11-3-2-9-14(11)10-8-12-4-6-13(7-5-12)15(16)17/h4-7,11H,2-3,8-10H2,1H3/t11-/m0/s1 D00IIQ DRUGINKE PFZYNGPCNCRLFU-NSHDSACASA-N D00IIQ DRUGSMIL CC1CCCN1CCC2=CC=C(C=C2)[N+](=O)[O-] D00IIQ DRUGTYPE Small molecular drug D00IIQ HIGHSTAT Investigative D00IJM DRUG__ID D00IJM D00IJM DRUGCLAS Clinical Trial Drug(s) D00IJM DRUGCOMP Edison Pharmaceuticals Inc D00IJM HIGHSTAT Phase 2 D00IJQ DRUG__ID D00IJQ D00IJQ DRUGCLAS Clinical Trial Drug(s) D00IJQ DRUGINCH 1S/C19H25ClN2O2.C4H4O4/c1-19(2)10-11-6-12(20)7-16(17(11)24-19)18(23)21-13-8-14-4-5-15(9-13)22(14)3;5-3(6)1-2-4(7)8/h6-7,13-15H,4-5,8-10H2,1-3H3,(H,21,23);1-2H,(H,5,6)(H,7,8)/b;2-1-/t13?,14-,15+; D00IJQ DRUGINKE HAFQATMFFHYNPN-BSLJCGBVSA-N D00IJQ DRUGSMIL CC1(CC2=C(O1)C(=CC(=C2)Cl)C(=O)NC3CC4CCC(C3)N4C)C.C(=CC(=O)O)C(=O)O D00IJQ DRUGTYPE Small molecular drug D00IJQ HIGHSTAT Phase 3 D00IKH DRUG__ID D00IKH D00IKH DRUGCLAS Discontinued Drug(s) D00IKH DRUGINCH 1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18) D00IKH DRUGINKE AOCCBINRVIKJHY-UHFFFAOYSA-N D00IKH DRUGSMIL CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F D00IKH DRUGTYPE Small molecular drug D00IKH HIGHSTAT Withdrawn from market D00IKI DRUG__ID D00IKI D00IKI DRUGCLAS Clinical Trial Drug(s) D00IKI DRUGCOMP Pfizer D00IKI HIGHSTAT Phase 1 D00IKQ DRUG__ID D00IKQ D00IKQ DRUGCLAS Investigative Drug(s) D00IKQ DRUGINCH 1S/C6H8N2O3S/c1-11-5-2-3-8-4-6(5)12(7,9)10/h2-4H,1H3,(H2,7,9,10) D00IKQ DRUGINKE YLDUTJXETDRGDZ-UHFFFAOYSA-N D00IKQ DRUGSMIL COC1=C(C=NC=C1)S(=O)(=O)N D00IKQ DRUGTYPE Small molecular drug D00IKQ HIGHSTAT Investigative D00IKR DRUG__ID D00IKR D00IKR DRUGCLAS Patented Agent(s) D00IKR DRUGINCH 1S/C22H28ClN3O4/c1-22(2,3)30-21(29)25-12-10-24(11-13-25)15-17-8-9-26(20(28)19(17)27)14-16-4-6-18(23)7-5-16/h4-9,27H,10-15H2,1-3H3 D00IKR DRUGINKE UPJZLOCUUOIMNC-UHFFFAOYSA-N D00IKR DRUGSMIL CC(C)(C)OC(=O)N1CCN(CC1)CC2=C(C(=O)N(C=C2)CC3=CC=C(C=C3)Cl)O D00IKR DRUGTYPE Small molecular drug D00IKR HIGHSTAT Patented D00IMW DRUG__ID D00IMW D00IMW DRUGCLAS Investigative Drug(s) D00IMW DRUGINCH 1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1 D00IMW DRUGINKE VWWQXMAJTJZDQX-UYBVJOGSSA-N D00IMW DRUGSMIL CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O D00IMW DRUGTYPE Small molecular drug D00IMW HIGHSTAT Investigative D00INM DRUG__ID D00INM D00INM DRUGCLAS Preclinical Drug(s) D00INM DRUGCOMP ViRexx Medical Corp D00INM HIGHSTAT Preclinical D00IOF DRUG__ID D00IOF D00IOF DRUGCLAS Investigative Drug(s) D00IOF DRUGINCH 1S/C21H30N4O3/c1-2-3-5-25-18(27)16-17(24(20(25)28)6-4-7-26)23-19(22-16)21-11-13-8-14(12-21)10-15(21)9-13/h13-15,26H,2-12H2,1H3,(H,22,23) D00IOF DRUGINKE CIBIXJYFYPFMTN-UHFFFAOYSA-N D00IOF DRUGSMIL CCCCN1C(=O)C2=C(N=C(N2)C34CC5CC(C3)CC4C5)N(C1=O)CCCO D00IOF DRUGTYPE Small molecular drug D00IOF HIGHSTAT Investigative D00IOS DRUG__ID D00IOS D00IOS DRUGCLAS Discontinued Drug(s) D00IOS DRUGCOMP Cytos Biotechnology AG D00IOS HIGHSTAT Terminated D00IPI DRUG__ID D00IPI D00IPI COMPCLAS Carbamide derivatives D00IPI DRUGCLAS Patented Agent(s) D00IPI DRUGCOMP NORTHEASTERN UNIVERSITY D00IPI DRUGTYPE Small molecular drug D00IPI HIGHSTAT Patented D00IPO DRUG__ID D00IPO D00IPO DRUGCLAS Investigative Drug(s) D00IPO DRUGINCH 1S/C12H16O2/c1-8(2)10-5-4-6-11(7-10)9(3)12(13)14/h4-9H,1-3H3,(H,13,14) D00IPO DRUGINKE DHFSUPPYOBITGY-UHFFFAOYSA-N D00IPO DRUGSMIL CC(C)C1=CC(=CC=C1)C(C)C(=O)O D00IPO DRUGTYPE Small molecular drug D00IPO HIGHSTAT Investigative D00IPP DRUG__ID D00IPP D00IPP DRUGCLAS Investigative Drug(s) D00IPP DRUGINCH 1S/C10H19N3O2/c1-6(2)8(11)10(15)13-5-3-4-7(13)9(12)14/h6-8H,3-5,11H2,1-2H3,(H2,12,14)/t7-,8-/m0/s1 D00IPP DRUGINKE AGVCUVJROUBIKP-YUMQZZPRSA-N D00IPP DRUGSMIL CC(C)C(C(=O)N1CCCC1C(=O)N)N D00IPP DRUGTYPE Small molecular drug D00IPP HIGHSTAT Investigative D00IPW DRUG__ID D00IPW D00IPW DRUGCLAS Discontinued Drug(s) D00IPW DRUGCOMP Novartis AG D00IPW HIGHSTAT Terminated D00IQH DRUG__ID D00IQH D00IQH DRUGCLAS Clinical Trial Drug(s) D00IQH DRUGCOMP Pfizer Inc; RaQualia Pharma Inc D00IQH DRUGINCH 1S/C26H29N5O3S/c1-5-24-29-25-19(4)28-18(3)16-23(25)31(24)21-10-8-20(9-11-21)14-15-27-26(32)30-35(33,34)22-12-6-17(2)7-13-22/h6-13,16H,5,14-15H2,1-4H3,(H2,27,30,32) D00IQH DRUGINKE HZVLFTCYCLXTGV-UHFFFAOYSA-N D00IQH DRUGSMIL CCC1=NC2=C(N1C3=CC=C(C=C3)CCNC(=O)NS(=O)(=O)C4=CC=C(C=C4)C)C=C(N=C2C)C D00IQH DRUGTYPE Small molecular drug D00IQH HIGHSTAT Phase 2 D00IQV DRUG__ID D00IQV D00IQV DRUGCLAS Investigative Drug(s) D00IQV DRUGCOMP ImmuneRegen BioSciences Inc D00IQV DRUGINCH 1S/C64H100N18O15S/c1-38(2)34-46(57(89)74-42(54(69)86)28-33-98(4,96)97)73-53(85)37-80(3)62(94)48(36-40-18-9-6-10-19-40)79-58(90)47(35-39-16-7-5-8-17-39)78-56(88)43(24-26-51(67)83)75-55(87)44(25-27-52(68)84)76-59(91)50-23-15-32-82(50)63(95)45(21-11-12-29-65)77-60(92)49-22-14-31-81(49)61(93)41(66)20-13-30-72-64(70)71/h5-10,16-19,38,41-50H,11-15,20-37,65-66H2,1-4H3,(H2,67,83)(H2,68,84)(H2,69,86)(H,73,85)(H,74,89)(H,75,87)(H,76,91)(H,77,92)(H,78,88)(H,79,90)(H4,70,71,72)/t41-,42-,43?,44-,45-,46-,47-,48-,49-,50-/m0/s1 D00IQV DRUGINKE OUPXSLGGCPUZJJ-HTTPISLZSA-N D00IQV DRUGSMIL CC(C)CC(C(=O)NC(CCS(=O)(=O)C)C(=O)N)NC(=O)CN(C)C(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D00IQV HIGHSTAT Investigative D00IRL DRUG__ID D00IRL D00IRL DRUGCLAS Investigative Drug(s) D00IRL DRUGINCH 1S/C16H17NO4/c1-19-14-4-2-12(3-5-14)15-10-13(18)11-16(21-15)17-6-8-20-9-7-17/h2-5,10-11H,6-9H2,1H3 D00IRL DRUGINKE QJIHTEXMXZZXDS-UHFFFAOYSA-N D00IRL DRUGSMIL COC1=CC=C(C=C1)C2=CC(=O)C=C(O2)N3CCOCC3 D00IRL DRUGTYPE Small molecular drug D00IRL HIGHSTAT Investigative D00IRU DRUG__ID D00IRU D00IRU DRUGCLAS Discontinued Drug(s) D00IRU DRUGCOMP Esteve D00IRU DRUGINCH 1S/C17H21FN4.C6H8O7/c18-17-5-3-15(4-6-17)16-7-11-21(12-8-16)9-1-2-10-22-14-19-13-20-22;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-7,13-14H,1-2,8-12H2;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D00IRU DRUGINKE LTBKOSQVBVYJKW-UHFFFAOYSA-N D00IRU DRUGSMIL C1CN(CC=C1C2=CC=C(C=C2)F)CCCCN3C=NC=N3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D00IRU DRUGTYPE Small molecular drug D00IRU HIGHSTAT Terminated D00ISN DRUG__ID D00ISN D00ISN DRUGCLAS Clinical Trial Drug(s) D00ISN DRUGCOMP Mitsubishi Tanabe Pharma Corp D00ISN DRUGINCH 1S/C19H30F3NO3.ClH/c1-2-3-4-5-6-11-26-17-8-7-15(12-16(17)19(20,21)22)9-10-18(23,13-24)14-25;/h7-8,12,24-25H,2-6,9-11,13-14,23H2,1H3;1H D00ISN DRUGINKE GEDVJGOVRLHFQG-UHFFFAOYSA-N D00ISN DRUGSMIL CCCCCCCOC1=C(C=C(C=C1)CCC(CO)(CO)N)C(F)(F)F.Cl D00ISN DRUGTYPE Small molecular drug D00ISN HIGHSTAT Phase 2 D00ITC DRUG__ID D00ITC D00ITC DRUGCLAS Clinical Trial Drug(s) D00ITC DRUGCOMP Portola pharmaceuticals D00ITC HIGHSTAT Phase 3 D00ITG DRUG__ID D00ITG D00ITG DRUGCLAS Discontinued Drug(s) D00ITG DRUGCOMP Parke-Davis & Co D00ITG DRUGINCH 1S/C17H17ClFN3O3/c18-13-14-10(5-12(19)15(13)21-4-3-8(20)6-21)16(23)11(17(24)25)7-22(14)9-1-2-9/h5,7-9H,1-4,6,20H2,(H,24,25) D00ITG DRUGINKE QGPKADBNRMWEQR-UHFFFAOYSA-N D00ITG DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)Cl)N4CCC(C4)N)F)C(=O)O D00ITG DRUGTYPE Small molecular drug D00ITG HIGHSTAT Terminated D00ITT DRUG__ID D00ITT D00ITT DRUGCLAS Patented Agent(s) D00ITT DRUGCOMP MEMORIAL SLOAN-KETTERING CANCER CENTER THE ROCKEFELLER UNIVERSITY D00ITT DRUGTYPE Small molecular drug D00ITT HIGHSTAT Patented D00IUB DRUG__ID D00IUB D00IUB DRUGCLAS Investigative Drug(s) D00IUB DRUGINCH 1S/C7H5NO/c8-5-6-1-3-7(9)4-2-6/h1-4,9H D00IUB DRUGINKE CVNOWLNNPYYEOH-UHFFFAOYSA-N D00IUB DRUGSMIL C1=CC(=CC=C1C#N)O D00IUB DRUGTYPE Small molecular drug D00IUB HIGHSTAT Investigative D00IUD DRUG__ID D00IUD D00IUD DRUGCLAS Clinical Trial Drug(s) D00IUD DRUGCOMP Kowa D00IUD DRUGINCH 1S/C24H19ClN2OS/c1-29-21-13-9-19(10-14-21)24-22(18-7-11-20(25)12-8-18)15-23(28)27(26-24)16-17-5-3-2-4-6-17/h2-15H,16H2,1H3 D00IUD DRUGINKE HEUAVAATAFEENP-UHFFFAOYSA-N D00IUD DRUGSMIL CSC1=CC=C(C=C1)C2=NN(C(=O)C=C2C3=CC=C(C=C3)Cl)CC4=CC=CC=C4 D00IUD DRUGTYPE Small molecular drug D00IUD HIGHSTAT Phase 2 D00IUG DRUG__ID D00IUG D00IUG DRUADIID FDA-AP-BF04-01199 D00IUG DRUGCLAS Approved Drug(s) D00IUG DRUGCOMP Allergan Pharmaceuticals D00IUG DRUGINCH 1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1 D00IUG DRUGINKE IXHBTMCLRNMKHZ-LBPRGKRZSA-N D00IUG DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O D00IUG DRUGTYPE Small molecular drug D00IUG HIGHSTAT Approved D00IUG THERCLAS Sympatholytics D00IUN DRUG__ID D00IUN D00IUN DRUGCLAS Investigative Drug(s) D00IUN DRUGINCH 1S/C15H14N2S/c1-12(17-8-7-16-11-17)13-2-4-14(5-3-13)15-6-9-18-10-15/h2-12H,1H3 D00IUN DRUGINKE CPEUHVZSVWFLMC-UHFFFAOYSA-N D00IUN DRUGSMIL CC(C1=CC=C(C=C1)C2=CSC=C2)N3C=CN=C3 D00IUN DRUGTYPE Small molecular drug D00IUN HIGHSTAT Investigative D00IVF DRUG__ID D00IVF D00IVF DRUGCLAS Clinical Trial Drug(s) D00IVF DRUGCOMP Polyphor D00IVF DRUGINCH 1S/C73H112N22O16/c1-5-38(2)58-70(108)88-52(24-30-79)65(103)83-47(17-10-25-74)62(100)85-49(21-27-76)63(101)86-51(23-29-78)66(104)89-53(33-41-35-80-45-15-8-6-13-43(41)45)67(105)87-50(22-28-77)64(102)84-48(20-26-75)61(99)82-39(3)60(98)91-55(37-96)72(110)95-32-12-19-57(95)73(111)94-31-11-18-56(94)69(107)93-59(40(4)97)71(109)90-54(68(106)92-58)34-42-36-81-46-16-9-7-14-44(42)46/h6-9,13-16,35-36,38-40,47-59,80-81,96-97H,5,10-12,17-34,37,74-79H2,1-4H3,(H,82,99)(H,83,103)(H,84,102)(H,85,100)(H,86,101)(H,87,105)(H,88,108)(H,89,104)(H,90,109)(H,91,98)(H,92,106)(H,93,107)/t38-,39-,40+,47-,48-,49+,50-,51-,52-,53-,54-,55-,56-,57+,58-,59-/m0/s1 D00IVF DRUGINKE RIDRXGOBXZLKHZ-NZUANIILSA-N D00IVF DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)N1)CC4=CNC5=CC=CC=C54)C(C)O)CO)C)CCN)CCN)CC6=CNC7=CC=CC=C76)CCN)CCN)CCCN)CCN D00IVF HIGHSTAT Phase 3 D00IVM DRUG__ID D00IVM D00IVM DRUGCLAS Patented Agent(s) D00IVM DRUGCOMP MERCK SHARP & DOHME CORP. MANLEY, Peter, J. NANDA, Kausik, K. TROTTER, B. Wesley D00IVM DRUGTYPE Small molecular drug D00IVM HIGHSTAT Patented D00IVN DRUG__ID D00IVN D00IVN DRUGCLAS Clinical Trial Drug(s) D00IVN DRUGCOMP OncoMed Pharmaceuticals Redwood City, CA D00IVN HIGHSTAT Phase 1 D00IWE DRUG__ID D00IWE D00IWE DRUGCLAS Investigative Drug(s) D00IWE DRUGCOMP Reviva Pharmaceuticals Inc D00IWE HIGHSTAT Investigative D00IWH DRUG__ID D00IWH D00IWH DRUGCLAS Investigative Drug(s) D00IWH DRUGINCH 1S/C11H13N3O5/c12-9(11(16)17)5-6-10(15)13-7-1-3-8(4-2-7)14(18)19/h1-4,9H,5-6,12H2,(H,13,15)(H,16,17)/t9-/m0/s1 D00IWH DRUGINKE WMZTYIRRBCGARG-VIFPVBQESA-N D00IWH DRUGSMIL C1=CC(=CC=C1NC(=O)CCC(C(=O)[O-])[NH3+])[N+](=O)[O-] D00IWH DRUGTYPE Small molecular drug D00IWH HIGHSTAT Investigative D00IWL DRUG__ID D00IWL D00IWL DRUGCLAS Clinical Trial Drug(s) D00IWL DRUGCOMP Northfield Laboratories D00IWL DRUGINCH 1S/C8H10NO6P.C5H8O2/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14;6-4-2-1-3-5-7/h2-3,11H,4H2,1H3,(H2,12,13,14);4-5H,1-3H2 D00IWL DRUGINKE SKKYPUWZZNPUMG-UHFFFAOYSA-N D00IWL DRUGSMIL CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O.C(CC=O)CC=O D00IWL HIGHSTAT Phase 3 D00IXB DRUG__ID D00IXB D00IXB DRUGCLAS Investigative Drug(s) D00IXB DRUGINCH 1S/C17H18O3/c1-4-15-16-9(2)13(18)7-5-11(16)12-6-8-14(19)10(3)17(12)20-15/h5-8,15,18-19H,4H2,1-3H3 D00IXB DRUGINKE IAFZPZLQCDKQGG-UHFFFAOYSA-N D00IXB DRUGSMIL CCC1C2=C(C=CC(=C2C)O)C3=C(O1)C(=C(C=C3)O)C D00IXB DRUGTYPE Small molecular drug D00IXB HIGHSTAT Investigative D00IXM DRUG__ID D00IXM D00IXM DRUGCLAS Clinical Trial Drug(s) D00IXM DRUGCOMP Barr Laboratories D00IXM HIGHSTAT Phase 3 D00IXN DRUG__ID D00IXN D00IXN DRUGCLAS Clinical Trial Drug(s) D00IXN DRUGINCH 1S/C6H11BO2/c8-7(9)6-4-2-1-3-5-6/h4,8-9H,1-3,5H2 D00IXN DRUGINKE XZWQKJXJNKYMAP-UHFFFAOYSA-N D00IXN DRUGSMIL B(C1=CCCCC1)(O)O D00IXN HIGHSTAT Phase 1 D00IYB DRUG__ID D00IYB D00IYB DRUGCLAS Clinical Trial Drug(s) D00IYB DRUGCOMP GE Healthcare D00IYB DRUGINCH 1S/C72H120N20O21S3/c1-45(91-108)71(3,4)82-26-21-47(22-27-83-72(5,6)46(2)92-109)20-25-77-58(95)19-12-18-57(94)76-23-11-10-16-50-65(103)89-54-42-115-116-43-55(90-67(105)52(37-62(99)100)85-59(96)38-81-63(101)49(86-68(54)106)17-13-24-80-70(74)75)69(107)87-51(36-48-14-8-7-9-15-48)66(104)88-53(41-114-44-61(98)84-50)64(102)79-29-31-111-33-35-112-34-32-110-30-28-78-60(97)40-113-39-56(73)93/h7-9,14-15,47,49-55,82-83,108-109H,10-13,16-44H2,1-6H3,(H2,73,93)(H,76,94)(H,77,95)(H,78,97)(H,79,102)(H,81,101)(H,84,98)(H,85,96)(H,86,106)(H,87,107)(H,88,104)(H,89,103)(H,90,105)(H,99,100)(H4,74,75,80)/t47?,49-,50-,51-,52-,53-,54-,55-/m0/s1 D00IYB DRUGINKE OTOMOKKNHNZSBB-CQSZQERZSA-N D00IYB DRUGSMIL CC(=NO)C(C)(C)NCCC(CCNC(=O)CCCC(=O)NCCCCC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(CSCC(=O)N1)C(=O)NCCOCCOCCOCCNC(=O)COCC(=O)N)CC3=CC=CC=C3)NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)CCNC(C)(C)C(=NO)C D00IYB DRUGTYPE Small molecular drug D00IYB HIGHSTAT Phase 2 D00IYM DRUG__ID D00IYM D00IYM DRUGCLAS Preclinical Drug(s) D00IYM DRUGCOMP AEterna Zentaris Inc D00IYM DRUGINCH 1S/C27H56NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-26-31-33(29,30)32-27-25-28(2,3)4/h12-13H,5-11,14-27H2,1-4H3/p+1 D00IYM DRUGINKE KCRSJPCXPQESIU-UHFFFAOYSA-O D00IYM DRUGSMIL CCCCCCCCC=CCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C D00IYM DRUGTYPE Small molecular drug D00IYM HIGHSTAT Preclinical D00IZD DRUG__ID D00IZD D00IZD DRUGCLAS Clinical Trial Drug(s) D00IZD DRUGCOMP DNAVEC Corp D00IZD HIGHSTAT Phase 2 D00IZW DRUG__ID D00IZW D00IZW DRUGCLAS Discontinued Drug(s) D00IZW DRUGCOMP Boehringer Mannheim GmbH D00IZW HIGHSTAT Terminated D00IZY DRUG__ID D00IZY D00IZY DRUGCLAS Clinical Trial Drug(s) D00IZY DRUGCOMP Deacon biosciences D00IZY HIGHSTAT Phase 2 D00JAH DRUG__ID D00JAH D00JAH DRUGCLAS Patented Agent(s) D00JAH DRUGCOMP Janssen Pharmaceutica NV D00JAH DRUGINCH 1S/C23H20N4O/c1-23(14-25,12-16-5-4-6-17(13-24)26-16)15-9-10-19-18-7-2-3-8-20(18)22(28)27-21(19)11-15/h4-6,9-11H,2-3,7-8,12H2,1H3,(H,27,28) D00JAH DRUGINKE WVGLSASLDWFLFS-UHFFFAOYSA-N D00JAH DRUGSMIL CC(CC1=NC(=CC=C1)C#N)(C#N)C2=CC3=C(C=C2)C4=C(CCCC4)C(=O)N3 D00JAH DRUGTYPE Small molecular drug D00JAH HIGHSTAT Patented D00JAT DRUG__ID D00JAT D00JAT DRUGCLAS Investigative Drug(s) D00JAT DRUGINCH 1S/C20H27NO/c22-16-7-6-15-11-19-17-3-1-2-8-20(17,18(15)12-16)9-10-21(19)13-14-4-5-14/h6-7,12,14,17,19,22H,1-5,8-11,13H2/t17?,19-,20-/m1/s1 D00JAT DRUGINKE NLBUEDSBXVNAPB-IPNZSQQUSA-N D00JAT DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)O)CC5CC5 D00JAT DRUGTYPE Small molecular drug D00JAT HIGHSTAT Investigative D00JAU DRUG__ID D00JAU D00JAU DRUGCLAS Approved Drug(s) D00JAU DRUGCOMP Bristol-Myers Squibb D00JAU DRUGINCH 1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30) D00JAU DRUGINKE YOSHYTLCDANDAN-UHFFFAOYSA-N D00JAU DRUGSMIL CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D00JAU DRUGTYPE Small molecular drug D00JAU HIGHSTAT Approved D00JAU THERCLAS Antihypertensive Agents D00JBC DRUG__ID D00JBC D00JBC DRUGCLAS Investigative Drug(s) D00JBC DRUGINCH 1S/C10H14N4O2/c1-3-4-5-14-9(15)7-8(12-6-11-7)13(2)10(14)16/h6H,3-5H2,1-2H3,(H,11,12) D00JBC DRUGINKE GDRIWEXJHHARCU-UHFFFAOYSA-N D00JBC DRUGSMIL CCCCN1C(=O)C2=C(N=CN2)N(C1=O)C D00JBC DRUGTYPE Small molecular drug D00JBC HIGHSTAT Investigative D00JBM DRUG__ID D00JBM D00JBM DRUGCLAS Investigative Drug(s) D00JBM DRUGCOMP UBE Industries Ltd D00JBM HIGHSTAT Investigative D00JCA DRUG__ID D00JCA D00JCA DRUGCLAS Clinical Trial Drug(s) D00JCA DRUGCOMP Octapharma AG D00JCA HIGHSTAT Phase 3 D00JCB DRUG__ID D00JCB D00JCB DRUGCLAS Clinical Trial Drug(s) D00JCB DRUGCOMP Crystal Mackall, MD D00JCB DRUGTYPE CAR T Cell Therapy (Dual specific) D00JCB HIGHSTAT Phase 1 D00JCQ DRUG__ID D00JCQ D00JCQ COMPCLAS Oxazolo[3,4-a]pyrazine derivatives D00JCQ DRUGCLAS Patented Agent(s) D00JCQ DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED Fukatsu, Kohji Nakayama, Yutaka Tarui, Naoki Mori, Masaaki Matsumoto, Hirokazu Kurasawa, Osamu Banno, Hiroshi D00JCQ DRUGINCH 1S/C26H32N4O3/c31-24(27-14-17-28-15-8-3-9-16-28)29-18-19-30-23(20-29)26(33-25(30)32,21-10-4-1-5-11-21)22-12-6-2-7-13-22/h1-2,4-7,10-13,23H,3,8-9,14-20H2,(H,27,31) D00JCQ DRUGINKE JJDDRYMIPIEXKX-UHFFFAOYSA-N D00JCQ DRUGSMIL C1CCN(CC1)CCNC(=O)N2CCN3C(C2)C(OC3=O)(C4=CC=CC=C4)C5=CC=CC=C5 D00JCQ DRUGTYPE Small molecular drug D00JCQ HIGHSTAT Patented D00JDJ DRUG__ID D00JDJ D00JDJ DRUGCLAS Clinical Trial Drug(s) D00JDJ DRUGCOMP Artax Biopharma Cambridge, MA D00JDJ DRUGINCH 1S/C21H22FNO2/c1-24-18-8-9-20-19(12-18)21(15-4-6-17(22)7-5-15)16(14-25-20)13-23-10-2-3-11-23/h4-9,12H,2-3,10-11,13-14H2,1H3 D00JDJ DRUGINKE VMMKGVRPILDZML-UHFFFAOYSA-N D00JDJ DRUGSMIL COC1=CC2=C(C=C1)OCC(=C2C3=CC=C(C=C3)F)CN4CCCC4 D00JDJ HIGHSTAT Phase 1 D00JDL DRUG__ID D00JDL D00JDL DRUGCLAS Clinical Trial Drug(s) D00JDL DRUGCOMP MacroGenics D00JDL DRUGTYPE Monoclonal antibody D00JDL HIGHSTAT Phase 1 D00JDP DRUG__ID D00JDP D00JDP DRUGCLAS Investigative Drug(s) D00JDP DRUGCOMP Amunix Inc D00JDP HIGHSTAT Investigative D00JEC DRUG__ID D00JEC D00JEC DRUGCLAS Patented Agent(s) D00JEC DRUGCOMP ABBOTT GMBH &amCO. KG ABBOTT LABORATORIES AMBERG, Wilhelm OCHSE, Michael LANGE, Udo BEHL, Berthold HORNBERGER, Wilfried MEZLER, Mario POHLKI, Frauke TURNER, Sean HUTCHINS, Charles D00JEC DRUGTYPE Small molecular drug D00JEC HIGHSTAT Patented D00JED DRUG__ID D00JED D00JED DRUGCLAS Clinical Trial Drug(s) D00JED DRUGCOMP Anacor Pharmaceuticals Inc D00JED DRUGINCH 1S/C15H9BN2O3/c17-7-10-1-2-13(5-11(10)8-18)21-14-3-4-15-12(6-14)9-20-16(15)19/h1-6,19H,9H2 D00JED DRUGINKE UBMGTTRDNUKZMT-UHFFFAOYSA-N D00JED DRUGSMIL B1(C2=C(CO1)C=C(C=C2)OC3=CC(=C(C=C3)C#N)C#N)O D00JED HIGHSTAT Phase 2 D00JEO DRUG__ID D00JEO D00JEO DRUGCLAS Investigative Drug(s) D00JEO DRUGINCH 1S/C145H242N44O48S2/c1-65(2)45-86(175-139(232)110(70(11)12)183-136(229)99(63-239)181-142(235)114(74(16)197)187-135(228)98(61-193)180-129(222)90(49-69(9)10)172-131(224)92(52-104(151)202)174-134(227)96(59-191)178-117(210)79(148)62-238)118(211)158-55-106(204)162-80(25-18-20-40-146)120(213)169-89(48-68(7)8)128(221)179-97(60-192)133(226)167-83(34-37-102(149)200)122(215)165-85(36-39-109(207)208)123(216)171-88(47-67(5)6)127(220)173-91(51-77-54-156-64-161-77)130(223)164-81(26-19-21-41-147)121(214)170-87(46-66(3)4)126(219)166-84(35-38-103(150)201)125(218)186-113(73(15)196)141(234)177-94(50-76-30-32-78(199)33-31-76)143(236)189-44-24-29-101(189)137(230)168-82(27-22-42-157-145(154)155)124(217)185-112(72(14)195)140(233)176-93(53-105(152)203)132(225)184-111(71(13)194)138(231)160-56-107(205)163-95(58-190)119(212)159-57-108(206)182-115(75(17)198)144(237)188-43-23-28-100(188)116(153)209/h30-33,54,64-75,79-101,110-115,190-199,238-239H,18-29,34-53,55-63,146-148H2,1-17H3,(H2,149,200)(H2,150,201)(H2,151,202)(H2,152,203)(H2,153,209)(H,156,161)(H,158,211)(H,159,212)(H,160,231)(H,162,204)(H,163,205)(H,164,223)(H,165,215)(H,166,219)(H,167,226)(H,168,230)(H,169,213)(H,170,214)(H,171,216)(H,172,224)(H,173,220)(H,174,227)(H,175,232)(H,176,233)(H,177,234)(H,178,210)(H,179,221)(H,180,222)(H,181,235)(H,182,206)(H,183,229)(H,184,225)(H,185,217)(H,186,218)(H,187,228)(H,207,208)(H4,154,155,157)/t71-,72-,73-,74-,75-,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100-,101-,110+,111+,112+,113+,114+,115+/m1/s1 D00JEO DRUGINKE AZCMZZXDDMAXIT-KOYPLZMPSA-N D00JEO DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N3CCCC3C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CS)N D00JEO HIGHSTAT Investigative D00JFE DRUG__ID D00JFE D00JFE DRUGCLAS Clinical Trial Drug(s) D00JFE DRUGCOMP Seragon pharmaceuticals D00JFE DRUGINCH 1S/C26H20ClFN2O2/c1-2-21(22-10-9-20(28)14-23(22)27)26(18-8-11-24-19(13-18)15-29-30-24)17-6-3-16(4-7-17)5-12-25(31)32/h3-15H,2H2,1H3,(H,29,30)(H,31,32)/b12-5+,26-21+ D00JFE DRUGINKE BURHGPHDEVGCEZ-KJGLQBJMSA-N D00JFE DRUGSMIL CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl D00JFE HIGHSTAT Phase 2 D00JFN DRUG__ID D00JFN D00JFN DRUGCLAS Investigative Drug(s) D00JFN DRUGCOMP State University of New York Stony Brook D00JFN HIGHSTAT Investigative D00JGL DRUG__ID D00JGL D00JGL DRUGCLAS Preclinical Drug(s) D00JGL DRUGINCH 1S/C23H18N4O3/c24-22(28)14-4-6-15(7-5-14)23-26-20(21(27-23)17-3-1-2-10-25-17)16-8-9-18-19(13-16)30-12-11-29-18/h1-10,13H,11-12H2,(H2,24,28)(H,26,27) D00JGL DRUGINKE DPDZHVCKYBCJHW-UHFFFAOYSA-N D00JGL DRUGSMIL C1COC2=C(O1)C=CC(=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5 D00JGL DRUGTYPE Small molecular drug D00JGL HIGHSTAT Preclinical D00JGN DRUG__ID D00JGN D00JGN DRUGCLAS Patented Agent(s) D00JGN DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D00JGN DRUGTYPE Small molecular drug D00JGN HIGHSTAT Patented D00JHE DRUG__ID D00JHE D00JHE DRUGCLAS Investigative Drug(s) D00JHE DRUGCOMP Isis Pharmaceuticals D00JHE DRUGTYPE Antisense drug D00JHE HIGHSTAT Investigative D00JHN DRUG__ID D00JHN D00JHN DRUGCLAS Investigative Drug(s) D00JHN DRUGINCH 1S/C15H20N4O2S/c1-20-13-5-4-12(10-14(13)21-2)18-15(22)17-6-3-8-19-9-7-16-11-19/h4-5,7,9-11H,3,6,8H2,1-2H3,(H2,17,18,22) D00JHN DRUGINKE FZQXMGLQANXZRP-UHFFFAOYSA-N D00JHN DRUGSMIL COC1=C(C=C(C=C1)NC(=S)NCCCN2C=CN=C2)OC D00JHN DRUGTYPE Small molecular drug D00JHN HIGHSTAT Investigative D00JID DRUG__ID D00JID D00JID DRUGCLAS Investigative Drug(s) D00JID DRUGINCH 1S/C44H58ClN7O10S/c1-4-25(2)38(52-42(59)37(24-63)47-26(3)53)43(60)50-35(22-28-10-16-31(54)17-11-28)40(57)48-33(7-5-6-20-46)39(56)49-34(21-27-8-14-30(45)15-9-27)41(58)51-36(44(61)62)23-29-12-18-32(55)19-13-29/h8-19,25,33-38,54-55,63H,4-7,20-24,46H2,1-3H3,(H,47,53)(H,48,57)(H,49,56)(H,50,60)(H,51,58)(H,52,59)(H,61,62)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D00JID DRUGINKE MJPZCPCJFBXRAJ-LBNFHWTGSA-N D00JID DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)Cl)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)C(CS)NC(=O)C D00JID DRUGTYPE Small molecular drug D00JID HIGHSTAT Investigative D00JIV DRUG__ID D00JIV D00JIV DRUGCLAS Investigative Drug(s) D00JIV DRUGCOMP Pfizer Inc D00JIV DRUGINCH 1S/C18H13FN6OS/c19-14-7-11(8-20)1-2-12(14)15-13(9-21)18(25-3-5-26-6-4-25)27-16(15)17-22-10-23-24-17/h1-2,7,10H,3-6H2,(H,22,23,24) D00JIV DRUGINKE MUENOTXSRZEFJV-UHFFFAOYSA-N D00JIV DRUGSMIL C1COCCN1C2=C(C(=C(S2)C3=NC=NN3)C4=C(C=C(C=C4)C#N)F)C#N D00JIV HIGHSTAT Investigative D00JIX DRUG__ID D00JIX D00JIX DRUGCLAS Investigative Drug(s) D00JIX DRUGCOMP Ikerchem D00JIX HIGHSTAT Investigative D00JJG DRUG__ID D00JJG D00JJG DRUGCLAS Clinical Trial Drug(s) D00JJG DRUGCOMP RAPID Pharmaceuticals D00JJG DRUGINCH 1S/C35H56N10O15/c1-13(36)29(54)41-22(12-46)32(57)43-26(16(4)49)34(59)45-27(17(5)50)35(60)44-25(15(3)48)33(58)40-21(11-23(37)52)30(55)39-20(10-18-6-8-19(51)9-7-18)31(56)42-24(14(2)47)28(38)53/h6-9,13-17,20-22,24-27,46-51H,10-12,36H2,1-5H3,(H2,37,52)(H2,38,53)(H,39,55)(H,40,58)(H,41,54)(H,42,56)(H,43,57)(H,44,60)(H,45,59)/t13-,14-,15-,16-,17-,20+,21+,22+,24+,25+,26+,27+/m1/s1 D00JJG DRUGINKE AKWRNBWMGFUAMF-ZESMOPTKSA-N D00JJG DRUGSMIL CC(C(C(=O)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(C)N)O D00JJG HIGHSTAT Phase 2 D00JJO DRUG__ID D00JJO D00JJO DRUGCLAS Investigative Drug(s) D00JJO DRUGINCH 1S/C22H22O2/c1-23-21-12-7-10-19(16-21)17-24-22-13-6-5-11-20(22)15-14-18-8-3-2-4-9-18/h2-13,16H,14-15,17H2,1H3 D00JJO DRUGINKE GYSNUAVEYIUVBT-UHFFFAOYSA-N D00JJO DRUGSMIL COC1=CC=CC(=C1)COC2=CC=CC=C2CCC3=CC=CC=C3 D00JJO DRUGTYPE Small molecular drug D00JJO HIGHSTAT Investigative D00JJP DRUG__ID D00JJP D00JJP DRUADIID CLI-01-ALDR-02389 D00JJP DRUGCLAS Investigative Drug(s) D00JJP DRUGINCH 1S/C23H27N5O3/c1-17-19(9-6-10-25-17)21(16-24)27-11-13-28(14-12-27)22(29)15-20(26-23(30)31-2)18-7-4-3-5-8-18/h3-10,20-21H,11-15H2,1-2H3,(H,26,30) D00JJP DRUGINKE PMKMCABYJLILBB-UHFFFAOYSA-N D00JJP DRUGSMIL CC1=C(C=CC=N1)C(C#N)N2CCN(CC2)C(=O)CC(C3=CC=CC=C3)NC(=O)OC D00JJP DRUGTYPE Small molecular drug D00JJP HIGHSTAT Investigative D00JJW DRUG__ID D00JJW D00JJW DRUADIID 800011384 D00JJW DRUGCLAS Clinical Trial Drug(s) D00JJW DRUGINCH 1S/C12H14N2O3/c1-7-9(13-2-3-13)12(17)8(6-15)10(11(7)16)14-4-5-14/h15H,2-6H2,1H3 D00JJW DRUGINKE JKDLOGLNPDVUCX-UHFFFAOYSA-N D00JJW DRUGSMIL CC1=C(C(=O)C(=C(C1=O)N2CC2)CO)N3CC3 D00JJW DRUGTYPE Small molecular drug D00JJW HIGHSTAT Phase 1 D00JJW THERCLAS Anticancer Agents D00JJZ DRUG__ID D00JJZ D00JJZ DRUGCLAS Clinical Trial Drug(s) D00JJZ DRUGCOMP Fibrocell science D00JJZ HIGHSTAT Phase 3 D00JKB DRUG__ID D00JKB D00JKB DRUADIID CLI-01-ALDR-02052 D00JKB DRUGCLAS Investigative Drug(s) D00JKB DRUGINCH 1S/C14H20N2O2/c1-9-7-10-8-11(15)5-6-12(10)16(9)13(17)18-14(2,3)4/h5-6,8-9H,7,15H2,1-4H3 D00JKB DRUGINKE YOELJPDARJMOOO-UHFFFAOYSA-N D00JKB DRUGSMIL CC1CC2=C(N1C(=O)OC(C)(C)C)C=CC(=C2)N D00JKB HIGHSTAT Investigative D00JKJ DRUG__ID D00JKJ D00JKJ DRUGCLAS Investigative Drug(s) D00JKJ DRUGCOMP Heat Biologics D00JKJ DRUGINCH 1S/C26H46N2.2HI/c1-25-14-12-21(28(5)17-6-7-18-28)19-20(25)10-11-22-23(25)13-15-26(2)24(22)9-8-16-27(26,3)4;;/h10,21-24H,6-9,11-19H2,1-5H3;2*1H/q+2;;/p-2/t21-,22+,23-,24-,25-,26-;;/m0../s1 D00JKJ DRUGINKE GGAGIPMNQXAXNH-XDMKMBKMSA-L D00JKJ DRUGSMIL CC12CCC(CC1=CCC3C2CCC4(C3CCC[N+]4(C)C)C)[N+]5(CCCC5)C.[I-].[I-] D00JKJ DRUGTYPE Small molecular drug D00JKJ HIGHSTAT Investigative D00JLX DRUG__ID D00JLX D00JLX DRUGCLAS Patented Agent(s) D00JLX DRUGCOMP FLEXUS BIOSCIENCES, INC D00JLX DRUGTYPE Small molecular drug D00JLX HIGHSTAT Patented D00JME DRUG__ID D00JME D00JME DRUGCLAS Investigative Drug(s) D00JME DRUGCOMP Summit Corp plc D00JME HIGHSTAT Investigative D00JMG DRUG__ID D00JMG D00JMG DRUGCLAS Investigative Drug(s) D00JMG DRUGCOMP HRA Pharma D00JMG HIGHSTAT Investigative D00JMT DRUG__ID D00JMT D00JMT DRUGCLAS Investigative Drug(s) D00JMT DRUGINCH 1S/C21H27N7O/c1-2-4-15(5-3-1)24-20-18-19(23-14-22-18)26-21(27-20)25-16-6-8-17(9-7-16)28-10-12-29-13-11-28/h6-9,14-15H,1-5,10-13H2,(H3,22,23,24,25,26,27) D00JMT DRUGINKE ZFLJHSQHILSNCM-UHFFFAOYSA-N D00JMT DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)NC4=CC=C(C=C4)N5CCOCC5 D00JMT DRUGTYPE Small molecular drug D00JMT HIGHSTAT Investigative D00JMY DRUG__ID D00JMY D00JMY DRUGCLAS Clinical Trial Drug(s) D00JMY DRUGCOMP Amplimmune Gaithersburg, MD D00JMY DRUGTYPE Monoclonal antibody D00JMY HIGHSTAT Phase 1 D00JMZ DRUG__ID D00JMZ D00JMZ DRUGCLAS Discontinued Drug(s) D00JMZ DRUGINCH 1S/C32H30N4O11/c1-15-23(29(37)45-5)27(19-9-7-11-21(13-19)35(41)42)25(17(3)33-15)31(39)47-32(40)26-18(4)34-16(2)24(30(38)46-6)28(26)20-10-8-12-22(14-20)36(43)44/h7-14,27-28,33-34H,1-6H3/t27-,28+ D00JMZ DRUGINKE PZNZOWSLQRURNA-HNRBIFIRSA-N D00JMZ DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(=O)C2=C(NC(=C(C2C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC)C)C)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC D00JMZ DRUGTYPE Small molecular drug D00JMZ HIGHSTAT Terminated D00JNH DRUG__ID D00JNH D00JNH DRUGCLAS Investigative Drug(s) D00JNH HIGHSTAT Investigative D00JNL DRUG__ID D00JNL D00JNL DRUGCLAS Discontinued Drug(s) D00JNL DRUGCOMP Hoechst Marion Roussel Inc D00JNL DRUGINCH 1S/C8H10N2OS/c11-8-7(9-3-4-10-8)6-2-1-5-12-6/h1-2,5,7,9H,3-4H2,(H,10,11) D00JNL DRUGINKE BBACKDMGYMXYLE-UHFFFAOYSA-N D00JNL DRUGSMIL C1CNC(=O)C(N1)C2=CC=CS2 D00JNL DRUGTYPE Small molecular drug D00JNL HIGHSTAT Terminated D00JNT DRUG__ID D00JNT D00JNT DRUGCLAS Discontinued Drug(s) D00JNT DRUGCOMP ViroPharma; ViroPharma Inc D00JNT DRUGINCH 1S/C20H21FN2O5S/c1-11(2)27-17-9-14-16(10-15(17)23-29(4,25)26)28-19(18(14)20(24)22-3)12-5-7-13(21)8-6-12/h5-11,23H,1-4H3,(H,22,24) D00JNT DRUGINKE VBRUONUESYTIDA-UHFFFAOYSA-N D00JNT DRUGSMIL CC(C)OC1=C(C=C2C(=C1)C(=C(O2)C3=CC=C(C=C3)F)C(=O)NC)NS(=O)(=O)C D00JNT DRUGTYPE Small molecular drug D00JNT HIGHSTAT Discontinued in Phase 1 D00JPB DRUG__ID D00JPB D00JPB DRUGCLAS Investigative Drug(s) D00JPB DRUGINCH 1S/C21H21N3O2/c22-21(25)20-11-10-19(15-24-20)26-18-8-6-17(7-9-18)14-23-13-12-16-4-2-1-3-5-16/h1-11,15,23H,12-14H2,(H2,22,25) D00JPB DRUGINKE RDWUBDSRHFANBO-UHFFFAOYSA-N D00JPB DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC=C(C=C2)OC3=CN=C(C=C3)C(=O)N D00JPB DRUGTYPE Small molecular drug D00JPB HIGHSTAT Investigative D00JPH DRUG__ID D00JPH D00JPH DRUGCLAS Investigative Drug(s) D00JPH DRUGINCH 1S/C16H15NO2/c18-12-15(11-13-7-3-1-4-8-13)17-16(19)14-9-5-2-6-10-14/h1-10,12,15H,11H2,(H,17,19)/t15-/m0/s1 D00JPH DRUGINKE HIVDFHSZNYCJQH-HNNXBMFYSA-N D00JPH DRUGSMIL C1=CC=C(C=C1)CC(C=O)NC(=O)C2=CC=CC=C2 D00JPH DRUGTYPE Small molecular drug D00JPH HIGHSTAT Investigative D00JPK DRUG__ID D00JPK D00JPK DRUGCLAS Investigative Drug(s) D00JPK DRUGCOMP Hygeia Therapeutics Inc D00JPK HIGHSTAT Investigative D00JPV DRUG__ID D00JPV D00JPV DRUGCLAS Investigative Drug(s) D00JPV DRUGINCH 1S/C13H10N2O/c1-2-6-10(7-3-1)14-13-15-11-8-4-5-9-12(11)16-13/h1-9H,(H,14,15) D00JPV DRUGINKE BFLIOKCEGCUTNH-UHFFFAOYSA-N D00JPV DRUGSMIL C1=CC=C(C=C1)NC2=NC3=CC=CC=C3O2 D00JPV DRUGTYPE Small molecular drug D00JPV HIGHSTAT Investigative D00JQA DRUG__ID D00JQA D00JQA DRUGCLAS Patented Agent(s) D00JQA DRUGINCH 1S/C13H10N2O2/c16-8-5-6-9(12(17)7-8)13-14-10-3-1-2-4-11(10)15-13/h1-7,16-17H,(H,14,15) D00JQA DRUGINKE MTDSHRDWHUXPQH-UHFFFAOYSA-N D00JQA DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C3=C(C=C(C=C3)O)O D00JQA DRUGTYPE Small molecular drug D00JQA HIGHSTAT Patented D00JQE DRUG__ID D00JQE D00JQE DRUGCLAS Clinical Trial Drug(s) D00JQE DRUGCOMP Bayer AG D00JQE DRUGINCH 1S/C30H37F4NO/c1-29(2)16-22-25(23(36)17-29)24(18-8-4-3-5-9-18)26(28(35-22)20-10-6-7-11-20)27(31)19-12-14-21(15-13-19)30(32,33)34/h12-15,18,20,23,27,36H,3-11,16-17H2,1-2H3/t23-,27-/m0/s1 D00JQE DRUGINKE BHKIPHICFOJGLD-HOFKKMOUSA-N D00JQE DRUGSMIL CC1(CC(C2=C(C1)N=C(C(=C2C3CCCCC3)C(C4=CC=C(C=C4)C(F)(F)F)F)C5CCCC5)O)C D00JQE HIGHSTAT Phase 1 D00JQQ DRUG__ID D00JQQ D00JQQ DRUGCLAS Discontinued Drug(s) D00JQQ DRUGCOMP Chugai Pharmaceutical Co Ltd D00JQQ DRUGINCH 1S/C22H19NO2/c1-16-6-2-3-7-18(16)13-10-17-11-14-19(15-12-17)23-21-9-5-4-8-20(21)22(24)25/h2-15,23H,1H3,(H,24,25)/b13-10+ D00JQQ DRUGINKE FUJSSIRYCZLXQW-JLHYYAGUSA-N D00JQQ DRUGSMIL CC1=CC=CC=C1C=CC2=CC=C(C=C2)NC3=CC=CC=C3C(=O)O D00JQQ HIGHSTAT Terminated D00JRA DRUG__ID D00JRA D00JRA DRUGCLAS Approved Drug(s) D00JRA DRUGCOMP Organon BioSciences D00JRA DRUGINCH 1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m0/s1 D00JRA DRUGINKE VSWBSWWIRNCQIJ-GJZGRUSLSA-N D00JRA DRUGSMIL CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24 D00JRA DRUGTYPE Small molecular drug D00JRA HIGHSTAT Approved D00JRD DRUG__ID D00JRD D00JRD DRUGCLAS Clinical Trial Drug(s) D00JRD DRUGINCH 1S/C23H40O5/c1-4-5-8-11-18(24)14-15-20-19(21(25)16-22(20)26)12-9-6-7-10-13-23(27)28-17(2)3/h6,9,14-15,17-22,24-26H,4-5,7-8,10-13,16H2,1-3H3/b9-6-,15-14+/t18-,19+,20+,21-,22+/m0/s1 D00JRD DRUGINKE FPABVZYYTCHNMK-YNRDDPJXSA-N D00JRD DRUGSMIL CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)OC(C)C)O)O)O D00JRD DRUGTYPE Small molecular drug D00JRD HIGHSTAT Phase 3 D00JRS DRUG__ID D00JRS D00JRS DRUGCLAS Preclinical Drugs D00JRS DRUGCOMP Abbott Laboratories D00JRS DRUGINCH 1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 D00JRS DRUGINKE KJHKTHWMRKYKJE-SUGCFTRWSA-N D00JRS DRUGSMIL CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O D00JRS DRUGTYPE Small molecular drug D00JRS HIGHSTAT Preclinical D00JRS THERCLAS Antiviral Agents D00JSG DRUG__ID D00JSG D00JSG DRUGCLAS Discontinued Drug(s) D00JSG DRUGCOMP Harvard University D00JSG HIGHSTAT Terminated D00JTE DRUG__ID D00JTE D00JTE DRUGCLAS Investigative Drug(s) D00JTE DRUGINCH 1S/C22H27NO/c1-23-20-12-13-21(23)15-17(14-20)16-22(24,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17,20-21,24H,12-16H2,1H3/t20-,21-/m1/s1 D00JTE DRUGINKE LAOBIJDCKIAALB-NHCUHLMSSA-N D00JTE DRUGSMIL CN1C2CCC1CC(C2)CC(C3=CC=CC=C3)(C4=CC=CC=C4)O D00JTE DRUGTYPE Small molecular drug D00JTE HIGHSTAT Investigative D00JUD DRUG__ID D00JUD D00JUD DRUGCLAS Investigative Drug(s) D00JUD DRUGINCH 1S/C16H10O3/c1-9-6-16(17)19-14-8-15-12(7-11(9)14)10-4-2-3-5-13(10)18-15/h2-8H,1H3 D00JUD DRUGINKE MOTTUNALIBKKNF-UHFFFAOYSA-N D00JUD DRUGSMIL CC1=CC(=O)OC2=CC3=C(C=C12)C4=CC=CC=C4O3 D00JUD DRUGTYPE Small molecular drug D00JUD HIGHSTAT Investigative D00JUI DRUG__ID D00JUI D00JUI COMPCLAS Triazolo-pyridine derivatives D00JUI DRUGCLAS Patented Agent(s) D00JUI DRUGCOMP F.HOFFMANN-LA ROCHE AG GENENTECH, INC LI, Wei D00JUI DRUGTYPE Small molecular drug D00JUI HIGHSTAT Patented D00JUO DRUG__ID D00JUO D00JUO DRUGCLAS Investigative Drug(s) D00JUO DRUGINCH 1S/C20H18ClN3OS/c1-13-10-17(14-4-2-5-15(21)11-14)23-12-16(13)18-6-3-8-24(18)20(25)19-22-7-9-26-19/h2,4-5,7,9-12,18H,3,6,8H2,1H3/t18-/m1/s1 D00JUO DRUGINKE GCSDBTCZHROCLZ-GOSISDBHSA-N D00JUO DRUGSMIL CC1=CC(=NC=C1C2CCCN2C(=O)C3=NC=CS3)C4=CC(=CC=C4)Cl D00JUO DRUGTYPE Small molecular drug D00JUO HIGHSTAT Investigative D00JVC DRUG__ID D00JVC D00JVC DRUGCLAS Investigative Drug(s) D00JVC DRUGCOMP Antibe Therapeutics Inc D00JVC DRUGINCH 1S/C16H11NO3S3/c17-10-3-6-14(18)12(7-10)15(19)20-11-4-1-9(2-5-11)13-8-22-23-16(13)21/h1-8,18H,17H2 D00JVC DRUGINKE IFYIEDLRMQRZEP-UHFFFAOYSA-N D00JVC DRUGSMIL C1=CC(=CC=C1C2=CSSC2=S)OC(=O)C3=C(C=CC(=C3)N)O D00JVC DRUGTYPE Small molecular drug D00JVC HIGHSTAT Investigative D00JVQ DRUG__ID D00JVQ D00JVQ DRUGCLAS Patented Agent(s) D00JVQ DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D00JVQ DRUGTYPE Small molecular drug D00JVQ HIGHSTAT Patented D00JVR DRUG__ID D00JVR D00JVR DRUGCLAS Approved Drug(s) D00JVR DRUGCOMP Meda Pharmaceuticals Inc D00JVR DRUGINCH 1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3 D00JVR DRUGINKE MBUVEWMHONZEQD-UHFFFAOYSA-N D00JVR DRUGSMIL CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl D00JVR DRUGTYPE Small molecular drug D00JVR HIGHSTAT Approved D00JVR THERCLAS Antiallergic Agents D00JWA DRUG__ID D00JWA D00JWA DRUGCLAS Investigative Drug(s) D00JWA DRUGINCH 1S/C16H13N3O2/c1-11(20)18-15-5-4-13(12-6-8-17-9-7-12)16(19-15)14-3-2-10-21-14/h2-10H,1H3,(H,18,19,20) D00JWA DRUGINKE STFZQXRQDWXSGW-UHFFFAOYSA-N D00JWA DRUGSMIL CC(=O)NC1=NC(=C(C=C1)C2=CC=NC=C2)C3=CC=CO3 D00JWA DRUGTYPE Small molecular drug D00JWA HIGHSTAT Investigative D00JWB DRUG__ID D00JWB D00JWB DRUGCLAS Investigative Drug(s) D00JWB DRUGINCH 1S/C16H18N4O2/c21-15(20-7-1-2-8-20)11-18-16(22)19-14-4-3-13-10-17-6-5-12(13)9-14/h3-6,9-10H,1-2,7-8,11H2,(H2,18,19,22) D00JWB DRUGINKE DMIDPTCQPIJYFE-UHFFFAOYSA-N D00JWB DRUGSMIL C1CCN(C1)C(=O)CNC(=O)NC2=CC3=C(C=C2)C=NC=C3 D00JWB DRUGTYPE Small molecular drug D00JWB HIGHSTAT Investigative D00JWL DRUG__ID D00JWL D00JWL DRUGCLAS Discontinued Drug(s) D00JWL DRUGCOMP Lexin Pharmaceutical D00JWL HIGHSTAT Terminated D00JWN DRUG__ID D00JWN D00JWN DRUGCLAS Drugs in Phase 1 Trial D00JWN DRUGTYPE Cell therapy D00JWN HIGHSTAT Phase 1/2 Trial D00JWN THERCLAS Antiviral Agents D00JWR DRUG__ID D00JWR D00JWR DRUGCLAS Investigative Drug(s) D00JWR DRUGINCH 1S/C12H12ClN3S2/c13-10-8-15-12(18-10)16-11(17)14-7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H2,14,15,16,17) D00JWR DRUGINKE FRTOQBKWAXWZAM-UHFFFAOYSA-N D00JWR DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NC=C(S2)Cl D00JWR DRUGTYPE Small molecular drug D00JWR HIGHSTAT Investigative D00JXJ DRUG__ID D00JXJ D00JXJ DRUGCLAS Investigative Drug(s) D00JXJ DRUGCOMP Isis Pharmaceuticals D00JXJ DRUGTYPE Antisense drug D00JXJ HIGHSTAT Investigative D00JXL DRUG__ID D00JXL D00JXL DRUGCLAS Investigative Drug(s) D00JXL DRUGINCH 1S/C16H12N2OS/c19-15(13-9-5-2-6-10-13)18-16-17-14(11-20-16)12-7-3-1-4-8-12/h1-11H,(H,17,18,19) D00JXL DRUGINKE NIRMZOKDACPPER-UHFFFAOYSA-N D00JXL DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC=CC=C3 D00JXL DRUGTYPE Small molecular drug D00JXL HIGHSTAT Investigative D00JXV DRUG__ID D00JXV D00JXV DRUGCLAS Investigative Drug(s) D00JXV DRUGCOMP Incyte Corp D00JXV HIGHSTAT Investigative D00JYL DRUG__ID D00JYL D00JYL DRUGCLAS Investigative Drug(s) D00JYL DRUGINCH 1S/C79H100ClN15O14S/c1-45(2)83-35-12-11-18-61(79(109)95-36-14-19-68(95)76(107)84-47(5)69(81)100)88-77(108)78(110-46(3)4)94-74(105)65(40-53-25-32-60(33-26-53)86-49(7)98)90-72(103)64(39-52-23-30-59(31-24-52)85-48(6)97)92-75(106)67(44-96)93-73(104)66(42-55-15-13-34-82-43-55)91-71(102)63(38-51-21-28-58(80)29-22-51)89-70(101)62(87-50(8)99)41-54-20-27-56-16-9-10-17-57(56)37-54/h9-10,13,15-17,20-34,37,43,45-47,61-68,78,83,96H,11-12,14,18-19,35-36,38-42,44H2,1-8H3,(H2,81,100)(H,84,107)(H,85,97)(H,86,98)(H,87,99)(H,88,108)(H,89,101)(H,90,103)(H,91,102)(H,92,106)(H,93,104)(H,94,105)/t47-,61+,62-,63-,64+,65-,66-,67+,68+,78-/m1/s1 D00JYL DRUGINKE GFSHJVRBLLVKAZ-UQWNDQPVSA-N D00JYL DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)SC(C)C D00JYL HIGHSTAT Investigative D00JZD DRUG__ID D00JZD D00JZD DRUGCLAS Clinical Trial Drug(s) D00JZD DRUGCOMP GlaxoSmithKline D00JZD HIGHSTAT Phase 3 D00JZS DRUG__ID D00JZS D00JZS DRUGCLAS Investigative Drug(s) D00JZS DRUGCOMP Cardiovascular biotherapeutics D00JZS DRUGTYPE Antibody D00JZS HIGHSTAT Investigative D00JZX DRUG__ID D00JZX D00JZX DRUGCLAS Discontinued Drug(s) D00JZX DRUGCOMP Enanta Pharmaceuticals Inc D00JZX HIGHSTAT Terminated D00KCB DRUG__ID D00KCB D00KCB DRUGCLAS Investigative Drug(s) D00KCB DRUGINCH 1S/C12H10FN3O4/c13-5-1-2-7-6(3-5)12(4-8(20-7)9(14)17)10(18)15-11(19)16-12/h1-3,8H,4H2,(H2,14,17)(H2,15,16,18,19)/t8-,12+/m0/s1 D00KCB DRUGINKE WAAPEIZFCHNLKK-QPUJVOFHSA-N D00KCB DRUGSMIL C1C(OC2=C(C13C(=O)NC(=O)N3)C=C(C=C2)F)C(=O)N D00KCB DRUGTYPE Small molecular drug D00KCB HIGHSTAT Investigative D00KCR DRUG__ID D00KCR D00KCR DRUGCLAS Investigative Drug(s) D00KCR DRUGCOMP Multimmune GmbH D00KCR HIGHSTAT Investigative D00KCT DRUG__ID D00KCT D00KCT DRUGCLAS Patented Agent(s) D00KCT DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D00KCT DRUGINCH 1S/C19H19ClN2O3/c20-14-8-9-15(13-6-2-1-3-7-13)16(12-14)21-18(25)22-19(17(23)24)10-4-5-11-19/h1-3,6-9,12H,4-5,10-11H2,(H,23,24)(H2,21,22,25) D00KCT DRUGINKE YBQHFZNBCISVBS-UHFFFAOYSA-N D00KCT DRUGSMIL C1CCC(C1)(C(=O)O)NC(=O)NC2=C(C=CC(=C2)Cl)C3=CC=CC=C3 D00KCT DRUGTYPE Small molecular drug D00KCT HIGHSTAT Patented D00KDF DRUG__ID D00KDF D00KDF DRUGCLAS Investigative Drug(s) D00KDF DRUGINCH 1S/C24H15N3O3/c28-23-19-17-11-5-1-3-7-13(11)26-15-9-10-16(30-15)27-14-8-4-2-6-12(14)18(22(27)21(17)26)20(19)24(29)25-23/h1-8,15-16H,9-10H2,(H,25,28,29) D00KDF DRUGINKE OTPNDVKVEAIXTI-UHFFFAOYSA-N D00KDF DRUGSMIL C1CC2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C1O2)C7=C53)C(=O)NC6=O D00KDF DRUGTYPE Small molecular drug D00KDF HIGHSTAT Investigative D00KDQ DRUG__ID D00KDQ D00KDQ DRUGCLAS Clinical Trial Drug(s) D00KDQ DRUGCOMP Sorrento Therapeutics, Inc. D00KDQ DRUGTYPE CAR T Cell Therapy D00KDQ HIGHSTAT Phase 1 D00KDT DRUG__ID D00KDT D00KDT COMPCLAS Oligooxopiperazine derivatives D00KDT DRUGCLAS Patented Agent(s) D00KDT DRUGCOMP NEW YORK UNIVERSITY UNIVERSITY OF SOUTHERN CALIFORNIA ARORA, Paramjit S. OLENYUK, Bogdan LAU, Brooke Bullock GRISHAGIN, Ivan D00KDT DRUGINCH 1S/C24H42N6O5/c1-14(2)12-17-23(34)29(9-8-27-17)19(13-15(3)4)24(35)28-10-11-30(22(33)16(28)5)18(21(26)32)6-7-20(25)31/h14-19,27H,6-13H2,1-5H3,(H2,25,31)(H2,26,32)/t16-,17-,18-,19-/m0/s1 D00KDT DRUGINKE FMTAQWMOLHFOLT-VJANTYMQSA-N D00KDT DRUGSMIL CC1C(=O)N(CCN1C(=O)C(CC(C)C)N2CCNC(C2=O)CC(C)C)C(CCC(=O)N)C(=O)N D00KDT DRUGTYPE Small molecular drug D00KDT HIGHSTAT Patented D00KDZ DRUG__ID D00KDZ D00KDZ DRUGCLAS Investigative Drug(s) D00KDZ DRUGINCH 1S/C16H16N2/c1-18(15-8-3-2-4-9-15)12-14-11-13-7-5-6-10-16(13)17-14/h2-11,17H,12H2,1H3 D00KDZ DRUGINKE KHSLYBCUWUKVBX-UHFFFAOYSA-N D00KDZ DRUGSMIL CN(CC1=CC2=CC=CC=C2N1)C3=CC=CC=C3 D00KDZ DRUGTYPE Small molecular drug D00KDZ HIGHSTAT Investigative D00KEF DRUG__ID D00KEF D00KEF DRUGCLAS Discontinued Drug(s) D00KEF DRUGCOMP Organon BioSciences D00KEF DRUGINCH 1S/C40H55N9O11S/c1-61(59,60)19-17-28(42)35(52)45-30(15-16-34(50)51)37(54)48-32(22-27-23-43-24-44-27)39(56)47-31(20-25-10-4-2-5-11-25)38(55)46-29(14-8-9-18-41)36(53)49-33(40(57)58)21-26-12-6-3-7-13-26/h2-7,10-13,23-24,28-33H,8-9,14-22,41-42H2,1H3,(H,43,44)(H,45,52)(H,46,55)(H,47,56)(H,48,54)(H,49,53)(H,50,51)(H,57,58)/t28-,29+,30-,31-,32-,33-/m0/s1 D00KEF DRUGINKE QUCFVNGGGFLOES-ACQYNFKHSA-N D00KEF DRUGSMIL CS(=O)(=O)CCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=CC=C3)C(=O)O)N D00KEF DRUGTYPE Small molecular drug D00KEF HIGHSTAT Discontinued in Phase 3 D00KEP DRUG__ID D00KEP D00KEP DRUGCLAS Investigative Drug(s) D00KEP DRUGINCH 1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20) D00KEP DRUGINKE KCXVZYZYPLLWCC-UHFFFAOYSA-N D00KEP DRUGSMIL C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O D00KEP DRUGTYPE Small molecular drug D00KEP HIGHSTAT Investigative D00KEX DRUG__ID D00KEX D00KEX COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D00KEX DRUGCLAS Patented Agent(s) D00KEX DRUGCOMP PHARMACYCLICS, INC D00KEX DRUGINCH 1S/C27H30N6O2/c1-18-11-12-19(14-23(18)35-5)22-16-33(27-25(22)26(28)29-17-30-27)21-9-6-8-20(15-21)32(4)24(34)10-7-13-31(2)3/h6-12,14-17H,13H2,1-5H3,(H2,28,29,30)/b10-7+ D00KEX DRUGINKE XIEVUMXHZAXKDT-JXMROGBWSA-N D00KEX DRUGSMIL CC1=C(C=C(C=C1)C2=CN(C3=NC=NC(=C23)N)C4=CC(=CC=C4)N(C)C(=O)C=CCN(C)C)OC D00KEX DRUGTYPE Small molecular drug D00KEX HIGHSTAT Patented D00KFB DRUG__ID D00KFB D00KFB DRUADIID FDA-AP-BF04-01202 D00KFB DRUGCLAS Approved Drug(s) D00KFB DRUGCOMP Reckitt Benckiser Llc D00KFB DRUGINCH 1S/C18H25NO.BrH/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H/t15-,17+,18+;/m1./s1 D00KFB DRUGINKE MISZALMBODQYFT-URVXVIKDSA-N D00KFB DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br D00KFB HIGHSTAT Approved D00KFF DRUG__ID D00KFF D00KFF DRUGCLAS Investigative Drug(s) D00KFF DRUGINCH 1S/C15H18F3NO2/c16-15(17,18)13(20)10-6-1-2-7-11-14(21)19-12-8-4-3-5-9-12/h3-5,8-9H,1-2,6-7,10-11H2,(H,19,21) D00KFF DRUGINKE KRCXZGYVOZSCSF-UHFFFAOYSA-N D00KFF DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)C(F)(F)F D00KFF DRUGTYPE Small molecular drug D00KFF HIGHSTAT Investigative D00KFI DRUG__ID D00KFI D00KFI COMPCLAS Azetidinyl-piperazine derivatives D00KFI DRUGCLAS Patented Agent(s) D00KFI DRUGCOMP JANSSEN PHARMACEUTICA NV D00KFI DRUGINCH 1S/C21H18ClF3N4O2S2/c22-17-14-2-1-12(21(23,24)25)7-16(14)33-18(17)20(31)29-8-13(9-29)27-3-5-28(6-4-27)19(30)15-10-32-11-26-15/h1-2,7,10-11,13H,3-6,8-9H2 D00KFI DRUGINKE HKKPDZNDQBHUOD-UHFFFAOYSA-N D00KFI DRUGSMIL C1CN(CCN1C2CN(C2)C(=O)C3=C(C4=C(S3)C=C(C=C4)C(F)(F)F)Cl)C(=O)C5=CSC=N5 D00KFI DRUGTYPE Small molecular drug D00KFI HIGHSTAT Patented D00KGB DRUG__ID D00KGB D00KGB DRUGCLAS Clinical Trial Drug(s) D00KGB DRUGCOMP Menarini D00KGB DRUGTYPE Monoclonal antibody D00KGB HIGHSTAT Phase 2/3 D00KGI DRUG__ID D00KGI D00KGI DRUGCLAS Clinical Trial Drug(s) D00KGI DRUGCOMP ImVisioN Therapeutics Inc D00KGI HIGHSTAT Phase 1 D00KGK DRUG__ID D00KGK D00KGK DRUGCLAS Investigative Drug(s) D00KGK DRUGINCH 1S/C9H6BrNO2/c10-7-5-3-1-2-4-6(5)11-9(13)8(7)12/h1-4,12H,(H,11,13) D00KGK DRUGINKE BSYFERFWIZPSKL-UHFFFAOYSA-N D00KGK DRUGSMIL C1=CC=C2C(=C1)C(=C(C(=O)N2)O)Br D00KGK DRUGTYPE Small molecular drug D00KGK HIGHSTAT Investigative D00KGL DRUG__ID D00KGL D00KGL DRUGCLAS Patented Agent(s) D00KGL DRUGCOMP F. HOFFMANN-LA ROCHE AG BANNER, David CECCARELLI, Simona M. GRETHER, Uwe HAAP, Wolfgang HILPERT, Hans KUEHNE, Holger MAUSER, Harald PLANCHER, Jean-Marc SANCHEZ, Rub Alvare D00KGL DRUGTYPE Small molecular drug D00KGL HIGHSTAT Patented D00KHD DRUG__ID D00KHD D00KHD DRUGCLAS Clinical Trial Drug(s) D00KHD DRUGCOMP Mitsubishi Pharma Corp D00KHD HIGHSTAT Phase 2 D00KHI DRUG__ID D00KHI D00KHI DRUGCLAS Clinical Trial Drug(s) D00KHI DRUGCOMP TNK TherapeuticsSan Diego, CA Sorrento Therapeutics San Diego, CA D00KHI HIGHSTAT Phase 1 D00KHM DRUG__ID D00KHM D00KHM DRUGCLAS Approved Drug(s) D00KHM DRUGCOMP Janssen Pharmaceutica D00KHM DRUGINCH 1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34) D00KHM DRUGINKE YVUQSNJEYSNKRX-UHFFFAOYSA-N D00KHM DRUGSMIL C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F D00KHM DRUGTYPE Small molecular drug D00KHM HIGHSTAT Approved D00KHM THERCLAS Antipsychotic Agents D00KIE DRUG__ID D00KIE D00KIE DRUGCLAS Clinical Trial Drug(s) D00KIE DRUGINCH 1S/C26H32N2O5.ClH/c1-18-19(2)26(29)33-23-17-24(31-4)25(16-20(18)23)32-15-7-10-27-11-13-28(14-12-27)21-8-5-6-9-22(21)30-3;/h5-6,8-9,16-17H,7,10-15H2,1-4H3;1H D00KIE DRUGINKE XMONKHCPLIYQCY-UHFFFAOYSA-N D00KIE DRUGSMIL CC1=C(C(=O)OC2=CC(=C(C=C12)OCCCN3CCN(CC3)C4=CC=CC=C4OC)OC)C.Cl D00KIE DRUGTYPE Small molecular drug D00KIE HIGHSTAT Phase 2 D00KII DRUG__ID D00KII D00KII DRUGCLAS Patented Agent(s) D00KII DRUGTYPE Small molecular drug D00KII HIGHSTAT Patented D00KIK DRUG__ID D00KIK D00KIK DRUGCLAS Investigative Drug(s) D00KIK DRUGINCH 1S/C20H27NS/c1-2-9-15-21(14-8-1)20(12-6-3-7-13-20)19-16-17-10-4-5-11-18(17)22-19/h4-5,10-11,16H,1-3,6-9,12-15H2 D00KIK DRUGINKE QDGRJLAJZNWVGV-UHFFFAOYSA-N D00KIK DRUGSMIL C1CCCN(CC1)C2(CCCCC2)C3=CC4=CC=CC=C4S3 D00KIK DRUGTYPE Small molecular drug D00KIK HIGHSTAT Investigative D00KIU DRUG__ID D00KIU D00KIU DRUGCLAS Investigative Drug(s) D00KIU DRUGCOMP MannKind Corp D00KIU HIGHSTAT Investigative D00KIV DRUG__ID D00KIV D00KIV DRUGCLAS Investigative Drug(s) D00KIV DRUGINCH 1S/C9H12NO2P/c10-9(13(11)12)7-6-8-4-2-1-3-5-8/h1-5,10-12H,6-7H2 D00KIV DRUGINKE YDYGVRIQAWAHCJ-UHFFFAOYSA-N D00KIV DRUGSMIL C1=CC=C(C=C1)CCC(=N)P(O)O D00KIV DRUGTYPE Small molecular drug D00KIV HIGHSTAT Investigative D00KJO DRUG__ID D00KJO D00KJO DRUGCLAS Preclinical Drug(s) D00KJO DRUGCOMP Mutabilis SA D00KJO DRUGINCH 1S/C15H13F2NO3/c1-2-8-6-12(19)14(7-10(8)16)21-13-4-3-9(15(18)20)5-11(13)17/h3-7,19H,2H2,1H3,(H2,18,20) D00KJO DRUGINKE QUHARGDBJJUOEB-UHFFFAOYSA-N D00KJO DRUGSMIL CCC1=CC(=C(C=C1F)OC2=C(C=C(C=C2)C(=O)N)F)O D00KJO HIGHSTAT Preclinical D00KJP DRUG__ID D00KJP D00KJP DRUGCLAS Investigative Drug(s) D00KJP DRUGINCH 1S/C22H24N4O4S2/c1-25(19-7-8-26(22(19)27)12-14-9-20(21(23)24)31-13-14)32(28,29)18-6-4-15-3-5-17(30-2)10-16(15)11-18/h3-6,9-11,13,19H,7-8,12H2,1-2H3,(H3,23,24)/t19-/m0/s1 D00KJP DRUGINKE YQYYTNCSSDRJHZ-IBGZPJMESA-N D00KJP DRUGSMIL CN(C1CCN(C1=O)CC2=CSC(=C2)C(=N)N)S(=O)(=O)C3=CC4=C(C=CC(=C4)OC)C=C3 D00KJP DRUGTYPE Small molecular drug D00KJP HIGHSTAT Investigative D00KJV DRUG__ID D00KJV D00KJV DRUGCLAS Investigative Drug(s) D00KJV DRUGINCH 1S/C10H21NO5/c1-2-3-4-11-6(5-12)7(13)8(14)9(15)10(11)16/h6-10,12-16H,2-5H2,1H3/t6-,7+,8+,9-,10+/m1/s1 D00KJV DRUGINKE JNYIOZRCMYRRED-KBDSZGMXSA-N D00KJV DRUGSMIL CCCCN1C(C(C(C(C1O)O)O)O)CO D00KJV DRUGTYPE Small molecular drug D00KJV HIGHSTAT Investigative D00KKD DRUG__ID D00KKD D00KKD DRUGCLAS Patented Agent(s) D00KKD DRUGCOMP WASHINGTON UNIVERSITY D00KKD DRUGTYPE Carbohydrates D00KKD HIGHSTAT Patented D00KKN DRUG__ID D00KKN D00KKN DRUGCLAS Investigative Drug(s) D00KKN DRUGINCH 1S/C19H22INO3/c1-2-22-16-5-3-4-6-17(16)24-19(18-13-21-11-12-23-18)14-7-9-15(20)10-8-14/h3-10,18-19,21H,2,11-13H2,1H3/t18-,19-/m0/s1 D00KKN DRUGINKE RVASAZVCHKJYMY-OALUTQOASA-N D00KKN DRUGSMIL CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=C(C=C3)I D00KKN DRUGTYPE Small molecular drug D00KKN HIGHSTAT Investigative D00KLH DRUG__ID D00KLH D00KLH DRUGCLAS Discontinued Drug(s) D00KLH DRUGCOMP Gedeon Richter Ltd D00KLH HIGHSTAT Terminated D00KLP DRUG__ID D00KLP D00KLP DRUGCLAS Clinical Trial Drug(s) D00KLP DRUGCOMP Grifols USA Los Angeles, CA D00KLP HIGHSTAT Phase 3 D00KMC DRUG__ID D00KMC D00KMC DRUGCLAS Investigative Drug(s) D00KMC DRUGINCH 1S/C18H19O8PS/c19-27(20,21)18(28(22,23)24)6-2-4-13-3-1-5-15(11-13)26-16-7-8-17-14(12-16)9-10-25-17/h1,3,5,7-12,18H,2,4,6H2,(H2,19,20,21)(H,22,23,24)/p-3 D00KMC DRUGINKE ILJWMHLLBUNHIQ-UHFFFAOYSA-K D00KMC DRUGSMIL C1=CC(=CC(=C1)OC2=CC3=C(C=C2)OC=C3)CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-] D00KMC DRUGTYPE Small molecular drug D00KMC HIGHSTAT Investigative D00KMI DRUG__ID D00KMI D00KMI DRUGCLAS Investigative Drug(s) D00KMI DRUGCOMP EvoGenix Pty Ltd D00KMI HIGHSTAT Investigative D00KML DRUG__ID D00KML D00KML DRUGCLAS Clinical Trial Drug(s) D00KML DRUGCOMP Synermore Biologics Taipei, Taiwan D00KML HIGHSTAT Phase 1 D00KMP DRUG__ID D00KMP D00KMP DRUGCLAS Investigative Drug(s) D00KMP DRUGINCH 1S/C19H26N2/c1-2-3-7-16-14-21(13-12-18(16)20)19-11-6-9-15-8-4-5-10-17(15)19/h4-6,8-11,16,18H,2-3,7,12-14,20H2,1H3 D00KMP DRUGINKE CPKGFALQFTVZTA-UHFFFAOYSA-N D00KMP DRUGSMIL CCCCC1CN(CCC1N)C2=CC=CC3=CC=CC=C32 D00KMP DRUGTYPE Small molecular drug D00KMP HIGHSTAT Investigative D00KMQ DRUG__ID D00KMQ D00KMQ DRUGCLAS Clinical Trial Drug(s) D00KMQ DRUGCOMP Novo Nordisk D00KMQ HIGHSTAT Phase 1 D00KNI DRUG__ID D00KNI D00KNI DRUGCLAS Clinical Trial Drug(s) D00KNI DRUGCOMP Boehringer Ingelheim Pharmaceuticals D00KNI HIGHSTAT Phase 1 D00KOE DRUG__ID D00KOE D00KOE DRUGCLAS Investigative Drug(s) D00KOE DRUGINCH 1S/C7H14N2/c1-5(2)6-3-7(8)9-4-6/h5-6H,3-4H2,1-2H3,(H2,8,9) D00KOE DRUGINKE PUOKLNVZFQOPOS-UHFFFAOYSA-N D00KOE DRUGSMIL CC(C)C1CC(=NC1)N D00KOE DRUGTYPE Small molecular drug D00KOE HIGHSTAT Investigative D00KOV DRUG__ID D00KOV D00KOV DRUGCLAS Discontinued Drug(s) D00KOV DRUGCOMP Dainippon Pharmaceutical Co Ltd D00KOV DRUGINCH 1S/C28H30FN3OS.C4H4O4/c29-22-11-13-23(14-12-22)32-18-16-31(17-19-32)15-5-10-27(33)30-28-24-7-2-1-6-21(24)20-34-26-9-4-3-8-25(26)28;5-3(6)1-2-4(7)8/h1-4,6-9,11-14,28H,5,10,15-20H2,(H,30,33);1-2H,(H,5,6)(H,7,8)/b;2-1- D00KOV DRUGINKE ZDZXCYHMVFLGMT-BTJKTKAUSA-N D00KOV DRUGSMIL C1CN(CCN1CCCC(=O)NC2C3=CC=CC=C3CSC4=CC=CC=C24)C5=CC=C(C=C5)F.C(=CC(=O)O)C(=O)O D00KOV DRUGTYPE Small molecular drug D00KOV HIGHSTAT Discontinued in Preregistration D00KPQ DRUG__ID D00KPQ D00KPQ COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D00KPQ DRUGCLAS Patented Agent(s) D00KPQ DRUGCOMP ADVINUS THERAPEUTICS LIMITED D00KPQ DRUGINCH 1S/C36H35N7O2/c1-41-13-15-42(16-14-41)20-23-5-7-25(8-6-23)32-18-30-34(37-22-38-35(30)40-32)29-3-2-4-33(31(29)21-44)43-36(45)28-12-11-26(24-9-10-24)17-27(28)19-39-43/h2-8,11-12,17-19,22,24,44H,9-10,13-16,20-21H2,1H3,(H,37,38,40) D00KPQ DRUGINKE HPYIZQVYHGPMDT-UHFFFAOYSA-N D00KPQ DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N=CN=C4N3)C5=C(C(=CC=C5)N6C(=O)C7=C(C=C(C=C7)C8CC8)C=N6)CO D00KPQ DRUGTYPE Small molecular drug D00KPQ HIGHSTAT Patented D00KPR DRUG__ID D00KPR D00KPR DRUGCLAS Investigative Drug(s) D00KPR DRUGINCH 1S/C6H14O2P2/c1-3-6(2,7)4-5-8-10-9/h7,9H,3-5H2,1-2H3 D00KPR DRUGINKE QGZAHEYJZLWZDX-UHFFFAOYSA-N D00KPR DRUGSMIL CCC(C)(CCOP=P)O D00KPR DRUGTYPE Small molecular drug D00KPR HIGHSTAT Investigative D00KQB DRUG__ID D00KQB D00KQB DRUGCLAS Investigative Drug(s) D00KQB DRUGINCH 1S/C13H21NO/c1-3-4-9-15-13-7-5-12(6-8-13)10-11(2)14/h5-8,11H,3-4,9-10,14H2,1-2H3 D00KQB DRUGINKE XYGSKZYABPNAKO-UHFFFAOYSA-N D00KQB DRUGSMIL CCCCOC1=CC=C(C=C1)CC(C)N D00KQB DRUGTYPE Small molecular drug D00KQB HIGHSTAT Investigative D00KQN DRUG__ID D00KQN D00KQN DRUGCLAS Clinical Trial Drug(s) D00KQN DRUGCOMP Aerovance D00KQN DRUGTYPE Monoclonal antibody D00KQN HIGHSTAT Phase 2 D00KQT DRUG__ID D00KQT D00KQT DRUGCLAS Discontinued Drug(s) D00KQT DRUGCOMP Fujisawa Pharmaceutical Co Ltd D00KQT DRUGINCH 1S/C30H37NO2/c1-2-3-4-5-6-15-22-33-29-21-14-13-20-27(29)24-30(32)31-28(26-18-11-8-12-19-26)23-25-16-9-7-10-17-25/h7-14,16-21,28H,2-6,15,22-24H2,1H3,(H,31,32) D00KQT DRUGINKE XUCJTVYTRXSOJC-UHFFFAOYSA-N D00KQT DRUGSMIL CCCCCCCCOC1=CC=CC=C1CC(=O)NC(CC2=CC=CC=C2)C3=CC=CC=C3 D00KQT HIGHSTAT Terminated D00KRE DRUG__ID D00KRE D00KRE DRUGCLAS Approved Drug(s) D00KRE DRUGCOMP Pharmacia & Upjohn AB D00KRE DRUGINCH 1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22) D00KRE DRUGINKE QQBDLJCYGRGAKP-UHFFFAOYSA-N D00KRE DRUGSMIL C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O D00KRE DRUGTYPE Small molecular drug D00KRE HIGHSTAT Approved D00KRL DRUG__ID D00KRL D00KRL DRUGCLAS Investigative Drug(s) D00KRL DRUGINCH 1S/C23H20N2O2/c1-2-27-23(26)19-14-12-18(13-15-19)22-20-10-6-7-11-21(20)25(24-22)16-17-8-4-3-5-9-17/h3-15H,2,16H2,1H3 D00KRL DRUGINKE LPROLPQTWKDPNU-UHFFFAOYSA-N D00KRL DRUGSMIL CCOC(=O)C1=CC=C(C=C1)C2=NN(C3=CC=CC=C32)CC4=CC=CC=C4 D00KRL DRUGTYPE Small molecular drug D00KRL HIGHSTAT Investigative D00KRQ DRUG__ID D00KRQ D00KRQ DRUGCLAS Investigative Drug(s) D00KRQ DRUGINCH 1S/C17H19NO/c1-2-6-15(7-3-1)19-17-9-5-4-8-16(17)14-10-12-18-13-11-14/h1-9,14,18H,10-13H2 D00KRQ DRUGINKE YWIYMDPWBAXEKQ-UHFFFAOYSA-N D00KRQ DRUGSMIL C1CNCCC1C2=CC=CC=C2OC3=CC=CC=C3 D00KRQ DRUGTYPE Small molecular drug D00KRQ HIGHSTAT Investigative D00KRT DRUG__ID D00KRT D00KRT DRUGCLAS Approved Drug(s) D00KRT DRUGINCH 1S/C43H48N2O6S2.Na/c1-42(2)38(44(28-14-16-30-52(46,47)48)36-26-24-32-18-10-12-20-34(32)40(36)42)22-8-6-5-7-9-23-39-43(3,4)41-35-21-13-11-19-33(35)25-27-37(41)45(39)29-15-17-31-53(49,50)51;/h5-13,18-27H,14-17,28-31H2,1-4H3,(H-,46,47,48,49,50,51);/q;+1/p-1 D00KRT DRUGINKE MOFVSTNWEDAEEK-UHFFFAOYSA-M D00KRT DRUGSMIL CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+] D00KRT DRUGTYPE Small molecular drug D00KRT HIGHSTAT Approved D00KSS DRUG__ID D00KSS D00KSS DRUGCLAS Investigative Drug(s) D00KSS DRUGINCH 1S/C10H14O3S2/c1-13-9-3-5-10(6-4-9)15(11,12)8-2-7-14/h3-6,14H,2,7-8H2,1H3 D00KSS DRUGINKE JIFLEYNNNKKNOQ-UHFFFAOYSA-N D00KSS DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)CCCS D00KSS DRUGTYPE Small molecular drug D00KSS HIGHSTAT Investigative D00KSU DRUG__ID D00KSU D00KSU DRUGCLAS Investigative Drug(s) D00KSU DRUGCOMP MaxThera Inc D00KSU HIGHSTAT Investigative D00KTE DRUG__ID D00KTE D00KTE DRUGCLAS Investigative Drug(s) D00KTE DRUGINCH 1S/C13H25N3O2/c1-3-5-8-15-12(17)11-7-6-9-16(11)13(18)10(14)4-2/h10-11H,3-9,14H2,1-2H3,(H,15,17)/t10-,11-/m0/s1 D00KTE DRUGINKE ZUFOHXXZTMOECH-QWRGUYRKSA-N D00KTE DRUGSMIL CCCCNC(=O)C1CCCN1C(=O)C(CC)N D00KTE DRUGTYPE Small molecular drug D00KTE HIGHSTAT Investigative D00KTI DRUG__ID D00KTI D00KTI DRUGCLAS Patented Agent(s) D00KTI DRUGCOMP NTZ LAB LTD [BG] D00KTI DRUGTYPE Small molecular drug D00KTI HIGHSTAT Patented D00KTN DRUG__ID D00KTN D00KTN DRUGCLAS Patented Agent(s) D00KTN DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D00KTN DRUGINCH 1S/C21H22F3N5O2/c22-21(23,24)14-8-7-13(17(11-14)29-9-2-1-3-10-29)12-25-19(30)26-15-5-4-6-16-18(15)28-20(31)27-16/h4-8,11H,1-3,9-10,12H2,(H2,25,26,30)(H2,27,28,31) D00KTN DRUGINKE ILFYSMXXQODUJS-UHFFFAOYSA-N D00KTN DRUGSMIL C1CCN(CC1)C2=C(C=CC(=C2)C(F)(F)F)CNC(=O)NC3=CC=CC4=C3NC(=O)N4 D00KTN DRUGTYPE Small molecular drug D00KTN HIGHSTAT Patented D00KTT DRUG__ID D00KTT D00KTT DRUGCLAS Investigative Drug(s) D00KTT DRUGINCH 1S/C16H15NO2S/c1-11(2)19-16(18)17-12-7-3-5-9-14(12)20-15-10-6-4-8-13(15)17/h3-11H,1-2H3 D00KTT DRUGINKE FFXIYTTZCCARMF-UHFFFAOYSA-N D00KTT DRUGSMIL CC(C)OC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D00KTT DRUGTYPE Small molecular drug D00KTT HIGHSTAT Investigative D00KTV DRUG__ID D00KTV D00KTV DRUGCLAS Clinical Trial Drug(s) D00KTV DRUGCOMP Kadmon D00KTV DRUGINCH 1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+ D00KTV DRUGINKE WUILNKCFCLNXOK-CFBAGHHKSA-N D00KTV DRUGSMIL CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C D00KTV DRUGTYPE Small molecular drug D00KTV HIGHSTAT Phase 2 D00KUD DRUG__ID D00KUD D00KUD DRUGCLAS Discontinued Drug(s) D00KUD DRUGCOMP Adolor D00KUD HIGHSTAT Discontinued in Phase 2 D00KVE DRUG__ID D00KVE D00KVE DRUGCLAS Preclinical Drug(s) D00KVE DRUGCOMP Santen Pharmaceutical Co Ltd D00KVE DRUGINCH 1S/C23H32N2O2/c1-26-22-11-10-21(19-23(22)27-2)12-14-25-17-15-24(16-18-25)13-6-9-20-7-4-3-5-8-20/h3-5,7-8,10-11,19H,6,9,12-18H2,1-2H3 D00KVE DRUGINKE UVSWWUWQVAQPJR-UHFFFAOYSA-N D00KVE DRUGSMIL COC1=C(C=C(C=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3)OC D00KVE DRUGTYPE Small molecular drug D00KVE HIGHSTAT Preclinical D00KVH DRUG__ID D00KVH D00KVH DRUGCLAS Investigative Drug(s) D00KVH DRUGCOMP Isis Pharmaceuticals D00KVH DRUGTYPE Antisense drug D00KVH HIGHSTAT Investigative D00KVO DRUG__ID D00KVO D00KVO DRUGCLAS Approved Drug(s) D00KVO DRUGCOMP GlaxoSmithKline D00KVO DRUGINCH 1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16) D00KVO DRUGINKE HXHWSAZORRCQMX-UHFFFAOYSA-N D00KVO DRUGSMIL CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC D00KVO DRUGTYPE Small molecular drug D00KVO HIGHSTAT Approved D00KVO THERCLAS Antiprotozoal Agents D00KVX DRUG__ID D00KVX D00KVX DRUGCLAS Clinical Trial Drug(s) D00KVX DRUGINCH 1S/C22H19N3O4S/c1-29-21-13-14(6-8-24-21)22(26)16-10-15(11-17(12-16)25-30(2,27)28)18-4-3-5-20-19(18)7-9-23-20/h3-13,23,25H,1-2H3 D00KVX DRUGINKE YUVDELGTFILMBB-UHFFFAOYSA-N D00KVX DRUGSMIL COC1=NC=CC(=C1)C(=O)C2=CC(=CC(=C2)C3=C4C=CNC4=CC=C3)NS(=O)(=O)C D00KVX DRUGTYPE Small molecular drug D00KVX HIGHSTAT Phase 1 D00KWA DRUG__ID D00KWA D00KWA DRUGCLAS Discontinued Drug(s) D00KWA DRUGCOMP Wyeth D00KWA DRUGINCH 1S/C15H25N3O/c1-11(2)16-9-6-10-17-15(19)18-14-12(3)7-5-8-13(14)4/h5,7-8,11,16H,6,9-10H2,1-4H3,(H2,17,18,19) D00KWA DRUGINKE WHJSFPCTWYLZRC-UHFFFAOYSA-N D00KWA DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)NCCCNC(C)C D00KWA DRUGTYPE Small molecular drug D00KWA HIGHSTAT Terminated D00KWF DRUG__ID D00KWF D00KWF DRUGCLAS Preclinical Drug(s) D00KWF DRUGCOMP Botanic Century (Beijing) Co Ltd D00KWF HIGHSTAT Preclinical D00KWL DRUG__ID D00KWL D00KWL DRUGCLAS Investigative Drug(s) D00KWL DRUGINCH 1S/C29H30N2O3/c1-23-22-31(28(33)30-27(23)32)20-12-5-13-21-34-29(24-14-6-2-7-15-24,25-16-8-3-9-17-25)26-18-10-4-11-19-26/h2-4,6-11,14-19,22H,5,12-13,20-21H2,1H3,(H,30,32,33) D00KWL DRUGINKE SLJLMYFAIDHROH-UHFFFAOYSA-N D00KWL DRUGSMIL CC1=CN(C(=O)NC1=O)CCCCCOC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D00KWL DRUGTYPE Small molecular drug D00KWL HIGHSTAT Investigative D00KXJ DRUG__ID D00KXJ D00KXJ DRUGCLAS Patented Agent(s) D00KXJ DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNITHE REGENTS OF THE UNIVERSITY OF CALIFORNIA HE, Biao FUJII, Naoaki YOU, Liang XU, Zhidong JABLONS, David M D00KXJ DRUGTYPE Small molecular drug D00KXJ HIGHSTAT Patented D00KXO DRUG__ID D00KXO D00KXO DRUGCLAS Clinical Trial Drug(s) D00KXO DRUGCOMP Perosphere Danbury, CT D00KXO DRUGINCH 1S/C22H48N12O2/c23-17(5-1-7-31-21(25)26)19(35)29-9-3-11-33-13-15-34(16-14-33)12-4-10-30-20(36)18(24)6-2-8-32-22(27)28/h17-18H,1-16,23-24H2,(H,29,35)(H,30,36)(H4,25,26,31)(H4,27,28,32)/t17-,18-/m0/s1 D00KXO DRUGINKE HRDUUSCYRPOMSO-ROUUACIJSA-N D00KXO DRUGSMIL C1CN(CCN1CCCNC(=O)C(CCCN=C(N)N)N)CCCNC(=O)C(CCCN=C(N)N)N D00KXO HIGHSTAT Phase 2 D00KXQ DRUG__ID D00KXQ D00KXQ DRUGCLAS Discontinued Drug(s) D00KXQ DRUGCOMP Fournier Pharma D00KXQ HIGHSTAT Terminated D00KXZ DRUG__ID D00KXZ D00KXZ DRUGCLAS Investigative Drug(s) D00KXZ DRUGINCH 1S/C18H28Cl2NO3P/c1-13(15-7-8-17(19)18(20)9-15)21-10-16(22)12-25(23,24)11-14-5-3-2-4-6-14/h7-9,13-14,16,21-22H,2-6,10-12H2,1H3,(H,23,24)/t13-,16-/m0/s1 D00KXZ DRUGINKE JGGVBBYJRQOPPA-BBRMVZONSA-N D00KXZ DRUGSMIL CC(C1=CC(=C(C=C1)Cl)Cl)NCC(CP(=O)(CC2CCCCC2)O)O D00KXZ DRUGTYPE Small molecular drug D00KXZ HIGHSTAT Investigative D00KZF DRUG__ID D00KZF D00KZF DRUGCLAS Discontinued Drug(s) D00KZF DRUGINCH 1S/C22H31N3O3/c1-28-19-7-3-2-6-18(19)24-13-10-23(11-14-24)12-15-25-20(26)16-22(17-21(25)27)8-4-5-9-22/h2-3,6-7H,4-5,8-17H2,1H3 D00KZF DRUGINKE AYYCFGDXLUPJAQ-UHFFFAOYSA-N D00KZF DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O D00KZF DRUGTYPE Small molecular drug D00KZF HIGHSTAT Terminated D00KZO DRUG__ID D00KZO D00KZO DRUGCLAS Investigative Drug(s) D00KZO DRUGINCH 1S/C25H28O4/c1-14(2)5-7-16-11-19-20-13-28-24-17(8-6-15(3)4)21(26)10-9-18(24)25(20)29-23(19)12-22(16)27/h5-6,9-12,20,25-27H,7-8,13H2,1-4H3/t20-,25-/m0/s1 D00KZO DRUGINKE SAXBNTXROWQAKX-CPJSRVTESA-N D00KZO DRUGSMIL CC(=CCC1=CC2=C(C=C1O)OC3C2COC4=C3C=CC(=C4CC=C(C)C)O)C D00KZO DRUGTYPE Small molecular drug D00KZO HIGHSTAT Investigative D00LAA DRUG__ID D00LAA D00LAA DRUGCLAS Investigative Drug(s) D00LAA DRUGCOMP Vantia Therapeutics D00LAA HIGHSTAT Investigative D00LAR DRUG__ID D00LAR D00LAR DRUGCLAS Investigative Drug(s) D00LAR DRUGINCH 1S/C26H31N7O3S/c1-26(2,3)30-24(34)17-33(37(35,36)25-7-5-6-10-29-25)21-12-20-11-19(13-27)8-9-23(20)32(15-21)16-22-14-28-18-31(22)4/h5-11,14,18,21H,12,15-17H2,1-4H3,(H,30,34) D00LAR DRUGINKE BRCRPMJRHQPZEZ-UHFFFAOYSA-N D00LAR DRUGSMIL CC(C)(C)NC(=O)CN(C1CC2=C(C=CC(=C2)C#N)N(C1)CC3=CN=CN3C)S(=O)(=O)C4=CC=CC=N4 D00LAR DRUGTYPE Small molecular drug D00LAR HIGHSTAT Investigative D00LBC DRUG__ID D00LBC D00LBC COMPCLAS Triazole gold complexes D00LBC DRUGCLAS Patented Agent(s) D00LBC DRUGTYPE Small molecular drug D00LBC HIGHSTAT Patented D00LBD DRUG__ID D00LBD D00LBD DRUGCLAS Discontinued Drug(s) D00LBD DRUGINCH 1S/C18H25N5O4/c1-11(25-2)17(24)22-5-7-23(8-6-22)18-20-13-10-15(27-4)14(26-3)9-12(13)16(19)21-18/h9-11H,5-8H2,1-4H3,(H2,19,20,21) D00LBD DRUGINKE YEOTYALSMRNXLJ-UHFFFAOYSA-N D00LBD DRUGSMIL CC(C(=O)N1CCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC)OC D00LBD DRUGTYPE Small molecular drug D00LBD HIGHSTAT Discontinued in Phase 3 D00LBX DRUG__ID D00LBX D00LBX DRUGCLAS Investigative Drug(s) D00LBX DRUGINCH 1S/C20H17NO6/c1-21-5-4-10-6-14-15(25-8-24-14)7-12(10)17(21)18-11-2-3-13-19(26-9-23-13)16(11)20(22)27-18/h2-3,6-7,17-18H,4-5,8-9H2,1H3/t17-,18+/m0/s1 D00LBX DRUGINKE IYGYMKDQCDOMRE-ZWKOTPCHSA-N D00LBX DRUGSMIL CN1CCC2=CC3=C(C=C2C1C4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3 D00LBX DRUGTYPE Small molecular drug D00LBX HIGHSTAT Investigative D00LCE DRUG__ID D00LCE D00LCE DRUGCLAS Investigative Drug(s) D00LCE DRUGINCH 1S/C12H11F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,7,10,18H,1H3,(H,17,19)/t7-,10-/m1/s1 D00LCE DRUGINKE YODXEQNROKSLLQ-GMSGAONNSA-N D00LCE DRUGSMIL CC(C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O D00LCE DRUGTYPE Small molecular drug D00LCE HIGHSTAT Investigative D00LCT DRUG__ID D00LCT D00LCT DRUGCLAS Discontinued Drug(s) D00LCT DRUGCOMP Merck KGaA D00LCT DRUGINCH 1S/C17H17N3O4/c1-17(2)16(22)15(23-13-6-7-14(21)20(3)19-13)11-8-10(9-18)4-5-12(11)24-17/h4-8,15-16,22H,1-3H3 D00LCT DRUGINKE RIBYSHCVSQIIJE-UHFFFAOYSA-N D00LCT DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)OC3=NN(C(=O)C=C3)C)O)C D00LCT HIGHSTAT Discontinued in Phase 1 D00LDI DRUG__ID D00LDI D00LDI DRUGCLAS Investigative Drug(s) D00LDI DRUGCOMP DNAVEC Corp D00LDI HIGHSTAT Investigative D00LEN DRUG__ID D00LEN D00LEN DRUGCLAS Investigative Drug(s) D00LEN DRUGTYPE siRNA drug D00LEN HIGHSTAT Investigative D00LEQ DRUG__ID D00LEQ D00LEQ DRUGCLAS Investigative Drug(s) D00LEQ DRUGINCH 1S/C11H14F3NO8/c12-11(13,14)10(22)15-6-3(17)1-5(9(20)21)23-8(6)7(19)4(18)2-16/h1,3-4,6-8,16-19H,2H2,(H,15,22)(H,20,21)/t3-,4-,6+,7+,8?/m0/s1 D00LEQ DRUGINKE GEGPMWUYMRCINJ-DELVFIHMSA-N D00LEQ DRUGSMIL C1=C(OC(C(C1O)NC(=O)C(F)(F)F)C(C(CO)O)O)C(=O)O D00LEQ DRUGTYPE Small molecular drug D00LEQ HIGHSTAT Investigative D00LFB DRUG__ID D00LFB D00LFB DRUGCLAS Approved Drug(s) D00LFB DRUGINCH 1S/C17H21NO3/c1-12(17(21)14-4-8-16(20)9-5-14)18-11-10-13-2-6-15(19)7-3-13/h2-9,12,17-21H,10-11H2,1H3/t12-,17-/m0/s1 D00LFB DRUGINKE IOVGROKTTNBUGK-SJCJKPOMSA-N D00LFB DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O D00LFB DRUGTYPE Small molecular drug D00LFB HIGHSTAT Approved D00LFB THERCLAS Sympathomimetics D00LFX DRUG__ID D00LFX D00LFX DRUGCLAS Investigative Drug(s) D00LFX DRUGINCH 1S/C18H25NO4S/c1-18-9-8-14-13-5-3-12(20)10-11(13)2-4-15(14)16(18)6-7-17(18)23-24(19,21)22/h3,5,10,14-17,20H,2,4,6-9H2,1H3,(H2,19,21,22)/t14-,15-,16+,17+,18+/m1/s1 D00LFX DRUGINKE NALROBPVVYUESB-ZBRFXRBCSA-N D00LFX DRUGSMIL CC12CCC3C(C1CCC2OS(=O)(=O)N)CCC4=C3C=CC(=C4)O D00LFX DRUGTYPE Small molecular drug D00LFX HIGHSTAT Investigative D00LGA DRUG__ID D00LGA D00LGA DRUGCLAS Clinical Trial Drug(s) D00LGA DRUGCOMP ZymoGenetics Inc D00LGA DRUGTYPE Antibody D00LGA HIGHSTAT Phase 2 D00LGR DRUG__ID D00LGR D00LGR DRUGCLAS Clinical Trial Drug(s) D00LGR DRUGCOMP Tolero Pharmaceuticals Lehi, UT D00LGR DRUGINCH 1S/C24H30ClN7O2S/c1-30(2)35(33,34)22-7-5-4-6-21(22)28-23-20(25)16-26-24(29-23)27-19-10-8-18(9-11-19)17-32-14-12-31(3)13-15-32/h4-11,16H,12-15,17H2,1-3H3,(H2,26,27,28,29) D00LGR DRUGINKE YUAALFPUEOYPNX-UHFFFAOYSA-N D00LGR DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)N(C)C)Cl D00LGR HIGHSTAT Phase 1/2 D00LHF DRUG__ID D00LHF D00LHF DRUGCLAS Clinical Trial Drug(s) D00LHF DRUGCOMP Gilead Sciences Inc D00LHF DRUGINCH 1S/C21H35N8O6P/c1-5-34-19(30)13(3)27-36(32,28-14(4)20(31)35-6-2)12-33-10-9-29-11-23-16-17(24-15-7-8-15)25-21(22)26-18(16)29/h11,13-15H,5-10,12H2,1-4H3,(H2,27,28,32)(H3,22,24,25,26)/t13-,14-/m0/s1 D00LHF DRUGINKE ANSPEDQTHURSFQ-KBPBESRZSA-N D00LHF DRUGSMIL CCOC(=O)C(C)NP(=O)(COCCN1C=NC2=C(N=C(N=C21)N)NC3CC3)NC(C)C(=O)OCC D00LHF DRUGTYPE Small molecular drug D00LHF HIGHSTAT Phase 1/2 D00LHI DRUG__ID D00LHI D00LHI DRUADIID 800023532 D00LHI DRUGCLAS Clinical Trial Drug(s) D00LHI HIGHSTAT Phase 2 D00LHN DRUG__ID D00LHN D00LHN DRUGCLAS Investigative Drug(s) D00LHN HIGHSTAT Investigative D00LHS DRUG__ID D00LHS D00LHS DRUGCLAS Investigative Drug(s) D00LHS DRUGINCH 1S/C33H35NO6S/c1-20(2)25-11-7-6-10-21(25)18-22-19-26(30(36)31(37)29(22)35)32(38)34-23-14-16-24(17-15-23)41(39,40)28-13-9-8-12-27(28)33(3,4)5/h6-17,19-20,35-37H,18H2,1-5H3,(H,34,38) D00LHS DRUGINKE PQAPVTKIEGUPRN-UHFFFAOYSA-N D00LHS DRUGSMIL CC(C)C1=CC=CC=C1CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4C(C)(C)C D00LHS DRUGTYPE Small molecular drug D00LHS HIGHSTAT Investigative D00LHT DRUG__ID D00LHT D00LHT DRUGCLAS Patented Agent(s) D00LHT DRUGINCH 1S/C17H20ClF2N3O2S/c1-11-16(12(2)22-21-11)26(24,25)23-7-5-17(20,6-8-23)10-13-3-4-14(18)9-15(13)19/h3-4,9H,5-8,10H2,1-2H3,(H,21,22) D00LHT DRUGINKE RXIULEDXXPGKEE-UHFFFAOYSA-N D00LHT DRUGSMIL CC1=C(C(=NN1)C)S(=O)(=O)N2CCC(CC2)(CC3=C(C=C(C=C3)Cl)F)F D00LHT DRUGTYPE Small molecular drug D00LHT HIGHSTAT Patented D00LJF DRUG__ID D00LJF D00LJF DRUGCLAS Clinical Trial Drug(s) D00LJF DRUGCOMP DAVA Pharmaceuticals; IntelGenx D00LJF HIGHSTAT Phase 2 D00LLI DRUG__ID D00LLI D00LLI DRUGCLAS Discontinued Drug(s) D00LLI DRUGCOMP Let's Talk Recovery Inc D00LLI HIGHSTAT Discontinued in Phase 2 D00LLN DRUG__ID D00LLN D00LLN DRUGCLAS Patented Agent(s) D00LLN DRUGCOMP KARUS THERAPEUTICS LTD D00LLN DRUGTYPE Small molecular drug D00LLN HIGHSTAT Patented D00LLO DRUG__ID D00LLO D00LLO DRUGCLAS Investigative Drug(s) D00LLO DRUGINCH 1S/C33H41N5O4/c1-21-16-26(39)17-22(2)27(21)19-28(35)33(42)38-20-24-11-7-6-10-23(24)18-30(38)32(41)37-29(14-8-9-15-34)31(40)36-25-12-4-3-5-13-25/h3-7,10-13,16-17,28-30,39H,8-9,14-15,18-20,34-35H2,1-2H3,(H,36,40)(H,37,41) D00LLO DRUGINKE RTMKKGXDPBYWCA-UHFFFAOYSA-N D00LLO DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCN)C(=O)NC4=CC=CC=C4)N)C)O D00LLO DRUGTYPE Small molecular drug D00LLO HIGHSTAT Investigative D00LMA DRUG__ID D00LMA D00LMA COMPCLAS Heteroaryl-carboxamide derivatives D00LMA DRUGCLAS Patented Agent(s) D00LMA DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D00LMA HIGHSTAT Patented D00LMG DRUG__ID D00LMG D00LMG DRUGCLAS Investigative Drug(s) D00LMG DRUGINCH 1S/C15H10O6/c16-8-3-1-7(2-4-8)11-5-9(17)13-12(21-11)6-10(18)14(19)15(13)20/h1-6,16,18-20H D00LMG DRUGINKE JVXZRQGOGOXCEC-UHFFFAOYSA-N D00LMG DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O)O D00LMG DRUGTYPE Small molecular drug D00LMG HIGHSTAT Investigative D00LMR DRUG__ID D00LMR D00LMR DRUGCLAS Investigative Drug(s) D00LMR DRUGCOMP Applied Protein Sciences LLC D00LMR HIGHSTAT Investigative D00LMT DRUG__ID D00LMT D00LMT DRUGCLAS Investigative Drug(s) D00LMT DRUGINCH 1S/C18H28N2/c1-16-5-7-17(8-6-16)15-19-13-9-18(10-14-19)20-11-3-2-4-12-20/h5-8,18H,2-4,9-15H2,1H3 D00LMT DRUGINKE XJYLZLHTPACMIL-UHFFFAOYSA-N D00LMT DRUGSMIL CC1=CC=C(C=C1)CN2CCC(CC2)N3CCCCC3 D00LMT DRUGTYPE Small molecular drug D00LMT HIGHSTAT Investigative D00LMY DRUG__ID D00LMY D00LMY DRUGCLAS Investigative Drug(s) D00LMY DRUGCOMP Roche Holding AG D00LMY HIGHSTAT Investigative D00LNK DRUG__ID D00LNK D00LNK DRUGCLAS Investigative Drug(s) D00LNK DRUGINCH 1S/C19H20F3NO3/c1-23(13-18(24)25)12-11-17(14-5-3-2-4-6-14)26-16-9-7-15(8-10-16)19(20,21)22/h2-10,17H,11-13H2,1H3,(H,24,25)/t17-/m1/s1 D00LNK DRUGINKE KZWQAWBTWNPFPW-QGZVFWFLSA-N D00LNK DRUGSMIL CN(CCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F)CC(=O)O D00LNK DRUGTYPE Small molecular drug D00LNK HIGHSTAT Investigative D00LNW DRUG__ID D00LNW D00LNW DRUGCLAS Clinical Trial Drug(s) D00LNW DRUGCOMP Karyopharm therapeutics D00LNW DRUGINCH 1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1- D00LNW DRUGINKE DEVSOMFAQLZNKR-RJRFIUFISA-N D00LNW DRUGSMIL C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D00LNW DRUGTYPE Small molecular drug D00LNW HIGHSTAT Phase 3 D00LOB DRUG__ID D00LOB D00LOB DRUGCLAS Clinical Trial Drug(s) D00LOB DRUGINCH 1S/C18H23F2N7O3/c1-12-9-24-15(25-11-18(19,20)13-5-3-2-4-6-13)16(29)27(12)10-14(28)23-7-8-30-26-17(21)22/h2-6,9H,7-8,10-11H2,1H3,(H,23,28)(H,24,25)(H4,21,22,26) D00LOB DRUGINKE IDCKXHIGLKQWMM-UHFFFAOYSA-N D00LOB DRUGSMIL CC1=CN=C(C(=O)N1CC(=O)NCCON=C(N)N)NCC(C2=CC=CC=C2)(F)F D00LOB DRUGTYPE Small molecular drug D00LOB HIGHSTAT Phase 1 D00LOL DRUG__ID D00LOL D00LOL DRUGCLAS Investigative Drug(s) D00LOL DRUGINCH 1S/C15H13N5O/c1-10-4-6-11(7-5-10)14(21)20-15(16)18-13(19-20)12-3-2-8-17-9-12/h2-9H,1H3,(H2,16,18,19) D00LOL DRUGINKE BIEYFOHSWAIQDF-UHFFFAOYSA-N D00LOL DRUGSMIL CC1=CC=C(C=C1)C(=O)N2C(=NC(=N2)C3=CN=CC=C3)N D00LOL DRUGTYPE Small molecular drug D00LOL HIGHSTAT Investigative D00LPZ DRUG__ID D00LPZ D00LPZ DRUGCLAS Investigative Drug(s) D00LPZ DRUGCOMP BioTie Therapies Corp D00LPZ HIGHSTAT Investigative D00LRC DRUG__ID D00LRC D00LRC DRUGCLAS Investigative Drug(s) D00LRC DRUGINCH 1S/C16H19NO2/c1-18-15-8-12-7-13(11-5-3-4-6-11)10-17-14(12)9-16(15)19-2/h7-11H,3-6H2,1-2H3 D00LRC DRUGINKE BYQWDMZNUPGMNG-UHFFFAOYSA-N D00LRC DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3CCCC3 D00LRC DRUGTYPE Small molecular drug D00LRC HIGHSTAT Investigative D00LRP DRUG__ID D00LRP D00LRP DRUGCLAS Clinical Trial Drug(s) D00LRP DRUGCOMP Pieris AG D00LRP HIGHSTAT Phase 1/2 D00LSD DRUG__ID D00LSD D00LSD DRUGCLAS Investigative Drug(s) D00LSD DRUGCOMP Genfit SA D00LSD HIGHSTAT Investigative D00LSI DRUG__ID D00LSI D00LSI DRUGCLAS Clinical Trial Drug(s) D00LSI DRUGCOMP 4SC AG D00LSI DRUGINCH 1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25) D00LSI DRUGINKE XPRDUGXOWVXZLL-UHFFFAOYSA-N D00LSI DRUGSMIL COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F D00LSI DRUGTYPE Small molecular drug D00LSI HIGHSTAT Phase 2 D00LSM DRUG__ID D00LSM D00LSM DRUGCLAS Investigative Drug(s) D00LSM DRUGCOMP Isis Pharmaceuticals D00LSM DRUGTYPE Antisense drug D00LSM HIGHSTAT Investigative D00LSQ DRUG__ID D00LSQ D00LSQ DRUGCLAS Patented Agent(s) D00LSQ DRUGTYPE Small molecular drug D00LSQ HIGHSTAT Patented D00LSW DRUG__ID D00LSW D00LSW DRUGCLAS Clinical Trial Drug(s) D00LSW DRUGCOMP Ferring Pharmaceuticals Inc D00LSW DRUGINCH 1S/C23H21ClFN5O2/c1-29-21-16(11-27-29)12-30(20-7-6-17(24)9-19(20)28-21)23(32)14-4-5-15(18(25)8-14)10-26-22(31)13-2-3-13/h4-9,11,13,28H,2-3,10,12H2,1H3,(H,26,31) D00LSW DRUGINKE VOEZSPDOPDPGSY-UHFFFAOYSA-N D00LSW DRUGSMIL CN1C2=C(CN(C3=C(N2)C=C(C=C3)Cl)C(=O)C4=CC(=C(C=C4)CNC(=O)C5CC5)F)C=N1 D00LSW DRUGTYPE Small molecular drug D00LSW HIGHSTAT Phase 2 D00LSZ DRUG__ID D00LSZ D00LSZ DRUGCLAS Investigative Drug(s) D00LSZ DRUGINCH 1S/C18H23NO3/c20-17(9-3-1-2-4-10-18(21)19-22)16-12-11-14-7-5-6-8-15(14)13-16/h5-8,11-13,17,20,22H,1-4,9-10H2,(H,19,21) D00LSZ DRUGINKE JWCSCYWHCCHTEF-UHFFFAOYSA-N D00LSZ DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(CCCCCCC(=O)NO)O D00LSZ DRUGTYPE Small molecular drug D00LSZ HIGHSTAT Investigative D00LVA DRUG__ID D00LVA D00LVA DRUGCLAS Discontinued Drug(s) D00LVA DRUGCOMP Sanofi-Aventis D00LVA DRUGINCH 1S/C13H16N2O/c1-2-11-10(14-5-1)8-13-4-7-15(9-13)6-3-12(13)16-11/h1-2,5,12H,3-4,6-9H2/t12-,13+/m0/s1 D00LVA DRUGINKE SUPRUPHAEXPGPF-QWHCGFSZSA-N D00LVA DRUGSMIL C1CN2CCC3(C2)C1OC4=C(C3)N=CC=C4 D00LVA DRUGTYPE Small molecular drug D00LVA HIGHSTAT Discontinued in Phase 3 D00LVD DRUG__ID D00LVD D00LVD DRUGCLAS Patented Agent(s) D00LVD DRUGINCH 1S/C30H33F2N7O2/c1-6-41-29-24(8-7-13-33-29)25-14-26(28-27(35-25)20(4)36-39(28)19(2)3)37(16-21-9-11-23(40-5)12-10-21)17-22-15-34-38(18-22)30(31)32/h7-15,18-19,30H,6,16-17H2,1-5H3 D00LVD DRUGINKE UXTFTMXAFOTATJ-UHFFFAOYSA-N D00LVD DRUGSMIL CCOC1=C(C=CC=N1)C2=NC3=C(C(=C2)N(CC4=CC=C(C=C4)OC)CC5=CN(N=C5)C(F)F)N(N=C3C)C(C)C D00LVD DRUGTYPE Small molecular drug D00LVD HIGHSTAT Patented D00LVW DRUG__ID D00LVW D00LVW DRUGCLAS Investigative Drug(s) D00LVW DRUGINCH 1S/C53H82N14O8/c1-3-31(2)43(49(74)62-38(44(55)69)13-7-8-20-54)67-46(71)39(14-9-21-60-51(56)57)63-47(72)42(27-33-16-18-37(68)19-17-33)65-48(73)41(26-32-11-5-4-6-12-32)64-45(70)40(15-10-22-61-52(58)59)66-50(75)53-28-34-23-35(29-53)25-36(24-34)30-53/h4-6,11-12,16-19,31,34-36,38-43,68H,3,7-10,13-15,20-30,54H2,1-2H3,(H2,55,69)(H,62,74)(H,63,72)(H,64,70)(H,65,73)(H,66,75)(H,67,71)(H4,56,57,60)(H4,58,59,61)/t31-,34?,35?,36?,38-,39-,40-,41-,42-,43-,53?/m0/s1 D00LVW DRUGINKE CHQPBFJDZBBZJD-OGHQQVQQSA-N D00LVW DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C34CC5CC(C3)CC(C5)C4 D00LVW HIGHSTAT Investigative D00LWD DRUG__ID D00LWD D00LWD DRUGCLAS Investigative Drug(s) D00LWD DRUGCOMP Angelini Pharmaceuticals SpA D00LWD HIGHSTAT Investigative D00LWF DRUG__ID D00LWF D00LWF DRUGCLAS Discontinued Drug(s) D00LWF DRUGCOMP LEO Pharma A/S D00LWF DRUGINCH 1S/C12H17N5/c1-4-12(2,3)17-11(15-9-13)16-10-6-5-7-14-8-10/h5-8H,4H2,1-3H3,(H2,15,16,17) D00LWF DRUGINKE HKZNADVVGXKQDL-UHFFFAOYSA-N D00LWF DRUGSMIL CCC(C)(C)N=C(NC#N)NC1=CN=CC=C1 D00LWF DRUGTYPE Small molecular drug D00LWF HIGHSTAT Discontinued in Phase 2 D00LWG DRUG__ID D00LWG D00LWG DRUGCLAS Investigative Drug(s) D00LWG DRUGINCH 1S/C51H70F3N15O10/c1-6-28(4)41(66-43(73)35(21-30-13-17-33(70)18-14-30)62-45(75)40(27(2)3)65-42(72)34(61-39(71)25-57-5)9-7-19-59-49(55)56)46(76)63-36(23-32-24-58-26-60-32)47(77)69-20-8-10-38(69)44(74)64-37(48(78)79)22-29-11-15-31(16-12-29)50(67-68-50)51(52,53)54/h11-18,24,26-28,34-38,40-41,57,70H,6-10,19-23,25H2,1-5H3,(H,58,60)(H,61,71)(H,62,75)(H,63,76)(H,64,74)(H,65,72)(H,66,73)(H,78,79)(H4,55,56,59)/t28-,34-,35-,36-,37-,38-,40-,41-/m0/s1 D00LWG DRUGINKE KSJIPXWEUUGTIY-LNEAKYCGSA-N D00LWG DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=C(C=C3)C4(N=N4)C(F)(F)F)C(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D00LWG HIGHSTAT Investigative D00LWQ DRUG__ID D00LWQ D00LWQ DRUGCLAS Investigative Drug(s) D00LWQ DRUGINCH 1S/C16H13BrO3/c1-20-16-9-7-11(10-13(16)17)6-8-15(19)12-4-2-3-5-14(12)18/h2-10,18H,1H3/b8-6+ D00LWQ DRUGINKE KXSKRIQLDQIBNJ-SOFGYWHQSA-N D00LWQ DRUGSMIL COC1=C(C=C(C=C1)C=CC(=O)C2=CC=CC=C2O)Br D00LWQ DRUGTYPE Small molecular drug D00LWQ HIGHSTAT Investigative D00LWR DRUG__ID D00LWR D00LWR DRUGCLAS Preclinical Drug(s) D00LWR DRUGCOMP BioVitrum D00LWR HIGHSTAT Preclinical D00LWS DRUG__ID D00LWS D00LWS DRUGCLAS Discontinued Drug(s) D00LWS DRUGCOMP Ono Pharmaceutical Co Ltd D00LWS DRUGINCH 1S/C21H32O4/c22-19(15-6-2-3-7-15)10-9-17-18-12-14(5-1-4-8-21(24)25)11-16(18)13-20(17)23/h5,9-10,15-20,22-23H,1-4,6-8,11-13H2,(H,24,25)/b10-9+,14-5+/t16-,17+,18-,19+,20+/m0/s1 D00LWS DRUGINKE DKLGLHQHLFISGJ-YLBFUXKPSA-N D00LWS DRUGSMIL C1CCC(C1)C(C=CC2C(CC3C2CC(=CCCCC(=O)O)C3)O)O D00LWS DRUGTYPE Small molecular drug D00LWS HIGHSTAT Discontinued in Phase 3 D00LWX DRUG__ID D00LWX D00LWX DRUGCLAS Discontinued Drug(s) D00LWX DRUGCOMP GD Searle & Co D00LWX HIGHSTAT Terminated D00LWY DRUG__ID D00LWY D00LWY DRUGCLAS Patented Agent(s) D00LWY DRUGCOMP X-RX DISCOVERY, INC D00LWY DRUGTYPE Small molecular drug D00LWY HIGHSTAT Patented D00LXB DRUG__ID D00LXB D00LXB DRUGCLAS Investigative Drug(s) D00LXB DRUGCOMP Aridis Pharmaceuticals LLC D00LXB HIGHSTAT Investigative D00LXD DRUG__ID D00LXD D00LXD DRUGCLAS Discontinued Drug(s) D00LXD DRUGCOMP Intarcia Therapeutics D00LXD HIGHSTAT Discontinued in Phase 2 D00LXH DRUG__ID D00LXH D00LXH DRUGCLAS Investigative Drug(s) D00LXH DRUGINCH 1S/C11H13BrN2/c1-8(13)7-14-5-4-9-6-10(12)2-3-11(9)14/h2-6,8H,7,13H2,1H3 D00LXH DRUGINKE UOWVUNAMIYCETC-UHFFFAOYSA-N D00LXH DRUGSMIL CC(CN1C=CC2=C1C=CC(=C2)Br)N D00LXH DRUGTYPE Small molecular drug D00LXH HIGHSTAT Investigative D00LYE DRUG__ID D00LYE D00LYE DRUGCLAS Investigative Drug(s) D00LYE DRUGCOMP Gamida Cell Ltd D00LYE HIGHSTAT Investigative D00LYI DRUG__ID D00LYI D00LYI DRUGCLAS Investigative Drug(s) D00LYI DRUGINCH 1S/C26H22N2O2/c1-18(19-8-3-2-4-9-19)28-26(30)21-11-7-12-22(16-21)27-17-24-23-13-6-5-10-20(23)14-15-25(24)29/h2-18,29H,1H3,(H,28,30) D00LYI DRUGINKE USDKSBHPFQRCGR-UHFFFAOYSA-N D00LYI DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=CC(=CC=C2)N=CC3=C(C=CC4=CC=CC=C43)O D00LYI DRUGTYPE Small molecular drug D00LYI HIGHSTAT Investigative D00LYW DRUG__ID D00LYW D00LYW DRUGCLAS Discontinued Drug(s) D00LYW DRUGCOMP Burroughs Wellcome Inc D00LYW DRUGINCH 1S/C10H7Cl3N4.C2H6O3S/c11-4-1-5(8(13)7(12)2-4)6-3-16-10(15)17-9(6)14;1-2-6(3,4)5/h1-3H,(H4,14,15,16,17);2H2,1H3,(H,3,4,5) D00LYW DRUGINKE NVKJAOGJEDODFZ-UHFFFAOYSA-N D00LYW DRUGSMIL CCS(=O)(=O)O.C1=C(C=C(C(=C1C2=CN=C(N=C2N)N)Cl)Cl)Cl D00LYW DRUGTYPE Small molecular drug D00LYW HIGHSTAT Terminated D00LZJ DRUG__ID D00LZJ D00LZJ DRUGCLAS Investigative Drug(s) D00LZJ DRUGINCH 1S/C22H36O/c1-4-5-6-7-8-16-22(2,3)20-14-12-18(13-15-20)19-10-9-11-21(23)17-19/h12-15,19,21,23H,4-11,16-17H2,1-3H3/t19-,21-/m1/s1 D00LZJ DRUGINKE SHSCKELICBAALI-TZIWHRDSSA-N D00LZJ DRUGSMIL CCCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D00LZJ DRUGTYPE Small molecular drug D00LZJ HIGHSTAT Investigative D00LZM DRUG__ID D00LZM D00LZM DRUGCLAS Investigative Drug(s) D00LZM HIGHSTAT Investigative D00LZO DRUG__ID D00LZO D00LZO DRUGCLAS Investigative Drug(s) D00LZO DRUGCOMP Cellzome D00LZO HIGHSTAT Investigative D00LZS DRUG__ID D00LZS D00LZS DRUGCLAS Investigative Drug(s) D00LZS DRUGINCH 1S/C39H49N7O10S/c1-20(2)13-29(44-36(51)31(21(3)4)46-34(49)28(41)18-42-33(48)23-14-24(39(55)56)16-25(40)15-23)35(50)45-30(19-57-27-11-6-5-7-12-27)32(47)37(52)43-26-10-8-9-22(17-26)38(53)54/h5-12,14-17,20-21,28-32,47H,13,18-19,40-41H2,1-4H3,(H,42,48)(H,43,52)(H,44,51)(H,45,50)(H,46,49)(H,53,54)(H,55,56)/t28-,29-,30-,31-,32+/m0/s1 D00LZS DRUGINKE DFWUMZBCWONAOR-QEUNAIBPSA-N D00LZS DRUGSMIL CC(C)CC(C(=O)NC(CSC1=CC=CC=C1)C(C(=O)NC2=CC=CC(=C2)C(=O)O)O)NC(=O)C(C(C)C)NC(=O)C(CNC(=O)C3=CC(=CC(=C3)N)C(=O)O)N D00LZS DRUGTYPE Small molecular drug D00LZS HIGHSTAT Investigative D00LZY DRUG__ID D00LZY D00LZY DRUGCLAS Investigative Drug(s) D00LZY DRUGCOMP Thrasos Therapeutics Inc D00LZY HIGHSTAT Investigative D00MAM DRUG__ID D00MAM D00MAM DRUGCLAS Investigative Drug(s) D00MAM DRUGCOMP Amgen Inc D00MAM HIGHSTAT Investigative D00MAN DRUG__ID D00MAN D00MAN DRUGCLAS Clinical Trial Drug(s) D00MAN DRUGCOMP Glenmark Pharmaceuticals Ltd D00MAN DRUGINCH 1S/C22H20FN3O2/c23-15-5-6-20-17(11-15)19(12-22(28-20)8-2-9-22)26-21(27)25-18-4-1-3-14-13-24-10-7-16(14)18/h1,3-7,10-11,13,19H,2,8-9,12H2,(H2,25,26,27)/t19-/m1/s1 D00MAN DRUGINKE JADKHWDNSKIILG-LJQANCHMSA-N D00MAN DRUGSMIL C1CC2(C1)CC(C3=C(O2)C=CC(=C3)F)NC(=O)NC4=CC=CC5=C4C=CN=C5 D00MAN DRUGTYPE Small molecular drug D00MAN HIGHSTAT Phase 1 D00MBG DRUG__ID D00MBG D00MBG DRUGCLAS Investigative Drug(s) D00MBG DRUGINCH 1S/C9H12N2O4S/c1-7-4-5-8(11(12)13)6-9(7)16(14,15)10(2)3/h4-6H,1-3H3 D00MBG DRUGINKE IFIUFCJFLGCQPH-UHFFFAOYSA-N D00MBG DRUGSMIL CC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N(C)C D00MBG DRUGTYPE Small molecular drug D00MBG HIGHSTAT Investigative D00MBR DRUG__ID D00MBR D00MBR DRUGCLAS Clinical Trial Drug(s) D00MBR DRUGCOMP Medarex D00MBR DRUGTYPE Antibody D00MBR HIGHSTAT Phase 2 D00MBY DRUG__ID D00MBY D00MBY DRUGCLAS Clinical Trial Drug(s) D00MBY DRUGCOMP GNT Pharma Co Ltd D00MBY DRUGINCH 1S/C16H14F3NO3/c17-16(18,19)11-3-1-10(2-4-11)7-8-20-12-5-6-14(21)13(9-12)15(22)23/h1-6,9,20-21H,7-8H2,(H,22,23) D00MBY DRUGINKE UTMVACIBQLDZLP-UHFFFAOYSA-N D00MBY DRUGSMIL C1=CC(=CC=C1CCNC2=CC(=C(C=C2)O)C(=O)O)C(F)(F)F D00MBY DRUGTYPE Small molecular drug D00MBY HIGHSTAT Phase 1 D00MCA DRUG__ID D00MCA D00MCA DRUGCLAS Investigative Drug(s) D00MCA DRUGCOMP Michigan Technological University D00MCA HIGHSTAT Investigative D00MCG DRUG__ID D00MCG D00MCG DRUGCLAS Investigative Drug(s) D00MCG DRUGINCH 1S/C17H16N2O3/c20-14-10-16(13-1-2-15-12(9-13)3-4-18-15)22-17(11-14)19-5-7-21-8-6-19/h1-4,9-11,18H,5-8H2 D00MCG DRUGINKE AWODDYAKSFDGCI-UHFFFAOYSA-N D00MCG DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC4=C(C=C3)NC=C4 D00MCG DRUGTYPE Small molecular drug D00MCG HIGHSTAT Investigative D00MCJ DRUG__ID D00MCJ D00MCJ DRUGCLAS Investigative Drug(s) D00MCJ DRUGINCH 1S/C18H12N2O/c21-17-10-9-12-5-1-2-6-13(12)11-14(17)18-19-15-7-3-4-8-16(15)20-18/h1-11H,(H,19,20) D00MCJ DRUGINKE OZPIXWTVOIXFBH-UHFFFAOYSA-N D00MCJ DRUGSMIL C1=CC=C2C=C(C(=O)C=CC2=C1)C3=NC4=CC=CC=C4N3 D00MCJ DRUGTYPE Small molecular drug D00MCJ HIGHSTAT Investigative D00MCY DRUG__ID D00MCY D00MCY DRUGCLAS Investigative Drug(s) D00MCY DRUGCOMP Recordati D00MCY DRUGINCH 1S/C26H33N5O5.ClH/c1-16(2)17-7-6-8-20(33-3)24(17)36-15-23(32)30-9-11-31(12-10-30)26-28-19-14-22(35-5)21(34-4)13-18(19)25(27)29-26;/h6-8,13-14,16H,9-12,15H2,1-5H3,(H2,27,28,29);1H D00MCY DRUGINKE YLPWNPUPMQZIKN-UHFFFAOYSA-N D00MCY DRUGSMIL CC(C)C1=C(C(=CC=C1)OC)OCC(=O)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC.Cl D00MCY DRUGTYPE Small molecular drug D00MCY HIGHSTAT Investigative D00MDP DRUG__ID D00MDP D00MDP DRUGCLAS Approved Drug(s) D00MDP DRUGCOMP Pfizer D00MDP DRUGINCH 1S/C18H21N3O5S2/c1-18(2)16(17(22)20-23)21(11-12-27-18)28(24,25)15-5-3-13(4-6-15)26-14-7-9-19-10-8-14/h3-10,16,23H,11-12H2,1-2H3,(H,20,22)/t16-/m0/s1 D00MDP DRUGINKE YKPYIPVDTNNYCN-INIZCTEOSA-N D00MDP DRUGSMIL CC1(C(N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OC3=CC=NC=C3)C(=O)NO)C D00MDP DRUGTYPE Small molecular drug D00MDP HIGHSTAT Approved D00MDP THERCLAS Anticancer Agents D00MEM DRUG__ID D00MEM D00MEM DRUGCLAS Investigative Drug(s) D00MEM DRUGINCH 1S/C31H34N6O4/c1-18-11-22(38)12-19(2)23(18)14-24(32)31(41)37-17-21-8-4-3-7-20(21)13-27(37)30(40)34-16-29(39)33-15-28-35-25-9-5-6-10-26(25)36-28/h3-12,24,27,38H,13-17,32H2,1-2H3,(H,33,39)(H,34,40)(H,35,36)/t24-,27?/m0/s1 D00MEM DRUGINKE LKKOHYJIXKBADA-BXXZMZEQSA-N D00MEM DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC(=O)NCC4=NC5=CC=CC=C5N4)N)C)O D00MEM DRUGTYPE Small molecular drug D00MEM HIGHSTAT Investigative D00MET DRUG__ID D00MET D00MET DRUGCLAS Investigative Drug(s) D00MET DRUGCOMP Metastatin Pharmaceuticals Inc D00MET HIGHSTAT Investigative D00MEV DRUG__ID D00MEV D00MEV DRUGCLAS Discontinued Drug(s) D00MEV DRUGCOMP Schering-Plough Corp D00MEV DRUGINCH 1S/C28H22O10/c1-9-3-13(29)25-19(37-9)5-11-21(15(31)7-17(33)23(11)27(25)35)22-12-6-20-26(14(30)4-10(2)38-20)28(36)24(12)18(34)8-16(22)32/h5-10,31-36H,3-4H2,1-2H3 D00MEV DRUGINKE JGQBYBXYRUCBQY-UHFFFAOYSA-N D00MEV DRUGSMIL CC1CC(=O)C2=C(O1)C=C3C(=C2O)C(=CC(=C3C4=C(C=C(C5=C(C6=C(C=C54)OC(CC6=O)C)O)O)O)O)O D00MEV DRUGTYPE Small molecular drug D00MEV HIGHSTAT Terminated D00MFA DRUG__ID D00MFA D00MFA DRUGCLAS Investigative Drug(s) D00MFA DRUGINCH 1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1 D00MFA DRUGINKE IAOZJIPTCAWIRG-QWRGUYRKSA-N D00MFA DRUGSMIL COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N D00MFA DRUGTYPE Small molecular drug D00MFA HIGHSTAT Investigative D00MFR DRUG__ID D00MFR D00MFR DRUGCLAS Investigative Drug(s) D00MFR DRUGINCH 1S/C14H14N2O/c1-9-14-11(6-7-16(9)2)12-8-10(17-3)4-5-13(12)15-14/h4-8H,1-3H3/p+1 D00MFR DRUGINKE GKOBEAWUMYEQIP-UHFFFAOYSA-O D00MFR DRUGSMIL CC1=[N+](C=CC2=C1NC3=C2C=C(C=C3)OC)C D00MFR DRUGTYPE Small molecular drug D00MFR HIGHSTAT Investigative D00MFV DRUG__ID D00MFV D00MFV DRUGCLAS Investigative Drug(s) D00MFV DRUGINCH 1S/C9H13N5/c1-3-6(2)14-5-13-7-8(10)11-4-12-9(7)14/h4-6H,3H2,1-2H3,(H2,10,11,12) D00MFV DRUGINKE WUUGZXPFGNZPJO-UHFFFAOYSA-N D00MFV DRUGSMIL CCC(C)N1C=NC2=C(N=CN=C21)N D00MFV DRUGTYPE Small molecular drug D00MFV HIGHSTAT Investigative D00MFW DRUG__ID D00MFW D00MFW DRUGCLAS Patented Agent(s) D00MFW DRUGINCH 1S/C19H13N3O7S2/c23-19-16(10-17(31(27,28)29)15-2-1-7-20-18(15)19)22-21-13-5-3-12-9-14(30(24,25)26)6-4-11(12)8-13/h1-10,23H,(H,24,25,26)(H,27,28,29) D00MFW DRUGINKE XGMFVZOKHBRUTL-UHFFFAOYSA-N D00MFW DRUGSMIL C1=CC2=C(C=C(C(=C2N=C1)O)N=NC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)O)S(=O)(=O)O D00MFW DRUGTYPE Small molecular drug D00MFW HIGHSTAT Patented D00MFY DRUG__ID D00MFY D00MFY DRUGCLAS Discontinued Drug(s) D00MFY DRUGCOMP Scios Inc D00MFY DRUGINCH 1S/C11H22NO5P/c12-10(11(13)14)7-9-4-2-1-3-8(9)5-6-18(15,16)17/h8-10H,1-7,12H2,(H,13,14)(H2,15,16,17) D00MFY DRUGINKE DHJQWBSZKBDBFP-UHFFFAOYSA-N D00MFY DRUGSMIL C1CCC(C(C1)CCP(=O)(O)O)CC(C(=O)O)N D00MFY DRUGTYPE Small molecular drug D00MFY HIGHSTAT Terminated D00MFZ DRUG__ID D00MFZ D00MFZ DRUGCLAS Investigative Drug(s) D00MFZ DRUGINCH 1S/C6H13NO3/c8-3-4-1-7-2-5(9)6(4)10/h4-10H,1-3H2/t4-,5-,6-/m0/s1 D00MFZ DRUGINKE QPYJXFZUIJOGNX-ZLUOBGJFSA-N D00MFZ DRUGSMIL C1C(C(C(CN1)O)O)CO D00MFZ DRUGTYPE Small molecular drug D00MFZ HIGHSTAT Investigative D00MGO DRUG__ID D00MGO D00MGO DRUGCLAS Patented Agent(s) D00MGO DRUGCOMP MERCK SHARP & DOHME CORP D00MGO HIGHSTAT Patented D00MGT DRUG__ID D00MGT D00MGT DRUGCLAS Investigative Drug(s) D00MGT DRUGINCH 1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1 D00MGT DRUGINKE INULNSAIIZKOQE-YOSAUDMPSA-N D00MGT DRUGSMIL CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-] D00MGT DRUGTYPE Small molecular drug D00MGT HIGHSTAT Investigative D00MHP DRUG__ID D00MHP D00MHP DRUGCLAS Clinical Trial Drug(s) D00MHP DRUGINCH 1S/C23H18N2O3/c26-23(27)20-9-2-4-11-22(20)24-17-7-5-8-19(14-17)28-15-18-13-12-16-6-1-3-10-21(16)25-18/h1-14,24H,15H2,(H,26,27) D00MHP DRUGINKE LMPZHLXYBWGGNT-UHFFFAOYSA-N D00MHP DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=CC(=C3)NC4=CC=CC=C4C(=O)O D00MHP DRUGTYPE Small molecular drug D00MHP HIGHSTAT Phase 2 D00MIF DRUG__ID D00MIF D00MIF DRUGCLAS Discontinued Drug(s) D00MIF DRUGCOMP Japan Tobacco Inc D00MIF HIGHSTAT Terminated D00MIG DRUG__ID D00MIG D00MIG DRUADIID CLI-01-ALDR-01448 D00MIG DRUGCLAS Investigative Drug(s) D00MIG DRUGINCH 1S/C17H20N2O4/c1-17(2)16(22)15(19-11(9-20)4-6-14(19)21)12-7-10(8-18)3-5-13(12)23-17/h3,5,7,11,15-16,20,22H,4,6,9H2,1-2H3/t11-,15+,16-/m0/s1 D00MIG DRUGINKE PBEGNZBJXJTFMB-XZJROXQQSA-N D00MIG DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)N3C(CCC3=O)CO)O)C D00MIG HIGHSTAT Investigative D00MIM DRUG__ID D00MIM D00MIM DRUADIID CLI-01-ALDR-08158 D00MIM DRUGCLAS Investigative Drug(s) D00MIM HIGHSTAT Investigative D00MIN DRUG__ID D00MIN D00MIN DRUGCLAS Approved Drug(s) D00MIN DRUGINCH 1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11) D00MIN DRUGINKE KNAHARQHSZJURB-UHFFFAOYSA-N D00MIN DRUGSMIL CCCC1=CC(=O)NC(=S)N1 D00MIN DRUGTYPE Small molecular drug D00MIN HIGHSTAT Approved D00MIN THERCLAS Antithyroid Agents D00MIX DRUG__ID D00MIX D00MIX DRUGCLAS Preclinical Drug(s) D00MIX DRUGCOMP Pfizer D00MIX DRUGINCH 1S/C17H19F3N2O4S/c1-10(6-11-2-4-12(5-3-11)26-8-15(24)25)21-7-14(23)13-9-27-16(22-13)17(18,19)20/h2-5,9-10,14,21,23H,6-8H2,1H3,(H,24,25)/t10-,14+/m1/s1 D00MIX DRUGINKE YVIXXPCJZAUQHJ-YGRLFVJLSA-N D00MIX DRUGSMIL CC(CC1=CC=C(C=C1)OCC(=O)O)NCC(C2=CSC(=N2)C(F)(F)F)O D00MIX HIGHSTAT Preclinical D00MJG DRUG__ID D00MJG D00MJG DRUGCLAS Investigative Drug(s) D00MJG DRUGINCH 1S/C31H39N5O3.ClH/c1-7-8-17-36-29-24(13-10-15-33-29)25(21-11-9-12-22(18-21)39-6)28(30(36)37)35-31(38)34-27-23(19(2)3)14-16-32-26(27)20(4)5;/h9-16,18-20,26,32H,7-8,17H2,1-6H3,(H2,34,35,38);1H D00MJG DRUGINKE UXCQVIIRKWYPHK-UHFFFAOYSA-N D00MJG DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=CNC3C(C)C)C(C)C)C4=CC(=CC=C4)OC.Cl D00MJG DRUGTYPE Small molecular drug D00MJG HIGHSTAT Investigative D00MJI DRUG__ID D00MJI D00MJI DRUGCLAS Clinical Trial Drug(s) D00MJI DRUGCOMP GenentechSouth San Francisco, CA D00MJI HIGHSTAT Phase 1 D00MLE DRUG__ID D00MLE D00MLE DRUGCLAS Investigative Drug(s) D00MLE DRUGINCH 1S/C19H15N3O/c20-14-8-11-17-18(12-14)22-19(21-17)13-6-9-16(10-7-13)23-15-4-2-1-3-5-15/h1-12H,20H2,(H,21,22) D00MLE DRUGINKE YDXHPXOLZYGIGV-UHFFFAOYSA-N D00MLE DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C3=NC4=C(N3)C=C(C=C4)N D00MLE DRUGTYPE Small molecular drug D00MLE HIGHSTAT Investigative D00MLJ DRUG__ID D00MLJ D00MLJ COMPCLAS Pyrazole derivatives D00MLJ DRUGCLAS Patented Agent(s) D00MLJ DRUGCOMP The Ohio State University Research Foundation D00MLJ DRUGTYPE Small molecular drug D00MLJ HIGHSTAT Patented D00MLN DRUG__ID D00MLN D00MLN DRUGCLAS Investigative Drug(s) D00MLN DRUGINCH 1S/C37H40N2O6/c1-38-14-12-24-19-31(42-4)33-21-27(24)28(38)17-23-8-11-30(41-3)32(18-23)44-26-9-6-22(7-10-26)16-29-35-25(13-15-39(29)2)20-34(43-5)36(40)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29+/m0/s1 D00MLN DRUGINKE YJRWQNIRFXVBRB-URLMMPGGSA-N D00MLN DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=CC(=C(C=C7CCN6C)OC)O3)OC)O)OC D00MLN DRUGTYPE Small molecular drug D00MLN HIGHSTAT Investigative D00MLQ DRUG__ID D00MLQ D00MLQ DRUGCLAS Discontinued Drug(s) D00MLQ DRUGCOMP Abbott Laboratories D00MLQ HIGHSTAT Terminated D00MLW DRUG__ID D00MLW D00MLW DRUGCLAS Approved Drug(s) D00MLW DRUGCOMP Ultragenyx D00MLW DRUGINCH 1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3 D00MLW DRUGINKE PJHKBYALYHRYSK-UHFFFAOYSA-N D00MLW DRUGSMIL CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC D00MLW DRUGTYPE Small molecular drug D00MLW HIGHSTAT Approved D00MLX DRUG__ID D00MLX D00MLX DRUGCLAS Clinical Trial Drug(s) D00MLX DRUGCOMP ViiV Healthcare D00MLX DRUGINCH 1S/C20H19F2N3O5.C14H18N6O.C8H11N3O3S/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22;15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21;9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28);1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19);1-2,6-7,12H,3-4H2,(H2,9,10,13)/t10-,15+;8-,10+;6-,7+/m110/s1 D00MLX DRUGINKE SRMOJRAUYXTFJA-RAKRLELNSA-N D00MLX DRUGSMIL CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O.C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO.C1C(OC(S1)CO)N2C=CC(=NC2=O)N D00MLX DRUGTYPE Small molecular drug D00MLX HIGHSTAT Phase 3 D00MMV DRUG__ID D00MMV D00MMV DRUGCLAS Discontinued Drug(s) D00MMV DRUGCOMP Regeneron pharmaceuticals D00MMV DRUGTYPE Monoclonal antibody D00MMV HIGHSTAT Discontinued in Phase 1 D00MNE DRUG__ID D00MNE D00MNE DRUGCLAS Investigative Drug(s) D00MNE DRUGINCH 1S/C25H28O4/c1-15(2)5-7-17-11-19(12-18(25(17)28)8-6-16(3)4)23-14-22(27)21-10-9-20(26)13-24(21)29-23/h5-6,9-13,23,26,28H,7-8,14H2,1-4H3/t23-/m0/s1 D00MNE DRUGINKE JBQLRZGPTDOWQA-QHCPKHFHSA-N D00MNE DRUGSMIL CC(=CCC1=CC(=CC(=C1O)CC=C(C)C)C2CC(=O)C3=C(O2)C=C(C=C3)O)C D00MNE DRUGTYPE Small molecular drug D00MNE HIGHSTAT Investigative D00MNG DRUG__ID D00MNG D00MNG DRUGCLAS Clinical Trial Drug(s) D00MNG DRUGCOMP Mymetics D00MNG HIGHSTAT Phase 1 D00MPA DRUG__ID D00MPA D00MPA DRUGCLAS Investigative Drug(s) D00MPA DRUGINCH 1S/C9H7N5O/c10-9-13-6(5-2-1-3-15-5)7-8(14-9)12-4-11-7/h1-4H,(H3,10,11,12,13,14) D00MPA DRUGINKE JZSMPSCWNAYWOI-UHFFFAOYSA-N D00MPA DRUGSMIL C1=COC(=C1)C2=C3C(=NC(=N2)N)N=CN3 D00MPA DRUGTYPE Small molecular drug D00MPA HIGHSTAT Investigative D00MPM DRUG__ID D00MPM D00MPM DRUGCLAS Investigative Drug(s) D00MPM DRUGINCH 1S/C20H24O3/c1-14(2)6-8-17-12-15(7-11-19(17)22)4-3-5-16-9-10-18(21)13-20(16)23/h6-7,9-13,21-23H,3-5,8H2,1-2H3 D00MPM DRUGINKE CMOZGCJOTGLPKO-UHFFFAOYSA-N D00MPM DRUGSMIL CC(=CCC1=C(C=CC(=C1)CCCC2=C(C=C(C=C2)O)O)O)C D00MPM DRUGTYPE Small molecular drug D00MPM HIGHSTAT Investigative D00MPX DRUG__ID D00MPX D00MPX DRUGCLAS Investigative Drug(s) D00MPX DRUGCOMP Jennerex Inc D00MPX HIGHSTAT Investigative D00MQS DRUG__ID D00MQS D00MQS DRUGCLAS Preclinical Drug(s) D00MQS DRUGCOMP Pfizer D00MQS DRUGINCH 1S/C18H18N2O2/c21-18-9-8-15-7-6-14(12-17(15)22-18)13-19-10-11-20-16-4-2-1-3-5-16/h1-9,12,19-20H,10-11,13H2 D00MQS DRUGINKE RNNKCHJUBXFBQB-UHFFFAOYSA-N D00MQS DRUGSMIL C1=CC=C(C=C1)NCCNCC2=CC3=C(C=C2)C=CC(=O)O3 D00MQS DRUGTYPE Small molecular drug D00MQS HIGHSTAT Preclinical D00MRH DRUG__ID D00MRH D00MRH DRUGCLAS Investigative Drug(s) D00MRH DRUGCOMP Reliance Life Sciences Group D00MRH HIGHSTAT Investigative D00MSP DRUG__ID D00MSP D00MSP DRUGCLAS Discontinued Drug(s) D00MSP DRUGCOMP Fujisawa Pharmaceutical Co Ltd D00MSP HIGHSTAT Terminated D00MSU DRUG__ID D00MSU D00MSU DRUGCLAS Investigative Drug(s) D00MSU DRUGINCH 1S/C14H16N2O/c15-13-7-6-11-2-1-3-12(14(11)16-13)17-9-8-10-4-5-10/h1-3,6-7,10H,4-5,8-9H2,(H2,15,16) D00MSU DRUGINKE YLXQVSWEPLSGKN-UHFFFAOYSA-N D00MSU DRUGSMIL C1CC1CCOC2=CC=CC3=C2N=C(C=C3)N D00MSU DRUGTYPE Small molecular drug D00MSU HIGHSTAT Investigative D00MTG DRUG__ID D00MTG D00MTG DRUGCLAS Clinical Trial Drug(s) D00MTG DRUGCOMP Sanofi D00MTG HIGHSTAT Phase 2 D00MUC DRUG__ID D00MUC D00MUC DRUGCLAS Clinical Trial Drug(s) D00MUC DRUGCOMP Tianjin Mycure Medical Technology Co., Ltd D00MUC DRUGTYPE CAR T Cell Therapy D00MUC HIGHSTAT Phase 1 D00MUJ DRUG__ID D00MUJ D00MUJ DRUGCLAS Investigative Drug(s) D00MUJ DRUGINCH 1S/C16H17NO4S/c1-2-6-12-9-10-15(14(11-12)16(18)19)17-22(20,21)13-7-4-3-5-8-13/h3-5,7-11,17H,2,6H2,1H3,(H,18,19) D00MUJ DRUGINKE LZDCSXYOKAIIJO-UHFFFAOYSA-N D00MUJ DRUGSMIL CCCC1=CC(=C(C=C1)NS(=O)(=O)C2=CC=CC=C2)C(=O)O D00MUJ DRUGTYPE Small molecular drug D00MUJ HIGHSTAT Investigative D00MVK DRUG__ID D00MVK D00MVK DRUGCLAS Discontinued Drug(s) D00MVK DRUGCOMP F Hoffmann-La Roche Ltd D00MVK HIGHSTAT Terminated D00MWE DRUG__ID D00MWE D00MWE DRUGCLAS Investigative Drug(s) D00MWE DRUGCOMP Ultragenyx Pharmaceutical D00MWE HIGHSTAT Investigative D00MXN DRUG__ID D00MXN D00MXN DRUGCLAS Clinical Trial Drug(s) D00MXN DRUGCOMP Merck & Co Inc D00MXN DRUGINCH 1S/C31H29F2N5O3/c32-21-10-19(11-22(33)13-21)25-16-35-31(7-1-2-8-31)29(41)38(25)17-26(39)36-23-6-5-18-14-30(15-20(18)12-23)24-4-3-9-34-27(24)37-28(30)40/h3-6,9-13,25,35H,1-2,7-8,14-17H2,(H,36,39)(H,34,37,40)/t25-,30+/m0/s1 D00MXN DRUGINKE AZAANWYREOQRFB-SETSBSEESA-N D00MXN DRUGSMIL C1CCC2(C1)C(=O)N(C(CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(CC6(C5)C7=C(NC6=O)N=CC=C7)C=C4 D00MXN DRUGTYPE Small molecular drug D00MXN HIGHSTAT Phase 2 D00MXR DRUG__ID D00MXR D00MXR DRUGCLAS Patented Agent(s) D00MXR DRUGCOMP KAINOS MEDICINE, INC D00MXR DRUGINCH 1S/C22H21ClN4O4S/c1-13-25-26-22-19(12-31-32(28,29)17-8-9-17)24-21(14-3-5-15(23)6-4-14)18-11-16(30-2)7-10-20(18)27(13)22/h3-7,10-11,17,19H,8-9,12H2,1-2H3/t19-/m0/s1 D00MXR DRUGINKE BTVRKLXZFWPBGV-IBGZPJMESA-N D00MXR DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)OC)C(=NC2COS(=O)(=O)C4CC4)C5=CC=C(C=C5)Cl D00MXR DRUGTYPE Small molecular drug D00MXR HIGHSTAT Patented D00MXS DRUG__ID D00MXS D00MXS DRUGCLAS Investigative Drug(s) D00MXS DRUGINCH 1S/C16H12O5/c1-20-15-12(19)7-10(17)14-11(18)8-13(21-16(14)15)9-5-3-2-4-6-9/h2-8,17,19H,1H3 D00MXS DRUGINKE XLTFNNCXVBYBSX-UHFFFAOYSA-N D00MXS DRUGSMIL COC1=C(C=C(C2=C1OC(=CC2=O)C3=CC=CC=C3)O)O D00MXS DRUGTYPE Small molecular drug D00MXS HIGHSTAT Investigative D00MXW DRUG__ID D00MXW D00MXW DRUGCLAS Investigative Drug(s) D00MXW DRUGINCH 1S/C21H19NO4/c1-14(23)15-5-2-3-6-16(15)17-7-4-8-18-19(24)13-20(26-21(17)18)22-9-11-25-12-10-22/h2-8,13H,9-12H2,1H3 D00MXW DRUGINKE GMTPLPJMRGXINX-UHFFFAOYSA-N D00MXW DRUGSMIL CC(=O)C1=CC=CC=C1C2=CC=CC3=C2OC(=CC3=O)N4CCOCC4 D00MXW DRUGTYPE Small molecular drug D00MXW HIGHSTAT Investigative D00MYQ DRUG__ID D00MYQ D00MYQ DRUADIID FDA-AP-BF04-01407 D00MYQ DRUGCLAS Approved Drug(s) D00MYQ DRUGCOMP Teva Womens Health Inc D00MYQ DRUGINCH 1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3 D00MYQ DRUGINKE BWPIARFWQZKAIA-UHFFFAOYSA-N D00MYQ DRUGSMIL CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13 D00MYQ DRUGTYPE Small molecular drug D00MYQ HIGHSTAT Approved D00MYQ THERCLAS Antidepressants D00MYT DRUG__ID D00MYT D00MYT DRUADIID FDA-AP-BF04-01301 D00MYT DRUGCLAS Approved Drug(s) D00MYT DRUGCOMP Abbott Laboratories D00MYT DRUGINCH 1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16) D00MYT DRUGINKE IUJDSEJGGMCXSG-UHFFFAOYSA-N D00MYT DRUGSMIL CCCC(C)C1(C(=O)NC(=S)NC1=O)CC D00MYT DRUGTYPE Small molecular drug D00MYT HIGHSTAT Approved D00MYT THERCLAS Hypnotics and Sedatives D00MYW DRUG__ID D00MYW D00MYW DRUGCLAS Clinical Trial Drug(s) D00MYW DRUGCOMP Nippon Shinyaku D00MYW DRUGINCH 1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1 D00MYW DRUGINKE UQTPDWDAYHAZNT-AWEZNQCLSA-N D00MYW DRUGSMIL CC(C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C D00MYW DRUGTYPE Small molecular drug D00MYW HIGHSTAT Phase 1/2 D00MZC DRUG__ID D00MZC D00MZC DRUGCLAS Investigative Drug(s) D00MZC DRUGCOMP Lytix Biopharma AS D00MZC HIGHSTAT Investigative D00MZD DRUG__ID D00MZD D00MZD DRUGCLAS Investigative Drug(s) D00MZD DRUGINCH 1S/C11H19N5O11P2/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(26-10)2-25-29(23,24)27-28(20,21)22/h4,6-7,10,17-18H,2-3H2,1H3,(H,23,24)(H2,20,21,22)(H3,12,13,14,19)/t4-,6-,7-,10-/m1/s1 D00MZD DRUGINKE QQODJOAVWUWVHJ-KQYNXXCUSA-N D00MZD DRUGSMIL CN1CN(C2=C1C(=O)NC(=N2)N)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O D00MZD DRUGTYPE Small molecular drug D00MZD HIGHSTAT Investigative D00MZK DRUG__ID D00MZK D00MZK DRUGCLAS Clinical Trial Drug(s) D00MZK DRUGINCH 1S/C26H25NO6/c28-24(29)17-32-23-13-7-8-19-16-26(31,15-14-22(19)23)18-33-25(30)27(20-9-3-1-4-10-20)21-11-5-2-6-12-21/h1-13,31H,14-18H2,(H,28,29)/t26-/m1/s1 D00MZK DRUGINKE UZJAIYJXBYWENR-AREMUKBSSA-N D00MZK DRUGSMIL C1CC(CC2=C1C(=CC=C2)OCC(=O)O)(COC(=O)N(C3=CC=CC=C3)C4=CC=CC=C4)O D00MZK DRUGTYPE Small molecular drug D00MZK HIGHSTAT Phase 2 D00MZS DRUG__ID D00MZS D00MZS DRUGCLAS Investigative Drug(s) D00MZS DRUGINCH 1S/C13H7Cl4NO2/c14-8-7(12(19)11(17)10(16)9(8)15)13(20)18-6-4-2-1-3-5-6/h1-5,19H,(H,18,20) D00MZS DRUGINKE BDOBMVIEWHZYDL-UHFFFAOYSA-N D00MZS DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)O D00MZS DRUGTYPE Small molecular drug D00MZS HIGHSTAT Investigative D00NAX DRUG__ID D00NAX D00NAX DRUADIID FDA-AP-BF04-00825 D00NAX DRUGCLAS Approved Drug(s) D00NAX DRUGCOMP Wyeth Pharmaceuticals D00NAX DRUGINCH 1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3 D00NAX DRUGINKE ZGUGWUXLJSTTMA-UHFFFAOYSA-N D00NAX DRUGSMIL CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31 D00NAX DRUGTYPE Small molecular drug D00NAX HIGHSTAT Approved D00NAX THERCLAS Antipsychotic Agents D00NBF DRUG__ID D00NBF D00NBF DRUGCLAS Clinical Trial Drug(s) D00NBF DRUGCOMP Genervon Biopharmaceuticals Pasadena, CA D00NBF HIGHSTAT Phase 2 D00NBJ DRUG__ID D00NBJ D00NBJ DRUGCLAS Clinical Trial Drug(s) D00NBJ DRUGCOMP Medivir Huddinge, Sweden D00NBJ DRUGINCH 1S/C16H21NO6/c1-22-16(20)12-8-10-13(11-9-12)23-15(19)7-5-3-2-4-6-14(18)17-21/h8-11,21H,2-7H2,1H3,(H,17,18) D00NBJ DRUGINKE XDZAHHULFQIBFE-UHFFFAOYSA-N D00NBJ DRUGSMIL COC(=O)C1=CC=C(C=C1)OC(=O)CCCCCCC(=O)NO D00NBJ HIGHSTAT Phase 2 D00NBW DRUG__ID D00NBW D00NBW DRUGCLAS Clinical Trial Drug(s) D00NBW DRUGCOMP Targovax Oslo, Norway D00NBW DRUGTYPE Oncolytic virus therapy D00NBW HIGHSTAT Phase 1/2 D00NCJ DRUG__ID D00NCJ D00NCJ DRUGCLAS Patented Agent(s) D00NCJ DRUGCOMP PFIZER INC. ASPNES, Gary, Erik DIDIUK, Mary, Theresa FILIPSKI, Kevin, James GUZMAN-PEREZ, Angel PFEFFERKORN, Jeffrey, Allen STEVENS, Benjamin, Dawson TU, Meihua, Mik D00NCJ DRUGINCH 1S/C25H26F3N5O3/c1-15(2)11-20(33-21-8-5-17(12-30-21)24(36)29-10-9-22(34)35)18-13-31-23(32-14-18)16-3-6-19(7-4-16)25(26,27)28/h3-8,12-15,20H,9-11H2,1-2H3,(H,29,36)(H,30,33)(H,34,35)/t20-/m0/s1 D00NCJ DRUGINKE DROAORWMIULFBS-FQEVSTJZSA-N D00NCJ DRUGSMIL CC(C)CC(C1=CN=C(N=C1)C2=CC=C(C=C2)C(F)(F)F)NC3=NC=C(C=C3)C(=O)NCCC(=O)O D00NCJ DRUGTYPE Small molecular drug D00NCJ HIGHSTAT Patented D00NCL DRUG__ID D00NCL D00NCL DRUGCLAS Investigative Drug(s) D00NCL DRUGINCH 1S/C14H13N5S/c1-2-7-15-12(6-1)17-14-18-13-9-8-16-19-10(9)4-3-5-11(13)20-14/h1-2,6-8H,3-5H2,(H,16,19)(H,15,17,18) D00NCL DRUGINKE DBISXWCOHGUFSF-UHFFFAOYSA-N D00NCL DRUGSMIL C1CC2=C(C=NN2)C3=C(C1)SC(=N3)NC4=CC=CC=N4 D00NCL DRUGTYPE Small molecular drug D00NCL HIGHSTAT Investigative D00NDF DRUG__ID D00NDF D00NDF DRUGCLAS Patented Agent(s) D00NDF DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D00NDF DRUGINCH 1S/C4H8O2/c1-3(5)4(2)6/h3,5H,1-2H3 D00NDF DRUGINKE ROWKJAVDOGWPAT-UHFFFAOYSA-N D00NDF DRUGSMIL CC(C(=O)C)O D00NDF DRUGTYPE Small molecular drug D00NDF HIGHSTAT Patented D00NEE DRUG__ID D00NEE D00NEE DRUGCLAS Investigative Drug(s) D00NEE DRUGINCH 1S/C46H62N8O12/c1-25(55)38(44(62)54-21-5-7-37(54)43(61)50-35(6-3-4-20-47)41(59)53-39(26(2)56)46(65)66)52-42(60)36(24-29-12-18-32(57)19-13-29)51-40(58)33(48)22-27-8-14-30(15-9-27)31-16-10-28(11-17-31)23-34(49)45(63)64/h8-19,25-26,33-39,55-57H,3-7,20-24,47-49H2,1-2H3,(H,50,61)(H,51,58)(H,52,60)(H,53,59)(H,63,64)(H,65,66)/t25-,26-,33+,34+,35+,36+,37+,38+,39+/m1/s1 D00NEE DRUGINKE IBJQKBDBQJHDOQ-KOXSSGOCSA-N D00NEE DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=C(C=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N)O D00NEE DRUGTYPE Small molecular drug D00NEE HIGHSTAT Investigative D00NEK DRUG__ID D00NEK D00NEK DRUGCLAS Investigative Drug(s) D00NEK DRUGINCH 1S/C20H15NO/c22-16-12-10-15(11-13-16)20-19(14-6-2-1-3-7-14)17-8-4-5-9-18(17)21-20/h1-13,21-22H D00NEK DRUGINKE HRWBDGGFCFVAHP-UHFFFAOYSA-N D00NEK DRUGSMIL C1=CC=C(C=C1)C2=C(NC3=CC=CC=C32)C4=CC=C(C=C4)O D00NEK DRUGTYPE Small molecular drug D00NEK HIGHSTAT Investigative D00NEL DRUG__ID D00NEL D00NEL DRUGCLAS Clinical Trial Drug(s) D00NEL DRUGCOMP Boehringer Ingelheim D00NEL DRUGTYPE Monoclonal antibody D00NEL HIGHSTAT Phase 1 D00NFW DRUG__ID D00NFW D00NFW DRUGCLAS Investigative Drug(s) D00NFW DRUGINCH 1S/C20H17N3/c1-2-18-22-19-16(14-9-5-3-6-10-14)13-17(21-20(19)23-18)15-11-7-4-8-12-15/h3-13H,2H2,1H3,(H,21,22,23) D00NFW DRUGINKE PMDYRFYZMJGDQY-UHFFFAOYSA-N D00NFW DRUGSMIL CCC1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D00NFW DRUGTYPE Small molecular drug D00NFW HIGHSTAT Investigative D00NGN DRUG__ID D00NGN D00NGN DRUGCLAS Discontinued Drug(s) D00NGN DRUGCOMP Janssen Pharmaceutica NV D00NGN DRUGINCH 1S/C22H26FN3O2S/c1-25(22-24-20-4-2-3-5-21(20)29-22)17-10-12-26(13-11-17)14-18(27)15-28-19-8-6-16(23)7-9-19/h2-9,17-18,27H,10-15H2,1H3 D00NGN DRUGINKE IGMKTIJBFUMVIN-UHFFFAOYSA-N D00NGN DRUGSMIL CN(C1CCN(CC1)CC(COC2=CC=C(C=C2)F)O)C3=NC4=CC=CC=C4S3 D00NGN DRUGTYPE Small molecular drug D00NGN HIGHSTAT Discontinued in Phase 3 D00NIT DRUG__ID D00NIT D00NIT DRUGCLAS Investigative Drug(s) D00NIT DRUGINCH 1S/C39H38F2N4O3/c1-43(2)30-20-23-44(24-21-30)36(46)26-34-33-14-8-9-15-35(33)45(25-22-39(34,40)41)38(48)28-16-18-29(19-17-28)42-37(47)32-13-7-6-12-31(32)27-10-4-3-5-11-27/h3-19,26,30H,20-25H2,1-2H3,(H,42,47)/b34-26- D00NIT DRUGINKE ICRPTZMWRJGNQI-CLIDGEQKSA-N D00NIT DRUGSMIL CN(C)C1CCN(CC1)C(=O)C=C2C3=CC=CC=C3N(CCC2(F)F)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6 D00NIT DRUGTYPE Small molecular drug D00NIT HIGHSTAT Investigative D00NIV DRUG__ID D00NIV D00NIV DRUGCLAS Investigative Drug(s) D00NIV DRUGCOMP ATyr Pharma Inc D00NIV HIGHSTAT Investigative D00NIX DRUG__ID D00NIX D00NIX DRUGCLAS Investigative Drug(s) D00NIX DRUGINCH 1S/C28H27N2O4/c1-31-25-9-8-19-14-24-22-16-27-26(33-18-34-27)15-20(22)10-12-30(24)17-23(19)28(25)32-13-5-11-29-21-6-3-2-4-7-21/h2-4,6-9,14-17,29H,5,10-13,18H2,1H3/q+1 D00NIX DRUGINKE BRNHZXILANUSDI-UHFFFAOYSA-N D00NIX DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCNC6=CC=CC=C6 D00NIX DRUGTYPE Small molecular drug D00NIX HIGHSTAT Investigative D00NJE DRUG__ID D00NJE D00NJE DRUGCLAS Investigative Drug(s) D00NJE DRUGCOMP Rockefeller University D00NJE DRUGINCH 1S/C34H52N7O17P3S/c1-19(2)14-21-6-8-22(9-7-21)20(3)33(46)62-13-12-36-24(42)10-11-37-31(45)28(44)34(4,5)16-55-61(52,53)58-60(50,51)54-15-23-27(57-59(47,48)49)26(43)32(56-23)41-18-40-25-29(35)38-17-39-30(25)41/h6-9,17-20,23,26-28,32,43-44H,10-16H2,1-5H3,(H,36,42)(H,37,45)(H,50,51)(H,52,53)(H2,35,38,39)(H2,47,48,49)/t20-,23+,26+,27+,28-,32+/m0/s1 D00NJE DRUGINKE ZWOQHSZKILPKKA-MIXAKNBRSA-N D00NJE DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O)O)O D00NJE DRUGTYPE Small molecular drug D00NJE HIGHSTAT Investigative D00NJJ DRUG__ID D00NJJ D00NJJ DRUGCLAS Approved Drug(s) D00NJJ DRUGINCH 1S/C21H25N5O8S2/c1-21(2)14(18(29)30)26-16(28)13(17(26)35-21)22-15(27)12(11-7-5-4-6-8-11)23-19(31)24-9-10-25(20(24)32)36(3,33)34/h4-8,12-14,17H,9-10H2,1-3H3,(H,22,27)(H,23,31)(H,29,30)/t12-,13-,14+,17-/m1/s1 D00NJJ DRUGINKE YPBATNHYBCGSSN-VWPFQQQWSA-N D00NJJ DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C D00NJJ DRUGTYPE Small molecular drug D00NJJ HIGHSTAT Approved D00NJJ THERCLAS Antibiotics D00NJL DRUG__ID D00NJL D00NJL DRUGCLAS Approved Drug(s) D00NJL DRUGINCH 1S/C21H26Cl2O/c1-20(2,3)13-21(4,5)16-7-9-19(24)15(11-16)10-14-6-8-17(22)12-18(14)23/h6-9,11-12,24H,10,13H2,1-5H3 D00NJL DRUGINKE HQVZOORKDNCGCK-UHFFFAOYSA-N D00NJL DRUGSMIL CC(C)(C)CC(C)(C)C1=CC(=C(C=C1)O)CC2=C(C=C(C=C2)Cl)Cl D00NJL DRUGTYPE Small molecular drug D00NJL HIGHSTAT Approved D00NKB DRUG__ID D00NKB D00NKB DRUGCLAS Approved Drug(s) D00NKB DRUGINCH 1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19) D00NKB DRUGINKE FNYLWPVRPXGIIP-UHFFFAOYSA-N D00NKB DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N D00NKB DRUGTYPE Small molecular drug D00NKB HIGHSTAT Approved D00NKB THERCLAS Diuretics D00NLD DRUG__ID D00NLD D00NLD DRUGCLAS Discontinued Drug(s) D00NLD DRUGINCH 1S/C14H17N5/c1-18(2)6-5-11-8-15-14-4-3-12(7-13(11)14)19-9-16-17-10-19/h3-4,7-10,15H,5-6H2,1-2H3 D00NLD DRUGINKE IGNXHSPBUUSUHB-UHFFFAOYSA-N D00NLD DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)N3C=NN=C3 D00NLD DRUGTYPE Small molecular drug D00NLD HIGHSTAT Terminated D00NNC DRUG__ID D00NNC D00NNC DRUGCLAS Approved Drug(s) D00NNC DRUGINCH 1S/C2H8O7P2/c1-2(3,10(4,5)6)11(7,8)9/h3H,1H3,(H2,4,5,6)(H2,7,8,9) D00NNC DRUGINKE DBVJJBKOTRCVKF-UHFFFAOYSA-N D00NNC DRUGSMIL CC(O)(P(=O)(O)O)P(=O)(O)O D00NNC DRUGTYPE Small molecular drug D00NNC HIGHSTAT Approved D00NNC THERCLAS Bone Density Conservation Agents D00NNI DRUG__ID D00NNI D00NNI DRUGCLAS Clinical Trial Drug(s) D00NNI DRUGCOMP Astellas Pharma Inc D00NNI HIGHSTAT Phase 2 D00NNP DRUG__ID D00NNP D00NNP DRUGCLAS Investigative Drug(s) D00NNP DRUGINCH 1S/C12H17BrN4S/c13-10-4-5-11(14-8-10)16-12(18)15-9-17-6-2-1-3-7-17/h4-5,8H,1-3,6-7,9H2,(H2,14,15,16,18) D00NNP DRUGINKE QIWYYZPJZHMEPR-UHFFFAOYSA-N D00NNP DRUGSMIL C1CCN(CC1)CNC(=S)NC2=NC=C(C=C2)Br D00NNP DRUGTYPE Small molecular drug D00NNP HIGHSTAT Investigative D00NOG DRUG__ID D00NOG D00NOG DRUGCLAS Investigative Drug(s) D00NOG DRUGINCH 1S/C66H96O2/c1-50(2)26-16-27-51(3)28-17-29-52(4)30-18-31-53(5)32-19-33-54(6)34-20-35-55(7)36-21-37-56(8)38-22-39-57(9)40-23-41-58(10)42-24-43-59(11)44-25-45-60(12)48-49-62-61(13)65(67)63-46-14-15-47-64(63)66(62)68/h14-15,26,28,30,32,34,36,38,40,42,44,46-48H,16-25,27,29,31,33,35,37,39,41,43,45,49H2,1-13H3/b51-28+,52-30+,53-32+,54-34+,55-36+,56-38+,57-40+,58-42+,59-44+,60-48+ D00NOG DRUGINKE YYDMANIEKFAEJC-RYZSZPJESA-N D00NOG DRUGSMIL CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C D00NOG DRUGTYPE Small molecular drug D00NOG HIGHSTAT Investigative D00NOH DRUG__ID D00NOH D00NOH DRUGCLAS Investigative Drug(s) D00NOH DRUGINCH 1S/C24H32O3/c1-17-7-6-10-18(13-17)8-2-4-11-21-22-15-19(9-3-5-12-24(26)27)14-20(22)16-23(21)25/h4,6-7,10-11,13-14,20-23,25H,2-3,5,8-9,12,15-16H2,1H3,(H,26,27)/b11-4+/t20-,21+,22-,23+/m0/s1 D00NOH DRUGINKE UZEWMXSWYKBMJG-ROHPBGETSA-N D00NOH DRUGSMIL CC1=CC(=CC=C1)CCC=CC2C(CC3C2CC(=C3)CCCCC(=O)O)O D00NOH DRUGTYPE Small molecular drug D00NOH HIGHSTAT Investigative D00NOL DRUG__ID D00NOL D00NOL DRUGCLAS Investigative Drug(s) D00NOL DRUGCOMP Merck & Co Inc D00NOL DRUGINCH 1S/C19H19ClFN3O4/c1-22(2)18(27)15-11-6-7-24(9-10-4-5-13(21)12(20)8-10)17(26)14(11)16(25)19(28)23(15)3/h4-5,8,25H,6-7,9H2,1-3H3 D00NOL DRUGINKE FFDVONMXYFIBBI-UHFFFAOYSA-N D00NOL DRUGSMIL CN1C(=C2CCN(C(=O)C2=C(C1=O)O)CC3=CC(=C(C=C3)F)Cl)C(=O)N(C)C D00NOL HIGHSTAT Investigative D00NOP DRUG__ID D00NOP D00NOP DRUGCLAS Preclinical Drug(s) D00NOP DRUGCOMP Oncolys BioPharma Inc D00NOP HIGHSTAT Preclinical D00NOY DRUG__ID D00NOY D00NOY DRUGCLAS Investigative Drug(s) D00NOY DRUGCOMP Amcyte D00NOY HIGHSTAT Investigative D00NPE DRUG__ID D00NPE D00NPE DRUGCLAS Investigative Drug(s) D00NPE DRUGCOMP Wyeth D00NPE HIGHSTAT Investigative D00NPN DRUG__ID D00NPN D00NPN DRUGCLAS Investigative Drug(s) D00NPN DRUGCOMP Isis Pharmaceuticals D00NPN DRUGTYPE Antisense drug D00NPN HIGHSTAT Investigative D00NPO DRUG__ID D00NPO D00NPO DRUGCLAS Clinical Trial Drug(s) D00NPO DRUGCOMP Abbott Laboratories; Genentech D00NPO HIGHSTAT Phase 3 D00NPP DRUG__ID D00NPP D00NPP DRUGCLAS Approved Drug(s) D00NPP DRUGCOMP GlaxoSmithKline D00NPP DRUGINCH 1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1 D00NPP DRUGINKE ARAIBEBZBOPLMB-UFGQHTETSA-N D00NPP DRUGSMIL CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N D00NPP DRUGTYPE Small molecular drug D00NPP HIGHSTAT Approved D00NPP THERCLAS Antiviral Agents D00NPT DRUG__ID D00NPT D00NPT DRUGCLAS Approved Drug(s) D00NPT DRUGINCH 1S/C9H12N2O7P2/c12-9(19(13,14)15,20(16,17)18)5-7-6-10-8-3-1-2-4-11(7)8/h1-4,6,12H,5H2,(H2,13,14,15)(H2,16,17,18) D00NPT DRUGINKE VMMKGHQPQIEGSQ-UHFFFAOYSA-N D00NPT DRUGSMIL C1=CC2=NC=C(N2C=C1)CC(O)(P(=O)(O)O)P(=O)(O)O D00NPT DRUGTYPE Small molecular drug D00NPT HIGHSTAT Approved D00NQN DRUG__ID D00NQN D00NQN DRUGCLAS Investigative Drug(s) D00NQN DRUGCOMP Isis Pharmaceuticals D00NQN DRUGTYPE Antisense drug D00NQN HIGHSTAT Investigative D00NQQ DRUG__ID D00NQQ D00NQQ DRUGCLAS Investigative Drug(s) D00NQQ DRUGINCH 1S/C11H18N5O11P3/c12-10-9-11(14-3-13-10)16(4-15-9)8-1-6(17)7(26-8)2-25-28(18,19)5-29(20,21)27-30(22,23)24/h3-4,6-8,17H,1-2,5H2,(H,18,19)(H,20,21)(H2,12,13,14)(H2,22,23,24)/t6-,7+,8+/m0/s1 D00NQQ DRUGINKE XETARULVTCYJAN-XLPZGREQSA-N D00NQQ DRUGSMIL C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O D00NQQ DRUGTYPE Small molecular drug D00NQQ HIGHSTAT Investigative D00NQV DRUG__ID D00NQV D00NQV DRUGCLAS Investigative Drug(s) D00NQV DRUGINCH 1S/C21H28IN3O/c1-16(2)26-20-5-4-12-23-21(20)24(3)19-10-13-25(14-11-19)15-17-6-8-18(22)9-7-17/h4-9,12,16,19H,10-11,13-15H2,1-3H3 D00NQV DRUGINKE ZJAXDNQQFMPNAV-UHFFFAOYSA-N D00NQV DRUGSMIL CC(C)OC1=C(N=CC=C1)N(C)C2CCN(CC2)CC3=CC=C(C=C3)I D00NQV DRUGTYPE Small molecular drug D00NQV HIGHSTAT Investigative D00NRB DRUG__ID D00NRB D00NRB DRUGCLAS Investigative Drug(s) D00NRB DRUGINCH 1S/C19H23NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h1,6-7,13,16,18,21H,3-5,8-12H2/t16-,18+,19+/m0/s1 D00NRB DRUGINKE OKICQDFBWUMTDE-QXAKKESOSA-N D00NRB DRUGSMIL C#CCN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O D00NRB DRUGTYPE Small molecular drug D00NRB HIGHSTAT Investigative D00NRJ DRUG__ID D00NRJ D00NRJ DRUGCLAS Investigative Drug(s) D00NRJ DRUGINCH 1S/C19H33N2OSi/c1-21(2)15-13-20(14-16-21)17-23(22,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3,5-6,9-10,19,22H,4,7-8,11-17H2,1-2H3/q+1 D00NRJ DRUGINKE GBISIIAKUATURW-UHFFFAOYSA-N D00NRJ DRUGSMIL C[N+]1(CCN(CC1)C[Si](C2CCCCC2)(C3=CC=CC=C3)O)C D00NRJ DRUGTYPE Small molecular drug D00NRJ HIGHSTAT Investigative D00NSA DRUG__ID D00NSA D00NSA DRUGCLAS Investigative Drug(s) D00NSA DRUGINCH 1S/C12H14N2O/c1-15-11-4-2-3-9-12(11)8-5-6-13-7-10(8)14-9/h2-4,13-14H,5-7H2,1H3 D00NSA DRUGINKE VPZWHBCLJCKHGZ-UHFFFAOYSA-N D00NSA DRUGSMIL COC1=CC=CC2=C1C3=C(N2)CNCC3 D00NSA DRUGTYPE Small molecular drug D00NSA HIGHSTAT Investigative D00NSD DRUG__ID D00NSD D00NSD DRUGCLAS Clinical Trial Drug(s) D00NSD DRUGCOMP Exelixis D00NSD HIGHSTAT Phase 2 D00NSM DRUG__ID D00NSM D00NSM DRUGCLAS Discontinued Drug(s) D00NSM DRUGCOMP CellMed AG D00NSM HIGHSTAT Discontinued in Phase 1/2 D00NST DRUG__ID D00NST D00NST DRUGCLAS Investigative Drug(s) D00NST DRUGINCH 1S/C12H13N3O/c1-8(13)7-15-12-9(6-14-15)2-3-11-10(12)4-5-16-11/h2-6,8H,7,13H2,1H3/t8-/m0/s1 D00NST DRUGINKE XAEAYQWCVVRSFL-QMMMGPOBSA-N D00NST DRUGSMIL CC(CN1C2=C(C=CC3=C2C=CO3)C=N1)N D00NST DRUGTYPE Small molecular drug D00NST HIGHSTAT Investigative D00NTR DRUG__ID D00NTR D00NTR DRUGCLAS Approved Drug(s) D00NTR HIGHSTAT Approved D00NTW DRUG__ID D00NTW D00NTW DRUGCLAS Discontinued Drug(s) D00NTW DRUGCOMP Boehringer Ingelheim Corp D00NTW HIGHSTAT Discontinued in Phase 2 D00NUG DRUG__ID D00NUG D00NUG DRUGCLAS Clinical Trial Drug(s) D00NUG DRUGCOMP UCB D00NUG DRUGTYPE Monoclonal antibody D00NUG HIGHSTAT Phase 3 D00NUK DRUG__ID D00NUK D00NUK DRUGCLAS Investigative Drug(s) D00NUK DRUGINCH 1S/C7H10N2O4S2/c1-14(10,11)9-6-2-4-7(5-3-6)15(8,12)13/h2-5,9H,1H3,(H2,8,12,13) D00NUK DRUGINKE KPLRLDFXFOARQY-UHFFFAOYSA-N D00NUK DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)S(=O)(=O)N D00NUK DRUGTYPE Small molecular drug D00NUK HIGHSTAT Investigative D00NUO DRUG__ID D00NUO D00NUO DRUGCLAS Preclinical Drug(s) D00NUO DRUGCOMP Ortho Dermatologics Raleigh, NC D00NUO HIGHSTAT Application submitted D00NVC DRUG__ID D00NVC D00NVC DRUGCLAS Investigative Drug(s) D00NVC DRUGINCH 1S/C43H59N7O9/c1-9-27(6)36(40(54)47-35(26(4)5)41(55)58-8)48-42(56)50-49-39(53)34(23-31-20-15-19-30-18-13-14-21-32(30)31)46-38(52)33(22-25(2)3)45-37(51)28(7)44-43(57)59-24-29-16-11-10-12-17-29/h10-21,25-28,33-36H,9,22-24H2,1-8H3,(H,44,57)(H,45,51)(H,46,52)(H,47,54)(H,49,53)(H2,48,50,56) D00NVC DRUGINKE KMJURIDKPLGXEZ-UHFFFAOYSA-N D00NVC DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CC=CC2=CC=CC=C21)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC3=CC=CC=C3 D00NVC DRUGTYPE Small molecular drug D00NVC HIGHSTAT Investigative D00NVM DRUG__ID D00NVM D00NVM DRUGCLAS Clinical Trial Drug(s) D00NVM DRUGCOMP Sunesis Pharmaceuticals Inc D00NVM DRUGINCH 1S/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1 D00NVM DRUGINKE XZAFZXJXZHRNAQ-STQMWFEESA-N D00NVM DRUGSMIL CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O D00NVM DRUGTYPE Small molecular drug D00NVM HIGHSTAT Phase 3 D00NVO DRUG__ID D00NVO D00NVO DRUGCLAS Clinical Trial Drug(s) D00NVO DRUGCOMP ASTA Medica AG D00NVO DRUGINCH 1S/C29H30FN3O/c30-24-14-12-23(13-15-24)21-28-26-10-4-5-11-27(26)29(34)33(31-28)25-9-6-18-32(20-17-25)19-16-22-7-2-1-3-8-22/h1-5,7-8,10-15,25H,6,9,16-21H2 D00NVO DRUGINKE HQFSNUYUXXPVKL-UHFFFAOYSA-N D00NVO DRUGSMIL C1CC(CCN(C1)CCC2=CC=CC=C2)N3C(=O)C4=CC=CC=C4C(=N3)CC5=CC=C(C=C5)F D00NVO DRUGTYPE Small molecular drug D00NVO HIGHSTAT Phase 2 D00NVU DRUG__ID D00NVU D00NVU DRUGCLAS Patented Agent(s) D00NVU DRUGTYPE Small molecular drug D00NVU HIGHSTAT Patented D00NVX DRUG__ID D00NVX D00NVX DRUGCLAS Approved Drug(s) D00NVX DRUGINCH 1S/C23H28N8/c1-3-5-11-21-25-22(12-6-4-2)31(28-21)16-17-13-14-20(24-15-17)18-9-7-8-10-19(18)23-26-29-30-27-23/h7-10,13-15H,3-6,11-12,16H2,1-2H3,(H,26,27,29,30) D00NVX DRUGINKE YONOBYIBNBCDSJ-UHFFFAOYSA-N D00NVX DRUGSMIL CCCCC1=NN(C(=N1)CCCC)CC2=CN=C(C=C2)C3=CC=CC=C3C4=NNN=N4 D00NVX DRUGTYPE Small molecular drug D00NVX HIGHSTAT Approved D00NVX THERCLAS Antihypertensive Agents D00NWF DRUG__ID D00NWF D00NWF DRUGCLAS Investigative Drug(s) D00NWF DRUGINCH 1S/C23H23N3O3/c1-15-7-10-18(24-23(29)17-5-4-6-19(13-17)26(2)3)14-21(15)25-22(28)16-8-11-20(27)12-9-16/h4-14,27H,1-3H3,(H,24,29)(H,25,28) D00NWF DRUGINKE PYEFPDQFAZNXLI-UHFFFAOYSA-N D00NWF DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)N(C)C)NC(=O)C3=CC=C(C=C3)O D00NWF DRUGTYPE Small molecular drug D00NWF HIGHSTAT Investigative D00NWT DRUG__ID D00NWT D00NWT DRUGCLAS Discontinued Drug(s) D00NWT DRUGCOMP Glaxo Wellcome plc D00NWT HIGHSTAT Discontinued in Phase 2 D00NWV DRUG__ID D00NWV D00NWV DRUGCLAS Clinical Trial Drug(s) D00NWV DRUGCOMP Xiamen Amoytop Biotech Co Ltd D00NWV HIGHSTAT Phase 3 D00NXA DRUG__ID D00NXA D00NXA DRUGCLAS Investigative Drug(s) D00NXA DRUGINCH 1S/C8H7BO3/c10-9(11)8-5-6-3-1-2-4-7(6)12-8/h1-5,10-11H D00NXA DRUGINKE PKRRNTJIHGOMRC-UHFFFAOYSA-N D00NXA DRUGSMIL B(C1=CC2=CC=CC=C2O1)(O)O D00NXA DRUGTYPE Small molecular drug D00NXA HIGHSTAT Investigative D00NXM DRUG__ID D00NXM D00NXM DRUGCLAS Clinical Trial Drug(s) D00NXM DRUGCOMP Anacor Pharmaceuticals Inc D00NXM DRUGINCH 1S/C11H16BNO4/c13-7-10-8-3-1-4-9(16-6-2-5-14)11(8)12(15)17-10/h1,3-4,10,14-15H,2,5-7,13H2/t10-/m1/s1 D00NXM DRUGINKE FXQIIDINBDJDKL-SNVBAGLBSA-N D00NXM DRUGSMIL B1(C2=C(C=CC=C2OCCCO)C(O1)CN)O D00NXM DRUGTYPE Small molecular drug D00NXM HIGHSTAT Phase 2 D00NXT DRUG__ID D00NXT D00NXT DRUGCLAS Clinical Trial Drug(s) D00NXT DRUGCOMP Amgen; Xencor D00NXT HIGHSTAT Phase 2 D00NYG DRUG__ID D00NYG D00NYG DRUGCLAS Investigative Drug(s) D00NYG DRUGINCH 1S/C17H12N4/c18-11-14-15(12-7-3-1-4-8-12)20-17(21-16(14)19)13-9-5-2-6-10-13/h1-10H,(H2,19,20,21) D00NYG DRUGINKE RVAUJCJDJMOIOL-UHFFFAOYSA-N D00NYG DRUGSMIL C1=CC=C(C=C1)C2=C(C(=NC(=N2)C3=CC=CC=C3)N)C#N D00NYG DRUGTYPE Small molecular drug D00NYG HIGHSTAT Investigative D00NYJ DRUG__ID D00NYJ D00NYJ DRUGCLAS Clinical Trial Drug(s) D00NYJ DRUGCOMP ASLAN Pharmaceuticals D00NYJ DRUGINCH 1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1 D00NYJ DRUGINKE UWXSAYUXVSFDBQ-CYBMUJFWSA-N D00NYJ DRUGSMIL CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl D00NYJ DRUGTYPE Small molecular drug D00NYJ HIGHSTAT Phase 2/3 D00NYL DRUG__ID D00NYL D00NYL DRUGCLAS Investigative Drug(s) D00NYL DRUGCOMP Genzyme Corp D00NYL HIGHSTAT Investigative D00NYT DRUG__ID D00NYT D00NYT DRUGCLAS Investigative Drug(s) D00NYT DRUGINCH 1S/C18H15NO4/c1-22-13-7-3-11(4-8-13)15-16(18(21)19-17(15)20)12-5-9-14(23-2)10-6-12/h3-10H,1-2H3,(H,19,20,21) D00NYT DRUGINKE WRDXDCMVUJADCC-UHFFFAOYSA-N D00NYT DRUGSMIL COC1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=C(C=C3)OC D00NYT DRUGTYPE Small molecular drug D00NYT HIGHSTAT Investigative D00NZL DRUG__ID D00NZL D00NZL DRUGCLAS Clinical Trial Drug(s) D00NZL DRUGCOMP Eli Lilly D00NZL DRUGINCH 1S/C18H22BrN5O3/c1-11-5-16(27-10-13-8-20-3-4-26-13)15(6-14(11)19)23-18(25)24-17-9-21-12(2)7-22-17/h5-7,9,13,20H,3-4,8,10H2,1-2H3,(H2,22,23,24,25)/t13-/m0/s1 D00NZL DRUGINKE SYYBDNPGDKKJDU-ZDUSSCGKSA-N D00NZL DRUGSMIL CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OCC3CNCCO3 D00NZL DRUGTYPE Small molecular drug D00NZL HIGHSTAT Phase 2 D00NZP DRUG__ID D00NZP D00NZP DRUGCLAS Investigative Drug(s) D00NZP DRUGINCH 1S/C36H41N5O5/c1-22-15-28(42)16-23(2)29(22)20-30(37)36(46)41(3)21-33(43)39-32(18-24-9-5-4-6-10-24)35(45)40-31(34(38)44)19-25-13-14-26-11-7-8-12-27(26)17-25/h4-17,30-32,42H,18-21,37H2,1-3H3,(H2,38,44)(H,39,43)(H,40,45)/t30-,31+,32-/m0/s1 D00NZP DRUGINKE LCSGBFCHAFMKLD-QAXCHELISA-N D00NZP DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N(C)CC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)N)N)C)O D00NZP DRUGTYPE Small molecular drug D00NZP HIGHSTAT Investigative D00OAB DRUG__ID D00OAB D00OAB DRUGCLAS Investigative Drug(s) D00OAB DRUGCOMP Epitomics Inc D00OAB HIGHSTAT Investigative D00OAN DRUG__ID D00OAN D00OAN DRUGCLAS Investigative Drug(s) D00OAN DRUGINCH 1S/C15H14N2O2/c1-2-7-19-15(18)13-8-11-10-5-3-4-6-12(10)17-14(11)9-16-13/h3-6,8-9,17H,2,7H2,1H3 D00OAN DRUGINKE WGRVAGIQTHEEQW-UHFFFAOYSA-N D00OAN DRUGSMIL CCCOC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D00OAN DRUGTYPE Small molecular drug D00OAN HIGHSTAT Investigative D00OAU DRUG__ID D00OAU D00OAU DRUGCLAS Clinical Trial Drug(s) D00OAU DRUGINCH 1S/C21H26N10O4/c1-2-31-28-18(27-29-31)16-14(33)15(34)20(35-16)30-10-23-13-17(22)25-21(26-19(13)30)24-12(9-32)8-11-6-4-3-5-7-11/h3-7,10,12,14-16,20,32-34H,2,8-9H2,1H3,(H3,22,24,25,26)/t12-,14-,15+,16-,20+/m0/s1 D00OAU DRUGINKE FLBKPDIBGNWXMT-NIQZGXKPSA-N D00OAU DRUGSMIL CCN1N=C(N=N1)C2C(C(C(O2)N3C=NC4=C(N=C(N=C43)NC(CC5=CC=CC=C5)CO)N)O)O D00OAU DRUGTYPE Small molecular drug D00OAU HIGHSTAT Phase 1 D00OAY DRUG__ID D00OAY D00OAY DRUGCLAS Approved Drug(s) D00OAY DRUGCOMP Kanebo D00OAY DRUGINCH 1S/C21H25N3O7S.ClH/c1-10-12(31-20(28)30-10)9-29-19(27)15-21(2,3)32-18-14(17(26)24(15)18)23-16(25)13(22)11-7-5-4-6-8-11;/h4-8,10,12-15,18H,9,22H2,1-3H3,(H,23,25);1H/t10?,12?,13-,14-,15+,18-;/m1./s1 D00OAY DRUGINKE DYYWCSJCOBIQFH-XFWACAJASA-N D00OAY DRUGSMIL CC1C(OC(=O)O1)COC(=O)C2C(SC3N2C(=O)C3NC(=O)C(C4=CC=CC=C4)N)(C)C.Cl D00OAY DRUGTYPE Small molecular drug D00OAY HIGHSTAT Approved D00OBS DRUG__ID D00OBS D00OBS DRUGCLAS Investigative Drug(s) D00OBS DRUGINCH 1S/C17H21BrN6O2/c18-10-3-4-11-9(8-22-13(11)7-10)6-14-16(26)23-12(15(25)24-14)2-1-5-21-17(19)20/h3-4,7-8,12,14,22H,1-2,5-6H2,(H,23,26)(H,24,25)(H4,19,20,21)/t12-,14-/m0/s1 D00OBS DRUGINKE HVWYYWIRLPBRTO-JSGCOSHPSA-N D00OBS DRUGSMIL C1=CC2=C(C=C1Br)NC=C2CC3C(=O)NC(C(=O)N3)CCCN=C(N)N D00OBS DRUGTYPE Small molecular drug D00OBS HIGHSTAT Investigative D00OCB DRUG__ID D00OCB D00OCB DRUGCLAS Preclinical Drug(s) D00OCB DRUGCOMP Vernalis; Novartis D00OCB DRUGINCH 1S/C20H20N2O4/c1-3-12-8-14(16(24)10-15(12)23)20-19(11(2)21-22-20)13-4-5-17-18(9-13)26-7-6-25-17/h4-5,8-10,23-24H,3,6-7H2,1-2H3,(H,21,22) D00OCB DRUGINKE OWPMENVYXDJDOW-UHFFFAOYSA-N D00OCB DRUGSMIL CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C D00OCB DRUGTYPE Small molecular drug D00OCB HIGHSTAT Preclinical D00OCB THERCLAS Anticancer Agents D00OCC DRUG__ID D00OCC D00OCC DRUGCLAS Investigative Drug(s) D00OCC DRUGINCH 1S/C16H18N2O2S/c19-21(20,15-6-2-1-3-7-15)16-8-4-5-14(13-16)18-11-9-17-10-12-18/h1-8,13,17H,9-12H2 D00OCC DRUGINKE KDBOZUADFFNYSM-UHFFFAOYSA-N D00OCC DRUGSMIL C1CN(CCN1)C2=CC(=CC=C2)S(=O)(=O)C3=CC=CC=C3 D00OCC DRUGTYPE Small molecular drug D00OCC HIGHSTAT Investigative D00OCS DRUG__ID D00OCS D00OCS DRUGCLAS Investigative Drug(s) D00OCS DRUGINCH 1S/C46H84N24O9/c47-17-5-1-2-6-18-57-37(74)26(12-8-20-59-43(49)50)67-39(76)28(14-10-22-61-45(53)54)69-40(77)29(15-11-23-62-46(55)56)68-38(75)27(13-9-21-60-44(51)52)66-30(71)16-4-3-7-19-58-41(78)34-32(72)33(73)42(79-34)70-25-65-31-35(48)63-24-64-36(31)70/h24-29,32-34,42,72-73H,1-23,47H2,(H,57,74)(H,58,78)(H,66,71)(H,67,76)(H,68,75)(H,69,77)(H2,48,63,64)(H4,49,50,59)(H4,51,52,60)(H4,53,54,61)(H4,55,56,62)/t26-,27-,28-,29-,32-,33+,34-,42+/m0/s1 D00OCS DRUGINKE AKYVNHGFJFUSDY-HYKQOWLKSA-N D00OCS DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NCCCCCCN)O)O)N D00OCS HIGHSTAT Investigative D00OCV DRUG__ID D00OCV D00OCV DRUGCLAS Investigative Drug(s) D00OCV DRUGINCH 1S/C13H18N2O/c1-9-10(7-8-15(2)3)13-11(14-9)5-4-6-12(13)16/h4-6,14,16H,7-8H2,1-3H3 D00OCV DRUGINKE HXNGZUVNHQYMKL-UHFFFAOYSA-N D00OCV DRUGSMIL CC1=C(C2=C(N1)C=CC=C2O)CCN(C)C D00OCV DRUGTYPE Small molecular drug D00OCV HIGHSTAT Investigative D00ODC DRUG__ID D00ODC D00ODC COMPCLAS Imidazo pyridine derivatives D00ODC DRUGCLAS Patented Agent(s) D00ODC DRUGCOMP THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES MARUGAN, Juan J. PATNAIK, Samarjit HEILIG, Markus A. SOUTHALL, Noel T. ZHENG, Wei D00ODC DRUGTYPE Small molecular drug D00ODC HIGHSTAT Patented D00ODF DRUG__ID D00ODF D00ODF DRUGCLAS Investigative Drug(s) D00ODF DRUGCOMP Isis Pharmaceuticals D00ODF DRUGTYPE Antisense drug D00ODF HIGHSTAT Investigative D00ODL DRUG__ID D00ODL D00ODL DRUGCLAS Investigative Drug(s) D00ODL DRUGINCH 1S/C31H38N6O4/c1-31(2,3)35-29(40)34-25(16-21-18-32-23-13-8-7-12-22(21)23)28(39)33-24-14-9-15-36-26(24)17-27(38)37(30(36)41)19-20-10-5-4-6-11-20/h4-8,10-13,18,24-26,32H,9,14-17,19H2,1-3H3,(H,33,39)(H2,34,35,40)/t24-,25+,26+/m1/s1 D00ODL DRUGINKE JQMXXJDAKTTXOB-ZNZIZOMTSA-N D00ODL DRUGSMIL CC(C)(C)NC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC3CCCN4C3CC(=O)N(C4=O)CC5=CC=CC=C5 D00ODL DRUGTYPE Small molecular drug D00ODL HIGHSTAT Investigative D00ODN DRUG__ID D00ODN D00ODN DRUGCLAS Investigative Drug(s) D00ODN DRUGINCH 1S/C18H14N4S/c1-3-7-14(8-4-1)11-22-13-21-16-17(22)19-12-20-18(16)23-15-9-5-2-6-10-15/h1-10,12-13H,11H2 D00ODN DRUGINKE ADCGNZUTMCMTDC-UHFFFAOYSA-N D00ODN DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C2N=CN=C3SC4=CC=CC=C4 D00ODN DRUGTYPE Small molecular drug D00ODN HIGHSTAT Investigative D00ODY DRUG__ID D00ODY D00ODY DRUGCLAS Patented Agent(s) D00ODY DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D00ODY DRUGTYPE Small molecular drug D00ODY HIGHSTAT Patented D00OEG DRUG__ID D00OEG D00OEG DRUGCLAS Discontinued Drug(s) D00OEG DRUGCOMP Pharmacia; Pfizer D00OEG HIGHSTAT Discontinued in Phase 3 D00OFN DRUG__ID D00OFN D00OFN DRUGCLAS Investigative Drug(s) D00OFN DRUGINCH 1S/C11H12N4S/c1-2-16-11-14-9(13-10(12)15-11)8-6-4-3-5-7-8/h3-7H,2H2,1H3,(H2,12,13,14,15) D00OFN DRUGINKE UMHVGNHYSDRNNN-UHFFFAOYSA-N D00OFN DRUGSMIL CCSC1=NC(=NC(=N1)N)C2=CC=CC=C2 D00OFN DRUGTYPE Small molecular drug D00OFN HIGHSTAT Investigative D00OFV DRUG__ID D00OFV D00OFV DRUGCLAS Investigative Drug(s) D00OFV DRUGINCH 1S/C31H29N5O4/c1-17(2)15-22-29(39)36-25-14-8-5-11-20(25)31(40,30(36)34-22)16-23-26-32-21-12-6-3-9-18(21)28(38)35(26)24-13-7-4-10-19(24)27(37)33-23/h3-14,17,22-23,30,34,40H,15-16H2,1-2H3,(H,33,37)/t22-,23-,30-,31-/m0/s1 D00OFV DRUGINKE MGMRIOLWEROPJY-FPACPZPDSA-N D00OFV DRUGSMIL CC(C)CC1C(=O)N2C(N1)C(C3=CC=CC=C32)(CC4C5=NC6=CC=CC=C6C(=O)N5C7=CC=CC=C7C(=O)N4)O D00OFV DRUGTYPE Small molecular drug D00OFV HIGHSTAT Investigative D00OGX DRUG__ID D00OGX D00OGX DRUGCLAS Approved Drug(s) D00OGX DRUGCOMP ASAC Pharmaceutical International AIE D00OGX HIGHSTAT Approved D00OHP DRUG__ID D00OHP D00OHP DRUGCLAS Investigative Drug(s) D00OHP DRUGCOMP Galectin Therapeutics Inc D00OHP HIGHSTAT Investigative D00OJL DRUG__ID D00OJL D00OJL DRUGCLAS Investigative Drug(s) D00OJL DRUGCOMP Provid Pharmaceuticals Inc D00OJL HIGHSTAT Investigative D00OKK DRUG__ID D00OKK D00OKK DRUGCLAS Investigative Drug(s) D00OKK DRUGCOMP Pico Pharmaceuticals Inc D00OKK HIGHSTAT Investigative D00OLA DRUG__ID D00OLA D00OLA DRUGCLAS Investigative Drug(s) D00OLA DRUGINCH 1S/C111H159N37O18/c1-4-19-77(136-96(157)80(28-13-46-126-106(114)115)135-92(153)73(112)55-64-58-132-74-25-10-7-22-70(64)74)94(155)140-84(32-17-50-130-110(122)123)100(161)145-87(53-62-36-42-68(150)43-37-62)102(163)148-90(57-66-60-134-76-27-12-9-24-72(66)76)105(166)143-82(30-15-48-128-108(118)119)98(159)138-79(21-6-3)95(156)141-85(33-18-51-131-111(124)125)101(162)146-88(54-63-38-44-69(151)45-39-63)103(164)147-89(56-65-59-133-75-26-11-8-23-71(65)75)104(165)142-81(29-14-47-127-107(116)117)97(158)137-78(20-5-2)93(154)139-83(31-16-49-129-109(120)121)99(160)144-86(91(113)152)52-61-34-40-67(149)41-35-61/h7-12,22-27,34-45,58-60,73,77-90,132-134,149-151H,4-6,13-21,28-33,46-57,112H2,1-3H3,(H2,113,152)(H,135,153)(H,136,157)(H,137,158)(H,138,159)(H,139,154)(H,140,155)(H,141,156)(H,142,165)(H,143,166)(H,144,160)(H,145,161)(H,146,162)(H,147,164)(H,148,163)(H4,114,115,126)(H4,116,117,127)(H4,118,119,128)(H4,120,121,129)(H4,122,123,130)(H4,124,125,131)/t73-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-/m0/s1 D00OLA DRUGINKE DRBRBJSYRQHXHE-TWUBVJIJSA-N D00OLA DRUGSMIL CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC8=CNC9=CC=CC=C98)N D00OLA HIGHSTAT Investigative D00OLH DRUG__ID D00OLH D00OLH DRUGCLAS Investigative Drug(s) D00OLH DRUGINCH 1S/C20H16O3/c21-17-7-1-14(2-8-17)13-20(15-3-9-18(22)10-4-15)16-5-11-19(23)12-6-16/h1-13,21-23H D00OLH DRUGINKE LZHPXIZTZSFAAE-UHFFFAOYSA-N D00OLH DRUGSMIL C1=CC(=CC=C1C=C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)O D00OLH DRUGTYPE Small molecular drug D00OLH HIGHSTAT Investigative D00OLX DRUG__ID D00OLX D00OLX DRUGCLAS Investigative Drug(s) D00OLX DRUGINCH 1S/C16H18N4O3/c1-10-6-5-7-11(8-10)9-23-15-17-13-12(18(15)2)14(21)20(4)16(22)19(13)3/h5-8H,9H2,1-4H3 D00OLX DRUGINKE AFSVTGXZVYXITM-UHFFFAOYSA-N D00OLX DRUGSMIL CC1=CC(=CC=C1)COC2=NC3=C(N2C)C(=O)N(C(=O)N3C)C D00OLX DRUGTYPE Small molecular drug D00OLX HIGHSTAT Investigative D00OLY DRUG__ID D00OLY D00OLY DRUGCLAS Patented Agent(s) D00OLY DRUGCOMP Xention Ltd D00OLY DRUGTYPE Small molecular drug D00OLY HIGHSTAT Patented D00OMJ DRUG__ID D00OMJ D00OMJ DRUGCLAS Investigative Drug(s) D00OMJ DRUGCOMP SJ Biomed Inc D00OMJ HIGHSTAT Investigative D00OMV DRUG__ID D00OMV D00OMV DRUGCLAS Investigative Drug(s) D00OMV DRUGINCH 1S/C35H42O8/c1-16(2)12-23(37)41-22-14-18(4)24-21(36)13-17(3)25(24)28-26(22)35(31(39)43-28)15-34-11-10-32(35,6)29(34)27-20(8-9-33(34,7)40)19(5)30(38)42-27/h10-11,13,16,20,22,25-29,40H,5,8-9,12,14-15H2,1-4,6-7H3/t20-,22-,25-,26+,27-,28+,29-,32+,33+,34-,35+/m0/s1 D00OMV DRUGINKE RAKYLPJLLBOHHN-CFTUDFFSSA-N D00OMV DRUGSMIL CC1=C2C(C3C(C(C1)OC(=O)CC(C)C)C4(CC56C=CC4(C5C7C(CCC6(C)O)C(=C)C(=O)O7)C)C(=O)O3)C(=CC2=O)C D00OMV DRUGTYPE Small molecular drug D00OMV HIGHSTAT Investigative D00OMW DRUG__ID D00OMW D00OMW DRUGCLAS Investigative Drug(s) D00OMW DRUGINCH 1S/C17H16N2O4S2/c1-8(2)12(16(22)23)19-15(21)13(25-17(19)24)11-9-6-4-5-7-10(9)18(3)14(11)20/h4-8,12H,1-3H3,(H,22,23)/b13-11- D00OMW DRUGINKE ICRQMQBVDGOOFY-QBFSEMIESA-N D00OMW DRUGSMIL CC(C)C(C(=O)O)N1C(=O)C(=C2C3=CC=CC=C3N(C2=O)C)SC1=S D00OMW DRUGTYPE Small molecular drug D00OMW HIGHSTAT Investigative D00ONE DRUG__ID D00ONE D00ONE DRUGCLAS Investigative Drug(s) D00ONE DRUGCOMP JW Pharmaceutical Corp D00ONE HIGHSTAT Investigative D00ONN DRUG__ID D00ONN D00ONN COMPCLAS Imidazo triazine derivatives D00ONN DRUGCLAS Patented Agent(s) D00ONN DRUGCOMP Pfizer Incorporated D00ONN DRUGINCH 1S/C19H18F3N7/c1-11-26-15(17-18(27(2)3)23-10-25-29(11)17)14-9-24-28(4)16(14)12-5-7-13(8-6-12)19(20,21)22/h5-10H,1-4H3 D00ONN DRUGINKE UXZUQMRCSXERSI-UHFFFAOYSA-N D00ONN DRUGSMIL CC1=NC(=C2N1N=CN=C2N(C)C)C3=C(N(N=C3)C)C4=CC=C(C=C4)C(F)(F)F D00ONN DRUGTYPE Small molecular drug D00ONN HIGHSTAT Patented D00OON DRUG__ID D00OON D00OON DRUGCLAS Clinical Trial Drug(s) D00OON DRUGCOMP BioAtla San Diego, CA D00OON HIGHSTAT Phase 1/2 D00OOZ DRUG__ID D00OOZ D00OOZ DRUGCLAS Clinical Trial Drug(s) D00OOZ DRUGCOMP Eisai Co Ltd D00OOZ DRUGINCH 1S/C40H66N2O9/c1-7-32(44)29(4)37-33(49-37)26-39(5,47)19-12-13-27(2)36-28(3)16-17-34(40(6,48)20-18-31(43)25-35(45)51-36)50-38(46)42-23-21-41(22-24-42)30-14-10-8-9-11-15-30/h12-13,16-17,19,28-34,36-37,43-44,47-48H,7-11,14-15,18,20-26H2,1-6H3/b17-16+,19-12+,27-13+ D00OOZ DRUGINKE MNOMBFWMICHMKG-DDEPDXEBSA-N D00OOZ DRUGSMIL CCC(C(C)C1C(O1)CC(C)(C=CC=C(C)C2C(C=CC(C(CCC(CC(=O)O2)O)(C)O)OC(=O)N3CCN(CC3)C4CCCCCC4)C)O)O D00OOZ DRUGTYPE Small molecular drug D00OOZ HIGHSTAT Phase 1 D00OPO DRUG__ID D00OPO D00OPO DRUGCLAS Investigative Drug(s) D00OPO DRUGINCH 1S/C43H46N2O10/c1-3-23-44(27-29-15-19-33(20-16-29)54-31-11-7-5-8-12-31)39(48)35-25-36(43(42(52)53,26-37(46)47)38(35)41(50)51)40(49)45(24-4-2)28-30-17-21-34(22-18-30)55-32-13-9-6-10-14-32/h5-22,35-36,38H,3-4,23-28H2,1-2H3,(H,46,47)(H,50,51)(H,52,53)/t35-,36-,38+,43-/m0/s1 D00OPO DRUGINKE SZUVGFMDDVSKSI-WIFOCOSTSA-N D00OPO DRUGSMIL CCCN(CC1=CC=C(C=C1)OC2=CC=CC=C2)C(=O)C3CC(C(C3C(=O)O)(CC(=O)O)C(=O)O)C(=O)N(CCC)CC4=CC=C(C=C4)OC5=CC=CC=C5 D00OPO DRUGTYPE Small molecular drug D00OPO HIGHSTAT Investigative D00OPX DRUG__ID D00OPX D00OPX DRUGCLAS Clinical Trial Drug(s) D00OPX DRUGCOMP Rigel Pharmaceuticals South San Francisco, CA D00OPX DRUGINCH 1S/C23H26FN6O9P.2Na/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4;;/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29);;/q;2*+1/p-2 D00OPX DRUGINKE HSYBQXDGYCYSGA-UHFFFAOYSA-L D00OPX DRUGSMIL CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)([O-])[O-])C.[Na+].[Na+] D00OPX HIGHSTAT Phase 3 D00OQL DRUG__ID D00OQL D00OQL DRUGCLAS Investigative Drug(s) D00OQL DRUGINCH 1S/C16H16O4/c1-9(17)8-19-14-7-6-12-11-4-3-5-13(11)16(18)20-15(12)10(14)2/h6-7H,3-5,8H2,1-2H3 D00OQL DRUGINKE JLYIBZRYQJEBHZ-UHFFFAOYSA-N D00OQL DRUGSMIL CC1=C(C=CC2=C1OC(=O)C3=C2CCC3)OCC(=O)C D00OQL DRUGTYPE Small molecular drug D00OQL HIGHSTAT Investigative D00ORM DRUG__ID D00ORM D00ORM DRUGCLAS Investigative Drug(s) D00ORM DRUGINCH 1S/C17H17NO2/c19-17(20)11-5-6-12-18-15-9-3-1-7-13(15)14-8-2-4-10-16(14)18/h1-4,7-10H,5-6,11-12H2,(H,19,20) D00ORM DRUGINKE YEPJVQJMLQBLOE-UHFFFAOYSA-N D00ORM DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCCC(=O)O D00ORM DRUGTYPE Small molecular drug D00ORM HIGHSTAT Investigative D00ORZ DRUG__ID D00ORZ D00ORZ DRUGCLAS Clinical Trial Drug(s) D00ORZ DRUGCOMP Bristol-Myers Squibb Co D00ORZ HIGHSTAT Phase 2 D00OSB DRUG__ID D00OSB D00OSB DRUGCLAS Investigative Drug(s) D00OSB DRUGINCH 1S/C70H101N19O18S2/c1-36(73)59(96)77-32-55(94)79-53-35-109-108-34-52(58(75)95)87-67(104)51(33-90)86-70(107)57(39(4)92)89-66(103)48(28-41-19-9-6-10-20-41)85-69(106)56(38(3)91)88-62(99)46(24-14-16-26-72)80-64(101)49(29-42-31-76-44-22-12-11-21-43(42)44)82-60(97)37(2)78-63(100)47(27-40-17-7-5-8-18-40)83-65(102)50(30-54(74)93)84-61(98)45(81-68(53)105)23-13-15-25-71/h5-12,17-22,31,36-39,45-53,56-57,76,90-92H,13-16,23-30,32-35,71-73H2,1-4H3,(H2,74,93)(H2,75,95)(H,77,96)(H,78,100)(H,79,94)(H,80,101)(H,81,105)(H,82,97)(H,83,102)(H,84,98)(H,85,106)(H,86,107)(H,87,104)(H,88,99)(H,89,103)/t36-,37+,38?,39?,45-,46+,47-,48-,49-,50+,51-,52-,53-,56+,57+/m0/s1 D00OSB DRUGINKE IMPCJRRYNLCKNP-IORPGQRLSA-N D00OSB DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)N)CO)C(C)O)CC3=CC=CC=C3)C(C)O)CCCCN)CC4=CNC5=CC=CC=C54 D00OSB HIGHSTAT Investigative D00OTC DRUG__ID D00OTC D00OTC DRUGCLAS Investigative Drug(s) D00OTC DRUGINCH 1S/C17H18O4/c1-19-14-8-13(9-15(11-14)20-2)5-4-12-6-7-17(21-3)16(18)10-12/h4-11,18H,1-3H3/b5-4+ D00OTC DRUGINKE UQIWTPQGJCCTPA-SNAWJCMRSA-N D00OTC DRUGSMIL COC1=C(C=C(C=C1)C=CC2=CC(=CC(=C2)OC)OC)O D00OTC DRUGTYPE Small molecular drug D00OTC HIGHSTAT Investigative D00OTH DRUG__ID D00OTH D00OTH DRUGCLAS Investigative Drug(s) D00OTH DRUGCOMP Piramal Healthcare Ltd D00OTH DRUGINCH 1S/C18H20N2/c1-19-12-6-7-14(13-19)20-17-10-4-2-8-15(17)16-9-3-5-11-18(16)20/h2-5,8-11,14H,6-7,12-13H2,1H3 D00OTH DRUGINKE QTWMKHMFYDJEBU-UHFFFAOYSA-N D00OTH DRUGSMIL CN1CCCC(C1)N2C3=CC=CC=C3C4=CC=CC=C42 D00OTH DRUGTYPE Small molecular drug D00OTH HIGHSTAT Investigative D00OTL DRUG__ID D00OTL D00OTL DRUGCLAS Clinical Trial Drug(s) D00OTL DRUGCOMP Cardiome Pharma; Merck D00OTL DRUGINCH 1S/C20H31NO4/c1-23-19-8-7-15(13-20(19)24-2)10-12-25-18-6-4-3-5-17(18)21-11-9-16(22)14-21/h7-8,13,16-18,22H,3-6,9-12,14H2,1-2H3/t16-,17-,18-/m1/s1 D00OTL DRUGINKE VBHQKCBVWWUUKN-KZNAEPCWSA-N D00OTL DRUGSMIL COC1=C(C=C(C=C1)CCOC2CCCCC2N3CCC(C3)O)OC D00OTL DRUGTYPE Small molecular drug D00OTL HIGHSTAT Phase 3 D00OTM DRUG__ID D00OTM D00OTM DRUGCLAS Clinical Trial Drug(s) D00OTM DRUGCOMP Eli Lilly Indianapolis, IN D00OTM HIGHSTAT Phase 1 D00OTQ DRUG__ID D00OTQ D00OTQ DRUGCLAS Investigative Drug(s) D00OTQ DRUGCOMP ProtAb Ltd D00OTQ DRUGTYPE Monoclonal antibody D00OTQ HIGHSTAT Investigative D00OTT DRUG__ID D00OTT D00OTT DRUGCLAS Approved Drug(s) D00OTT DRUGCOMP Isis Pharmaceuticals D00OTT DRUGTYPE Antisense drug D00OTT HIGHSTAT Approved D00OUF DRUG__ID D00OUF D00OUF DRUGCLAS Investigative Drug(s) D00OUF DRUGINCH 1S/C19H30N2O/c1-3-8-19(9-4-1)22-17-7-12-20-15-10-18(11-16-20)21-13-5-2-6-14-21/h1,3-4,8-9,18H,2,5-7,10-17H2 D00OUF DRUGINKE GCJKCPQHXFIKIF-UHFFFAOYSA-N D00OUF DRUGSMIL C1CCN(CC1)C2CCN(CC2)CCCOC3=CC=CC=C3 D00OUF DRUGTYPE Small molecular drug D00OUF HIGHSTAT Investigative D00OUG DRUG__ID D00OUG D00OUG DRUGCLAS Patented Agent(s) D00OUG DRUGINCH 1S/C16H9BrO4/c17-11-4-1-9(2-5-11)12-7-10-3-6-14(19)13(8-18)15(10)21-16(12)20/h1-8,19H D00OUG DRUGINKE DJSPMRZGTUKARX-UHFFFAOYSA-N D00OUG DRUGSMIL C1=CC(=CC=C1C2=CC3=C(C(=C(C=C3)O)C=O)OC2=O)Br D00OUG DRUGTYPE Small molecular drug D00OUG HIGHSTAT Patented D00OVC DRUG__ID D00OVC D00OVC DRUGCLAS Clinical Trial Drug(s) D00OVC DRUGCOMP Roche Holding AG D00OVC DRUGINCH 1S/C17H17ClN6O2/c1-22(2)8-13-20-16(21-26-13)15-12-7-23(3)17(25)14-10(18)5-4-6-11(14)24(12)9-19-15/h4-6,9H,7-8H2,1-3H3 D00OVC DRUGINKE JCYLWUVDHLVGER-UHFFFAOYSA-N D00OVC DRUGSMIL CN1CC2=C(N=CN2C3=C(C1=O)C(=CC=C3)Cl)C4=NOC(=N4)CN(C)C D00OVC HIGHSTAT Phase 2 D00OVE DRUG__ID D00OVE D00OVE DRUGCLAS Clinical Trial Drug(s) D00OVE DRUGCOMP Pfizer D00OVE HIGHSTAT Phase 1 D00OVU DRUG__ID D00OVU D00OVU DRUGCLAS Approved Drug(s) D00OVU DRUGINCH 1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1 D00OVU DRUGINKE JYTNQNCOQXFQPK-MRXNPFEDSA-N D00OVU DRUGSMIL CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl D00OVU DRUGTYPE Small molecular drug D00OVU HIGHSTAT Approved D00OWE DRUG__ID D00OWE D00OWE DRUGCLAS Investigative Drug(s) D00OWE DRUGINCH 1S/C22H14F3NO2S2/c23-22(24,25)14-8-9-18-15(11-14)19(27)20(30-18)21(28)26-12-16(17-7-4-10-29-17)13-5-2-1-3-6-13/h1-12,27H,(H,26,28)/b16-12+ D00OWE DRUGINKE MWRHQMNEBAXDOF-FOWTUZBSSA-N D00OWE DRUGSMIL C1=CC=C(C=C1)C(=CNC(=O)C2=C(C3=C(S2)C=CC(=C3)C(F)(F)F)O)C4=CC=CS4 D00OWE DRUGTYPE Small molecular drug D00OWE HIGHSTAT Investigative D00OWF DRUG__ID D00OWF D00OWF DRUGCLAS Patented Agent(s) D00OWF DRUGINCH 1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3 D00OWF DRUGINKE BXNJHAXVSOCGBA-UHFFFAOYSA-N D00OWF DRUGSMIL CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC D00OWF DRUGTYPE Small molecular drug D00OWF HIGHSTAT Patented D00OWU DRUG__ID D00OWU D00OWU DRUGCLAS Clinical Trial Drug(s) D00OWU DRUGCOMP Reckitt benckiser pharmaceutical D00OWU HIGHSTAT Phase 2 D00OWZ DRUG__ID D00OWZ D00OWZ DRUGCLAS Investigative Drug(s) D00OWZ DRUGINCH 1S/C11H10N2O2S/c1-15-9-4-2-8(3-5-9)10(14)13-11-12-6-7-16-11/h2-7H,1H3,(H,12,13,14) D00OWZ DRUGINKE PPERAEKJEHRHOY-UHFFFAOYSA-N D00OWZ DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=NC=CS2 D00OWZ DRUGTYPE Small molecular drug D00OWZ HIGHSTAT Investigative D00OXH DRUG__ID D00OXH D00OXH DRUGCLAS Investigative Drug(s) D00OXH DRUGINCH 1S/C21H34O4/c1-2-3-6-9-17(22)12-13-18-16-14-20(25-15-16)19(18)10-7-4-5-8-11-21(23)24/h4,7,12-13,16-20,22H,2-3,5-6,8-11,14-15H2,1H3,(H,23,24)/b7-4-,13-12+/t16-,17-,18-,19+,20-/m0/s1 D00OXH DRUGINKE DJKDIKIDYDXHDD-IGUVKOCZSA-N D00OXH DRUGSMIL CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O D00OXH DRUGTYPE Small molecular drug D00OXH HIGHSTAT Investigative D00OXP DRUG__ID D00OXP D00OXP DRUGCLAS Clinical Trial Drug(s) D00OXP DRUGCOMP bluebird bio D00OXP DRUGTYPE CAR T Cell Therapy D00OXP HIGHSTAT Phase 1 D00OYC DRUG__ID D00OYC D00OYC DRUGCLAS Clinical Trial Drug(s) D00OYC DRUGCOMP VentiRx Pharmaceuticals Seattle, WA D00OYC HIGHSTAT Phase 2 D00OYQ DRUG__ID D00OYQ D00OYQ DRUGCLAS Clinical Trial Drug(s) D00OYQ DRUGCOMP MetaPhore Pharmaceuticals D00OYQ DRUGINCH 1S/C21H35N5.2ClH.Mn/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20;;;/h5-7,18-25H,1-4,8-15H2;2*1H;/q;;;+2/p-2/t18-,19-,20-,21-;;;/m1.../s1 D00OYQ DRUGINKE WXEMWBBXVXHEPU-XNPJUPKFSA-L D00OYQ DRUGSMIL C1CCC2C(C1)NCCNC3CCCCC3NCC4=CC=CC(=N4)CN2.Cl[Mn]Cl D00OYQ DRUGTYPE Small molecular drug D00OYQ HIGHSTAT Phase 2 D00OZA DRUG__ID D00OZA D00OZA DRUGCLAS Investigative Drug(s) D00OZA DRUGINCH 1S/C12H8N2O/c1-2-8-6-9-4-3-5-10(12(13)15)11(9)14-7-8/h1,3-7H,(H2,13,15) D00OZA DRUGINKE FVYCGVPNXRWDOH-UHFFFAOYSA-N D00OZA DRUGSMIL C#CC1=CN=C2C(=C1)C=CC=C2C(=O)N D00OZA DRUGTYPE Small molecular drug D00OZA HIGHSTAT Investigative D00OZC DRUG__ID D00OZC D00OZC DRUGCLAS Clinical Trial Drug(s) D00OZC DRUGCOMP Therapix Biosciences Givatayim, Israel D00OZC HIGHSTAT Phase 3 D00OZN DRUG__ID D00OZN D00OZN DRUGCLAS Investigative Drug(s) D00OZN DRUGINCH 1S/C14H11F3N2O/c15-14(16,17)11-3-1-2-10(8-11)9-4-6-12(7-5-9)19-13(18)20/h1-8H,(H3,18,19,20) D00OZN DRUGINKE MHFIGSQWRVHNRG-UHFFFAOYSA-N D00OZN DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)C2=CC=C(C=C2)NC(=O)N D00OZN DRUGTYPE Small molecular drug D00OZN HIGHSTAT Investigative D00OZS DRUG__ID D00OZS D00OZS DRUGCLAS Investigative Drug(s) D00OZS DRUGINCH 1S/C12H17NO5S/c1-2-3-4-9-17-12(14)10-5-7-11(8-6-10)18-19(13,15)16/h5-8H,2-4,9H2,1H3,(H2,13,15,16) D00OZS DRUGINKE ZFWKNIDIWKSQEP-UHFFFAOYSA-N D00OZS DRUGSMIL CCCCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D00OZS DRUGTYPE Small molecular drug D00OZS HIGHSTAT Investigative D00PAG DRUG__ID D00PAG D00PAG DRUGCLAS Investigative Drug(s) D00PAG DRUGINCH 1S/C10H15N5O9P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(23-10)1-22-25(18,19)24-26(20,21)27/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H2,11,12,13)(H2,20,21,27)/t4-,6-,7-,10-/m1/s1/i27+3 D00PAG DRUGINKE HCIKUKNAJRJFOW-JWNXZZODSA-N D00PAG DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=S)(O)O)O)O)N D00PAG DRUGTYPE Small molecular drug D00PAG HIGHSTAT Investigative D00PAS DRUG__ID D00PAS D00PAS DRUGCLAS Investigative Drug(s) D00PAS DRUGINCH 1S/C21H22O5/c1-12(2)4-6-14-17(24-3)9-8-16-19(14)26-20-15-7-5-13(22)10-18(15)25-11-21(16,20)23/h4-5,7-10,20,22-23H,6,11H2,1-3H3/t20-,21+/m0/s1 D00PAS DRUGINKE ZHPYEBFYLDGZKF-LEWJYISDSA-N D00PAS DRUGSMIL CC(=CCC1=C(C=CC2=C1OC3C2(COC4=C3C=CC(=C4)O)O)OC)C D00PAS DRUGTYPE Small molecular drug D00PAS HIGHSTAT Investigative D00PBI DRUG__ID D00PBI D00PBI DRUGCLAS Investigative Drug(s) D00PBI DRUGCOMP Suven Life Sciences Ltd D00PBI HIGHSTAT Investigative D00PBS DRUG__ID D00PBS D00PBS DRUGCLAS Drugs in Phase 1 Trial D00PBS DRUGTYPE Cell therapy D00PBS HIGHSTAT Phase 1/2 Trial D00PBS THERCLAS Antiviral Agents D00PBX DRUG__ID D00PBX D00PBX DRUGCLAS Approved Drug(s) D00PBX DRUGCOMP AbbVie D00PBX DRUGINCH 1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54) D00PBX DRUGINKE LQBVNQSMGBZMKD-UHFFFAOYSA-N D00PBX DRUGSMIL CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C D00PBX DRUGTYPE Small molecular drug D00PBX HIGHSTAT Approved D00PCE DRUG__ID D00PCE D00PCE DRUGCLAS Investigative Drug(s) D00PCE DRUGINCH 1S/C16H22ClN3O2/c1-20-10-3-4-11(20)6-9(5-10)19-16(21)12-7-13(17)14(18)8-15(12)22-2/h7-11H,3-6,18H2,1-2H3,(H,19,21) D00PCE DRUGINKE HTMNINCXKXABOI-UHFFFAOYSA-N D00PCE DRUGSMIL CN1C2CCC1CC(C2)NC(=O)C3=CC(=C(C=C3OC)N)Cl D00PCE DRUGTYPE Small molecular drug D00PCE HIGHSTAT Investigative D00PDG DRUG__ID D00PDG D00PDG DRUGCLAS Discontinued Drug(s) D00PDG DRUGCOMP Corcept Therapeutics D00PDG DRUGINCH 1S/C26H25F4N3O3S/c1-2-36-17-25-14-18-15-31-33(22-7-5-21(27)6-8-22)24(18)13-20(25)11-12-32(16-25)37(34,35)23-9-3-19(4-10-23)26(28,29)30/h3-10,13,15H,2,11-12,14,16-17H2,1H3/t25-/m1/s1 D00PDG DRUGINKE SLKURXRZHJOZOD-RUZDIDTESA-N D00PDG DRUGSMIL CCOCC12CC3=C(C=C1CCN(C2)S(=O)(=O)C4=CC=C(C=C4)C(F)(F)F)N(N=C3)C5=CC=C(C=C5)F D00PDG DRUGTYPE Small molecular drug D00PDG HIGHSTAT Discontinued in Phase 1/2 D00PDQ DRUG__ID D00PDQ D00PDQ DRUGCLAS Investigative Drug(s) D00PDQ DRUGCOMP BioZyme Inc D00PDQ HIGHSTAT Investigative D00PEC DRUG__ID D00PEC D00PEC DRUGCLAS Investigative Drug(s) D00PEC DRUGINCH 1S/C12H18N4S2/c13-11(14)17-6-4-9-2-1-3-10(8-9)5-7-18-12(15)16/h1-3,8H,4-7H2,(H3,13,14)(H3,15,16) D00PEC DRUGINKE YEUSLPIIQGZHQB-UHFFFAOYSA-N D00PEC DRUGSMIL C1=CC(=CC(=C1)CCSC(=N)N)CCSC(=N)N D00PEC DRUGTYPE Small molecular drug D00PEC HIGHSTAT Investigative D00PEH DRUG__ID D00PEH D00PEH DRUGCLAS Approved Drug(s) D00PEH DRUGCOMP GlaxoSmithKline D00PEH DRUGINCH 1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,28,30H,1-3H3,(H,32,33) D00PEH DRUGINKE SVOQIEJWJCQGDQ-UHFFFAOYSA-N D00PEH DRUGSMIL CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C D00PEH DRUGTYPE Small molecular drug D00PEH HIGHSTAT Approved D00PEJ DRUG__ID D00PEJ D00PEJ DRUGCLAS Investigative Drug(s) D00PEJ DRUGINCH 1S/C16H15N5O2S/c17-16(18)20-15-14-10-13(7-6-11(14)8-9-19-15)24(22,23)21-12-4-2-1-3-5-12/h1-10,21H,(H4,17,18,19,20) D00PEJ DRUGINKE NNEJXIJKGKRBBF-UHFFFAOYSA-N D00PEJ DRUGSMIL C1=CC=C(C=C1)NS(=O)(=O)C2=CC3=C(C=C2)C=CN=C3N=C(N)N D00PEJ DRUGTYPE Small molecular drug D00PEJ HIGHSTAT Investigative D00PEN DRUG__ID D00PEN D00PEN DRUGCLAS Clinical Trial Drug(s) D00PEN DRUGCOMP MacroGenics D00PEN DRUGTYPE Monoclonal antibody D00PEN HIGHSTAT Phase 1/2 D00PES DRUG__ID D00PES D00PES DRUGCLAS Patented Agent(s) D00PES DRUGINCH 1S/C15H20N2O2/c18-15(19)5-3-4-13-6-7-14(16-12-13)8-11-17-9-1-2-10-17/h3-4,6-7,12H,1-2,5,8-11H2,(H,18,19)/b4-3+ D00PES DRUGINKE YAJGYOKZMAZQGT-ONEGZZNKSA-N D00PES DRUGSMIL C1CCN(C1)CCC2=NC=C(C=C2)C=CCC(=O)O D00PES DRUGTYPE Small molecular drug D00PES HIGHSTAT Patented D00PEU DRUG__ID D00PEU D00PEU DRUGCLAS Investigative Drug(s) D00PEU DRUGINCH 1S/C23H24FN3O2/c1-16-20(23(29)27-12-3-2-4-21(27)25-16)11-15-26-13-9-18(10-14-26)22(28)17-5-7-19(24)8-6-17/h2-8,12,18H,9-11,13-15H2,1H3 D00PEU DRUGINKE HXCNRYXBZNHDNE-UHFFFAOYSA-N D00PEU DRUGSMIL CC1=C(C(=O)N2C=CC=CC2=N1)CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F D00PEU DRUGTYPE Small molecular drug D00PEU HIGHSTAT Investigative D00PEV DRUG__ID D00PEV D00PEV DRUGCLAS Patented Agent(s) D00PEV DRUGCOMP DEBRECENI EGYETEM D00PEV DRUGTYPE Carbohydrates D00PEV HIGHSTAT Patented D00PFD DRUG__ID D00PFD D00PFD COMPCLAS Benzyl pyrrolyloxoacetamide derivatives D00PFD DRUGCLAS Patented Agent(s) D00PFD DRUGCOMP IRONWOOD PHARMACEUTICALS, INC. HUDSON, Colleen BARDEN, Timothy, C. JIA, James MERMERIAN, Ara PENG, Bo YANG, Jane YU, Xiang, Y. SPROTT, Kevin FRETZEN, AngelikIRONWOOD PHARMACEUTICALS, INC. SPROTT, Kevin TALLEY, John, Jeffrey YANG, Jane PENG, Bo D00PFD DRUGINCH 1S/C23H20ClN3O3S/c1-13-10-18-22(31-13)20(14(2)27(18)12-15-4-6-16(24)7-5-15)21(28)23(29)26-17-8-9-25-19(11-17)30-3/h4-11H,12H2,1-3H3,(H,25,26,29) D00PFD DRUGINKE KJJWMDHJTAKZAD-UHFFFAOYSA-N D00PFD DRUGSMIL CC1=CC2=C(S1)C(=C(N2CC3=CC=C(C=C3)Cl)C)C(=O)C(=O)NC4=CC(=NC=C4)OC D00PFD DRUGTYPE Small molecular drug D00PFD HIGHSTAT Patented D00PFS DRUG__ID D00PFS D00PFS COMPCLAS Azetidinyl-piperidine derivatives D00PFS DRUGCLAS Patented Agent(s) D00PFS DRUGTYPE Small molecular drug D00PFS HIGHSTAT Patented D00PFT DRUG__ID D00PFT D00PFT DRUGCLAS Patented Agent(s) D00PFT DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D00PFT DRUGINCH 1S/C25H26N6O/c1-17(2)28-24(32)18-5-8-21(9-6-18)29-25-27-12-11-22(30-25)19-7-10-23(20(15-19)16-26)31-13-3-4-14-31/h5-12,15,17H,3-4,13-14H2,1-2H3,(H,28,32)(H,27,29,30) D00PFT DRUGINKE FJNGYFUMQJIPOQ-UHFFFAOYSA-N D00PFT DRUGSMIL CC(C)NC(=O)C1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)N4CCCC4)C#N D00PFT DRUGTYPE Small molecular drug D00PFT HIGHSTAT Patented D00PFW DRUG__ID D00PFW D00PFW DRUGCLAS Discontinued Drug(s) D00PFW DRUGCOMP AstraZeneca D00PFW DRUGTYPE Small molecular drug D00PFW HIGHSTAT Discontinued in Phase 2 D00PGA DRUG__ID D00PGA D00PGA DRUGCLAS Investigative Drug(s) D00PGA DRUGCOMP RegenX Biosciences LLC D00PGA HIGHSTAT Investigative D00PGF DRUG__ID D00PGF D00PGF DRUGCLAS Investigative Drug(s) D00PGF DRUGCOMP RespiVert Ltd D00PGF HIGHSTAT Investigative D00PGP DRUG__ID D00PGP D00PGP COMPCLAS Benzamide derivatives D00PGP DRUGCLAS Patented Agent(s) D00PGP DRUGCOMP THE JOHNS HOPKINS UNIVERSITY The National Institutes of Health D00PGP DRUGINCH 1S/C26H27N3O4S/c30-26(27-23-7-11-25(12-8-23)34(31,32)29-15-17-33-18-16-29)21-5-9-24(10-6-21)28-14-13-20-3-1-2-4-22(20)19-28/h1-12H,13-19H2,(H,27,30) D00PGP DRUGINKE AXIVYOPFBOAPKD-UHFFFAOYSA-N D00PGP DRUGSMIL C1CN(CC2=CC=CC=C21)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)S(=O)(=O)N5CCOCC5 D00PGP DRUGTYPE Small molecular drug D00PGP HIGHSTAT Patented D00PHK DRUG__ID D00PHK D00PHK COMPCLAS Carboxylic acid derivatives D00PHK DRUGCLAS Patented Agent(s) D00PHK DRUGCOMP ELI LILLY AND COMPANY D00PHK DRUGTYPE Small molecular drug D00PHK HIGHSTAT Patented D00PIE DRUG__ID D00PIE D00PIE DRUGCLAS Discontinued Drug(s) D00PIE DRUGCOMP KuDOS Pharmaceuticals; Novacea D00PIE DRUGINCH 1S/C22H28N4O6/c1-25(2,31)11-9-23-13-5-6-14(24-10-12-26(3,4)32)18-17(13)21(29)19-15(27)7-8-16(28)20(19)22(18)30/h5-8,23-24,27-28H,9-12H2,1-4H3 D00PIE DRUGINKE YZBAXVICWUUHGG-UHFFFAOYSA-N D00PIE DRUGSMIL C[N+](C)(CCNC1=C2C(=C(C=C1)NCC[N+](C)(C)[O-])C(=O)C3=C(C=CC(=C3C2=O)O)O)[O-] D00PIE DRUGTYPE Small molecular drug D00PIE HIGHSTAT Discontinued in Phase 1 D00PJE DRUG__ID D00PJE D00PJE COMPCLAS Tetra-hydro-carboline derivatives D00PJE DRUGCLAS Patented Agent(s) D00PJE DRUGINCH 1S/C29H33N3O3/c1-2-20-5-3-6-21(15-20)17-32-24-18-31(14-8-22(24)23-7-4-13-30-26(23)32)25(33)16-28-9-11-29(19-28,12-10-28)27(34)35/h3-7,13,15H,2,8-12,14,16-19H2,1H3,(H,34,35) D00PJE DRUGINKE KFNXYFDWAKJOGZ-UHFFFAOYSA-N D00PJE DRUGSMIL CCC1=CC(=CC=C1)CN2C3=C(CCN(C3)C(=O)CC45CCC(C4)(CC5)C(=O)O)C6=C2N=CC=C6 D00PJE DRUGTYPE Small molecular drug D00PJE HIGHSTAT Patented D00PJJ DRUG__ID D00PJJ D00PJJ DRUGCLAS Clinical Trial Drug(s) D00PJJ DRUGCOMP Fujisawa Pharmaceutical Co Ltd; aestus therapeutics D00PJJ DRUGINCH 1S/C21H23Cl2N3O3S/c1-3-4-5-10-30(28,29)25-21(27)15-7-9-19-20(11-15)26(14(2)24-19)13-16-6-8-17(22)12-18(16)23/h6-9,11-12H,3-5,10,13H2,1-2H3,(H,25,27) D00PJJ DRUGINKE UYGZODVVDUIDDQ-UHFFFAOYSA-N D00PJJ DRUGSMIL CCCCCS(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(N2CC3=C(C=C(C=C3)Cl)Cl)C D00PJJ DRUGTYPE Small molecular drug D00PJJ HIGHSTAT Phase 2 D00PJK DRUG__ID D00PJK D00PJK DRUGCLAS Investigative Drug(s) D00PJK DRUGCOMP Southern Research Institute D00PJK HIGHSTAT Investigative D00PJT DRUG__ID D00PJT D00PJT DRUGCLAS Investigative Drug(s) D00PJT DRUGINCH 1S/C16H13FO2/c1-10-2-4-11(5-3-10)15-9-14(18)13-7-6-12(17)8-16(13)19-15/h2-8,15H,9H2,1H3/t15-/m0/s1 D00PJT DRUGINKE QNQXLNDULBVXEX-HNNXBMFYSA-N D00PJT DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)F D00PJT DRUGTYPE Small molecular drug D00PJT HIGHSTAT Investigative D00PJY DRUG__ID D00PJY D00PJY DRUGCLAS Approved Drug(s) D00PJY DRUGCOMP Cypress Bioscience Inc D00PJY HIGHSTAT Approved D00PLH DRUG__ID D00PLH D00PLH DRUGCLAS Investigative Drug(s) D00PLH DRUGINCH 1S/C14H8F4O2/c15-7-1-3-11(17)9(5-7)13(19)14(20)10-6-8(16)2-4-12(10)18/h1-6,13,19H D00PLH DRUGINKE DMPZBXMNYCXAQZ-UHFFFAOYSA-N D00PLH DRUGSMIL C1=CC(=C(C=C1F)C(C(=O)C2=C(C=CC(=C2)F)F)O)F D00PLH DRUGTYPE Small molecular drug D00PLH HIGHSTAT Investigative D00PLM DRUG__ID D00PLM D00PLM DRUGCLAS Investigative Drug(s) D00PLM DRUGINCH 1S/C10H8N2O2S/c13-10(12-14)9-4-3-8(15-9)7-2-1-5-11-6-7/h1-6,14H,(H,12,13) D00PLM DRUGINKE VJJJKVTXSSPWSW-UHFFFAOYSA-N D00PLM DRUGSMIL C1=CC(=CN=C1)C2=CC=C(S2)C(=O)NO D00PLM DRUGTYPE Small molecular drug D00PLM HIGHSTAT Investigative D00PLP DRUG__ID D00PLP D00PLP COMPCLAS Pyrazole derivatives D00PLP DRUGCLAS Patented Agent(s) D00PLP DRUGCOMP Arena Pharmaceuticals, Inc D00PLP DRUGTYPE Small molecular drug D00PLP HIGHSTAT Patented D00PLV DRUG__ID D00PLV D00PLV DRUGCLAS Approved Drug(s) D00PLV DRUGINCH 1S/5CN.Fe.NO/c5*1-2;;1-2/q5*-1;+6;-1 D00PLV DRUGINKE CDLSWOALPINAJL-UHFFFAOYSA-N D00PLV DRUGSMIL [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+6] D00PLV DRUGTYPE Small molecular drug D00PLV HIGHSTAT Approved D00PLV THERCLAS Antihypertensive Agents D00PLX DRUG__ID D00PLX D00PLX DRUGCLAS Investigative Drug(s) D00PLX DRUGCOMP Mystic Pharmaceuticals Inc D00PLX HIGHSTAT Investigative D00PMA DRUG__ID D00PMA D00PMA DRUGCLAS Discontinued Drug(s) D00PMA DRUGINCH 1S/C27H35N3O2.3ClH/c1-3-11-29(12-4-1)15-17-31-24-9-7-22-19-23-8-10-25(21-27(23)28-26(22)20-24)32-18-16-30-13-5-2-6-14-30;;;/h7-10,19-21H,1-6,11-18H2;3*1H D00PMA DRUGINKE IXDXMHOJTVBKJI-UHFFFAOYSA-N D00PMA DRUGSMIL C1CCN(CC1)CCOC2=CC3=C(C=C2)C=C4C=CC(=CC4=N3)OCCN5CCCCC5.Cl.Cl.Cl D00PMA DRUGTYPE Small molecular drug D00PMA HIGHSTAT Discontinued in Phase 2 D00PMB DRUG__ID D00PMB D00PMB DRUGCLAS Clinical Trial Drug(s) D00PMB DRUGCOMP Inovio Pharmaceuticals D00PMB HIGHSTAT Phase 3 D00PMF DRUG__ID D00PMF D00PMF DRUGCLAS Investigative Drug(s) D00PMF DRUGINCH 1S/C4H5BrN4O2.ClH/c5-1-2(9-6)7-4(11)8-3(1)10;/h6H2,(H3,7,8,9,10,11);1H D00PMF DRUGINKE FSNHPVKPJNIXAD-UHFFFAOYSA-N D00PMF DRUGSMIL C1(=C(NC(=O)NC1=O)NN)Br.Cl D00PMF DRUGTYPE Small molecular drug D00PMF HIGHSTAT Investigative D00PMS DRUG__ID D00PMS D00PMS DRUGCLAS Investigative Drug(s) D00PMS DRUGINCH 1S/C17H19N5O2/c1-2-3-6-22-14(21-15-16(18)19-9-20-17(15)22)8-11-4-5-12-13(7-11)24-10-23-12/h4-5,7,9H,2-3,6,8,10H2,1H3,(H2,18,19,20) D00PMS DRUGINKE JCDXXNIRWRRGBX-UHFFFAOYSA-N D00PMS DRUGSMIL CCCCN1C(=NC2=C(N=CN=C21)N)CC3=CC4=C(C=C3)OCO4 D00PMS DRUGTYPE Small molecular drug D00PMS HIGHSTAT Investigative D00PNU DRUG__ID D00PNU D00PNU DRUGCLAS Discontinued Drug(s) D00PNU DRUGCOMP TeGenero ImmunoTherapeutics AG D00PNU DRUGTYPE Antibody D00PNU HIGHSTAT Discontinued in Phase 1 D00POF DRUG__ID D00POF D00POF DRUGCLAS Investigative Drug(s) D00POF DRUGINCH 1S/C19H16N2/c20-19(21)18-11-10-16-12-15(8-9-17(16)13-18)7-6-14-4-2-1-3-5-14/h1-13H,(H3,20,21)/b7-6+ D00POF DRUGINKE YRAFBVUQILDIDH-VOTSOKGWSA-N D00POF DRUGSMIL C1=CC=C(C=C1)C=CC2=CC3=C(C=C2)C=C(C=C3)C(=N)N D00POF DRUGTYPE Small molecular drug D00POF HIGHSTAT Investigative D00POS DRUG__ID D00POS D00POS DRUGCLAS Clinical Trial Drug(s) D00POS DRUGINCH 1S/C23H27N5OS/c1-29-21-10-6-5-9-20(21)27-13-11-26(12-14-27)16-17-15-24-22-18-7-3-4-8-19(18)25-23(30-2)28(17)22/h3-10,17H,11-16H2,1-2H3 D00POS DRUGINKE DVYBIZHLZSDANU-UHFFFAOYSA-N D00POS DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CC3CN=C4N3C(=NC5=CC=CC=C54)SC D00POS HIGHSTAT Phase 1 D00PPB DRUG__ID D00PPB D00PPB DRUGCLAS Investigative Drug(s) D00PPB DRUGINCH 1S/C21H16F3NO2/c22-21(23,24)17-6-4-5-15(13-17)14-25-20(26)16-9-11-19(12-10-16)27-18-7-2-1-3-8-18/h1-13H,14H2,(H,25,26) D00PPB DRUGINKE FWPNYHMMZRISQJ-UHFFFAOYSA-N D00PPB DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)NCC3=CC(=CC=C3)C(F)(F)F D00PPB DRUGTYPE Small molecular drug D00PPB HIGHSTAT Investigative D00PPV DRUG__ID D00PPV D00PPV DRUGCLAS Discontinued Drug(s) D00PPV DRUGCOMP Pharmacia & Upjohn Co D00PPV HIGHSTAT Terminated D00PQC DRUG__ID D00PQC D00PQC DRUGCLAS Investigative Drug(s) D00PQC DRUGINCH 1S/C9H16N3O14P3/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 D00PQC DRUGINKE PCDQPRRSZKQHHS-XVFCMESISA-N D00PQC DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D00PQC DRUGTYPE Small molecular drug D00PQC HIGHSTAT Investigative D00PQS DRUG__ID D00PQS D00PQS DRUGCLAS Investigative Drug(s) D00PQS DRUGCOMP Diamyd Medical AB D00PQS HIGHSTAT Investigative D00PRE DRUG__ID D00PRE D00PRE DRUGCLAS Investigative Drug(s) D00PRE DRUGINCH 1S/C13H10F3NO2S/c14-13(15,16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)20(17,18)19/h1-8H,(H2,17,18,19) D00PRE DRUGINKE WWPFVDFIDSAULR-UHFFFAOYSA-N D00PRE DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)S(=O)(=O)N)C(F)(F)F D00PRE DRUGTYPE Small molecular drug D00PRE HIGHSTAT Investigative D00PRI DRUG__ID D00PRI D00PRI DRUGCLAS Approved Drug(s) D00PRI DRUGINCH 1S/C10H16N2O8.Ca.2Na/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;;/q;+2;2*+1/p-4 D00PRI DRUGINKE SHWNNYZBHZIQQV-UHFFFAOYSA-J D00PRI DRUGSMIL C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Ca+2] D00PRI DRUGTYPE Small molecular drug D00PRI HIGHSTAT Approved D00PRR DRUG__ID D00PRR D00PRR DRUGCLAS Investigative Drug(s) D00PRR DRUGINCH 1S/C10H16ClN5O8P2/c1-12-8-7-9(15-10(11)14-8)16(5-13-7)2-6(3-23-25(17,18)19)4-24-26(20,21)22/h5-6H,2-4H2,1H3,(H,12,14,15)(H2,17,18,19)(H2,20,21,22) D00PRR DRUGINKE GMCUIIHBWNOHIM-UHFFFAOYSA-N D00PRR DRUGSMIL CNC1=C2C(=NC(=N1)Cl)N(C=N2)CC(COP(=O)(O)O)COP(=O)(O)O D00PRR DRUGTYPE Small molecular drug D00PRR HIGHSTAT Investigative D00PSG DRUG__ID D00PSG D00PSG DRUGCLAS Clinical Trial Drug(s) D00PSG DRUGCOMP Medinox Inc D00PSG HIGHSTAT Phase 2 D00PSJ DRUG__ID D00PSJ D00PSJ DRUGCLAS Investigative Drug(s) D00PSJ DRUGINCH 1S/C6H11N3/c1-9-5-8-4-6(9)2-3-7/h4-5H,2-3,7H2,1H3 D00PSJ DRUGINKE CPAGZVLINCPJEH-UHFFFAOYSA-N D00PSJ DRUGSMIL CN1C=NC=C1CCN D00PSJ DRUGTYPE Small molecular drug D00PSJ HIGHSTAT Investigative D00PSW DRUG__ID D00PSW D00PSW DRUGCLAS Investigative Drug(s) D00PSW DRUGINCH 1S/C17H25N3/c1-2-4-15-18-19-16(20(15)5-3-1)17-9-12-6-13(10-17)8-14(7-12)11-17/h12-14H,1-11H2 D00PSW DRUGINKE VFTQRHWULYJKCI-UHFFFAOYSA-N D00PSW DRUGSMIL C1CCC2=NN=C(N2CC1)C34CC5CC(C3)CC(C5)C4 D00PSW DRUGTYPE Small molecular drug D00PSW HIGHSTAT Investigative D00PTE DRUG__ID D00PTE D00PTE COMPCLAS Imidazopyridazine derivatives D00PTE DRUGCLAS Patented Agent(s) D00PTE DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D00PTE DRUGTYPE Small molecular drug D00PTE HIGHSTAT Patented D00PTZ DRUG__ID D00PTZ D00PTZ DRUGCLAS Clinical Trial Drug(s) D00PTZ DRUGCOMP Tampa D00PTZ HIGHSTAT Phase 3 D00PUF DRUG__ID D00PUF D00PUF DRUGCLAS Investigative Drug(s) D00PUF DRUGINCH 1S/C4H9NO3/c5-2-3(6)1-4(7)8/h3,6H,1-2,5H2,(H,7,8) D00PUF DRUGINKE YQGDEPYYFWUPGO-UHFFFAOYSA-N D00PUF DRUGSMIL C(C(CN)O)C(=O)O D00PUF DRUGTYPE Small molecular drug D00PUF HIGHSTAT Investigative D00PUR DRUG__ID D00PUR D00PUR DRUGCLAS Investigative Drug(s) D00PUR DRUGINCH 1S/C20H14OS/c21-18-9-4-7-15(12-18)14-6-3-8-16(11-14)20-13-17-5-1-2-10-19(17)22-20/h1-13,21H D00PUR DRUGINKE BQKUVAJYBNSSNI-UHFFFAOYSA-N D00PUR DRUGSMIL C1=CC=C2C(=C1)C=C(S2)C3=CC=CC(=C3)C4=CC(=CC=C4)O D00PUR DRUGTYPE Small molecular drug D00PUR HIGHSTAT Investigative D00PUT DRUG__ID D00PUT D00PUT DRUGCLAS Clinical Trial Drug(s) D00PUT DRUGCOMP Abbvie D00PUT HIGHSTAT Phase 2 D00PVE DRUG__ID D00PVE D00PVE DRUGCLAS Patented Agent(s) D00PVE DRUGINCH 1S/C17H13NO6S/c1-25(20,21)15-5-3-2-4-10(15)16-18-12-9-14-13(22-6-7-23-14)8-11(12)17(19)24-16/h2-5,8-9H,6-7H2,1H3 D00PVE DRUGINKE NYGGGQOBPHOCIJ-UHFFFAOYSA-N D00PVE DRUGSMIL CS(=O)(=O)C1=CC=CC=C1C2=NC3=CC4=C(C=C3C(=O)O2)OCCO4 D00PVE DRUGTYPE Small molecular drug D00PVE HIGHSTAT Patented D00PVH DRUG__ID D00PVH D00PVH DRUGCLAS Patented Agent(s) D00PVH DRUGCOMP Abbott D00PVH DRUGINCH 1S/C19H15Cl2N5S/c1-12-24-25-19(26(12)16-6-2-5-15(20)17(16)21)23-10-13-4-3-8-22-18(13)14-7-9-27-11-14/h2-9,11H,10H2,1H3,(H,23,25) D00PVH DRUGINKE SMJNWZUHIGQMEW-UHFFFAOYSA-N D00PVH DRUGSMIL CC1=NN=C(N1C2=C(C(=CC=C2)Cl)Cl)NCC3=C(N=CC=C3)C4=CSC=C4 D00PVH DRUGTYPE Small molecular drug D00PVH HIGHSTAT Patented D00PVO DRUG__ID D00PVO D00PVO DRUGCLAS Investigative Drug(s) D00PVO DRUGINCH 1S/C19H16BrN3O2S/c1-12-2-7-17(25-12)15-8-18(24)23-10-22(11-26-19(23)16(15)9-21)14-5-3-13(20)4-6-14/h2-7,15H,8,10-11H2,1H3 D00PVO DRUGINKE DCNZODDMKOTPHQ-UHFFFAOYSA-N D00PVO DRUGSMIL CC1=CC=C(O1)C2CC(=O)N3CN(CSC3=C2C#N)C4=CC=C(C=C4)Br D00PVO DRUGTYPE Small molecular drug D00PVO HIGHSTAT Investigative D00PWQ DRUG__ID D00PWQ D00PWQ DRUGCLAS Patented Agent(s) D00PWQ DRUGINCH 1S/C16H11BrN2O/c17-9-5-6-14-11(7-9)12-8-15(20)18-13-4-2-1-3-10(13)16(12)19-14/h1-7,19H,8H2,(H,18,20) D00PWQ DRUGINKE QQUXFYAWXPMDOE-UHFFFAOYSA-N D00PWQ DRUGSMIL C1C2=C(C3=CC=CC=C3NC1=O)NC4=C2C=C(C=C4)Br D00PWQ DRUGTYPE Small molecular drug D00PWQ HIGHSTAT Patented D00PWV DRUG__ID D00PWV D00PWV DRUGCLAS Investigative Drug(s) D00PWV DRUGINCH 1S/C17H18O2/c1-12(14-7-4-3-5-8-14)15-9-6-10-16(11-15)13(2)17(18)19/h3-13H,1-2H3,(H,18,19) D00PWV DRUGINKE WHCCIVDFHWZGFN-UHFFFAOYSA-N D00PWV DRUGSMIL CC(C1=CC=CC=C1)C2=CC(=CC=C2)C(C)C(=O)O D00PWV DRUGTYPE Small molecular drug D00PWV HIGHSTAT Investigative D00PXF DRUG__ID D00PXF D00PXF DRUGCLAS Investigative Drug(s) D00PXF DRUGINCH 1S/C17H12FN3/c18-16-3-1-2-15(8-16)17-10-20-12-21(17)11-14-6-4-13(9-19)5-7-14/h1-8,10,12H,11H2 D00PXF DRUGINKE XBUPVQPMTRYFDV-UHFFFAOYSA-N D00PXF DRUGSMIL C1=CC(=CC(=C1)F)C2=CN=CN2CC3=CC=C(C=C3)C#N D00PXF DRUGTYPE Small molecular drug D00PXF HIGHSTAT Investigative D00PXO DRUG__ID D00PXO D00PXO DRUGCLAS Investigative Drug(s) D00PXO DRUGINCH 1S/C23H18Cl3FN4O3S/c24-23(25,26)21(30-22(35)28-16-11-12-17(27)18(13-16)31(33)34)29-20(32)19(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13,19,21H,(H,29,32)(H2,28,30,35) D00PXO DRUGINKE HLCDNLNLQNYZTK-UHFFFAOYSA-N D00PXO DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC3=CC(=C(C=C3)F)[N+](=O)[O-] D00PXO DRUGTYPE Small molecular drug D00PXO HIGHSTAT Investigative D00PXQ DRUG__ID D00PXQ D00PXQ DRUGCLAS Discontinued Drug(s) D00PXQ DRUGCOMP Sanofi-Aventis D00PXQ DRUGINCH 1S/C23H24FN3O2S/c24-19-8-10-20(11-9-19)26-16-14-25(15-17-26)12-3-13-27-21-6-1-4-18-5-2-7-22(23(18)21)30(27,28)29/h1-2,4-11H,3,12-17H2 D00PXQ DRUGINKE VGIGHGMPMUCLIQ-UHFFFAOYSA-N D00PXQ DRUGSMIL C1CN(CCN1CCCN2C3=CC=CC4=C3C(=CC=C4)S2(=O)=O)C5=CC=C(C=C5)F D00PXQ DRUGTYPE Small molecular drug D00PXQ HIGHSTAT Terminated D00PYB DRUG__ID D00PYB D00PYB DRUGCLAS Investigative Drug(s) D00PYB DRUGINCH 1S/C18H19NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-12,17H,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1 D00PYB DRUGINKE XYYVYLMBEZUESM-CMKMFDCUSA-N D00PYB DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)C=C4 D00PYB DRUGTYPE Small molecular drug D00PYB HIGHSTAT Investigative D00PYD DRUG__ID D00PYD D00PYD DRUGCLAS Investigative Drug(s) D00PYD DRUGCOMP Isis Pharmaceuticals D00PYD DRUGTYPE Antisense drug D00PYD HIGHSTAT Investigative D00PYP DRUG__ID D00PYP D00PYP DRUGCLAS Discontinued Drug(s) D00PYP DRUGCOMP Neurocrine Biosci D00PYP DRUGINCH 1S/C31H31F3N8O8S2.2ClH/c1-39-5-7-40(8-6-39)24-17(33)9-15-23(19(24)34)41(4-3-32)10-16(25(15)43)30(48)50-11-14-12-51-28-21(27(45)42(28)22(14)29(46)47)37-26(44)20(38-49-2)18-13-52-31(35)36-18;;/h9-10,13,21,28H,3-8,11-12H2,1-2H3,(H2,35,36)(H,37,44)(H,46,47);2*1H/b38-20-;;/t21-,28-;;/m1../s1 D00PYP DRUGINKE DSGXXSRGPIYUHF-ZVOUVGCISA-N D00PYP DRUGSMIL CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)OCC4=C(N5C(C(C5=O)NC(=O)C(=NOC)C6=CSC(=N6)N)SC4)C(=O)O)CCF)F.Cl.Cl D00PYP DRUGTYPE Small molecular drug D00PYP HIGHSTAT Terminated D00PYW DRUG__ID D00PYW D00PYW DRUGCLAS Investigative Drug(s) D00PYW DRUGINCH 1S/C15H19N3O2/c1-3-15(4-2-14(1)18-6-5-16-13-18)20-12-9-17-7-10-19-11-8-17/h1-6,13H,7-12H2 D00PYW DRUGINKE PXFGMZGVHWPLCC-UHFFFAOYSA-N D00PYW DRUGSMIL C1COCCN1CCOC2=CC=C(C=C2)N3C=CN=C3 D00PYW DRUGTYPE Small molecular drug D00PYW HIGHSTAT Investigative D00PZE DRUG__ID D00PZE D00PZE DRUGCLAS Investigative Drug(s) D00PZE DRUGINCH 1S/C18H24O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14,17,19-21H,2-7H2,1H3/t11-,12+,14-,17-,18-/m0/s1 D00PZE DRUGINKE DILDHNKDVHLEQB-XSSYPUMDSA-N D00PZE DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)O)O D00PZE DRUGTYPE Small molecular drug D00PZE HIGHSTAT Investigative D00PZH DRUG__ID D00PZH D00PZH DRUGCLAS Discontinued Drug(s) D00PZH DRUGCOMP Amylin Pharmaceuticals Inc D00PZH DRUGINCH 1S/C127H205N37O40/c1-59(2)44-81(156-122(200)99(63(9)10)142-68(15)171)105(183)139-54-96(178)143-74(22-16-18-40-128)106(184)151-84(47-62(7)8)114(192)159-90(57-166)119(197)148-77(34-37-92(130)174)108(186)146-79(36-39-98(180)181)109(187)153-83(46-61(5)6)113(191)154-85(50-71-53-137-58-141-71)115(193)145-75(23-17-19-41-129)107(185)152-82(45-60(3)4)112(190)147-78(35-38-93(131)175)111(189)162-103(67(14)170)125(203)158-88(49-70-28-32-73(173)33-29-70)126(204)164-43-21-25-91(164)120(198)149-76(24-20-42-138-127(135)136)110(188)161-102(66(13)169)124(202)157-87(52-95(133)177)117(195)160-100(64(11)167)121(199)140-55-97(179)144-89(56-165)118(196)155-86(51-94(132)176)116(194)163-101(65(12)168)123(201)150-80(104(134)182)48-69-26-30-72(172)31-27-69/h26-33,53,58-67,74-91,99-103,165-170,172-173H,16-25,34-52,54-57,128-129H2,1-15H3,(H2,130,174)(H2,131,175)(H2,132,176)(H2,133,177)(H2,134,182)(H,137,141)(H,139,183)(H,140,199)(H,142,171)(H,143,178)(H,144,179)(H,145,193)(H,146,186)(H,147,190)(H,148,197)(H,149,198)(H,150,201)(H,151,184)(H,152,185)(H,153,187)(H,154,191)(H,155,196)(H,156,200)(H,157,202)(H,158,203)(H,159,192)(H,160,195)(H,161,188)(H,162,189)(H,163,194)(H,180,181)(H4,135,136,138)/t64-,65-,66-,67-,74+,75+,76+,77+,78+,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,99+,100+,101+,102+,103+/m1/s1 D00PZH DRUGINKE ZLFXHYNEZYAYPG-AABHONRUSA-N D00PZH DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C D00PZH DRUGTYPE Small molecular drug D00PZH HIGHSTAT Terminated D00PZK DRUG__ID D00PZK D00PZK DRUGCLAS Discontinued Drug(s) D00PZK DRUGCOMP Acacia Pharma Ltd D00PZK HIGHSTAT Discontinued in Phase 2 D00PZM DRUG__ID D00PZM D00PZM DRUGCLAS Investigative Drug(s) D00PZM DRUGINCH 1S/C20H20O5/c1-20(2)17(22)8-13-15(25-20)6-5-11-14-9-23-16-7-10(21)3-4-12(16)19(14)24-18(11)13/h3-7,14,17,19,21-22H,8-9H2,1-2H3/t14-,17?,19-/m0/s1 D00PZM DRUGINKE ZCLUCQDBFSBCJB-OZIHFDBSSA-N D00PZM DRUGSMIL CC1(C(CC2=C(O1)C=CC3=C2OC4C3COC5=C4C=CC(=C5)O)O)C D00PZM DRUGTYPE Small molecular drug D00PZM HIGHSTAT Investigative D00QAQ DRUG__ID D00QAQ D00QAQ DRUGCLAS Investigative Drug(s) D00QAQ DRUGCOMP Terpenoid Therapeutics D00QAQ HIGHSTAT Investigative D00QAR DRUG__ID D00QAR D00QAR DRUGCLAS Clinical Trial Drug(s) D00QAR DRUGINCH 1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1 D00QAR DRUGINKE JGSARLDLIJGVTE-MBNYWOFBSA-N D00QAR DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C D00QAR DRUGTYPE Small molecular drug D00QAR HIGHSTAT Phase 3 D00QAX DRUG__ID D00QAX D00QAX DRUGCLAS Preclinical Drug(s) D00QAX DRUGCOMP Pfizer Inc D00QAX DRUGINCH 1S/C15H17N3O4/c1-8(2)18-11-4-3-10(5-9(11)6-13(18)19)17-7-12(14(16)20)22-15(17)21/h3-5,8,12H,6-7H2,1-2H3,(H2,16,20)/t12-/m1/s1 D00QAX DRUGINKE FKMDICPKYZOJFW-GFCCVEGCSA-N D00QAX DRUGSMIL CC(C)N1C(=O)CC2=C1C=CC(=C2)N3CC(OC3=O)C(=O)N D00QAX HIGHSTAT Preclinical D00QBV DRUG__ID D00QBV D00QBV DRUGCLAS Investigative Drug(s) D00QBV DRUGTYPE Aptamer D00QBV HIGHSTAT Investigative D00QCB DRUG__ID D00QCB D00QCB DRUGCLAS Discontinued Drug(s) D00QCB DRUGINCH 1S/C29H60NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-24-33-27-29(22-21-25-34-29)28-36-37(31,32)35-26-23-30(2,3)4/h5-28H2,1-4H3 D00QCB DRUGINKE OEWZGBLJCYAMEG-UHFFFAOYSA-N D00QCB DRUGSMIL CCCCCCCCCCCCCCCCCCOCC1(CCCO1)COP(=O)([O-])OCC[N+](C)(C)C D00QCB DRUGTYPE Small molecular drug D00QCB HIGHSTAT Discontinued in Phase 2 D00QCL DRUG__ID D00QCL D00QCL DRUGCLAS Investigative Drug(s) D00QCL DRUGINCH 1S/C21H20O6/c1-11(2)4-9-14-15(23)10-16(26-3)17-18(24)19(25)20(27-21(14)17)12-5-7-13(22)8-6-12/h4-8,10,22-23,25H,9H2,1-3H3 D00QCL DRUGINKE VMLJAWUWVVHRNG-UHFFFAOYSA-N D00QCL DRUGSMIL CC(=CCC1=C2C(=C(C=C1O)OC)C(=O)C(=C(O2)C3=CC=C(C=C3)O)O)C D00QCL DRUGTYPE Small molecular drug D00QCL HIGHSTAT Investigative D00QCP DRUG__ID D00QCP D00QCP DRUGCLAS Investigative Drug(s) D00QCP DRUGINCH 1S/C13H19NO2/c1-10-13(15,11-7-5-4-6-8-11)16-9-12(2,3)14-10/h4-8,10,14-15H,9H2,1-3H3/t10-,13+/m0/s1 D00QCP DRUGINKE NGHJSSNVKXEBAB-GXFFZTMASA-N D00QCP DRUGSMIL CC1C(OCC(N1)(C)C)(C2=CC=CC=C2)O D00QCP DRUGTYPE Small molecular drug D00QCP HIGHSTAT Investigative D00QCV DRUG__ID D00QCV D00QCV DRUGCLAS Investigative Drug(s) D00QCV DRUGCOMP Green Cross Corp D00QCV HIGHSTAT Investigative D00QCX DRUG__ID D00QCX D00QCX DRUGCLAS Investigative Drug(s) D00QCX DRUGCOMP Louisiana State University D00QCX HIGHSTAT Investigative D00QDE DRUG__ID D00QDE D00QDE DRUGCLAS Investigative Drug(s) D00QDE DRUGINCH 1S/C16H10BrNO3/c17-15-11-5-8(19)2-4-13(11)18-16-10-3-1-9(20)6-14(10)21-7-12(15)16/h1-6,19-20H,7H2 D00QDE DRUGINKE UHDQHUPIXKORDL-UHFFFAOYSA-N D00QDE DRUGSMIL C1C2=C(C3=C(C=CC(=C3)O)N=C2C4=C(O1)C=C(C=C4)O)Br D00QDE DRUGTYPE Small molecular drug D00QDE HIGHSTAT Investigative D00QDJ DRUG__ID D00QDJ D00QDJ DRUGCLAS Investigative Agents D00QDJ DRUGCOMP GlaxoSmithKline D00QDJ DRUGINCH 1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34) D00QDJ DRUGINKE LIRYPHYGHXZJBZ-UHFFFAOYSA-N D00QDJ DRUGSMIL CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5 D00QDJ DRUGTYPE Small molecular drug D00QDJ HIGHSTAT Investigative D00QDJ THERCLAS Antiviral Agents D00QDR DRUG__ID D00QDR D00QDR DRUGCLAS Investigative Drug(s) D00QDR DRUGINCH 1S/C41H32O26/c42-17-1-12(2-18(43)28(17)52)36(57)62-11-27-33(64-37(58)13-3-19(44)29(53)20(45)4-13)34(65-38(59)14-5-21(46)30(54)22(47)6-14)35(66-39(60)15-7-23(48)31(55)24(49)8-15)41(63-27)67-40(61)16-9-25(50)32(56)26(51)10-16/h1-10,27,33-35,41-56H,11H2/t27-,33-,34+,35-,41+/m1/s1 D00QDR DRUGINKE QJYNZEYHSMRWBK-NIKIMHBISA-N D00QDR DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O D00QDR DRUGTYPE Small molecular drug D00QDR HIGHSTAT Investigative D00QEP DRUG__ID D00QEP D00QEP DRUGCLAS Approved Drug(s) D00QEP DRUGCOMP Pfizer D00QEP DRUGTYPE Antibody D00QEP HIGHSTAT Approved D00QEP TRADNAME Besponsa D00QET DRUG__ID D00QET D00QET DRUGCLAS Approved Drug(s) D00QET DRUGCOMP Schering-Plough Corporation D00QET DRUGINCH 1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1 D00QET DRUGINKE UCHDWCPVSPXUMX-TZIWLTJVSA-N D00QET DRUGSMIL CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O D00QET DRUGTYPE Small molecular drug D00QET HIGHSTAT Approved D00QET THERCLAS Antiasthmatic Agents D00QEZ DRUG__ID D00QEZ D00QEZ DRUGCLAS Patented Agent(s) D00QEZ DRUGCOMP GRUENENTHAL GMBH [DE] D00QEZ DRUGTYPE Small molecular drug D00QEZ HIGHSTAT Patented D00QFL DRUG__ID D00QFL D00QFL DRUGCLAS Investigative Drug(s) D00QFL DRUGINCH 1S/C19H24NO5P/c1-19(2,26(22,23)24)18(21)20-13-7-9-15-8-6-12-17(14-15)25-16-10-4-3-5-11-16/h3-6,8,10-12,14H,7,9,13H2,1-2H3,(H,20,21)(H2,22,23,24) D00QFL DRUGINKE AGJZDRXKAQZWEP-UHFFFAOYSA-N D00QFL DRUGSMIL CC(C)(C(=O)NCCCC1=CC(=CC=C1)OC2=CC=CC=C2)P(=O)(O)O D00QFL DRUGTYPE Small molecular drug D00QFL HIGHSTAT Investigative D00QFV DRUG__ID D00QFV D00QFV DRUGCLAS Investigative Drug(s) D00QFV DRUGCOMP ERYtech Pharma D00QFV HIGHSTAT Investigative D00QFY DRUG__ID D00QFY D00QFY DRUGCLAS Discontinued Drug(s) D00QFY DRUGCOMP Astellas D00QFY DRUGINCH 1S/C24H30O5.Na/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28;/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28);/q;+1/p-1/b13-12+; D00QFY DRUGINKE YTCZZXIRLARSET-UEIGIMKUSA-M D00QFY DRUGSMIL CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)[O-])O)O.[Na+] D00QFY DRUGTYPE Small molecular drug D00QFY HIGHSTAT Discontinued in Phase 3 D00QGB DRUG__ID D00QGB D00QGB DRUGCLAS Investigative Drug(s) D00QGB DRUGCOMP Organix Inc D00QGB HIGHSTAT Investigative D00QGF DRUG__ID D00QGF D00QGF DRUGCLAS Investigative Drug(s) D00QGF DRUGCOMP Isis Pharmaceuticals D00QGF DRUGTYPE Antisense drug D00QGF HIGHSTAT Investigative D00QGV DRUG__ID D00QGV D00QGV DRUGCLAS Clinical Trial Drug(s) D00QGV DRUGCOMP Amarillo biosciences D00QGV HIGHSTAT Phase 2 D00QHT DRUG__ID D00QHT D00QHT DRUGCLAS Discontinued Drug(s) D00QHT DRUGCOMP Alkermes Inc D00QHT DRUGINCH 1S/C26H40N4O6/c1-4-21(23(31)25(33)27-11-8-12-30-13-15-35-16-14-30)28-24(32)22(17-19(2)3)29-26(34)36-18-20-9-6-5-7-10-20/h5-7,9-10,19,21-22H,4,8,11-18H2,1-3H3,(H,27,33)(H,28,32)(H,29,34)/t21?,22-/m0/s1 D00QHT DRUGINKE TZVQRMYLYQNBOA-KEKNWZKVSA-N D00QHT DRUGSMIL CCC(C(=O)C(=O)NCCCN1CCOCC1)NC(=O)C(CC(C)C)NC(=O)OCC2=CC=CC=C2 D00QHT DRUGTYPE Small molecular drug D00QHT HIGHSTAT Terminated D00QIA DRUG__ID D00QIA D00QIA DRUGCLAS Investigative Drug(s) D00QIA DRUGINCH 1S/C11H21NO3/c1-8(2)6-9(7-13)12-10(14)15-11(3,4)5/h7-9H,6H2,1-5H3,(H,12,14)/t9-/m0/s1 D00QIA DRUGINKE RQSBRFZHUKLKNO-VIFPVBQESA-N D00QIA DRUGSMIL CC(C)CC(C=O)NC(=O)OC(C)(C)C D00QIA DRUGTYPE Small molecular drug D00QIA HIGHSTAT Investigative D00QIJ DRUG__ID D00QIJ D00QIJ DRUGCLAS Preclinical Drug(s) D00QIJ DRUGCOMP Alnylam Pharmaceuticals & Medtronic, Inc. D00QIJ DRUGTYPE Antisense drug D00QIJ HIGHSTAT Preclinical D00QIJ THERCLAS Antisense D00QIK DRUG__ID D00QIK D00QIK DRUGCLAS Discontinued Drug(s) D00QIK DRUGINCH 1S/C12H19NO4/c1-4-5-7-9-12(11(16)17-9,13-10(7)15)8(14)6(2)3/h6-9,14H,4-5H2,1-3H3,(H,13,15)/t7-,8+,9+,12-/m1/s1 D00QIK DRUGINKE KMXHEXRPYSXLRN-JDVQERKKSA-N D00QIK DRUGSMIL CCCC1C2C(C(=O)O2)(NC1=O)C(C(C)C)O D00QIK HIGHSTAT Terminated D00QIU DRUG__ID D00QIU D00QIU DRUGCLAS Investigative Drug(s) D00QIU DRUGINCH 1S/C20H32O5/c1-2-3-8-14-18(22)19(23)15-10-7-5-4-6-9-12-17(21)13-11-16-20(24)25/h4-7,9-10,12,15,17-19,21-23H,2-3,8,11,13-14,16H2,1H3,(H,24,25)/b6-4-,7-5+,12-9+,15-10+/t17-,18+,19-/m1/s1 D00QIU DRUGINKE UXVRTOKOJOMENI-WLPVFMORSA-N D00QIU DRUGSMIL CCCCCC(C(C=CC=CC=CC=CC(CCCC(=O)O)O)O)O D00QIU DRUGTYPE Small molecular drug D00QIU HIGHSTAT Investigative D00QJA DRUG__ID D00QJA D00QJA COMPCLAS Biphenyl carboxamidopropanoic acid derivatives D00QJA DRUGCLAS Patented Agent(s) D00QJA DRUGCOMP JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj GRECO, Michael, N. SHOOK, Brian XU, Guozhang ZHANG, Rui D00QJA DRUGINCH 1S/C33H27ClF6N2O3/c1-18-13-20(31(45)41-12-11-30(43)44)4-8-26(18)28-15-23(33(38,39)40)5-3-21(28)17-42-24-7-10-27(29(34)16-24)25-9-6-22(14-19(25)2)32(35,36)37/h3-10,13-16,42H,11-12,17H2,1-2H3,(H,41,45)(H,43,44) D00QJA DRUGINKE DUDZHUBPDPKULT-UHFFFAOYSA-N D00QJA DRUGSMIL CC1=C(C=CC(=C1)C(=O)NCCC(=O)O)C2=C(C=CC(=C2)C(F)(F)F)CNC3=CC(=C(C=C3)C4=C(C=C(C=C4)C(F)(F)F)C)Cl D00QJA DRUGTYPE Small molecular drug D00QJA HIGHSTAT Patented D00QJL DRUG__ID D00QJL D00QJL DRUGCLAS Clinical Trial Drug(s) D00QJL DRUGCOMP Solvay SA D00QJL HIGHSTAT Phase 3 D00QKI DRUG__ID D00QKI D00QKI DRUGCLAS Clinical Trial Drug(s) D00QKI DRUGCOMP Pharmacopeia; Schering-Plough D00QKI DRUGINCH 1S/C21H23N3O5/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4/h6-10,13,22-23,25H,5H2,1-4H3/t13-/m1/s1 D00QKI DRUGINKE RXIUEIPPLAFSDF-CYBMUJFWSA-N D00QKI DRUGSMIL CCC(C1=CC=C(O1)C)NC2=C(C(=O)C2=O)NC3=CC=CC(=C3O)C(=O)N(C)C D00QKI DRUGTYPE Small molecular drug D00QKI HIGHSTAT Phase 2 D00QKL DRUG__ID D00QKL D00QKL DRUGCLAS Clinical Trial Drug(s) D00QKL DRUGCOMP Johann Wolfgang Goethe-Universitat Frankfurt am Main D00QKL HIGHSTAT Phase 1/2 D00QKS DRUG__ID D00QKS D00QKS DRUGCLAS Clinical Trial Drug(s) D00QKS DRUGCOMP Exonhit D00QKS HIGHSTAT Phase 2 D00QLG DRUG__ID D00QLG D00QLG DRUGCLAS Investigative Drug(s) D00QLG DRUGCOMP Advaxis Inc D00QLG HIGHSTAT Investigative D00QLH DRUG__ID D00QLH D00QLH DRUGCLAS Investigative Drug(s) D00QLH DRUGINCH 1S/C32H36N4O6/c1-19-13-24(37)14-20(2)25(19)16-26(33)31(41)36-18-22-10-8-7-9-21(22)15-28(36)30(40)34-27(17-29(38)39)32(42)35(3)23-11-5-4-6-12-23/h4-14,26-28,37H,15-18,33H2,1-3H3,(H,34,40)(H,38,39)/t26-,27+,28-/m0/s1 D00QLH DRUGINKE HEKBLCZSNQVJKZ-IARZGTGTSA-N D00QLH DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C(=O)N(C)C4=CC=CC=C4)N)C)O D00QLH DRUGTYPE Small molecular drug D00QLH HIGHSTAT Investigative D00QLM DRUG__ID D00QLM D00QLM DRUGCLAS Investigative Drug(s) D00QLM DRUGINCH 1S/C11H18N5O12P3/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(27-11)1-26-29(19,20)4-30(21,22)28-31(23,24)25/h2-3,5,7-8,11,17-18H,1,4H2,(H,19,20)(H,21,22)(H2,12,13,14)(H2,23,24,25)/t5-,7-,8-,11-/m1/s1 D00QLM DRUGINKE CAWZRIXWFRFUQB-IOSLPCCCSA-N D00QLM DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O)O)N D00QLM DRUGTYPE Small molecular drug D00QLM HIGHSTAT Investigative D00QLR DRUG__ID D00QLR D00QLR DRUGCLAS Investigative Drug(s) D00QLR DRUGINCH 1S/C21H30N2/c1-16(2)10-12-21-13-15-22(5)20(21)23(14-11-17(3)4)19-9-7-6-8-18(19)21/h6-11,20H,12-15H2,1-5H3/t20-,21+/m1/s1 D00QLR DRUGINKE NUWYFFDZPIGJJO-RTWAWAEBSA-N D00QLR DRUGSMIL CC(=CCC12CCN(C1N(C3=CC=CC=C23)CC=C(C)C)C)C D00QLR DRUGTYPE Small molecular drug D00QLR HIGHSTAT Investigative D00QMQ DRUG__ID D00QMQ D00QMQ DRUGCLAS Investigative Drug(s) D00QMQ DRUGINCH 1S/C22H27Cl2N5S/c1-2-8-28(16-6-7-18-20(15-16)30-22(25)26-18)12-9-27-10-13-29(14-11-27)19-5-3-4-17(23)21(19)24/h1,3-5,16H,6-15H2,(H2,25,26) D00QMQ DRUGINKE AWFHSDHVMOYPMI-UHFFFAOYSA-N D00QMQ DRUGSMIL C#CCN(CCN1CCN(CC1)C2=C(C(=CC=C2)Cl)Cl)C3CCC4=C(C3)SC(=N4)N D00QMQ DRUGTYPE Small molecular drug D00QMQ HIGHSTAT Investigative D00QMZ DRUG__ID D00QMZ D00QMZ DRUGCLAS Investigative Drug(s) D00QMZ DRUGINCH 1S/C30H43N3O6/c1-6-8-16-31-27(35)19-25(34)24(17-21-12-10-9-11-13-21)32-30(37)28(20(3)7-2)33-29(36)23-15-14-22(38-4)18-26(23)39-5/h9-15,18,20,24-25,28,34H,6-8,16-17,19H2,1-5H3,(H,31,35)(H,32,37)(H,33,36)/t20-,24?,25?,28-/m0/s1 D00QMZ DRUGINKE BLKHGZANZRGYRY-WUCHSTEBSA-N D00QMZ DRUGSMIL CCCCNC(=O)CC(C(CC1=CC=CC=C1)NC(=O)C(C(C)CC)NC(=O)C2=C(C=C(C=C2)OC)OC)O D00QMZ DRUGTYPE Small molecular drug D00QMZ HIGHSTAT Investigative D00QNV DRUG__ID D00QNV D00QNV DRUGCLAS Patented Agent(s) D00QNV DRUGINCH 1S/C20H29N7O/c1-5-15(16(28)6-2)24-20-25-18(22-11-14-8-7-9-21-10-14)17-19(26-20)27(12-23-17)13(3)4/h7-10,12-13,15-16,28H,5-6,11H2,1-4H3,(H2,22,24,25,26)/t15-,16?/m1/s1 D00QNV DRUGINKE VFEDEOUBYBLDKN-AAFJCEBUSA-N D00QNV DRUGSMIL CCC(C(CC)O)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CN=CC=C3 D00QNV DRUGTYPE Small molecular drug D00QNV HIGHSTAT Patented D00QNW DRUG__ID D00QNW D00QNW DRUGCLAS Clinical Trial Drug(s) D00QNW DRUGCOMP Merck D00QNW DRUGSMIL failed D00QNW DRUGTYPE Combination drug D00QNW HIGHSTAT Phase 3 D00QOF DRUG__ID D00QOF D00QOF DRUGCLAS Clinical Trial Drug(s) D00QOF DRUGINCH 1S/C18H25F3N4O/c19-18(20,21)15-5-6-22-16(14-15)24-12-10-23(11-13-24)7-1-2-8-25-9-3-4-17(25)26/h5-6,14H,1-4,7-13H2 D00QOF DRUGINKE YKJJCYZZWWSBEW-UHFFFAOYSA-N D00QOF DRUGSMIL C1CC(=O)N(C1)CCCCN2CCN(CC2)C3=NC=CC(=C3)C(F)(F)F D00QOF DRUGTYPE Small molecular drug D00QOF HIGHSTAT Phase 2 D00QOG DRUG__ID D00QOG D00QOG DRUGCLAS Discontinued Drug(s) D00QOG DRUGCOMP Pierre Fabre SA D00QOG DRUGINCH 1S/C15H15ClO/c1-15(2,17)12-9-7-11(8-10-12)13-5-3-4-6-14(13)16/h3-10,17H,1-2H3 D00QOG DRUGINKE VILCOLBQTAITPH-UHFFFAOYSA-N D00QOG DRUGSMIL CC(C)(C1=CC=C(C=C1)C2=CC=CC=C2Cl)O D00QOG DRUGTYPE Small molecular drug D00QOG HIGHSTAT Terminated D00QOH DRUG__ID D00QOH D00QOH DRUGCLAS Investigative Drug(s) D00QOH DRUGCOMP Oscotec Inc D00QOH HIGHSTAT Investigative D00QOJ DRUG__ID D00QOJ D00QOJ DRUGCLAS Clinical Trial Drug(s) D00QOJ HIGHSTAT Phase 2 D00QOL DRUG__ID D00QOL D00QOL DRUGCLAS Investigative Drug(s) D00QOL DRUGINCH 1S/C17H23NO/c19-17-15(13-14-7-3-1-4-8-14)11-12-18(17)16-9-5-2-6-10-16/h1,3-4,7-8,15-16H,2,5-6,9-13H2 D00QOL DRUGINKE DGGDICYTCJZLPW-UHFFFAOYSA-N D00QOL DRUGSMIL C1CCC(CC1)N2CCC(C2=O)CC3=CC=CC=C3 D00QOL DRUGTYPE Small molecular drug D00QOL HIGHSTAT Investigative D00QPG DRUG__ID D00QPG D00QPG DRUGCLAS Investigative Drug(s) D00QPG DRUGINCH 1S/C17H16N2O/c1-19(2)13-9-7-12(8-10-13)11-15-14-5-3-4-6-16(14)18-17(15)20/h3-11H,1-2H3,(H,18,20) D00QPG DRUGINKE UAKWLVYMKBWHMX-UHFFFAOYSA-N D00QPG DRUGSMIL CN(C)C1=CC=C(C=C1)C=C2C3=CC=CC=C3NC2=O D00QPG DRUGTYPE Small molecular drug D00QPG HIGHSTAT Investigative D00QPU DRUG__ID D00QPU D00QPU DRUGCLAS Investigative Drug(s) D00QPU DRUGINCH 1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/t13-,14-,15-,16-,18-,19-/m0/s1 D00QPU DRUGINKE CZWCKYRVOZZJNM-USOAJAOKSA-N D00QPU DRUGSMIL CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)OS(=O)(=O)O)C D00QPU DRUGTYPE Small molecular drug D00QPU HIGHSTAT Investigative D00QSV DRUG__ID D00QSV D00QSV DRUGCLAS Investigative Drug(s) D00QSV DRUGINCH 1S/C10H15NO/c1-8(11)6-9-4-3-5-10(7-9)12-2/h3-5,7-8H,6,11H2,1-2H3 D00QSV DRUGINKE VEJWNIYARKAHFI-UHFFFAOYSA-N D00QSV DRUGSMIL CC(CC1=CC(=CC=C1)OC)N D00QSV DRUGTYPE Small molecular drug D00QSV HIGHSTAT Investigative D00QTA DRUG__ID D00QTA D00QTA DRUGCLAS Investigative Drug(s) D00QTA DRUGCOMP Arrow Therapeutics Ltd D00QTA HIGHSTAT Investigative D00QTL DRUG__ID D00QTL D00QTL DRUGCLAS Investigative Drug(s) D00QTL DRUGCOMP ImCure Therapeutics D00QTL HIGHSTAT Investigative D00QTU DRUG__ID D00QTU D00QTU DRUGCLAS Investigative Drug(s) D00QTU DRUGCOMP Threshold Pharmaceuticals Inc D00QTU HIGHSTAT Investigative D00QTX DRUG__ID D00QTX D00QTX DRUGCLAS Investigative Drug(s) D00QTX DRUGINCH 1S/C21H33ClO4/c22-18-14-20(24)17(12-13-19(23)15-8-4-3-5-9-15)16(18)10-6-1-2-7-11-21(25)26/h1,6,12-13,15-20,23-24H,2-5,7-11,14H2,(H,25,26)/b6-1-,13-12+/t16?,17-,18-,19-,20-/m1/s1 D00QTX DRUGINKE ZOQXTNLUBHPZOZ-GZFHOOQWSA-N D00QTX DRUGSMIL C1CCC(CC1)C(C=CC2C(CC(C2CC=CCCCC(=O)O)Cl)O)O D00QTX DRUGTYPE Small molecular drug D00QTX HIGHSTAT Investigative D00QUJ DRUG__ID D00QUJ D00QUJ DRUGCLAS Investigative Drug(s) D00QUJ DRUGCOMP Kyorin Pharmaceutical Co Ltd D00QUJ HIGHSTAT Investigative D00QUN DRUG__ID D00QUN D00QUN DRUGCLAS Investigative Drug(s) D00QUN DRUGINCH 1S/C21H36NO5P/c1-4-5-6-7-8-9-10-11-12-13-18-28(25,26-19(2)3)27-21-16-14-20(15-17-21)22(23)24/h14-17,19H,4-13,18H2,1-3H3 D00QUN DRUGINKE VZXZHBVWVCMVBS-UHFFFAOYSA-N D00QUN DRUGSMIL CCCCCCCCCCCCP(=O)(OC1=CC=C(C=C1)[N+](=O)[O-])OC(C)C D00QUN DRUGTYPE Small molecular drug D00QUN HIGHSTAT Investigative D00QUZ DRUG__ID D00QUZ D00QUZ DRUGCLAS Clinical Trial Drug(s) D00QUZ DRUGCOMP TransTech Pharma Inc D00QUZ HIGHSTAT Phase 1/2 D00QVP DRUG__ID D00QVP D00QVP DRUGCLAS Investigative Drug(s) D00QVP DRUGINCH 1S/C15H11NOS/c17-9-5-6-13-11(7-9)12-8-18-14-4-2-1-3-10(14)15(12)16-13/h1-7,16-17H,8H2 D00QVP DRUGINKE BVGUKMAMOJMOFD-UHFFFAOYSA-N D00QVP DRUGSMIL C1C2=C(C3=CC=CC=C3S1)NC4=C2C=C(C=C4)O D00QVP DRUGTYPE Small molecular drug D00QVP HIGHSTAT Investigative D00QVT DRUG__ID D00QVT D00QVT DRUGCLAS Clinical Trial Drug(s) D00QVT DRUGCOMP University of Michigan D00QVT DRUGINCH 1S/C23H35N9O8S/c1-11(34)32-4-2-3-17(32)23(40)29-14(5-12-7-26-10-27-12)20(37)30-15(8-33)21(38)31-16(9-41)22(39)28-13(19(25)36)6-18(24)35/h7,10,13-17,33,41H,2-6,8-9H2,1H3,(H2,24,35)(H2,25,36)(H,26,27)(H,28,39)(H,29,40)(H,30,37)(H,31,38)/t13-,14-,15-,16-,17-/m0/s1 D00QVT DRUGINKE MMHDBUJXLOFTLC-WOYTXXSLSA-N D00QVT DRUGSMIL CC(=O)N1CCCC1C(=O)NC(CC2=CN=CN2)C(=O)NC(CO)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)N D00QVT DRUGTYPE Small molecular drug D00QVT HIGHSTAT Phase 2 D00QVY DRUG__ID D00QVY D00QVY DRUGCLAS Patented Agent(s) D00QVY DRUGINCH 1S/C11H16O2/c1-3-4-5-10-8(2)6-9(12)7-11(10)13/h6-7,12-13H,3-5H2,1-2H3 D00QVY DRUGINKE IYOQFZBJNROXMO-UHFFFAOYSA-N D00QVY DRUGSMIL CCCCC1=C(C=C(C=C1C)O)O D00QVY DRUGTYPE Small molecular drug D00QVY HIGHSTAT Patented D00QWK DRUG__ID D00QWK D00QWK DRUGCLAS Clinical Trial Drug(s) D00QWK DRUGCOMP Shenzhen Geno-Immune Medical Institute D00QWK DRUGTYPE CAR T Cell Therapy D00QWK HIGHSTAT Phase 1/2 D00QWP DRUG__ID D00QWP D00QWP DRUGCLAS Investigative Drug(s) D00QWP DRUGCOMP Hygeia Therapeutics Inc D00QWP HIGHSTAT Investigative D00QWU DRUG__ID D00QWU D00QWU DRUGCLAS Clinical Trial Drug(s) D00QWU DRUGCOMP Bristol-Myers Squibb; Exelixis D00QWU DRUGINCH 1S/C28H29ClN2O3S/c1-27(2,23-11-6-7-12-24(23)29)26-30-25(28(3,4)32)18-31(26)21-15-13-19(14-16-21)20-9-8-10-22(17-20)35(5,33)34/h6-18,32H,1-5H3 D00QWU DRUGINKE JLPURTXCSILYLW-UHFFFAOYSA-N D00QWU DRUGSMIL CC(C)(C1=CC=CC=C1Cl)C2=NC(=CN2C3=CC=C(C=C3)C4=CC(=CC=C4)S(=O)(=O)C)C(C)(C)O D00QWU HIGHSTAT Phase 1 D00QXB DRUG__ID D00QXB D00QXB DRUGCLAS Clinical Trial Drug(s) D00QXB DRUGCOMP Charity Medical School of the Humboldt University of Berlin D00QXB DRUGTYPE Vaccine D00QXB HIGHSTAT Phase 2 D00QXV DRUG__ID D00QXV D00QXV DRUGCLAS Discontinued Drug(s) D00QXV DRUGCOMP Bristol-Myers Squibb Co D00QXV DRUGINCH 1S/C20H24FN5O/c1-27-19-13-22-14-24-20(19)26-9-7-25(8-10-26)6-2-3-15-12-23-18-5-4-16(21)11-17(15)18/h4-5,11-14,23H,2-3,6-10H2,1H3 D00QXV DRUGINKE NRLXAYBZNVHRFL-UHFFFAOYSA-N D00QXV DRUGSMIL COC1=CN=CN=C1N2CCN(CC2)CCCC3=CNC4=C3C=C(C=C4)F D00QXV DRUGTYPE Small molecular drug D00QXV HIGHSTAT Discontinued in Phase 2 D00QYH DRUG__ID D00QYH D00QYH DRUGCLAS Investigative Drug(s) D00QYH DRUGINCH 1S/C69H111N23O16S/c1-39(2)32-47(86-58(98)44(17-9-26-78-68(73)74)83-63(103)52-20-12-29-91(52)65(105)45(18-10-27-79-69(75)76)84-56(96)42(71)22-23-54(72)94)59(99)89-50(37-93)61(101)87-48(34-41-35-77-38-81-41)60(100)82-43(16-7-8-25-70)57(97)80-36-55(95)90-28-11-19-51(90)62(102)85-46(24-31-109-3)66(106)92-30-13-21-53(92)64(104)88-49(67(107)108)33-40-14-5-4-6-15-40/h4-6,14-15,35,38-39,42-53,93H,7-13,16-34,36-37,70-71H2,1-3H3,(H2,72,94)(H,77,81)(H,80,97)(H,82,100)(H,83,103)(H,84,96)(H,85,102)(H,86,98)(H,87,101)(H,88,104)(H,89,99)(H,107,108)(H4,73,74,78)(H4,75,76,79)/t42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-/m0/s1 D00QYH DRUGINKE XXCCRHIAIBQDPX-PEWBXTNBSA-N D00QYH DRUGSMIL CC(C)CC(C(=O)NC(CO)C(=O)NC(CC1=CN=CN1)C(=O)NC(CCCCN)C(=O)NCC(=O)N2CCCC2C(=O)NC(CCSC)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C5CCCN5C(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)N)N D00QYH DRUGTYPE Small molecular drug D00QYH HIGHSTAT Investigative D00QYO DRUG__ID D00QYO D00QYO DRUGCLAS Investigative Drug(s) D00QYO DRUGINCH 1S/C10H16N5O11P3/c1-5-6(24-28(19,20)26-29(21,22)25-27(16,17)18)2-7(23-5)15-4-14-8-9(11)12-3-13-10(8)15/h3-7H,2H2,1H3,(H,19,20)(H,21,22)(H2,11,12,13)(H2,16,17,18)/t5-,6+,7-/m1/s1 D00QYO DRUGINKE ZJGUOEYCABTFNH-DSYKOEDSSA-N D00QYO DRUGSMIL CC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)OP(=O)(O)OP(=O)(O)OP(=O)(O)O D00QYO DRUGTYPE Small molecular drug D00QYO HIGHSTAT Investigative D00QZA DRUG__ID D00QZA D00QZA DRUGCLAS Investigative Drug(s) D00QZA DRUGINCH 1S/C15H23N7O4S/c1-2-17-15(25)18-3-4-27-5-8-10(23)11(24)14(26-8)22-7-21-9-12(16)19-6-20-13(9)22/h6-8,10-11,14,23-24H,2-5H2,1H3,(H2,16,19,20)(H2,17,18,25)/t8-,10+,11-,14?/m1/s1 D00QZA DRUGINKE CACMCLIHCDTJHL-XLAISSFRSA-N D00QZA DRUGSMIL CCNC(=O)NCCSCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D00QZA DRUGTYPE Small molecular drug D00QZA HIGHSTAT Investigative D00QZJ DRUG__ID D00QZJ D00QZJ DRUGCLAS Investigative Drug(s) D00QZJ DRUGCOMP Access Pharmaceuticals Inc D00QZJ HIGHSTAT Investigative D00RAK DRUG__ID D00RAK D00RAK DRUGCLAS Investigative Drug(s) D00RAK DRUGINCH 1S/C9H13N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h4,6,15-17H,1-2H2,(H4,10,11,13,14,18)/t4-,6+/m1/s1 D00RAK DRUGINKE YQIFAMYNGGOTFB-XINAWCOVSA-N D00RAK DRUGSMIL C1C(=NC2=C(N1)N=C(NC2=O)N)C(C(CO)O)O D00RAK DRUGTYPE Small molecular drug D00RAK HIGHSTAT Investigative D00RAM DRUG__ID D00RAM D00RAM DRUGCLAS Drugs in Phase 1 Trial D00RAM DRUGTYPE Cell therapy D00RAM HIGHSTAT Phase 1/2 Trial D00RAM THERCLAS Antiviral Agents D00RAO DRUG__ID D00RAO D00RAO DRUGCLAS Investigative Drug(s) D00RAO DRUGINCH 1S/C20H22O7/c1-6-9(2)18(23)25-13-8-20(5)14(21)7-12(27-20)10(3)16(22)17-15(13)11(4)19(24)26-17/h6-7,13,15-17,22H,3-4,8H2,1-2,5H3/b9-6-/t13-,15-,16+,17+,20-/m1/s1 D00RAO DRUGINKE LEMMNOMGQFFVKL-NPUWKFQTSA-N D00RAO DRUGSMIL CC=C(C)C(=O)OC1CC2(C(=O)C=C(O2)C(=C)C(C3C1C(=C)C(=O)O3)O)C D00RAO DRUGTYPE Small molecular drug D00RAO HIGHSTAT Investigative D00RBV DRUG__ID D00RBV D00RBV DRUGCLAS Investigative Drug(s) D00RBV DRUGINCH 1S/C16H14N2O2/c1-19-15-7-12-6-13(11-4-3-5-17-9-11)10-18-14(12)8-16(15)20-2/h3-10H,1-2H3 D00RBV DRUGINKE KYJQMVJJOORKLO-UHFFFAOYSA-N D00RBV DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CN=CC=C3 D00RBV DRUGTYPE Small molecular drug D00RBV HIGHSTAT Investigative D00RCI DRUG__ID D00RCI D00RCI DRUGCLAS Approved Drug(s) D00RCI DRUGCOMP NPS D00RCI DRUGINCH 1S/C164H252N44O55S/c1-21-77(11)126(156(255)187-95(44-46-114(167)214)141(240)206-130(83(17)211)160(259)186-93(42-33-34-49-165)140(239)202-129(80(14)24-4)159(258)208-131(84(18)212)161(260)200-111(163(262)263)66-125(230)231)203-151(250)100(54-76(9)10)189-145(244)103(57-88-67-175-92-41-32-31-40-90(88)92)192-147(246)105(60-116(169)216)199-157(256)127(78(12)22-2)204-152(251)102(56-87-38-29-26-30-39-87)190-149(248)109(64-123(226)227)195-137(236)94(43-35-50-174-164(171)172)183-134(233)82(16)179-133(232)81(15)180-142(241)98(52-74(5)6)188-146(245)104(59-115(168)215)194-150(249)110(65-124(228)229)196-143(242)99(53-75(7)8)198-158(257)128(79(13)23-3)205-162(261)132(85(19)213)207-153(252)106(61-117(170)217)193-139(238)97(48-51-264-20)185-138(237)96(45-47-120(220)221)184-148(247)108(63-122(224)225)197-155(254)113(72-210)201-144(243)101(55-86-36-27-25-28-37-86)191-154(253)112(71-209)182-119(219)70-177-136(235)107(62-121(222)223)181-118(218)69-176-135(234)91(166)58-89-68-173-73-178-89/h25-32,36-41,67-68,73-85,91,93-113,126-132,175,209-213H,21-24,33-35,42-66,69-72,165-166H2,1-20H3,(H2,167,214)(H2,168,215)(H2,169,216)(H2,170,217)(H,173,178)(H,176,234)(H,177,235)(H,179,232)(H,180,241)(H,181,218)(H,182,219)(H,183,233)(H,184,247)(H,185,237)(H,186,259)(H,187,255)(H,188,245)(H,189,244)(H,190,248)(H,191,253)(H,192,246)(H,193,238)(H,194,249)(H,195,236)(H,196,242)(H,197,254)(H,198,257)(H,199,256)(H,200,260)(H,201,243)(H,202,239)(H,203,250)(H,204,251)(H,205,261)(H,206,240)(H,207,252)(H,208,258)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,262,263)(H4,171,172,174)/t77-,78-,79-,80-,81-,82-,83+,84+,85+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,126-,127-,128-,129-,130-,131-,132-/m0/s1 D00RCI DRUGINKE CILIXQOJUNDIDU-ASQIGDHWSA-N D00RCI DRUGSMIL CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CN=CN5)N D00RCI DRUGTYPE Small molecular drug D00RCI HIGHSTAT Approved D00RCV DRUG__ID D00RCV D00RCV DRUGCLAS Investigative Drug(s) D00RCV DRUGINCH 1S/C14H16O2S/c1-3-4-5-8-11-17-14-10-7-6-9-13(14)16-12(2)15/h6-7,9-10H,3-4,11H2,1-2H3 D00RCV DRUGINKE MMWWBFVDWFUERO-UHFFFAOYSA-N D00RCV DRUGSMIL CCCC#CCSC1=CC=CC=C1OC(=O)C D00RCV DRUGTYPE Small molecular drug D00RCV HIGHSTAT Investigative D00RDE DRUG__ID D00RDE D00RDE DRUGCLAS Investigative Drug(s) D00RDE DRUGINCH 1S/C13H14N4O2S/c1-15-10-2-4-11(5-3-10)16-17-12-6-8-13(9-7-12)20(14,18)19/h2-9,15H,1H3,(H2,14,18,19) D00RDE DRUGINKE RMLHDMTUTOMVIX-UHFFFAOYSA-N D00RDE DRUGSMIL CNC1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)N D00RDE DRUGTYPE Small molecular drug D00RDE HIGHSTAT Investigative D00RDI DRUG__ID D00RDI D00RDI DRUGCLAS Investigative Drug(s) D00RDI DRUGCOMP Opsona Therapeutics Ltd D00RDI HIGHSTAT Investigative D00RDL DRUG__ID D00RDL D00RDL DRUGCLAS Patented Agent(s) D00RDL DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D00RDL DRUGINCH 1S/C20H19F3N2O3/c21-20(22,23)14-8-9-15(13-6-2-1-3-7-13)16(12-14)24-18(28)25-19(17(26)27)10-4-5-11-19/h1-3,6-9,12H,4-5,10-11H2,(H,26,27)(H2,24,25,28) D00RDL DRUGINKE LZSZOARSNJNBDV-UHFFFAOYSA-N D00RDL DRUGSMIL C1CCC(C1)(C(=O)O)NC(=O)NC2=C(C=CC(=C2)C(F)(F)F)C3=CC=CC=C3 D00RDL DRUGTYPE Small molecular drug D00RDL HIGHSTAT Patented D00RDO DRUG__ID D00RDO D00RDO DRUGCLAS Patented Agent(s) D00RDO DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D00RDO DRUGTYPE Carbohydrates D00RDO HIGHSTAT Patented D00RDS DRUG__ID D00RDS D00RDS DRUGCLAS Investigative Drug(s) D00RDS DRUGINCH 1S/C20H20N2O/c1-20(2,3)16-10-8-14(9-11-16)19(23)22-17-12-15-6-4-5-7-18(15)21-13-17/h4-13H,1-3H3,(H,22,23) D00RDS DRUGINKE MUZWQZALZQTMBA-UHFFFAOYSA-N D00RDS DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D00RDS DRUGTYPE Small molecular drug D00RDS HIGHSTAT Investigative D00RDY DRUG__ID D00RDY D00RDY DRUGCLAS Investigative Drug(s) D00RDY DRUGINCH 1S/C11H13IN4O3/c12-3-6-7(17)8(18)11(19-6)16-2-1-5-9(13)14-4-15-10(5)16/h1-2,4,6-8,11,17-18H,3H2,(H2,13,14,15)/t6-,7-,8-,11-/m1/s1 D00RDY DRUGINKE RUOLUSLZJXGWAU-KCGFPETGSA-N D00RDY DRUGSMIL C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CI)O)O D00RDY DRUGTYPE Small molecular drug D00RDY HIGHSTAT Investigative D00REB DRUG__ID D00REB D00REB DRUGCLAS Investigative Drug(s) D00REB DRUGINCH 1S/C26H35N3O3/c1-16-2-3-20(25(31)29-14-21-12-27-13-22(15-29)32-21)7-23(16)28-24(30)11-26-8-17-4-18(9-26)6-19(5-17)10-26/h2-3,7,17-19,21-22,27H,4-6,8-15H2,1H3,(H,28,30) D00REB DRUGINKE XYNNEMHCLNODBL-UHFFFAOYSA-N D00REB DRUGSMIL CC1=C(C=C(C=C1)C(=O)N2CC3CNCC(C2)O3)NC(=O)CC45CC6CC(C4)CC(C6)C5 D00REB DRUGTYPE Small molecular drug D00REB HIGHSTAT Investigative D00REK DRUG__ID D00REK D00REK DRUGCLAS Investigative Drug(s) D00REK DRUGINCH 1S/C19H16N2O2/c22-13-15-10-11-18(23-15)19-16-8-4-5-9-17(16)21(20-19)12-14-6-2-1-3-7-14/h1-11,22H,12-13H2 D00REK DRUGINKE OQQVFCKUDYMWGV-UHFFFAOYSA-N D00REK DRUGSMIL C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)C4=CC=C(O4)CO D00REK DRUGTYPE Small molecular drug D00REK HIGHSTAT Investigative D00REW DRUG__ID D00REW D00REW DRUGCLAS Investigative Drug(s) D00REW DRUGINCH 1S/C18H16N4O2S/c1-21(2)13-8-9-19-17-14(13)15-16(25-17)18(23)22(10-20-15)11-4-6-12(24-3)7-5-11/h4-10H,1-3H3/i3-1 D00REW DRUGINKE COQPVKMATNFNLG-KTXUZGJCSA-N D00REW DRUGSMIL CN(C)C1=C2C3=C(C(=O)N(C=N3)C4=CC=C(C=C4)OC)SC2=NC=C1 D00REW DRUGTYPE Small molecular drug D00REW HIGHSTAT Investigative D00RFY DRUG__ID D00RFY D00RFY DRUGCLAS Investigative Drug(s) D00RFY DRUGINCH 1S/C16H12O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-7,17-19H,1H3 D00RFY DRUGINKE MBNGWHIJMBWFHU-UHFFFAOYSA-N D00RFY DRUGSMIL COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O D00RFY DRUGTYPE Small molecular drug D00RFY HIGHSTAT Investigative D00RFZ DRUG__ID D00RFZ D00RFZ DRUGCLAS Discontinued Drug(s) D00RFZ DRUGCOMP Pharmasset Inc D00RFZ DRUGINCH 1S/C10H14FN3O4/c1-10(11)7(16)5(4-15)18-8(10)14-3-2-6(12)13-9(14)17/h2-3,5,7-8,15-16H,4H2,1H3,(H2,12,13,17)/t5-,7-,8-,10-/m1/s1 D00RFZ DRUGINKE NYPIRLYMDJMKGW-VPCXQMTMSA-N D00RFZ DRUGSMIL CC1(C(C(OC1N2C=CC(=NC2=O)N)CO)O)F D00RFZ DRUGTYPE Small molecular drug D00RFZ HIGHSTAT Terminated D00RGD DRUG__ID D00RGD D00RGD DRUGCLAS Investigative Drug(s) D00RGD DRUGINCH 1S/C13H18N2O3/c16-12(11-6-5-9-14-10-11)7-3-1-2-4-8-13(17)15-18/h5-6,9-10,18H,1-4,7-8H2,(H,15,17) D00RGD DRUGINKE AAHQDWBMLVLXAC-UHFFFAOYSA-N D00RGD DRUGSMIL C1=CC(=CN=C1)C(=O)CCCCCCC(=O)NO D00RGD DRUGTYPE Small molecular drug D00RGD HIGHSTAT Investigative D00RGF DRUG__ID D00RGF D00RGF DRUGCLAS Clinical Trial Drug(s) D00RGF DRUGCOMP Green cross D00RGF HIGHSTAT Phase 1 D00RGL DRUG__ID D00RGL D00RGL DRUGCLAS Investigative Drug(s) D00RGL DRUGINCH 1S/C62H63N9O12/c63-55(74)33-52(70-58(77)49(28-37-13-5-2-6-14-37)67-56(75)48(27-36-11-3-1-4-12-36)66-53(61(80)81)31-40-34-64-46-17-9-7-15-44(40)46)60(79)69-50(29-38-19-23-42(72)24-20-38)57(76)68-51(30-39-21-25-43(73)26-22-39)59(78)71-54(62(82)83)32-41-35-65-47-18-10-8-16-45(41)47/h1-26,34-35,48-54,64-66,72-73H,27-33H2,(H2,63,74)(H,67,75)(H,68,76)(H,69,79)(H,70,77)(H,71,78)(H,80,81)(H,82,83)/t48-,49-,50-,51-,52-,53+,54-/m0/s1 D00RGL DRUGINKE NXCOTRHNIBGFLM-ZYWWURNJSA-N D00RGL DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(=O)N)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)O)NC(CC7=CNC8=CC=CC=C87)C(=O)O D00RGL HIGHSTAT Investigative D00RGO DRUG__ID D00RGO D00RGO DRUGCLAS Investigative Drug(s) D00RGO DRUGINCH 1S/C10H4N6O/c17-9-6-4-2-1-3-5(6)7-8(9)13-16-10(11-7)12-14-15-16/h1-4H D00RGO DRUGINKE DPANHMGWPXVBQI-UHFFFAOYSA-N D00RGO DRUGSMIL C1=CC=C2C(=C1)C3=NC4=NN=NN4N=C3C2=O D00RGO DRUGTYPE Small molecular drug D00RGO HIGHSTAT Investigative D00RGP DRUG__ID D00RGP D00RGP DRUGCLAS Investigative Drug(s) D00RGP DRUGINCH 1S/C21H24O7/c1-24-16-6-11(4-5-15(16)22)20-13-9-28-21(14(13)10-27-20)12-7-17(25-2)19(23)18(8-12)26-3/h4-8,13-14,20-23H,9-10H2,1-3H3/t13-,14-,20+,21+/m0/s1 D00RGP DRUGINKE VJOBNGRIBLNUKN-BMHXQBNDSA-N D00RGP DRUGSMIL COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC D00RGP DRUGTYPE Small molecular drug D00RGP HIGHSTAT Investigative D00RGX DRUG__ID D00RGX D00RGX DRUGCLAS Clinical Trial Drug(s) D00RGX DRUGCOMP GenentechSouth San Francisco, CA D00RGX HIGHSTAT Phase 1 D00RHH DRUG__ID D00RHH D00RHH DRUGCLAS Investigative Drug(s) D00RHH DRUGINCH 1S/C30H35FN2O5/c1-19(2)33-26(15-14-23(34)17-24(35)18-27(36)37)28(20-10-12-21(31)13-11-20)25-9-6-16-32(30(38)29(25)33)22-7-4-3-5-8-22/h3-5,7-8,10-13,19,23-24,34-35H,6,9,14-18H2,1-2H3,(H,36,37)/p-1/t23-,24-/m1/s1 D00RHH DRUGINKE OMBVEVHRIQULKW-DNQXCXABSA-M D00RHH DRUGSMIL CC(C)N1C(=C(C2=C1C(=O)N(CCC2)C3=CC=CC=C3)C4=CC=C(C=C4)F)CCC(CC(CC(=O)[O-])O)O D00RHH DRUGTYPE Small molecular drug D00RHH HIGHSTAT Investigative D00RIB DRUG__ID D00RIB D00RIB DRUGCLAS Discontinued Drug(s) D00RIB DRUGCOMP Questcor Pharmaceuticals Inc D00RIB HIGHSTAT Discontinued in Phase 1 D00RIK DRUG__ID D00RIK D00RIK DRUGCLAS Investigative Drug(s) D00RIK DRUGCOMP Compugen Ltd D00RIK HIGHSTAT Investigative D00RIX DRUG__ID D00RIX D00RIX DRUGCLAS Investigative Drug(s) D00RIX DRUGINCH 1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H D00RIX DRUGINKE KZNIFHPLKGYRTM-UHFFFAOYSA-N D00RIX DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O D00RIX DRUGTYPE Small molecular drug D00RIX HIGHSTAT Investigative D00RJA DRUG__ID D00RJA D00RJA DRUGCLAS Patented Agent(s) D00RJA DRUGINCH 1S/C23H25N5O4/c1-4-20(10-11-24)32-23(30)26-15(2)16-6-5-7-18(12-16)27-22(29)28-19-9-8-17(14-25)21(13-19)31-3/h5-9,12-13,15,20H,4,10H2,1-3H3,(H,26,30)(H2,27,28,29)/t15-,20?/m0/s1 D00RJA DRUGINKE PJFQWSNOXLEDDZ-OOJLDXBWSA-N D00RJA DRUGSMIL CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C#N)OC D00RJA DRUGTYPE Small molecular drug D00RJA HIGHSTAT Patented D00RJB DRUG__ID D00RJB D00RJB DRUGCLAS Clinical Trial Drug(s) D00RJB DRUGCOMP Hoechst AG D00RJB DRUGINCH 1S/C19H16ClNO4/c1-13-10-15(21(23)19(22)11-13)12-24-16-6-8-18(9-7-16)25-17-4-2-14(20)3-5-17/h2-11,23H,12H2,1H3 D00RJB DRUGINKE UDYUIWXQUBNDHC-UHFFFAOYSA-N D00RJB DRUGSMIL CC1=CC(=O)N(C(=C1)COC2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)O D00RJB DRUGTYPE Small molecular drug D00RJB HIGHSTAT Phase 2 D00RJE DRUG__ID D00RJE D00RJE DRUGCLAS Clinical Trial Drug(s) D00RJE DRUGCOMP Almirall Prodesfarma SA D00RJE DRUGINCH 1S/C18H24ClN3O2/c19-14-7-13(17(8-15(14)20)24-10-11-1-2-11)18(23)21-16-9-22-5-3-12(16)4-6-22/h7-8,11-12,16H,1-6,9-10,20H2,(H,21,23) D00RJE DRUGINKE DBQMQBCSKXTCIJ-UHFFFAOYSA-N D00RJE DRUGSMIL C1CC1COC2=CC(=C(C=C2C(=O)NC3CN4CCC3CC4)Cl)N D00RJE DRUGTYPE Small molecular drug D00RJE HIGHSTAT Phase 3 D00RJJ DRUG__ID D00RJJ D00RJJ DRUGCLAS Approved Drug(s) D00RJJ DRUGCOMP Organon International D00RJJ DRUGINCH 1S/C80H113ClN18O13/c1-9-84-79(85-10-2)88-38-17-15-24-60(70(104)94-62(41-49(5)6)71(105)93-61(25-16-18-39-89-80(86-11-3)87-12-4)78(112)99-40-20-26-68(99)77(111)90-50(7)69(82)103)92-73(107)64(44-53-30-35-59(102)36-31-53)97-76(110)67(48-100)98-75(109)66(46-55-21-19-37-83-47-55)96-74(108)65(43-52-28-33-58(81)34-29-52)95-72(106)63(91-51(8)101)45-54-27-32-56-22-13-14-23-57(56)42-54/h13-14,19,21-23,27-37,42,47,49-50,60-68,100,102H,9-12,15-18,20,24-26,38-41,43-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,107)(H,93,105)(H,94,104)(H,95,106)(H,96,108)(H,97,110)(H,98,109)(H2,84,85,88)(H2,86,87,89)/t50-,60-,61+,62+,63-,64+,65-,66-,67+,68+/m1/s1 D00RJJ DRUGINKE GJNXBNATEDXMAK-PFLSVRRQSA-N D00RJJ DRUGSMIL CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC D00RJJ DRUGTYPE Small molecular drug D00RJJ HIGHSTAT Approved D00RJJ THERCLAS Abortifacient Agents D00RJT DRUG__ID D00RJT D00RJT DRUGCLAS Investigative Drug(s) D00RJT DRUGINCH 1S/NO3/c2-1(3)4/q-1 D00RJT DRUGINKE NHNBFGGVMKEFGY-UHFFFAOYSA-N D00RJT DRUGSMIL [N+](=O)([O-])[O-] D00RJT DRUGTYPE Small molecular drug D00RJT HIGHSTAT Investigative D00RKV DRUG__ID D00RKV D00RKV COMPCLAS Carbamate derivatives D00RKV DRUGCLAS Patented Agent(s) D00RKV DRUGCOMP Astellas Pharma Inc. AOKI, Satoshi MUNAKATA, Ryosuke KAWANO, Noriyuki D00RKV DRUGTYPE Small molecular drug D00RKV HIGHSTAT Patented D00RLE DRUG__ID D00RLE D00RLE DRUGCLAS Investigative Drug(s) D00RLE DRUGINCH 1S/C16H13ClN2O/c1-19-16(20)14-5-3-2-4-13(14)15(18-19)10-11-6-8-12(17)9-7-11/h2-9H,10H2,1H3 D00RLE DRUGINKE QZOXWSKLFOUEKD-UHFFFAOYSA-N D00RLE DRUGSMIL CN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=C(C=C3)Cl D00RLE DRUGTYPE Small molecular drug D00RLE HIGHSTAT Investigative D00RLO DRUG__ID D00RLO D00RLO DRUGCLAS Investigative Drug(s) D00RLO DRUGINCH 1S/C6H15BrN.BrH/c1-8(2,3)6-4-5-7;/h4-6H2,1-3H3;1H/q+1;/p-1 D00RLO DRUGINKE NNZGNZHUGJAKKT-UHFFFAOYSA-M D00RLO DRUGSMIL C[N+](C)(C)CCCBr.[Br-] D00RLO DRUGTYPE Small molecular drug D00RLO HIGHSTAT Investigative D00RMC DRUG__ID D00RMC D00RMC DRUGCLAS Clinical Trial Drug(s) D00RMC DRUGCOMP Boehringer Ingelheim Corp D00RMC DRUGINCH 1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24) D00RMC DRUGINKE FTFRZXFNZVCRSK-UHFFFAOYSA-N D00RMC DRUGSMIL CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl D00RMC DRUGTYPE Small molecular drug D00RMC HIGHSTAT Phase 1 D00RMD DRUG__ID D00RMD D00RMD DRUGCLAS Discontinued Drug(s) D00RMD DRUGCOMP Fujisawa Pharmaceutical Co Ltd D00RMD DRUGINCH 1S/C13H16FN3O2/c1-10(18)16-6-8-17(9-7-16)15-13(19)11-2-4-12(14)5-3-11/h2-5H,6-9H2,1H3,(H,15,19) D00RMD DRUGINKE XTOKQKWTUYYVAO-UHFFFAOYSA-N D00RMD DRUGSMIL CC(=O)N1CCN(CC1)NC(=O)C2=CC=C(C=C2)F D00RMD DRUGTYPE Small molecular drug D00RMD HIGHSTAT Discontinued in Phase 2 D00RNA DRUG__ID D00RNA D00RNA DRUGCLAS Investigative Drug(s) D00RNA DRUGINCH 1S/C12H11NO4/c14-11(13-16)6-5-9-7-8-3-1-2-4-10(8)17-12(9)15/h1-4,7,16H,5-6H2,(H,13,14) D00RNA DRUGINKE HJRCGMHZQDXQAO-UHFFFAOYSA-N D00RNA DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)O2)CCC(=O)NO D00RNA DRUGTYPE Small molecular drug D00RNA HIGHSTAT Investigative D00RNB DRUG__ID D00RNB D00RNB DRUGCLAS Clinical Trial Drug(s) D00RNB DRUGINCH 1S/C18H26N2O/c1-13-6-5-7-14(2)17(13)19-18(21)16-8-3-4-11-20(16)12-15-9-10-15/h5-7,15-16H,3-4,8-12H2,1-2H3,(H,19,21) D00RNB DRUGINKE DNUYDQISHIJMLD-UHFFFAOYSA-N D00RNB DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2CC3CC3 D00RNB HIGHSTAT Phase 1 D00RNS DRUG__ID D00RNS D00RNS DRUGCLAS Patented Agent(s) D00RNS DRUGINCH 1S/C21H25BrN4O2S/c1-26(2)14-4-3-5-19(27)23-17-10-12-18(13-11-17)24-21(29)25-20(28)15-6-8-16(22)9-7-15/h6-13H,3-5,14H2,1-2H3,(H,23,27)(H2,24,25,28,29) D00RNS DRUGINKE NWWFPYSNQAXIIL-UHFFFAOYSA-N D00RNS DRUGSMIL CN(C)CCCCC(=O)NC1=CC=C(C=C1)NC(=S)NC(=O)C2=CC=C(C=C2)Br D00RNS DRUGTYPE Small molecular drug D00RNS HIGHSTAT Patented D00RNZ DRUG__ID D00RNZ D00RNZ DRUGCLAS Investigative Drug(s) D00RNZ DRUGINCH 1S/C16H12O3/c17-16-9-7-13-6-8-14(10-15(13)19-16)18-11-12-4-2-1-3-5-12/h1-10H,11H2 D00RNZ DRUGINKE QDLFCBKKECTJSK-UHFFFAOYSA-N D00RNZ DRUGSMIL C1=CC=C(C=C1)COC2=CC3=C(C=C2)C=CC(=O)O3 D00RNZ DRUGTYPE Small molecular drug D00RNZ HIGHSTAT Investigative D00ROR DRUG__ID D00ROR D00ROR DRUGCLAS Drugs in Phase 1 Trial D00ROR DRUGTYPE Cell therapy D00ROR HIGHSTAT Phase 1/2 Trial D00ROR THERCLAS Antiviral Agents D00ROV DRUG__ID D00ROV D00ROV DRUGCLAS Discontinued Drug(s) D00ROV DRUGCOMP Fujisawa Pharmaceutical Co Ltd D00ROV DRUGINCH 1S/C16H15N7O5S3/c17-16-20-7(4-31-16)9(22-28)12(24)21-10-13(25)23-11(15(26)27)8(5-30-14(10)23)29-3-6-1-18-19-2-6/h1-2,4,10,14,28H,3,5H2,(H2,17,20)(H,18,19)(H,21,24)(H,26,27)/b22-9+/t10-,14-/m1/s1 D00ROV DRUGINKE RNWMKMFWVBYAMX-KXDGEKGBSA-N D00ROV DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)C(=O)O)SCC4=CNN=C4 D00ROV HIGHSTAT Discontinued in Phase 1 D00ROY DRUG__ID D00ROY D00ROY DRUGCLAS Clinical Trial Drug(s) D00ROY DRUGCOMP Biodel D00ROY HIGHSTAT Phase 1 D00RPV DRUG__ID D00RPV D00RPV DRUGCLAS Investigative Drug(s) D00RPV DRUGCOMP Epiphany Biosciences D00RPV HIGHSTAT Investigative D00RPW DRUG__ID D00RPW D00RPW DRUGCLAS Patented Agent(s) D00RPW DRUGTYPE Small molecular drug D00RPW HIGHSTAT Patented D00RQQ DRUG__ID D00RQQ D00RQQ DRUGCLAS Investigative Drug(s) D00RQQ DRUGCOMP Astellas Pharma Inc D00RQQ HIGHSTAT Investigative D00RQW DRUG__ID D00RQW D00RQW COMPCLAS Biaryl mannoside derivatives D00RQW DRUGCLAS Patented Agent(s) D00RQW DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D00RQW DRUGTYPE Carbohydrates D00RQW HIGHSTAT Patented D00RRB DRUG__ID D00RRB D00RRB COMPCLAS Isoflavone derivatives D00RRB DRUGCLAS Patented Agent(s) D00RRB DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D00RRB DRUGTYPE Small molecular drug D00RRB HIGHSTAT Patented D00RRU DRUG__ID D00RRU D00RRU DRUGCLAS Clinical Trial Drug(s) D00RRU DRUGCOMP Biogen Idec D00RRU HIGHSTAT Phase 3 D00RRV DRUG__ID D00RRV D00RRV DRUGCLAS Investigative Drug(s) D00RRV DRUGINCH 1S/C12H11N3/c1-2-4-12-11(3-1)10(7-14-12)8-15-6-5-13-9-15/h1-7,9,14H,8H2 D00RRV DRUGINKE FRADTKAUXQUOIJ-UHFFFAOYSA-N D00RRV DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CN3C=CN=C3 D00RRV DRUGTYPE Small molecular drug D00RRV HIGHSTAT Investigative D00RSK DRUG__ID D00RSK D00RSK DRUGCLAS Discontinued Drug(s) D00RSK DRUGCOMP GlaxoSmithKline D00RSK DRUGINCH 1S/C21H19N3O3S/c1-3-27-17-10-6-16(7-11-17)21-20(19-5-4-14-22-24(19)23-21)15-8-12-18(13-9-15)28(2,25)26/h4-14H,3H2,1-2H3 D00RSK DRUGINKE NXMZBNYLCVTRGB-UHFFFAOYSA-N D00RSK DRUGSMIL CCOC1=CC=C(C=C1)C2=NN3C(=C2C4=CC=C(C=C4)S(=O)(=O)C)C=CC=N3 D00RSK DRUGTYPE Small molecular drug D00RSK HIGHSTAT Discontinued in Phase 3 D00RSK THERCLAS Analgesics D00RST DRUG__ID D00RST D00RST DRUGCLAS Investigative Drug(s) D00RST DRUGINCH 1S/C20H36N2O2/c1-2-8-24-9-6-4-3-5-7-21-19(23)22-20-13-16-10-17(14-20)12-18(11-16)15-20/h16-18H,2-15H2,1H3,(H2,21,22,23) D00RST DRUGINKE GXOBIXGHFWBEMM-UHFFFAOYSA-N D00RST DRUGSMIL CCCOCCCCCCNC(=O)NC12CC3CC(C1)CC(C3)C2 D00RST DRUGTYPE Small molecular drug D00RST HIGHSTAT Investigative D00RTC DRUG__ID D00RTC D00RTC DRUGCLAS Clinical Trial Drug(s) D00RTC DRUGCOMP Eleven Biotherapeutics Cambridge, MA D00RTC HIGHSTAT Phase 3 D00RTM DRUG__ID D00RTM D00RTM DRUGCLAS Investigative Drug(s) D00RTM DRUGINCH 1S/C13H18N2/c1-15(2)9-5-6-11-10-14-13-8-4-3-7-12(11)13/h3-4,7-8,10,14H,5-6,9H2,1-2H3 D00RTM DRUGINKE QHNWPRMHGXRBAO-UHFFFAOYSA-N D00RTM DRUGSMIL CN(C)CCCC1=CNC2=CC=CC=C21 D00RTM DRUGTYPE Small molecular drug D00RTM HIGHSTAT Investigative D00RTU DRUG__ID D00RTU D00RTU DRUGCLAS Investigative Drug(s) D00RTU DRUGCOMP Algeta ASA D00RTU DRUGTYPE Antibody D00RTU HIGHSTAT Investigative D00RUE DRUG__ID D00RUE D00RUE DRUGCLAS Patented Agent(s) D00RUE DRUGINCH 1S/C26H27N3O3S/c1-31-23-17-20(10-11-22(23)32-16-15-28-13-5-6-14-28)29-18-19-9-12-24(27-25(19)26(29)30)33-21-7-3-2-4-8-21/h2-4,7-12,17H,5-6,13-16,18H2,1H3 D00RUE DRUGINKE PULOMQYOCPKDEH-UHFFFAOYSA-N D00RUE DRUGSMIL COC1=C(C=CC(=C1)N2CC3=C(C2=O)N=C(C=C3)SC4=CC=CC=C4)OCCN5CCCC5 D00RUE DRUGTYPE Small molecular drug D00RUE HIGHSTAT Patented D00RUN DRUG__ID D00RUN D00RUN DRUGCLAS Investigative Drug(s) D00RUN DRUGINCH 1S/C13H20N2/c1-13(2,3)9-7-5-4-6-8-12-10-14-11-15-12/h10-11H,6-9H2,1-3H3,(H,14,15) D00RUN DRUGINKE CNQBABLURIQXNU-UHFFFAOYSA-N D00RUN DRUGSMIL CC(C)(C)CCC#CCCC1=CN=CN1 D00RUN DRUGTYPE Small molecular drug D00RUN HIGHSTAT Investigative D00RWP DRUG__ID D00RWP D00RWP DRUGCLAS Investigative Drug(s) D00RWP DRUGINCH 1S/C139H211N43O42/c1-65(2)38-84(166-122(208)86(40-67(5)6)167-124(210)88(43-75-31-33-79(189)34-32-75)162-106(194)55-152-115(201)70(11)158-132(218)98(60-184)177-128(214)95(49-104(144)192)171-123(209)87(41-68(7)8)174-137(223)112(72(13)187)181-131(217)90(160-105(193)51-141)44-76-52-151-81-27-19-18-26-80(76)81)117(203)155-58-109(197)182-37-23-30-101(182)135(221)173-91(45-77-53-148-63-156-77)121(207)159-71(12)116(202)179-111(69(9)10)136(222)154-57-108(196)163-94(48-103(143)191)127(213)169-92(46-78-54-149-64-157-78)126(212)165-83(29-22-36-150-139(146)147)120(206)176-99(61-185)133(219)168-89(42-74-24-16-15-17-25-74)125(211)178-100(62-186)134(220)172-96(50-110(198)199)129(215)164-82(28-20-21-35-140)119(205)170-93(47-102(142)190)118(204)153-56-107(195)161-85(39-66(3)4)130(216)180-113(73(14)188)138(224)175-97(59-183)114(145)200/h15-19,24-27,31-34,52-54,63-73,82-101,111-113,151,183-189H,20-23,28-30,35-51,55-62,140-141H2,1-14H3,(H2,142,190)(H2,143,191)(H2,144,192)(H2,145,200)(H,148,156)(H,149,157)(H,152,201)(H,153,204)(H,154,222)(H,155,203)(H,158,218)(H,159,207)(H,160,193)(H,161,195)(H,162,194)(H,163,196)(H,164,215)(H,165,212)(H,166,208)(H,167,210)(H,168,219)(H,169,213)(H,170,205)(H,171,209)(H,172,220)(H,173,221)(H,174,223)(H,175,224)(H,176,206)(H,177,214)(H,178,211)(H,179,202)(H,180,216)(H,181,217)(H,198,199)(H4,146,147,150)/t70-,71-,72+,73+,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,111-,112-,113-/m0/s1 D00RWP DRUGINKE VYHIHGYPAVCHDV-RUKUCZSXSA-N D00RWP DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)CN D00RWP HIGHSTAT Investigative D00RWQ DRUG__ID D00RWQ D00RWQ DRUGCLAS Clinical Trial Drug(s) D00RWQ DRUGCOMP CeNeRx Pharma D00RWQ DRUGINCH 1S/C14H8F4O4S/c15-8-1-3-12-10(5-8)22-11-6-9(21-7-14(16,17)18)2-4-13(11)23(12,19)20/h1-6H,7H2 D00RWQ DRUGINKE PDIMOTRDGUQMNY-UHFFFAOYSA-N D00RWQ DRUGSMIL C1=CC2=C(C=C1OCC(F)(F)F)OC3=C(S2(=O)=O)C=CC(=C3)F D00RWQ DRUGTYPE Small molecular drug D00RWQ HIGHSTAT Phase 2 D00RWU DRUG__ID D00RWU D00RWU DRUGCLAS Investigative Drug(s) D00RWU DRUGCOMP Ottawa Hospital Research Institute D00RWU HIGHSTAT Investigative D00RWW DRUG__ID D00RWW D00RWW DRUGCLAS Clinical Trial Drug(s) D00RWW DRUGCOMP Drugs for Neglected Diseases initiative D00RWW DRUGINCH 1S/C12H13N3O3S/c1-14-11(13-7-12(14)15(16)17)8-18-9-3-5-10(19-2)6-4-9/h3-7H,8H2,1-2H3 D00RWW DRUGINKE MIWWSGDADVMLTG-UHFFFAOYSA-N D00RWW DRUGSMIL CN1C(=CN=C1COC2=CC=C(C=C2)SC)[N+](=O)[O-] D00RWW DRUGTYPE Small molecular drug D00RWW HIGHSTAT Phase 2/3 D00RXR DRUG__ID D00RXR D00RXR DRUGCLAS Discontinued Drug(s) D00RXR DRUGCOMP Amylin Pharmaceuticals Inc D00RXR HIGHSTAT Discontinued in Phase 1 D00RXS DRUG__ID D00RXS D00RXS DRUGCLAS Investigative Drug(s) D00RXS DRUGSMIL C1=NC2=C(C1C3C(C(C(N3)CO)O)O)NC(=NC2=O)N D00RXS DRUGTYPE Small molecular drug D00RXS HIGHSTAT Investigative D00RYA DRUG__ID D00RYA D00RYA DRUGCLAS Clinical Trial Drug(s) D00RYA DRUGCOMP S*BIO Pte Ltd D00RYA DRUGINCH 1S/C26H30N4O4/c1-2-12-30(11-1)13-16-33-24-7-5-21-17-20(24)18-31-14-3-4-15-32-19-22-6-8-25(34-22)23-9-10-27-26(28-21)29-23/h3-10,17H,1-2,11-16,18-19H2,(H,27,28,29)/b4-3+ D00RYA DRUGINKE NNXDIGHYPZHXTR-ONEGZZNKSA-N D00RYA DRUGSMIL C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC=C(O4)C5=NC(=NC=C5)NC(=C3)C=C2 D00RYA HIGHSTAT Phase 1 D00RYU DRUG__ID D00RYU D00RYU DRUGCLAS Clinical Trial Drug(s) D00RYU DRUGCOMP Innate Pharma SA D00RYU HIGHSTAT Phase 2 D00RZA DRUG__ID D00RZA D00RZA DRUGCLAS Investigative Drug(s) D00RZA DRUGCOMP Epiphany Biosciences D00RZA HIGHSTAT Investigative D00RZN DRUG__ID D00RZN D00RZN DRUGCLAS Investigative Drug(s) D00RZN DRUGINCH 1S/C21H22O6/c1-11(2)4-5-12-6-13(7-19(26-3)21(12)25)17-10-16(24)20-15(23)8-14(22)9-18(20)27-17/h4,6-9,17,22-23,25H,5,10H2,1-3H3/t17-/m0/s1 D00RZN DRUGINKE UQFQODVSORPELA-KRWDZBQOSA-N D00RZN DRUGSMIL CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)OC)O)C D00RZN DRUGTYPE Small molecular drug D00RZN HIGHSTAT Investigative D00SAA DRUG__ID D00SAA D00SAA DRUGCLAS Investigative Drug(s) D00SAA DRUGINCH 1S/C13H12O2/c1-8(2)11-7-9-5-3-4-6-10(9)12(14)13(11)15/h3-8H,1-2H3 D00SAA DRUGINKE KGCDZSGUSQQVKL-UHFFFAOYSA-N D00SAA DRUGSMIL CC(C)C1=CC2=CC=CC=C2C(=O)C1=O D00SAA DRUGTYPE Small molecular drug D00SAA HIGHSTAT Investigative D00SAB DRUG__ID D00SAB D00SAB DRUGCLAS Investigative Drug(s) D00SAB DRUGINCH 1S/C15H12N2/c1-11-4-2-5-12(8-11)14-9-15-13(10-17-14)6-3-7-16-15/h2-10H,1H3 D00SAB DRUGINKE QFKQBMHTZFGQHK-UHFFFAOYSA-N D00SAB DRUGSMIL CC1=CC(=CC=C1)C2=NC=C3C=CC=NC3=C2 D00SAB DRUGTYPE Small molecular drug D00SAB HIGHSTAT Investigative D00SAH DRUG__ID D00SAH D00SAH DRUGCLAS Patented Agent(s) D00SAH DRUGCOMP Japan Science and Technology Agency D00SAH DRUGINCH 1S/C12H19NO3/c1-10(2)13(7-8-14)6-5-11(15)12-4-3-9-16-12/h3-4,9-10,14H,5-8H2,1-2H3 D00SAH DRUGINKE DCZMNFQBOIDRNH-UHFFFAOYSA-N D00SAH DRUGSMIL CC(C)N(CCC(=O)C1=CC=CO1)CCO D00SAH DRUGTYPE Small molecular drug D00SAH HIGHSTAT Patented D00SAR DRUG__ID D00SAR D00SAR DRUGCLAS Patented Agent(s) D00SAR DRUGCOMP THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK D00SAR DRUGTYPE Small molecular drug D00SAR HIGHSTAT Patented D00SBD DRUG__ID D00SBD D00SBD DRUGCLAS Clinical Trial Drug(s) D00SBD DRUGCOMP Dong-A Pharmaceutical Co Ltd D00SBD DRUGINCH 1S/C20H18O8/c1-24-14-5-4-11(6-16(14)25-2)15-9-13(21)20-17(26-3)7-12(8-18(20)28-15)27-10-19(22)23/h4-9H,10H2,1-3H3,(H,22,23) D00SBD DRUGINKE BCPQOBQIVJZOFL-UHFFFAOYSA-N D00SBD DRUGSMIL COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3OC)OCC(=O)O)OC D00SBD DRUGTYPE Small molecular drug D00SBD HIGHSTAT Phase 2 D00SBN DRUG__ID D00SBN D00SBN DRUGCLAS Approved Drug(s) D00SBN DRUGINCH 1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2 D00SBN DRUGINKE CYXKNKQEMFBLER-UHFFFAOYSA-N D00SBN DRUGSMIL C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3 D00SBN DRUGTYPE Small molecular drug D00SBN HIGHSTAT Approved D00SBN THERCLAS Vasodilator Agents D00SBU DRUG__ID D00SBU D00SBU DRUGCLAS Clinical Trial Drug(s) D00SBU DRUGCOMP Ensysce Biosciences San Diego, CA D00SBU HIGHSTAT Phase 1 D00SBX DRUG__ID D00SBX D00SBX DRUGCLAS Investigative Drug(s) D00SBX DRUGINCH 1S/C14H11Cl2NO4/c15-8-3-7(13(19)11(16)4-8)6-17-9-1-2-10(14(20)21)12(18)5-9/h1-5,17-19H,6H2,(H,20,21) D00SBX DRUGINKE RTEYSQSXRFVKTJ-UHFFFAOYSA-N D00SBX DRUGSMIL C1=CC(=C(C=C1NCC2=C(C(=CC(=C2)Cl)Cl)O)O)C(=O)O D00SBX HIGHSTAT Investigative D00SCI DRUG__ID D00SCI D00SCI DRUGCLAS Investigative Drug(s) D00SCI DRUGINCH 1S/C18H25N5S2/c1-12(2)14-9-13-15(20-11-21-16(13)24-14)22-5-7-23(8-6-22)17-19-10-18(3,4)25-17/h9,11-12H,5-8,10H2,1-4H3 D00SCI DRUGINKE FUGQNAUKABUDQI-UHFFFAOYSA-N D00SCI DRUGSMIL CC(C)C1=CC2=C(N=CN=C2S1)N3CCN(CC3)C4=NCC(S4)(C)C D00SCI DRUGTYPE Small molecular drug D00SCI HIGHSTAT Investigative D00SDJ DRUG__ID D00SDJ D00SDJ DRUGCLAS Investigative Drug(s) D00SDJ DRUGINCH 1S/C27H34F3N5O2/c1-26(2,3)25-31-22(27(28,29)30)18-23(32-25)34-16-14-33(15-17-34)12-6-7-13-35-20-9-5-4-8-19(20)21(36)10-11-24(35)37/h4-5,8-9,18H,6-7,10-17H2,1-3H3 D00SDJ DRUGINKE FKHBHNWGBJHKGW-UHFFFAOYSA-N D00SDJ DRUGSMIL CC(C)(C)C1=NC(=CC(=N1)N2CCN(CC2)CCCCN3C(=O)CCC(=O)C4=CC=CC=C43)C(F)(F)F D00SDJ DRUGTYPE Small molecular drug D00SDJ HIGHSTAT Investigative D00SDP DRUG__ID D00SDP D00SDP DRUGCLAS Investigative Drug(s) D00SDP DRUGINCH 1S/C26H32N2/c1-2-6-21(7-3-1)27-22-12-11-20-16-25-23-8-4-5-13-26(23,24(20)17-22)14-15-28(25)18-19-9-10-19/h1-3,6-7,11-12,17,19,23,25,27H,4-5,8-10,13-16,18H2/t23-,25+,26+/m0/s1 D00SDP DRUGINKE UVUFQEMGPJPSIS-SKBVVQJISA-N D00SDP DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)NC5=CC=CC=C5)CC6CC6 D00SDP DRUGTYPE Small molecular drug D00SDP HIGHSTAT Investigative D00SDQ DRUG__ID D00SDQ D00SDQ DRUGCLAS Investigative Drug(s) D00SDQ DRUGINCH 1S/C17H16ClFN4OS/c1-17(6-7-25-16(20)23-17)12-8-11(3-4-13(12)19)22-15(24)14-5-2-10(18)9-21-14/h2-5,8-9H,6-7H2,1H3,(H2,20,23)(H,22,24)/t17-/m0/s1 D00SDQ DRUGINKE VVZZZUNCWSTIOI-KRWDZBQOSA-N D00SDQ DRUGSMIL CC1(CCSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)Cl)F D00SDQ DRUGTYPE Small molecular drug D00SDQ HIGHSTAT Investigative D00SDR DRUG__ID D00SDR D00SDR DRUGCLAS Patented Agent(s) D00SDR DRUGINCH 1S/C15H13N3O/c1-19-12-4-2-3-10(7-12)11-5-6-14-13(8-11)15(16)18-9-17-14/h2-9H,1H3,(H2,16,17,18) D00SDR DRUGINKE HAFNABUNLVCDOP-UHFFFAOYSA-N D00SDR DRUGSMIL COC1=CC=CC(=C1)C2=CC3=C(C=C2)N=CN=C3N D00SDR DRUGTYPE Small molecular drug D00SDR HIGHSTAT Patented D00SEB DRUG__ID D00SEB D00SEB DRUADIID FDA-AP-BF04-01286 D00SEB DRUGCLAS Approved Drug(s) D00SEB DRUGCOMP Merck & Co D00SEB DRUGINCH 1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1 D00SEB DRUGINKE GBXSMTUPTTWBMN-XIRDDKMYSA-N D00SEB DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O D00SEB DRUGTYPE Small molecular drug D00SEB HIGHSTAT Approved D00SEB THERCLAS Antihypertensive Agents D00SEC DRUG__ID D00SEC D00SEC DRUGCLAS Investigative Drug(s) D00SEC DRUGINCH 1S/C17H19N3O/c1-3-4-5-14-15(12-6-8-13(21-2)9-7-12)20-17-16(14)18-10-11-19-17/h6-11H,3-5H2,1-2H3,(H,19,20) D00SEC DRUGINKE WVMANZPBOBRWCB-UHFFFAOYSA-N D00SEC DRUGSMIL CCCCC1=C(NC2=NC=CN=C12)C3=CC=C(C=C3)OC D00SEC DRUGTYPE Small molecular drug D00SEC HIGHSTAT Investigative D00SEE DRUG__ID D00SEE D00SEE DRUGCLAS Investigative Drug(s) D00SEE DRUGINCH 1S/C13H19NOS/c15-13(10-6-1-2-7-11-16)14-12-8-4-3-5-9-12/h3-5,8-9,16H,1-2,6-7,10-11H2,(H,14,15) D00SEE DRUGINKE CFKBMXXDXYFDET-UHFFFAOYSA-N D00SEE DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCCS D00SEE DRUGTYPE Small molecular drug D00SEE HIGHSTAT Investigative D00SFN DRUG__ID D00SFN D00SFN DRUGCLAS Clinical Trial Drug(s) D00SFN DRUGINCH 1S/C15H12O5/c16-8-12-13(17)2-1-3-14(12)20-9-10-4-6-11(7-5-10)15(18)19/h1-8,17H,9H2,(H,18,19) D00SFN DRUGINKE XEDONBRPTABQFB-UHFFFAOYSA-N D00SFN DRUGSMIL C1=CC(=C(C(=C1)OCC2=CC=C(C=C2)C(=O)O)C=O)O D00SFN DRUGTYPE Small molecular drug D00SFN HIGHSTAT Phase 2 D00SFY DRUG__ID D00SFY D00SFY DRUGCLAS Clinical Trial Drug(s) D00SFY DRUGCOMP Ajinomoto Co Inc D00SFY DRUGINCH 1S/C21H29FN2O7/c1-10(2)24-11(3)14(7-12-5-6-13(29-4)8-15(12)22)20(23-24)31-21-19(28)18(27)17(26)16(9-25)30-21/h5-6,8,10,16-19,21,25-28H,7,9H2,1-4H3/t16-,17-,18+,19-,21+/m1/s1 D00SFY DRUGINKE AOBLNYCSGWSIPG-YRIDSSQKSA-N D00SFY DRUGSMIL CC1=C(C(=NN1C(C)C)OC2C(C(C(C(O2)CO)O)O)O)CC3=C(C=C(C=C3)OC)F D00SFY HIGHSTAT Phase 1 D00SGD DRUG__ID D00SGD D00SGD DRUGCLAS Approved Drug(s) D00SGD DRUGCOMP Sanofi Pasteur D00SGD HIGHSTAT Approved D00SGZ DRUG__ID D00SGZ D00SGZ DRUGCLAS Investigative Drug(s) D00SGZ DRUGINCH 1S/C35H38F2N4O4/c1-24-28(15-22-45-24)33(43)38-26-11-9-25(10-12-26)34(44)41-21-16-35(36,37)30(29-7-3-4-8-31(29)41)23-32(42)40-19-13-27(14-20-40)39-17-5-2-6-18-39/h3-4,7-12,15,22-23,27H,2,5-6,13-14,16-21H2,1H3,(H,38,43)/b30-23- D00SGZ DRUGINKE VDUUABBYYOPFAW-WMMMYUQOSA-N D00SGZ DRUGSMIL CC1=C(C=CO1)C(=O)NC2=CC=C(C=C2)C(=O)N3CCC(C(=CC(=O)N4CCC(CC4)N5CCCCC5)C6=CC=CC=C63)(F)F D00SGZ DRUGTYPE Small molecular drug D00SGZ HIGHSTAT Investigative D00SHQ DRUG__ID D00SHQ D00SHQ DRUGCLAS Approved Drug(s) D00SHQ DRUGINCH 1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 D00SHQ DRUGINKE RKLNONIVDFXQRX-UHFFFAOYSA-N D00SHQ DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)Br)O)CCCC(=O)C3=CC=C(C=C3)F D00SHQ DRUGTYPE Small molecular drug D00SHQ HIGHSTAT Approved D00SHS DRUG__ID D00SHS D00SHS DRUGCLAS Clinical Trial Drug(s) D00SHS DRUGCOMP Sangart D00SHS HIGHSTAT Phase 3 D00SHX DRUG__ID D00SHX D00SHX DRUGCLAS Investigative Drug(s) D00SHX DRUGINCH 1S/C15H23N/c1-12-10-13(2)15(14(3)11-12)6-9-16-7-4-5-8-16/h10-11H,4-9H2,1-3H3 D00SHX DRUGINKE IYOUBSBBWJSRIG-UHFFFAOYSA-N D00SHX DRUGSMIL CC1=CC(=C(C(=C1)C)CCN2CCCC2)C D00SHX DRUGTYPE Small molecular drug D00SHX HIGHSTAT Investigative D00SIA DRUG__ID D00SIA D00SIA DRUGCLAS Clinical Trial Drug(s) D00SIA DRUGCOMP ArQule D00SIA HIGHSTAT Phase 1 D00SIC DRUG__ID D00SIC D00SIC DRUGCLAS Investigative Drug(s) D00SIC DRUGCOMP Isis Pharmaceuticals D00SIC DRUGTYPE Antisense drug D00SIC HIGHSTAT Investigative D00SIR DRUG__ID D00SIR D00SIR DRUGCLAS Discontinued Drug(s) D00SIR DRUGCOMP Sankyo Co Ltd D00SIR DRUGINCH 1S/C20H22N6O6S3.H2O4S/c1-9-12(3-4-27)35-8-25(9)5-10-6-33-18-14(17(29)26(18)15(10)19(30)31)23-16(28)13(24-32-2)11-7-34-20(21)22-11;1-5(2,3)4/h7-8,14,18,27H,3-6H2,1-2H3,(H3-,21,22,23,28,30,31);(H2,1,2,3,4)/b24-13+;/t14-,18-;/m1./s1 D00SIR DRUGINKE WNNXOUAREUXOEN-CZFAVYDOSA-N D00SIR DRUGSMIL CC1=C(SC=[N+]1CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O)CCO.OS(=O)(=O)[O-] D00SIR DRUGTYPE Small molecular drug D00SIR HIGHSTAT Terminated D00SIZ DRUG__ID D00SIZ D00SIZ DRUGCLAS Clinical Trial Drug(s) D00SIZ DRUGCOMP Genentech South San Francisco, CA D00SIZ HIGHSTAT Phase 2 D00SJE DRUG__ID D00SJE D00SJE DRUADIID FDA-AP-BF04-00714 D00SJE DRUGCLAS Approved Drug(s) D00SJE DRUGCOMP Eli Lilly D00SJE DRUGINCH 1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17) D00SJE DRUGINKE KQPKPCNLIDLUMF-UHFFFAOYSA-N D00SJE DRUGSMIL CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C D00SJE DRUGTYPE Small molecular drug D00SJE HIGHSTAT Approved D00SJE THERCLAS Hypnotics and Sedatives D00SJN DRUG__ID D00SJN D00SJN DRUGCLAS Investigative Drug(s) D00SJN DRUGCOMP Immunomedics Inc D00SJN DRUGTYPE Vaccine D00SJN HIGHSTAT Investigative D00SJT DRUG__ID D00SJT D00SJT DRUGCLAS Investigative Drug(s) D00SJT DRUGINCH 1S/C6H6FNO2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,(H2,8,9,10) D00SJT DRUGINKE LFLSATHZMYYIAQ-UHFFFAOYSA-N D00SJT DRUGSMIL C1=CC(=CC=C1F)S(=O)(=O)N D00SJT DRUGTYPE Small molecular drug D00SJT HIGHSTAT Investigative D00SJX DRUG__ID D00SJX D00SJX DRUGCLAS Investigative Drug(s) D00SJX DRUGCOMP Boston University D00SJX HIGHSTAT Investigative D00SKM DRUG__ID D00SKM D00SKM DRUGCLAS Clinical Trial Drug(s) D00SKM DRUGCOMP Tessa Therapeutics Singapore D00SKM HIGHSTAT Phase 1 D00SKS DRUG__ID D00SKS D00SKS DRUGCLAS Investigative Drug(s) D00SKS DRUGCOMP Gilead Sciences Inc D00SKS DRUGINCH 1S/C33H49N2O12PS/c1-6-45-48(38,46-7-2)22-44-26-10-8-24(9-11-26)18-29(34-33(37)47-31-21-43-32-28(31)16-17-42-32)30(36)20-35(19-23(3)4)49(39,40)27-14-12-25(41-5)13-15-27/h8-15,23,28-32,36H,6-7,16-22H2,1-5H3,(H,34,37)/t28-,29-,30+,31-,32+/m0/s1 D00SKS DRUGINKE FCLYPCIMVVLLRN-FXSYQQGGSA-N D00SKS DRUGSMIL CCOP(=O)(COC1=CC=C(C=C1)CC(C(CN(CC(C)C)S(=O)(=O)C2=CC=C(C=C2)OC)O)NC(=O)OC3COC4C3CCO4)OCC D00SKS HIGHSTAT Investigative D00SLD DRUG__ID D00SLD D00SLD DRUGCLAS Patented Agent(s) D00SLD DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D00SLD DRUGTYPE Small molecular drug D00SLD HIGHSTAT Patented D00SLE DRUG__ID D00SLE D00SLE DRUGCLAS Investigative Drug(s) D00SLE DRUGINCH 1S/C15H11NO2S/c17-12-6-4-10(5-7-12)14-9-16-15(19-14)11-2-1-3-13(18)8-11/h1-9,17-18H D00SLE DRUGINKE WBUPCNHALRFMCB-UHFFFAOYSA-N D00SLE DRUGSMIL C1=CC(=CC(=C1)O)C2=NC=C(S2)C3=CC=C(C=C3)O D00SLE DRUGTYPE Small molecular drug D00SLE HIGHSTAT Investigative D00SLJ DRUG__ID D00SLJ D00SLJ DRUGCLAS Investigative Drug(s) D00SLJ DRUGINCH 1S/C18H20N2O3/c21-17(13-18(22)20-23)19-12-11-16(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-10,16,23H,11-13H2,(H,19,21)(H,20,22) D00SLJ DRUGINKE UYRUQIFSLBHLGY-UHFFFAOYSA-N D00SLJ DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)CC(=O)NO)C2=CC=CC=C2 D00SLJ DRUGTYPE Small molecular drug D00SLJ HIGHSTAT Investigative D00SLR DRUG__ID D00SLR D00SLR DRUGCLAS Investigative Drug(s) D00SLR DRUGINCH 1S/C24H28N4O4/c1-13(2)25-11-21(29)27-15-5-7-17-19(9-15)24(32)20-10-16(6-8-18(20)23(17)31)28-22(30)12-26-14(3)4/h5-10,13-14,25-26H,11-12H2,1-4H3,(H,27,29)(H,28,30) D00SLR DRUGINKE DKNQCGLIKICHPF-UHFFFAOYSA-N D00SLR DRUGSMIL CC(C)NCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CNC(C)C D00SLR DRUGTYPE Small molecular drug D00SLR HIGHSTAT Investigative D00SLY DRUG__ID D00SLY D00SLY DRUGCLAS Approved Drug(s) D00SLY DRUGCOMP GlaxoSmithKline D00SLY DRUGINCH 1S/C29H34NO2/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25/h1-15,31H,16-24H2/q+1 D00SLY DRUGINKE FVTWTVQXNAJTQP-UHFFFAOYSA-N D00SLY DRUGSMIL C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5 D00SLY DRUGTYPE Small molecular drug D00SLY HIGHSTAT Approved D00SMC DRUG__ID D00SMC D00SMC DRUGCLAS Investigative Drug(s) D00SMC DRUGCOMP Panacea Pharmaceuticals Inc D00SMC HIGHSTAT Investigative D00SML DRUG__ID D00SML D00SML DRUGCLAS Investigative Drug(s) D00SML DRUGCOMP Neumedicines Inc D00SML HIGHSTAT Investigative D00SMU DRUG__ID D00SMU D00SMU DRUGCLAS Clinical Trial Drug(s) D00SMU DRUGCOMP Bluebird bio D00SMU HIGHSTAT Phase 3 D00SNI DRUG__ID D00SNI D00SNI DRUGCLAS Investigative Drug(s) D00SNI DRUGCOMP Isis Pharmaceuticals D00SNI DRUGTYPE Antisense drug D00SNI HIGHSTAT Investigative D00SNJ DRUG__ID D00SNJ D00SNJ DRUGCLAS Investigative Drug(s) D00SNJ DRUGINCH 1S/C24H26N2O/c1-18(19-8-3-2-4-9-19)26-16-14-21(15-17-26)25-24(27)23-13-7-11-20-10-5-6-12-22(20)23/h2-13,18,21H,14-17H2,1H3,(H,25,27) D00SNJ DRUGINKE ZNKBVXRAPNKVHW-UHFFFAOYSA-N D00SNJ DRUGSMIL CC(C1=CC=CC=C1)N2CCC(CC2)NC(=O)C3=CC=CC4=CC=CC=C43 D00SNJ DRUGTYPE Small molecular drug D00SNJ HIGHSTAT Investigative D00SNO DRUG__ID D00SNO D00SNO DRUGCLAS Investigative Drug(s) D00SNO DRUGINCH 1S/C18H18N4O/c1-21(2)10-9-19-13-7-8-14-17-16(13)18(23)12-5-3-4-6-15(12)22(17)11-20-14/h3-8,11,19H,9-10H2,1-2H3 D00SNO DRUGINKE ZRCXWSWJMWWTFD-UHFFFAOYSA-N D00SNO DRUGSMIL CN(C)CCNC1=C2C3=C(C=C1)N=CN3C4=CC=CC=C4C2=O D00SNO DRUGTYPE Small molecular drug D00SNO HIGHSTAT Investigative D00SNY DRUG__ID D00SNY D00SNY DRUGCLAS Investigative Drug(s) D00SNY DRUGCOMP ALS Therapy Development Foundation Inc D00SNY HIGHSTAT Investigative D00SOE DRUG__ID D00SOE D00SOE DRUGCLAS Investigative Drug(s) D00SOE DRUGINCH 1S/C66H108N16O26/c1-7-34(6)53(65(106)74-40(19-21-50(91)92)58(99)78-45(29-84)62(103)76-43(26-51(93)94)61(102)81-52(33(4)5)66(107)108)82-64(105)47(31-86)80-63(104)46(30-85)79-59(100)41(24-32(2)3)75-56(97)38(13-9-11-23-68)72-57(98)39(18-20-49(89)90)73-60(101)42(25-35-14-16-36(87)17-15-35)71-48(88)27-70-55(96)44(28-83)77-54(95)37(69)12-8-10-22-67/h14-17,32-34,37-47,52-53,83-87H,7-13,18-31,67-69H2,1-6H3,(H,70,96)(H,71,88)(H,72,98)(H,73,101)(H,74,106)(H,75,97)(H,76,103)(H,77,95)(H,78,99)(H,79,100)(H,80,104)(H,81,102)(H,82,105)(H,89,90)(H,91,92)(H,93,94)(H,107,108)/t34-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,52-,53-/m0/s1 D00SOE DRUGINKE OYOJPGJCPOXGEB-QBAAMSOUSA-N D00SOE DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCCN)N D00SOE HIGHSTAT Investigative D00SOM DRUG__ID D00SOM D00SOM DRUGCLAS Investigative Drug(s) D00SOM DRUGINCH 1S/C14H23N/c1-2-4-15-14(3-1)12-6-10-5-11(8-12)9-13(14)7-10/h10-13,15H,1-9H2 D00SOM DRUGINKE MAKUVZBPESPZLP-UHFFFAOYSA-N D00SOM DRUGSMIL C1CCNC2(C1)C3CC4CC(C3)CC2C4 D00SOM DRUGTYPE Small molecular drug D00SOM HIGHSTAT Investigative D00SOZ DRUG__ID D00SOZ D00SOZ DRUGCLAS Clinical Trial Drug(s) D00SOZ DRUGINCH 1S/C26H28N6O4S/c1-20(2)36-26(33)17-28-25-8-3-6-22(30-25)19-31(37(34,35)24-7-4-13-27-16-24)18-21-9-11-23(12-10-21)32-15-5-14-29-32/h3-16,20H,17-19H2,1-2H3,(H,28,30) D00SOZ DRUGINKE VIQCWEGEHRBLAC-UHFFFAOYSA-N D00SOZ DRUGSMIL CC(C)OC(=O)CNC1=CC=CC(=N1)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4 D00SOZ HIGHSTAT Phase 3 D00SPK DRUG__ID D00SPK D00SPK DRUGCLAS Discontinued Drug(s) D00SPK DRUGCOMP Eisai Co Ltd D00SPK DRUGINCH 1S/C22H21ClN4O4.Na/c23-15-2-3-17-16(10-15)20(24-11-13-1-4-18-19(9-13)31-12-30-18)26-22(25-17)27-7-5-14(6-8-27)21(28)29;/h1-4,9-10,14H,5-8,11-12H2,(H,28,29)(H,24,25,26);/q;+1/p-1 D00SPK DRUGINKE LDYABEHPDDRNAF-UHFFFAOYSA-M D00SPK DRUGSMIL C1CN(CCC1C(=O)[O-])C2=NC3=C(C=C(C=C3)Cl)C(=N2)NCC4=CC5=C(C=C4)OCO5.[Na+] D00SPK DRUGTYPE Small molecular drug D00SPK HIGHSTAT Discontinued in Phase 2 D00SQD DRUG__ID D00SQD D00SQD DRUGCLAS Investigative Drug(s) D00SQD DRUGCOMP Isis Pharmaceuticals D00SQD DRUGTYPE Antisense drug D00SQD HIGHSTAT Investigative D00SQN DRUG__ID D00SQN D00SQN DRUGCLAS Approved Drug(s) D00SQN DRUGCOMP HUYA Bioscience International; Quintiles D00SQN DRUGINCH 1S/C22H19FN4O2/c23-18-8-9-20(19(24)12-18)27-22(29)17-6-3-16(4-7-17)14-26-21(28)10-5-15-2-1-11-25-13-15/h1-13H,14,24H2,(H,26,28)(H,27,29)/b10-5+ D00SQN DRUGINKE SZMJVTADHFNAIS-BJMVGYQFSA-N D00SQN DRUGSMIL C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N D00SQN DRUGTYPE Small molecular drug D00SQN HIGHSTAT Registered D00SRE DRUG__ID D00SRE D00SRE DRUGCLAS Investigative Drug(s) D00SRE DRUGCOMP Therapeutic Systems Research Laboratories D00SRE HIGHSTAT Investigative D00SRM DRUG__ID D00SRM D00SRM DRUGCLAS Investigative Drug(s) D00SRM DRUGINCH 1S/C20H12N2O3/c23-15-9-14-18(22-13-8-4-3-7-12(13)21-14)17-16(15)19(24)10-5-1-2-6-11(10)20(17)25/h1-9,21-23H D00SRM DRUGINKE LCEVOWBTRGTTAG-UHFFFAOYSA-N D00SRM DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=C4C(=C3C2=O)NC5=CC=CC=C5N4)O D00SRM DRUGTYPE Small molecular drug D00SRM HIGHSTAT Investigative D00SRS DRUG__ID D00SRS D00SRS DRUGCLAS Investigative Drug(s) D00SRS DRUGINCH 1S/C20H22O7/c1-5-10(2)18(23)26-15-8-20(4)16(22)7-13(27-20)12(9-21)6-14-17(15)11(3)19(24)25-14/h5-7,14-15,17,21H,3,8-9H2,1-2,4H3/b10-5-,12-6-/t14-,15-,17+,20-/m1/s1 D00SRS DRUGINKE BMVJFNLJSZHNNS-ZXRHVTAXSA-N D00SRS DRUGSMIL CC=C(C)C(=O)OC1CC2(C(=O)C=C(O2)C(=CC3C1C(=C)C(=O)O3)CO)C D00SRS DRUGTYPE Small molecular drug D00SRS HIGHSTAT Investigative D00SSW DRUG__ID D00SSW D00SSW DRUGCLAS Investigative Drug(s) D00SSW DRUGINCH 1S/C10H9NO4S/c11-7-1-2-9-6(3-7)4-8(5-10(9)12)16(13,14)15/h1-5,12H,11H2,(H,13,14,15) D00SSW DRUGINKE KYARBIJYVGJZLB-UHFFFAOYSA-N D00SSW DRUGSMIL C1=CC2=C(C=C(C=C2C=C1N)S(=O)(=O)O)O D00SSW DRUGTYPE Small molecular drug D00SSW HIGHSTAT Investigative D00SSZ DRUG__ID D00SSZ D00SSZ DRUGCLAS Clinical Trial Drug(s) D00SSZ DRUGCOMP Astellas Pharma Inc D00SSZ DRUGINCH 1S/C20H31N3O6S2/c1-11(2)18-15(24)9-17(26)29-13-6-4-5-7-30-31-10-14(20(28)23-18)22-19(27)12(3)21-16(25)8-13/h4,6,11-15,18,24H,5,7-10H2,1-3H3,(H,21,25)(H,22,27)(H,23,28)/b6-4+/t12-,13-,14-,15+,18-/m1/s1 D00SSZ DRUGINKE XFLBOEMFLGLWFF-HDXRNPEWSA-N D00SSZ DRUGSMIL CC1C(=O)NC2CSSCCC=CC(CC(=O)N1)OC(=O)CC(C(NC2=O)C(C)C)O D00SSZ HIGHSTAT Phase 1 D00STJ DRUG__ID D00STJ D00STJ DRUGCLAS Approved Drug(s) D00STJ DRUGINCH 1S/C31H55N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(36)32-26-22-23-34(31(39)33-26)30-29(38)28(37)25(24-35)40-30/h22-23,25,28-30,35,37-38H,2-21,24H2,1H3,(H,32,33,36,39)/t25-,28-,29+,30-/m1/s1 D00STJ DRUGINKE SAMRUMKYXPVKPA-VFKOLLTISA-N D00STJ DRUGSMIL CCCCCCCCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)O D00STJ DRUGTYPE Small molecular drug D00STJ HIGHSTAT Approved D00STL DRUG__ID D00STL D00STL DRUGCLAS Approved Drug(s) D00STL DRUGCOMP Novartis AG D00STL DRUGINCH 1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37) D00STL DRUGINKE HHZIURLSWUIHRB-UHFFFAOYSA-N D00STL DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5 D00STL DRUGTYPE Small molecular drug D00STL HIGHSTAT Approved D00STL THERCLAS Anticancer Agents D00STZ DRUG__ID D00STZ D00STZ DRUGCLAS Investigative Drug(s) D00STZ DRUGCOMP Marinomed Biotechnologie GmbH D00STZ HIGHSTAT Investigative D00SUC DRUG__ID D00SUC D00SUC DRUGCLAS Patented Agent(s) D00SUC DRUGINCH 1S/C17H14ClN3O3/c1-11-8-14(18)3-2-13(11)10-24-16-5-7-20-21(16)15-9-12(17(22)23)4-6-19-15/h2-9H,10H2,1H3,(H,22,23) D00SUC DRUGINKE PSOBPHXKKHPWMU-UHFFFAOYSA-N D00SUC DRUGSMIL CC1=C(C=CC(=C1)Cl)COC2=CC=NN2C3=NC=CC(=C3)C(=O)O D00SUC DRUGTYPE Small molecular drug D00SUC HIGHSTAT Patented D00SUK DRUG__ID D00SUK D00SUK DRUGCLAS Clinical Trial Drug(s) D00SUK DRUGINCH 1S/C22H32N4O4/c1-3-13-25-17-16(18(29)26(14-4-2)20(25)30)23-19(24-17)22-10-7-21(8-11-22,9-12-22)6-5-15(27)28/h3-14H2,1-2H3,(H,23,24)(H,27,28) D00SUK DRUGINKE ZWTVVWUOTJRXKM-UHFFFAOYSA-N D00SUK DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CCC(CC3)(CC4)CCC(=O)O D00SUK DRUGTYPE Small molecular drug D00SUK HIGHSTAT Phase 2 D00SVK DRUG__ID D00SVK D00SVK DRUGCLAS Patented Agent(s) D00SVK DRUGCOMP MERCK SHARP & DOHME CORP. KEENAN, Kevin, A. NORTHRUP, Alan, B D00SVK HIGHSTAT Patented D00SVP DRUG__ID D00SVP D00SVP DRUGCLAS Clinical Trial Drug(s) D00SVP DRUGCOMP Pfizer Inc D00SVP DRUGINCH 1S/C21H28N2O2S.ClH/c1-17(2)15-22-16-18-9-11-19(12-10-18)20-7-3-4-8-21(20)26(24,25)23-13-5-6-14-23;/h3-4,7-12,17,22H,5-6,13-16H2,1-2H3;1H D00SVP DRUGINKE WRNZYMZEVIVCFL-UHFFFAOYSA-N D00SVP DRUGSMIL CC(C)CNCC1=CC=C(C=C1)C2=CC=CC=C2S(=O)(=O)N3CCCC3.Cl D00SVP DRUGTYPE Small molecular drug D00SVP HIGHSTAT Phase 1 D00SVU DRUG__ID D00SVU D00SVU DRUGCLAS Approved Drug(s) D00SVU DRUGINCH 1S/C17H20ClN3O3/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23) D00SVU DRUGINKE WUKZPHOXUVCQOR-UHFFFAOYSA-N D00SVU DRUGSMIL CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4 D00SVU DRUGTYPE Small molecular drug D00SVU HIGHSTAT Approved D00SWN DRUG__ID D00SWN D00SWN DRUGCLAS Investigative Drug(s) D00SWN DRUGCOMP MingSight Pharmaceuticals D00SWN HIGHSTAT Investigative D00SWQ DRUG__ID D00SWQ D00SWQ DRUGCLAS Clinical Trial Drug(s) D00SWQ DRUGCOMP Metabolic Solutions Development D00SWQ DRUGINCH 1S/C19H18N2O4S/c1-2-12-5-8-15(20-10-12)16(22)11-25-14-6-3-13(4-7-14)9-17-18(23)21-19(24)26-17/h3-8,10,17H,2,9,11H2,1H3,(H,21,23,24) D00SWQ DRUGINKE IRNJSRAGRIZIHD-UHFFFAOYSA-N D00SWQ DRUGSMIL CCC1=CN=C(C=C1)C(=O)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 D00SWQ DRUGTYPE Small molecular drug D00SWQ HIGHSTAT Phase 2 D00SXO DRUG__ID D00SXO D00SXO DRUGCLAS Investigative Drug(s) D00SXO DRUGINCH 1S/C17H12N2O2/c1-11-15-16(19(18-11)12-7-3-2-4-8-12)13-9-5-6-10-14(13)21-17(15)20/h2-10H,1H3 D00SXO DRUGINKE XQVHTRBZHCYIDD-UHFFFAOYSA-N D00SXO DRUGSMIL CC1=NN(C2=C1C(=O)OC3=CC=CC=C32)C4=CC=CC=C4 D00SXO DRUGTYPE Small molecular drug D00SXO HIGHSTAT Investigative D00SYV DRUG__ID D00SYV D00SYV DRUGCLAS Clinical Trial Drug(s) D00SYV DRUGCOMP Glaxosmithkline D00SYV HIGHSTAT Phase 1 D00SZR DRUG__ID D00SZR D00SZR DRUGCLAS Patented Agent(s) D00SZR DRUGCOMP Celus-Pharmaceuticals D00SZR DRUGINCH 1S/C29H43FO2/c1-6-29(32,7-2)17-8-10-20(3)25-14-15-26-22(11-9-16-28(25,26)5)12-13-23-18-24(31)19-27(30)21(23)4/h8,12-14,17,20,24,26-27,31-32H,4,6-7,9-11,15-16,18-19H2,1-3,5H3/b17-8+,22-12+,23-13-/t20-,24+,26-,27-,28+/m0/s1 D00SZR DRUGINKE LRLWXBHFPGSUOX-GJQYOBCGSA-N D00SZR DRUGSMIL CCC(CC)(C=CCC(C)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)F)O)C)O D00SZR DRUGTYPE Small molecular drug D00SZR HIGHSTAT Patented D00TAP DRUG__ID D00TAP D00TAP DRUGCLAS Discontinued Drug(s) D00TAP DRUGCOMP BioPort Corporation D00TAP HIGHSTAT Discontinued in Phase 1 D00TBD DRUG__ID D00TBD D00TBD DRUGCLAS Investigative Drug(s) D00TBD DRUGCOMP Pfizer Inc D00TBD DRUGINCH 1S/C32H34Cl2N4O4S/c1-19-29(35-20(2)30(19)32(40)38-14-6-7-21(38)17-37-12-3-4-13-37)16-24-23-15-22(10-11-28(23)36-31(24)39)43(41,42)18-25-26(33)8-5-9-27(25)34/h5,8-11,15-16,21,35H,3-4,6-7,12-14,17-18H2,1-2H3,(H,36,39)/b24-16-/t21-/m1/s1 D00TBD DRUGINKE OYONTEXKYJZFHA-SSHUPFPWSA-N D00TBD DRUGSMIL CC1=C(NC(=C1C(=O)N2CCCC2CN3CCCC3)C)C=C4C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O D00TBD DRUGTYPE Small molecular drug D00TBD HIGHSTAT Investigative D00TBG DRUG__ID D00TBG D00TBG DRUGCLAS Investigative Drug(s) D00TBG DRUGINCH 1S/C25H26F2N2O4/c1-15(2)24-23(16-3-7-18(26)8-4-16)28-25(17-5-9-19(27)10-6-17)29(24)12-11-20(30)13-21(31)14-22(32)33/h3-12,15,20-21,30-31H,13-14H2,1-2H3,(H,32,33)/p-1/b12-11+/t20-,21-/m1/s1 D00TBG DRUGINKE TVIKMEWXHYDWEQ-LKWCPCFXSA-M D00TBG DRUGSMIL CC(C)C1=C(N=C(N1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)F D00TBG DRUGTYPE Small molecular drug D00TBG HIGHSTAT Investigative D00TBI DRUG__ID D00TBI D00TBI DRUGCLAS Patented Agent(s) D00TBI DRUGINCH 1S/C26H25Cl2N7O/c1-18-24(26(36)33(2)34-15-4-3-5-16-34)31-25(22-13-10-20(27)17-23(22)28)35(18)21-11-8-19(9-12-21)7-6-14-30-32-29/h8-13,17H,3-5,14-16H2,1-2H3 D00TBI DRUGINKE ZHBIOSWRXRWSAO-UHFFFAOYSA-N D00TBI DRUGSMIL CC1=C(N=C(N1C2=CC=C(C=C2)C#CCN=[N+]=[N-])C3=C(C=C(C=C3)Cl)Cl)C(=O)N(C)N4CCCCC4 D00TBI DRUGTYPE Small molecular drug D00TBI HIGHSTAT Patented D00TBJ DRUG__ID D00TBJ D00TBJ DRUGCLAS Investigative Drug(s) D00TBJ DRUGCOMP Pfizer Inc D00TBJ HIGHSTAT Investigative D00TBS DRUG__ID D00TBS D00TBS DRUGCLAS Investigative Drug(s) D00TBS DRUGCOMP Sun Pharmaceutical Industries Ltd D00TBS HIGHSTAT Investigative D00TCL DRUG__ID D00TCL D00TCL DRUGCLAS Patented Agent(s) D00TCL DRUGTYPE Small molecular drug D00TCL HIGHSTAT Patented D00TCM DRUG__ID D00TCM D00TCM DRUGCLAS Approved Drug(s) D00TCM DRUGCOMP Berna Biotech D00TCM HIGHSTAT Approved D00TDJ DRUG__ID D00TDJ D00TDJ DRUGCLAS Investigative Drug(s) D00TDJ DRUGINCH 1S/C10H12N4S2/c1-2-15-9(11)13-6-3-4-8-7(5-6)14-10(12)16-8/h3-5H,2H2,1H3,(H2,11,13)(H2,12,14) D00TDJ DRUGINKE NXVMLACGHCLFBM-UHFFFAOYSA-N D00TDJ DRUGSMIL CCSC(=NC1=CC2=C(C=C1)SC(=N2)N)N D00TDJ DRUGTYPE Small molecular drug D00TDJ HIGHSTAT Investigative D00TED DRUG__ID D00TED D00TED DRUGCLAS Clinical Trial Drug(s) D00TED DRUGCOMP Janssen Research & Development Raritan, NJ D00TED HIGHSTAT Phase 1 D00TEI DRUG__ID D00TEI D00TEI DRUGCLAS Investigative Drug(s) D00TEI DRUGINCH 1S/C15H20N2O7P2/c1-10(2)24-13-5-3-11(4-6-13)12-7-8-16-14(9-12)17-15(25(18,19)20)26(21,22)23/h3-10,15H,1-2H3,(H,16,17)(H2,18,19,20)(H2,21,22,23) D00TEI DRUGINKE DTXBFSJBRGLOHO-UHFFFAOYSA-N D00TEI DRUGSMIL CC(C)OC1=CC=C(C=C1)C2=CC(=NC=C2)NC(P(=O)(O)O)P(=O)(O)O D00TEI DRUGTYPE Small molecular drug D00TEI HIGHSTAT Investigative D00TEN DRUG__ID D00TEN D00TEN DRUGCLAS Preclinical Drug(s) D00TEN DRUGCOMP Aventis Behring LLC D00TEN HIGHSTAT Preclinical D00TFA DRUG__ID D00TFA D00TFA DRUGCLAS Investigative Drug(s) D00TFA DRUGINCH 1S/C29H46N2O3S/c1-29(2,27(32)33)35-26-18-16-24(17-19-26)20-22-31(28(34)30-25-14-7-4-8-15-25)21-10-9-13-23-11-5-3-6-12-23/h16-19,23,25H,3-15,20-22H2,1-2H3,(H,30,34)(H,32,33) D00TFA DRUGINKE PKNYXWMTHFMHKD-UHFFFAOYSA-N D00TFA DRUGSMIL CC(C)(C(=O)O)SC1=CC=C(C=C1)CCN(CCCCC2CCCCC2)C(=O)NC3CCCCC3 D00TFA DRUGTYPE Small molecular drug D00TFA HIGHSTAT Investigative D00TFF DRUG__ID D00TFF D00TFF DRUGCLAS Patented Agent(s) D00TFF DRUGCOMP F. HOFFMANN-LA ROCHE AG ANDERSON, Kevin William CHEN, Yi CHEN, Zhi LUK, Kin-Chun Thomas ROSSMAN, Pamela Loreen SUN, Hongmao WOVKULICH, Peter Michael D00TFF HIGHSTAT Patented D00TGC DRUG__ID D00TGC D00TGC DRUGCLAS Investigative Drug(s) D00TGC DRUGINCH 1S/C16H21N3OS/c1-16(2,3)12-7-5-11(6-8-12)10-21-15-18-13(17)9-14(20)19(15)4/h5-9H,10,17H2,1-4H3 D00TGC DRUGINKE AJMIFZLEDTUBTN-UHFFFAOYSA-N D00TGC DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CSC2=NC(=CC(=O)N2C)N D00TGC DRUGTYPE Small molecular drug D00TGC HIGHSTAT Investigative D00TGR DRUG__ID D00TGR D00TGR DRUGCLAS Approved Drug(s) D00TGR DRUGCOMP Ferring Pharmaceuticals D00TGR DRUGINCH 1S/C18H15NO8S2.2Na/c20-28(21,22)26-15-8-4-13(5-9-15)18(17-3-1-2-12-19-17)14-6-10-16(11-7-14)27-29(23,24)25;;/h1-12,18H,(H,20,21,22)(H,23,24,25);;/q;2*+1/p-2 D00TGR DRUGINKE GOZDTZWAMGHLDY-UHFFFAOYSA-L D00TGR DRUGSMIL C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].[Na+].[Na+] D00TGR DRUGTYPE Small molecular drug D00TGR HIGHSTAT Approved D00THA DRUG__ID D00THA D00THA DRUGCLAS Clinical Trial Drug(s) D00THA DRUGCOMP Qlt D00THA DRUGINCH 1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9-,18-14+ D00THA DRUGINKE QGNJRVVDBSJHIZ-AQDFTDIISA-N D00THA DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C D00THA DRUGTYPE Small molecular drug D00THA HIGHSTAT Phase 2 D00THG DRUG__ID D00THG D00THG DRUGCLAS Clinical Trial Drug(s) D00THG DRUGCOMP Santen Pharmaceutical Co Ltd D00THG HIGHSTAT Phase 2 D00THJ DRUG__ID D00THJ D00THJ COMPCLAS 1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivatives D00THJ DRUGCLAS Patented Agent(s) D00THJ DRUGTYPE Small molecular drug D00THJ HIGHSTAT Patented D00TIB DRUG__ID D00TIB D00TIB DRUGCLAS Patented Agent(s) D00TIB DRUGCOMP C4T S.C. A.R.L D00TIB DRUGTYPE Small molecular drug D00TIB HIGHSTAT Patented D00TIG DRUG__ID D00TIG D00TIG DRUGCLAS Clinical Trial Drug(s) D00TIG DRUGCOMP Roche D00TIG DRUGINCH 1S/C49H66N10O10S2.C2H4O2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41;1-2(3)4/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64);1H3,(H,3,4)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+;/m1./s1 D00TIG DRUGINKE XQEJFZYLWPSJOV-XJQYZYIXSA-N D00TIG DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O.CC(=O)O D00TIG DRUGTYPE Small molecular drug D00TIG HIGHSTAT Preregistration D00TIO DRUG__ID D00TIO D00TIO DRUGCLAS Investigative Drug(s) D00TIO DRUGINCH 1S/C24H29FO4/c1-14(2)17-9-21(15(3)4)24(22(10-17)16-5-7-18(25)8-6-16)28-13-20-11-19(26)12-23(27)29-20/h5-10,14-15,19-20,26H,11-13H2,1-4H3/t19-,20?/m1/s1 D00TIO DRUGINKE JMEOINPEUMGNEF-FIWHBWSRSA-N D00TIO DRUGSMIL CC(C)C1=CC(=C(C(=C1)C(C)C)OCC2CC(CC(=O)O2)O)C3=CC=C(C=C3)F D00TIO DRUGTYPE Small molecular drug D00TIO HIGHSTAT Investigative D00TJF DRUG__ID D00TJF D00TJF DRUGCLAS Investigative Drug(s) D00TJF DRUGINCH 1S/C14H11ClN4/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,16H2,(H,17,18,19) D00TJF DRUGINKE AWAYNEMCHILZCF-UHFFFAOYSA-N D00TJF DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC=NC3=C2C=C(C=C3)N D00TJF DRUGTYPE Small molecular drug D00TJF HIGHSTAT Investigative D00TJV DRUG__ID D00TJV D00TJV DRUGCLAS Investigative Drug(s) D00TJV DRUGCOMP Incozen Therapeutics Pvt Ltd D00TJV HIGHSTAT Investigative D00TJX DRUG__ID D00TJX D00TJX DRUGCLAS Clinical Trial Drug(s) D00TJX DRUGCOMP Human Genome Sciences D00TJX HIGHSTAT Phase 3 D00TKC DRUG__ID D00TKC D00TKC DRUGCLAS Discontinued Drug(s) D00TKC DRUGCOMP Nobex Corp D00TKC HIGHSTAT Terminated D00TKJ DRUG__ID D00TKJ D00TKJ DRUGCLAS Investigative Drug(s) D00TKJ DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=C(C4=NC3=O)F)NO D00TKJ DRUGTYPE Small molecular drug D00TKJ HIGHSTAT Investigative D00TKO DRUG__ID D00TKO D00TKO DRUGCLAS Investigative Drug(s) D00TKO DRUGINCH 1S/C11H11NO2S/c1-15(13,14)11-6-4-10(5-7-11)12-8-2-3-9-12/h2-9H,1H3 D00TKO DRUGINKE NIVLUABJSRHBFE-UHFFFAOYSA-N D00TKO DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)N2C=CC=C2 D00TKO DRUGTYPE Small molecular drug D00TKO HIGHSTAT Investigative D00TLD DRUG__ID D00TLD D00TLD DRUGCLAS Discontinued Drug(s) D00TLD DRUGINCH 1S/C21H31N3O12S/c1-9(25)22-18(21(6,7)37-24-31)19(30)23-15-17(34-12(4)28)16(33-11(3)27)14(8-32-10(2)26)36-20(15)35-13(5)29/h14-18,20H,8H2,1-7H3,(H,22,25)(H,23,30)/t14-,15-,16-,17-,18+,20-/m1/s1 D00TLD DRUGINKE VISYVRBZWPNIOD-GFJCLWMYSA-N D00TLD DRUGSMIL CC(=O)NC(C(=O)NC1C(C(C(OC1OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)C(C)(C)SN=O D00TLD DRUGTYPE Small molecular drug D00TLD HIGHSTAT Discontinued in Phase 1 D00TLM DRUG__ID D00TLM D00TLM DRUGCLAS Clinical Trial Drug(s) D00TLM DRUGINCH 1S/C22H21FN4O/c23-18-6-4-16(5-7-18)8-9-26-10-12-27(13-11-26)22(28)20-3-1-2-19-17(14-24)15-25-21(19)20/h1-7,15,25H,8-13H2 D00TLM DRUGINKE AQRLDDAFYYAIJP-UHFFFAOYSA-N D00TLM DRUGSMIL C1CN(CCN1CCC2=CC=C(C=C2)F)C(=O)C3=CC=CC4=C3NC=C4C#N D00TLM DRUGTYPE Small molecular drug D00TLM HIGHSTAT Phase 2 D00TLN DRUG__ID D00TLN D00TLN DRUADIID FDA-AP-BF04-01011 D00TLN DRUGCLAS Approved Drug(s) D00TLN DRUGCOMP Merck & Co D00TLN DRUGINCH 1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3 D00TLN DRUGINKE JJCFRYNCJDLXIK-UHFFFAOYSA-N D00TLN DRUGSMIL CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1 D00TLN DRUGTYPE Small molecular drug D00TLN HIGHSTAT Approved D00TLN THERCLAS Antihistamines D00TLP DRUG__ID D00TLP D00TLP DRUADIID 800021857 D00TLP DRUGCLAS Approved Drug(s) D00TLP DRUGCOMP Johnson & Johnson D00TLP DRUGINCH 1S/C38H47N5O7S2/c1-21(2)30-20-51-35(40-30)29-18-32(26-13-14-31(49-5)22(3)33(26)39-29)50-24-16-27-28(17-24)36(45)43(4)15-9-7-6-8-10-23-19-38(23,41-34(27)44)37(46)42-52(47,48)25-11-12-25/h8,10,13-14,18,20-21,23-25,27-28H,6-7,9,11-12,15-17,19H2,1-5H3,(H,41,44)(H,42,46)/b10-8-/t23-,24-,27-,28-,38-/m1/s1 D00TLP DRUGINKE JTZZSQYMACOLNN-VDWJNHBNSA-N D00TLP DRUGSMIL CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC D00TLP DRUGTYPE Small molecular drug D00TLP HIGHSTAT Approved D00TLP THERCLAS Antiinfective Agents D00TMK DRUG__ID D00TMK D00TMK DRUGCLAS Clinical Trial Drug(s) D00TMK DRUGCOMP Sanofi PasteurSwiftwater, PA D00TMK HIGHSTAT Phase 2 D00TMQ DRUG__ID D00TMQ D00TMQ COMPCLAS Azetidine-1-carboxamide derivatives D00TMQ DRUGCLAS Patented Agent(s) D00TMQ DRUGINCH 1S/C22H24ClF3N2O2/c1-21(2,3)27-20(29)28-12-16(13-28)30-19(14-8-10-15(23)11-9-14)17-6-4-5-7-18(17)22(24,25)26/h4-11,16,19H,12-13H2,1-3H3,(H,27,29)/t19-/m1/s1 D00TMQ DRUGINKE BNLYOVHLLDBOFZ-LJQANCHMSA-N D00TMQ DRUGSMIL CC(C)(C)NC(=O)N1CC(C1)OC(C2=CC=C(C=C2)Cl)C3=CC=CC=C3C(F)(F)F D00TMQ DRUGTYPE Small molecular drug D00TMQ HIGHSTAT Patented D00TNC DRUG__ID D00TNC D00TNC DRUGCLAS Discontinued Drug(s) D00TNC DRUGINCH 1S/C12H10N4O2/c1-3-17-6-7-8(1)13-5-10-11(7)15-12(14-10)9-2-4-18-16-9/h2,4-5H,1,3,6H2,(H,14,15) D00TNC DRUGINKE ITPFSYAYHHPKRT-UHFFFAOYSA-N D00TNC DRUGSMIL C1COCC2=C3C(=CN=C21)NC(=N3)C4=NOC=C4 D00TNC DRUGTYPE Small molecular drug D00TNC HIGHSTAT Discontinued in Phase 2 D00TNN DRUG__ID D00TNN D00TNN DRUGCLAS Investigative Drug(s) D00TNN DRUGINCH 1S/C18H21NO2/c1-2-7-17(8-3-1)21-18-11-9-16(10-12-18)20-14-15-6-4-5-13-19-15/h1-3,7-12,15,19H,4-6,13-14H2 D00TNN DRUGINKE CSJNBXMUZIPBKQ-UHFFFAOYSA-N D00TNN DRUGSMIL C1CCNC(C1)COC2=CC=C(C=C2)OC3=CC=CC=C3 D00TNN DRUGTYPE Small molecular drug D00TNN HIGHSTAT Investigative D00TNR DRUG__ID D00TNR D00TNR DRUGCLAS Investigative Drug(s) D00TNR DRUGINCH 1S/C32H37N5O5/c33-25(18-23-13-15-24(38)16-14-23)32(42)37-17-7-12-28(37)31(41)36-27(20-22-10-5-2-6-11-22)30(40)35-26(29(34)39)19-21-8-3-1-4-9-21/h1-6,8-11,13-16,25-28,38H,7,12,17-20,33H2,(H2,34,39)(H,35,40)(H,36,41)/t25-,26-,27-,28-/m0/s1 D00TNR DRUGINKE XIJHWXXXIMEHKW-LJWNLINESA-N D00TNR DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)N D00TNR DRUGTYPE Small molecular drug D00TNR HIGHSTAT Investigative D00TNZ DRUG__ID D00TNZ D00TNZ DRUGCLAS Clinical Trial Drug(s) D00TNZ DRUGCOMP PsiOxus Therapeutics Plymouth Meeting, PA D00TNZ HIGHSTAT Phase 1 D00TOF DRUG__ID D00TOF D00TOF DRUGCLAS Investigative Drug(s) D00TOF DRUGINCH 1S/C20H22O6/c21-9-15(5-13-1-3-17-19(7-13)25-11-23-17)16(10-22)6-14-2-4-18-20(8-14)26-12-24-18/h1-4,7-8,15-16,21-22H,5-6,9-12H2/t15-,16-/m0/s1 D00TOF DRUGINKE JKCVMTYNARDGET-HOTGVXAUSA-N D00TOF DRUGSMIL C1OC2=C(O1)C=C(C=C2)CC(CO)C(CC3=CC4=C(C=C3)OCO4)CO D00TOF DRUGTYPE Small molecular drug D00TOF HIGHSTAT Investigative D00TPC DRUG__ID D00TPC D00TPC DRUGCLAS Investigative Drug(s) D00TPC DRUGCOMP MAT Biopharma D00TPC HIGHSTAT Investigative D00TPG DRUG__ID D00TPG D00TPG DRUGCLAS Investigative Drug(s) D00TPG DRUGINCH 1S/C11H10N2O2/c14-11(15)10-7-9(12-13-10)6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H,12,13)(H,14,15) D00TPG DRUGINKE YYEOXPLPYNYVRY-UHFFFAOYSA-N D00TPG DRUGSMIL C1=CC=C(C=C1)CC2=CC(=NN2)C(=O)O D00TPG DRUGTYPE Small molecular drug D00TPG HIGHSTAT Investigative D00TPI DRUG__ID D00TPI D00TPI DRUGCLAS Investigative Drug(s) D00TPI HIGHSTAT Investigative D00TPO DRUG__ID D00TPO D00TPO DRUGCLAS Investigative Drug(s) D00TPO DRUGINCH 1S/C22H25NO2/c1-3-4-7-14-23-16-20(19-8-5-6-9-21(19)23)22(24)15-17-10-12-18(25-2)13-11-17/h5-6,8-13,16H,3-4,7,14-15H2,1-2H3 D00TPO DRUGINKE KQRKUKYSZPHOKC-UHFFFAOYSA-N D00TPO DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)OC D00TPO DRUGTYPE Small molecular drug D00TPO HIGHSTAT Investigative D00TPQ DRUG__ID D00TPQ D00TPQ DRUGCLAS Investigative Drug(s) D00TPQ DRUGCOMP Viron Therapeutics Inc D00TPQ HIGHSTAT Investigative D00TPW DRUG__ID D00TPW D00TPW DRUGCLAS Clinical Trial Drug(s) D00TPW DRUGCOMP Foresight Biotherapeutics Inc D00TPW HIGHSTAT Phase 3 D00TQI DRUG__ID D00TQI D00TQI DRUGCLAS Investigative Drug(s) D00TQI DRUGCOMP Isis Pharmaceuticals D00TQI DRUGTYPE Antisense drug D00TQI HIGHSTAT Investigative D00TQN DRUG__ID D00TQN D00TQN DRUGCLAS Discontinued Drug(s) D00TQN DRUGCOMP Japan Tobacco Inc D00TQN HIGHSTAT Discontinued in Phase 2 D00TQR DRUG__ID D00TQR D00TQR DRUGCLAS Investigative Drug(s) D00TQR DRUGINCH 1S/C9H12N4O2/c1-3-4-13-7-6(10-5-11-7)8(14)12(2)9(13)15/h5H,3-4H2,1-2H3,(H,10,11) D00TQR DRUGINKE MCPROACZLSAAPY-UHFFFAOYSA-N D00TQR DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)C)NC=N2 D00TQR DRUGTYPE Small molecular drug D00TQR HIGHSTAT Investigative D00TRF DRUG__ID D00TRF D00TRF DRUGCLAS Investigative Drug(s) D00TRF DRUGINCH 1S/C9H12N2O3/c12-9(11-13)6-10-14-7-8-4-2-1-3-5-8/h1-5,10,13H,6-7H2,(H,11,12) D00TRF DRUGINKE PMVJGZGFFBJYLQ-UHFFFAOYSA-N D00TRF DRUGSMIL C1=CC=C(C=C1)CONCC(=O)NO D00TRF DRUGTYPE Small molecular drug D00TRF HIGHSTAT Investigative D00TRL DRUG__ID D00TRL D00TRL DRUGCLAS Discontinued Drug(s) D00TRL DRUGCOMP Evolutec Group plc D00TRL HIGHSTAT Terminated D00TRV DRUG__ID D00TRV D00TRV DRUGCLAS Approved Drug(s) D00TRV DRUGCOMP Bausch & Lomb D00TRV DRUGINCH 1S/C19H21ClFN3O3/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23/h7,9-11H,1-6,8,22H2,(H,26,27)/t10-/m1/s1 D00TRV DRUGINKE QFFGVLORLPOAEC-SNVBAGLBSA-N D00TRV DRUGSMIL C1CCN(CC(C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F D00TRV DRUGTYPE Small molecular drug D00TRV HIGHSTAT Approved D00TRY DRUG__ID D00TRY D00TRY DRUGCLAS Investigative Drug(s) D00TRY DRUGINCH 1S/C13H23NO3/c1-13(2,3)17-12(16)14-11(9-15)10-7-5-4-6-8-10/h9-11H,4-8H2,1-3H3,(H,14,16)/t11-/m1/s1 D00TRY DRUGINKE BDSGOSWEKUGHOV-LLVKDONJSA-N D00TRY DRUGSMIL CC(C)(C)OC(=O)NC(C=O)C1CCCCC1 D00TRY DRUGTYPE Small molecular drug D00TRY HIGHSTAT Investigative D00TRZ DRUG__ID D00TRZ D00TRZ DRUGCLAS Investigative Drug(s) D00TRZ DRUGINCH 1S/C19H30O/c1-4-5-13-19(2,3)17-11-9-15(10-12-17)16-7-6-8-18(20)14-16/h9-12,16,18,20H,4-8,13-14H2,1-3H3/t16-,18-/m1/s1 D00TRZ DRUGINKE WMICXNJEJDOUPN-SJLPKXTDSA-N D00TRZ DRUGSMIL CCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D00TRZ DRUGTYPE Small molecular drug D00TRZ HIGHSTAT Investigative D00TSX DRUG__ID D00TSX D00TSX DRUGCLAS Investigative Drug(s) D00TSX DRUGINCH 1S/C47H59N13O7/c1-2-3-12-35-42(63)60-39(23-31-25-51-26-54-31)46(67)58-37(21-27-15-16-28-9-4-5-10-29(28)20-27)44(65)57-36(14-8-19-52-47(49)50)43(64)59-38(22-30-24-53-33-13-7-6-11-32(30)33)45(66)56-34(41(48)62)17-18-40(61)55-35/h4-7,9-11,13,15-16,20,24-26,34-39,53H,2-3,8,12,14,17-19,21-23H2,1H3,(H2,48,62)(H,51,54)(H,55,61)(H,56,66)(H,57,65)(H,58,67)(H,59,64)(H,60,63)(H4,49,50,52)/t34-,35-,36-,37+,38-,39-/m0/s1 D00TSX DRUGINKE AYKQERUAGGPJLP-WYLITWLFSA-N D00TSX DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CC6=CN=CN6 D00TSX DRUGTYPE Small molecular drug D00TSX HIGHSTAT Investigative D00TSY DRUG__ID D00TSY D00TSY DRUGCLAS Investigative Drug(s) D00TSY DRUGINCH 1S/C79H104ClN19O18/c1-42(2)33-56(68(105)89-55(15-10-11-31-83-43(3)4)76(113)99-32-12-16-64(99)75(112)85-44(5)66(81)103)90-70(107)58(36-48-22-29-54(30-23-48)88-77(82)114)92-71(108)59(37-47-20-27-53(28-21-47)87-67(104)61-39-65(102)97-79(116)96-61)93-74(111)63(41-100)95-73(110)62(40-84-78(115)98-117-7)94-72(109)60(35-46-18-25-52(80)26-19-46)91-69(106)57(86-45(6)101)38-49-17-24-50-13-8-9-14-51(50)34-49/h8-9,13-14,17-30,34,42-44,55-64,83,100H,10-12,15-16,31-33,35-41H2,1-7H3,(H2,81,103)(H,85,112)(H,86,101)(H,87,104)(H,89,105)(H,90,107)(H,91,106)(H,92,108)(H,93,111)(H,94,109)(H,95,110)(H3,82,88,114)(H2,84,98,115)(H2,96,97,102,116)/t44-,55+,56+,57-,58-,59+,60-,61+,62-,63+,64+/m1/s1 D00TSY DRUGINKE AJPARKCOZVUOMV-NOXGGNAKSA-N D00TSY DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CNC(=O)NOC)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D00TSY HIGHSTAT Investigative D00TTS DRUG__ID D00TTS D00TTS DRUGCLAS Discontinued Drug(s) D00TTS DRUGCOMP Stem Cell Therapeutics Corp D00TTS HIGHSTAT Terminated D00TUB DRUG__ID D00TUB D00TUB DRUGCLAS Investigative Drug(s) D00TUB DRUGINCH 1S/C14H11N3O2/c15-9-6-4-8(5-7-9)13-16-12-10(14(19)17-13)2-1-3-11(12)18/h1-7,18H,15H2,(H,16,17,19) D00TUB DRUGINKE FNYTYXJFOSRUTI-UHFFFAOYSA-N D00TUB DRUGSMIL C1=CC2=C(C(=C1)O)N=C(NC2=O)C3=CC=C(C=C3)N D00TUB DRUGTYPE Small molecular drug D00TUB HIGHSTAT Investigative D00TUH DRUG__ID D00TUH D00TUH DRUGCLAS Investigative Drug(s) D00TUH DRUGINCH 1S/C21H19NO4/c1-14(23)15-5-7-16(8-6-15)17-3-2-4-18-19(24)13-20(26-21(17)18)22-9-11-25-12-10-22/h2-8,13H,9-12H2,1H3 D00TUH DRUGINKE OEHLKVQEMZKDOJ-UHFFFAOYSA-N D00TUH DRUGSMIL CC(=O)C1=CC=C(C=C1)C2=CC=CC3=C2OC(=CC3=O)N4CCOCC4 D00TUH DRUGTYPE Small molecular drug D00TUH HIGHSTAT Investigative D00TUP DRUG__ID D00TUP D00TUP DRUGCLAS Clinical Trial Drug(s) D00TUP DRUGCOMP VRT D00TUP HIGHSTAT Phase 3 D00TUR DRUG__ID D00TUR D00TUR DRUGCLAS Clinical Trial Drug(s) D00TUR DRUGCOMP Eli Lilly D00TUR HIGHSTAT Phase 2 D00TVG DRUG__ID D00TVG D00TVG DRUGCLAS Patented Agent(s) D00TVG DRUGCOMP ABIDE THERAPEUTICS, INC. THE SCRIPPS RESEARCH INSTITUTE D00TVG DRUGTYPE Small molecular drug D00TVG HIGHSTAT Patented D00TVI DRUG__ID D00TVI D00TVI DRUGCLAS Discontinued Drug(s) D00TVI DRUGCOMP Sanofi-Synthelabo D00TVI HIGHSTAT Terminated D00TVL DRUG__ID D00TVL D00TVL DRUGCLAS Patented Agent(s) D00TVL DRUGCOMP China Pharmaceutical University D00TVL DRUGINCH 1S/C31H31NO8S/c1-19-15-20(2)31(21(3)16-19)41(37,38)32(18-30(35)36)26-13-14-27(25-8-6-5-7-24(25)26)40-28(17-29(33)34)22-9-11-23(39-4)12-10-22/h5-16,28H,17-18H2,1-4H3,(H,33,34)(H,35,36) D00TVL DRUGINKE PSPVUIANHULZSQ-UHFFFAOYSA-N D00TVL DRUGSMIL CC1=CC(=C(C(=C1)C)S(=O)(=O)N(CC(=O)O)C2=CC=C(C3=CC=CC=C32)OC(CC(=O)O)C4=CC=C(C=C4)OC)C D00TVL DRUGTYPE Small molecular drug D00TVL HIGHSTAT Patented D00TVY DRUG__ID D00TVY D00TVY DRUGCLAS Investigative Drug(s) D00TVY DRUGINCH 1S/C67H97F2N12O23P/c1-7-35(5)54(63(97)76-46(33-38-15-19-40(82)20-16-38)60(94)77-47(66(100)101)31-34(3)4)78-62(96)49-12-10-30-81(49)65(99)55(36(6)8-2)79-58(92)44(24-28-53(88)89)72-56(90)43(23-27-52(86)87)73-59(93)45(32-37-13-17-39(18-14-37)67(68,69)105(102,103)104)75-57(91)42(22-25-50(71)83)74-61(95)48-11-9-29-80(48)64(98)41(70)21-26-51(84)85/h13-20,34-36,41-49,54-55,82H,7-12,21-33,70H2,1-6H3,(H2,71,83)(H,72,90)(H,73,93)(H,74,95)(H,75,91)(H,76,97)(H,77,94)(H,78,96)(H,79,92)(H,84,85)(H,86,87)(H,88,89)(H,100,101)(H2,102,103,104)/t35-,36-,41-,42-,43-,44-,45-,46-,47-,48-,49-,54-,55-/m0/s1 D00TVY DRUGINKE FOSUHZNVGWOSJD-VBIHGRSYSA-N D00TVY DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C2CCCN2C(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=C(C=C3)C(F)(F)P(=O)(O)O)NC(=O)C(CCC(=O)N)NC(=O)C4CCCN4C(=O)C(CCC(=O)O)N D00TVY HIGHSTAT Investigative D00TWA DRUG__ID D00TWA D00TWA DRUGCLAS Investigative Drug(s) D00TWA DRUGINCH 1S/C13H10OS3/c14-7-9-6-13(16-8-9)12-4-3-11(17-12)10-2-1-5-15-10/h1-6,8,14H,7H2 D00TWA DRUGINKE CTGDOERMEKYCRZ-UHFFFAOYSA-N D00TWA DRUGSMIL C1=CSC(=C1)C2=CC=C(S2)C3=CC(=CS3)CO D00TWA DRUGTYPE Small molecular drug D00TWA HIGHSTAT Investigative D00TWC DRUG__ID D00TWC D00TWC DRUGCLAS Investigative Drug(s) D00TWC DRUGINCH 1S/C19H14Cl2O2/c1-12-4-2-3-5-15(12)13-6-8-19(17(22)10-13)23-18-9-7-14(20)11-16(18)21/h2-11,22H,1H3 D00TWC DRUGINKE VDWAWADVXJMBAA-UHFFFAOYSA-N D00TWC DRUGSMIL CC1=CC=CC=C1C2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D00TWC DRUGTYPE Small molecular drug D00TWC HIGHSTAT Investigative D00TWK DRUG__ID D00TWK D00TWK DRUGCLAS Investigative Drug(s) D00TWK DRUGINCH 1S/C14H14O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h3-9,15-17H,1-2H2 D00TWK DRUGINKE HITJFUSPLYBJPE-UHFFFAOYSA-N D00TWK DRUGSMIL C1=CC(=CC=C1CCC2=CC(=CC(=C2)O)O)O D00TWK DRUGTYPE Small molecular drug D00TWK HIGHSTAT Investigative D00TWV DRUG__ID D00TWV D00TWV DRUGCLAS Investigative Drug(s) D00TWV DRUGINCH 1S/C29H27ClIN7O2/c1-2-5-25-33-27(30)26(29(40)32-15-14-18-10-13-24(39)23(31)16-18)38(25)17-19-8-11-20(12-9-19)21-6-3-4-7-22(21)28-34-36-37-35-28/h3-4,6-13,16,39H,2,5,14-15,17H2,1H3,(H,32,40)(H,34,35,36,37)/i31-2 D00TWV DRUGINKE WMCDNTWPKXBICS-DYSJZCPFSA-N D00TWV DRUGSMIL CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)NCCC5=CC(=C(C=C5)O)I)Cl D00TWV DRUGTYPE Small molecular drug D00TWV HIGHSTAT Investigative D00TXL DRUG__ID D00TXL D00TXL DRUGCLAS Clinical Trial Drug(s) D00TXL DRUGCOMP University of Pennsylvania D00TXL HIGHSTAT Phase 1 D00TXZ DRUG__ID D00TXZ D00TXZ COMPCLAS 4-aryl quinol derivatives D00TXZ DRUGCLAS Patented Agent(s) D00TXZ DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D00TXZ DRUGINCH 1S/C13H9NO2S/c15-9-5-7-13(16,8-6-9)12-14-10-3-1-2-4-11(10)17-12/h1-8,16H D00TXZ DRUGINKE SDYBYKXWYDVVKP-UHFFFAOYSA-N D00TXZ DRUGSMIL C1=CC=C2C(=C1)N=C(S2)C3(C=CC(=O)C=C3)O D00TXZ DRUGTYPE Small molecular drug D00TXZ HIGHSTAT Patented D00TYI DRUG__ID D00TYI D00TYI DRUGCLAS Investigative Drug(s) D00TYI DRUGCOMP TG Biotech Inc D00TYI HIGHSTAT Investigative D00TYP DRUG__ID D00TYP D00TYP DRUGCLAS Investigative Drug(s) D00TYP DRUGCOMP Kinentia Biosciences LLC D00TYP HIGHSTAT Investigative D00TYR DRUG__ID D00TYR D00TYR DRUGCLAS Investigative Drug(s) D00TYR DRUGCOMP Jeil Pharmaceutical Co Ltd D00TYR HIGHSTAT Investigative D00TYW DRUG__ID D00TYW D00TYW DRUGCLAS Investigative Drug(s) D00TYW DRUGINCH 1S/C20H32O4/c1-3-5-7-9-11-13-16-15-18(22)19(20(23)24-16)17(21)14-12-10-8-6-4-2/h15,22H,3-14H2,1-2H3 D00TYW DRUGINKE UXMFHBGEDUHLJO-UHFFFAOYSA-N D00TYW DRUGSMIL CCCCCCCC1=CC(=C(C(=O)O1)C(=O)CCCCCCC)O D00TYW DRUGTYPE Small molecular drug D00TYW HIGHSTAT Investigative D00TYX DRUG__ID D00TYX D00TYX DRUGCLAS Investigative Drug(s) D00TYX DRUGINCH 1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3/i2T3,3T3 D00TYX DRUGINKE KQKPFRSPSRPDEB-KERYDJPLSA-N D00TYX DRUGSMIL CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C D00TYX DRUGTYPE Small molecular drug D00TYX HIGHSTAT Investigative D00TZD DRUG__ID D00TZD D00TZD DRUGCLAS Investigative Drug(s) D00TZD DRUGINCH 1S/C18H13BrN4O/c1-2-4-17(24)22-14-7-8-16-15(10-14)18(21-11-20-16)23-13-6-3-5-12(19)9-13/h3,5-11H,1H3,(H,22,24)(H,20,21,23) D00TZD DRUGINKE BTYYWOYVBXILOJ-UHFFFAOYSA-N D00TZD DRUGSMIL CC#CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br D00TZD DRUGTYPE Small molecular drug D00TZD HIGHSTAT Investigative D00UAE DRUG__ID D00UAE D00UAE DRUGCLAS Clinical Trial Drug(s) D00UAE DRUGCOMP Peregrine Pharmaceuticals D00UAE DRUGTYPE Monoclonal antibody D00UAE HIGHSTAT Phase 3 D00UAQ DRUG__ID D00UAQ D00UAQ DRUGCLAS Patented Agent(s) D00UAQ DRUGINCH 1S/C26H29Cl2F3N4O5S/c1-2-41(39,40)21-6-5-16(27)10-15(21)12-35-24(37)18-11-20(26(29,30)31)19(22(28)23(18)33-25(35)38)14-34-8-3-4-17(13-34)32-7-9-36/h5-6,10-11,17,32,36H,2-4,7-9,12-14H2,1H3,(H,33,38)/t17-/m0/s1 D00UAQ DRUGINKE YWUVDJQWNVIFHU-KRWDZBQOSA-N D00UAQ DRUGSMIL CCS(=O)(=O)C1=C(C=C(C=C1)Cl)CN2C(=O)C3=CC(=C(C(=C3NC2=O)Cl)CN4CCCC(C4)NCCO)C(F)(F)F D00UAQ DRUGTYPE Small molecular drug D00UAQ HIGHSTAT Patented D00UBK DRUG__ID D00UBK D00UBK DRUGCLAS Discontinued Drug(s) D00UBK DRUGINCH 1S/C37H37N7O2/c1-3-5-11-23-43(36(45)28-13-7-6-8-14-28)29-21-22-33-32(24-29)37(46)44(34(38-33)12-4-2)25-26-17-19-27(20-18-26)30-15-9-10-16-31(30)35-39-41-42-40-35/h6-10,13-22,24H,3-5,11-12,23,25H2,1-2H3,(H,39,40,41,42) D00UBK DRUGINKE JQXJNTQZCWEHKS-UHFFFAOYSA-N D00UBK DRUGSMIL CCCCCN(C1=CC2=C(C=C1)N=C(N(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)CCC)C(=O)C6=CC=CC=C6 D00UBK DRUGTYPE Small molecular drug D00UBK HIGHSTAT Terminated D00UBR DRUG__ID D00UBR D00UBR DRUGCLAS Investigative Drug(s) D00UBR DRUGINCH 1S/C20H23NO2/c22-20(21-15-16-8-3-1-4-9-16)23-19-13-7-12-18(14-19)17-10-5-2-6-11-17/h2,5-7,10-14,16H,1,3-4,8-9,15H2,(H,21,22) D00UBR DRUGINKE AARHPAICPBZNBZ-UHFFFAOYSA-N D00UBR DRUGSMIL C1CCC(CC1)CNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D00UBR DRUGTYPE Small molecular drug D00UBR HIGHSTAT Investigative D00UBX DRUG__ID D00UBX D00UBX DRUGCLAS Clinical Trial Drug(s) D00UBX DRUGCOMP Tanox; Biogen D00UBX HIGHSTAT Phase 3 D00UCC DRUG__ID D00UCC D00UCC DRUGCLAS Discontinued Drug(s) D00UCC DRUGINCH 1S/C21H22F3NO8S/c1-20(2)30-11-19(33-20)18(25(27)13-26)12-34(28,29)17-9-7-15(8-10-17)31-14-3-5-16(6-4-14)32-21(22,23)24/h3-10,13,18-19,27H,11-12H2,1-2H3/t18-,19-/m1/s1 D00UCC DRUGINKE IVPPTWCRAFCOFJ-RTBURBONSA-N D00UCC DRUGSMIL CC1(OCC(O1)C(CS(=O)(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)OC(F)(F)F)N(C=O)O)C D00UCC DRUGTYPE Small molecular drug D00UCC HIGHSTAT Discontinued in Phase 1 D00UCE DRUG__ID D00UCE D00UCE DRUGCLAS Investigative Drug(s) D00UCE HIGHSTAT Investigative D00UCP DRUG__ID D00UCP D00UCP DRUGCLAS Investigative Drug(s) D00UCP DRUGINCH 1S/C22H22N2O3S/c1-17-11-13-19(14-12-17)28(26,27)24-21-10-6-5-9-20(21)22(25)23-16-15-18-7-3-2-4-8-18/h2-14,24H,15-16H2,1H3,(H,23,25) D00UCP DRUGINKE QLFGNZRFLMFTDF-UHFFFAOYSA-N D00UCP DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCCC3=CC=CC=C3 D00UCP DRUGTYPE Small molecular drug D00UCP HIGHSTAT Investigative D00UCW DRUG__ID D00UCW D00UCW DRUGCLAS Discontinued Drug(s) D00UCW DRUGINCH 1S/C26H35F2NO7/c1-5-11-32-13-15-34-24(30)21-17(3)29-18(4)22(25(31)35-16-14-33-12-6-2)23(21)19-9-7-8-10-20(19)36-26(27)28/h7-10,23,26,29H,5-6,11-16H2,1-4H3 D00UCW DRUGINKE ASCWBYZMMHUZMQ-UHFFFAOYSA-N D00UCW DRUGSMIL CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2OC(F)F)C(=O)OCCOCCC)C)C D00UCW DRUGTYPE Small molecular drug D00UCW HIGHSTAT Discontinued in Phase 1 D00UCX DRUG__ID D00UCX D00UCX DRUGCLAS Investigative Drug(s) D00UCX DRUGINCH 1S/C149H225N39O46/c1-17-76(10)119(145(230)179-101(57-83-31-20-18-21-32-83)133(218)166-80(14)125(210)174-104(60-86-63-158-91-36-25-24-35-89(86)91)136(221)176-100(56-73(4)5)137(222)185-117(74(6)7)143(228)173-92(37-26-28-52-150)127(212)159-66-111(197)168-98(148(233)234)39-30-54-157-149(154)155)187-132(217)97(47-51-115(203)204)172-131(216)93(38-27-29-53-151)169-123(208)78(12)163-122(207)77(11)165-130(215)96(44-48-109(153)195)167-110(196)65-160-129(214)95(46-50-114(201)202)171-134(219)99(55-72(2)3)175-135(220)102(59-85-40-42-88(194)43-41-85)177-140(225)106(68-189)181-142(227)108(70-191)182-144(229)118(75(8)9)186-139(224)105(62-116(205)206)178-141(226)107(69-190)183-147(232)121(82(16)193)188-138(223)103(58-84-33-22-19-23-34-84)180-146(231)120(81(15)192)184-112(198)67-161-128(213)94(45-49-113(199)200)170-124(209)79(13)164-126(211)90(152)61-87-64-156-71-162-87/h18-25,31-36,40-43,63-64,71-82,90,92-108,117-121,158,189-194H,17,26-30,37-39,44-62,65-70,150-152H2,1-16H3,(H2,153,195)(H,156,162)(H,159,212)(H,160,214)(H,161,213)(H,163,207)(H,164,211)(H,165,215)(H,166,218)(H,167,196)(H,168,197)(H,169,208)(H,170,209)(H,171,219)(H,172,216)(H,173,228)(H,174,210)(H,175,220)(H,176,221)(H,177,225)(H,178,226)(H,179,230)(H,180,231)(H,181,227)(H,182,229)(H,183,232)(H,184,198)(H,185,222)(H,186,224)(H,187,217)(H,188,223)(H,199,200)(H,201,202)(H,203,204)(H,205,206)(H,233,234)(H4,154,155,157)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-,121-/m0/s1 D00UCX DRUGINKE UVENJQHDPZDEHP-KTKZVXAJSA-N D00UCX DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N D00UCX HIGHSTAT Investigative D00UDD DRUG__ID D00UDD D00UDD DRUGCLAS Investigative Drug(s) D00UDD DRUGCOMP Isis Pharmaceuticals D00UDD DRUGTYPE Antisense drug D00UDD HIGHSTAT Investigative D00UDJ DRUG__ID D00UDJ D00UDJ DRUGCLAS Patented Agent(s) D00UDJ DRUGCOMP GE HEALTHCARE LIMITED D00UDJ DRUGTYPE Small molecular drug D00UDJ HIGHSTAT Patented D00UDL DRUG__ID D00UDL D00UDL DRUGCLAS Investigative Drug(s) D00UDL DRUGCOMP Isis Pharmaceuticals D00UDL DRUGTYPE Antisense drug D00UDL HIGHSTAT Investigative D00UDP DRUG__ID D00UDP D00UDP DRUGCLAS Clinical Trial Drug(s) D00UDP DRUGCOMP Erimos D00UDP DRUGINCH 1S/C22H30O4/c1-15(11-17-7-9-19(23-3)21(13-17)25-5)16(2)12-18-8-10-20(24-4)22(14-18)26-6/h7-10,13-16H,11-12H2,1-6H3/t15-,16+ D00UDP DRUGINKE ORQFDHFZSMXRLM-IYBDPMFKSA-N D00UDP DRUGSMIL CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC D00UDP DRUGTYPE Small molecular drug D00UDP HIGHSTAT Phase 2 D00UDX DRUG__ID D00UDX D00UDX DRUGCLAS Investigative Drug(s) D00UDX DRUGINCH 1S/C8H22N4/c9-6-4-2-1-3-5-7-12-8(10)11/h8,12H,1-7,9-11H2 D00UDX DRUGINKE SKGAVCHIFDRDTK-UHFFFAOYSA-N D00UDX DRUGSMIL C(CCCN)CCCNC(N)N D00UDX DRUGTYPE Small molecular drug D00UDX HIGHSTAT Investigative D00UEC DRUG__ID D00UEC D00UEC DRUGCLAS Clinical Trial Drug(s) D00UEC DRUGCOMP Astellas D00UEC DRUGINCH 1S/C19H16ClF3N4O2/c1-19(2,29-15-13(22)7-10(20)8-14(15)23)18-26-25-17(27(18)3)11-5-4-9(16(24)28)6-12(11)21/h4-8H,1-3H3,(H2,24,28) D00UEC DRUGINKE CMQOKZCYVZFZLZ-UHFFFAOYSA-N D00UEC DRUGSMIL CC(C)(C1=NN=C(N1C)C2=C(C=C(C=C2)C(=O)N)F)OC3=C(C=C(C=C3F)Cl)F D00UEC HIGHSTAT Phase 1 D00UEG DRUG__ID D00UEG D00UEG DRUGCLAS Discontinued Drug(s) D00UEG DRUGINCH 1S/C22H18BrN3O2/c23-17-11-13-18(14-12-17)24-22(28)26-20(16-9-5-2-6-10-16)19(21(27)25-26)15-7-3-1-4-8-15/h1-14,19-20H,(H,24,28)(H,25,27) D00UEG DRUGINKE LMUQHXHWJWQXSD-UHFFFAOYSA-N D00UEG DRUGSMIL C1=CC=C(C=C1)C2C(N(NC2=O)C(=O)NC3=CC=C(C=C3)Br)C4=CC=CC=C4 D00UEG DRUGTYPE Small molecular drug D00UEG HIGHSTAT Terminated D00UEQ DRUG__ID D00UEQ D00UEQ DRUGCLAS Discontinued Drug(s) D00UEQ DRUGINCH 1S/C17H23ClO4/c1-2-20-16(19)17(13-22-17)11-5-3-4-6-12-21-15-9-7-14(18)8-10-15/h7-10H,2-6,11-13H2,1H3/t17-/m1/s1 D00UEQ DRUGINKE DZLOHEOHWICNIL-QGZVFWFLSA-N D00UEQ DRUGSMIL CCOC(=O)C1(CO1)CCCCCCOC2=CC=C(C=C2)Cl D00UEQ DRUGTYPE Small molecular drug D00UEQ HIGHSTAT Terminated D00UET DRUG__ID D00UET D00UET DRUGCLAS Clinical Trial Drug(s) D00UET DRUGCOMP Sanofi D00UET DRUGINCH 1S/C14H16N2O2/c17-14-13-2-1-12(9-10(13)3-8-16-14)18-11-4-6-15-7-5-11/h1-3,8-9,11,15H,4-7H2,(H,16,17) D00UET DRUGINKE IPEXHQGMTHOKQV-UHFFFAOYSA-N D00UET DRUGSMIL C1CNCCC1OC2=CC3=C(C=C2)C(=O)NC=C3 D00UET HIGHSTAT Phase 2 D00UFJ DRUG__ID D00UFJ D00UFJ DRUGCLAS Investigative Drug(s) D00UFJ DRUGINCH 1S/C16H11ClN2OS/c17-13-8-6-12(7-9-13)15(20)19-16-18-14(10-21-16)11-4-2-1-3-5-11/h1-10H,(H,18,19,20) D00UFJ DRUGINKE ZLQJUNKKCMQVHA-UHFFFAOYSA-N D00UFJ DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC=C(C=C3)Cl D00UFJ DRUGTYPE Small molecular drug D00UFJ HIGHSTAT Investigative D00UFR DRUG__ID D00UFR D00UFR DRUGCLAS Investigative Drug(s) D00UFR DRUGINCH 1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/p-3/b3-1- D00UFR DRUGINKE GTZCVFVGUGFEME-IWQZZHSRSA-K D00UFR DRUGSMIL C(C(=CC(=O)[O-])C(=O)[O-])C(=O)[O-] D00UFR DRUGTYPE Small molecular drug D00UFR HIGHSTAT Investigative D00UFZ DRUG__ID D00UFZ D00UFZ DRUGCLAS Clinical Trial Drug(s) D00UFZ DRUGCOMP Amgen D00UFZ HIGHSTAT Phase 2 D00UGC DRUG__ID D00UGC D00UGC DRUGCLAS Clinical Trial Drug(s) D00UGC DRUGCOMP Histogen San Diego, CA D00UGC HIGHSTAT Phase 1/2 D00UGX DRUG__ID D00UGX D00UGX DRUGCLAS Clinical Trial Drug(s) D00UGX DRUGCOMP Celgene Cellular Therapeutics D00UGX HIGHSTAT Phase 2 D00UGY DRUG__ID D00UGY D00UGY DRUGCLAS Drugs in Phase 1 Trial D00UGY DRUGTYPE Cell therapy D00UGY HIGHSTAT Phase 1/2 Trial D00UGY THERCLAS Antiviral Agents D00UHK DRUG__ID D00UHK D00UHK DRUGCLAS Investigative Drug(s) D00UHK DRUGCOMP Kuhnil Pharmaceutical Co Ltd D00UHK HIGHSTAT Investigative D00UIK DRUG__ID D00UIK D00UIK DRUGCLAS Investigative Drug(s) D00UIK DRUGINCH 1S/C17H15NO/c19-17-11-10-16(14-8-4-5-9-15(14)17)18-12-13-6-2-1-3-7-13/h1-11,18-19H,12H2 D00UIK DRUGINKE GXGORQOUKCMHGK-UHFFFAOYSA-N D00UIK DRUGSMIL C1=CC=C(C=C1)CNC2=CC=C(C3=CC=CC=C32)O D00UIK DRUGTYPE Small molecular drug D00UIK HIGHSTAT Investigative D00UIN DRUG__ID D00UIN D00UIN DRUGCLAS Investigative Drug(s) D00UIN DRUGINCH 1S/C20H22N2O3/c1-4-12-22(13-5-1)14-15-23-16-8-10-17(11-9-16)24-20-21-18-6-2-3-7-19(18)25-20/h2-3,6-11H,1,4-5,12-15H2 D00UIN DRUGINKE ZIQGASWXUSSORV-UHFFFAOYSA-N D00UIN DRUGSMIL C1CCN(CC1)CCOC2=CC=C(C=C2)OC3=NC4=CC=CC=C4O3 D00UIN DRUGTYPE Small molecular drug D00UIN HIGHSTAT Investigative D00UJF DRUG__ID D00UJF D00UJF DRUGCLAS Approved Drug(s) D00UJF DRUGINCH 1S/C18H32O16/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18/h1,5-18,20-30H,2-4H2 D00UJF DRUGINKE FZWBNHMXJMCXLU-UHFFFAOYSA-N D00UJF DRUGSMIL C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O D00UJF DRUGTYPE Small molecular drug D00UJF HIGHSTAT Approved D00UKA DRUG__ID D00UKA D00UKA DRUGCLAS Investigative Drug(s) D00UKA DRUGINCH 1S/C61H84N10O18S/c1-7-10-21-42(65-57(81)47(32-37-25-27-39(28-26-37)89-90(85,86)87)68-56(80)45(29-30-50(72)73)71-60(84)88-61(4,5)6)53(77)64-43(22-11-8-2)54(78)69-48(33-38-35-63-41-24-17-16-20-40(38)41)58(82)66-44(23-12-9-3)55(79)70-49(34-51(74)75)59(83)67-46(52(62)76)31-36-18-14-13-15-19-36/h13-20,24-28,35,42-49,63H,7-12,21-23,29-34H2,1-6H3,(H2,62,76)(H,64,77)(H,65,81)(H,66,82)(H,67,83)(H,68,80)(H,69,78)(H,70,79)(H,71,84)(H,72,73)(H,74,75)(H,85,86,87)/t42-,43-,44-,45+,46-,47-,48-,49-/m0/s1 D00UKA DRUGINKE JFEDUJOXWDESON-LMZFJFGWSA-N D00UKA DRUGSMIL CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CCCC)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CCC(=O)O)NC(=O)OC(C)(C)C D00UKA HIGHSTAT Investigative D00UKN DRUG__ID D00UKN D00UKN DRUGCLAS Drugs in Phase 2 Trial D00UKN DRUGTYPE Cell therapy D00UKN HIGHSTAT Phase 2 Trial D00UKN THERCLAS Antiviral Agents D00ULT DRUG__ID D00ULT D00ULT DRUGCLAS Investigative Drug(s) D00ULT DRUGINCH 1S/C11H19F3O/c1-2-3-4-5-6-7-8-9-10(15)11(12,13)14/h2-9H2,1H3 D00ULT DRUGINKE ZKJPGCCWKBTIBE-UHFFFAOYSA-N D00ULT DRUGSMIL CCCCCCCCCC(=O)C(F)(F)F D00ULT DRUGTYPE Small molecular drug D00ULT HIGHSTAT Investigative D00ULY DRUG__ID D00ULY D00ULY DRUGCLAS Clinical Trial Drug(s) D00ULY DRUGCOMP Bristol-Myers Squibb; KAI Pharmaceuticals D00ULY DRUGSMIL failed D00ULY DRUGTYPE Combination drug D00ULY HIGHSTAT Phase 2 D00UMG DRUG__ID D00UMG D00UMG DRUGCLAS Investigative Drug(s) D00UMG DRUGINCH 1S/C23H23Cl2N3O3/c24-16-5-6-19-15(11-16)13-20(26-19)22(30)27-21(12-14-3-1-2-4-18(14)25)23(31)28-9-7-17(29)8-10-28/h1-6,11,13,17,21,26,29H,7-10,12H2,(H,27,30)/t21-/m0/s1 D00UMG DRUGINKE HJMXVPPJJMSWFO-NRFANRHFSA-N D00UMG DRUGSMIL C1CN(CCC1O)C(=O)C(CC2=CC=CC=C2Cl)NC(=O)C3=CC4=C(N3)C=CC(=C4)Cl D00UMG DRUGTYPE Small molecular drug D00UMG HIGHSTAT Investigative D00UMJ DRUG__ID D00UMJ D00UMJ DRUGCLAS Investigative Drug(s) D00UMJ DRUGCOMP Nanomerics D00UMJ HIGHSTAT Investigative D00UNK DRUG__ID D00UNK D00UNK DRUGCLAS Clinical Trial Drug(s) D00UNK DRUGCOMP ImmunoGen Waltham, MA D00UNK HIGHSTAT Phase 2 D00UOI DRUG__ID D00UOI D00UOI DRUGCLAS Investigative Drug(s) D00UOI DRUGINCH 1S/C35H36FN3O5/c1-22(2)39-30(17-16-28(40)18-29(41)19-31(42)43)32(26-12-14-27(36)15-13-26)33(25-6-4-3-5-7-25)34(39)35(44)38-21-24-10-8-23(20-37)9-11-24/h3-15,22,28-29,40-41H,16-19,21H2,1-2H3,(H,38,44)(H,42,43)/p-1/t28-,29-/m1/s1 D00UOI DRUGINKE LRCUHVRZXKUPFJ-FQLXRVMXSA-M D00UOI DRUGSMIL CC(C)N1C(=C(C(=C1C(=O)NCC2=CC=C(C=C2)C#N)C3=CC=CC=C3)C4=CC=C(C=C4)F)CCC(CC(CC(=O)[O-])O)O D00UOI DRUGTYPE Small molecular drug D00UOI HIGHSTAT Investigative D00UOQ DRUG__ID D00UOQ D00UOQ DRUGCLAS Clinical Trial Drug(s) D00UOQ DRUGCOMP Universitat Wurzburg D00UOQ DRUGTYPE Antibody D00UOQ HIGHSTAT Phase 1/2 D00UOR DRUG__ID D00UOR D00UOR DRUGCLAS Approved Drug(s) D00UOR DRUGCOMP Canyon Pharmaceuticals D00UOR DRUGINCH 1S/C287H440N80O110S6/c1-25-133(19)226-281(470)345-161(87-125(3)4)235(424)306-111-208(395)320-180(116-370)266(455)344-175(101-219(415)416)237(426)307-105-202(389)316-151(62-75-212(401)402)242(431)321-145(41-30-33-81-288)240(429)339-170(96-197(297)384)258(447)326-152(57-70-193(293)380)249(438)351-185(121-481-478-118-182-239(428)310-107-201(388)313-147(55-68-191(291)378)232(421)303-108-205(392)317-169(95-196(296)383)257(446)322-146(42-31-34-82-289)241(430)350-186(271(460)360-226)122-482-479-119-183(268(457)323-149(61-74-211(399)400)234(423)304-110-207(394)319-179(115-369)265(454)342-173(99-200(300)387)264(453)357-223(130(13)14)279(468)355-182)352-253(442)164(90-128(9)10)335-269(458)184-120-480-483-123-187(354-262(451)177(103-221(419)420)347-283(472)230(137(23)374)362-263(452)167(93-141-49-53-144(377)54-50-141)346-278(467)224(131(15)16)359-276(465)222(301)129(11)12)272(461)363-229(136(22)373)282(471)330-157(66-79-216(409)410)248(437)348-178(114-368)238(427)309-106-203(390)315-150(56-69-192(292)379)243(432)340-171(97-198(298)385)259(448)334-163(89-127(7)8)252(441)353-184)270(459)358-225(132(17)18)280(469)364-228(135(21)372)277(466)311-112-204(391)314-148(60-73-210(397)398)233(422)305-113-209(396)356-231(138(24)375)286(475)367-86-38-46-190(367)275(464)331-159(43-32-35-83-290)284(473)365-84-36-44-188(365)273(462)328-153(58-71-194(294)381)247(436)349-181(117-371)267(456)338-168(94-142-104-302-124-312-142)256(445)341-172(98-199(299)386)260(449)343-174(100-218(413)414)236(425)308-109-206(393)318-176(102-220(417)418)261(450)337-165(91-139-39-28-27-29-40-139)254(443)327-154(63-76-213(403)404)244(433)325-158(67-80-217(411)412)250(439)361-227(134(20)26-2)285(474)366-85-37-45-189(366)274(463)329-156(65-78-215(407)408)245(434)324-155(64-77-214(405)406)246(435)336-166(92-140-47-51-143(376)52-48-140)255(444)333-162(88-126(5)6)251(440)332-160(287(476)477)59-72-195(295)382/h27-29,39-40,47-54,104,124-138,145-190,222-231,368-377H,25-26,30-38,41-46,55-103,105-123,288-290,301H2,1-24H3,(H2,291,378)(H2,292,379)(H2,293,380)(H2,294,381)(H2,295,382)(H2,296,383)(H2,297,384)(H2,298,385)(H2,299,386)(H2,300,387)(H,302,312)(H,303,421)(H,304,423)(H,305,422)(H,306,424)(H,307,426)(H,308,425)(H,309,427)(H,310,428)(H,311,466)(H,313,388)(H,314,391)(H,315,390)(H,316,389)(H,317,392)(H,318,393)(H,319,394)(H,320,395)(H,321,431)(H,322,446)(H,323,457)(H,324,434)(H,325,433)(H,326,447)(H,327,443)(H,328,462)(H,329,463)(H,330,471)(H,331,464)(H,332,440)(H,333,444)(H,334,448)(H,335,458)(H,336,435)(H,337,450)(H,338,456)(H,339,429)(H,340,432)(H,341,445)(H,342,454)(H,343,449)(H,344,455)(H,345,470)(H,346,467)(H,347,472)(H,348,437)(H,349,436)(H,350,430)(H,351,438)(H,352,442)(H,353,441)(H,354,451)(H,355,468)(H,356,396)(H,357,453)(H,358,459)(H,359,465)(H,360,460)(H,361,439)(H,362,452)(H,363,461)(H,364,469)(H,397,398)(H,399,400)(H,401,402)(H,403,404)(H,405,406)(H,407,408)(H,409,410)(H,411,412)(H,413,414)(H,415,416)(H,417,418)(H,419,420)(H,476,477)/t133-,134-,135+,136+,137+,138+,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,222-,223-,224-,225-,226-,227-,228-,229-,230-,231-/m0/s1 D00UOR DRUGINKE XYWBJDRHGNULKG-OUMQNGNKSA-N D00UOR DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(C(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CN=CN7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C D00UOR DRUGTYPE Small molecular drug D00UOR HIGHSTAT Approved D00UOZ DRUG__ID D00UOZ D00UOZ DRUGCLAS Discontinued Drug(s) D00UOZ DRUGCOMP MedImmune D00UOZ HIGHSTAT Discontinued in Phase 1 D00UPU DRUG__ID D00UPU D00UPU DRUGCLAS Investigative Drug(s) D00UPU DRUGCOMP Rhone-Poulenc Rorer Inc D00UPU HIGHSTAT Investigative D00UQF DRUG__ID D00UQF D00UQF DRUGCLAS Preclinical Drug(s) D00UQF DRUGINCH 1S/C28H22Cl3NO4/c1-16(2)27-21(26(32-36-27)25-22(29)7-4-8-23(25)30)15-35-20-12-11-18(24(31)14-20)10-9-17-5-3-6-19(13-17)28(33)34/h3-14,16H,15H2,1-2H3,(H,33,34)/b10-9+ D00UQF DRUGINKE BYTNEISLBIENSA-MDZDMXLPSA-N D00UQF DRUGSMIL CC(C)C1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)COC3=CC(=C(C=C3)C=CC4=CC(=CC=C4)C(=O)O)Cl D00UQF DRUGTYPE Small molecular drug D00UQF HIGHSTAT Preclinical D00UQW DRUG__ID D00UQW D00UQW DRUGCLAS Clinical Trial Drug(s) D00UQW DRUGCOMP Roche D00UQW HIGHSTAT Phase 1 D00URP DRUG__ID D00URP D00URP DRUGCLAS Investigative Drug(s) D00URP DRUGINCH 1S/C15H14O3/c1-8-5-11(16)6-10-7-18-15-9(2)13(17)4-3-12(15)14(8)10/h3-6,16-17H,7H2,1-2H3 D00URP DRUGINKE UUVHCOKGCFXIER-UHFFFAOYSA-N D00URP DRUGSMIL CC1=CC(=CC2=C1C3=C(C(=C(C=C3)O)C)OC2)O D00URP DRUGTYPE Small molecular drug D00URP HIGHSTAT Investigative D00URZ DRUG__ID D00URZ D00URZ DRUGCLAS Clinical Trial Drug(s) D00URZ HIGHSTAT Phase 2 D00USF DRUG__ID D00USF D00USF DRUGCLAS Approved Drug(s) D00USF DRUGCOMP Angelini research laboratories D00USF DRUGINCH 1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2 D00USF DRUGINKE PHLBKPHSAVXXEF-UHFFFAOYSA-N D00USF DRUGSMIL C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl D00USF DRUGTYPE Small molecular drug D00USF HIGHSTAT Approved D00USF THERCLAS Antidepressants D00USS DRUG__ID D00USS D00USS DRUGCLAS Approved Drug(s) D00USS DRUGCOMP Avant Immunotherapeutics D00USS HIGHSTAT Approved D00USX DRUG__ID D00USX D00USX DRUGCLAS Discontinued Drug(s) D00USX DRUGINCH 1S/C15H14N8O5S4.ClH.H2O/c16-15-18-5(2-30-15)8(21-28)11(24)19-9-12(25)23-10(14(26)27)6(3-29-13(9)23)31-4-32-7-1-17-22-20-7;;/h1-2,9,13,28H,3-4H2,(H2,16,18)(H,19,24)(H,26,27)(H,17,20,22);1H;1H2/b21-8-;;/t9-,13-;;/m1../s1 D00USX DRUGINKE LBWIJMWZWJRRMO-AWXOXGPMSA-N D00USX DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)C(=O)O)SCSC4=NNN=C4.O.Cl D00USX DRUGTYPE Small molecular drug D00USX HIGHSTAT Discontinued in Phase 3 D00UTD DRUG__ID D00UTD D00UTD DRUGCLAS Approved Drug(s) D00UTD DRUGCOMP Shionogi & Co Ltd D00UTD DRUGINCH 1S/C2H4O3.2H3N.Pt/c3-1-2(4)5;;;/h3H,1H2,(H,4,5);2*1H3; D00UTD DRUGINKE ZAXCMPAWRCMABN-UHFFFAOYSA-N D00UTD DRUGSMIL C(C(=O)O)O.N.N.[Pt] D00UTD DRUGTYPE Small molecular drug D00UTD HIGHSTAT Approved D00UTF DRUG__ID D00UTF D00UTF DRUGCLAS Investigative Drug(s) D00UTF DRUGINCH 1S/C23H19Cl2N7O2/c1-32(2)22(33)14-5-3-13(4-6-14)19-8-7-17(12-20(19)21-28-30-31-29-21)26-23(34)27-18-10-15(24)9-16(25)11-18/h3-12H,1-2H3,(H2,26,27,34)(H,28,29,30,31) D00UTF DRUGINKE FQIPXFVYNAMLDB-UHFFFAOYSA-N D00UTF DRUGSMIL CN(C)C(=O)C1=CC=C(C=C1)C2=C(C=C(C=C2)NC(=O)NC3=CC(=CC(=C3)Cl)Cl)C4=NNN=N4 D00UTF DRUGTYPE Small molecular drug D00UTF HIGHSTAT Investigative D00UTU DRUG__ID D00UTU D00UTU DRUGCLAS Investigative Drug(s) D00UTU DRUGINCH 1S/C18H12BrN3O3/c1-9(23)25-22-16-10-5-2-3-8-13(10)20-17(16)14-11-6-4-7-12(19)15(11)21-18(14)24/h2-8,21,24H,1H3/b22-16- D00UTU DRUGINKE CHULSJBNZJIYCG-JWGURIENSA-N D00UTU DRUGSMIL CC(=O)ON=C1C2=CC=CC=C2N=C1C3=C(NC4=C3C=CC=C4Br)O D00UTU DRUGTYPE Small molecular drug D00UTU HIGHSTAT Investigative D00UUG DRUG__ID D00UUG D00UUG DRUGCLAS Investigative Drug(s) D00UUG DRUGINCH 1S/C23H22N4O8/c24-23-26-16-6-1-11(10-15(16)20(31)27-23)9-14(21(32)33)12-2-4-13(5-3-12)19(30)25-17(22(34)35)7-8-18(28)29/h1-6,10,14,17H,7-9H2,(H,25,30)(H,28,29)(H,32,33)(H,34,35)(H3,24,26,27,31)/t14-,17-/m0/s1 D00UUG DRUGINKE DAOQLLQRJAXMGY-YOEHRIQHSA-N D00UUG DRUGSMIL C1=CC(=CC=C1C(CC2=CC3=C(C=C2)N=C(NC3=O)N)C(=O)O)C(=O)NC(CCC(=O)O)C(=O)O D00UUG DRUGTYPE Small molecular drug D00UUG HIGHSTAT Investigative D00UUL DRUG__ID D00UUL D00UUL DRUGCLAS Clinical Trial Drug(s) D00UUL DRUGCOMP Novo Nordisk D00UUL HIGHSTAT Phase 3 D00UUM DRUG__ID D00UUM D00UUM DRUGCLAS Investigative Drug(s) D00UUM DRUGINCH 1S/C8H12N5O4P/c9-7-6-8(11-3-10-7)13(4-12-6)1-2-17-5-18(14,15)16/h3-4H,1-2,5H2,(H2,9,10,11)(H2,14,15,16) D00UUM DRUGINKE SUPKOOSCJHTBAH-UHFFFAOYSA-N D00UUM DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N D00UUM DRUGTYPE Small molecular drug D00UUM HIGHSTAT Investigative D00UVA DRUG__ID D00UVA D00UVA DRUGCLAS Approved Drug(s) D00UVA DRUGCOMP Onyx Pharmaceuticals D00UVA DRUGINCH 1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1 D00UVA DRUGINKE BLMPQMFVWMYDKT-NZTKNTHTSA-N D00UVA DRUGSMIL CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4 D00UVA DRUGTYPE Small molecular drug D00UVA HIGHSTAT Approved D00UVU DRUG__ID D00UVU D00UVU DRUGCLAS Clinical Trial Drug(s) D00UVU DRUGCOMP Lunamed Operations AG D00UVU DRUGINCH 1S/C39H70N2O13/c1-5-7-9-11-12-13-14-15-16-17-18-20-22-31(45)52-28(24-49-30(44)21-19-10-8-6-2)25-50-39-36(48)37(34(46)29(23-42)53-39)54-38-33(41-27(4)43)35(47)32(40)26(3)51-38/h14-15,26,28-29,32-39,42,46-48H,5-13,16-25,40H2,1-4H3,(H,41,43)/b15-14+/t26-,28-,29-,32+,33-,34-,35+,36-,37+,38+,39+/m1/s1 D00UVU DRUGINKE PANDRCFROUDETH-YLSOAJEOSA-N D00UVU DRUGSMIL CCCCCCCC=CCCCCCC(=O)OC(COC1C(C(C(C(O1)CO)O)OC2C(C(C(C(O2)C)N)O)NC(=O)C)O)COC(=O)CCCCCC D00UVU HIGHSTAT Phase 1/2 D00UWL DRUG__ID D00UWL D00UWL DRUGCLAS Investigative Drug(s) D00UWL DRUGINCH 1S/C46H73N13O10/c1-8-26(5)37(43(66)55-33(21-29-22-50-24-52-29)44(67)59-19-11-13-34(59)41(64)58-38(45(68)69)27(6)9-2)57-40(63)32(20-28-14-16-30(60)17-15-28)54-42(65)36(25(3)4)56-39(62)31(53-35(61)23-49-7)12-10-18-51-46(47)48/h14-17,22,24-27,31-34,36-38,49,60H,8-13,18-21,23H2,1-7H3,(H,50,52)(H,53,61)(H,54,65)(H,55,66)(H,56,62)(H,57,63)(H,58,64)(H,68,69)(H4,47,48,51) D00UWL DRUGINKE ZVUNAQTWOGAJRE-UHFFFAOYSA-N D00UWL DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(C(C)CC)C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D00UWL DRUGTYPE Small molecular drug D00UWL HIGHSTAT Investigative D00UWY DRUG__ID D00UWY D00UWY DRUGCLAS Clinical Trial Drug(s) D00UWY DRUGCOMP Revance Therapeutics Inc D00UWY DRUGINCH 1S/C20H36O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22-4-2/h8-9,11-12H,3-7,10,13-19H2,1-2H3/b9-8-,12-11-/i10D2 D00UWY DRUGINKE FMMOOAYVCKXGMF-XMCVDNGOSA-N D00UWY DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)OCC D00UWY DRUGTYPE Small molecular drug D00UWY HIGHSTAT Phase 2 D00UXT DRUG__ID D00UXT D00UXT DRUADIID FDA-AP-BF04-01161 D00UXT DRUGCLAS Approved Drug(s) D00UXT DRUGCOMP Ortho Mcneil Pharmaceutical Inc D00UXT DRUGINCH 1S/C9H6I3NO3.Na/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16;/h2H,1H3,(H,13,14)(H,15,16);/q;+1/p-1 D00UXT DRUGINKE UCPVOMHRDXMAIZ-UHFFFAOYSA-M D00UXT DRUGSMIL CC(=O)NC1=C(C=C(C(=C1I)C(=O)[O-])I)I.[Na+] D00UXT DRUGTYPE Small molecular drug D00UXT HIGHSTAT Approved D00UYB DRUG__ID D00UYB D00UYB DRUGCLAS Investigative Drug(s) D00UYB DRUGCOMP Medlmmune LLC D00UYB DRUGTYPE Monoclonal antibody D00UYB HIGHSTAT Investigative D00UYE DRUG__ID D00UYE D00UYE DRUADIID FDA-AP-BF04-01523 D00UYE DRUGCLAS Approved Drug(s) D00UYE DRUGCOMP Apotex Inc D00UYE DRUGINCH 1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3 D00UYE DRUGINKE XADCESSVHJOZHK-UHFFFAOYSA-N D00UYE DRUGSMIL CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2 D00UYE DRUGTYPE Small molecular drug D00UYE HIGHSTAT Approved D00UYE THERCLAS Anesthetics D00UYR DRUG__ID D00UYR D00UYR DRUGCLAS Clinical Trial Drug(s) D00UYR DRUGCOMP Innovative Med Concepts Tuscaloosa, AL D00UYR HIGHSTAT Phase 2 D00UZO DRUG__ID D00UZO D00UZO DRUGCLAS Investigative Drug(s) D00UZO DRUGINCH 1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(24)25-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21,23H2,1H3/b7-6-,10-9-,13-12-,16-15- D00UZO DRUGINKE DLHLOYYQQGSXCC-DOFZRALJSA-N D00UZO DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCCN D00UZO DRUGTYPE Small molecular drug D00UZO HIGHSTAT Investigative D00UZR DRUG__ID D00UZR D00UZR DRUGCLAS Approved Drug(s) D00UZR DRUGCOMP Onyx Pharmaceuticals; Pfizer D00UZR DRUGINCH 1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29) D00UZR DRUGINKE AHJRHEGDXFFMBM-UHFFFAOYSA-N D00UZR DRUGSMIL CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C D00UZR DRUGTYPE Small molecular drug D00UZR HIGHSTAT Approved D00UZR THERCLAS Anticancer Agents D00UZR TRADNAME Ibrance D00VAJ DRUG__ID D00VAJ D00VAJ DRUGCLAS Discontinued Drug(s) D00VAJ DRUGINCH 1S/C17H23N5O4/c1-2-26-14(23)7-9-20-17(25)21-13-8-10-22(16(13)24)12-5-3-11(4-6-12)15(18)19/h3-6,13H,2,7-10H2,1H3,(H3,18,19)(H2,20,21,25)/t13-/m0/s1 D00VAJ DRUGINKE VJDOPFARMOLELX-ZDUSSCGKSA-N D00VAJ DRUGSMIL CCOC(=O)CCNC(=O)NC1CCN(C1=O)C2=CC=C(C=C2)C(=N)N D00VAJ DRUGTYPE Small molecular drug D00VAJ HIGHSTAT Discontinued in Phase 3 D00VAN DRUG__ID D00VAN D00VAN DRUGCLAS Investigative Drug(s) D00VAN DRUGINCH 1S/C15H14BrN3S/c1-10-4-2-5-11(8-10)14(18-19-15(17)20)12-6-3-7-13(16)9-12/h2-9H,1H3,(H3,17,19,20)/b18-14+ D00VAN DRUGINKE UUHYYCURIRMTND-NBVRZTHBSA-N D00VAN DRUGSMIL CC1=CC(=CC=C1)C(=NNC(=S)N)C2=CC(=CC=C2)Br D00VAN DRUGTYPE Small molecular drug D00VAN HIGHSTAT Investigative D00VBP DRUG__ID D00VBP D00VBP DRUGCLAS Patented Agent(s) D00VBP DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D00VBP DRUGTYPE Small molecular drug D00VBP HIGHSTAT Patented D00VBT DRUG__ID D00VBT D00VBT DRUGCLAS Discontinued Drug(s) D00VBT DRUGCOMP Schering AG D00VBT DRUGINCH 1S/C22H29ClN6O2/c1-28-7-9-29(10-8-28)18-12-15(11-16(23)13-18)21(30)26-19-14-24-27-20(19)22(31)25-17-5-3-2-4-6-17/h11-14,17H,2-10H2,1H3,(H,24,27)(H,25,31)(H,26,30) D00VBT DRUGINKE OALDDSAHYZPJQM-UHFFFAOYSA-N D00VBT DRUGSMIL CN1CCN(CC1)C2=CC(=CC(=C2)C(=O)NC3=C(NN=C3)C(=O)NC4CCCCC4)Cl D00VBT DRUGTYPE Small molecular drug D00VBT HIGHSTAT Discontinued in Phase 1 D00VBW DRUG__ID D00VBW D00VBW DRUGCLAS Investigative Drug(s) D00VBW DRUGINCH 1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6-,12-11+,16-8+,17-13+ D00VBW DRUGINKE FPIPGXGPPPQFEQ-IOUUIBBYSA-N D00VBW DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C D00VBW DRUGTYPE Small molecular drug D00VBW HIGHSTAT Investigative D00VBX DRUG__ID D00VBX D00VBX DRUGCLAS Investigative Drug(s) D00VBX DRUGINCH 1S/C12H10O4S/c1-17(14,15)10-6-4-9(5-7-10)12(13)11-3-2-8-16-11/h2-8H,1H3 D00VBX DRUGINKE CWRZECMEZICAFW-UHFFFAOYSA-N D00VBX DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C(=O)C2=CC=CO2 D00VBX DRUGTYPE Small molecular drug D00VBX HIGHSTAT Investigative D00VCH DRUG__ID D00VCH D00VCH DRUGCLAS Investigative Drug(s) D00VCH DRUGCOMP FAES Farma SA D00VCH HIGHSTAT Investigative D00VCW DRUG__ID D00VCW D00VCW DRUGCLAS Investigative Drug(s) D00VCW DRUGINCH 1S/C22H36ClNO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)24-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,24,25)/b7-6-,10-9-,13-12-,16-15- D00VCW DRUGINKE SCJNCDSAIRBRIA-DOFZRALJSA-N D00VCW DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCCl D00VCW DRUGTYPE Small molecular drug D00VCW HIGHSTAT Investigative D00VCZ DRUG__ID D00VCZ D00VCZ DRUGCLAS Investigative Drug(s) D00VCZ DRUGCOMP Shire plc D00VCZ HIGHSTAT Investigative D00VEM DRUG__ID D00VEM D00VEM COMPCLAS 1,2-diamino cyclopentane-based derivatives D00VEM DRUGCLAS Patented Agent(s) D00VEM DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D00VEM DRUGINCH 1S/C21H19ClN6OS/c22-13-8-9-17-19(12-13)30-21(27-17)26-16-6-3-5-15(16)25-20(29)14-4-1-2-7-18(14)28-23-10-11-24-28/h1-2,4,7-12,15-16H,3,5-6H2,(H,25,29)(H,26,27)/t15-,16-/m0/s1 D00VEM DRUGINKE PCFLJOMEOCZUJL-HOTGVXAUSA-N D00VEM DRUGSMIL C1CC(C(C1)NC(=O)C2=CC=CC=C2N3N=CC=N3)NC4=NC5=C(S4)C=C(C=C5)Cl D00VEM DRUGTYPE Small molecular drug D00VEM HIGHSTAT Patented D00VEZ DRUG__ID D00VEZ D00VEZ DRUGCLAS Investigative Drug(s) D00VEZ DRUGINCH 1S/C11H17NO8/c12-4(9(15)16)1-11(10(17)18)2-6-8(20-11)7(14)5(13)3-19-6/h4-8,13-14H,1-3,12H2,(H,15,16)(H,17,18)/p-1/t4-,5+,6?,7+,8?,11-/m1/s1 D00VEZ DRUGINKE NRTJEXLNSCGBJU-LUHIGIFZSA-M D00VEZ DRUGSMIL C1C2C(C(C(CO2)O)O)OC1(CC(C(=O)[O-])[NH3+])C(=O)[O-] D00VEZ DRUGTYPE Small molecular drug D00VEZ HIGHSTAT Investigative D00VFE DRUG__ID D00VFE D00VFE DRUADIID FDA-AP-BF04-01368 D00VFE DRUGCLAS Approved Drug(s) D00VFE DRUGCOMP Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co D00VFE DRUGINCH 1S/C42H65N13O10.C2H4O2.H2O/c1-22(2)33(53-35(58)28(50-32(57)20-45-6)9-7-15-47-42(43)44)38(61)51-29(17-25-11-13-27(56)14-12-25)36(59)54-34(23(3)4)39(62)52-30(18-26-19-46-21-48-26)40(63)55-16-8-10-31(55)37(60)49-24(5)41(64)65;1-2(3)4;/h11-14,19,21-24,28-31,33-34,45,56H,7-10,15-18,20H2,1-6H3,(H,46,48)(H,49,60)(H,50,57)(H,51,61)(H,52,62)(H,53,58)(H,54,59)(H,64,65)(H4,43,44,47);1H3,(H,3,4);1H2/t24-,28-,29-,30-,31-,33-,34-;;/m0../s1 D00VFE DRUGINKE YBZYNINTWCLDQA-UHKVWXOHSA-N D00VFE DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)CNC.CC(=O)O.O D00VFE DRUGTYPE Small molecular drug D00VFE HIGHSTAT Approved D00VFH DRUG__ID D00VFH D00VFH DRUGCLAS Clinical Trial Drug(s) D00VFH DRUGCOMP Pharmaxis Ltd D00VFH HIGHSTAT Phase 1 D00VFM DRUG__ID D00VFM D00VFM DRUGCLAS Investigative Drug(s) D00VFM DRUGINCH 1S/C23H28ClN3O/c24-20-6-4-5-19(15-20)16-23(11-2-1-3-12-23)13-14-28-21-9-7-18(8-10-21)17-27-22(25)26/h2,4-11,15H,1,3,12-14,16-17H2,(H4,25,26,27) D00VFM DRUGINKE VJXVVAAVNHDMTH-UHFFFAOYSA-N D00VFM DRUGSMIL C1CC=CC(C1)(CCOC2=CC=C(C=C2)CN=C(N)N)CC3=CC(=CC=C3)Cl D00VFM HIGHSTAT Investigative D00VFM THERCLAS Antifungal Agents D00VGP DRUG__ID D00VGP D00VGP DRUGCLAS Investigative Drug(s) D00VGP DRUGCOMP Xaragen Pharma Ltd D00VGP HIGHSTAT Investigative D00VHG DRUG__ID D00VHG D00VHG DRUGCLAS Investigative Drug(s) D00VHG DRUGINCH 1S/C19H22N2O5S/c1-12-6-4-5-7-15(12)10-17(22)21-16-8-13(2)19(14(3)9-16)27(25,26)20-11-18(23)24/h4-9,20H,10-11H2,1-3H3,(H,21,22)(H,23,24) D00VHG DRUGINKE CJKKMQCZOLCXAM-UHFFFAOYSA-N D00VHG DRUGSMIL CC1=CC=CC=C1CC(=O)NC2=CC(=C(C(=C2)C)S(=O)(=O)NCC(=O)O)C D00VHG DRUGTYPE Small molecular drug D00VHG HIGHSTAT Investigative D00VHN DRUG__ID D00VHN D00VHN DRUGCLAS Investigative Drug(s) D00VHN DRUGINCH 1S/C19H35NO5P/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-25-26(22,23)24/h9-12,21-24H,2-8,13-16,20H2,1H3/q+1 D00VHN DRUGINKE CGCGFGUOJDITDE-UHFFFAOYSA-N D00VHN DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO[P+](O)(O)O)N D00VHN DRUGTYPE Small molecular drug D00VHN HIGHSTAT Investigative D00VHS DRUG__ID D00VHS D00VHS DRUGCLAS Investigative Drug(s) D00VHS DRUGINCH 1S/C15H11NO2S/c17-12-5-1-10(2-6-12)14-9-16-19-15(14)11-3-7-13(18)8-4-11/h1-9,17-18H D00VHS DRUGINKE OCBISDMDUBGFSN-UHFFFAOYSA-N D00VHS DRUGSMIL C1=CC(=CC=C1C2=C(SN=C2)C3=CC=C(C=C3)O)O D00VHS DRUGTYPE Small molecular drug D00VHS HIGHSTAT Investigative D00VHW DRUG__ID D00VHW D00VHW DRUGCLAS Investigative Drug(s) D00VHW DRUGINCH 1S/C22H27NO/c1-2-6-18(7-3-1)14-19-10-12-23(13-11-19)16-20-15-21-8-4-5-9-22(21)24-17-20/h1-9,19-20H,10-17H2 D00VHW DRUGINKE SLJXLWDNADHNLA-UHFFFAOYSA-N D00VHW DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4OC3 D00VHW DRUGTYPE Small molecular drug D00VHW HIGHSTAT Investigative D00VJC DRUG__ID D00VJC D00VJC DRUGCLAS Clinical Trial Drug(s) D00VJC HIGHSTAT Phase 1 D00VJY DRUG__ID D00VJY D00VJY DRUGCLAS Investigative Drug(s) D00VJY DRUGINCH 1S/C8H18O/c1-2-3-4-5-6-7-8-9/h9H,2-8H2,1H3 D00VJY DRUGINKE KBPLFHHGFOOTCA-UHFFFAOYSA-N D00VJY DRUGSMIL CCCCCCCCO D00VJY DRUGTYPE Small molecular drug D00VJY HIGHSTAT Investigative D00VKB DRUG__ID D00VKB D00VKB DRUGCLAS Investigative Drug(s) D00VKB DRUGINCH 1S/C13H23F3O2S/c1-2-3-4-5-6-7-8-9-10-19(18)11-12(17)13(14,15)16/h2-11H2,1H3 D00VKB DRUGINKE PWWCYKIIRMNUAY-UHFFFAOYSA-N D00VKB DRUGSMIL CCCCCCCCCCS(=O)CC(=O)C(F)(F)F D00VKB DRUGTYPE Small molecular drug D00VKB HIGHSTAT Investigative D00VKK DRUG__ID D00VKK D00VKK DRUGCLAS Clinical Trial Drug(s) D00VKK DRUGCOMP Vascular Pharmaceuticals Research Triangle Park, NC D00VKK HIGHSTAT Phase 2 D00VKV DRUG__ID D00VKV D00VKV DRUGCLAS Investigative Drug(s) D00VKV DRUGINCH 1S/C15H23NS/c1-3-9-15(10-4-1,14-8-7-13-17-14)16-11-5-2-6-12-16/h7-8,13H,1-6,9-12H2 D00VKV DRUGINKE JUZZEWSCNBCFRL-UHFFFAOYSA-N D00VKV DRUGSMIL C1CCC(CC1)(C2=CC=CS2)N3CCCCC3 D00VKV DRUGTYPE Small molecular drug D00VKV HIGHSTAT Investigative D00VLF DRUG__ID D00VLF D00VLF DRUGCLAS Discontinued Drug(s) D00VLF DRUGCOMP Okairos D00VLF DRUGINCH 1S/C15H27N3O6S/c1-8(2)12(15(23)24)18-13(20)10(6-7-25)17-11(19)5-3-4-9(16)14(21)22/h8-10,12,25H,3-7,16H2,1-2H3,(H,17,19)(H,18,20)(H,21,22)(H,23,24)/t9-,10-,12+/m0/s1 D00VLF DRUGINKE WDPVNDRNBJNETA-JBLDHEPKSA-N D00VLF DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(CCS)NC(=O)CCCC(C(=O)O)N D00VLF DRUGTYPE Small molecular drug D00VLF HIGHSTAT Discontinued in Phase 1/2 D00VLQ DRUG__ID D00VLQ D00VLQ COMPCLAS Hydroxyqunoline analogs D00VLQ DRUGCLAS Patented Agent(s) D00VLQ DRUGINCH 1S/C10H7NO3/c12-8-4-3-7(10(13)14)6-2-1-5-11-9(6)8/h1-5,12H,(H,13,14) D00VLQ DRUGINKE JGRPKOGHYBAVMW-UHFFFAOYSA-N D00VLQ DRUGSMIL C1=CC2=C(C=CC(=C2N=C1)O)C(=O)O D00VLQ DRUGTYPE Small molecular drug D00VLQ HIGHSTAT Patented D00VMA DRUG__ID D00VMA D00VMA DRUGCLAS Clinical Trial Drug(s) D00VMA DRUGCOMP Novo Nordisk A/S D00VMA HIGHSTAT Phase 3 D00VMO DRUG__ID D00VMO D00VMO DRUGCLAS Investigative Drug(s) D00VMO DRUGINCH 1S/C25H25ClFNO4/c1-14(2)25-20(9-8-18(29)12-19(30)13-23(31)32)24(15-3-6-17(27)7-4-15)21-11-16(26)5-10-22(21)28-25/h3-11,14,18-19,29-30H,12-13H2,1-2H3,(H,31,32)/p-1/b9-8+/t18?,19-/m1/s1 D00VMO DRUGINKE FMCKOMPEFSASBD-FLRXWSLESA-M D00VMO DRUGSMIL CC(C)C1=NC2=C(C=C(C=C2)Cl)C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F D00VMO DRUGTYPE Small molecular drug D00VMO HIGHSTAT Investigative D00VMX DRUG__ID D00VMX D00VMX COMPCLAS Aromatic acetylene derivatives D00VMX DRUGCLAS Investigative Drug(s) D00VMX DRUGTYPE Small molecule immunotherapy D00VMX HIGHSTAT Investigative D00VMY DRUG__ID D00VMY D00VMY DRUGCLAS Investigative Drug(s) D00VMY DRUGCOMP National Research Council of Canada D00VMY HIGHSTAT Investigative D00VNC DRUG__ID D00VNC D00VNC DRUGCLAS Investigative Drug(s) D00VNC DRUGINCH 1S/C30H48O3/c1-25(2)14-15-27(5)16-17-30(24(32)33)19(20(27)18-25)8-9-22-28(6)12-11-23(31)26(3,4)21(28)10-13-29(22,30)7/h8,20-23,31H,9-18H2,1-7H3,(H,32,33)/t20-,21?,22+,23-,27+,28-,29+,30+/m0/s1 D00VNC DRUGINKE QGOSJBZFTWGWDU-ROOBTRRZSA-N D00VNC DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C(=O)O)C)C D00VNC DRUGTYPE Small molecular drug D00VNC HIGHSTAT Investigative D00VNH DRUG__ID D00VNH D00VNH DRUGCLAS Clinical Trial Drug(s) D00VNH DRUGINCH 1S/C14H15F3N3O6P/c15-14(16,17)8-5-9-11(6-10(8)19-1-3-26-4-2-19)20(7-27(23,24)25)13(22)12(21)18-9/h5-6H,1-4,7H2,(H,18,21)(H2,23,24,25) D00VNH DRUGINKE WZMQMKNCWDCCMT-UHFFFAOYSA-N D00VNH DRUGSMIL C1COCCN1C2=CC3=C(C=C2C(F)(F)F)NC(=O)C(=O)N3CP(=O)(O)O D00VNH DRUGTYPE Small molecular drug D00VNH HIGHSTAT Phase 1 D00VOE DRUG__ID D00VOE D00VOE DRUGCLAS Clinical Trial Drug(s) D00VOE DRUGCOMP GenVec D00VOE HIGHSTAT Phase 1 D00VOF DRUG__ID D00VOF D00VOF DRUGCLAS Investigative Drug(s) D00VOF DRUGCOMP Polaris Pharmaceuticals Inc D00VOF HIGHSTAT Investigative D00VOK DRUG__ID D00VOK D00VOK DRUGCLAS Investigative Drug(s) D00VOK DRUGTYPE Small molecule immunotherapy D00VOK HIGHSTAT Investigative D00VPT DRUG__ID D00VPT D00VPT DRUGCLAS Preclinical Drug(s) D00VPT DRUGCOMP GlaxoSmithKline D00VPT DRUGINCH 1S/C26H24N2O/c1-3-22(19-12-6-4-7-13-19)28-26(29)24-18(2)25(20-14-8-5-9-15-20)27-23-17-11-10-16-21(23)24/h4-17,22H,3H2,1-2H3,(H,28,29)/t22-/m0/s1 D00VPT DRUGINKE MQNYRKWJSMQECI-QFIPXVFZSA-N D00VPT DRUGSMIL CCC(C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)C D00VPT DRUGTYPE Small molecular drug D00VPT HIGHSTAT Preclinical D00VPU DRUG__ID D00VPU D00VPU DRUGCLAS Discontinued Drug(s) D00VPU DRUGCOMP Solvay D00VPU HIGHSTAT Discontinued in Phase 1 D00VPV DRUG__ID D00VPV D00VPV DRUGCLAS Discontinued Drug(s) D00VPV DRUGINCH 1S/C36H31F2N5O4S/c1-41(20-23-10-5-3-6-11-23)21-28-31-33(44)43(26-12-7-4-8-13-26)36(46)42(22-27-29(37)14-9-15-30(27)38)34(31)48-32(28)24-16-18-25(19-17-24)39-35(45)40-47-2/h3-19H,20-22H2,1-2H3,(H2,39,40,45) D00VPV DRUGINKE UCQSBGOFELXYIN-UHFFFAOYSA-N D00VPV DRUGSMIL CN(CC1=CC=CC=C1)CC2=C(SC3=C2C(=O)N(C(=O)N3CC4=C(C=CC=C4F)F)C5=CC=CC=C5)C6=CC=C(C=C6)NC(=O)NOC D00VPV DRUGTYPE Small molecular drug D00VPV HIGHSTAT Discontinued in Phase 2 D00VQI DRUG__ID D00VQI D00VQI DRUGCLAS Discontinued Drug(s) D00VQI DRUGINCH 1S/C23H38N2O5/c1-2-3-4-8-11-21(26)25-16-22(27)24-15-18-17(19-13-14-20(18)30-19)10-7-5-6-9-12-23(28)29/h5,7,17-20H,2-4,6,8-16H2,1H3,(H,24,27)(H,25,26)(H,28,29)/b7-5-/t17-,18+,19+,20-/m1/s1 D00VQI DRUGINKE OPZODFCEYJMBAM-OXVBEWKXSA-N D00VQI DRUGSMIL CCCCCCC(=O)NCC(=O)NCC1C2CCC(C1CC=CCCCC(=O)O)O2 D00VQI DRUGTYPE Small molecular drug D00VQI HIGHSTAT Discontinued in Phase 2 D00VQT DRUG__ID D00VQT D00VQT DRUGCLAS Clinical Trial Drug(s) D00VQT DRUGCOMP Cell>Point LLC D00VQT DRUGINCH 1S/C20H36N4O12S2.O.Tc/c25-3-9-13(27)15(29)11(19(33)35-9)23-17(31)7(5-37)21-1-2-22-8(6-38)18(32)24-12-16(30)14(28)10(4-26)36-20(12)34;;/h7-16,19-20,25-30,33-34,37-38H,1-6H2,(H,23,31)(H,24,32);;/q-2;;+4/p-2 D00VQT DRUGINKE XUWZVUPFDWQUTO-UHFFFAOYSA-L D00VQT DRUGSMIL C(C[N-]C(C[S-])C(=O)NC1C(C(C(OC1O)CO)O)O)[N-]C(C[S-])C(=O)NC2C(C(C(OC2O)CO)O)O.O=[Tc+4] D00VQT HIGHSTAT Phase 3 D00VQZ DRUG__ID D00VQZ D00VQZ DRUGCLAS Investigative Drug(s) D00VQZ DRUGINCH 1S/C7H7N3O4/c11-7(9-12)8-5-1-3-6(4-2-5)10(13)14/h1-4,12H,(H2,8,9,11) D00VQZ DRUGINKE DXBVARSUKIUCDK-UHFFFAOYSA-N D00VQZ DRUGSMIL C1=CC(=CC=C1NC(=O)NO)[N+](=O)[O-] D00VQZ DRUGTYPE Small molecular drug D00VQZ HIGHSTAT Investigative D00VRV DRUG__ID D00VRV D00VRV DRUGCLAS Investigative Drug(s) D00VRV DRUGINCH 1S/C20H24BrN3O/c1-4-24(5-2)20(25)12-9-14-13-7-6-8-16-18(13)15(19(21)22-16)10-17(14)23(3)11-12/h6-9,12,17,22H,4-5,10-11H2,1-3H3/t12-,17-/m1/s1 D00VRV DRUGINKE VKRAXSZEDRWLAG-SJKOYZFVSA-N D00VRV DRUGSMIL CCN(CC)C(=O)C1CN(C2CC3=C(NC4=CC=CC(=C34)C2=C1)Br)C D00VRV DRUGTYPE Small molecular drug D00VRV HIGHSTAT Investigative D00VSQ DRUG__ID D00VSQ D00VSQ DRUGCLAS Investigative Drug(s) D00VSQ DRUGCOMP ProCor Pharmaceuticals D00VSQ DRUGINCH 1S/C14H20BNO2S/c1-13(2)14(3,4)18-15(17-13)9-8-11-6-7-12(19-5)16-10-11/h6-10H,1-5H3/b9-8+ D00VSQ DRUGINKE MTGNTJQBNWXEMY-CMDGGOBGSA-N D00VSQ DRUGSMIL B1(OC(C(O1)(C)C)(C)C)C=CC2=CN=C(C=C2)SC D00VSQ HIGHSTAT Investigative D00VSX DRUG__ID D00VSX D00VSX DRUGCLAS Patented Agent(s) D00VSX DRUGCOMP NTZ LAB LTD [BG] D00VSX DRUGTYPE Small molecular drug D00VSX HIGHSTAT Patented D00VUG DRUG__ID D00VUG D00VUG DRUGCLAS Clinical Trial Drug(s) D00VUG DRUGCOMP Fujifilm Pharmaceuticals D00VUG DRUGTYPE Antibody D00VUG HIGHSTAT Phase 2 D00VUI DRUG__ID D00VUI D00VUI DRUGCLAS Clinical Trial Drug(s) D00VUI DRUGINCH 1S/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6H D00VUI DRUGINKE ZCCUUQDIBDJBTK-UHFFFAOYSA-N D00VUI DRUGSMIL C1=CC(=O)OC2=CC3=C(C=CO3)C=C21 D00VUI DRUGTYPE Small molecular drug D00VUI HIGHSTAT Phase 3 D00VUL DRUG__ID D00VUL D00VUL DRUGCLAS Approved Drug(s) D00VUL DRUGINCH 1S/C11H11N5/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8/h1-7H,(H4,12,13,14) D00VUL DRUGINKE QPFYXYFORQJZEC-UHFFFAOYSA-N D00VUL DRUGSMIL C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N D00VUL DRUGTYPE Small molecular drug D00VUL HIGHSTAT Approved D00VUN DRUG__ID D00VUN D00VUN DRUGCLAS Clinical Trial Drug(s) D00VUN DRUGCOMP TaiRx Taipei, Taiwan D00VUN DRUGINCH 1S/C16H13FNO5P.2Na/c1-23-14-6-5-11-15(16(14)24(20,21)22)13(19)8-12(18-11)9-3-2-4-10(17)7-9;;/h2-8H,1H3,(H,18,19)(H2,20,21,22);;/q;2*+1/p-2 D00VUN DRUGINKE ZRPWVAHVWBPHID-UHFFFAOYSA-L D00VUN DRUGSMIL COC1=C(C2=C(C=C1)NC(=CC2=O)C3=CC(=CC=C3)F)P(=O)([O-])[O-].[Na+].[Na+] D00VUN HIGHSTAT Phase 1 D00VUO DRUG__ID D00VUO D00VUO DRUGCLAS Investigative Drug(s) D00VUO DRUGINCH 1S/C16H15NO/c1-18-15-7-6-13-4-5-14(16(13)10-15)9-12-3-2-8-17-11-12/h2-3,6-11H,4-5H2,1H3/b14-9+ D00VUO DRUGINKE NDEGTMIIOPDVPA-NTEUORMPSA-N D00VUO DRUGSMIL COC1=CC2=C(CCC2=CC3=CN=CC=C3)C=C1 D00VUO DRUGTYPE Small molecular drug D00VUO HIGHSTAT Investigative D00VUT DRUG__ID D00VUT D00VUT DRUGCLAS Investigative Drug(s) D00VUT DRUGINCH 1S/C28H31FN2O/c29-24-13-11-21(12-14-24)27(32)20-30-17-18-31-19-25(30)15-16-26(31)28(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-14,25-28,32H,15-20H2/t25-,26-,27-/m0/s1 D00VUT DRUGINKE FESQDZTUIIZPPV-QKDODKLFSA-N D00VUT DRUGSMIL C1CC(N2CCN(C1C2)CC(C3=CC=C(C=C3)F)O)C(C4=CC=CC=C4)C5=CC=CC=C5 D00VUT DRUGTYPE Small molecular drug D00VUT HIGHSTAT Investigative D00VVB DRUG__ID D00VVB D00VVB DRUGCLAS Investigative Drug(s) D00VVB DRUGINCH 1S/C17H26N2O3/c1-4-5-6-7-8-13-21-16-11-9-15(10-12-16)18-17(20)22-19-14(2)3/h9-12H,4-8,13H2,1-3H3,(H,18,20) D00VVB DRUGINKE YXHJSUXZTSOPMI-UHFFFAOYSA-N D00VVB DRUGSMIL CCCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D00VVB DRUGTYPE Small molecular drug D00VVB HIGHSTAT Investigative D00VWN DRUG__ID D00VWN D00VWN DRUGCLAS Investigative Drug(s) D00VWN DRUGINCH 1S/C10H16O/c1-9(2)5-4-6-10(3)7-8-11/h5,7-8H,4,6H2,1-3H3/b10-7+ D00VWN DRUGINKE WTEVQBCEXWBHNA-JXMROGBWSA-N D00VWN DRUGSMIL CC(=CCCC(=CC=O)C)C D00VWN DRUGTYPE Small molecular drug D00VWN HIGHSTAT Investigative D00VWR DRUG__ID D00VWR D00VWR DRUGCLAS Investigative Drug(s) D00VWR DRUGINCH 1S/C8H14O2/c1-3-8(4-2)5-6-10-7(8)9/h3-6H2,1-2H3 D00VWR DRUGINKE OKKTUDVXPHANCU-UHFFFAOYSA-N D00VWR DRUGSMIL CCC1(CCOC1=O)CC D00VWR DRUGTYPE Small molecular drug D00VWR HIGHSTAT Investigative D00VXE DRUG__ID D00VXE D00VXE DRUGCLAS Investigative Drug(s) D00VXE DRUGINCH 1S/C23H24N2OS/c26-22(24-23-12-15-9-16(13-23)11-17(10-15)14-23)25-18-5-1-3-7-20(18)27-21-8-4-2-6-19(21)25/h1-8,15-17H,9-14H2,(H,24,26) D00VXE DRUGINKE YTNHIPMOCAHDRX-UHFFFAOYSA-N D00VXE DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)N4C5=CC=CC=C5SC6=CC=CC=C64 D00VXE DRUGTYPE Small molecular drug D00VXE HIGHSTAT Investigative D00VXM DRUG__ID D00VXM D00VXM DRUGCLAS Investigative Drug(s) D00VXM DRUGINCH 1S/C11H14ClNO3/c1-8-7-9(12)4-5-10(8)16-6-2-3-11(14)13-15/h4-5,7,15H,2-3,6H2,1H3,(H,13,14) D00VXM DRUGINKE JHSXDAWGLCZYSM-UHFFFAOYSA-N D00VXM DRUGSMIL CC1=C(C=CC(=C1)Cl)OCCCC(=O)NO D00VXM DRUGTYPE Small molecular drug D00VXM HIGHSTAT Investigative D00VXV DRUG__ID D00VXV D00VXV DRUGCLAS Patented Agent(s) D00VXV DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D00VXV DRUGINCH 1S/C60H70BrN9O8/c1-35(62-3)54(71)66-48-34-70(50-21-12-11-20-49(50)69(59(48)76)33-46-44-28-27-42(61)30-41(44)26-29-52(46)78-5)58(75)40-24-22-39(23-25-40)56(73)64-43-31-51(57(74)65-47-19-13-17-37-14-9-10-18-45(37)47)68(32-43)60(77)53(38-15-7-6-8-16-38)67-55(72)36(2)63-4/h9-12,14,18,20-30,35-36,38,43,47-48,51,53,62-63H,6-8,13,15-17,19,31-34H2,1-5H3,(H,64,73)(H,65,74)(H,66,71)(H,67,72)/t35-,36-,43-,47+,48-,51-,53-/m0/s1 D00VXV DRUGINKE OVCDDAXIBKWFRB-SFDZCEMOSA-N D00VXV DRUGSMIL CC(C(=O)NC1CN(C2=CC=CC=C2N(C1=O)CC3=C(C=CC4=C3C=CC(=C4)Br)OC)C(=O)C5=CC=C(C=C5)C(=O)NC6CC(N(C6)C(=O)C(C7CCCCC7)NC(=O)C(C)NC)C(=O)NC8CCCC9=CC=CC=C89)NC D00VXV DRUGTYPE Small molecular drug D00VXV HIGHSTAT Patented D00VXZ DRUG__ID D00VXZ D00VXZ DRUGCLAS Investigative Drug(s) D00VXZ DRUGCOMP Yaupon Therapeutics Inc D00VXZ HIGHSTAT Investigative D00VYC DRUG__ID D00VYC D00VYC DRUGCLAS Investigative Drug(s) D00VYC DRUGINCH 1S/C60H79N19O13S2/c1-32(80)71-43(24-34-15-17-37(81)18-16-34)54(88)72-41(14-8-22-68-60(64)65)52(86)79-48-30-94-93-29-47(50(61)84)78-56(90)45(25-35-27-69-39-12-6-5-11-38(35)39)76-51(85)40(13-7-21-67-59(62)63)73-55(89)44(23-33-9-3-2-4-10-33)75-57(91)46(26-36-28-66-31-70-36)77-53(87)42(74-58(48)92)19-20-49(82)83/h2-6,9-12,15-18,27-28,31,40-48,69,81H,7-8,13-14,19-26,29-30H2,1H3,(H2,61,84)(H,66,70)(H,71,80)(H,72,88)(H,73,89)(H,74,92)(H,75,91)(H,76,85)(H,77,87)(H,78,90)(H,79,86)(H,82,83)(H4,62,63,67)(H4,64,65,68)/t40-,41-,42+,43-,44-,45+,46-,47+,48+/m0/s1 D00VYC DRUGINKE FEKXKTLLBDRSQH-XVRHLUALSA-N D00VYC DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N D00VYC HIGHSTAT Investigative D00VYD DRUG__ID D00VYD D00VYD DRUGCLAS Investigative Drug(s) D00VYD DRUGINCH 1S/C12H10ClNO2/c13-10-4-1-3-9(7-10)8-14-6-2-5-11(14)12(15)16/h1-7H,8H2,(H,15,16) D00VYD DRUGINKE VPTUTBZAHHDMAA-UHFFFAOYSA-N D00VYD DRUGSMIL C1=CC(=CC(=C1)Cl)CN2C=CC=C2C(=O)O D00VYD DRUGTYPE Small molecular drug D00VYD HIGHSTAT Investigative D00VZA DRUG__ID D00VZA D00VZA DRUGCLAS Investigative Drug(s) D00VZA DRUGINCH 1S/C16H11NO3/c17-10-13(16(20)12-4-2-1-3-5-12)8-11-6-7-14(18)15(19)9-11/h1-9,18-19H/b13-8+ D00VZA DRUGINKE QBKFKKGORMOFFU-MDWZMJQESA-N D00VZA DRUGSMIL C1=CC=C(C=C1)C(=O)C(=CC2=CC(=C(C=C2)O)O)C#N D00VZA DRUGTYPE Small molecular drug D00VZA HIGHSTAT Investigative D00VZE DRUG__ID D00VZE D00VZE DRUGCLAS Investigative Drug(s) D00VZE DRUGINCH 1S/C17H28N2O/c20-16(18-15-4-2-1-3-5-15)19-17-9-12-6-13(10-17)8-14(7-12)11-17/h12-15H,1-11H2,(H2,18,19,20) D00VZE DRUGINKE VESXWSWSGQONHC-UHFFFAOYSA-N D00VZE DRUGSMIL C1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D00VZE DRUGTYPE Small molecular drug D00VZE HIGHSTAT Investigative D00VZF DRUG__ID D00VZF D00VZF DRUGCLAS Discontinued Drug(s) D00VZF DRUGCOMP Uniroyal Chemical Co Inc D00VZF DRUGINCH 1S/C11H9N3O3S/c15-8(12-6-4-2-1-3-5-6)7-9(16)13-11(18)14-10(7)17/h1-5,7H,(H,12,15)(H2,13,14,16,17,18) D00VZF DRUGINKE JARCFMKMOFFIGZ-UHFFFAOYSA-N D00VZF DRUGSMIL C1=CC=C(C=C1)NC(=O)C2C(=O)NC(=S)NC2=O D00VZF DRUGTYPE Small molecular drug D00VZF HIGHSTAT Discontinued in Phase 2 D00VZZ DRUG__ID D00VZZ D00VZZ DRUGCLAS Approved Drug(s) D00VZZ DRUGINCH 1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1 D00VZZ DRUGINKE AURFZBICLPNKBZ-SYBPFIFISA-N D00VZZ DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C D00VZZ DRUGTYPE Small molecular drug D00VZZ HIGHSTAT approved D00WAM DRUG__ID D00WAM D00WAM DRUGCLAS Approved Drug(s) D00WAM DRUGINCH 1S/C8H8F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-2,13-14H,3H2,(H2,12,15,16) D00WAM DRUGINKE DMDGGSIALPNSEE-UHFFFAOYSA-N D00WAM DRUGSMIL C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1 D00WAM DRUGTYPE Small molecular drug D00WAM HIGHSTAT Approved D00WAM THERCLAS Diuretics D00WBN DRUG__ID D00WBN D00WBN DRUGCLAS Clinical Trial Drug(s) D00WBN DRUGCOMP Alvine Pharmaceuticals Inc D00WBN HIGHSTAT Phase 2 D00WBS DRUG__ID D00WBS D00WBS DRUGCLAS Investigative Drug(s) D00WBS DRUGINCH 1S/C26H43NO5/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16-,17-,18+,19-,20+,21+,22+,25+,26-/m1/s1 D00WBS DRUGINKE WVULKSPCQVQLCU-BUXLTGKBSA-N D00WBS DRUGSMIL CC(CCC(=O)NCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C D00WBS DRUGTYPE Small molecular drug D00WBS HIGHSTAT Investigative D00WBU DRUG__ID D00WBU D00WBU DRUGCLAS Investigative Drug(s) D00WBU DRUGINCH 1S/C31H33N5O5/c1-17-11-21(37)12-18(2)22(17)14-23(32)31(41)36-16-20-8-4-3-7-19(20)13-27(36)30(40)35-26(15-28(38)39)29-33-24-9-5-6-10-25(24)34-29/h3-12,23,26-27,37H,13-16,32H2,1-2H3,(H,33,34)(H,35,40)(H,38,39)/t23-,26+,27-/m0/s1 D00WBU DRUGINKE USVQTDLSVBRMCR-RNJDCESWSA-N D00WBU DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C4=NC5=CC=CC=C5N4)N)C)O D00WBU DRUGTYPE Small molecular drug D00WBU HIGHSTAT Investigative D00WCT DRUG__ID D00WCT D00WCT DRUGCLAS Clinical Trial Drug(s) D00WCT DRUGCOMP Eagle Vision Pharmaceutical Corp D00WCT HIGHSTAT Phase 2 D00WCX DRUG__ID D00WCX D00WCX DRUGCLAS Approved Drug(s) D00WCX DRUGINCH 1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24) D00WCX DRUGINKE IIBYAHWJQTYFKB-UHFFFAOYSA-N D00WCX DRUGSMIL CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl D00WCX DRUGTYPE Small molecular drug D00WCX HIGHSTAT Approved D00WCX THERCLAS Antilipemic Agents D00WDA DRUG__ID D00WDA D00WDA COMPCLAS Indazole amide derivatives D00WDA DRUGCLAS Patented Agent(s) D00WDA DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D00WDA DRUGTYPE Small molecular drug D00WDA HIGHSTAT Patented D00WDM DRUG__ID D00WDM D00WDM DRUGCLAS Investigative Drug(s) D00WDM DRUGCOMP GCH&P D00WDM HIGHSTAT Investigative D00WDY DRUG__ID D00WDY D00WDY DRUGCLAS Clinical Trial Drug(s) D00WDY DRUGCOMP Bristol-Myers Squibb Co D00WDY DRUGINCH 1S/C21H19Cl2FN4O4S/c1-33(30,31)15-2-3-18(17(24)8-15)28-12-16(23)19(9-20(28)29)32-14-4-6-27(7-5-14)21-25-10-13(22)11-26-21/h2-3,8-12,14H,4-7H2,1H3 D00WDY DRUGINKE OGIAVRWXUPYGGC-UHFFFAOYSA-N D00WDY DRUGSMIL CS(=O)(=O)C1=CC(=C(C=C1)N2C=C(C(=CC2=O)OC3CCN(CC3)C4=NC=C(C=N4)Cl)Cl)F D00WDY HIGHSTAT Phase 1 D00WEL DRUG__ID D00WEL D00WEL DRUGCLAS Discontinued Drug(s) D00WEL DRUGCOMP American Biogenetic Sciences Inc D00WEL HIGHSTAT Terminated D00WEP DRUG__ID D00WEP D00WEP DRUGCLAS Investigative Drug(s) D00WEP DRUGCOMP Biolex Therapeutics Inc D00WEP HIGHSTAT Investigative D00WEQ DRUG__ID D00WEQ D00WEQ DRUGCLAS Investigative Drug(s) D00WEQ DRUGINCH 1S/C11H16BrNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3 D00WEQ DRUGINKE FXMWUTGUCAKGQL-UHFFFAOYSA-N D00WEQ DRUGSMIL CC(CC1=CC(=C(C=C1OC)Br)OC)N D00WEQ DRUGTYPE Small molecular drug D00WEQ HIGHSTAT Investigative D00WEV DRUG__ID D00WEV D00WEV DRUGCLAS Investigative Drug(s) D00WEV DRUGINCH 1S/C43H47N7O9/c1-21-13-27(51)14-22(2)29(21)19-32(44)38(54)37-28-8-6-5-7-24(28)18-34(46-37)41(57)47-33(11-12-36(52)53)40(56)48-35(39(45)55)20-50-42(58)30-16-23-9-10-26(49(3)4)15-25(23)17-31(30)43(50)59/h5-10,13-17,32-35,37,46,51H,11-12,18-20,44H2,1-4H3,(H2,45,55)(H,47,57)(H,48,56)(H,52,53)/t32-,33-,34?,35?,37?/m0/s1 D00WEV DRUGINKE XJJAERVDDMSANL-TXQDRJNYSA-N D00WEV DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)C2C3=CC=CC=C3CC(N2)C(=O)NC(CCC(=O)O)C(=O)NC(CN4C(=O)C5=C(C4=O)C=C6C=C(C=CC6=C5)N(C)C)C(=O)N)N)C)O D00WEV DRUGTYPE Small molecular drug D00WEV HIGHSTAT Investigative D00WFB DRUG__ID D00WFB D00WFB DRUGCLAS Investigative Drug(s) D00WFB DRUGINCH 1S/C16H12O4/c17-11-3-1-10(2-4-11)7-13-9-15(19)14-6-5-12(18)8-16(14)20-13/h1-6,8-9,17-18H,7H2 D00WFB DRUGINKE ZUDKQDRWUFGUDQ-UHFFFAOYSA-N D00WFB DRUGSMIL C1=CC(=CC=C1CC2=CC(=O)C3=C(O2)C=C(C=C3)O)O D00WFB DRUGTYPE Small molecular drug D00WFB HIGHSTAT Investigative D00WFQ DRUG__ID D00WFQ D00WFQ DRUGCLAS Investigative Drug(s) D00WFQ DRUGINCH 1S/C11H9N3O3/c1-8-4-2-3-5-10(8)11(15)13-7-9(6-12-13)14(16)17/h2-7H,1H3 D00WFQ DRUGINKE ORXYMBYYSLQOLK-UHFFFAOYSA-N D00WFQ DRUGSMIL CC1=CC=CC=C1C(=O)N2C=C(C=N2)[N+](=O)[O-] D00WFQ DRUGTYPE Small molecular drug D00WFQ HIGHSTAT Investigative D00WFU DRUG__ID D00WFU D00WFU DRUGCLAS Investigative Drug(s) D00WFU DRUGINCH 1S/C20H19N3O/c1-14(2)19(24)23-20-21-17(15-9-5-3-6-10-15)13-18(22-20)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,21,22,23,24) D00WFU DRUGINKE AGCKGTMTDBKSHH-UHFFFAOYSA-N D00WFU DRUGSMIL CC(C)C(=O)NC1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D00WFU DRUGTYPE Small molecular drug D00WFU HIGHSTAT Investigative D00WHC DRUG__ID D00WHC D00WHC DRUGCLAS Investigative Drug(s) D00WHC DRUGCOMP SICOR Inc D00WHC HIGHSTAT Investigative D00WHH DRUG__ID D00WHH D00WHH COMPCLAS 4-pyridone derivatives D00WHH DRUGCLAS Patented Agent(s) D00WHH DRUGTYPE Small molecular drug D00WHH HIGHSTAT Patented D00WHL DRUG__ID D00WHL D00WHL DRUGCLAS Clinical Trial Drug(s) D00WHL DRUGCOMP Renovo Group plc D00WHL DRUGINCH 1S/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h1,3-6,8-11H,2H2,(H2,12,13,14)/t3-,4-,5-,6-/m1/s1 D00WHL DRUGINKE VFRROHXSMXFLSN-KVTDHHQDSA-N D00WHL DRUGSMIL C(C(C(C(C(C=O)O)O)O)O)OP(=O)(O)O D00WHL HIGHSTAT Phase 2 D00WHO DRUG__ID D00WHO D00WHO DRUGCLAS Investigative Drug(s) D00WHO DRUGINCH 1S/C15H14ClN3O3/c1-3-22-15(21)13-11-7-18(2)14(20)12-9(16)5-4-6-10(12)19(11)8-17-13/h4-6,8H,3,7H2,1-2H3 D00WHO DRUGINKE WSDBAFQWNWJTNG-UHFFFAOYSA-N D00WHO DRUGSMIL CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC=C3Cl)C D00WHO DRUGTYPE Small molecular drug D00WHO HIGHSTAT Investigative D00WJC DRUG__ID D00WJC D00WJC DRUGCLAS Clinical Trial Drug(s) D00WJC DRUGCOMP Roche/GenentechSouth San Francisco, CA D00WJC HIGHSTAT Phase 1 D00WJE DRUG__ID D00WJE D00WJE DRUADIID CLI-01-ALDR-11552 D00WJE DRUGCLAS Discontinued Drug(s) D00WJE DRUGCOMP Sun Pharmaceutical Industries Ltd D00WJE DRUGINCH 1S/C23H26F2N2O3.2ClH/c24-20-7-3-18(4-8-20)23(19-5-9-21(25)10-6-19)27-14-12-26(13-15-27)11-1-2-16-30-17-22(28)29;;/h1-10,23H,11-17H2,(H,28,29);2*1H/b2-1+;; D00WJE DRUGINKE KAQMKGKFTBFMGE-SEPHDYHBSA-N D00WJE DRUGSMIL C1CN(CCN1CC=CCOCC(=O)O)C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F.Cl.Cl D00WJE HIGHSTAT Discontinued in Phase 2 D00WKK DRUG__ID D00WKK D00WKK DRUGCLAS Investigative Drug(s) D00WKK DRUGINCH 1S/C22H23N3O2/c26-22(19-8-4-10-23-16-19,20-9-5-11-24-17-20)21(18-6-2-1-3-7-18)25-12-14-27-15-13-25/h1-11,16-17,21,26H,12-15H2 D00WKK DRUGINKE WPLZJOHYEBBPRT-UHFFFAOYSA-N D00WKK DRUGSMIL C1COCCN1C(C2=CC=CC=C2)C(C3=CN=CC=C3)(C4=CN=CC=C4)O D00WKK DRUGTYPE Small molecular drug D00WKK HIGHSTAT Investigative D00WKL DRUG__ID D00WKL D00WKL DRUGCLAS Investigative Drug(s) D00WKL DRUGCOMP Pharmaxis Ltd D00WKL HIGHSTAT Investigative D00WMC DRUG__ID D00WMC D00WMC DRUGCLAS Investigative Drug(s) D00WMC DRUGINCH 1S/C15H11N3OS/c19-14(12-6-8-16-9-7-12)18-15-17-13(10-20-15)11-4-2-1-3-5-11/h1-10H,(H,17,18,19) D00WMC DRUGINKE PUUUVNHZQJNJSV-UHFFFAOYSA-N D00WMC DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC=NC=C3 D00WMC DRUGTYPE Small molecular drug D00WMC HIGHSTAT Investigative D00WME DRUG__ID D00WME D00WME DRUGCLAS Clinical Trial Drug(s) D00WME DRUGCOMP Amgen; Takeda D00WME DRUGTYPE Monoclonal antibody D00WME HIGHSTAT Phase 2 D00WMJ DRUG__ID D00WMJ D00WMJ DRUGCLAS Clinical Trial Drug(s) D00WMJ DRUGCOMP CMC Contrast AB D00WMJ HIGHSTAT Phase 2 D00WMK DRUG__ID D00WMK D00WMK DRUGCLAS Approved Drug(s) D00WMK DRUGCOMP GlaxoSmithKline D00WMK DRUGINCH 1S/C27H29F3O6S.C24H33Cl2NO5/c1-14-9-16-17-11-19(29)18-10-15(31)6-7-24(18,2)26(17,30)21(32)12-25(16,3)27(14,23(34)37-13-28)36-22(33)20-5-4-8-35-20;25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h4-8,10,14,16-17,19,21,32H,9,11-13H2,1-3H3;5-9,14,24,27-30H,1-4,10-13,15-17H2/t14-,16+,17?,19+,21+,24+,25+,26+,27+;24-/m10/s1 D00WMK DRUGINKE IVFHIIPWLILHCX-KVXXQBCDSA-N D00WMK DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl D00WMK DRUGTYPE Small molecular drug D00WMK HIGHSTAT Approved D00WMS DRUG__ID D00WMS D00WMS DRUGCLAS Investigative Drug(s) D00WMS DRUGINCH 1S/C13H19NO/c1-10(14-13(2,3)4)12(15)11-8-6-5-7-9-11/h5-10,14H,1-4H3 D00WMS DRUGINKE JQNSRSIGKZYQAA-UHFFFAOYSA-N D00WMS DRUGSMIL CC(C(=O)C1=CC=CC=C1)NC(C)(C)C D00WMS DRUGTYPE Small molecular drug D00WMS HIGHSTAT Investigative D00WMV DRUG__ID D00WMV D00WMV DRUGCLAS Investigative Drug(s) D00WMV DRUGINCH 1S/C34H28N4/c1-3-10-33-29(8-1)31-16-18-37(33)23-27-6-5-7-28(20-27)24-38-19-17-32(30-9-2-4-11-34(30)38)36-22-26-14-12-25(13-15-26)21-35-31/h1-20H,21-24H2/p+2 D00WMV DRUGINKE HZWVJPDDZQOYGA-UHFFFAOYSA-P D00WMV DRUGSMIL C1C2=CC=C(CNC3=CC=[N+](CC4=CC=CC(=C4)C[N+]5=CC=C(N1)C6=CC=CC=C65)C7=CC=CC=C37)C=C2 D00WMV DRUGTYPE Small molecular drug D00WMV HIGHSTAT Investigative D00WNA DRUG__ID D00WNA D00WNA DRUGCLAS Investigative Drug(s) D00WNA DRUGINCH 1S/C21H21N3O4/c1-14(19-9-4-5-10-22-19)24(3)21(26)20-12-18(28-23-20)13-27-17-8-6-7-16(11-17)15(2)25/h4-12,14H,13H2,1-3H3/t14-/m0/s1 D00WNA DRUGINKE JMYDHMCYZKRDPD-AWEZNQCLSA-N D00WNA DRUGSMIL CC(C1=CC=CC=N1)N(C)C(=O)C2=NOC(=C2)COC3=CC=CC(=C3)C(=O)C D00WNA DRUGTYPE Small molecular drug D00WNA HIGHSTAT Investigative D00WOE DRUG__ID D00WOE D00WOE DRUGCLAS Investigative Drug(s) D00WOE DRUGINCH 1S/C13H12ClNO2S/c1-18(16,17)15-13-8-4-11(5-9-13)10-2-6-12(14)7-3-10/h2-9,15H,1H3 D00WOE DRUGINKE XUCHFNFYOSJPDH-UHFFFAOYSA-N D00WOE DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)Cl D00WOE DRUGTYPE Small molecular drug D00WOE HIGHSTAT Investigative D00WOK DRUG__ID D00WOK D00WOK DRUGCLAS Investigative Drug(s) D00WOK DRUGINCH 1S/C10H15N4O14P3/c15-6-4(1-25-30(21,22)28-31(23,24)27-29(18,19)20)26-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,23,24)(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 D00WOK DRUGINKE HAEJPQIATWHALX-KQYNXXCUSA-N D00WOK DRUGSMIL C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D00WOK DRUGTYPE Small molecular drug D00WOK HIGHSTAT Investigative D00WON DRUG__ID D00WON D00WON DRUGCLAS Investigative Drug(s) D00WON DRUGINCH 1S/C7H12O2/c1-3-7(2)4-5-9-6(7)8/h3-5H2,1-2H3 D00WON DRUGINKE DRTXQTMTWPIHLI-UHFFFAOYSA-N D00WON DRUGSMIL CCC1(CCOC1=O)C D00WON DRUGTYPE Small molecular drug D00WON HIGHSTAT Investigative D00WOT DRUG__ID D00WOT D00WOT DRUGCLAS Discontinued Drug(s) D00WOT DRUGCOMP UCB Celltech D00WOT DRUGTYPE Antibody D00WOT HIGHSTAT Discontinued in Phase 2 D00WOX DRUG__ID D00WOX D00WOX DRUGCLAS Clinical Trial Drug(s) D00WOX DRUGCOMP Advanced cell technology D00WOX HIGHSTAT Phase 1/2 D00WPT DRUG__ID D00WPT D00WPT DRUGCLAS Clinical Trial Drug(s) D00WPT DRUGCOMP Metabolic Pharmaceuticals D00WPT DRUGINCH 1S/C71H103N23O25S4/c1-3-32(2)55-68(117)89-44(56(74)105)27-120-122-30-47-65(114)88-43(26-95)62(111)87-42(23-54(103)104)70(119)94-18-6-8-48(94)66(115)81-36(7-4-16-78-71(75)76)57(106)90-46(29-123-121-28-45(63(112)91-47)80-51(98)24-72)64(113)84-39(21-50(73)97)60(109)83-38(19-33-10-12-35(96)13-11-33)59(108)85-40(22-53(101)102)61(110)86-41(20-34-25-77-31-79-34)69(118)93-17-5-9-49(93)67(116)82-37(58(107)92-55)14-15-52(99)100/h10-13,25,31-32,36-49,55,95-96H,3-9,14-24,26-30,72H2,1-2H3,(H2,73,97)(H2,74,105)(H,77,79)(H,80,98)(H,81,115)(H,82,116)(H,83,109)(H,84,113)(H,85,108)(H,86,110)(H,87,111)(H,88,114)(H,89,117)(H,90,106)(H,91,112)(H,92,107)(H,99,100)(H,101,102)(H,103,104)(H4,75,76,78)/t32-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-,55-/m0/s1 D00WPT DRUGINKE KJQOYUHYAZGPIZ-PIJHVLQJSA-N D00WPT DRUGSMIL CCC(C)C1C(=O)NC(CSSCC2C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)NC(C(=O)NC(CSSCC(C(=O)N2)NC(=O)CN)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)N1)CCC(=O)O)CC5=CNC=N5)CC(=O)O)CC6=CC=C(C=C6)O)CC(=O)N)CCCNC(=N)N)CC(=O)O)CO)C(=O)N D00WPT HIGHSTAT Phase 1 D00WPT THERCLAS Analgesics D00WPU DRUG__ID D00WPU D00WPU DRUGCLAS Investigative Drug(s) D00WPU DRUGCOMP University of Illinois D00WPU DRUGINCH 1S/C15H20N2O2/c18-8-4-2-1-3-5-13-9-15(11-16-10-13)19-12-14-6-7-17-14/h9-11,14,17-18H,1-2,4,6-8,12H2/t14-/m0/s1 D00WPU DRUGINKE WONBUILDJNKYCB-AWEZNQCLSA-N D00WPU DRUGSMIL C1CNC1COC2=CN=CC(=C2)C#CCCCCO D00WPU DRUGTYPE Small molecular drug D00WPU HIGHSTAT Investigative D00WSM DRUG__ID D00WSM D00WSM DRUGCLAS Investigative Drug(s) D00WSM DRUGINCH 1S/C17H13NO3/c1-11-5-4-7-13(9-11)18-16(19)14-10-12-6-2-3-8-15(12)21-17(14)20/h2-10H,1H3,(H,18,19) D00WSM DRUGINKE XUNAVIWFCXQWCJ-UHFFFAOYSA-N D00WSM DRUGSMIL CC1=CC(=CC=C1)NC(=O)C2=CC3=CC=CC=C3OC2=O D00WSM DRUGTYPE Small molecular drug D00WSM HIGHSTAT Investigative D00WSN DRUG__ID D00WSN D00WSN DRUGCLAS Investigative Drug(s) D00WSN DRUGINCH 1S/C15H15N3O5/c19-15(13-5-6-14(23-13)18(20)21)16-11-3-1-2-4-12(11)17-7-9-22-10-8-17/h1-6H,7-10H2,(H,16,19) D00WSN DRUGINKE BIQWNNXDPVEAPZ-UHFFFAOYSA-N D00WSN DRUGSMIL C1COCCN1C2=CC=CC=C2NC(=O)C3=CC=C(O3)[N+](=O)[O-] D00WSN DRUGTYPE Small molecular drug D00WSN HIGHSTAT Investigative D00WUC DRUG__ID D00WUC D00WUC DRUGCLAS Investigative Drug(s) D00WUC DRUGCOMP Polaris Pharmaceuticals Inc D00WUC HIGHSTAT Investigative D00WUF DRUG__ID D00WUF D00WUF DRUGCLAS Approved Drug(s) D00WUF DRUGCOMP Pfizer D00WUF DRUGINCH 1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1 D00WUF DRUGINKE AYXYPKUFHZROOJ-ZETCQYMHSA-N D00WUF DRUGSMIL CC(C)CC(CC(=O)O)CN D00WUF DRUGTYPE Small molecular drug D00WUF HIGHSTAT Approved D00WVG DRUG__ID D00WVG D00WVG DRUGCLAS Investigative Drug(s) D00WVG DRUGINCH 1S/C14H15N3S/c1-2-6-11(7-3-1)13-10-18-14(15-13)17-16-12-8-4-5-9-12/h1-3,6-7,10H,4-5,8-9H2,(H,15,17) D00WVG DRUGINKE WUSIIHCESPBBHG-UHFFFAOYSA-N D00WVG DRUGSMIL C1CCC(=NNC2=NC(=CS2)C3=CC=CC=C3)C1 D00WVG DRUGTYPE Small molecular drug D00WVG HIGHSTAT Investigative D00WVI DRUG__ID D00WVI D00WVI DRUGCLAS Investigative Drug(s) D00WVI DRUGCOMP Astellas Pharma Inc D00WVI DRUGINCH 1S/C19H27N3O4S/c23-17(24)6-1-3-13-7-9-22(10-8-13)19-15-11-27(25,26)12-16(15)20-18(21-19)14-4-2-5-14/h13-14H,1-12H2,(H,23,24) D00WVI DRUGINKE NFFANIJTECFGGM-UHFFFAOYSA-N D00WVI DRUGSMIL C1CC(C1)C2=NC3=C(CS(=O)(=O)C3)C(=N2)N4CCC(CC4)CCCC(=O)O D00WVI DRUGTYPE Small molecular drug D00WVI HIGHSTAT Investigative D00WVW DRUG__ID D00WVW D00WVW DRUGCLAS Approved Drug(s) D00WVW DRUGCOMP Astellas D00WVW DRUGINCH 1S/C21H30N4O5S.ClH.3H2O/c1-12(2)25(13(3)4)8-7-22-20(28)15-11-31-21(23-15)24-19(27)14-9-17(29-5)18(30-6)10-16(14)26;;;;/h9-13,26H,7-8H2,1-6H3,(H,22,28)(H,23,24,27);1H;3*1H2 D00WVW DRUGINKE NPTDXIXCQCFGKC-UHFFFAOYSA-N D00WVW DRUGSMIL CC(C)N(CCNC(=O)C1=CSC(=N1)NC(=O)C2=CC(=C(C=C2O)OC)OC)C(C)C.O.O.O.Cl D00WVW DRUGTYPE Small molecular drug D00WVW HIGHSTAT Approved D00WWU DRUG__ID D00WWU D00WWU DRUGCLAS Discontinued Drug(s) D00WWU DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D00WWU DRUGINCH 1S/C23H26FN5O2S/c1-25-22(30)26-9-10-29-21(16-32-23(29)27-19-4-2-3-18(24)15-19)17-5-7-20(8-6-17)28-11-13-31-14-12-28/h2-8,15-16H,9-14H2,1H3,(H2,25,26,30) D00WWU DRUGINKE NBGPMRBRSOZDOV-UHFFFAOYSA-N D00WWU DRUGSMIL CNC(=O)NCCN1C(=CSC1=NC2=CC(=CC=C2)F)C3=CC=C(C=C3)N4CCOCC4 D00WWU HIGHSTAT Discontinued in Phase 1 D00WYS DRUG__ID D00WYS D00WYS DRUGCLAS Investigative Drug(s) D00WYS DRUGINCH 1S/C21H15NOS/c23-18-9-4-8-16(12-18)19-13-17(15-6-2-1-3-7-15)14-20(22-19)21-10-5-11-24-21/h1-14,23H D00WYS DRUGINKE ARUHBJGNLAPWGO-UHFFFAOYSA-N D00WYS DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CC=CS3)C4=CC(=CC=C4)O D00WYS DRUGTYPE Small molecular drug D00WYS HIGHSTAT Investigative D00WYV DRUG__ID D00WYV D00WYV DRUGCLAS Discontinued Drug(s) D00WYV DRUGCOMP US Army Medical Research Institute of Infectious Diseases D00WYV HIGHSTAT Terminated D00WZE DRUG__ID D00WZE D00WZE DRUGCLAS Investigative Drug(s) D00WZE DRUGCOMP Isis Pharmaceuticals D00WZE DRUGTYPE Antisense drug D00WZE HIGHSTAT Investigative D00WZG DRUG__ID D00WZG D00WZG DRUGCLAS Investigative Drug(s) D00WZG DRUGINCH 1S/C19H16N2O3/c1-22-18-11-15-16(20-13-21-17(15)12-19(18)23-2)9-6-10-24-14-7-4-3-5-8-14/h3-5,7-8,11-13H,10H2,1-2H3 D00WZG DRUGINKE SKJFTWBCHDIBAC-UHFFFAOYSA-N D00WZG DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)C#CCOC3=CC=CC=C3)OC D00WZG DRUGTYPE Small molecular drug D00WZG HIGHSTAT Investigative D00WZH DRUG__ID D00WZH D00WZH DRUGCLAS Patented Agent(s) D00WZH DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D00WZH DRUGTYPE Small molecular drug D00WZH HIGHSTAT Patented D00WZI DRUG__ID D00WZI D00WZI DRUGCLAS Investigative Drug(s) D00WZI DRUGINCH 1S/C9H9BO2S/c1-6-2-3-8-7(4-6)5-9(13-8)10(11)12/h2-5,11-12H,1H3 D00WZI DRUGINKE DHNHZPQPQAINDI-UHFFFAOYSA-N D00WZI DRUGSMIL B(C1=CC2=C(S1)C=CC(=C2)C)(O)O D00WZI DRUGTYPE Small molecular drug D00WZI HIGHSTAT Investigative D00WZJ DRUG__ID D00WZJ D00WZJ COMPCLAS 2,2-dimethylbenzopyran derivatives D00WZJ DRUGCLAS Patented Agent(s) D00WZJ DRUGCOMP Shenyang Pharmaceutical University, Peop. Rep. China D00WZJ DRUGINCH 1S/C21H20O5/c1-21(2)11-10-15-18(26-21)9-6-14(20(15)24)16(22)7-4-13-5-8-19(25-3)17(23)12-13/h4-12,23-24H,1-3H3/b7-4+ D00WZJ DRUGINKE XCJXATSREUCGQN-QPJJXVBHSA-N D00WZJ DRUGSMIL CC1(C=CC2=C(O1)C=CC(=C2O)C(=O)C=CC3=CC(=C(C=C3)OC)O)C D00WZJ DRUGTYPE Small molecular drug D00WZJ HIGHSTAT Patented D00WZK DRUG__ID D00WZK D00WZK DRUGCLAS Clinical Trial Drug(s) D00WZK DRUGCOMP Nabriva therapeutics D00WZK DRUGINCH 1S/C28H45NO5S/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3/t16-,17+,18?,20?,21?,22-,24+,25+,26-,27+,28+/m1/s1 D00WZK DRUGINKE KPVIXBKIJXZQJX-IJUBVZAWSA-N D00WZK DRUGSMIL CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C D00WZK DRUGTYPE Small molecular drug D00WZK HIGHSTAT Phase 2 D00XBC DRUG__ID D00XBC D00XBC DRUGCLAS Clinical Trial Drug(s) D00XBC DRUGCOMP GlaxoSmithKline plc D00XBC DRUGINCH 1S/C24H25ClN4O5S2/c1-24(2,31)23(30)26-13-15-6-4-7-16(12-15)14-29-17-8-5-9-18(34-3)21(17)22(27-29)28-36(32,33)20-11-10-19(25)35-20/h4-12,31H,13-14H2,1-3H3,(H,26,30)(H,27,28) D00XBC DRUGINKE YTEVTHHGQMUPHC-UHFFFAOYSA-N D00XBC DRUGSMIL CC(C)(C(=O)NCC1=CC(=CC=C1)CN2C3=C(C(=CC=C3)OC)C(=N2)NS(=O)(=O)C4=CC=C(S4)Cl)O D00XBC HIGHSTAT Phase 1 D00XBH DRUG__ID D00XBH D00XBH DRUGCLAS Preclinical Drug(s) D00XBH DRUGCOMP MNLpharma Ltd D00XBH HIGHSTAT Preclinical D00XBM DRUG__ID D00XBM D00XBM DRUGCLAS Investigative Drug(s) D00XBM DRUGINCH 1S/C37H49N11O6/c1-48-30(20-22-11-14-26(49)15-12-22)34(53)44-21-31(50)45-29(19-23-10-13-24-6-2-3-7-25(24)18-23)33(52)46-27(8-4-16-42-36(38)39)32(51)47-28(35(48)54)9-5-17-43-37(40)41/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,53)(H,45,50)(H,46,52)(H,47,51)(H4,38,39,42)(H4,40,41,43)/t27-,28+,29-,30+/m0/s1 D00XBM DRUGINKE KKHZUKILPGNUFR-RRGQHJHPSA-N D00XBM DRUGSMIL CN1C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C1=O)CCCN=C(N)N)CCCN=C(N)N)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O D00XBM DRUGTYPE Small molecular drug D00XBM HIGHSTAT Investigative D00XCC DRUG__ID D00XCC D00XCC DRUGCLAS Investigative Drug(s) D00XCC DRUGINCH 1S/C18H21N3O2/c19-15(11-13-7-3-1-4-8-13)18(23)21-16(17(20)22)12-14-9-5-2-6-10-14/h1-10,15-16H,11-12,19H2,(H2,20,22)(H,21,23)/t15-,16-/m1/s1 D00XCC DRUGINKE XXPXQEQOAZMUDD-HZPDHXFCSA-N D00XCC DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)N D00XCC DRUGTYPE Small molecular drug D00XCC HIGHSTAT Investigative D00XCL DRUG__ID D00XCL D00XCL DRUGCLAS Investigative Drug(s) D00XCL DRUGINCH 1S/C9H13N3O3S2/c10-7-1-3-8(4-2-7)17(14,15)12-9(13)11-5-6-16/h1-4,16H,5-6,10H2,(H2,11,12,13) D00XCL DRUGINKE LHVDNDIAMJOEKH-UHFFFAOYSA-N D00XCL DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)NC(=O)NCCS D00XCL DRUGTYPE Small molecular drug D00XCL HIGHSTAT Investigative D00XCX DRUG__ID D00XCX D00XCX DRUGCLAS Clinical Trial Drug(s) D00XCX DRUGINCH 1S/C21H16F2N2O4/c1-2-21(28)7-18(26)29-9-12-13(21)5-17-19-11(8-25(17)20(12)27)3-10-4-14(22)15(23)6-16(10)24-19/h3-6,28H,2,7-9H2,1H3/t21-/m1/s1 D00XCX DRUGINKE LFQCJSBXBZRMTN-OAQYLSRUSA-N D00XCX DRUGSMIL CCC1(CC(=O)OCC2=C1C=C3C4=C(CN3C2=O)C=C5C=C(C(=CC5=N4)F)F)O D00XCX DRUGTYPE Small molecular drug D00XCX HIGHSTAT Phase 2 D00XDG DRUG__ID D00XDG D00XDG DRUGCLAS Investigative Drug(s) D00XDG DRUGINCH 1S/C10H9N3O2/c11-8(14)7-9(12)15-10(13-7)6-4-2-1-3-5-6/h1-5H,12H2,(H2,11,14) D00XDG DRUGINKE UPWLRKVVLBSIPK-UHFFFAOYSA-N D00XDG DRUGSMIL C1=CC=C(C=C1)C2=NC(=C(O2)N)C(=O)N D00XDG DRUGTYPE Small molecular drug D00XDG HIGHSTAT Investigative D00XDN DRUG__ID D00XDN D00XDN COMPCLAS Pyrazole derivatives D00XDN DRUGCLAS Patented Agent(s) D00XDN DRUGCOMP 7TM PHARMA A/S RECEVEUR, Jean-Marie NIELSEN, Peter, Aadal HOEGBERG, Thomas LINGET, Jean-Michel COOPER, Martin NOERREGAARD, Pia, Karina D00XDN DRUGTYPE Small molecular drug D00XDN HIGHSTAT Patented D00XEM DRUG__ID D00XEM D00XEM COMPCLAS Beta-cyclodextrin conjugate derivatives D00XEM DRUGCLAS Patented Agent(s) D00XEM DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE NANTES UNIVERSITE DE PICARDIE JULES VERNE UNIVERSITE LILLE 1 SCIENCES ET TECHNOLOGIES INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) UNIVERSITE D'AUVERGNE - CLERMONT-FERRAND 1 D00XEM DRUGTYPE Carbohydrates D00XEM HIGHSTAT Patented D00XEN DRUG__ID D00XEN D00XEN DRUGCLAS Investigative Drug(s) D00XEN DRUGINCH 1S/C28H29Cl2N3O.ClH/c29-25-8-5-9-26(27(25)30)33-16-14-32(15-17-33)13-4-3-12-31-28(34)21-10-11-24-22(19-21)18-20-6-1-2-7-23(20)24;/h1-2,5-11,19H,3-4,12-18H2,(H,31,34);1H D00XEN DRUGINKE PFIWYJNBKGCVFM-UHFFFAOYSA-N D00XEN DRUGSMIL C1CN(CCN1CCCCNC(=O)C2=CC3=C(C=C2)C4=CC=CC=C4C3)C5=C(C(=CC=C5)Cl)Cl.Cl D00XEN DRUGTYPE Small molecular drug D00XEN HIGHSTAT Investigative D00XEU DRUG__ID D00XEU D00XEU DRUGCLAS Discontinued Drug(s) D00XEU DRUGCOMP GlaxoSmithKline D00XEU DRUGINCH 1S/C32H38ClN5O4/c1-20(2)42-29-13-12-24(16-27(29)33)32(41)35-25(17-34-30(40)19-37(4)5)15-22-8-10-23(11-9-22)28-18-38-14-6-7-26(21(3)39)31(38)36-28/h6-14,16,18,20-21,25,39H,15,17,19H2,1-5H3,(H,34,40)(H,35,41)/t21-,25-/m0/s1 D00XEU DRUGINKE WHMXDBPHBVLYRC-OFVILXPXSA-N D00XEU DRUGSMIL CC(C)OC1=C(C=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)C3=CN4C=CC=C(C4=N3)C(C)O)CNC(=O)CN(C)C)Cl D00XEU DRUGTYPE Small molecular drug D00XEU HIGHSTAT Terminated D00XEU THERCLAS Anticancer Agents D00XEX DRUG__ID D00XEX D00XEX DRUGCLAS Clinical Trial Drug(s) D00XEX HIGHSTAT Phase 1 D00XFM DRUG__ID D00XFM D00XFM COMPCLAS Phthalazinone derivatives D00XFM DRUGCLAS Patented Agent(s) D00XFM DRUGCOMP GLENMARK PHARMACEUTICALS S.A D00XFM DRUGINCH 1S/C27H23ClF2N4O3/c1-27(2,3)26(37)31-13-15-4-8-21(28)20(10-15)24(35)33-18-7-5-16-14-32-34(25(36)19(16)12-18)23-9-6-17(29)11-22(23)30/h4-12,14H,13H2,1-3H3,(H,31,37)(H,33,35) D00XFM DRUGINKE UWLKNQSOSOPRPR-UHFFFAOYSA-N D00XFM DRUGSMIL CC(C)(C)C(=O)NCC1=CC(=C(C=C1)Cl)C(=O)NC2=CC3=C(C=C2)C=NN(C3=O)C4=C(C=C(C=C4)F)F D00XFM DRUGTYPE Small molecular drug D00XFM HIGHSTAT Patented D00XFT DRUG__ID D00XFT D00XFT COMPCLAS Pyrazole derivatives D00XFT DRUGCLAS Patented Agent(s) D00XFT DRUGTYPE Small molecular drug D00XFT HIGHSTAT Patented D00XFY DRUG__ID D00XFY D00XFY DRUGCLAS Investigative Drug(s) D00XFY DRUGTYPE Combination drug (Antisense drug) D00XFY HIGHSTAT Investigative D00XFY THERCLAS Antisense D00XGW DRUG__ID D00XGW D00XGW DRUGCLAS Investigative Drug(s) D00XGW DRUGINCH 1S/C14H10Cl3NO2/c1-7-2-3-10(16)12(4-7)18-14(20)9-5-8(15)6-11(17)13(9)19/h2-6,19H,1H3,(H,18,20) D00XGW DRUGINKE UCOQCHLODZCXRH-UHFFFAOYSA-N D00XGW DRUGSMIL CC1=CC(=C(C=C1)Cl)NC(=O)C2=C(C(=CC(=C2)Cl)Cl)O D00XGW DRUGTYPE Small molecular drug D00XGW HIGHSTAT Investigative D00XHC DRUG__ID D00XHC D00XHC DRUGCLAS Investigative Drug(s) D00XHC DRUGINCH 1S/C19H22N2OS/c1-13(2)20(14(3)4)19(22)21-15-9-5-7-11-17(15)23-18-12-8-6-10-16(18)21/h5-14H,1-4H3 D00XHC DRUGINKE RSDPPDLPSMZJPP-UHFFFAOYSA-N D00XHC DRUGSMIL CC(C)N(C(C)C)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D00XHC DRUGTYPE Small molecular drug D00XHC HIGHSTAT Investigative D00XHD DRUG__ID D00XHD D00XHD DRUGCLAS Approved Drug(s) D00XHD DRUGCOMP Chugai D00XHD DRUGINCH 1S/C20H24FN3O4/c1-22-11-4-3-7-23(9-11)17-15(21)8-13-16(19(17)28-2)24(12-5-6-12)10-14(18(13)25)20(26)27/h8,10-12,22H,3-7,9H2,1-2H3,(H,26,27) D00XHD DRUGINKE MGQLHRYJBWGORO-UHFFFAOYSA-N D00XHD DRUGSMIL CNC1CCCN(C1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F D00XHD DRUGTYPE Small molecular drug D00XHD HIGHSTAT Approved D00XHH DRUG__ID D00XHH D00XHH DRUGCLAS Patented Agent(s) D00XHH DRUGINCH 1S/C16H15NO4/c1-10-2-4-11(5-3-10)12-6-7-13(14(18)8-12)16(21)17-9-15(19)20/h2-8,18H,9H2,1H3,(H,17,21)(H,19,20) D00XHH DRUGINKE POKDHYRFSOQLCV-UHFFFAOYSA-N D00XHH DRUGSMIL CC1=CC=C(C=C1)C2=CC(=C(C=C2)C(=O)NCC(=O)O)O D00XHH DRUGTYPE Small molecular drug D00XHH HIGHSTAT Patented D00XIB DRUG__ID D00XIB D00XIB DRUGCLAS Investigative Drug(s) D00XIB DRUGINCH 1S/C11H14N2O3S/c1-7(14)13-11-5-2-8-6-9(17(12,15)16)3-4-10(8)11/h3-4,6,11H,2,5H2,1H3,(H,13,14)(H2,12,15,16) D00XIB DRUGINKE RUUYVLNZHGCPRP-UHFFFAOYSA-N D00XIB DRUGSMIL CC(=O)NC1CCC2=C1C=CC(=C2)S(=O)(=O)N D00XIB HIGHSTAT Investigative D00XIP DRUG__ID D00XIP D00XIP DRUGCLAS Clinical Trial Drug(s) D00XIP DRUGCOMP Bavarian Nordic D00XIP DRUGTYPE Vaccine D00XIP HIGHSTAT Phase 1 D00XIX DRUG__ID D00XIX D00XIX DRUGCLAS Investigative Drug(s) D00XIX DRUGINCH 1S/C16H11ClOS2/c1-10-2-4-11(5-3-10)14-15(19-20-16(14)18)12-6-8-13(17)9-7-12/h2-9H,1H3 D00XIX DRUGINKE CUFDVUQUYHTZLD-UHFFFAOYSA-N D00XIX DRUGSMIL CC1=CC=C(C=C1)C2=C(SSC2=O)C3=CC=C(C=C3)Cl D00XIX DRUGTYPE Small molecular drug D00XIX HIGHSTAT Investigative D00XJA DRUG__ID D00XJA D00XJA DRUGCLAS Investigative Drug(s) D00XJA DRUGINCH 1S/C11H8O5/c1-15-7-2-3-9-6(4-7)5-8(10(12)13)11(14)16-9/h2-5H,1H3,(H,12,13) D00XJA DRUGINKE XIQQAIQZABTSNZ-UHFFFAOYSA-N D00XJA DRUGSMIL COC1=CC2=C(C=C1)OC(=O)C(=C2)C(=O)O D00XJA DRUGTYPE Small molecular drug D00XJA HIGHSTAT Investigative D00XJR DRUG__ID D00XJR D00XJR DRUGCLAS Investigative Drug(s) D00XJR DRUGINCH 1S/C13H15ClN4O/c1-17-4-6-18(7-5-17)13(19)12-15-10-3-2-9(14)8-11(10)16-12/h2-3,8H,4-7H2,1H3,(H,15,16) D00XJR DRUGINKE MOIWSUQWIOVGRH-UHFFFAOYSA-N D00XJR DRUGSMIL CN1CCN(CC1)C(=O)C2=NC3=C(N2)C=C(C=C3)Cl D00XJR DRUGTYPE Small molecular drug D00XJR HIGHSTAT Investigative D00XKA DRUG__ID D00XKA D00XKA DRUADIID CLI-01-ALDR-02038 D00XKA DRUGCLAS Investigative Drug(s) D00XKA DRUGINCH 1S/C25H36N2O2S.ClH/c1-24(2,3)20-16-19(17-21(23(20)29)25(4,5)6)30-15-12-22(28)27(7)14-11-18-10-8-9-13-26-18;/h8-10,13,16-17,29H,11-12,14-15H2,1-7H3;1H D00XKA DRUGINKE MCQQQXHGLCUPHW-UHFFFAOYSA-N D00XKA DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SCCC(=O)N(C)CCC2=CC=CC=N2.Cl D00XKA DRUGTYPE Small molecular drug D00XKA HIGHSTAT Investigative D00XKB DRUG__ID D00XKB D00XKB DRUGCLAS Clinical Trial Drug(s) D00XKB DRUGINCH 1S/C30H25FN4O/c1-4-8-20-14-22(17-33-16-20)21-9-6-10-23(15-21)30(24-13-19(3)29(36)35(5-2)18-24)25-11-7-12-26(31)27(25)28(32)34-30/h6-7,9-18H,5H2,1-3H3,(H2,32,34)/t30-/m0/s1 D00XKB DRUGINKE TUGLMYZSOPKJOA-PMERELPUSA-N D00XKB DRUGSMIL CCN1C=C(C=C(C1=O)C)C2(C3=C(C(=CC=C3)F)C(=N2)N)C4=CC=CC(=C4)C5=CN=CC(=C5)C#CC D00XKB DRUGTYPE Small molecular drug D00XKB HIGHSTAT Clinical trial D00XKE DRUG__ID D00XKE D00XKE DRUGCLAS Patented Agent(s) D00XKE DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D00XKE DRUGTYPE Carbohydrates D00XKE HIGHSTAT Patented D00XKH DRUG__ID D00XKH D00XKH DRUGCLAS Investigative Drug(s) D00XKH DRUGINCH 1S/C15H26N4O8S/c1-2-3-6-19(27)15(26)28-8-10(13(23)17-7-12(21)22)18-11(20)5-4-9(16)14(24)25/h9-10,27H,2-8,16H2,1H3,(H,17,23)(H,18,20)(H,21,22)(H,24,25)/t9-,10-/m0/s1 D00XKH DRUGINKE JHOFGABPPOTPEX-UWVGGRQHSA-N D00XKH DRUGSMIL CCCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D00XKH DRUGTYPE Small molecular drug D00XKH HIGHSTAT Investigative D00XKM DRUG__ID D00XKM D00XKM DRUGCLAS Investigative Drug(s) D00XKM DRUGINCH 1S/C10H12O3/c11-9(6-7-10(12)13)8-4-2-1-3-5-8/h1-5,9,11H,6-7H2,(H,12,13) D00XKM DRUGINKE OGQGIKZPOBBMNO-UHFFFAOYSA-N D00XKM DRUGSMIL C1=CC=C(C=C1)C(CCC(=O)O)O D00XKM DRUGTYPE Small molecular drug D00XKM HIGHSTAT Investigative D00XLE DRUG__ID D00XLE D00XLE DRUGCLAS Clinical Trial Drug(s) D00XLE DRUGCOMP Pfizer Inc D00XLE HIGHSTAT Phase 1 D00XLU DRUG__ID D00XLU D00XLU DRUGCLAS Investigative Drug(s) D00XLU DRUGINCH 1S/C19H17NO3S/c21-18-11-13-19(14-12-18)24(22,23)20(17-9-5-2-6-10-17)15-16-7-3-1-4-8-16/h1-14,21H,15H2 D00XLU DRUGINKE IXILNJSCQSTWEB-UHFFFAOYSA-N D00XLU DRUGSMIL C1=CC=C(C=C1)CN(C2=CC=CC=C2)S(=O)(=O)C3=CC=C(C=C3)O D00XLU DRUGTYPE Small molecular drug D00XLU HIGHSTAT Investigative D00XMF DRUG__ID D00XMF D00XMF DRUGCLAS Patented Agent(s) D00XMF DRUGINCH 1S/C11H9Cl2NO3/c12-8-2-1-6(3-9(8)13)11-7(4-10(15)16)5-17-14-11/h1-3,7H,4-5H2,(H,15,16) D00XMF DRUGINKE JUWLIQWWDGCIRH-UHFFFAOYSA-N D00XMF DRUGSMIL C1C(C(=NO1)C2=CC(=C(C=C2)Cl)Cl)CC(=O)O D00XMF DRUGTYPE Small molecular drug D00XMF HIGHSTAT Patented D00XMO DRUG__ID D00XMO D00XMO DRUGCLAS Investigative Drug(s) D00XMO DRUGINCH 1S/C14H17ClO/c1-2-16-14-5-3-4-12(14)10-11-6-8-13(15)9-7-11/h6-10,14H,2-5H2,1H3/b12-10+ D00XMO DRUGINKE VORGMCXCJIDOMV-ZRDIBKRKSA-N D00XMO DRUGSMIL CCOC1CCCC1=CC2=CC=C(C=C2)Cl D00XMO DRUGTYPE Small molecular drug D00XMO HIGHSTAT Investigative D00XMP DRUG__ID D00XMP D00XMP DRUGCLAS Investigative Drug(s) D00XMP DRUGINCH 1S/C13H20N2/c1-12(13-6-4-3-5-7-13)15-10-8-14(2)9-11-15/h3-7,12H,8-11H2,1-2H3 D00XMP DRUGINKE CQTKDGNXBCFBTR-UHFFFAOYSA-N D00XMP DRUGSMIL CC(C1=CC=CC=C1)N2CCN(CC2)C D00XMP DRUGTYPE Small molecular drug D00XMP HIGHSTAT Investigative D00XMZ DRUG__ID D00XMZ D00XMZ DRUGCLAS Clinical Trial Drug(s) D00XMZ HIGHSTAT Phase 1 D00XNC DRUG__ID D00XNC D00XNC DRUGCLAS Investigative Drug(s) D00XNC DRUGCOMP Cambridge Antibody Technology Group plc D00XNC DRUGTYPE Antibody D00XNC HIGHSTAT Investigative D00XND DRUG__ID D00XND D00XND DRUGCLAS Investigative Drug(s) D00XND DRUGCOMP PharmedArtis GmbH D00XND HIGHSTAT Investigative D00XNF DRUG__ID D00XNF D00XNF DRUGCLAS Investigative Drug(s) D00XNF DRUGINCH 1S/C19H27NO2S/c1-18(2,3)13-8-12(9-14(16(13)21)19(4,5)6)10-15-17(22)20(7)11-23-15/h8-10,21H,11H2,1-7H3/b15-10- D00XNF DRUGINKE IXCMEASJCGKKQS-GDNBJRDFSA-N D00XNF DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N(CS2)C D00XNF DRUGTYPE Small molecular drug D00XNF HIGHSTAT Investigative D00XNW DRUG__ID D00XNW D00XNW DRUGCLAS Clinical Trial Drug(s) D00XNW DRUGCOMP Alcon Research Ltd D00XNW HIGHSTAT Phase 2 D00XNY DRUG__ID D00XNY D00XNY DRUGCLAS Investigative Drug(s) D00XNY DRUGINCH 1S/C6H8N2O2.ClH/c9-6-4-1-2-7-3-5(4)10-8-6;/h7H,1-3H2,(H,8,9);1H D00XNY DRUGINKE ZDZDSZQYRBZPNN-UHFFFAOYSA-N D00XNY DRUGSMIL C1CNCC2=C1C(=O)NO2.Cl D00XNY DRUGTYPE Small molecular drug D00XNY HIGHSTAT Investigative D00XOQ DRUG__ID D00XOQ D00XOQ DRUGCLAS Investigative Drug(s) D00XOQ DRUGINCH 1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2 D00XOQ DRUGINKE ANWALZPQHPAZFO-UHFFFAOYSA-N D00XOQ DRUGSMIL C1COCCN1CCCN2C=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F D00XOQ DRUGTYPE Small molecular drug D00XOQ HIGHSTAT Investigative D00XOT DRUG__ID D00XOT D00XOT DRUGCLAS Investigative Drug(s) D00XOT DRUGINCH 1S/C12H12O3/c13-7-8-15-12-6-5-11(14)9-3-1-2-4-10(9)12/h1-6,13-14H,7-8H2 D00XOT DRUGINKE PABAILNRYWRUQG-UHFFFAOYSA-N D00XOT DRUGSMIL C1=CC=C2C(=C1)C(=CC=C2OCCO)O D00XOT DRUGTYPE Small molecular drug D00XOT HIGHSTAT Investigative D00XOV DRUG__ID D00XOV D00XOV DRUGCLAS Investigative Drug(s) D00XOV DRUGINCH 1S/C44H51N5O8/c1-30-19-21-33(22-20-30)28-55-34-26-37(40(50)48-39(18-10-11-25-45)44(53,54)42-46-35-16-8-9-17-38(35)57-42)49(27-34)41(51)36(24-23-31-12-4-2-5-13-31)47-43(52)56-29-32-14-6-3-7-15-32/h2-9,12-17,19-22,34,36-37,39,53-54H,10-11,18,23-29,45H2,1H3,(H,47,52)(H,48,50)/t34-,36-,37+,39+/m1/s1 D00XOV DRUGINKE KGNDCEVUMONOKF-UGPLYTSKSA-N D00XOV DRUGSMIL CC1=CC=C(C=C1)COC2CC(N(C2)C(=O)C(CCC3=CC=CC=C3)NC(=O)OCC4=CC=CC=C4)C(=O)NC(CCCCN)C(C5=NC6=CC=CC=C6O5)(O)O D00XOV DRUGTYPE Small molecular drug D00XOV HIGHSTAT Investigative D00XPA DRUG__ID D00XPA D00XPA DRUGCLAS Discontinued Drug(s) D00XPA DRUGCOMP Merck D00XPA HIGHSTAT Discontinued in Phase 3 D00XPB DRUG__ID D00XPB D00XPB DRUGCLAS Investigative Drug(s) D00XPB DRUGINCH 1S/C24H22BrNO.ClH/c1-3-16-26(2)17-18-4-6-19(7-5-18)20-8-10-21(11-9-20)24(27)22-12-14-23(25)15-13-22;/h3-15H,1,16-17H2,2H3;1H D00XPB DRUGINKE MCMDJJBPNGLKKM-UHFFFAOYSA-N D00XPB DRUGSMIL CN(CC=C)CC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)Br.Cl D00XPB DRUGTYPE Small molecular drug D00XPB HIGHSTAT Investigative D00XPC DRUG__ID D00XPC D00XPC DRUGCLAS Approved Drug(s) D00XPC DRUGINCH 1S/C25H31ClF2O5/c1-5-21(32)33-25(20(31)12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15-,16-,18-,19-,22-,23-,24-,25-/m0/s1 D00XPC DRUGINKE BDSYKGHYMJNPAB-LICBFIPMSA-N D00XPC DRUGSMIL CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl D00XPC DRUGTYPE Small molecular drug D00XPC HIGHSTAT Approved D00XPC THERCLAS Antiinflammatory Agents D00XPD DRUG__ID D00XPD D00XPD DRUGCLAS Investigative Drug(s) D00XPD DRUGCOMP Isis Pharmaceuticals D00XPD DRUGTYPE Antisense drug D00XPD HIGHSTAT Investigative D00XPZ DRUG__ID D00XPZ D00XPZ DRUGCLAS Investigative Drug(s) D00XPZ DRUGCOMP Elbion NV D00XPZ HIGHSTAT Investigative D00XQK DRUG__ID D00XQK D00XQK DRUGCLAS Discontinued Drug(s) D00XQK DRUGCOMP Ontario Inc D00XQK HIGHSTAT Terminated D00XQO DRUG__ID D00XQO D00XQO DRUGCLAS Clinical Trial Drug(s) D00XQO DRUGINCH 1S/C25H36O5/c1-16(10-12-20-17(2)8-6-14-25(20,3)4)7-5-9-18-11-13-21(29-23(18)27)19-15-22(26)30-24(19)28/h7,11,15,21,23-24,27-28H,5-6,8-10,12-14H2,1-4H3/b16-7+/t21-,23-,24-/m1/s1 D00XQO DRUGINKE FGJIDQWRRLDGDB-CPIXEKRISA-N D00XQO DRUGSMIL CC1=C(C(CCC1)(C)C)CCC(=CCCC2=CCC(OC2O)C3=CC(=O)OC3O)C D00XQO DRUGTYPE Small molecular drug D00XQO HIGHSTAT Phase 2 D00XQV DRUG__ID D00XQV D00XQV DRUGCLAS Investigative Drug(s) D00XQV DRUGINCH 1S/C28H35N5O5/c29-21(16-19-10-12-20(34)13-11-19)27(37)33-15-5-9-24(33)26(36)31-22(17-18-6-2-1-3-7-18)28(38)32-14-4-8-23(32)25(30)35/h1-3,6-7,10-13,21-24,34H,4-5,8-9,14-17,29H2,(H2,30,35)(H,31,36)/t21?,22-,23?,24?/m1/s1 D00XQV DRUGINKE LSQXZIUREIDSHZ-NJEQKKOJSA-N D00XQV DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)N4CCCC4C(=O)N D00XQV DRUGTYPE Small molecular drug D00XQV HIGHSTAT Investigative D00XRH DRUG__ID D00XRH D00XRH DRUGCLAS Investigative Drug(s) D00XRH DRUGINCH 1S/C20H23N5O2/c1-12-7-16-17(13-8-15(27-2)10-22-9-13)11-23-19(18(16)25-20(12)26)24-14-3-5-21-6-4-14/h7-11,14,21H,3-6H2,1-2H3,(H,23,24)(H,25,26) D00XRH DRUGINKE FPQQERRFPULCIK-UHFFFAOYSA-N D00XRH DRUGSMIL CC1=CC2=C(C(=NC=C2C3=CC(=CN=C3)OC)NC4CCNCC4)NC1=O D00XRH DRUGTYPE Small molecular drug D00XRH HIGHSTAT Investigative D00XRI DRUG__ID D00XRI D00XRI DRUGCLAS Discontinued Drug(s) D00XRI DRUGCOMP Tsumura & Co D00XRI DRUGINCH 1S/C39H44N2O6/c1-7-45-38-36(44-6)22-27-15-17-41(3)31-19-25-10-13-32(42-4)34(20-25)46-28-11-8-24(9-12-28)18-30-29-23-35(47-39(38)37(27)31)33(43-5)21-26(29)14-16-40(30)2/h8-13,20-23,30-31H,7,14-19H2,1-6H3/t30-,31-/m0/s1 D00XRI DRUGINKE VNBSKOLSTYLJBG-CONSDPRKSA-N D00XRI DRUGSMIL CCOC1=C(C=C2CCN(C3C2=C1OC4=C(C=C5CCN(C(C5=C4)CC6=CC=C(C=C6)OC7=C(C=CC(=C7)C3)OC)C)OC)C)OC D00XRI DRUGTYPE Small molecular drug D00XRI HIGHSTAT Terminated D00XRK DRUG__ID D00XRK D00XRK DRUGCLAS Discontinued Drug(s) D00XRK DRUGCOMP Bristol-Myers Squibb Co D00XRK DRUGINCH 1S/C30H45N3O6/c1-29(2,3)38-27(36)32-23(17-21-13-9-7-10-14-21)25(34)19-31-20-26(35)24(18-22-15-11-8-12-16-22)33-28(37)39-30(4,5)6/h7-16,23-26,31,34-35H,17-20H2,1-6H3,(H,32,36)(H,33,37)/t23-,24-,25+,26+/m0/s1 D00XRK DRUGINKE KKRYDPVDJYCEER-QEGGNFSNSA-N D00XRK DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(CNCC(C(CC2=CC=CC=C2)NC(=O)OC(C)(C)C)O)O D00XRK HIGHSTAT Terminated D00XRM DRUG__ID D00XRM D00XRM DRUGCLAS Investigative Drug(s) D00XRM DRUGCOMP Isis Pharmaceuticals D00XRM DRUGTYPE Antisense drug D00XRM HIGHSTAT Investigative D00XRN DRUG__ID D00XRN D00XRN DRUGCLAS Patented Agent(s) D00XRN DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D00XRN DRUGTYPE Small molecular drug D00XRN HIGHSTAT Patented D00XSL DRUG__ID D00XSL D00XSL DRUADIID 800034123 D00XSL DRUGCLAS Investigative Drug(s) D00XSL HIGHSTAT Investigative D00XSP DRUG__ID D00XSP D00XSP DRUGCLAS Investigative Drug(s) D00XSP DRUGCOMP Servier D00XSP HIGHSTAT Investigative D00XSQ DRUG__ID D00XSQ D00XSQ DRUGCLAS Investigative Drug(s) D00XSQ DRUGCOMP Ipsen D00XSQ HIGHSTAT Investigative D00XTC DRUG__ID D00XTC D00XTC DRUGCLAS Investigative Drug(s) D00XTC DRUGINCH 1S/C30H37N5O4S2/c1-20-28(38)35-18-9-13-24(35)27(37)33-23(12-3-2-8-19-40-41-25-14-6-7-17-31-25)26(36)34-30(29(39)32-20)16-15-21-10-4-5-11-22(21)30/h4-7,10-11,14,17,20,23-24H,2-3,8-9,12-13,15-16,18-19H2,1H3,(H,32,39)(H,33,37)(H,34,36)/t20-,23-,24+,30+/m0/s1 D00XTC DRUGINKE ZGCIQVPLYZBUHQ-AEPSZFNXSA-N D00XTC DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC3(CCC4=CC=CC=C43)C(=O)N1)CCCCCSSC5=CC=CC=N5 D00XTC DRUGTYPE Small molecular drug D00XTC HIGHSTAT Investigative D00XTS DRUG__ID D00XTS D00XTS DRUGCLAS Discontinued Drug(s) D00XTS DRUGCOMP Rottapharm Madaus D00XTS HIGHSTAT Terminated D00XUE DRUG__ID D00XUE D00XUE DRUGCLAS Investigative Drug(s) D00XUE DRUGINCH 1S/C9H17NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h7-8H,1-6,10H2,(H,11,12)/t8-/m0/s1 D00XUE DRUGINKE ORQXBVXKBGUSBA-QMMMGPOBSA-N D00XUE DRUGSMIL C1CCC(CC1)CC(C(=O)O)N D00XUE DRUGTYPE Small molecular drug D00XUE HIGHSTAT Investigative D00XUF DRUG__ID D00XUF D00XUF DRUGCLAS Investigative Drug(s) D00XUF DRUGINCH 1S/C17H16N6O/c1-2-3-7-13(24)21-16-14-17(20-10-19-16)23-15(22-14)12-6-4-5-11(8-12)9-18/h4-6,8,10H,2-3,7H2,1H3,(H2,19,20,21,22,23,24) D00XUF DRUGINKE FKLAKSOWIZORFH-UHFFFAOYSA-N D00XUF DRUGSMIL CCCCC(=O)NC1=NC=NC2=C1NC(=N2)C3=CC=CC(=C3)C#N D00XUF DRUGTYPE Small molecular drug D00XUF HIGHSTAT Investigative D00XUN DRUG__ID D00XUN D00XUN DRUADIID FDA-AP-BF04-00458 D00XUN DRUGCLAS Approved Drug(s) D00XUN DRUGCOMP Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co D00XUN DRUGINCH 1S/C2H8O7P2.2Na/c1-2(3,10(4,5)6)11(7,8)9;;/h3H,1H3,(H2,4,5,6)(H2,7,8,9);;/q;2*+1/p-2 D00XUN DRUGINKE GWBBVOVXJZATQQ-UHFFFAOYSA-L D00XUN DRUGSMIL CC(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+] D00XUN DRUGTYPE Small molecular drug D00XUN HIGHSTAT Approved D00XVE DRUG__ID D00XVE D00XVE DRUGCLAS Clinical Trial Drug(s) D00XVE DRUGCOMP Bayer HealthCare Pharmaceuticals Whippany, NJ D00XVE HIGHSTAT Phase 1 D00XVL DRUG__ID D00XVL D00XVL DRUGCLAS Clinical Trial Drug(s) D00XVL DRUGCOMP Intra-Cellular; Takeda D00XVL DRUGINCH 1S/C29H26FN7O/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3/t22-,23+/m1/s1 D00XVL DRUGINKE BBIPVJCGIASXJB-PKTZIBPZSA-N D00XVL DRUGSMIL CN1C(=O)C2=C(N(N=C2N3C1=NC4C3CCC4)CC5=CC=C(C=C5)C6=NC(=CC=C6)F)NC7=CC=CC=C7 D00XVL HIGHSTAT Phase 1/2 D00XVS DRUG__ID D00XVS D00XVS DRUGCLAS Investigative Drug(s) D00XVS DRUGINCH 1S/C30H46O3/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h20-23,31H,1,8-17H2,2-7H3,(H,32,33)/t20-,21+,22-,23+,27+,28-,29-,30+/m1/s1 D00XVS DRUGINKE DZVARQVBYAEZFI-JZQYXDLISA-N D00XVS DRUGSMIL CC1=C2C3CCC4C5(CCC(C(C5CCC4(C3(CCC2(CCC1=C)C(=O)O)C)C)(C)C)O)C D00XVS DRUGTYPE Small molecular drug D00XVS HIGHSTAT Investigative D00XVV DRUG__ID D00XVV D00XVV DRUGCLAS Investigative Drug(s) D00XVV DRUGINCH 1S/C25H34N4O2/c1-31-23-12-6-5-11-22(23)28-18-15-27(16-19-28)17-20-29(24-13-7-8-14-26-24)25(30)21-9-3-2-4-10-21/h5-8,11-14,21H,2-4,9-10,15-20H2,1H3/i25-1 D00XVV DRUGINKE SBPRIAGPYFYCRT-FNNGWQQSSA-N D00XVV DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4 D00XVV DRUGTYPE Small molecular drug D00XVV HIGHSTAT Investigative D00XWB DRUG__ID D00XWB D00XWB DRUGCLAS Clinical Trial Drug(s) D00XWB DRUGCOMP Pierre Fabre SA D00XWB DRUGINCH 1S/C20H25NO2S2.BrH/c1-15(13-24-19-9-5-3-7-17(19)22-2)11-21-16-12-23-18-8-4-6-10-20(18)25-14-16;/h3-10,15-16,21H,11-14H2,1-2H3;1H/t15-,16+;/m0./s1 D00XWB DRUGINKE CUWFVJMNULNBTG-IDVLALEDSA-N D00XWB DRUGSMIL CC(CNC1COC2=CC=CC=C2SC1)CSC3=CC=CC=C3OC.Br D00XWB DRUGTYPE Small molecular drug D00XWB HIGHSTAT Phase 1 D00XWD DRUG__ID D00XWD D00XWD DRUADIID FDA-AP-BF04-00386 D00XWD DRUGCLAS Approved Drug(s) D00XWD DRUGCOMP Novartis D00XWD DRUGINCH 1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/b20-11+ D00XWD DRUGINKE IKBKZGMPCYNSLU-RGVLZGJSSA-N D00XWD DRUGSMIL CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)OC D00XWD DRUGTYPE Small molecular drug D00XWD HIGHSTAT Approved D00XWF DRUG__ID D00XWF D00XWF DRUGCLAS Clinical Trial Drug(s) D00XWF DRUGCOMP Rebiotix D00XWF HIGHSTAT Phase 3 D00XWZ DRUG__ID D00XWZ D00XWZ DRUGCLAS Patented Agent(s) D00XWZ DRUGCOMP KARUS THERAPEUTICS LTD D00XWZ DRUGTYPE Small molecular drug D00XWZ HIGHSTAT Patented D00XXZ DRUG__ID D00XXZ D00XXZ COMPCLAS N-acylpiperidine ether derivatives D00XXZ DRUGCLAS Patented Agent(s) D00XXZ DRUGCOMP PFIZER LIMITED D00XXZ HIGHSTAT Patented D00XZH DRUG__ID D00XZH D00XZH DRUGCLAS Investigative Drug(s) D00XZH DRUGINCH 1S/C21H27NO/c1-17(2)21(23)13-15-22(16-14-21)20(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,17,20,23H,13-16H2,1-2H3 D00XZH DRUGINKE BOIJUJOJZXIYHU-UHFFFAOYSA-N D00XZH DRUGSMIL CC(C)C1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)O D00XZH DRUGTYPE Small molecular drug D00XZH HIGHSTAT Investigative D00XZP DRUG__ID D00XZP D00XZP DRUGCLAS Discontinued Drug(s) D00XZP DRUGCOMP Grupo Uriach D00XZP HIGHSTAT Discontinued in Phase 1 D00XZY DRUG__ID D00XZY D00XZY DRUGCLAS Approved Drug(s) D00XZY DRUGCOMP VABIOTECH D00XZY HIGHSTAT Approved D00XZZ DRUG__ID D00XZZ D00XZZ DRUGCLAS Investigative Drug(s) D00XZZ DRUGINCH 1S/C16H18N2O/c1-2-3-5-13-7-9-14(10-8-13)16(19)18-15-6-4-11-17-12-15/h4,6-12H,2-3,5H2,1H3,(H,18,19) D00XZZ DRUGINKE KDHOWTVYQKITMO-UHFFFAOYSA-N D00XZZ DRUGSMIL CCCCC1=CC=C(C=C1)C(=O)NC2=CN=CC=C2 D00XZZ DRUGTYPE Small molecular drug D00XZZ HIGHSTAT Investigative D00YAH DRUG__ID D00YAH D00YAH DRUGCLAS Clinical Trial Drug(s) D00YAH DRUGCOMP Eisai Woodcliff Lake, NJ D00YAH HIGHSTAT Phase 1 D00YAS DRUG__ID D00YAS D00YAS DRUGCLAS Investigative Drug(s) D00YAS DRUGCOMP Quro Science Inc D00YAS DRUGINCH 1S/C13H21N3.ClH/c1-2-5-16-6-3-4-10-7-12-11(8-13(10)16)9-14-15-12;/h9-10,13H,2-8H2,1H3,(H,14,15);1H/t10-,13-;/m1./s1 D00YAS DRUGINKE HJHVRVJTYPKTHX-HTMVYDOJSA-N D00YAS DRUGSMIL CCCN1CCCC2C1CC3=C(C2)NN=C3.Cl D00YAS DRUGTYPE Small molecular drug D00YAS HIGHSTAT Investigative D00YAZ DRUG__ID D00YAZ D00YAZ DRUGCLAS Investigative Drug(s) D00YAZ DRUGINCH 1S/C18H20FNO3S/c19-14-4-2-1-3-13(14)17(18(23)11-5-6-11)20-8-7-15(24)12(10-20)9-16(21)22/h1-4,9,11,15,17,24H,5-8,10H2,(H,21,22)/b12-9- D00YAZ DRUGINKE ZWUQVNSJSJHFPS-XFXZXTDPSA-N D00YAZ DRUGSMIL C1CC1C(=O)C(C2=CC=CC=C2F)N3CCC(C(=CC(=O)O)C3)S D00YAZ DRUGTYPE Small molecular drug D00YAZ HIGHSTAT Investigative D00YBT DRUG__ID D00YBT D00YBT DRUGCLAS Patented Agent(s) D00YBT DRUGCOMP NTZ LAB LTD [BG] D00YBT DRUGTYPE Small molecular drug D00YBT HIGHSTAT Patented D00YBU DRUG__ID D00YBU D00YBU DRUGCLAS Investigative Drug(s) D00YBU DRUGINCH 1S/C30H38N8O7/c31-30(32)33-13-7-12-20-26(42)34-17-24(39)35-23(16-25(40)41)29(45)38-22(15-19-10-5-2-6-11-19)28(44)37-21(27(43)36-20)14-18-8-3-1-4-9-18/h1-6,8-11,20-23H,7,12-17H2,(H,34,42)(H,35,39)(H,36,43)(H,37,44)(H,38,45)(H,40,41)(H4,31,32,33)/t20-,21-,22+,23-/m0/s1 D00YBU DRUGINKE VYLBOUQMYNRGBR-GPJHCHHRSA-N D00YBU DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CC=CC=C2)CC3=CC=CC=C3)CC(=O)O D00YBU DRUGTYPE Small molecular drug D00YBU HIGHSTAT Investigative D00YBW DRUG__ID D00YBW D00YBW DRUGCLAS Clinical Trial Drug(s) D00YBW DRUGCOMP NormOxys Inc D00YBW HIGHSTAT Phase 1/2 D00YBZ DRUG__ID D00YBZ D00YBZ DRUGCLAS Clinical Trial Drug(s) D00YBZ DRUGCOMP Ocucure therapeutics D00YBZ DRUGINCH 1S/C20H16N2O/c23-20-17-8-4-5-9-18(17)21-19(22-20)16-12-10-15(11-13-16)14-6-2-1-3-7-14/h1-13,19,21H,(H,22,23) D00YBZ DRUGINKE XRUAOBKXCFNPCK-UHFFFAOYSA-N D00YBZ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C3NC4=CC=CC=C4C(=O)N3 D00YBZ HIGHSTAT Phase 1 D00YCG DRUG__ID D00YCG D00YCG DRUGCLAS Investigative Drug(s) D00YCG DRUGINCH 1S/C14H14N2O/c1-2-8-16(7-1)9-10-17-13-3-4-14-12(11-13)5-6-15-14/h1-8,11,15H,9-10H2 D00YCG DRUGINKE NSZDJRLPCLOQAM-UHFFFAOYSA-N D00YCG DRUGSMIL C1=CN(C=C1)CCOC2=CC3=C(C=C2)NC=C3 D00YCG DRUGTYPE Small molecular drug D00YCG HIGHSTAT Investigative D00YCO DRUG__ID D00YCO D00YCO DRUGCLAS Investigative Drug(s) D00YCO DRUGINCH 1S/C47H66O13/c1-29-20-19-21-31(3)42(53)38(50)24-17-11-10-12-18-25-40(60-41(52)27-26-30(2)39(51)28-29)33(5)43(54)32(4)36(48)22-15-13-14-16-23-37(49)34(6)58-47-46(57-9)44(55)45(56-8)35(7)59-47/h10-24,26,28,32-35,37-40,43-47,49-51,54-55H,25,27H2,1-9H3/b11-10+,14-13+,18-12+,20-19+,22-15+,23-16+,24-17+,29-28+,30-26-,31-21+/t32?,33?,34?,35-,37?,38?,39?,40?,43?,44+,45+,46-,47-/m1/s1 D00YCO DRUGINKE FXSFWUNCIOIMAC-YHQXOMPPSA-N D00YCO DRUGSMIL CC1C(C(C(C(O1)OC(C)C(C=CC=CC=CC(=O)C(C)C(C(C)C2CC=CC=CC=CC(C(=O)C(=CC=CC(=CC(C(=CCC(=O)O2)C)O)C)C)O)O)O)OC)O)OC D00YCO DRUGTYPE Small molecular drug D00YCO HIGHSTAT Investigative D00YCU DRUG__ID D00YCU D00YCU DRUGCLAS Investigative Drug(s) D00YCU DRUGINCH 1S/C13H10N2O/c16-11-6-7-13-12(8-11)14-9-15(13)10-4-2-1-3-5-10/h1-9,16H D00YCU DRUGINKE OQAPWZCMAFFBBL-UHFFFAOYSA-N D00YCU DRUGSMIL C1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)O D00YCU DRUGTYPE Small molecular drug D00YCU HIGHSTAT Investigative D00YCW DRUG__ID D00YCW D00YCW DRUGCLAS Investigative Drug(s) D00YCW DRUGINCH 1S/C21H27NO/c1-2-9-20(18-10-5-3-6-11-18)22-16-14-21(23,15-17-22)19-12-7-4-8-13-19/h3-8,10-13,20,23H,2,9,14-17H2,1H3 D00YCW DRUGINKE HVKSQGJIDXVAKX-UHFFFAOYSA-N D00YCW DRUGSMIL CCCC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D00YCW DRUGTYPE Small molecular drug D00YCW HIGHSTAT Investigative D00YDN DRUG__ID D00YDN D00YDN DRUGCLAS Clinical Trial Drug(s) D00YDN DRUGCOMP CXR Biosciences Ltd D00YDN HIGHSTAT Phase 1 D00YDR DRUG__ID D00YDR D00YDR DRUGCLAS Investigative Drug(s) D00YDR DRUGINCH 1S/C22H29N3O2/c1-23-9-7-15-11-14-12-22(21(26)27-2)19-17(8-10-25(13-14)20(15)22)16-5-3-4-6-18(16)24-19/h3-6,14-15,20,23-24H,7-13H2,1-2H3/t14?,15-,20-,22+/m0/s1 D00YDR DRUGINKE YKMOJVPLIUXEIP-JNBMDGLNSA-N D00YDR DRUGSMIL CNCCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC D00YDR DRUGTYPE Small molecular drug D00YDR HIGHSTAT Investigative D00YEB DRUG__ID D00YEB D00YEB DRUGCLAS Investigative Drug(s) D00YEB DRUGINCH 1S/C23H27NO2/c1-3-7-21(25)26-20-11-6-9-17-15-19-22-16(12-14-24(19)13-4-2)8-5-10-18(22)23(17)20/h5-6,8-11,19H,3-4,7,12-15H2,1-2H3/t19-/m1/s1 D00YEB DRUGINKE PSFOXKHONDMYHK-LJQANCHMSA-N D00YEB DRUGSMIL CCCC(=O)OC1=CC=CC2=C1C3=CC=CC4=C3C(C2)N(CC4)CCC D00YEB DRUGTYPE Small molecular drug D00YEB HIGHSTAT Investigative D00YEF DRUG__ID D00YEF D00YEF DRUGCLAS Investigative Drug(s) D00YEF DRUGINCH 1S/C10H24N2O6S2/c11-19(13,14)17-9-7-5-3-1-2-4-6-8-10-18-20(12,15)16/h1-10H2,(H2,11,13,14)(H2,12,15,16) D00YEF DRUGINKE XPDWKENHTJHZSC-UHFFFAOYSA-N D00YEF DRUGSMIL C(CCCCCOS(=O)(=O)N)CCCCOS(=O)(=O)N D00YEF DRUGTYPE Small molecular drug D00YEF HIGHSTAT Investigative D00YEO DRUG__ID D00YEO D00YEO DRUGCLAS Discontinued Drug(s) D00YEO DRUGCOMP Novazyme Pharmaceuticals Inc D00YEO HIGHSTAT Terminated D00YER DRUG__ID D00YER D00YER DRUGCLAS Clinical Trial Drug(s) D00YER DRUGCOMP Hanmi Pharmaceutical Co Ltd D00YER DRUGINCH 1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29) D00YER DRUGINKE LPFWVDIFUFFKJU-UHFFFAOYSA-N D00YER DRUGSMIL COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C D00YER DRUGTYPE Small molecular drug D00YER HIGHSTAT Phase 2 D00YEV DRUG__ID D00YEV D00YEV DRUGCLAS Clinical Trial Drug(s) D00YEV DRUGINCH 1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7,17-19H D00YEV DRUGINKE FXNFHKRTJBSTCS-UHFFFAOYSA-N D00YEV DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O D00YEV DRUGTYPE Small molecular drug D00YEV HIGHSTAT Phase 2 D00YFP DRUG__ID D00YFP D00YFP DRUGCLAS Discontinued Drug(s) D00YFP DRUGCOMP Roche D00YFP HIGHSTAT Discontinued in Phase 2 D00YGA DRUG__ID D00YGA D00YGA DRUGCLAS Discontinued Drug(s) D00YGA DRUGCOMP SmithKline Beecham plc D00YGA DRUGINCH 1S/C21H21F3N2O5/c1-26(20-25-16-4-2-3-5-17(16)31-20)10-11-29-15-8-6-14(7-9-15)12-18(19(27)28)30-13-21(22,23)24/h2-9,18H,10-13H2,1H3,(H,27,28)/t18-/m0/s1 D00YGA DRUGINKE IRAAJHYKQDFNFO-SFHVURJKSA-N D00YGA DRUGSMIL CN(CCOC1=CC=C(C=C1)CC(C(=O)O)OCC(F)(F)F)C2=NC3=CC=CC=C3O2 D00YGA DRUGTYPE Small molecular drug D00YGA HIGHSTAT Terminated D00YGP DRUG__ID D00YGP D00YGP DRUGCLAS Investigative Drug(s) D00YGP DRUGINCH 1S/C15H10O5/c16-10-1-2-14-9(5-10)6-13(15(19)20-14)8-3-11(17)7-12(18)4-8/h1-7,16-18H D00YGP DRUGINKE DKFCOAXLNVHDTF-UHFFFAOYSA-N D00YGP DRUGSMIL C1=CC2=C(C=C1O)C=C(C(=O)O2)C3=CC(=CC(=C3)O)O D00YGP DRUGTYPE Small molecular drug D00YGP HIGHSTAT Investigative D00YGY DRUG__ID D00YGY D00YGY DRUGCLAS Patented Agent(s) D00YGY DRUGCOMP JANSSEN PHARMACEUTICA N.V. DVORAK, Curt, A. RUDOLPH, Dale, A. SHIREMAN, Brock, TJanssen Pharmaceutica NV D00YGY DRUGTYPE Small molecular drug D00YGY HIGHSTAT Patented D00YHD DRUG__ID D00YHD D00YHD DRUGCLAS Investigative Drug(s) D00YHD DRUGINCH 1S/C21H21NO/c1-15(2)21(18-10-12-22-13-11-18)17-8-6-16(7-9-17)19-4-3-5-20(23)14-19/h3-15,21,23H,1-2H3 D00YHD DRUGINKE YNPHCSJZYQIGGU-UHFFFAOYSA-N D00YHD DRUGSMIL CC(C)C(C1=CC=C(C=C1)C2=CC(=CC=C2)O)C3=CC=NC=C3 D00YHD DRUGTYPE Small molecular drug D00YHD HIGHSTAT Investigative D00YHI DRUG__ID D00YHI D00YHI DRUGCLAS Investigative Drug(s) D00YHI DRUGINCH 1S/C20H25NO3/c1-13(2)11-21-9-8-20-7-6-15(22)10-17(20)24-19-16(23-3)5-4-14(12-21)18(19)20/h4-7,15,17,22H,1,8-12H2,2-3H3/t15-,17-,20-/m0/s1 D00YHI DRUGINKE FEKQBPRIVQKBRM-KNBMTAEXSA-N D00YHI DRUGSMIL CC(=C)CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O D00YHI DRUGTYPE Small molecular drug D00YHI HIGHSTAT Investigative D00YID DRUG__ID D00YID D00YID DRUGCLAS Investigative Drug(s) D00YID DRUGCOMP Isis Pharmaceuticals D00YID DRUGTYPE Antisense drug D00YID HIGHSTAT Investigative D00YIS DRUG__ID D00YIS D00YIS DRUGCLAS Investigative Drug(s) D00YIS DRUGINCH 1S/C14H15O7PS/c15-22(16,17)14(23(18,19)20)10-11-5-4-8-13(9-11)21-12-6-2-1-3-7-12/h1-9,14H,10H2,(H2,15,16,17)(H,18,19,20)/p-3 D00YIS DRUGINKE QZTDQEVQGQAOKB-UHFFFAOYSA-K D00YIS DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)CC(P(=O)([O-])[O-])S(=O)(=O)[O-] D00YIS DRUGTYPE Small molecular drug D00YIS HIGHSTAT Investigative D00YJD DRUG__ID D00YJD D00YJD DRUGCLAS Investigative Drug(s) D00YJD DRUGCOMP Selvita Life Sciences Solutions D00YJD HIGHSTAT Investigative D00YJI DRUG__ID D00YJI D00YJI DRUGCLAS Investigative Drug(s) D00YJI DRUGCOMP Eos Neuroscience Inc D00YJI HIGHSTAT Investigative D00YLF DRUG__ID D00YLF D00YLF DRUGCLAS Approved Drug(s) D00YLF HIGHSTAT Approved D00YLM DRUG__ID D00YLM D00YLM DRUGCLAS Clinical Trial Drug(s) D00YLM DRUGINCH 1S/C20H25NO3.CH4O3S/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17;1-5(2,3)4/h2-10,15,19,22-24H,11-14H2,1H3;1H3,(H,2,3,4)/t15-,19+;/m0./s1 D00YLM DRUGINKE OZBWUANKVIMZIA-WRRDZZDISA-N D00YLM DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)(C3=CC=CC=C3)O.CS(=O)(=O)O D00YLM DRUGTYPE Small molecular drug D00YLM HIGHSTAT Phase 2 D00YLW DRUG__ID D00YLW D00YLW DRUGCLAS Approved Drug(s) D00YLW DRUGCOMP Aventis Pharmaceuticals Inc. D00YLW DRUGINCH 1S/C19H20N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,20H,5-8,10H2/t11?,12-,13+,14? D00YLW DRUGINKE UKTAZPQNNNJVKR-AKJUYKBHSA-N D00YLW DRUGSMIL C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54 D00YLW DRUGTYPE Small molecular drug D00YLW HIGHSTAT Approved D00YLW THERCLAS Antiemetics D00YMM DRUG__ID D00YMM D00YMM DRUGCLAS Investigative Drug(s) D00YMM DRUGCOMP Novozymes A/S D00YMM HIGHSTAT Investigative D00YMN DRUG__ID D00YMN D00YMN DRUGCLAS Investigative Drug(s) D00YMN DRUGCOMP Aiko Biotechnology Inc D00YMN HIGHSTAT Investigative D00YNA DRUG__ID D00YNA D00YNA DRUGCLAS Investigative Drug(s) D00YNA DRUGINCH 1S/C15H11NO2S/c17-12-5-1-3-10(7-12)14-9-16-15(19-14)11-4-2-6-13(18)8-11/h1-9,17-18H D00YNA DRUGINKE OYFRXCWZMBHNHW-UHFFFAOYSA-N D00YNA DRUGSMIL C1=CC(=CC(=C1)O)C2=CN=C(S2)C3=CC(=CC=C3)O D00YNA DRUGTYPE Small molecular drug D00YNA HIGHSTAT Investigative D00YNI DRUG__ID D00YNI D00YNI DRUGCLAS Investigative Drug(s) D00YNI DRUGINCH 1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m0/s1 D00YNI DRUGINKE HSUGRBWQSSZJOP-LEWJYISDSA-N D00YNI DRUGSMIL CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC D00YNI DRUGTYPE Small molecular drug D00YNI HIGHSTAT Investigative D00YNJ DRUG__ID D00YNJ D00YNJ DRUGCLAS Investigative Drug(s) D00YNJ DRUGCOMP X-BODY BioSciences D00YNJ DRUGTYPE Antibody D00YNJ HIGHSTAT Investigative D00YNK DRUG__ID D00YNK D00YNK DRUGCLAS Investigative Drug(s) D00YNK DRUGCOMP MiRagen Therapeutics Inc D00YNK HIGHSTAT Investigative D00YNW DRUG__ID D00YNW D00YNW DRUGCLAS Investigative Drug(s) D00YNW DRUGINCH 1S/C28H45N7O6/c1-8-10-11-12-13-34(7)16-22(36)19(14-24(37)38)30-26(39)21(9-2)35-17-23(28(4,5)6)31-25(27(35)40)29-15-20-18(3)32-41-33-20/h17,19,21H,8-16H2,1-7H3,(H,29,31)(H,30,39)(H,37,38) D00YNW DRUGINKE XIMITGPWYYFUQF-UHFFFAOYSA-N D00YNW DRUGSMIL CCCCCCN(C)CC(=O)C(CC(=O)O)NC(=O)C(CC)N1C=C(N=C(C1=O)NCC2=NON=C2C)C(C)(C)C D00YNW DRUGTYPE Small molecular drug D00YNW HIGHSTAT Investigative D00YNY DRUG__ID D00YNY D00YNY DRUGCLAS Investigative Drug(s) D00YNY DRUGCOMP University of Virginia D00YNY DRUGINCH 1S/C15H11ClN2OS/c16-11-3-1-10(2-4-11)14-9-20-15(18-14)17-12-5-7-13(19)8-6-12/h1-9,19H,(H,17,18) D00YNY DRUGINKE ZFGXZJKLOFCECI-UHFFFAOYSA-N D00YNY DRUGSMIL C1=CC(=CC=C1C2=CSC(=N2)NC3=CC=C(C=C3)O)Cl D00YNY DRUGTYPE Small molecular drug D00YNY HIGHSTAT Investigative D00YOM DRUG__ID D00YOM D00YOM DRUGCLAS Investigative Drug(s) D00YOM DRUGINCH 1S/C16H14N2O/c1-11-7-8-14-15(19)13(10-17-16(14)18-11)9-12-5-3-2-4-6-12/h2-8,10H,9H2,1H3,(H,17,18,19) D00YOM DRUGINKE QRUPNIJLOWMQBO-UHFFFAOYSA-N D00YOM DRUGSMIL CC1=NC2=C(C=C1)C(=O)C(=CN2)CC3=CC=CC=C3 D00YOM DRUGTYPE Small molecular drug D00YOM HIGHSTAT Investigative D00YOV DRUG__ID D00YOV D00YOV DRUGCLAS Clinical Trial Drug(s) D00YOV DRUGCOMP Micromet AG D00YOV DRUGTYPE Antibody D00YOV HIGHSTAT Phase 1 D00YOW DRUG__ID D00YOW D00YOW DRUGCLAS Discontinued Drug(s) D00YOW DRUGCOMP Laboratorios Menarini SA D00YOW DRUGINCH 1S/C30H24N2O4/c33-29(31-16-15-20-5-7-23(8-6-20)30(34)35)24-10-9-21-12-14-27(18-25(21)17-24)36-19-26-13-11-22-3-1-2-4-28(22)32-26/h1-14,17-18H,15-16,19H2,(H,31,33)(H,34,35) D00YOW DRUGINKE IXSRNSVQRMOPTQ-UHFFFAOYSA-N D00YOW DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)COC3=CC4=C(C=CC(=C4)C(=O)NCCC5=CC=C(C=C5)C(=O)O)C=C3 D00YOW HIGHSTAT Terminated D00YOY DRUG__ID D00YOY D00YOY COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D00YOY DRUGCLAS Patented Agent(s) D00YOY DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D00YOY DRUGTYPE Small molecular drug D00YOY HIGHSTAT Patented D00YPH DRUG__ID D00YPH D00YPH DRUGCLAS Investigative Drug(s) D00YPH DRUGINCH 1S/C16H11NO3/c18-15-13(16(19)20)11-8-4-5-9-12(11)17-14(15)10-6-2-1-3-7-10/h1-9,18H,(H,19,20) D00YPH DRUGINKE XAPRFLSJBSXESP-UHFFFAOYSA-N D00YPH DRUGSMIL C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2O)C(=O)O D00YPH DRUGTYPE Small molecular drug D00YPH HIGHSTAT Investigative D00YPO DRUG__ID D00YPO D00YPO DRUGCLAS Investigative Drug(s) D00YPO DRUGINCH 1S/C18H20N4O/c1-12-10-17(23)20-21-18(12)13-6-8-14(9-7-13)22-11-19-15-4-2-3-5-16(15)22/h6-9,11-12H,2-5,10H2,1H3,(H,20,23) D00YPO DRUGINKE KDEKNYKHIZTSLE-UHFFFAOYSA-N D00YPO DRUGSMIL CC1CC(=O)NN=C1C2=CC=C(C=C2)N3C=NC4=C3CCCC4 D00YPO DRUGTYPE Small molecular drug D00YPO HIGHSTAT Investigative D00YPR DRUG__ID D00YPR D00YPR DRUGCLAS Clinical Trial Drug(s) D00YPR DRUGCOMP OSI Pharmaceuticals D00YPR DRUGINCH 1S/C20H24BrF2N5O3S/c21-12-9-14(22)13(15(23)10-12)11-31-18-16(17(24)29)19(32-27-18)26-20(30)25-5-1-2-6-28-7-3-4-8-28/h9-10H,1-8,11H2,(H2,24,29)(H2,25,26,30) D00YPR DRUGINKE HXHAJRMTJXHJJZ-UHFFFAOYSA-N D00YPR DRUGSMIL C1CCN(C1)CCCCNC(=O)NC2=C(C(=NS2)OCC3=C(C=C(C=C3F)Br)F)C(=O)N D00YPR DRUGTYPE Small molecular drug D00YPR HIGHSTAT Phase 2 D00YPR THERCLAS Anticancer Agents D00YPW DRUG__ID D00YPW D00YPW DRUGCLAS Discontinued Drug(s) D00YPW DRUGINCH 1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19) D00YPW DRUGINKE REZGGXNDEMKIQB-UHFFFAOYSA-N D00YPW DRUGSMIL CCCOC1=CC=CC=C1C2=NC3=NNN=C3C(=O)N2 D00YPW DRUGTYPE Small molecular drug D00YPW HIGHSTAT Terminated D00YQI DRUG__ID D00YQI D00YQI DRUGCLAS Clinical Trial Drug(s) D00YQI DRUGTYPE Monoclonal antibody D00YQI HIGHSTAT Phase 3 D00YQZ DRUG__ID D00YQZ D00YQZ DRUGCLAS Discontinued Drug(s) D00YQZ DRUGCOMP Merck & Co Inc D00YQZ DRUGINCH 1S/C25H27N3O4S.ClH/c1-33(30,31)27-20-5-7-24-22(14-20)23(29)15-25(32-24)8-10-28(11-9-25)21-6-4-18-12-17(16-26)2-3-19(18)13-21;/h2-3,5,7,12,14,21,27H,4,6,8-11,13,15H2,1H3;1H/t21-;/m1./s1 D00YQZ DRUGINKE BASAUWFNEPUJDQ-ZMBIFBSDSA-N D00YQZ DRUGSMIL CS(=O)(=O)NC1=CC2=C(C=C1)OC3(CCN(CC3)C4CCC5=C(C4)C=CC(=C5)C#N)CC2=O.Cl D00YQZ DRUGTYPE Small molecular drug D00YQZ HIGHSTAT Terminated D00YRD DRUG__ID D00YRD D00YRD COMPCLAS Heteroaryl-azepine derivatives D00YRD DRUGCLAS Patented Agent(s) D00YRD DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D00YRD DRUGTYPE Small molecular drug D00YRD HIGHSTAT Patented D00YRF DRUG__ID D00YRF D00YRF DRUGCLAS Investigative Drug(s) D00YRF DRUGCOMP UCB SA D00YRF HIGHSTAT Investigative D00YRS DRUG__ID D00YRS D00YRS DRUGCLAS Patented Agent(s) D00YRS DRUGTYPE Small molecular drug D00YRS HIGHSTAT Patented D00YSJ DRUG__ID D00YSJ D00YSJ DRUGCLAS Discontinued Drug(s) D00YSJ DRUGCOMP CV Therapeutics D00YSJ DRUGINCH 1S/C14H19N5O5/c20-3-8-10(21)11(22)14(24-8)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-23-4-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t7-,8-,10-,11-,14-/m1/s1 D00YSJ DRUGINKE OESBDSFYJMDRJY-BAYCTPFLSA-N D00YSJ DRUGSMIL C1COCC1NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O D00YSJ DRUGTYPE Small molecular drug D00YSJ HIGHSTAT Discontinued in Phase 3 D00YTQ DRUG__ID D00YTQ D00YTQ DRUGCLAS Investigative Drug(s) D00YTQ DRUGINCH 1S/C14H17N5.ClH/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15;/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18);1H D00YTQ DRUGINKE MIDKPVLYXNLFGZ-UHFFFAOYSA-N D00YTQ DRUGSMIL CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN.Cl D00YTQ DRUGTYPE Small molecular drug D00YTQ HIGHSTAT Investigative D00YTS DRUG__ID D00YTS D00YTS DRUGCLAS Investigative Drug(s) D00YTS HIGHSTAT Investigative D00YTX DRUG__ID D00YTX D00YTX DRUGCLAS Investigative Drug(s) D00YTX DRUGCOMP Oryzon Genomics SA D00YTX HIGHSTAT Investigative D00YUB DRUG__ID D00YUB D00YUB DRUGCLAS Discontinued Drug(s) D00YUB DRUGCOMP Takeda Pharmaceutical Co Ltd D00YUB HIGHSTAT Discontinued in Phase 2 D00YUO DRUG__ID D00YUO D00YUO DRUGCLAS Investigative Drug(s) D00YUO DRUGINCH 1S/C8H9BINO3/c10-5-8(12)11-7-3-1-2-6(4-7)9(13)14/h1-4,13-14H,5H2,(H,11,12) D00YUO DRUGINKE LMHXPDZPXBIIEX-UHFFFAOYSA-N D00YUO DRUGSMIL B(C1=CC(=CC=C1)NC(=O)CI)(O)O D00YUO DRUGTYPE Small molecular drug D00YUO HIGHSTAT Investigative D00YUP DRUG__ID D00YUP D00YUP DRUGCLAS Clinical Trial Drug(s) D00YUP DRUGCOMP Lumosa Therapeutics Taipei, Taiwan D00YUP HIGHSTAT Phase 1 D00YUQ DRUG__ID D00YUQ D00YUQ DRUGCLAS Clinical Trial Drug(s) D00YUQ DRUGCOMP University of Pennsylvania D00YUQ DRUGTYPE CAR T Cell Therapy D00YUQ HIGHSTAT Phase 1 D00YUX DRUG__ID D00YUX D00YUX DRUGCLAS Investigative Drug(s) D00YUX DRUGINCH 1S/C65H95N19O22S4/c1-29(2)18-37-63(104)84-17-7-10-46(84)65(106)83-16-6-9-45(83)62(103)81-42-27-110-108-26-41(72-49(89)23-66)59(100)80-43(60(101)78-39(24-85)57(98)76-37)28-109-107-25-40(51(69)92)79-54(95)34(19-32-11-13-33(86)14-12-32)74-56(97)36(22-50(90)91)75-61(102)44-8-5-15-82(44)64(105)38(21-48(68)88)77-55(96)35(20-47(67)87)73-53(94)31(4)70-52(93)30(3)71-58(42)99/h11-14,29-31,34-46,85-86H,5-10,15-28,66H2,1-4H3,(H2,67,87)(H2,68,88)(H2,69,92)(H,70,93)(H,71,99)(H,72,89)(H,73,94)(H,74,97)(H,75,102)(H,76,98)(H,77,96)(H,78,101)(H,79,95)(H,80,100)(H,81,103)(H,90,91)/t30-,31-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-/m0/s1 D00YUX DRUGINKE VUVGEYBNLLGGBG-MVPSLEAZSA-N D00YUX DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(CSSCC3C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CSSCC(C(=O)N3)NC(=O)CN)C(=O)NC(C(=O)N1)C)CC(C)C)CO)C(=O)N)CC6=CC=C(C=C6)O)CC(=O)O)CC(=O)N)CC(=O)N D00YUX DRUGTYPE Small molecular drug D00YUX HIGHSTAT Investigative D00YVE DRUG__ID D00YVE D00YVE DRUGCLAS Investigative Drug(s) D00YVE DRUGINCH 1S/C13H15N/c1-10(14)8-11-6-7-12-4-2-3-5-13(12)9-11/h2-7,9-10H,8,14H2,1H3 D00YVE DRUGINKE UPQSZFKXKRKCGZ-UHFFFAOYSA-N D00YVE DRUGSMIL CC(CC1=CC2=CC=CC=C2C=C1)N D00YVE DRUGTYPE Small molecular drug D00YVE HIGHSTAT Investigative D00YVF DRUG__ID D00YVF D00YVF DRUADIID 800033171 D00YVF DRUGCLAS Approved Drug(s) D00YVF DRUGCOMP Eli Lilly D00YVF DRUGINCH 1S/C184H282N50O60S/c1-16-94(10)147(178(289)213-114(52-58-144(257)258)163(274)218-121(73-101-77-195-105-39-24-23-38-103(101)105)168(279)215-116(68-90(2)3)165(276)205-107(41-26-28-61-186)158(269)219-122(75-134(189)243)154(265)198-79-135(244)196-83-139(248)231-63-30-43-129(231)175(286)225-127(87-238)174(285)223-125(85-236)155(266)200-80-136(245)202-96(12)181(292)233-65-32-45-131(233)183(294)234-66-33-46-132(234)182(293)232-64-31-44-130(232)176(287)222-124(84-235)150(190)261)229-170(281)119(71-99-34-19-17-20-35-99)217-166(277)117(69-91(4)5)214-159(270)108(42-29-62-194-184(191)192)212-177(288)146(93(8)9)228-151(262)95(11)203-156(267)111(49-55-141(251)252)208-161(272)112(50-56-142(253)254)209-162(273)113(51-57-143(255)256)210-164(275)115(59-67-295-15)211-160(271)110(47-53-133(188)242)207-157(268)106(40-25-27-60-185)206-172(283)126(86-237)224-167(278)118(70-92(6)7)216-169(280)123(76-145(259)260)220-173(284)128(88-239)226-180(291)149(98(14)241)230-171(282)120(72-100-36-21-18-22-37-100)221-179(290)148(97(13)240)227-138(247)82-199-153(264)109(48-54-140(249)250)204-137(246)81-197-152(263)104(187)74-102-78-193-89-201-102/h17-24,34-39,77-78,89-98,104,106-132,146-149,195,235-241H,16,25-33,40-76,79-88,185-187H2,1-15H3,(H2,188,242)(H2,189,243)(H2,190,261)(H,193,201)(H,196,244)(H,197,263)(H,198,265)(H,199,264)(H,200,266)(H,202,245)(H,203,267)(H,204,246)(H,205,276)(H,206,283)(H,207,268)(H,208,272)(H,209,273)(H,210,275)(H,211,271)(H,212,288)(H,213,289)(H,214,270)(H,215,279)(H,216,280)(H,217,277)(H,218,274)(H,219,269)(H,220,284)(H,221,290)(H,222,287)(H,223,285)(H,224,278)(H,225,286)(H,226,291)(H,227,247)(H,228,262)(H,229,281)(H,230,282)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H4,191,192,194)/t94-,95-,96-,97+,98+,104-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,146-,147-,148-,149-/m0/s1 D00YVF DRUGINKE HTQBXNHDCUEHJF-XWLPCZSASA-N D00YVF DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N D00YVF DRUGTYPE Small molecular drug D00YVF HIGHSTAT Approved D00YVF THERCLAS Hypoglycemic Agents D00YVJ DRUG__ID D00YVJ D00YVJ DRUGCLAS Investigative Drug(s) D00YVJ DRUGINCH 1S/C25H36F2N4O8/c1-12(2)20(25(38)39)30-22(35)13(3)29-24(37)21(14(4)32)31-23(36)18(7-8-19(33)34)28-10-9-15-5-6-16(26)17(27)11-15/h5-6,11-14,18,20-21,28,32H,7-10H2,1-4H3,(H,29,37)(H,30,35)(H,31,36)(H,33,34)(H,38,39)/t13-,14?,18-,20-,21-/m0/s1 D00YVJ DRUGINKE VPSVLXPCERTAAH-WHJBMRRRSA-N D00YVJ DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCCC1=CC(=C(C=C1)F)F D00YVJ DRUGTYPE Small molecular drug D00YVJ HIGHSTAT Investigative D00YVL DRUG__ID D00YVL D00YVL DRUGCLAS Patented Agent(s) D00YVL DRUGCOMP the Shanghai Institute of Technology together with the East China University of Science and Technology D00YVL DRUGTYPE Small molecular drug D00YVL HIGHSTAT Patented D00YWH DRUG__ID D00YWH D00YWH DRUGCLAS Discontinued Drug(s) D00YWH DRUGCOMP Shikoku Chemicals Corp D00YWH HIGHSTAT Terminated D00YWL DRUG__ID D00YWL D00YWL DRUGCLAS Clinical Trial Drug(s) D00YWL DRUGCOMP Medarex Inc D00YWL DRUGTYPE Antibody D00YWL HIGHSTAT Phase 2 D00YWP DRUG__ID D00YWP D00YWP DRUADIID FDA-AP-BF04-00575 D00YWP DRUGCLAS Approved Drug(s) D00YWP DRUGCOMP Aspen Global Inc D00YWP DRUGINCH 1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1 D00YWP DRUGINKE NPAGDVCDWIYMMC-IZPLOLCNSA-N D00YWP DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34 D00YWP DRUGTYPE Small molecular drug D00YWP HIGHSTAT Approved D00YWP THERCLAS Anabolic Agents D00YWZ DRUG__ID D00YWZ D00YWZ DRUGCLAS Investigative Drug(s) D00YWZ DRUGINCH 1S/C13H11N3S/c14-9-3-1-8(2-4-9)10-7-17-11-5-6-16-13(15)12(10)11/h1-7H,14H2,(H2,15,16) D00YWZ DRUGINKE RSUCBZJSTXEGSF-UHFFFAOYSA-N D00YWZ DRUGSMIL C1=CC(=CC=C1C2=CSC3=C2C(=NC=C3)N)N D00YWZ DRUGTYPE Small molecular drug D00YWZ HIGHSTAT Investigative D00YXA DRUG__ID D00YXA D00YXA DRUGCLAS Patented Agent(s) D00YXA DRUGCOMP ABBVIE INC D00YXA DRUGINCH 1S/C22H21F2N3O/c1-13-10-18-15(12-25-13)7-9-20(24)21(18)27-22(28)26-16-8-6-14(11-16)17-4-2-3-5-19(17)23/h2-5,7,9-10,12,14,16H,6,8,11H2,1H3,(H2,26,27,28)/t14-,16+/m0/s1 D00YXA DRUGINKE PJVXUKARZNCIRA-GOEBONIOSA-N D00YXA DRUGSMIL CC1=CC2=C(C=CC(=C2NC(=O)NC3CCC(C3)C4=CC=CC=C4F)F)C=N1 D00YXA DRUGTYPE Small molecular drug D00YXA HIGHSTAT Patented D00YXE DRUG__ID D00YXE D00YXE DRUGCLAS Investigative Drug(s) D00YXE DRUGINCH 1S/C15H9ClN4/c16-9-5-6-12-13(7-9)20-15(19-12)14-8-17-10-3-1-2-4-11(10)18-14/h1-8H,(H,19,20) D00YXE DRUGINKE SOUPHJBGFDZRAD-UHFFFAOYSA-N D00YXE DRUGSMIL C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=C(C=C4)Cl D00YXE DRUGTYPE Small molecular drug D00YXE HIGHSTAT Investigative D00YXG DRUG__ID D00YXG D00YXG DRUGCLAS Clinical Trial Drug(s) D00YXG DRUGCOMP National Cancer Institute (NCI) D00YXG DRUGTYPE CAR T Cell Therapy D00YXG HIGHSTAT Phase 1/2 D00YXL DRUG__ID D00YXL D00YXL COMPCLAS 2-pyrazinone derivatives D00YXL DRUGCLAS Patented Agent(s) D00YXL DRUGTYPE Small molecular drug D00YXL HIGHSTAT Patented D00YXR DRUG__ID D00YXR D00YXR DRUGCLAS Investigative Drug(s) D00YXR DRUGCOMP WntResearch AB D00YXR DRUGINCH 1S/C26H42N6O12S2/c1-13(2)8-17(26(43)44)32-24(41)15(4-5-20(35)36)30-25(42)18(11-45)29-19(34)10-27-22(39)16(9-21(37)38)31-23(40)14(28-12-33)6-7-46-3/h12-18,45H,4-11H2,1-3H3,(H,27,39)(H,28,33)(H,29,34)(H,30,42)(H,31,40)(H,32,41)(H,35,36)(H,37,38)(H,43,44)/t14-,15-,16-,17-,18-/m0/s1 D00YXR DRUGINKE WFZPJYYCTSHDJI-ATIWLJMLSA-N D00YXR DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CS)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CCSC)NC=O D00YXR HIGHSTAT Investigative D00YXU DRUG__ID D00YXU D00YXU DRUGCLAS Clinical Trial Drug(s) D00YXU DRUGCOMP ChemoCentryx Inc D00YXU HIGHSTAT Phase 1 D00YYA DRUG__ID D00YYA D00YYA COMPCLAS Cyclopentane carboxamide derivatives D00YYA DRUGCLAS Patented Agent(s) D00YYA DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, Cangming D00YYA DRUGTYPE Small molecular drug D00YYA HIGHSTAT Patented D00YYO DRUG__ID D00YYO D00YYO DRUGCLAS Patented Agent(s) D00YYO DRUGINCH 1S/C27H21F3N6O3/c1-13-23(26(38)34-16-6-8-22-15(9-16)11-32-36-22)24(35-27(39)33-13)14-5-7-21(30)17(10-14)25(37)31-12-18-19(28)3-2-4-20(18)29/h2-11,24H,12H2,1H3,(H,31,37)(H,32,36)(H,34,38)(H2,33,35,39) D00YYO DRUGINKE YJQKIQOVJOGHMP-UHFFFAOYSA-N D00YYO DRUGSMIL CC1=C(C(NC(=O)N1)C2=CC(=C(C=C2)F)C(=O)NCC3=C(C=CC=C3F)F)C(=O)NC4=CC5=C(C=C4)NN=C5 D00YYO DRUGTYPE Small molecular drug D00YYO HIGHSTAT Patented D00YYQ DRUG__ID D00YYQ D00YYQ DRUGCLAS Investigative Drug(s) D00YYQ DRUGCOMP Isis Pharmaceuticals D00YYQ DRUGTYPE Antisense drug D00YYQ HIGHSTAT Investigative D00YZA DRUG__ID D00YZA D00YZA DRUGCLAS Approved Drug(s) D00YZA DRUGINCH 1S/C6H12N3PS/c11-10(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2 D00YZA DRUGINKE FOCVUCIESVLUNU-UHFFFAOYSA-N D00YZA DRUGSMIL C1CN1P(=S)(N2CC2)N3CC3 D00YZA DRUGTYPE Small molecular drug D00YZA HIGHSTAT Approved D00YZD DRUG__ID D00YZD D00YZD DRUGCLAS Approved Drug(s) D00YZD DRUGCOMP GlaxoSmithKline D00YZD DRUGINCH 1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1 D00YZD DRUGINKE RHWKPHLQXYSBKR-BMIGLBTASA-N D00YZD DRUGSMIL CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O D00YZD DRUGTYPE Small molecular drug D00YZD HIGHSTAT Approved D00YZP DRUG__ID D00YZP D00YZP DRUGCLAS Discontinued Drug(s) D00YZP DRUGCOMP Emergent Europe Ltd D00YZP HIGHSTAT Discontinued in Phase 1 D00ZAI DRUG__ID D00ZAI D00ZAI COMPCLAS Isoquinolinone derivatives D00ZAI DRUGCLAS Patented Agent(s) D00ZAI DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D00ZAI DRUGTYPE Small molecular drug D00ZAI HIGHSTAT Patented D00ZAJ DRUG__ID D00ZAJ D00ZAJ DRUGCLAS Investigative Drug(s) D00ZAJ DRUGINCH 1S/C13H12N4/c1-17-11-7-10(9-5-3-2-4-6-9)8-15-12(11)16-13(17)14/h2-8H,1H3,(H2,14,15,16) D00ZAJ DRUGINKE UQVKZNNCIHJZLS-UHFFFAOYSA-N D00ZAJ DRUGSMIL CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1N D00ZAJ DRUGTYPE Small molecular drug D00ZAJ HIGHSTAT Investigative D00ZBH DRUG__ID D00ZBH D00ZBH DRUGCLAS Investigative Drug(s) D00ZBH DRUGINCH 1S/C7H8FO3PS/c8-6-3-1-5(2-4-6)7(13)12(9,10)11/h1-4,7,13H,(H2,9,10,11) D00ZBH DRUGINKE SWPCIELITKHGKY-UHFFFAOYSA-N D00ZBH DRUGSMIL C1=CC(=CC=C1C(P(=O)(O)O)S)F D00ZBH DRUGTYPE Small molecular drug D00ZBH HIGHSTAT Investigative D00ZBL DRUG__ID D00ZBL D00ZBL DRUGCLAS Investigative Drug(s) D00ZBL DRUGINCH 1S/C16H13NO3/c1-2-3-11-8-13(19)9-14-15(11)20-16(17-14)10-4-6-12(18)7-5-10/h2,4-9,18-19H,1,3H2 D00ZBL DRUGINKE XQORYXRHJJULMI-UHFFFAOYSA-N D00ZBL DRUGSMIL C=CCC1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D00ZBL DRUGTYPE Small molecular drug D00ZBL HIGHSTAT Investigative D00ZBQ DRUG__ID D00ZBQ D00ZBQ DRUGCLAS Investigative Drug(s) D00ZBQ DRUGCOMP Taxolog Inc D00ZBQ HIGHSTAT Investigative D00ZBZ DRUG__ID D00ZBZ D00ZBZ DRUGCLAS Investigative Drug(s) D00ZBZ DRUGSMIL failed D00ZBZ DRUGTYPE Combination drug (Antisense drug) D00ZBZ HIGHSTAT Investigative D00ZBZ THERCLAS Antisense D00ZCD DRUG__ID D00ZCD D00ZCD COMPCLAS Piperazine urea derivatives D00ZCD DRUGCLAS Patented Agent(s) D00ZCD DRUGCOMP JANSEN PHARMACEUTICA NV HAWRYLUK, Natalie, A D00ZCD DRUGTYPE Small molecular drug D00ZCD HIGHSTAT Patented D00ZCN DRUG__ID D00ZCN D00ZCN DRUGCLAS Approved Drug(s) D00ZCN DRUGCOMP Merck & Co D00ZCN DRUGINCH 1S/C52H88N10O15/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75)/t28?,29?,30-,33-,34+,35+,36-,37+,38-,40+,41+,42+,43+,44+,45+,46+/m1/s1 D00ZCN DRUGINKE JYIKNQVWKBUSNH-OGZDCFRISA-N D00ZCN DRUGSMIL CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O D00ZCN DRUGTYPE Small molecular drug D00ZCN HIGHSTAT Approved D00ZCN THERCLAS Antifungal Agents D00ZCT DRUG__ID D00ZCT D00ZCT DRUGCLAS Approved Drug(s) D00ZCT DRUGCOMP Bristol-myers squibb D00ZCT DRUGINCH 1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38) D00ZCT DRUGINKE SWMDAPWAQQTBOG-UHFFFAOYSA-N D00ZCT DRUGSMIL CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC D00ZCT DRUGTYPE Small molecular drug D00ZCT HIGHSTAT Approved D00ZCU DRUG__ID D00ZCU D00ZCU DRUGCLAS Investigative Drug(s) D00ZCU DRUGINCH 1S/C16H18N2OS.ClH/c1-11(17)7-12-9-18-16-5-4-13(8-15(12)16)19-10-14-3-2-6-20-14;/h2-6,8-9,11,18H,7,10,17H2,1H3;1H D00ZCU DRUGINKE PYJBJMIBANAOFJ-UHFFFAOYSA-N D00ZCU DRUGSMIL CC(CC1=CNC2=C1C=C(C=C2)OCC3=CC=CS3)N.Cl D00ZCU DRUGTYPE Small molecular drug D00ZCU HIGHSTAT Investigative D00ZDO DRUG__ID D00ZDO D00ZDO DRUGCLAS Clinical Trial Drug(s) D00ZDO DRUGCOMP Selecta Biosciences Watertown, MA D00ZDO HIGHSTAT Phase 1 D00ZDX DRUG__ID D00ZDX D00ZDX DRUGCLAS Investigative Drug(s) D00ZDX DRUGINCH 1S/C22H28FNO4/c1-15-18(27-12-9-24-7-10-26-11-8-24)13-19-20(21(15)23)22(25)17(14-28-19)16-5-3-2-4-6-16/h13-14,16H,2-12H2,1H3 D00ZDX DRUGINKE PHQKNLJAPYWXQQ-UHFFFAOYSA-N D00ZDX DRUGSMIL CC1=C(C=C2C(=C1F)C(=O)C(=CO2)C3CCCCC3)OCCN4CCOCC4 D00ZDX DRUGTYPE Small molecular drug D00ZDX HIGHSTAT Investigative D00ZEG DRUG__ID D00ZEG D00ZEG DRUGCLAS Clinical Trial Drug(s) D00ZEG DRUGCOMP Solvay SA D00ZEG DRUGINCH 1S/C28H40N4O5/c1-5-6-14-31-24(33)22-26(35)32(27(36)23(25(31)34)28(22,2)3)15-10-9-13-29-16-18-30(19-17-29)20-11-7-8-12-21(20)37-4/h7-8,11-12,22-23H,5-6,9-10,13-19H2,1-4H3 D00ZEG DRUGINKE BXNRTMZZILHVNJ-UHFFFAOYSA-N D00ZEG DRUGSMIL CCCCN1C(=O)C2C(=O)N(C(=O)C(C1=O)C2(C)C)CCCCN3CCN(CC3)C4=CC=CC=C4OC D00ZEG DRUGTYPE Small molecular drug D00ZEG HIGHSTAT Phase 1 D00ZEN DRUG__ID D00ZEN D00ZEN DRUGCLAS Clinical Trial Drug(s) D00ZEN DRUGCOMP Sanofi Pasteur D00ZEN HIGHSTAT Phase 3 D00ZEY DRUG__ID D00ZEY D00ZEY DRUGCLAS Investigative Drug(s) D00ZEY DRUGINCH 1S/C21H23BrN2OS/c1-3-12-24(2)13-4-5-14-25-18-10-11-19-20(15-18)26-23-21(19)16-6-8-17(22)9-7-16/h3,6-11,15H,1,4-5,12-14H2,2H3 D00ZEY DRUGINKE PDHRIPJKNGUCJP-UHFFFAOYSA-N D00ZEY DRUGSMIL CN(CCCCOC1=CC2=C(C=C1)C(=NS2)C3=CC=C(C=C3)Br)CC=C D00ZEY DRUGTYPE Small molecular drug D00ZEY HIGHSTAT Investigative D00ZFC DRUG__ID D00ZFC D00ZFC DRUGCLAS Investigative Drug(s) D00ZFC DRUGCOMP Pharmagenesis Inc D00ZFC HIGHSTAT Investigative D00ZFP DRUG__ID D00ZFP D00ZFP DRUGCLAS Approved Drug(s) D00ZFP DRUGINCH 1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1 D00ZFP DRUGINKE DNXHEGUUPJUMQT-CBZIJGRNSA-N D00ZFP DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O D00ZFP DRUGTYPE Small molecular drug D00ZFP HIGHSTAT Approved D00ZFP THERCLAS Antimenopausal Agents D00ZFQ DRUG__ID D00ZFQ D00ZFQ DRUGCLAS Clinical Trial Drug(s) D00ZFQ DRUGCOMP National Institute of Allergy and Infectious Diseases D00ZFQ HIGHSTAT Phase 1 D00ZFY DRUG__ID D00ZFY D00ZFY COMPCLAS Carbamide derivatives D00ZFY DRUGCLAS Patented Agent(s) D00ZFY DRUGCOMP SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY ZHANG, Qingwen D00ZFY DRUGTYPE Small molecular drug D00ZFY HIGHSTAT Patented D00ZGA DRUG__ID D00ZGA D00ZGA DRUGCLAS Discontinued Drug(s) D00ZGA DRUGCOMP GlaxoSmithKline D00ZGA DRUGINCH 1S/C30H35F7N4O2/c1-18-13-24(31)5-6-26(18)27-17-25(40-11-9-39(10-12-40)20(3)42)7-8-41(27)28(43)38(4)19(2)21-14-22(29(32,33)34)16-23(15-21)30(35,36)37/h5-6,13-16,19,25,27H,7-12,17H2,1-4H3/t19-,25+,27-/m1/s1 D00ZGA DRUGINKE XGGTZCKQRWXCHW-WMTVXVAQSA-N D00ZGA DRUGSMIL CC1=C(C=CC(=C1)F)C2CC(CCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C(=O)C D00ZGA DRUGTYPE Small molecular drug D00ZGA HIGHSTAT Withdrawn from market D00ZGE DRUG__ID D00ZGE D00ZGE DRUGCLAS Discontinued Drug(s) D00ZGE DRUGCOMP Poniard Pharmaceuticals Inc D00ZGE HIGHSTAT Discontinued in Phase 2 D00ZGF DRUG__ID D00ZGF D00ZGF DRUGCLAS Clinical Trial Drug(s) D00ZGF DRUGCOMP Dong-A Pharmaceutical Co Ltd D00ZGF DRUGINCH 1S/C19H27ClN6O2/c1-28-18-12-17(21)16(20)11-15(18)19(27)22-13-14-3-8-25(9-4-14)6-2-7-26-10-5-23-24-26/h5,10-12,14H,2-4,6-9,13,21H2,1H3,(H,22,27) D00ZGF DRUGINKE AULLTYAISZREAX-UHFFFAOYSA-N D00ZGF DRUGSMIL COC1=CC(=C(C=C1C(=O)NCC2CCN(CC2)CCCN3C=CN=N3)Cl)N D00ZGF HIGHSTAT Phase 1 D00ZGG DRUG__ID D00ZGG D00ZGG DRUGCLAS Patented Agent(s) D00ZGG DRUGCOMP MERCK SHARP &amDOHME CORP. LIN, Linus, S. CHIODA, Marc, D. LIU, Ping NARGUND, Ravi, P D00ZGG DRUGTYPE Small molecular drug D00ZGG HIGHSTAT Patented D00ZGT DRUG__ID D00ZGT D00ZGT DRUGCLAS Clinical Trial Drug(s) D00ZGT DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D00ZGT HIGHSTAT Phase 3 D00ZGW DRUG__ID D00ZGW D00ZGW DRUGCLAS Investigative Drug(s) D00ZGW DRUGINCH 1S/C18H19ClN4O/c1-4-23-17-14(10-22-23)16(19)15(9-20-17)18(24)21-8-13-6-5-11(2)7-12(13)3/h5-7,9-10H,4,8H2,1-3H3,(H,21,24) D00ZGW DRUGINKE XLMANSLWCIMZAE-UHFFFAOYSA-N D00ZGW DRUGSMIL CCN1C2=NC=C(C(=C2C=N1)Cl)C(=O)NCC3=C(C=C(C=C3)C)C D00ZGW DRUGTYPE Small molecular drug D00ZGW HIGHSTAT Investigative D00ZHM DRUG__ID D00ZHM D00ZHM DRUGCLAS Clinical Trial Drug(s) D00ZHM DRUGCOMP Anterogen Co Ltd D00ZHM HIGHSTAT Phase 2 D00ZHR DRUG__ID D00ZHR D00ZHR DRUGCLAS Investigative Drug(s) D00ZHR DRUGCOMP AntiCancer Inc D00ZHR HIGHSTAT Investigative D00ZIK DRUG__ID D00ZIK D00ZIK DRUGCLAS Investigative Drug(s) D00ZIK DRUGINCH 1S/C22H19N7O/c1-13-6-3-4-9-16(13)29-17(27-15-8-5-7-14(2)18(15)22(29)30)10-28-12-26-19-20(23)24-11-25-21(19)28/h3-9,11-12H,10H2,1-2H3,(H2,23,24,25) D00ZIK DRUGINKE GNWHRHGTIBRNSM-UHFFFAOYSA-N D00ZIK DRUGSMIL CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C(N=CN=C54)N D00ZIK DRUGTYPE Small molecular drug D00ZIK HIGHSTAT Investigative D00ZJG DRUG__ID D00ZJG D00ZJG DRUGCLAS Investigative Drug(s) D00ZJG DRUGINCH 1S/C23H30FO5P/c1-14(2)20-9-15(3)10-21(17-5-6-22(24)16(4)11-17)19(20)7-8-30(28,29)13-18(25)12-23(26)27/h5-6,9-11,14,18,25H,7-8,12-13H2,1-4H3,(H,26,27)(H,28,29)/t18-/m0/s1 D00ZJG DRUGINKE IZGDXVLRMHXOJV-SFHVURJKSA-N D00ZJG DRUGSMIL CC1=CC(=C(C(=C1)C(C)C)CCP(=O)(CC(CC(=O)O)O)O)C2=CC(=C(C=C2)F)C D00ZJG DRUGTYPE Small molecular drug D00ZJG HIGHSTAT Investigative D00ZKC DRUG__ID D00ZKC D00ZKC DRUGCLAS Discontinued Drug(s) D00ZKC DRUGCOMP Triangle Pharmaceuticals Inc D00ZKC DRUGINCH 1S/C10H14N6O3/c1-5-3-16(10(18)13-9(5)11)8-2-6(14-15-12)7(4-17)19-8/h3,6-8,17H,2,4H2,1H3,(H2,11,13,18)/t6-,7+,8+/m0/s1 D00ZKC DRUGINKE GZSDAHQGNUAEBC-XLPZGREQSA-N D00ZKC DRUGSMIL CC1=CN(C(=O)N=C1N)C2CC(C(O2)CO)N=[N+]=[N-] D00ZKC DRUGTYPE Small molecular drug D00ZKC HIGHSTAT Discontinued in Phase 2 D00ZKW DRUG__ID D00ZKW D00ZKW DRUGCLAS Investigative Drug(s) D00ZKW DRUGINCH 1S/C8H17N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h7,9H,1-6H2,(H,11,12)(H2,13,14,15) D00ZKW DRUGINKE CUVGUPIVTLGRGI-UHFFFAOYSA-N D00ZKW DRUGSMIL C1CN(CC(N1)C(=O)O)CCCP(=O)(O)O D00ZKW DRUGTYPE Small molecular drug D00ZKW HIGHSTAT Investigative D00ZLC DRUG__ID D00ZLC D00ZLC DRUGCLAS Clinical Trial Drug(s) D00ZLC DRUGCOMP GenVec D00ZLC HIGHSTAT Phase 2 D00ZME DRUG__ID D00ZME D00ZME DRUGCLAS Investigative Drug(s) D00ZME DRUGINCH 1S/C18H16N2/c1-13(20-9-8-19-12-20)14-6-7-18-16(10-14)11-15-4-2-3-5-17(15)18/h2-10,12-13H,11H2,1H3 D00ZME DRUGINKE QOKBMECMKDLYIV-UHFFFAOYSA-N D00ZME DRUGSMIL CC(C1=CC2=C(C=C1)C3=CC=CC=C3C2)N4C=CN=C4 D00ZME DRUGTYPE Small molecular drug D00ZME HIGHSTAT Investigative D00ZMK DRUG__ID D00ZMK D00ZMK DRUGCLAS Investigative Drug(s) D00ZMK DRUGINCH 1S/C39H51N5O6S/c1-24-18-28(43(6)17-16-40-5)19-25(2)35(24)50-22-32(46)41-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(3,4)36(44)37(48)42-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,40,45,47H,16-17,20-23H2,1-6H3,(H,41,46)(H,42,48)/t30-,31+,33-,34-,36+/m0/s1 D00ZMK DRUGINKE LDLOTPBPEFKMMQ-SQKWSBCUSA-N D00ZMK DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)N(C)CCNC D00ZMK DRUGTYPE Small molecular drug D00ZMK HIGHSTAT Investigative D00ZMN DRUG__ID D00ZMN D00ZMN DRUGCLAS Investigative Drug(s) D00ZMN DRUGCOMP Central South University D00ZMN DRUGINCH 1S/C12H10FNO/c1-9-5-6-12(15)14(8-9)11-4-2-3-10(13)7-11/h2-8H,1H3 D00ZMN DRUGINKE JDZYVVUJIQYGRX-UHFFFAOYSA-N D00ZMN DRUGSMIL CC1=CN(C(=O)C=C1)C2=CC(=CC=C2)F D00ZMN DRUGTYPE Small molecular drug D00ZMN HIGHSTAT Investigative D00ZMS DRUG__ID D00ZMS D00ZMS DRUGCLAS Investigative Drug(s) D00ZMS DRUGINCH 1S/C6H17NO6P2/c1-3-5(2)7-4-6(14(8,9)10)15(11,12)13/h5-7H,3-4H2,1-2H3,(H2,8,9,10)(H2,11,12,13) D00ZMS DRUGINKE BDBDLQIJTHDVGZ-UHFFFAOYSA-N D00ZMS DRUGSMIL CCC(C)NCC(P(=O)(O)O)P(=O)(O)O D00ZMS DRUGTYPE Small molecular drug D00ZMS HIGHSTAT Investigative D00ZMU DRUG__ID D00ZMU D00ZMU DRUGCLAS Clinical Trial Drug(s) D00ZMU DRUGCOMP CDG Therapeutics Chicago, IL D00ZMU HIGHSTAT Phase 1 D00ZMY DRUG__ID D00ZMY D00ZMY DRUGCLAS Investigative Drug(s) D00ZMY DRUGINCH 1S/C20H22O2/c21-20(14-16-8-3-1-4-9-16)22-19-13-7-12-18(15-19)17-10-5-2-6-11-17/h2,5-7,10-13,15-16H,1,3-4,8-9,14H2 D00ZMY DRUGINKE VBMZBWIWRKLCHP-UHFFFAOYSA-N D00ZMY DRUGSMIL C1CCC(CC1)CC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D00ZMY DRUGTYPE Small molecular drug D00ZMY HIGHSTAT Investigative D00ZNP DRUG__ID D00ZNP D00ZNP DRUGCLAS Discontinued Drug(s) D00ZNP HIGHSTAT Discontinued in Phase 2 D00ZNS DRUG__ID D00ZNS D00ZNS DRUGCLAS Discontinued Drug(s) D00ZNS DRUGCOMP Devgen NV D00ZNS HIGHSTAT Terminated D00ZOF DRUG__ID D00ZOF D00ZOF DRUGCLAS Approved Drug(s) D00ZOF DRUGINCH 1S/C3H6O3.Na/c1-2(4)3(5)6;/h2,4H,1H3,(H,5,6);/q;+1/p-1 D00ZOF DRUGINKE NGSFWBMYFKHRBD-UHFFFAOYSA-M D00ZOF DRUGSMIL CC(C(=O)[O-])O.[Na+] D00ZOF DRUGTYPE Small molecular drug D00ZOF HIGHSTAT Approved D00ZPJ DRUG__ID D00ZPJ D00ZPJ DRUGCLAS Investigative Drug(s) D00ZPJ DRUGINCH 1S/C19H14ClN3O/c1-24-14-5-7-17-16(10-14)19(22-13-3-2-8-21-11-13)15-6-4-12(20)9-18(15)23-17/h2-11H,1H3,(H,22,23) D00ZPJ DRUGINKE LUUDYHCKONVRQY-UHFFFAOYSA-N D00ZPJ DRUGSMIL COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CN=CC=C4 D00ZPJ DRUGTYPE Small molecular drug D00ZPJ HIGHSTAT Investigative D00ZPR DRUG__ID D00ZPR D00ZPR DRUGCLAS Clinical Trial Drug(s) D00ZPR DRUGCOMP Zensun (Shanghai) Sci-Tech Co Ltd D00ZPR HIGHSTAT Phase 3 D00ZPT DRUG__ID D00ZPT D00ZPT DRUGCLAS Clinical Trial Drug(s) D00ZPT DRUGCOMP Boehringer Ingelheim Corp D00ZPT DRUGINCH 1S/C22H23ClN4O4.Na/c1-13-9-14(3-6-19(13)27-7-8-31-12-20(27)28)22(29)26-18(11-30-2)21-24-16-5-4-15(23)10-17(16)25-21;/h3-6,9-10,18H,7-8,11-12H2,1-2H3,(H2,24,25,26,29);/q;+1/p-1/t18-;/m0./s1 D00ZPT DRUGINKE OJSUHLVJVGHFKW-FERBBOLQSA-M D00ZPT DRUGSMIL CC1=C(C=CC(=C1)C(=O)[N-]C(COC)C2=NC3=C(N2)C=C(C=C3)Cl)N4CCOCC4=O.[Na+] D00ZPT HIGHSTAT Phase 1 D00ZRO DRUG__ID D00ZRO D00ZRO COMPCLAS Macrocycle derivatives D00ZRO DRUGCLAS Patented Agent(s) D00ZRO DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D00ZRO DRUGTYPE Small molecule immunotherapy D00ZRO HIGHSTAT Patented D00ZRS DRUG__ID D00ZRS D00ZRS DRUGCLAS Clinical Trial Drug(s) D00ZRS DRUGCOMP National Cancer Institute D00ZRS HIGHSTAT Phase 1 D00ZSD DRUG__ID D00ZSD D00ZSD DRUGCLAS Investigative Drug(s) D00ZSD DRUGINCH 1S/C12H17NO3S/c14-12(13-15)9-5-2-6-10-17(16)11-7-3-1-4-8-11/h1,3-4,7-8,15H,2,5-6,9-10H2,(H,13,14) D00ZSD DRUGINKE LIZWRHXVIWNMIS-UHFFFAOYSA-N D00ZSD DRUGSMIL C1=CC=C(C=C1)S(=O)CCCCCC(=O)NO D00ZSD DRUGTYPE Small molecular drug D00ZSD HIGHSTAT Investigative D00ZSF DRUG__ID D00ZSF D00ZSF DRUGCLAS Investigative Drug(s) D00ZSF DRUGCOMP Abeille Pharmaceuticals Inc D00ZSF HIGHSTAT Investigative D00ZTD DRUG__ID D00ZTD D00ZTD DRUGCLAS Approved Drug(s) D00ZTD DRUGINCH 1S/C22H36N2O4/c1-20(2,23)13-24-19(25)12-14-3-5-21(6-4-14)26-22(28-27-21)17-8-15-7-16(10-17)11-18(22)9-15/h14-18H,3-13,23H2,1-2H3,(H,24,25) D00ZTD DRUGINKE VXYZBLXGCYNIHP-UHFFFAOYSA-N D00ZTD DRUGSMIL CC(C)(CNC(=O)CC1CCC2(CC1)OC3(C4CC5CC(C4)CC3C5)OO2)N D00ZTD DRUGTYPE Small molecular drug D00ZTD HIGHSTAT Approved D00ZUQ DRUG__ID D00ZUQ D00ZUQ DRUGCLAS Investigative Drug(s) D00ZUQ DRUGINCH 1S/C11H15NO4S/c1-2-16-11(13)8-5-9-3-6-10(7-4-9)17(12,14)15/h3-4,6-7H,2,5,8H2,1H3,(H2,12,14,15) D00ZUQ DRUGINKE OJBJALUJMRMNIR-UHFFFAOYSA-N D00ZUQ DRUGSMIL CCOC(=O)CCC1=CC=C(C=C1)S(=O)(=O)N D00ZUQ DRUGTYPE Small molecular drug D00ZUQ HIGHSTAT Investigative D00ZUU DRUG__ID D00ZUU D00ZUU DRUGCLAS Discontinued Drug(s) D00ZUU DRUGCOMP Ono Pharmaceutical Co Ltd D00ZUU DRUGINCH 1S/C21H34N4O4S/c1-14-13-30-21(25(14)2)24-23-20(28)18(26)17(15-9-11-29-12-10-15)22-19(27)16-7-5-3-4-6-8-16/h14-17H,3-13H2,1-2H3,(H,22,27)(H,23,28)/b24-21-/t14-,17+/m1/s1 D00ZUU DRUGINKE BTZCSXIUAFVRTE-CHGLIHOBSA-N D00ZUU DRUGSMIL CC1CSC(=NNC(=O)C(=O)C(C2CCOCC2)NC(=O)C3CCCCCC3)N1C D00ZUU HIGHSTAT Discontinued in Phase 2 D00ZVM DRUG__ID D00ZVM D00ZVM DRUGCLAS Clinical Trial Drug(s) D00ZVM DRUGCOMP Bayer healthcare pharmaceuticals D00ZVM HIGHSTAT Phase 1 D00ZVS DRUG__ID D00ZVS D00ZVS DRUGCLAS Clinical Trial Drug(s) D00ZVS DRUGCOMP SEIKAGAKU CORPORATION D00ZVS HIGHSTAT Phase 3 D00ZVY DRUG__ID D00ZVY D00ZVY COMPCLAS Pyrazolopyridine derivatives D00ZVY DRUGCLAS Patented Agent(s) D00ZVY DRUGCOMP LIGAND PHARMACEUTICALS INCORPORATED COLE, Andrew, G. JAMES, Ray, A. SHAO, Yuefei LETOURNEAU, Jeffrey, J. QUINTERO, Jorge, G. RIVIELLO, Christopher, Mark ZHI, Lin D00ZVY HIGHSTAT Patented D00ZWA DRUG__ID D00ZWA D00ZWA DRUGCLAS Investigative Drug(s) D00ZWA DRUGINCH 1S/C19H36O11P2/c1-15(2)7-5-8-16(3)10-12-29-32(26,27)30-31(24,25)28-11-6-9-17(20)13-19(4,23)14-18(21)22/h7,10,17,20,23H,5-6,8-9,11-14H2,1-4H3,(H,21,22)(H,24,25)(H,26,27)/b16-10+ D00ZWA DRUGINKE FPMYZHYONYFBNX-MHWRWJLKSA-N D00ZWA DRUGSMIL CC(=CCCC(=CCOP(=O)(O)OP(=O)(O)OCCCC(CC(C)(CC(=O)O)O)O)C)C D00ZWA DRUGTYPE Small molecular drug D00ZWA HIGHSTAT Investigative D00ZWE DRUG__ID D00ZWE D00ZWE DRUGCLAS Investigative Drug(s) D00ZWE DRUGCOMP Affitech A/S D00ZWE HIGHSTAT Investigative D00ZWG DRUG__ID D00ZWG D00ZWG DRUGCLAS Discontinued Drug(s) D00ZWG DRUGCOMP NeuroSearch A/S D00ZWG DRUGINCH 1S/C15H11ClF3N3/c16-11-4-1-9(2-5-11)8-22-13-6-3-10(15(17,18)19)7-12(13)21-14(22)20/h1-7H,8H2,(H2,20,21) D00ZWG DRUGINKE GXQCVUZORDAARJ-UHFFFAOYSA-N D00ZWG DRUGSMIL C1=CC(=CC=C1CN2C3=C(C=C(C=C3)C(F)(F)F)N=C2N)Cl D00ZWG DRUGTYPE Small molecular drug D00ZWG HIGHSTAT Terminated D00ZWU DRUG__ID D00ZWU D00ZWU DRUGCLAS Investigative Drug(s) D00ZWU DRUGINCH 1S/C20H20N2O/c1-2-3-6-15-9-11-16(12-10-15)20(23)22-18-13-17-7-4-5-8-19(17)21-14-18/h4-5,7-14H,2-3,6H2,1H3,(H,22,23) D00ZWU DRUGINKE LEGBMUNFZPMJOG-UHFFFAOYSA-N D00ZWU DRUGSMIL CCCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D00ZWU DRUGTYPE Small molecular drug D00ZWU HIGHSTAT Investigative D00ZXR DRUG__ID D00ZXR D00ZXR COMPCLAS Heteroaryl-carboxamide derivatives D00ZXR DRUGCLAS Patented Agent(s) D00ZXR DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D00ZXR HIGHSTAT Patented D00ZXX DRUG__ID D00ZXX D00ZXX DRUGCLAS Investigative Drug(s) D00ZXX DRUGINCH 1S/C23H27N3O4/c1-3-28-20-11-8-15(14-21(20)29-4-2)23-25-22(26-30-23)18-7-5-6-17-16(18)9-10-19(17)24-12-13-27/h5-8,11,14,19,24,27H,3-4,9-10,12-13H2,1-2H3 D00ZXX DRUGINKE NUIKTBLZSPQGCP-UHFFFAOYSA-N D00ZXX DRUGSMIL CCOC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCC(C4=CC=C3)NCCO)OCC D00ZXX DRUGTYPE Small molecular drug D00ZXX HIGHSTAT Investigative D00ZYK DRUG__ID D00ZYK D00ZYK DRUGCLAS Investigative Drug(s) D00ZYK DRUGINCH 1S/C11H11NO2/c13-11(14)6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6H2,(H,13,14) D00ZYK DRUGINKE GOLXRNDWAUTYKT-UHFFFAOYSA-N D00ZYK DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCC(=O)O D00ZYK DRUGTYPE Small molecular drug D00ZYK HIGHSTAT Investigative D00ZZB DRUG__ID D00ZZB D00ZZB DRUGCLAS Investigative Drug(s) D00ZZB DRUGCOMP Anacor Pharmaceuticals Inc D00ZZB HIGHSTAT Investigative D00ZZH DRUG__ID D00ZZH D00ZZH DRUGCLAS Discontinued Drug(s) D00ZZH DRUGINCH 1S/C15H14ClN7O5S2.Na/c1-22-15(18-20-21-22)30-5-6-4-29-13-10(12(25)23(13)11(6)14(26)27)17-9(24)3-7-2-8(16)19-28-7;/h2,10,13H,3-5H2,1H3,(H,17,24)(H,26,27);/q;+1/p-1/t10-,13-;/m1./s1 D00ZZH DRUGINKE XQPMNRFOIDADDS-HTMVYDOJSA-M D00ZZH DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CC(=NO4)Cl)SC2)C(=O)[O-].[Na+] D00ZZH DRUGTYPE Small molecular drug D00ZZH HIGHSTAT Terminated D00ZZJ DRUG__ID D00ZZJ D00ZZJ DRUGCLAS Patented Agent(s) D00ZZJ DRUGCOMP RANBAXY LABORATORIES LIMITED KHERA, Manoj Kumar PALLE, Venkata P. SATTIGERI, Viswajanani SATTIGERI, Jitendra SONI, Ajay RAUF, Abdul Rehman Abdul SIVAKUMAR, R. REDDY, Ranadheer R. MUSIB, Arpita CLIFFE, Ian A. BHATNAGAR, Pradip Kumar RAY, Abhijit SRIVASTAVA, Punit DASTIDAR, Sunanda Ghosh D00ZZJ DRUGTYPE Small molecular drug D00ZZJ HIGHSTAT Patented D01AAD DRUG__ID D01AAD D01AAD DRUGCLAS Investigative Drug(s) D01AAD DRUGINCH 1S/C22H12N2O4/c25-20-12-3-1-2-4-13(12)21(26)18-14(20)6-7-15-19(18)24-22(23-15)11-5-8-16-17(9-11)28-10-27-16/h1-9H,10H2,(H,23,24) D01AAD DRUGINKE FHLORIZAZVWSPG-UHFFFAOYSA-N D01AAD DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=NC4=C(N3)C=CC5=C4C(=O)C6=CC=CC=C6C5=O D01AAD DRUGTYPE Small molecular drug D01AAD HIGHSTAT Investigative D01AAH DRUG__ID D01AAH D01AAH DRUGCLAS Clinical Trial Drug(s) D01AAH DRUGCOMP The First Affiliated Hospital of Soochow University D01AAH DRUGTYPE CAR T Cell Therapy D01AAH HIGHSTAT Phase 2 D01AAI DRUG__ID D01AAI D01AAI DRUGCLAS Investigative Drug(s) D01AAI DRUGINCH 1S/C21H17N5O2/c1-28-18-11-5-4-10-17(18)24-21(27)26-20-15-8-2-3-9-16(15)23-19(25-20)14-7-6-12-22-13-14/h2-13H,1H3,(H2,23,24,25,26,27) D01AAI DRUGINKE YRAFEJSZTVWUMD-UHFFFAOYSA-N D01AAI DRUGSMIL COC1=CC=CC=C1NC(=O)NC2=NC(=NC3=CC=CC=C32)C4=CN=CC=C4 D01AAI DRUGTYPE Small molecular drug D01AAI HIGHSTAT Investigative D01ABR DRUG__ID D01ABR D01ABR DRUGCLAS Investigative Drug(s) D01ABR DRUGINCH 1S/C21H28N2O/c1-2-16-24-21-11-7-6-10-19(21)17-20(18-8-4-3-5-9-18)23-14-12-22-13-15-23/h3-11,20,22H,2,12-17H2,1H3 D01ABR DRUGINKE PSIGDYKJTYBHDY-UHFFFAOYSA-N D01ABR DRUGSMIL CCCOC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3 D01ABR DRUGTYPE Small molecular drug D01ABR HIGHSTAT Investigative D01ABX DRUG__ID D01ABX D01ABX DRUGCLAS Clinical Trial Drug(s) D01ABX DRUGCOMP Pfizer Inc D01ABX DRUGINCH 1S/C23H32FN3O4/c1-22(2)18-4-3-17(24)13-19(18)27(20(22)28)21(29)25-14-16-5-9-26(10-6-16)15-23(30)7-11-31-12-8-23/h3-4,13,16,30H,5-12,14-15H2,1-2H3,(H,25,29) D01ABX DRUGINKE AGMOFKKOVMRGAK-UHFFFAOYSA-N D01ABX DRUGSMIL CC1(C2=C(C=C(C=C2)F)N(C1=O)C(=O)NCC3CCN(CC3)CC4(CCOCC4)O)C D01ABX DRUGTYPE Small molecular drug D01ABX HIGHSTAT Phase 1 D01ACE DRUG__ID D01ACE D01ACE DRUGCLAS Investigative Drug(s) D01ACE DRUGCOMP Biofrontera Bioscience GmbH D01ACE HIGHSTAT Investigative D01ACT DRUG__ID D01ACT D01ACT DRUGCLAS Investigative Drug(s) D01ACT DRUGINCH 1S/C10H13NO5S/c1-2-7-15-10(12)8-3-5-9(6-4-8)16-17(11,13)14/h3-6H,2,7H2,1H3,(H2,11,13,14) D01ACT DRUGINKE LUBKCXRNDIXVCG-UHFFFAOYSA-N D01ACT DRUGSMIL CCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D01ACT DRUGTYPE Small molecular drug D01ACT HIGHSTAT Investigative D01ADA DRUG__ID D01ADA D01ADA DRUGCLAS Investigative Drug(s) D01ADA DRUGINCH 1S/C20H23NO2/c1-3-7-21-8-6-14-9-12(2)10-15-18(14)16(21)11-13-4-5-17(22)20(23)19(13)15/h4-5,9-10,16,22-23H,3,6-8,11H2,1-2H3/t16-/m1/s1 D01ADA DRUGINKE IQXHLUBOFQZZLM-MRXNPFEDSA-N D01ADA DRUGSMIL CCCN1CCC2=C3C1CC4=C(C3=CC(=C2)C)C(=C(C=C4)O)O D01ADA DRUGTYPE Small molecular drug D01ADA HIGHSTAT Investigative D01ADE DRUG__ID D01ADE D01ADE DRUGCLAS Patented Agent(s) D01ADE DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D01ADE DRUGTYPE Small molecular drug D01ADE HIGHSTAT Patented D01ADH DRUG__ID D01ADH D01ADH DRUGCLAS Clinical Trial Drug(s) D01ADH DRUGCOMP AdeTherapeutics Inc D01ADH HIGHSTAT Phase 2 D01ADK DRUG__ID D01ADK D01ADK DRUGCLAS Investigative Drug(s) D01ADK DRUGINCH 1S/C47H59N9O10/c1-3-4-15-38(45(64)54-36(25-41(59)60)43(62)53-35(42(49)61)23-28-11-6-5-7-12-28)55(2)47(66)37(24-30-26-50-34-14-9-8-13-32(30)34)52-40(58)27-51-44(63)39-16-10-21-56(39)46(65)33(48)22-29-17-19-31(57)20-18-29/h5-9,11-14,17-20,26,33,35-39,50,57H,3-4,10,15-16,21-25,27,48H2,1-2H3,(H2,49,61)(H,51,63)(H,52,58)(H,53,62)(H,54,64)(H,59,60)/t33-,35-,36-,37-,38-,39+/m0/s1 D01ADK DRUGINKE XMLJSDGQSNTHPG-TVUSJDTQSA-N D01ADK DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N D01ADK DRUGTYPE Small molecular drug D01ADK HIGHSTAT Investigative D01ADL DRUG__ID D01ADL D01ADL DRUGCLAS Clinical Trial Drug(s) D01ADL DRUGCOMP LFB Biotechnologies D01ADL DRUGTYPE Antibody D01ADL HIGHSTAT Phase 2/3 D01AEF DRUG__ID D01AEF D01AEF DRUGCLAS Clinical Trial Drug(s) D01AEF DRUGCOMP Memorial Sloan-Kettering Cancer Center D01AEF DRUGINCH 1S/C15H14N2O4/c1-4-9-7-5-10(20-2)11(21-3)6-8(7)12-13(16-9)15(19)17-14(12)18/h5-6H,4H2,1-3H3,(H,17,18,19) D01AEF DRUGINKE ULVWJFBHQIXEPE-UHFFFAOYSA-N D01AEF DRUGSMIL CCC1=NC2=C(C3=CC(=C(C=C31)OC)OC)C(=O)NC2=O D01AEF HIGHSTAT Phase 2 D01AET DRUG__ID D01AET D01AET DRUGCLAS Clinical Trial Drug(s) D01AET DRUGCOMP Mesoblast New York, NY D01AET HIGHSTAT Phase 3 D01AFG DRUG__ID D01AFG D01AFG DRUGCLAS Discontinued Drug(s) D01AFG DRUGCOMP Genentech D01AFG HIGHSTAT Discontinued in Phase 2 D01AFH DRUG__ID D01AFH D01AFH DRUGCLAS Investigative Drug(s) D01AFH DRUGINCH 1S/C14H11NO6/c16-12-7-9(6-11(14(12)18)15(19)20)13(17)8-21-10-4-2-1-3-5-10/h1-7,16,18H,8H2 D01AFH DRUGINKE JFIYNCBDNTXFDN-UHFFFAOYSA-N D01AFH DRUGSMIL C1=CC=C(C=C1)OCC(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-] D01AFH DRUGTYPE Small molecular drug D01AFH HIGHSTAT Investigative D01AFN DRUG__ID D01AFN D01AFN DRUGCLAS Patented Agent(s) D01AFN DRUGCOMP HUA MEDICINE (SHANGHAI) LTD D01AFN DRUGINCH 1S/C18H17FN2O2S/c1-24(22,23)17-7-4-6-16(13-17)21-12-10-18(19,14-21)9-8-15-5-2-3-11-20-15/h2-7,11,13H,10,12,14H2,1H3 D01AFN DRUGINKE FBIPFOUWZKBKQR-UHFFFAOYSA-N D01AFN DRUGSMIL CS(=O)(=O)C1=CC=CC(=C1)N2CCC(C2)(C#CC3=CC=CC=N3)F D01AFN DRUGTYPE Small molecular drug D01AFN HIGHSTAT Patented D01AFV DRUG__ID D01AFV D01AFV DRUGCLAS Investigative Drug(s) D01AFV DRUGINCH 1S/C14H17BrO3/c15-11-6-7-13(18-9-14(16)17)12(8-11)10-4-2-1-3-5-10/h6-8,10H,1-5,9H2,(H,16,17) D01AFV DRUGINKE ZWQTTYNQLIMKNE-UHFFFAOYSA-N D01AFV DRUGSMIL C1CCC(CC1)C2=C(C=CC(=C2)Br)OCC(=O)O D01AFV DRUGTYPE Small molecular drug D01AFV HIGHSTAT Investigative D01AGR DRUG__ID D01AGR D01AGR DRUGCLAS Investigative Drug(s) D01AGR DRUGINCH 1S/C15H15ClN2O2/c16-12-3-1-11(2-4-12)13-5-6-14(20-13)15(19)18-9-7-17-8-10-18/h1-6,17H,7-10H2 D01AGR DRUGINKE FSVUGYFGMKVKHY-UHFFFAOYSA-N D01AGR DRUGSMIL C1CN(CCN1)C(=O)C2=CC=C(O2)C3=CC=C(C=C3)Cl D01AGR DRUGTYPE Small molecular drug D01AGR HIGHSTAT Investigative D01AHI DRUG__ID D01AHI D01AHI DRUGCLAS Clinical Trial Drug(s) D01AHI DRUGCOMP Dance BiopharmaBrisbane, CA D01AHI HIGHSTAT Phase 2 D01AHL DRUG__ID D01AHL D01AHL DRUGCLAS Investigative Drug(s) D01AHL DRUGINCH 1S/C13H12O2/c14-10-3-4-12-9(6-10)5-8-1-2-11(15)7-13(8)12/h3-4,6-8,14H,1-2,5H2 D01AHL DRUGINKE TVWXDDLDMKKZJT-UHFFFAOYSA-N D01AHL DRUGSMIL C1CC(=O)C=C2C1CC3=C2C=CC(=C3)O D01AHL DRUGTYPE Small molecular drug D01AHL HIGHSTAT Investigative D01AHO DRUG__ID D01AHO D01AHO DRUGCLAS Approved Drug(s) D01AHO DRUGCOMP Speciality European Pharma D01AHO DRUGINCH 1S/C72H95ClN14O14/c1-41(2)32-54(64(93)80-53(17-10-11-30-77-42(3)4)72(101)87-31-13-18-60(87)69(98)78-43(5)63(75)92)81-68(97)58(38-62(74)91)84-70(99)61(37-46-22-27-52(90)28-23-46)86(7)71(100)59(40-88)85-67(96)57(36-48-14-12-29-76-39-48)83-66(95)56(34-45-20-25-51(73)26-21-45)82-65(94)55(79-44(6)89)35-47-19-24-49-15-8-9-16-50(49)33-47/h8-9,12,14-16,19-29,33,39,41-43,53-61,77,88,90H,10-11,13,17-18,30-32,34-38,40H2,1-7H3,(H2,74,91)(H2,75,92)(H,78,98)(H,79,89)(H,80,93)(H,81,97)(H,82,94)(H,83,95)(H,84,99)(H,85,96)/t43-,53+,54+,55-,56-,57-,58-,59+,60+,61+/m1/s1 D01AHO DRUGINKE AIWRTTMUVOZGPW-HSPKUQOVSA-N D01AHO DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C D01AHO DRUGTYPE Small molecular drug D01AHO HIGHSTAT Approved D01AHO THERCLAS Anticancer Agents D01AIM DRUG__ID D01AIM D01AIM DRUGCLAS Clinical Trial Drug(s) D01AIM DRUGCOMP Shanghai Medical University D01AIM HIGHSTAT Phase 3 D01AIN DRUG__ID D01AIN D01AIN DRUGCLAS Clinical Trial Drug(s) D01AIN DRUGCOMP Wyeth; pfizer D01AIN DRUGTYPE Antibody D01AIN HIGHSTAT Phase 2 D01AJM DRUG__ID D01AJM D01AJM DRUGCLAS Discontinued Drug(s) D01AJM DRUGCOMP Rosanto Pharmaceuticals Ltd D01AJM HIGHSTAT Terminated D01AJO DRUG__ID D01AJO D01AJO COMPCLAS Imidazo bicyclic iminium derivatives D01AJO DRUGCLAS Patented Agent(s) D01AJO DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D01AJO DRUGTYPE Small molecular drug D01AJO HIGHSTAT Patented D01AJQ DRUG__ID D01AJQ D01AJQ DRUGCLAS Investigative Drug(s) D01AJQ DRUGINCH 1S/C22H24N2O6/c25-21(23-11-15-7-3-1-4-8-15)29-17-13-27-20-18(14-28-19(17)20)30-22(26)24-12-16-9-5-2-6-10-16/h1-10,17-20H,11-14H2,(H,23,25)(H,24,26)/t17-,18+,19-,20-/m1/s1 D01AJQ DRUGINKE PERBLOUPRPLYHU-IYWMVGAKSA-N D01AJQ DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)NCC3=CC=CC=C3)OC(=O)NCC4=CC=CC=C4 D01AJQ DRUGTYPE Small molecular drug D01AJQ HIGHSTAT Investigative D01AJY DRUG__ID D01AJY D01AJY DRUGCLAS Approved Drug(s) D01AJY DRUGCOMP Norvatis Phamaceuticals Corporation D01AJY DRUGINCH 1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14) D01AJY DRUGINKE KPYSYYIEGFHWSV-UHFFFAOYSA-N D01AJY DRUGSMIL C1=CC(=CC=C1C(CC(=O)O)CN)Cl D01AJY DRUGTYPE Small molecular drug D01AJY HIGHSTAT Approved D01AJY THERCLAS Muscle Relaxants D01AJZ DRUG__ID D01AJZ D01AJZ DRUGCLAS Investigative Drug(s) D01AJZ DRUGINCH 1S/C15H10N4/c16-9-12-4-3-5-13(8-12)19-10-15(18-11-19)14-6-1-2-7-17-14/h1-8,10-11H D01AJZ DRUGINKE WFXSTBNPVNZJHP-UHFFFAOYSA-N D01AJZ DRUGSMIL C1=CC=NC(=C1)C2=CN(C=N2)C3=CC=CC(=C3)C#N D01AJZ DRUGTYPE Small molecular drug D01AJZ HIGHSTAT Investigative D01AKK DRUG__ID D01AKK D01AKK DRUGCLAS Clinical Trial Drug(s) D01AKK DRUGCOMP Alexion pharmaceuticals D01AKK HIGHSTAT Phase 2/3 D01AKU DRUG__ID D01AKU D01AKU DRUGCLAS Clinical Trial Drug(s) D01AKU DRUGCOMP Mt Cook Pharma D01AKU HIGHSTAT Phase 1 D01ALJ DRUG__ID D01ALJ D01ALJ DRUGCLAS Investigative Drug(s) D01ALJ DRUGCOMP BioVersys GmbH D01ALJ HIGHSTAT Investigative D01ALP DRUG__ID D01ALP D01ALP DRUGCLAS Investigative Drug(s) D01ALP DRUGCOMP MBC Pharma Inc D01ALP HIGHSTAT Investigative D01ALS DRUG__ID D01ALS D01ALS DRUGCLAS Investigative Drug(s) D01ALS DRUGINCH 1S/C10H7NS2/c1-8-11-9(7-13-8)4-5-10-3-2-6-12-10/h2-3,6-7H,1H3 D01ALS DRUGINKE SSSIEHWNKPXIHQ-UHFFFAOYSA-N D01ALS DRUGSMIL CC1=NC(=CS1)C#CC2=CC=CS2 D01ALS DRUGTYPE Small molecular drug D01ALS HIGHSTAT Investigative D01AMS DRUG__ID D01AMS D01AMS DRUGCLAS Investigative Drug(s) D01AMS DRUGINCH 1S/C16H24N2O3/c1-12-8-7-9-14(13(12)2)17-15(19)10-5-3-4-6-11-16(20)18-21/h7-9,21H,3-6,10-11H2,1-2H3,(H,17,19)(H,18,20) D01AMS DRUGINKE HBVNZQXOOFVNBV-UHFFFAOYSA-N D01AMS DRUGSMIL CC1=C(C(=CC=C1)NC(=O)CCCCCCC(=O)NO)C D01AMS DRUGTYPE Small molecular drug D01AMS HIGHSTAT Investigative D01AMV DRUG__ID D01AMV D01AMV DRUGCLAS Investigative Drug(s) D01AMV DRUGINCH 1S/C15H9FN4/c16-11-4-5-14-13(7-11)15(19-9-18-14)20-12-3-1-2-10(6-12)8-17/h1-7,9H,(H,18,19,20) D01AMV DRUGINKE NWRSWZMZACUZPY-UHFFFAOYSA-N D01AMV DRUGSMIL C1=CC(=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)F)C#N D01AMV DRUGTYPE Small molecular drug D01AMV HIGHSTAT Investigative D01ANE DRUG__ID D01ANE D01ANE DRUGCLAS Investigative Drug(s) D01ANE DRUGCOMP Arana Therapeutics Ltd D01ANE HIGHSTAT Investigative D01AOI DRUG__ID D01AOI D01AOI DRUGCLAS Investigative Drug(s) D01AOI DRUGINCH 1S/C17H18N2O/c18-11-14-1-2-16-10-17(4-3-15(16)9-14)20-12-13-5-7-19-8-6-13/h1-4,9-10,13,19H,5-8,12H2 D01AOI DRUGINKE SHJHTXWKDLOBQS-UHFFFAOYSA-N D01AOI DRUGSMIL C1CNCCC1COC2=CC3=C(C=C2)C=C(C=C3)C#N D01AOI DRUGTYPE Small molecular drug D01AOI HIGHSTAT Investigative D01APA DRUG__ID D01APA D01APA DRUGCLAS Investigative Drug(s) D01APA DRUGINCH 1S/C32H43N7O7/c1-2-3-19-45-32(44)37-17-15-36(16-18-37)27(40)21-33-30(42)25-20-29(39(35-25)24-11-5-4-6-12-24)46-22-28(41)38-14-8-13-26(38)31(43)34-23-9-7-10-23/h4-6,11-12,20,23,26H,2-3,7-10,13-19,21-22H2,1H3,(H,33,42)(H,34,43)/t26-/m0/s1 D01APA DRUGINKE QCKRRHRHLONWIP-SANMLTNESA-N D01APA DRUGSMIL CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)C2=NN(C(=C2)OCC(=O)N3CCCC3C(=O)NC4CCC4)C5=CC=CC=C5 D01APA DRUGTYPE Small molecular drug D01APA HIGHSTAT Investigative D01APL DRUG__ID D01APL D01APL DRUGCLAS Investigative Drug(s) D01APL DRUGINCH 1S/C16H18N2O/c1-18-8-10(9-19)5-13-12-3-2-4-14-16(12)11(7-17-14)6-15(13)18/h2-5,7,10,15,17,19H,6,8-9H2,1H3/t10-,15-/m1/s1 D01APL DRUGINKE BIXJFIJYBLJTMK-MEBBXXQBSA-N D01APL DRUGSMIL CN1CC(C=C2C1CC3=CNC4=CC=CC2=C34)CO D01APL DRUGTYPE Small molecular drug D01APL HIGHSTAT Investigative D01APZ DRUG__ID D01APZ D01APZ DRUGCLAS Investigative Drug(s) D01APZ DRUGINCH 1S/C61H88N20O13S3/c62-38(17-7-21-69-59(63)64)49(84)74-39(18-8-22-70-60(65)66)56(91)80-24-10-20-46(80)57(92)81-31-36(82)28-47(81)55(90)72-30-48(83)73-43(29-37-16-11-25-95-37)52(87)79-45-33-97-96-32-44(53(88)75-40(58(93)94)19-9-23-71-61(67)68)78-51(86)42(27-35-14-5-2-6-15-35)76-50(85)41(77-54(45)89)26-34-12-3-1-4-13-34/h1-6,11-16,25,36,38-47,82H,7-10,17-24,26-33,62H2,(H,72,90)(H,73,83)(H,74,84)(H,75,88)(H,76,85)(H,77,89)(H,78,86)(H,79,87)(H,93,94)(H4,63,64,69)(H4,65,66,70)(H4,67,68,71)/t36?,38-,39-,40?,41-,42?,43?,44?,45-,46-,47-/m1/s1 D01APZ DRUGINKE QRPRDXXCSGEGJN-AAAINLOGSA-N D01APZ DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CS3)C(=O)NC4CSSCC(NC(=O)C(NC(=O)C(NC4=O)CC5=CC=CC=C5)CC6=CC=CC=C6)C(=O)NC(CCCN=C(N)N)C(=O)O)O D01APZ HIGHSTAT Investigative D01AQC DRUG__ID D01AQC D01AQC DRUGCLAS Investigative Drug(s) D01AQC DRUGINCH 1S/C51H61N9O10/c1-3-4-19-43(50(69)59-41(28-45(63)64)49(68)57-39(46(53)65)25-31-13-7-5-8-14-31)60(2)51(70)42(27-34-29-54-38-18-12-11-17-36(34)38)56-44(62)30-55-48(67)40(26-32-15-9-6-10-16-32)58-47(66)37(52)24-33-20-22-35(61)23-21-33/h5-18,20-23,29,37,39-43,54,61H,3-4,19,24-28,30,52H2,1-2H3,(H2,53,65)(H,55,67)(H,56,62)(H,57,68)(H,58,66)(H,59,69)(H,63,64)/t37-,39-,40+,41-,42-,43-/m0/s1 D01AQC DRUGINKE KKPFQTRKARZYLE-NOGCUKNYSA-N D01AQC DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N D01AQC DRUGTYPE Small molecular drug D01AQC HIGHSTAT Investigative D01AQN DRUG__ID D01AQN D01AQN DRUGCLAS Investigative Drug(s) D01AQN HIGHSTAT Investigative D01AQT DRUG__ID D01AQT D01AQT DRUGCLAS Approved Drug(s) D01AQT DRUGINCH 1S/C26H31Cl2N5O3/c1-19(2)31-9-11-32(12-10-31)21-4-6-22(7-5-21)34-14-23-15-35-26(36-23,16-33-18-29-17-30-33)24-8-3-20(27)13-25(24)28/h3-8,13,17-19,23H,9-12,14-16H2,1-2H3/t23-,26-/m0/s1 D01AQT DRUGINKE BLSQLHNBWJLIBQ-OZXSUGGESA-N D01AQT DRUGSMIL CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl D01AQT DRUGTYPE Small molecular drug D01AQT HIGHSTAT Approved D01AQT THERCLAS Antifungal Agents D01ARE DRUG__ID D01ARE D01ARE DRUGCLAS Investigative Drug(s) D01ARE DRUGINCH 1S/C10H10N2S/c1-11-10-5-4-9(13-10)8-3-2-6-12-7-8/h2-7,11H,1H3 D01ARE DRUGINKE OUEHWWLIEPNPDR-UHFFFAOYSA-N D01ARE DRUGSMIL CNC1=CC=C(S1)C2=CN=CC=C2 D01ARE DRUGTYPE Small molecular drug D01ARE HIGHSTAT Investigative D01ARG DRUG__ID D01ARG D01ARG DRUGCLAS Investigative Drug(s) D01ARG DRUGCOMP DARA BioSciences D01ARG HIGHSTAT Investigative D01ARU DRUG__ID D01ARU D01ARU DRUGCLAS Clinical Trial Drug(s) D01ARU DRUGCOMP DisperSol Technologies D01ARU DRUGTYPE Small molecular drug D01ARU HIGHSTAT Phase 1 D01ARY DRUG__ID D01ARY D01ARY DRUGCLAS Investigative Drug(s) D01ARY DRUGINCH 1S/C108H158N26O41S/c1-8-56(4)89(105(171)134-41-15-20-77(134)103(169)126-64(32-37-86(150)151)95(161)123-63(31-36-85(148)149)96(162)129-70(44-58-21-25-60(139)26-22-58)100(166)128-68(42-55(2)3)98(164)127-67(106(172)173)29-34-78(109)140)131-97(163)65(33-38-87(152)153)124-94(160)62(30-35-84(146)147)125-99(165)69(43-57-16-10-9-11-17-57)130-101(167)71(45-88(154)155)118-79(141)46-113-90(156)72(51-135)119-80(142)47-114-91(157)73(52-136)120-81(143)48-115-92(158)74(53-137)121-82(144)49-116-93(159)75(54-138)122-83(145)50-117-102(168)76-19-12-13-40-133(76)104(170)66(18-14-39-112-107(110)111)132-176(174,175)61-27-23-59(24-28-61)108(5,6)7/h9-11,16-17,21-28,55-56,62-77,89,132,135-139H,8,12-15,18-20,29-54H2,1-7H3,(H2,109,140)(H,113,156)(H,114,157)(H,115,158)(H,116,159)(H,117,168)(H,118,141)(H,119,142)(H,120,143)(H,121,144)(H,122,145)(H,123,161)(H,124,160)(H,125,165)(H,126,169)(H,127,164)(H,128,166)(H,129,162)(H,130,167)(H,131,163)(H,146,147)(H,148,149)(H,150,151)(H,152,153)(H,154,155)(H,172,173)(H4,110,111,112)/t56-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76+,77-,89-/m0/s1 D01ARY DRUGINKE QVAVWYLBNALTPM-TVNHPFTQSA-N D01ARY DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D01ARY HIGHSTAT Investigative D01ASM DRUG__ID D01ASM D01ASM DRUGCLAS Clinical Trial Drug(s) D01ASM DRUGCOMP Scios Inc D01ASM DRUGINCH 1S/C21H23NO4/c1-13(2)11-19(20(23)24)22-21(25)26-12-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h3-10,13,18-19H,11-12H2,1-2H3,(H,22,25)(H,23,24)/t19-/m0/s1 D01ASM DRUGINKE CBPJQFCAFFNICX-IBGZPJMESA-N D01ASM DRUGSMIL CC(C)CC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 D01ASM DRUGTYPE Small molecular drug D01ASM HIGHSTAT Phase 2 D01ATS DRUG__ID D01ATS D01ATS DRUGCLAS Investigative Drug(s) D01ATS DRUGCOMP LEO Pharma A/S D01ATS HIGHSTAT Investigative D01AUI DRUG__ID D01AUI D01AUI DRUGCLAS Investigative Drug(s) D01AUI DRUGSMIL CCCCCN=C(N)NNC=C1C=NC2=C1C=C(C=C2)OC.C(=CC(=O)O)C(=O)O D01AUI DRUGTYPE Small molecular drug D01AUI HIGHSTAT Investigative D01AUL DRUG__ID D01AUL D01AUL DRUGCLAS Discontinued Drug(s) D01AUL DRUGCOMP Merck & Co Inc D01AUL DRUGINCH 1S/C18H21N3O2/c1-5-13-8-14(18(22)20-12(13)4)19-9-15-21-16-10(2)6-7-11(3)17(16)23-15/h6-8,19H,5,9H2,1-4H3,(H,20,22) D01AUL DRUGINKE VDZJXIOFISBBLT-UHFFFAOYSA-N D01AUL DRUGSMIL CCC1=C(NC(=O)C(=C1)NCC2=NC3=C(C=CC(=C3O2)C)C)C D01AUL DRUGTYPE Small molecular drug D01AUL HIGHSTAT Discontinued in Phase 1 D01AUS DRUG__ID D01AUS D01AUS DRUGCLAS Investigative Drug(s) D01AUS DRUGINCH 1S/C21H16O4/c22-20(16-6-8-18(9-7-16)21(23)24)17-10-12-19(13-11-17)25-14-15-4-2-1-3-5-15/h1-13H,14H2,(H,23,24) D01AUS DRUGINKE ZSVDQQIAIVOVRI-UHFFFAOYSA-N D01AUS DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)C(=O)O D01AUS DRUGTYPE Small molecular drug D01AUS HIGHSTAT Investigative D01AUX DRUG__ID D01AUX D01AUX DRUGCLAS Investigative Drug(s) D01AUX DRUGINCH 1S/C22H19NO3/c24-21(23-20-9-5-4-8-19(20)22(25)26)15-12-16-10-13-18(14-11-16)17-6-2-1-3-7-17/h1-11,13-14H,12,15H2,(H,23,24)(H,25,26) D01AUX DRUGINKE CAYOKBAXZPGNTO-UHFFFAOYSA-N D01AUX DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(=O)NC3=CC=CC=C3C(=O)O D01AUX DRUGTYPE Small molecular drug D01AUX HIGHSTAT Investigative D01AVF DRUG__ID D01AVF D01AVF DRUGCLAS Investigative Drug(s) D01AVF DRUGCOMP Sanofi D01AVF HIGHSTAT Investigative D01AVM DRUG__ID D01AVM D01AVM DRUGCLAS Investigative Drug(s) D01AVM DRUGINCH 1S/C22H28O4/c1-3-26-20(24)12-14-11-19-18-6-4-13-10-15(23)5-7-16(13)17(18)8-9-22(19,2)21(14)25/h5,7,10,14,17-19,23H,3-4,6,8-9,11-12H2,1-2H3/t14?,17-,18-,19+,22+/m1/s1 D01AVM DRUGINKE SRWMNPAYNHYCEU-LRHWGCDKSA-N D01AVM DRUGSMIL CCOC(=O)CC1CC2C3CCC4=C(C3CCC2(C1=O)C)C=CC(=C4)O D01AVM DRUGTYPE Small molecular drug D01AVM HIGHSTAT Investigative D01AVS DRUG__ID D01AVS D01AVS DRUGCLAS Investigative Drug(s) D01AVS DRUGINCH 1S/C15H22N2O4/c1-21-13(10-6-3-7-11-14(18)17-20)15(19)16-12-8-4-2-5-9-12/h2,4-5,8-9,13,20H,3,6-7,10-11H2,1H3,(H,16,19)(H,17,18) D01AVS DRUGINKE JHNWNLJPMOWGAH-UHFFFAOYSA-N D01AVS DRUGSMIL COC(CCCCCC(=O)NO)C(=O)NC1=CC=CC=C1 D01AVS DRUGTYPE Small molecular drug D01AVS HIGHSTAT Investigative D01AWD DRUG__ID D01AWD D01AWD DRUGCLAS Investigative Drug(s) D01AWD DRUGINCH 1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5-,6+/m1/s1 D01AWD DRUGINKE NBSCHQHZLSJFNQ-DVKNGEFBSA-N D01AWD DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)OP(=O)(O)O D01AWD DRUGTYPE Small molecular drug D01AWD HIGHSTAT Investigative D01AWE DRUG__ID D01AWE D01AWE DRUGCLAS Investigative Drug(s) D01AWE DRUGINCH 1S/C23H38N7O17P3S/c1-12(31)51-7-6-25-14(32)4-5-26-21(35)18(34)23(2,3)9-44-50(41,42)47-49(39,40)43-8-13-17(46-48(36,37)38)16(33)22(45-13)30-11-29-15-19(24)27-10-28-20(15)30/h10-11,13,16-18,22,33-34H,4-9H2,1-3H3,(H,25,32)(H,26,35)(H,39,40)(H,41,42)(H2,24,27,28)(H2,36,37,38)/t13-,16-,17-,18+,22-/m1/s1 D01AWE DRUGINKE ZSLZBFCDCINBPY-ZSJPKINUSA-N D01AWE DRUGSMIL CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D01AWE DRUGTYPE Small molecular drug D01AWE HIGHSTAT Investigative D01AWH DRUG__ID D01AWH D01AWH DRUGCLAS Patented Agent(s) D01AWH DRUGCOMP MEMORIAL SLOAN-KETTERING CANCER CENTER THE ROCKEFELLER UNIVERSITY D01AWH DRUGTYPE Small molecular drug D01AWH HIGHSTAT Patented D01AXA DRUG__ID D01AXA D01AXA DRUGCLAS Investigative Drug(s) D01AXA DRUGINCH 1S/C25H42N8O12/c1-11(2)7-14(21(41)32-16(9-19(38)39)23(43)33-17(10-34)24(44)45)31-20(40)13(5-4-6-28-25(26)27)30-22(42)15(8-18(36)37)29-12(3)35/h11,13-17,34H,4-10H2,1-3H3,(H,29,35)(H,30,42)(H,31,40)(H,32,41)(H,33,43)(H,36,37)(H,38,39)(H,44,45)(H4,26,27,28)/t13-,14-,15-,16-,17-/m0/s1 D01AXA DRUGINKE MBZXDXZGPJKBRJ-WOYTXXSLSA-N D01AXA DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C D01AXA DRUGTYPE Small molecular drug D01AXA HIGHSTAT Investigative D01AXB DRUG__ID D01AXB D01AXB DRUGCLAS Approved Drug(s) D01AXB DRUGCOMP Eli Lilly D01AXB DRUGINCH 1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1 D01AXB DRUGINKE ZEUITGRIYCTCEM-KRWDZBQOSA-N D01AXB DRUGSMIL CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32 D01AXB DRUGTYPE Small molecular drug D01AXB HIGHSTAT Approved D01AXB THERCLAS Antidepressants D01AXK DRUG__ID D01AXK D01AXK DRUGCLAS Patented Agent(s) D01AXK DRUGCOMP KADMON CORPORATION, LLC D01AXK DRUGTYPE Antibody D01AXK HIGHSTAT Patented D01AXT DRUG__ID D01AXT D01AXT DRUGCLAS Discontinued Drug(s) D01AXT DRUGCOMP Nascent Pharmaceuticals D01AXT HIGHSTAT Discontinued in Phase 2 D01AYF DRUG__ID D01AYF D01AYF DRUGCLAS Clinical Trial Drug(s) D01AYF DRUGCOMP Glaxosmithkline; novavax; vaxart D01AYF DRUGTYPE Vaccine D01AYF HIGHSTAT Phase 1 D01AYJ DRUG__ID D01AYJ D01AYJ DRUADIID 800031190 D01AYJ DRUGCLAS Approved Drug(s) D01AYJ DRUGCOMP Celtic Pharma D01AYJ DRUGINCH 1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+ D01AYJ DRUGINKE DOMXUEMWDBAQBQ-WEVVVXLNSA-N D01AYJ DRUGSMIL CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21 D01AYJ DRUGTYPE Small molecular drug D01AYJ HIGHSTAT Approved D01AYJ THERCLAS Antifungal Agents D01AYP DRUG__ID D01AYP D01AYP COMPCLAS Bromo benzyl ether derivatives D01AYP DRUGCLAS Patented Agent(s) D01AYP DRUGCOMP INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES [CN] D01AYP DRUGTYPE Small molecule immunotherapy D01AYP HIGHSTAT Patented D01AYX DRUG__ID D01AYX D01AYX DRUGCLAS Clinical Trial Drug(s) D01AYX DRUGCOMP AstraZeneca D01AYX DRUGINCH 1S/C26H28N4O/c1-4-5-18-12-21(16-28-15-18)19-6-7-20-14-25(10-8-22(31-3)9-11-25)26(23(20)13-19)29-17(2)24(27)30-26/h6-7,12-13,15-16,22H,8-11,14H2,1-3H3,(H2,27,30) D01AYX DRUGINKE WKDNQONLGXOZRG-UHFFFAOYSA-N D01AYX DRUGSMIL CC#CC1=CC(=CN=C1)C2=CC3=C(CC4(C35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2 D01AYX DRUGTYPE Small molecular drug D01AYX HIGHSTAT Phase 2/3 D01AZG DRUG__ID D01AZG D01AZG DRUGCLAS Approved Drug(s) D01AZG DRUGCOMP Janssen-Cilag D01AZG DRUGINCH 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 D01AZG DRUGINKE RAPZEAPATHNIPO-UHFFFAOYSA-N D01AZG DRUGSMIL CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F D01AZG DRUGTYPE Small molecular drug D01AZG HIGHSTAT Approved D01AZG THERCLAS Antipsychotic Agents D01AZJ DRUG__ID D01AZJ D01AZJ DRUGCLAS Investigative Drug(s) D01AZJ DRUGINCH 1S/C19H18FN5O/c1-11(2)24-10-14-9-13(6-7-15(14)19(24)26)17-12(3)25(23-22-17)16-5-4-8-21-18(16)20/h4-9,11H,10H2,1-3H3/i20-1 D01AZJ DRUGINKE ZUWMBBZBDLJVHD-LRFGSCOBSA-N D01AZJ DRUGSMIL CC1=C(N=NN1C2=C(N=CC=C2)F)C3=CC4=C(C=C3)C(=O)N(C4)C(C)C D01AZJ DRUGTYPE Small molecular drug D01AZJ HIGHSTAT Investigative D01AZP DRUG__ID D01AZP D01AZP DRUGCLAS Clinical Trial Drug(s) D01AZP DRUGCOMP Iliad Chemicals Pty Ltd D01AZP DRUGINCH 1S/C20H20O7/c1-10-16(12-6-7-13(23-2)18(22)19(12)27-10)17(21)11-8-14(24-3)20(26-5)15(9-11)25-4/h6-9,22H,1-5H3 D01AZP DRUGINKE RADMJHVVIZTENA-UHFFFAOYSA-N D01AZP DRUGSMIL CC1=C(C2=C(O1)C(=C(C=C2)OC)O)C(=O)C3=CC(=C(C(=C3)OC)OC)OC D01AZP DRUGTYPE Small molecular drug D01AZP HIGHSTAT Phase 2 D01BAG DRUG__ID D01BAG D01BAG DRUGCLAS Investigative Drug(s) D01BAG DRUGINCH 1S/C20H19N3O6S/c1-11-8-22(10-14(21)18(25)26)20(29)23(17(11)24)9-13-7-15(30-16(13)19(27)28)12-5-3-2-4-6-12/h2-8,14H,9-10,21H2,1H3,(H,25,26)(H,27,28)/t14-/m0/s1 D01BAG DRUGINKE LCZDCKMQSBGXAH-AWEZNQCLSA-N D01BAG DRUGSMIL CC1=CN(C(=O)N(C1=O)CC2=C(SC(=C2)C3=CC=CC=C3)C(=O)O)CC(C(=O)O)N D01BAG DRUGTYPE Small molecular drug D01BAG HIGHSTAT Investigative D01BAK DRUG__ID D01BAK D01BAK DRUGCLAS Investigative Drug(s) D01BAK DRUGINCH 1S/C30H36N4O4/c35-27(11-17-33-13-3-1-4-14-33)31-21-7-9-23-25(19-21)30(38)26-20-22(8-10-24(26)29(23)37)32-28(36)12-18-34-15-5-2-6-16-34/h7-10,19-20H,1-6,11-18H2,(H,31,35)(H,32,36) D01BAK DRUGINKE OFUHVIUIKBRCMP-UHFFFAOYSA-N D01BAK DRUGSMIL C1CCN(CC1)CCC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CCN5CCCCC5 D01BAK DRUGTYPE Small molecular drug D01BAK HIGHSTAT Investigative D01BAU DRUG__ID D01BAU D01BAU DRUGCLAS Clinical Trial Drug(s) D01BAU DRUGCOMP Supernus Pharmaceuticals D01BAU HIGHSTAT Phase 2 D01BBB DRUG__ID D01BBB D01BBB DRUGCLAS Clinical Trial Drug(s) D01BBB DRUGCOMP Viriom Ltd D01BBB HIGHSTAT Phase 2/3 D01BBR DRUG__ID D01BBR D01BBR DRUGCLAS Discontinued Drug(s) D01BBR DRUGCOMP A H Robins Co Inc D01BBR DRUGINCH 1S/C11H11F3N2O2/c12-11(13,14)7-2-1-3-8(4-7)18-9-5-16(6-9)10(15)17/h1-4,9H,5-6H2,(H2,15,17) D01BBR DRUGINKE LIAILJLSVRAGSM-UHFFFAOYSA-N D01BBR DRUGSMIL C1C(CN1C(=O)N)OC2=CC=CC(=C2)C(F)(F)F D01BBR DRUGTYPE Small molecular drug D01BBR HIGHSTAT Discontinued in Phase 2 D01BCI DRUG__ID D01BCI D01BCI DRUGCLAS Investigative Drug(s) D01BCI DRUGINCH 1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m1/s1 D01BCI DRUGINKE QNAYBMKLOCPYGJ-UWTATZPHSA-N D01BCI DRUGSMIL CC(C(=O)O)N D01BCI DRUGTYPE Small molecular drug D01BCI HIGHSTAT Investigative D01BCK DRUG__ID D01BCK D01BCK DRUGCLAS Investigative Drug(s) D01BCK DRUGINCH 1S/C11H9NO2/c13-11(12-14)10-7-3-5-8-4-1-2-6-9(8)10/h1-7,14H,(H,12,13) D01BCK DRUGINKE JRZGPWOEHDOVMC-UHFFFAOYSA-N D01BCK DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C(=O)NO D01BCK DRUGTYPE Small molecular drug D01BCK HIGHSTAT Investigative D01BCL DRUG__ID D01BCL D01BCL DRUGCLAS Investigative Drug(s) D01BCL DRUGINCH 1S/C11H13NO2/c12-11(10(13)14)6-5-8-3-1-2-4-9(8)7-11/h1-4H,5-7,12H2,(H,13,14) D01BCL DRUGINKE CDULPPOISZOUTK-UHFFFAOYSA-N D01BCL DRUGSMIL C1CC(CC2=CC=CC=C21)(C(=O)O)N D01BCL DRUGTYPE Small molecular drug D01BCL HIGHSTAT Investigative D01BCQ DRUG__ID D01BCQ D01BCQ DRUGCLAS Discontinued Drug(s) D01BCQ DRUGINCH 1S/C17H17N3O2/c1-4-13-11(2)20-10-14(18-17(20)19-16(13)22-3)15(21)12-8-6-5-7-9-12/h5-10H,4H2,1-3H3 D01BCQ DRUGINKE NRJVHCSYLGLURI-UHFFFAOYSA-N D01BCQ DRUGSMIL CCC1=C(N2C=C(N=C2N=C1OC)C(=O)C3=CC=CC=C3)C D01BCQ DRUGTYPE Small molecular drug D01BCQ HIGHSTAT Terminated D01BDJ DRUG__ID D01BDJ D01BDJ DRUGCLAS Investigative Drug(s) D01BDJ DRUGINCH 1S/C16H16O/c1-3-8-14(9-4-1)16(12-7-13-17-16)15-10-5-2-6-11-15/h1-6,8-11H,7,12-13H2 D01BDJ DRUGINKE ONRSPOWNRLCCGF-UHFFFAOYSA-N D01BDJ DRUGSMIL C1CC(OC1)(C2=CC=CC=C2)C3=CC=CC=C3 D01BDJ DRUGTYPE Small molecular drug D01BDJ HIGHSTAT Investigative D01BDY DRUG__ID D01BDY D01BDY DRUGCLAS Clinical Trial Drug(s) D01BDY DRUGCOMP Grunenthal GmbH D01BDY DRUGINCH 1S/C16H25NO3/c1-17(2)11-13-7-8-14(18)10-16(13,19)12-5-4-6-15(9-12)20-3/h4-6,9,13-14,18-19H,7-8,10-11H2,1-3H3/t13-,14-,16+/m1/s1 D01BDY DRUGINKE LQJLLAOISDVBJM-FMKPAKJESA-N D01BDY DRUGSMIL CN(C)CC1CCC(CC1(C2=CC(=CC=C2)OC)O)O D01BDY DRUGTYPE Small molecular drug D01BDY HIGHSTAT Phase 2 D01BEX DRUG__ID D01BEX D01BEX DRUGCLAS Investigative Drug(s) D01BEX DRUGCOMP Pieris AG D01BEX HIGHSTAT Investigative D01BFA DRUG__ID D01BFA D01BFA DRUGCLAS Investigative Drug(s) D01BFA DRUGCOMP BIKAM Pharmaceuticals Inc D01BFA HIGHSTAT Investigative D01BGG DRUG__ID D01BGG D01BGG COMPCLAS Isoflavone derivatives D01BGG DRUGCLAS Patented Agent(s) D01BGG DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D01BGG DRUGTYPE Small molecular drug D01BGG HIGHSTAT Patented D01BGK DRUG__ID D01BGK D01BGK DRUGCLAS Investigative Drug(s) D01BGK DRUGINCH 1S/C17H21NO3/c1-20-16-13-21-17(18-16)15(19)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3 D01BGK DRUGINKE PLTPISAOEFIJFK-UHFFFAOYSA-N D01BGK DRUGSMIL COC1=COC(=N1)C(=O)CCCCCCC2=CC=CC=C2 D01BGK DRUGTYPE Small molecular drug D01BGK HIGHSTAT Investigative D01BGU DRUG__ID D01BGU D01BGU DRUGCLAS Investigative Drug(s) D01BGU DRUGCOMP Ultragenyx Pharmaceutical D01BGU HIGHSTAT Investigative D01BGW DRUG__ID D01BGW D01BGW DRUGCLAS Investigative Drug(s) D01BGW DRUGINCH 1S/C11H15N3O/c1-8(12)7-14-11-5-10(15-2)4-3-9(11)6-13-14/h3-6,8H,7,12H2,1-2H3/t8-/m0/s1 D01BGW DRUGINKE WSEWULCWBQDNEH-QMMMGPOBSA-N D01BGW DRUGSMIL CC(CN1C2=C(C=CC(=C2)OC)C=N1)N D01BGW HIGHSTAT Investigative D01BGY DRUG__ID D01BGY D01BGY DRUGCLAS Investigative Drug(s) D01BGY DRUGINCH 1S/C30H35NO6/c1-34-26-12-6-22(7-13-26)30(23-8-14-27(35-2)15-9-23,24-10-16-28(36-3)17-11-24)37-20-19-31-18-4-5-25(31)21-29(32)33/h6-17,25H,4-5,18-21H2,1-3H3,(H,32,33)/t25-/m1/s1 D01BGY DRUGINKE LVXQSLPHTYSBIW-RUZDIDTESA-N D01BGY DRUGSMIL COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)(C3=CC=C(C=C3)OC)OCCN4CCCC4CC(=O)O D01BGY DRUGTYPE Small molecular drug D01BGY HIGHSTAT Investigative D01BHC DRUG__ID D01BHC D01BHC DRUGCLAS Investigative Drug(s) D01BHC DRUGCOMP Biota Holdings Ltd D01BHC HIGHSTAT Investigative D01BIQ DRUG__ID D01BIQ D01BIQ DRUGCLAS Investigative Drug(s) D01BIQ DRUGCOMP California Stem Cell Inc D01BIQ HIGHSTAT Investigative D01BIZ DRUG__ID D01BIZ D01BIZ DRUGCLAS Investigative Drug(s) D01BIZ DRUGINCH 1S/C45H67N13O9/c1-24(2)20-33(52-38(60)32(18-13-19-49-43(47)48)54-45(66)67-23-28-14-9-8-10-15-28)39(61)56-36(26(5)6)42(64)57-58-44(65)53-34(21-29-22-50-31-17-12-11-16-30(29)31)40(62)55-35(25(3)4)41(63)51-27(7)37(46)59/h8-12,14-17,22,24-27,32-36,50H,13,18-21,23H2,1-7H3,(H2,46,59)(H,51,63)(H,52,60)(H,54,66)(H,55,62)(H,56,61)(H,57,64)(H4,47,48,49)(H2,53,58,65) D01BIZ DRUGINKE TXGCKASBHJKJOM-UHFFFAOYSA-N D01BIZ DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3 D01BIZ DRUGTYPE Small molecular drug D01BIZ HIGHSTAT Investigative D01BJB DRUG__ID D01BJB D01BJB DRUGCLAS Investigative Drug(s) D01BJB DRUGINCH 1S/C22H31NO2/c1-13(24)20-14(12-23)10-19-17-5-4-15-11-16(25)6-8-21(15,2)18(17)7-9-22(19,20)3/h4,14,16-20,25H,5-11H2,1-3H3/t14-,16-,17+,18-,19-,20-,21-,22-/m0/s1 D01BJB DRUGINKE VSBHRRMYCDQLJF-ZDNYCOCVSA-N D01BJB DRUGSMIL CC(=O)C1C(CC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C#N D01BJB DRUGTYPE Small molecular drug D01BJB HIGHSTAT Investigative D01BJK DRUG__ID D01BJK D01BJK DRUGCLAS Investigative Drug(s) D01BJK DRUGCOMP AFFiRiS AG D01BJK DRUGTYPE Vaccine D01BJK HIGHSTAT Investigative D01BJO DRUG__ID D01BJO D01BJO DRUGCLAS Investigative Drug(s) D01BJO DRUGCOMP Medisyn Technologies Inc D01BJO HIGHSTAT Investigative D01BJS DRUG__ID D01BJS D01BJS DRUGCLAS Investigative Drug(s) D01BJS DRUGCOMP HanAll Biopharma Co Ltd D01BJS HIGHSTAT Investigative D01BJZ DRUG__ID D01BJZ D01BJZ DRUGCLAS Investigative Drug(s) D01BJZ DRUGINCH 1S/C20H25NO/c1-22-20-10-7-16(8-11-20)12-13-21-15-17-6-9-18-4-2-3-5-19(18)14-17/h2-5,7-8,10-11,17,21H,6,9,12-15H2,1H3 D01BJZ DRUGINKE NJWKVUCAVMYELV-UHFFFAOYSA-N D01BJZ DRUGSMIL COC1=CC=C(C=C1)CCNCC2CCC3=CC=CC=C3C2 D01BJZ DRUGTYPE Small molecular drug D01BJZ HIGHSTAT Investigative D01BKS DRUG__ID D01BKS D01BKS DRUGCLAS Investigative Drug(s) D01BKS DRUGINCH 1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42-/m0/s1 D01BKS DRUGINKE RWXIFXNRCLMQCD-JBVRGBGGSA-N D01BKS DRUGSMIL CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C D01BKS DRUGTYPE Small molecular drug D01BKS HIGHSTAT Investigative D01BMA DRUG__ID D01BMA D01BMA DRUADIID CLI-01-ALDR-02840 D01BMA DRUGCLAS Investigative Drug(s) D01BMA DRUGINCH 1S/C27H50O7P2/c1-5-9-19-31-35(28,32-20-10-6-2)24-26(18-23-30-27-16-14-13-15-17-27)25-36(29,33-21-11-7-3)34-22-12-8-4/h13-17,26H,5-12,18-25H2,1-4H3 D01BMA DRUGINKE QTBMDDQRDDABNC-UHFFFAOYSA-N D01BMA DRUGSMIL CCCCOP(=O)(CC(CCOC1=CC=CC=C1)CP(=O)(OCCCC)OCCCC)OCCCC D01BMA DRUGTYPE Small molecular drug D01BMA HIGHSTAT Investigative D01BMX DRUG__ID D01BMX D01BMX COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D01BMX DRUGCLAS Patented Agent(s) D01BMX DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA MOUNT SINAI SCHOOL OF MEDICINE DAR, Arvin, C. DAS, Tirtha, K. SOS, Martin BIVONA, Trever, G. SHOKAT, Kevan, M. CAGAN, Ross, LUniversity of California and Icahn School of Medicine at Mount Sinai D01BMX DRUGTYPE Small molecular drug D01BMX HIGHSTAT Patented D01BOD DRUG__ID D01BOD D01BOD DRUGCLAS Investigative Drug(s) D01BOD DRUGCOMP ViaCyte Inc D01BOD HIGHSTAT Investigative D01BOE DRUG__ID D01BOE D01BOE DRUGCLAS Investigative Drug(s) D01BOE DRUGCOMP University of Veterinary; Pharmaceutical Sciences Brno D01BOE HIGHSTAT Investigative D01BPF DRUG__ID D01BPF D01BPF DRUGCLAS Discontinued Drug(s) D01BPF DRUGCOMP Bristol-Myers Squibb Co D01BPF DRUGINCH 1S/C22H30N6O3S/c1-23-32(29,30)15-17-5-6-20-19(12-17)18(13-25-20)4-3-7-27-8-10-28(11-9-27)22-21(31-2)14-24-16-26-22/h5-6,12-14,16,23,25H,3-4,7-11,15H2,1-2H3 D01BPF DRUGINKE WRZVGHXUPBWIOO-UHFFFAOYSA-N D01BPF DRUGSMIL CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC D01BPF DRUGTYPE Small molecular drug D01BPF HIGHSTAT Discontinued in Phase 3 D01BPI DRUG__ID D01BPI D01BPI DRUGCLAS Investigative Drug(s) D01BPI DRUGINCH 1S/C22H27FO7/c1-21-6-4-13-20(26)30-16(12-5-7-28-10-12)9-22(13,2)18(21)17(24)15(29-11-23)8-14(21)19(25)27-3/h5,7,10,13-16,18H,4,6,8-9,11H2,1-3H3/t13-,14-,15-,16-,18-,21-,22-/m0/s1 D01BPI DRUGINKE DDPYLPBMPHWVGO-VOVNARLJSA-N D01BPI DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCF)C)C4=COC=C4 D01BPI DRUGTYPE Small molecular drug D01BPI HIGHSTAT Investigative D01BPP DRUG__ID D01BPP D01BPP DRUGCLAS Clinical Trial Drug(s) D01BPP DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NN)O)O)CC)OC)C(=O)OC)O.CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N.C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N D01BPP DRUGTYPE Small molecular drug D01BPP HIGHSTAT Phase 1 D01BPR DRUG__ID D01BPR D01BPR DRUGCLAS Investigative Drug(s) D01BPR DRUGINCH 1S/C12H17N.ClH/c1-3-7-12(8-4-1)11-13-9-5-2-6-10-13;/h1,3-4,7-8H,2,5-6,9-11H2;1H D01BPR DRUGINKE MPPIBJJDFLONMO-UHFFFAOYSA-N D01BPR DRUGSMIL C1CCN(CC1)CC2=CC=CC=C2.Cl D01BPR DRUGTYPE Small molecular drug D01BPR HIGHSTAT Investigative D01BQC DRUG__ID D01BQC D01BQC DRUADIID FDA-AP-BF04-00477 D01BQC DRUGCLAS Approved Drug(s) D01BQC DRUGCOMP Glaxosmithkline D01BQC DRUGINCH 1S/C18H18N6O8S3/c25-13(9-4-2-1-3-5-9)14(26)19-11-15(27)24-12(17(28)29)10(6-33-16(11)24)7-34-18-20-21-22-23(18)8-35(30,31)32/h1-5,11,13,16,25H,6-8H2,(H,19,26)(H,28,29)(H,30,31,32)/t11-,13-,16-/m1/s1 D01BQC DRUGINKE DYAIAHUQIPBDIP-AXAPSJFSSA-N D01BQC DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O D01BQC DRUGTYPE Small molecular drug D01BQC HIGHSTAT Approved D01BQC THERCLAS Antibiotics D01BQD DRUG__ID D01BQD D01BQD DRUGCLAS Investigative Drug(s) D01BQD DRUGINCH 1S/C20H17N3O/c21-15-8-11-18-19(13-15)23-20(22-18)12-14-6-9-17(10-7-14)24-16-4-2-1-3-5-16/h1-11,13H,12,21H2,(H,22,23) D01BQD DRUGINKE KVTYWLATLSZWKO-UHFFFAOYSA-N D01BQD DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CC3=NC4=C(N3)C=C(C=C4)N D01BQD DRUGTYPE Small molecular drug D01BQD HIGHSTAT Investigative D01BQI DRUG__ID D01BQI D01BQI DRUGCLAS Investigative Drug(s) D01BQI DRUGINCH 1S/C17H15NO3/c1-11-6-7-15-14(8-11)16(19)17(20)18(15)10-12-4-3-5-13(9-12)21-2/h3-9H,10H2,1-2H3 D01BQI DRUGINKE ZSPZSZMUOMBLFZ-UHFFFAOYSA-N D01BQI DRUGSMIL CC1=CC2=C(C=C1)N(C(=O)C2=O)CC3=CC(=CC=C3)OC D01BQI DRUGTYPE Small molecular drug D01BQI HIGHSTAT Investigative D01BQJ DRUG__ID D01BQJ D01BQJ DRUGCLAS Discontinued Drug(s) D01BQJ DRUGINCH 1S/C15H12BrClN2O2/c1-15(2)18-14(12-5-3-4-6-19(12)20)9-7-10(16)11(17)8-13(9)21-15/h3-8H,1-2H3 D01BQJ DRUGINKE YUEQBWZPZJXBHY-UHFFFAOYSA-N D01BQJ DRUGSMIL CC1(N=C(C2=CC(=C(C=C2O1)Cl)Br)C3=CC=CC=[N+]3[O-])C D01BQJ HIGHSTAT Terminated D01BQK DRUG__ID D01BQK D01BQK DRUGCLAS Approved Drug(s) D01BQK DRUGINCH 1S/CH4N2O.H2O2/c2-1(3)4;1-2/h(H4,2,3,4);1-2H D01BQK DRUGINKE AQLJVWUFPCUVLO-UHFFFAOYSA-N D01BQK DRUGSMIL C(=O)(N)N.OO D01BQK DRUGTYPE Small molecular drug D01BQK HIGHSTAT Approved D01BRD DRUG__ID D01BRD D01BRD DRUGCLAS Clinical Trial Drug(s) D01BRD DRUGCOMP Seattle Genetics Bothell, WA D01BRD HIGHSTAT Phase 1 D01BRX DRUG__ID D01BRX D01BRX DRUGCLAS Investigative Drug(s) D01BRX DRUGCOMP Immuron Ltd D01BRX HIGHSTAT Investigative D01BSX DRUG__ID D01BSX D01BSX DRUGCLAS Patented Agent(s) D01BSX DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D01BSX DRUGTYPE Small molecular drug D01BSX HIGHSTAT Patented D01BTF DRUG__ID D01BTF D01BTF DRUGCLAS Investigative Drug(s) D01BTF DRUGINCH 1S/C89H139N27O24S4/c1-43(2)67-82(135)101-40-64(119)102-53(18-12-30-97-87(91)92)74(127)113-68(44(3)4)83(136)109-59(36-47-22-24-49(118)25-23-47)77(130)107-58(20-14-32-99-89(95)96)85(138)116-33-15-21-63(116)81(134)111-62(80(133)108-60(37-48-39-100-52-17-11-10-16-50(48)52)78(131)104-55(26-27-65(120)121)75(128)114-69(45(5)6)86(139)140)42-144-143-41-61(79(132)105-57(29-35-142-9)76(129)112-67)110-72(125)54(19-13-31-98-88(93)94)103-73(126)56(28-34-141-8)106-84(137)70(46(7)117)115-71(124)51(90)38-66(122)123/h10-11,16-17,22-25,39,43-46,51,53-63,67-70,100,117-118H,12-15,18-21,26-38,40-42,90H2,1-9H3,(H,101,135)(H,102,119)(H,103,126)(H,104,131)(H,105,132)(H,106,137)(H,107,130)(H,108,133)(H,109,136)(H,110,125)(H,111,134)(H,112,129)(H,113,127)(H,114,128)(H,115,124)(H,120,121)(H,122,123)(H,139,140)(H4,91,92,97)(H4,93,94,98)(H4,95,96,99) D01BTF DRUGINKE ORRDHOMWDPJSNL-UHFFFAOYSA-N D01BTF DRUGSMIL CC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CCSC)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCSC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)O)CCCNC(=N)N)CC5=CC=C(C=C5)O)C(C)C)CCCNC(=N)N D01BTF DRUGTYPE Small molecular drug D01BTF HIGHSTAT Investigative D01BTV DRUG__ID D01BTV D01BTV DRUGCLAS Investigative Drug(s) D01BTV DRUGINCH 1S/C2H5NO3/c3-6-1-2(4)5/h1,3H2,(H,4,5) D01BTV DRUGINKE NQRKYASMKDDGHT-UHFFFAOYSA-N D01BTV DRUGSMIL C(C(=O)O)ON D01BTV DRUGTYPE Small molecular drug D01BTV HIGHSTAT Investigative D01BUB DRUG__ID D01BUB D01BUB DRUGCLAS Investigative Drug(s) D01BUB DRUGINCH 1S/C6H4F2O/c7-4-1-2-5(8)6(9)3-4/h1-3,9H D01BUB DRUGINKE INXKVYFOWNAVMU-UHFFFAOYSA-N D01BUB DRUGSMIL C1=CC(=C(C=C1F)O)F D01BUB DRUGTYPE Small molecular drug D01BUB HIGHSTAT Investigative D01BUS DRUG__ID D01BUS D01BUS DRUGCLAS Discontinued Drug(s) D01BUS DRUGCOMP MorphoSys AG D01BUS DRUGTYPE Antibody D01BUS HIGHSTAT Discontinued in Phase 1 D01BUT DRUG__ID D01BUT D01BUT DRUGCLAS Investigative Drug(s) D01BUT DRUGCOMP Beijing Institute of Pharmacology and Toxicology D01BUT DRUGINCH 1S/C70H93ClN18O12/c1-40(2)32-52(61(94)83-51(20-12-30-79-70(75)76)68(101)89-31-13-21-58(89)67(100)80-41(3)59(72)92)84-64(97)56(37-46-16-10-28-77-38-46)85-60(93)50(19-11-29-78-69(73)74)82-66(99)57(39-90)88-65(98)54(34-43-14-6-5-7-15-43)87-63(96)55(35-44-23-26-49(71)27-24-44)86-62(95)53(81-42(4)91)36-45-22-25-47-17-8-9-18-48(47)33-45/h5-10,14-18,22-28,33,38,40-41,50-58,90H,11-13,19-21,29-32,34-37,39H2,1-4H3,(H2,72,92)(H,80,100)(H,81,91)(H,82,99)(H,83,94)(H,84,97)(H,85,93)(H,86,95)(H,87,96)(H,88,98)(H4,73,74,78)(H4,75,76,79)/t41-,50+,51+,52+,53-,54-,55-,56-,57+,58+/m1/s1 D01BUT DRUGINKE CRMRBNHNJMIODJ-OIIKBFRESA-N D01BUT DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CN=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C D01BUT HIGHSTAT Investigative D01BVI DRUG__ID D01BVI D01BVI DRUGCLAS Clinical Trial Drug(s) D01BVI DRUGCOMP Vicept Therapeutics Inc D01BVI DRUGINCH 1S/C12H6Cl4S/c13-7-1-3-8(4-2-7)17-12-6-10(15)9(14)5-11(12)16/h1-6H D01BVI DRUGINKE QUWSDLYBOVGOCW-UHFFFAOYSA-N D01BVI DRUGSMIL C1=CC(=CC=C1SC2=CC(=C(C=C2Cl)Cl)Cl)Cl D01BVI DRUGTYPE Small molecular drug D01BVI HIGHSTAT Phase 2 D01BVR DRUG__ID D01BVR D01BVR DRUGCLAS Investigative Drug(s) D01BVR DRUGINCH 1S/C11H18N2OS/c1-2-3-9-10(15-13-11(9)14)8-4-6-12-7-5-8/h8,12H,2-7H2,1H3,(H,13,14) D01BVR DRUGINKE INIXNNKFVDXPBJ-UHFFFAOYSA-N D01BVR DRUGSMIL CCCC1=C(SNC1=O)C2CCNCC2 D01BVR DRUGTYPE Small molecular drug D01BVR HIGHSTAT Investigative D01BVU DRUG__ID D01BVU D01BVU COMPCLAS Platinum IV complexes D01BVU DRUGCLAS Patented Agent(s) D01BVU DRUGCOMP H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE TURKSON, James JOVE, Richard SEBTI, Said D01BVU DRUGTYPE Small molecular drug D01BVU HIGHSTAT Patented D01BWJ DRUG__ID D01BWJ D01BWJ DRUGCLAS Investigative Drug(s) D01BWJ DRUGCOMP MD Anderson Cancer Center D01BWJ HIGHSTAT Investigative D01BWV DRUG__ID D01BWV D01BWV DRUGCLAS Investigative Drug(s) D01BWV DRUGINCH 1S/C28H34N4/c1-3-5-16-28(17-6-4-2)26-22(21-14-10-11-15-23(21)30-26)18-24(32-28)27-29-19-25(31-27)20-12-8-7-9-13-20/h7-15,19,24,30,32H,3-6,16-18H2,1-2H3,(H,29,31)/t24-/m1/s1 D01BWV DRUGINKE FOBFICSYUINKAA-XMMPIXPASA-N D01BWV DRUGSMIL CCCCC1(C2=C(CC(N1)C3=NC=C(N3)C4=CC=CC=C4)C5=CC=CC=C5N2)CCCC D01BWV DRUGTYPE Small molecular drug D01BWV HIGHSTAT Investigative D01BXA DRUG__ID D01BXA D01BXA DRUGCLAS Patented Agent(s) D01BXA DRUGINCH 1S/C23H20FNO4/c24-15-22(26)25(16-17-7-6-12-21-23(17)28-14-13-27-21)19-10-4-5-11-20(19)29-18-8-2-1-3-9-18/h1-12H,13-16H2/i24-1 D01BXA DRUGINKE UDPFMHCLCUMIOF-MIGPCILRSA-N D01BXA DRUGSMIL C1COC2=C(C=CC=C2O1)CN(C3=CC=CC=C3OC4=CC=CC=C4)C(=O)CF D01BXA DRUGTYPE Small molecular drug D01BXA HIGHSTAT Patented D01BXE DRUG__ID D01BXE D01BXE DRUGCLAS Investigative Drug(s) D01BXE DRUGINCH 1S/C19H12Cl3N3OS/c20-14-4-2-13(3-5-14)18-17(25-7-8-27-19(25)24-18)10-23-26-11-12-1-6-15(21)16(22)9-12/h1-10H,11H2/b23-10+ D01BXE DRUGINKE ZQWBOKJVVYNKTL-AUEPDCJTSA-N D01BXE DRUGSMIL C1=CC(=CC=C1C2=C(N3C=CSC3=N2)C=NOCC4=CC(=C(C=C4)Cl)Cl)Cl D01BXE DRUGTYPE Small molecular drug D01BXE HIGHSTAT Investigative D01BXV DRUG__ID D01BXV D01BXV DRUGCLAS Patented Agent(s) D01BXV DRUGINCH 1S/C5H8Br2O2/c1-9-5(8)4(2-6)3-7/h4H,2-3H2,1H3 D01BXV DRUGINKE USXVPPOARMSYGY-UHFFFAOYSA-N D01BXV DRUGSMIL COC(=O)C(CBr)CBr D01BXV DRUGTYPE Small molecular drug D01BXV HIGHSTAT Patented D01BYB DRUG__ID D01BYB D01BYB DRUGCLAS Approved Drug(s) D01BYB DRUGINCH 1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 D01BYB DRUGINKE ZKHQWZAMYRWXGA-KQYNXXCUSA-N D01BYB DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N D01BYB DRUGTYPE Small molecular drug D01BYB HIGHSTAT Approved D01BYB THERCLAS Dietary supplement D01BZE DRUG__ID D01BZE D01BZE DRUGCLAS Investigative Drug(s) D01BZE DRUGINCH 1S/C30H48O4/c1-25(2)12-14-30(24(33)34)15-13-28(6)18(19(30)16-25)8-9-22-27(5)17-20(31)23(32)26(3,4)21(27)10-11-29(22,28)7/h8,19-23,31-32H,9-17H2,1-7H3,(H,33,34)/t19-,20+,21-,22+,23-,27-,28+,29+,30-/m0/s1 D01BZE DRUGINKE MDZKJHQSJHYOHJ-LLICELPBSA-N D01BZE DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1)C)C(=O)O)C D01BZE DRUGTYPE Small molecular drug D01BZE HIGHSTAT Investigative D01BZH DRUG__ID D01BZH D01BZH DRUGCLAS Investigative Drug(s) D01BZH DRUGINCH 1S/C18H29N7O8/c19-18(20)21-3-1-2-8-16(32)22-6-11(26)23-10(5-12(27)28)17(33)25-9-4-7(15(31)24-8)13(29)14(9)30/h7-10,13-14,29-30H,1-6H2,(H,22,32)(H,23,26)(H,24,31)(H,25,33)(H,27,28)(H4,19,20,21)/t7-,8+,9+,10+,13-,14-/m1/s1 D01BZH DRUGINKE VNLGSUKLIVHSOW-KOWOESDJSA-N D01BZH DRUGSMIL C1C2C(C(C1NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)O)O D01BZH DRUGTYPE Small molecular drug D01BZH HIGHSTAT Investigative D01BZP DRUG__ID D01BZP D01BZP DRUGCLAS Investigative Drug(s) D01BZP DRUGCOMP IThemba Pharmaceuticals Pty Ltd D01BZP HIGHSTAT Investigative D01BZR DRUG__ID D01BZR D01BZR DRUGCLAS Investigative Drug(s) D01BZR DRUGCOMP Intra-Cellular Therapies Inc D01BZR HIGHSTAT Investigative D01CAC DRUG__ID D01CAC D01CAC DRUGCLAS Investigative Drug(s) D01CAC DRUGINCH 1S/C20H23NO2/c1-23-19-11-9-18(10-12-19)20(22)21-14-5-8-17(13-15-21)16-6-3-2-4-7-16/h2-4,6-7,9-12,17H,5,8,13-15H2,1H3 D01CAC DRUGINKE SLZXHOMMTNEABC-UHFFFAOYSA-N D01CAC DRUGSMIL COC1=CC=C(C=C1)C(=O)N2CCCC(CC2)C3=CC=CC=C3 D01CAC DRUGTYPE Small molecular drug D01CAC HIGHSTAT Investigative D01CAH DRUG__ID D01CAH D01CAH DRUGCLAS Drugs in Phase 2 Trial D01CAH DRUGTYPE Cell therapy D01CAH HIGHSTAT Phase 2/3 Trial D01CAH THERCLAS Antiviral Agents D01CAJ DRUG__ID D01CAJ D01CAJ DRUGCLAS Discontinued Drug(s) D01CAJ DRUGCOMP AstraZeneca plc D01CAJ HIGHSTAT Discontinued in Phase 1 D01CAY DRUG__ID D01CAY D01CAY DRUGCLAS Investigative Drug(s) D01CAY DRUGINCH 1S/C20H20O5/c1-21-17-7-5-13(11-19(17)23-3)15-9-10-16(25-15)14-6-8-18(22-2)20(12-14)24-4/h5-12H,1-4H3 D01CAY DRUGINKE ZESHRVUYCRWWFA-UHFFFAOYSA-N D01CAY DRUGSMIL COC1=C(C=C(C=C1)C2=CC=C(O2)C3=CC(=C(C=C3)OC)OC)OC D01CAY DRUGTYPE Small molecular drug D01CAY HIGHSTAT Investigative D01CBE DRUG__ID D01CBE D01CBE DRUGCLAS Clinical Trial Drug(s) D01CBE DRUGCOMP Oncopeptides Stockholm, Sweden D01CBE HIGHSTAT Phase 2 D01CBG DRUG__ID D01CBG D01CBG DRUGCLAS Clinical Trial Drug(s) D01CBG DRUGCOMP Sarepta Therapeutics Cambridge, MA D01CBG HIGHSTAT Phase 2 D01CBK DRUG__ID D01CBK D01CBK DRUGCLAS Clinical Trial Drug(s) D01CBK DRUGCOMP Ose pharma D01CBK HIGHSTAT Phase 3 D01CBU DRUG__ID D01CBU D01CBU DRUGCLAS Investigative Drug(s) D01CBU DRUGCOMP Sun Yat-Sen University D01CBU DRUGINCH 1S/C36H39N5/c1-5-40(6-2)32-22-17-28(18-23-32)34-35(29-19-24-33(25-20-29)41(7-3)8-4)39-36(38-34)30-15-12-27(13-16-30)14-21-31-11-9-10-26-37-31/h9-26H,5-8H2,1-4H3,(H,38,39)/b21-14+ D01CBU DRUGINKE VXANOYUPSVZIAA-KGENOOAVSA-N D01CBU DRUGSMIL CCN(CC)C1=CC=C(C=C1)C2=C(N=C(N2)C3=CC=C(C=C3)C=CC4=CC=CC=N4)C5=CC=C(C=C5)N(CC)CC D01CBU DRUGTYPE Small molecular drug D01CBU HIGHSTAT Investigative D01CBV DRUG__ID D01CBV D01CBV DRUGCLAS Discontinued Drug(s) D01CBV DRUGCOMP Merck & Co Inc D01CBV DRUGINCH 1S/C4H4ClNS.ClH/c5-1-4-2-7-3-6-4;/h2-3H,1H2;1H D01CBV DRUGINKE NVTBASMQHFMANH-UHFFFAOYSA-N D01CBV DRUGSMIL C1=C(N=CS1)CCl.Cl D01CBV DRUGTYPE Small molecular drug D01CBV HIGHSTAT Discontinued in Phase 1 D01CCG DRUG__ID D01CCG D01CCG DRUGCLAS Investigative Drug(s) D01CCG DRUGINCH 1S/C18H16O2/c1-14-4-2-3-5-17(14)12-10-15-6-8-16(9-7-15)11-13-18(19)20/h2-9H,11,13H2,1H3,(H,19,20) D01CCG DRUGINKE FODHWOBAQBTTFS-UHFFFAOYSA-N D01CCG DRUGSMIL CC1=CC=CC=C1C#CC2=CC=C(C=C2)CCC(=O)O D01CCG DRUGTYPE Small molecular drug D01CCG HIGHSTAT Investigative D01CCT DRUG__ID D01CCT D01CCT DRUGCLAS Patented Agent(s) D01CCT DRUGCOMP Universit de Montral D01CCT DRUGINCH 1S/C18H13N5O5/c24-18(10-5-13-1-6-15(7-2-13)22(25)26)17-12-21(20-19-17)11-14-3-8-16(9-4-14)23(27)28/h1-10,12H,11H2/b10-5+ D01CCT DRUGINKE CVKOJPBBOPIMAL-BJMVGYQFSA-N D01CCT DRUGSMIL C1=CC(=CC=C1CN2C=C(N=N2)C(=O)C=CC3=CC=C(C=C3)[N+](=O)[O-])[N+](=O)[O-] D01CCT DRUGTYPE Small molecular drug D01CCT HIGHSTAT Patented D01CDE DRUG__ID D01CDE D01CDE DRUGCLAS Clinical Trial Drug(s) D01CDE DRUGCOMP Boehringer Ingelheim Corp D01CDE DRUGINCH 1S/C18H24N4O2/c1-3-21-15-6-4-5-7-16(15)22(18(21)24)17(23)19-12-10-13-8-9-14(11-12)20(13)2/h4-7,12-14H,3,8-11H2,1-2H3,(H,19,23)/t12?,13-,14?/m0/s1 D01CDE DRUGINKE MZRKHUUDDHJVHS-MOKVOYLWSA-N D01CDE DRUGSMIL CCN1C2=CC=CC=C2N(C1=O)C(=O)NC3CC4CCC(C3)N4C D01CDE DRUGTYPE Small molecular drug D01CDE HIGHSTAT Phase 1 D01CDK DRUG__ID D01CDK D01CDK DRUGCLAS Patented Agent(s) D01CDK DRUGINCH 1S/C22H19F3N6/c23-22(24,25)15-9-10-17-16(13-15)18(14-7-3-1-4-8-14)19(20-27-29-30-28-20)21(26-17)31-11-5-2-6-12-31/h1,3-4,7-10,13H,2,5-6,11-12H2,(H,27,28,29,30) D01CDK DRUGINKE SUXQAVNHOCPUSH-UHFFFAOYSA-N D01CDK DRUGSMIL C1CCN(CC1)C2=NC3=C(C=C(C=C3)C(F)(F)F)C(=C2C4=NNN=N4)C5=CC=CC=C5 D01CDK DRUGTYPE Small molecular drug D01CDK HIGHSTAT Patented D01CDL DRUG__ID D01CDL D01CDL DRUGCLAS Investigative Drug(s) D01CDL DRUGINCH 1S/C22H28O7/c1-23-17-9-13(10-18(24-2)21(17)27-5)15-7-8-16(29-15)14-11-19(25-3)22(28-6)20(12-14)26-4/h9-12,15-16H,7-8H2,1-6H3/t15-,16-/m1/s1 D01CDL DRUGINKE YCCPYTPBHUIHGW-HZPDHXFCSA-N D01CDL DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2CCC(O2)C3=CC(=C(C(=C3)OC)OC)OC D01CDL DRUGTYPE Small molecular drug D01CDL HIGHSTAT Investigative D01CEG DRUG__ID D01CEG D01CEG DRUGCLAS Clinical Trial Drug(s) D01CEG DRUGCOMP Piramal Healthcare Ltd D01CEG HIGHSTAT Phase 2 D01CEQ DRUG__ID D01CEQ D01CEQ DRUGCLAS Discontinued Drug(s) D01CEQ DRUGCOMP Cerenis D01CEQ HIGHSTAT Discontinued in Phase 1/2 D01CFL DRUG__ID D01CFL D01CFL COMPCLAS Benzothiazoline derivatives D01CFL DRUGCLAS Patented Agent(s) D01CFL DRUGINCH 1S/C15H14ClNO3S/c1-19-11-5-8(6-12(20-2)14(11)18)15-17-10-7-9(16)3-4-13(10)21-15/h3-7,15,17-18H,1-2H3 D01CFL DRUGINKE LQDWIAAYFSZPAR-UHFFFAOYSA-N D01CFL DRUGSMIL COC1=CC(=CC(=C1O)OC)C2NC3=C(S2)C=CC(=C3)Cl D01CFL DRUGTYPE Small molecular drug D01CFL HIGHSTAT Patented D01CFO DRUG__ID D01CFO D01CFO DRUGCLAS Investigative Drug(s) D01CFO DRUGINCH 1S/C47H76N14O8/c1-5-29(4)39(45(69)57-33(40(49)64)15-9-10-22-48)61-42(66)35(17-12-24-55-47(52)53)58-43(67)37(27-31-18-20-32(62)21-19-31)60-44(68)36(26-30-13-7-6-8-14-30)59-41(65)34(16-11-23-54-46(50)51)56-38(63)25-28(2)3/h6-8,13-14,18-21,28-29,33-37,39,62H,5,9-12,15-17,22-27,48H2,1-4H3,(H2,49,64)(H,56,63)(H,57,69)(H,58,67)(H,59,65)(H,60,68)(H,61,66)(H4,50,51,54)(H4,52,53,55)/t29-,33-,34-,35-,36-,37-,39-/m0/s1 D01CFO DRUGINKE WYGLGBXUEUHKTI-INYUMPDKSA-N D01CFO DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)CC(C)C D01CFO DRUGTYPE Small molecular drug D01CFO HIGHSTAT Investigative D01CFQ DRUG__ID D01CFQ D01CFQ DRUGCLAS Investigative Drug(s) D01CFQ DRUGCOMP Lixte Biotechnology Holdings Inc D01CFQ HIGHSTAT Investigative D01CGC DRUG__ID D01CGC D01CGC DRUGCLAS Investigative Drug(s) D01CGC DRUGINCH 1S/C21H39NO3/c1-3-4-5-14-17-20(23)22(2)19-16-13-11-9-7-6-8-10-12-15-18-21(24)25/h7,9H,3-6,8,10-19H2,1-2H3,(H,24,25)/b9-7- D01CGC DRUGINKE CJHOGNAQWWHHBN-CLFYSBASSA-N D01CGC DRUGSMIL CCCCCCC(=O)N(C)CCCCC=CCCCCCCC(=O)O D01CGC DRUGTYPE Small molecular drug D01CGC HIGHSTAT Investigative D01CGM DRUG__ID D01CGM D01CGM DRUGCLAS Investigative Drug(s) D01CGM DRUGINCH 1S/C22H22FN3O2S/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29) D01CGM DRUGINKE SMYALUSCZJXWHG-UHFFFAOYSA-N D01CGM DRUGSMIL C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=S D01CGM DRUGTYPE Small molecular drug D01CGM HIGHSTAT Investigative D01CGQ DRUG__ID D01CGQ D01CGQ DRUGCLAS Patented Agent(s) D01CGQ DRUGCOMP NEW ENGLAND BIOLABS INC D01CGQ DRUGTYPE Nucleotide D01CGQ HIGHSTAT Patented D01CGR DRUG__ID D01CGR D01CGR DRUGCLAS Investigative Drug(s) D01CGR DRUGINCH 1S/C15H17N3/c1-11(2)15-13(9-18-8-7-16-10-18)12-5-3-4-6-14(12)17-15/h3-8,10-11,17H,9H2,1-2H3 D01CGR DRUGINKE NZXGMVRYQLENHC-UHFFFAOYSA-N D01CGR DRUGSMIL CC(C)C1=C(C2=CC=CC=C2N1)CN3C=CN=C3 D01CGR DRUGTYPE Small molecular drug D01CGR HIGHSTAT Investigative D01CGV DRUG__ID D01CGV D01CGV DRUGCLAS Clinical Trial Drug(s) D01CGV DRUGCOMP Prosidion Ltd D01CGV DRUGINCH 1S/C21H25N3O4S/c25-21(24-20-14-22-9-10-23-20)19(13-15-7-11-28-12-8-15)16-1-3-17(4-2-16)29(26,27)18-5-6-18/h1-4,9-10,14-15,18-19H,5-8,11-13H2,(H,23,24,25)/t19-/m1/s1 D01CGV DRUGINKE DQIITKNITDKAJZ-LJQANCHMSA-N D01CGV DRUGSMIL C1CC1S(=O)(=O)C2=CC=C(C=C2)C(CC3CCOCC3)C(=O)NC4=NC=CN=C4 D01CGV HIGHSTAT Phase 2 D01CGX DRUG__ID D01CGX D01CGX DRUGCLAS Clinical Trial Drug(s) D01CGX HIGHSTAT Phase 3 D01CHD DRUG__ID D01CHD D01CHD DRUGCLAS Investigative Drug(s) D01CHD HIGHSTAT Investigative D01CHI DRUG__ID D01CHI D01CHI DRUGCLAS Approved Drug(s) D01CHI HIGHSTAT Approved D01CIB DRUG__ID D01CIB D01CIB DRUGCLAS Clinical Trial Drug(s) D01CIB DRUGCOMP Sanofi D01CIB HIGHSTAT Phase 1 D01CIK DRUG__ID D01CIK D01CIK COMPCLAS Heteroaryl-cyclopropylamine derivatives D01CIK DRUGCLAS Patented Agent(s) D01CIK DRUGCOMP ORYZON GENOMICS SA [ESORYZON GENOMICS S.A. BAKER, Jonathan, Alleman CASTRO PALOMINO, Julio FYFE, Matthew, Colin, Thor MAES, Tamara MARTINELL PEDEMONTE, MarORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D01CIK DRUGTYPE Small molecular drug D01CIK HIGHSTAT Patented D01CIN DRUG__ID D01CIN D01CIN DRUGCLAS Investigative Drug(s) D01CIN DRUGCOMP Stanford University D01CIN DRUGINCH 1S/C15H13N3S/c1-11-3-2-4-13(9-11)17-15-18-14(10-19-15)12-5-7-16-8-6-12/h2-10H,1H3,(H,17,18) D01CIN DRUGINKE KATNUHQNJGNLPW-UHFFFAOYSA-N D01CIN DRUGSMIL CC1=CC(=CC=C1)NC2=NC(=CS2)C3=CC=NC=C3 D01CIN DRUGTYPE Small molecular drug D01CIN HIGHSTAT Investigative D01CJB DRUG__ID D01CJB D01CJB DRUGCLAS Discontinued Drug(s) D01CJB DRUGCOMP Viventia Biotech D01CJB HIGHSTAT Terminated D01CJE DRUG__ID D01CJE D01CJE COMPCLAS 4-(thiazol-5-yl)-pyrimidine derivatives D01CJE DRUGCLAS Patented Agent(s) D01CJE DRUGCOMP CHANGZHOU LE SUN PHARMACEUTICALS LIMITED D01CJE DRUGINCH 1S/C15H15FN6O2S2/c1-8-13(25-15(18-2)20-8)12-11(16)7-19-14(22-12)21-9-4-3-5-10(6-9)26(17,23)24/h3-7H,1-2H3,(H,18,20)(H2,17,23,24)(H,19,21,22) D01CJE DRUGINKE GAIOPWBQKZMUNO-UHFFFAOYSA-N D01CJE DRUGSMIL CC1=C(SC(=N1)NC)C2=NC(=NC=C2F)NC3=CC(=CC=C3)S(=O)(=O)N D01CJE DRUGTYPE Small molecular drug D01CJE HIGHSTAT Patented D01CJY DRUG__ID D01CJY D01CJY DRUGCLAS Clinical Trial Drug(s) D01CJY HIGHSTAT Phase 2 D01CJZ DRUG__ID D01CJZ D01CJZ DRUGCLAS Investigative Drug(s) D01CJZ DRUGINCH 1S/C11H19N3/c1(3-11-8-13-9-14-11)2-10-4-6-12-7-5-10/h8-10,12H,1-7H2,(H,13,14) D01CJZ DRUGINKE YPGRNKJNOSUCLY-UHFFFAOYSA-N D01CJZ DRUGSMIL C1CNCCC1CCCC2=CN=CN2 D01CJZ DRUGTYPE Small molecular drug D01CJZ HIGHSTAT Investigative D01CKB DRUG__ID D01CKB D01CKB COMPCLAS Carbamide derivatives D01CKB DRUGCLAS Patented Agent(s) D01CKB DRUGCOMP ASCEPION PHARMACEUTICALS, INC. JIANG, Shan GAO, Xiaoyong WANG, Qishan D01CKB DRUGTYPE Small molecular drug D01CKB HIGHSTAT Patented D01CKY DRUG__ID D01CKY D01CKY DRUGCLAS Approved Drug(s) D01CKY DRUGINCH 1S/C20H28O5S.Na/c1-12(2)14-10-13-6-7-17-19(3,8-5-9-20(17,4)18(21)22)15(13)11-16(14)26(23,24)25;/h10-12,17H,5-9H2,1-4H3,(H,21,22)(H,23,24,25);/q;+1/p-1/t17-,19-,20-;/m1./s1 D01CKY DRUGINKE RCVIHORGZULVTN-YGJXXQMASA-M D01CKY DRUGSMIL CC(C)C1=C(C=C2C(=C1)CCC3C2(CCCC3(C)C(=O)O)C)S(=O)(=O)[O-].[Na+] D01CKY DRUGTYPE Small molecular drug D01CKY HIGHSTAT Approved D01CLK DRUG__ID D01CLK D01CLK DRUGCLAS Investigative Drug(s) D01CLK DRUGCOMP Chronogen D01CLK HIGHSTAT Investigative D01CNB DRUG__ID D01CNB D01CNB DRUGCLAS Clinical Trial Drug(s) D01CNB DRUGCOMP Eisai Ltd. D01CNB DRUGINCH 1S/C21H27NO6/c1-4-22-15-10-14-6-5-7-16(23)20(26)17(24)9-8-12(2)13(3)28-21(27)19(14)18(25)11-15/h5-6,8-13,16,20,22-23,25-26H,4,7H2,1-3H3/b6-5+,9-8-/t12-,13+,16+,20+/m1/s1 D01CNB DRUGINKE MWUFVYLAWAXDHQ-HMNLTAHHSA-N D01CNB DRUGSMIL CCNC1=CC2=C(C(=C1)O)C(=O)OC(C(C=CC(=O)C(C(CC=C2)O)O)C)C D01CNB DRUGTYPE Small molecular drug D01CNB HIGHSTAT Phase 2 D01CND DRUG__ID D01CND D01CND DRUGCLAS Patented Agent(s) D01CND DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D01CND DRUGTYPE Carbohydrates D01CND HIGHSTAT Patented D01CNF DRUG__ID D01CNF D01CNF DRUGCLAS Investigative Drug(s) D01CNF DRUGINCH 1S/C17H25N5O15P2/c1-6(23)34-13-11(25)8(36-17(13)27)3-33-39(30,31)37-38(28,29)32-2-7-10(24)12(26)16(35-7)22-5-21-9-14(18)19-4-20-15(9)22/h4-5,7-8,10-13,16-17,24-27H,2-3H2,1H3,(H,28,29)(H,30,31)(H2,18,19,20)/t7-,8-,10-,11-,12-,13-,16-,17?/m1/s1 D01CNF DRUGINKE BFNOPXRXIQJDHO-YDKGJHSESA-N D01CNF DRUGSMIL CC(=O)OC1C(C(OC1O)COP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)O)O D01CNF DRUGTYPE Small molecular drug D01CNF HIGHSTAT Investigative D01CNV DRUG__ID D01CNV D01CNV DRUGCLAS Discontinued Drug(s) D01CNV DRUGCOMP PLIVA dd D01CNV DRUGINCH 1S/C13H16N2O5S/c1-9(16)14-10-2-4-11(5-3-10)21(17,18)15-12-6-19-8-20-7-13(12)15/h2-5,12-13H,6-8H2,1H3,(H,14,16) D01CNV DRUGINKE AEDPBBOGLHONFN-UHFFFAOYSA-N D01CNV DRUGSMIL CC(=O)NC1=CC=C(C=C1)S(=O)(=O)N2C3C2COCOC3 D01CNV HIGHSTAT Terminated D01COH DRUG__ID D01COH D01COH DRUGCLAS Investigative Drug(s) D01COH DRUGCOMP Zambon Co SpA D01COH HIGHSTAT Investigative D01CON DRUG__ID D01CON D01CON DRUGCLAS Clinical Trial Drug(s) D01CON DRUGCOMP Adma biologics D01CON HIGHSTAT Phase 3 D01CQJ DRUG__ID D01CQJ D01CQJ DRUGCLAS Investigative Drug(s) D01CQJ DRUGCOMP Kolon Life Science Inc D01CQJ HIGHSTAT Investigative D01CQU DRUG__ID D01CQU D01CQU DRUGCLAS Investigative Drug(s) D01CQU DRUGINCH 1S/C27H29N5O5/c1-4-14-31-25-23(26(35)32(15-5-2)27(31)36)29-24(30-25)19-8-12-21(13-9-19)37-16-22(34)28-20-10-6-18(7-11-20)17(3)33/h6-13H,4-5,14-16H2,1-3H3,(H,28,34)(H,29,30) D01CQU DRUGINKE ZKUCFFYOQOJLGT-UHFFFAOYSA-N D01CQU DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C(=O)C D01CQU DRUGTYPE Small molecular drug D01CQU HIGHSTAT Investigative D01CRB DRUG__ID D01CRB D01CRB DRUGCLAS Approved Drug(s) D01CRB DRUGINCH 1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1 D01CRB DRUGINKE OUYCCCASQSFEME-QMMMGPOBSA-N D01CRB DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)O D01CRB DRUGTYPE Small molecular drug D01CRB HIGHSTAT Approved D01CRB THERCLAS Dietary supplement D01CRJ DRUG__ID D01CRJ D01CRJ DRUGCLAS Investigative Drug(s) D01CRJ DRUGINCH 1S/C29H36O3/c30-27(29(22-11-23-29)21-10-14-24-12-2-1-3-13-24)19-8-6-17-25-15-4-5-16-26(25)18-7-9-20-28(31)32/h1-3,6,8,12-13,17-19,25,27,30H,4-5,7,9,11,15-16,20-23H2,(H,31,32)/b17-6+,19-8+,26-18+ D01CRJ DRUGINKE HILRZHRCCODTSA-AHQVELJISA-N D01CRJ DRUGSMIL C1CCC(=CCCCC(=O)O)C(C1)C=CC=CC(C2(CCC2)CC#CC3=CC=CC=C3)O D01CRJ DRUGTYPE Small molecular drug D01CRJ HIGHSTAT Investigative D01CRK DRUG__ID D01CRK D01CRK DRUGCLAS Investigative Drug(s) D01CRK DRUGINCH 1S/C15H14N2/c1-2-4-15-14(3-1)13(11-17-15)6-5-12-7-9-16-10-8-12/h1-4,7-11,17H,5-6H2 D01CRK DRUGINKE UUEYCHLWAOBOHG-UHFFFAOYSA-N D01CRK DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCC3=CC=NC=C3 D01CRK DRUGTYPE Small molecular drug D01CRK HIGHSTAT Investigative D01CRX DRUG__ID D01CRX D01CRX DRUGCLAS Patented Agent(s) D01CRX DRUGCOMP GALAPAGOS NV D01CRX DRUGTYPE Small molecular drug D01CRX HIGHSTAT Patented D01CSE DRUG__ID D01CSE D01CSE DRUGCLAS Investigative Drug(s) D01CSE DRUGINCH 1S/C14H11Br2N3OS/c15-10-3-1-2-8(4-10)13(18-19-14(17)21)9-5-11(16)7-12(20)6-9/h1-7,20H,(H3,17,19,21)/b18-13- D01CSE DRUGINKE PWIIBRZZZZNLFE-AQTBWJFISA-N D01CSE DRUGSMIL C1=CC(=CC(=C1)Br)C(=NNC(=S)N)C2=CC(=CC(=C2)Br)O D01CSE DRUGTYPE Small molecular drug D01CSE HIGHSTAT Investigative D01CSM DRUG__ID D01CSM D01CSM DRUGCLAS Investigative Drug(s) D01CSM DRUGINCH 1S/C30H32ClN3O8S/c1-32(2)28(36)24-15-19(35)17-33(24)30(21-8-6-7-9-25(21)41-4)22-14-18(31)10-12-23(22)34(29(30)37)43(38,39)27-13-11-20(40-3)16-26(27)42-5/h6-14,16,19,24,35H,15,17H2,1-5H3/t19-,24+,30+/m1/s1/i3T3,5T3 D01CSM DRUGINKE NJXZWIIMWNEOGJ-KGKCFUOPSA-N D01CSM DRUGSMIL CN(C)C(=O)C1CC(CN1C2(C3=C(C=CC(=C3)Cl)N(C2=O)S(=O)(=O)C4=C(C=C(C=C4)OC)OC)C5=CC=CC=C5OC)O D01CSM DRUGTYPE Small molecular drug D01CSM HIGHSTAT Investigative D01CSZ DRUG__ID D01CSZ D01CSZ DRUGCLAS Investigative Drug(s) D01CSZ DRUGINCH 1S/C12H14N2O/c1-8(2)14-10-5-6-11(15)12-9(10)4-3-7-13-12/h3-8,14-15H,1-2H3 D01CSZ DRUGINKE BRXAKDWFCHQCDT-UHFFFAOYSA-N D01CSZ DRUGSMIL CC(C)NC1=C2C=CC=NC2=C(C=C1)O D01CSZ DRUGTYPE Small molecular drug D01CSZ HIGHSTAT Investigative D01CTM DRUG__ID D01CTM D01CTM DRUGCLAS Investigative Drug(s) D01CTM DRUGINCH 1S/C30H30F3N5O/c1-34-29(39)15-10-25-20-28(38(36-25)27-13-11-26(12-14-27)37-18-16-35-17-19-37)23-4-2-21(3-5-23)22-6-8-24(9-7-22)30(31,32)33/h2-9,11-14,20,35H,10,15-19H2,1H3,(H,34,39) D01CTM DRUGINKE GHBUPSVATJKTRR-UHFFFAOYSA-N D01CTM DRUGSMIL CNC(=O)CCC1=NN(C(=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)N5CCNCC5 D01CTM DRUGTYPE Small molecular drug D01CTM HIGHSTAT Investigative D01CTR DRUG__ID D01CTR D01CTR DRUGCLAS Clinical Trial Drug(s) D01CTR DRUGCOMP ProMetic Biotherapeutics Quebec, Canada D01CTR HIGHSTAT Phase 2/3 D01CUC DRUG__ID D01CUC D01CUC DRUGCLAS Clinical Trial Drug(s) D01CUC DRUGCOMP Shenzhen Geno-Immune Medical Institute D01CUC DRUGTYPE CAR T Cell Therapy D01CUC HIGHSTAT Phase 1/2 D01CUJ DRUG__ID D01CUJ D01CUJ DRUGCLAS Investigative Drug(s) D01CUJ DRUGINCH 1S/C13H16N2O5/c1-3-4-14-12(18)8(2)6-15(13(14)19)11-5-9(17)10(7-16)20-11/h1,6,9-11,16-17H,4-5,7H2,2H3/t9-,10+,11+/m0/s1 D01CUJ DRUGINKE LZHTUGCZNRVCGE-HBNTYKKESA-N D01CUJ DRUGSMIL CC1=CN(C(=O)N(C1=O)CC#C)C2CC(C(O2)CO)O D01CUJ DRUGTYPE Small molecular drug D01CUJ HIGHSTAT Investigative D01CUO DRUG__ID D01CUO D01CUO DRUGCLAS Clinical Trial Drug(s) D01CUO DRUGCOMP Trillium Therapeutics Mississauga, Canada D01CUO DRUGTYPE Recombinant protein D01CUO HIGHSTAT Phase 1 D01CUR DRUG__ID D01CUR D01CUR DRUGCLAS Investigative Drug(s) D01CUR DRUGINCH 1S/C13H12N2O/c1-2-16-13-7-10-9-5-3-4-6-11(9)15-12(10)8-14-13/h3-8,15H,2H2,1H3 D01CUR DRUGINKE FNNPSIGQQWCKKB-UHFFFAOYSA-N D01CUR DRUGSMIL CCOC1=NC=C2C(=C1)C3=CC=CC=C3N2 D01CUR DRUGTYPE Small molecular drug D01CUR HIGHSTAT Investigative D01CWN DRUG__ID D01CWN D01CWN DRUGCLAS Investigative Drug(s) D01CWN DRUGINCH 1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m1/s1 D01CWN DRUGINKE CIWBSHSKHKDKBQ-MVHIGOERSA-N D01CWN DRUGSMIL C(C(C1C(=C(C(=O)O1)O)O)O)O D01CWN DRUGTYPE Small molecular drug D01CWN HIGHSTAT Investigative D01CXD DRUG__ID D01CXD D01CXD DRUGCLAS Investigative Drug(s) D01CXD DRUGINCH 1S/C15H15N/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-8,15H,9-10,16H2 D01CXD DRUGINKE GEICAQNIOJFRQN-UHFFFAOYSA-N D01CXD DRUGSMIL C1C2=CC=CC=C2C(C3=CC=CC=C31)CN D01CXD DRUGTYPE Small molecular drug D01CXD HIGHSTAT Investigative D01CXJ DRUG__ID D01CXJ D01CXJ DRUGCLAS Clinical Trial Drug(s) D01CXJ DRUGCOMP Pacgen life science D01CXJ HIGHSTAT Phase 2 D01CXM DRUG__ID D01CXM D01CXM DRUGCLAS Investigative Drug(s) D01CXM DRUGINCH 1S/C13H12O4/c1-3-16-12-7-11-9(4-5-13(15)17-11)6-10(12)8(2)14/h4-7H,3H2,1-2H3 D01CXM DRUGINKE YPWNHEXIUIFWSP-UHFFFAOYSA-N D01CXM DRUGSMIL CCOC1=C(C=C2C=CC(=O)OC2=C1)C(=O)C D01CXM DRUGTYPE Small molecular drug D01CXM HIGHSTAT Investigative D01CXW DRUG__ID D01CXW D01CXW DRUGCLAS Clinical Trial Drug(s) D01CXW DRUGCOMP Medimmune D01CXW DRUGTYPE Monoclonal antibody D01CXW HIGHSTAT Phase 1 D01CYA DRUG__ID D01CYA D01CYA DRUGCLAS Approved Drug(s) D01CYA DRUGCOMP Cephalon D01CYA DRUGINCH 1S/C16H21Cl2N3O2.ClH/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23;/h5-6,11H,2-4,7-10H2,1H3,(H,22,23);1H D01CYA DRUGINKE ZHSKUOZOLHMKEA-UHFFFAOYSA-N D01CYA DRUGSMIL CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl D01CYA DRUGTYPE Small molecular drug D01CYA HIGHSTAT Approved D01CYI DRUG__ID D01CYI D01CYI DRUGCLAS Investigative Drug(s) D01CYI DRUGINCH 1S/C14H10N2O3/c17-10-3-1-9(2-4-10)16-8-15-13-7-11(18)5-6-12(13)14(16)19/h1-8,17-18H D01CYI DRUGINKE NECCEJFVHJYYDA-UHFFFAOYSA-N D01CYI DRUGSMIL C1=CC(=CC=C1N2C=NC3=C(C2=O)C=CC(=C3)O)O D01CYI DRUGTYPE Small molecular drug D01CYI HIGHSTAT Investigative D01CYK DRUG__ID D01CYK D01CYK DRUGCLAS Clinical Trial Drug(s) D01CYK DRUGCOMP Meiji seika pharma D01CYK HIGHSTAT Phase 1 D01CYT DRUG__ID D01CYT D01CYT DRUGCLAS Clinical Trial Drug(s) D01CYT DRUGCOMP Elan Corp plc D01CYT HIGHSTAT Phase 1 D01CYW DRUG__ID D01CYW D01CYW DRUGCLAS Investigative Drug(s) D01CYW DRUGCOMP Obio Pharmaceutical Holdings Ltd D01CYW HIGHSTAT Investigative D01CZH DRUG__ID D01CZH D01CZH DRUGCLAS Approved Drug(s) D01CZH DRUGCOMP Wolwo Biotech Co Ltd D01CZH HIGHSTAT Approved D01DAD DRUG__ID D01DAD D01DAD DRUGCLAS Discontinued Drug(s) D01DAD DRUGCOMP Pfizer D01DAD DRUGINCH 1S/C22H23N3O2S/c1-16-24-11-12-25(16)18-5-7-19(8-6-18)28-20-4-2-3-17(15-20)22(21(23)26)9-13-27-14-10-22/h2-8,11-12,15H,9-10,13-14H2,1H3,(H2,23,26) D01DAD DRUGINKE VPTONMHDLLMOOV-UHFFFAOYSA-N D01DAD DRUGSMIL CC1=NC=CN1C2=CC=C(C=C2)SC3=CC=CC(=C3)C4(CCOCC4)C(=O)N D01DAD DRUGTYPE Small molecular drug D01DAD HIGHSTAT Discontinued in Phase 2 D01DAQ DRUG__ID D01DAQ D01DAQ DRUGCLAS Investigative Drug(s) D01DAQ DRUGINCH 1S/C8H8FN5O2/c9-5-4(12-8(16)13-6(5)15)3-14-2-1-11-7(14)10/h1-2H,3H2,(H2,10,11)(H2,12,13,15,16) D01DAQ DRUGINKE SFEMKOUUPCFITA-UHFFFAOYSA-N D01DAQ DRUGSMIL C1=CN(C(=N1)N)CC2=C(C(=O)NC(=O)N2)F D01DAQ DRUGTYPE Small molecular drug D01DAQ HIGHSTAT Investigative D01DAU DRUG__ID D01DAU D01DAU DRUGCLAS Investigative Drug(s) D01DAU DRUGINCH 1S/C15H16N2/c1-2-3-4-6-13-7-5-8-14(9-13)10-15-11-16-12-17-15/h5,7-9,11-12H,2-3,10H2,1H3,(H,16,17) D01DAU DRUGINKE JAPGJDHRYBFKBD-UHFFFAOYSA-N D01DAU DRUGSMIL CCCC#CC1=CC=CC(=C1)CC2=CN=CN2 D01DAU DRUGTYPE Small molecular drug D01DAU HIGHSTAT Investigative D01DAW DRUG__ID D01DAW D01DAW DRUGCLAS Discontinued Drug(s) D01DAW DRUGCOMP Solvay D01DAW DRUGINCH 1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28) D01DAW DRUGINKE CYGODHVAJQTCBG-UHFFFAOYSA-N D01DAW DRUGSMIL C1CN(CCN1CC2=CC(=CC=C2)C3=CC=CC=C3)C4=CC=CC5=C4OC(=O)N5 D01DAW DRUGTYPE Small molecular drug D01DAW HIGHSTAT Discontinued in Phase 3 D01DBB DRUG__ID D01DBB D01DBB DRUGCLAS Patented Agent(s) D01DBB DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D01DBB DRUGTYPE Small molecular drug D01DBB HIGHSTAT Patented D01DBF DRUG__ID D01DBF D01DBF DRUGCLAS Investigative Drug(s) D01DBF DRUGCOMP APIT Laboratories GmbH D01DBF HIGHSTAT Investigative D01DBQ DRUG__ID D01DBQ D01DBQ DRUGCLAS Approved Drug(s) D01DBQ DRUGINCH 1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3/t16-,21+,23+,24-,26+,27+,28+,29+,31+,32-/m0/s1 D01DBQ DRUGINKE NRUKOCRGYNPUPR-QBPJDGROSA-N D01DBQ DRUGSMIL COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O D01DBQ DRUGTYPE Small molecular drug D01DBQ HIGHSTAT Approved D01DBQ THERCLAS Anticancer Agents D01DBW DRUG__ID D01DBW D01DBW DRUGCLAS Investigative Drug(s) D01DBW DRUGINCH 1S/C79H100ClN15O14S/c1-45(2)83-35-12-11-18-61(79(109)95-36-14-19-68(95)76(107)84-47(5)69(81)100)88-77(108)78(110-46(3)4)94-74(105)65(40-53-25-32-60(33-26-53)86-49(7)98)90-72(103)64(39-52-23-30-59(31-24-52)85-48(6)97)92-75(106)67(44-96)93-73(104)66(42-55-15-13-34-82-43-55)91-71(102)63(38-51-21-28-58(80)29-22-51)89-70(101)62(87-50(8)99)41-54-20-27-56-16-9-10-17-57(56)37-54/h9-10,13,15-17,20-34,37,43,45-47,61-68,78,83,96H,11-12,14,18-19,35-36,38-42,44H2,1-8H3,(H2,81,100)(H,84,107)(H,85,97)(H,86,98)(H,87,99)(H,88,108)(H,89,101)(H,90,103)(H,91,102)(H,92,106)(H,93,104)(H,94,105)/t47-,61+,62-,63-,64+,65-,66-,67+,68+,78+/m1/s1 D01DBW DRUGINKE GFSHJVRBLLVKAZ-FYZIRFIYSA-N D01DBW DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)SC(C)C D01DBW HIGHSTAT Investigative D01DCE DRUG__ID D01DCE D01DCE DRUGCLAS Investigative Drug(s) D01DCE DRUGINCH 1S/C15H15NS/c16-12-6-8-13(9-7-12)17-15-10-5-11-3-1-2-4-14(11)15/h1-4,6-9,15H,5,10,16H2 D01DCE DRUGINKE WWGLOFVWIRHNNH-UHFFFAOYSA-N D01DCE DRUGSMIL C1CC2=CC=CC=C2C1SC3=CC=C(C=C3)N D01DCE DRUGTYPE Small molecular drug D01DCE HIGHSTAT Investigative D01DCJ DRUG__ID D01DCJ D01DCJ DRUGCLAS Clinical Trial Drug(s) D01DCJ DRUGCOMP Geron Corp D01DCJ HIGHSTAT Phase 1 D01DCZ DRUG__ID D01DCZ D01DCZ DRUGCLAS Investigative Drug(s) D01DCZ DRUGCOMP Isis Pharmaceuticals D01DCZ DRUGTYPE Antisense drug D01DCZ HIGHSTAT Investigative D01DDB DRUG__ID D01DDB D01DDB DRUGCLAS Investigative Drug(s) D01DDB DRUGINCH 1S/C18H16N4O/c1-13(23)20-16-9-5-6-14(10-16)17-11-19-12-18(22-17)21-15-7-3-2-4-8-15/h2-12H,1H3,(H,20,23)(H,21,22) D01DDB DRUGINKE MKRMZWIJCMWBDU-UHFFFAOYSA-N D01DDB DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2=CN=CC(=N2)NC3=CC=CC=C3 D01DDB DRUGTYPE Small molecular drug D01DDB HIGHSTAT Investigative D01DDN DRUG__ID D01DDN D01DDN DRUGCLAS Clinical Trial Drug(s) D01DDN DRUGCOMP Merck D01DDN DRUGINCH 1S/C14H16N2O4/c1-14(5-6-14)4-2-3-8-7-9(17)20-12-10(8)11(18)15-13(19)16-12/h7H,2-6H2,1H3,(H2,15,16,18,19) D01DDN DRUGINKE ARJKMWXLIHZLQZ-UHFFFAOYSA-N D01DDN DRUGSMIL CC1(CC1)CCCC2=CC(=O)OC3=C2C(=O)NC(=O)N3 D01DDN DRUGTYPE Small molecular drug D01DDN HIGHSTAT Phase 2 D01DDQ DRUG__ID D01DDQ D01DDQ DRUGCLAS Investigative Drug(s) D01DDQ DRUGCOMP Isis Pharmaceuticals D01DDQ DRUGTYPE Antisense drug D01DDQ HIGHSTAT Investigative D01DEU DRUG__ID D01DEU D01DEU DRUGCLAS Investigative Drug(s) D01DEU HIGHSTAT Investigative D01DFK DRUG__ID D01DFK D01DFK DRUGCLAS Investigative Drug(s) D01DFK DRUGCOMP Isis Pharmaceuticals D01DFK DRUGTYPE Antisense drug D01DFK HIGHSTAT Investigative D01DFX DRUG__ID D01DFX D01DFX DRUGCLAS Investigative Drug(s) D01DFX DRUGINCH 1S/C10H11N3/c1-9-12-6-7-13(9)8-10-2-4-11-5-3-10/h2-7H,8H2,1H3 D01DFX DRUGINKE MNSNMTASPOHKEI-UHFFFAOYSA-N D01DFX DRUGSMIL CC1=NC=CN1CC2=CC=NC=C2 D01DFX DRUGTYPE Small molecular drug D01DFX HIGHSTAT Investigative D01DGN DRUG__ID D01DGN D01DGN DRUGCLAS Approved Drug(s) D01DGN HIGHSTAT Approved D01DGZ DRUG__ID D01DGZ D01DGZ DRUGCLAS Clinical Trial Drug(s) D01DGZ DRUGCOMP AbbVie D01DGZ DRUGINCH 1S/C28H21F4NO7/c29-26(30)37-17-6-7-18-19(13-21(38-22(18)12-17)14-1-3-15(4-2-14)24(34)35)33-25(36)27(9-10-27)16-5-8-20-23(11-16)40-28(31,32)39-20/h1-8,11-12,19,21,26H,9-10,13H2,(H,33,36)(H,34,35)/t19-,21-/m1/s1 D01DGZ DRUGINKE QVDYQHXNAQHIKH-TZIWHRDSSA-N D01DGZ DRUGSMIL C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4CC(OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O D01DGZ HIGHSTAT Phase 2 D01DHT DRUG__ID D01DHT D01DHT DRUGCLAS Patented Agent(s) D01DHT DRUGCOMP MERCK SHARP &amDOHME CORP. DEVITA, Robert, J. HE, Shuwen LIU, Jian CERNAK, Timothy, A. KRIKORIAN, Arto, D. YANG, Ginger XuQiang WU, Zhicai YU, Yang SHEN, Dong-Ming LAI, Zhong HONG, Qingmei NARGUND, Ravi, P D01DHT DRUGINCH 1S/C27H25FN4O2/c28-23-3-1-2-21(15-23)26-30-27(32-31-26)22-12-13-24(29-16-22)20-10-8-19(9-11-20)18-6-4-17(5-7-18)14-25(33)34/h1-3,8-13,15-18H,4-7,14H2,(H,33,34)(H,30,31,32) D01DHT DRUGINKE IMVHPASOWCDZEL-UHFFFAOYSA-N D01DHT DRUGSMIL C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NC=C(C=C3)C4=NNC(=N4)C5=CC(=CC=C5)F D01DHT DRUGTYPE Small molecular drug D01DHT HIGHSTAT Patented D01DHW DRUG__ID D01DHW D01DHW DRUGCLAS Investigative Drug(s) D01DHW DRUGINCH 1S/C27H24NO5/c1-29-24-8-7-18-13-23-21-15-26-25(32-17-33-26)14-19(21)9-10-28(23)16-22(18)27(24)31-12-11-30-20-5-3-2-4-6-20/h2-8,13-16H,9-12,17H2,1H3/q+1 D01DHW DRUGINKE BTWWJBNJLCMOGS-UHFFFAOYSA-N D01DHW DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCOC6=CC=CC=C6 D01DHW DRUGTYPE Small molecular drug D01DHW HIGHSTAT Investigative D01DIM DRUG__ID D01DIM D01DIM DRUGCLAS Clinical Trial Drug(s) D01DIM DRUGCOMP Novartis OncologyEast Hanover, NJ D01DIM HIGHSTAT Phase 1/2 D01DIQ DRUG__ID D01DIQ D01DIQ DRUGCLAS Investigative Drug(s) D01DIQ DRUGINCH 1S/C32H36N2O9/c1-7-17-15-34-25-13-20(17)30(29(36)41-6,16-42-28(35)18-10-23(38-3)27(40-5)24(11-18)39-4)31-14-26(34)43-32(25,31)33-22-9-8-19(37-2)12-21(22)31/h7-12,20,25-26,33H,13-16H2,1-6H3/b17-7-/t20-,25-,26-,30-,31-,32-/m0/s1 D01DIQ DRUGINKE JIBNKPQBEIZZCU-DYWXBFQLSA-N D01DIQ DRUGSMIL CC=C1CN2C3CC1C(C45C3(NC6=C4C=C(C=C6)OC)OC2C5)(COC(=O)C7=CC(=C(C(=C7)OC)OC)OC)C(=O)OC D01DIQ DRUGTYPE Small molecular drug D01DIQ HIGHSTAT Investigative D01DIT DRUG__ID D01DIT D01DIT DRUGCLAS Investigative Drug(s) D01DIT DRUGINCH 1S/C20H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h6-7,9-10,22H,2-5,8,11-19H2,1H3,(H,21,23)/b7-6-,10-9- D01DIT DRUGINKE KQXDGUVSAAQARU-HZJYTTRNSA-N D01DIT DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)NCCO D01DIT DRUGTYPE Small molecular drug D01DIT HIGHSTAT Investigative D01DJA DRUG__ID D01DJA D01DJA DRUGCLAS Discontinued Drug(s) D01DJA DRUGCOMP Kyowa Hakko Kogyo Co Ltd D01DJA HIGHSTAT Terminated D01DJI DRUG__ID D01DJI D01DJI DRUGCLAS Clinical Trial Drug(s) D01DJI DRUGCOMP PhytoCeutica Inc D01DJI HIGHSTAT Phase 2 D01DJZ DRUG__ID D01DJZ D01DJZ COMPCLAS Indoline derivatives D01DJZ DRUGCLAS Patented Agent(s) D01DJZ DRUGCOMP KBP BIOSCIENCES CO., LTD D01DJZ DRUGTYPE Small molecular drug D01DJZ HIGHSTAT Patented D01DLT DRUG__ID D01DLT D01DLT DRUGCLAS Clinical Trial Drug(s) D01DLT DRUGCOMP PharmaCyte Biotech Laguna Hills, CA D01DLT HIGHSTAT Phase 2 D01DMN DRUG__ID D01DMN D01DMN DRUGCLAS Investigative Drug(s) D01DMN DRUGINCH 1S/C21H23NO6/c1-11(23)22-15-7-5-12-9-18(26-2)20(27-3)21(28-4)19(12)13-6-8-16(24)17(25)10-14(13)15/h6,8-10,15H,5,7H2,1-4H3,(H,22,23)(H,24,25)/t15-/m0/s1 D01DMN DRUGINKE PRGILOMAMBLWNG-HNNXBMFYSA-N D01DMN DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)O)OC)OC)OC D01DMN DRUGTYPE Small molecular drug D01DMN HIGHSTAT Investigative D01DMS DRUG__ID D01DMS D01DMS DRUGCLAS Investigative Drug(s) D01DMS DRUGINCH 1S/C7H8IN3O4/c8-3-1-11(2-4(9)6(13)14)7(15)10-5(3)12/h1,4H,2,9H2,(H,13,14)(H,10,12,15)/t4-/m0/s1 D01DMS DRUGINKE AXXYLTBQIQBTES-BYPYZUCNSA-N D01DMS DRUGSMIL C1=C(C(=O)NC(=O)N1CC(C(=O)O)N)I D01DMS DRUGTYPE Small molecular drug D01DMS HIGHSTAT Investigative D01DMT DRUG__ID D01DMT D01DMT DRUGCLAS Investigative Drug(s) D01DMT DRUGCOMP INSERM D01DMT DRUGINCH 1S/C32H55N3O2/c1-21(2)7-6-8-22(3)26-9-10-27-25-17-29(34-16-13-23-19-33-20-35-23)32(37)18-24(36)11-15-31(32,5)28(25)12-14-30(26,27)4/h19-22,24-29,34,36-37H,6-18H2,1-5H3,(H,33,35)/t22-,24+,25+,26-,27+,28+,29-,30-,31-,32+/m1/s1 D01DMT DRUGINKE AVFNYTPENXWWCA-BULFVYHESA-N D01DMT DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)NCCC5=CN=CN5)C D01DMT DRUGTYPE Small molecular drug D01DMT HIGHSTAT Investigative D01DNH DRUG__ID D01DNH D01DNH DRUGCLAS Patented Agent(s) D01DNH DRUGCOMP Amorepacific Corp D01DNH DRUGINCH 1S/C22H23F2N3O3S2/c1-12(2)14-6-5-7-15(8-14)22-26-19(11-31-22)21(28)25-13(3)16-9-17(23)20(18(24)10-16)27-32(4,29)30/h5-13,27H,1-4H3,(H,25,28)/t13-/m1/s1 D01DNH DRUGINKE PCULXRGTXBQRDF-CYBMUJFWSA-N D01DNH DRUGSMIL CC(C)C1=CC=CC(=C1)C2=NC(=CS2)C(=O)NC(C)C3=CC(=C(C(=C3)F)NS(=O)(=O)C)F D01DNH DRUGTYPE Small molecular drug D01DNH HIGHSTAT Patented D01DNN DRUG__ID D01DNN D01DNN DRUGCLAS Investigative Drug(s) D01DNN DRUGINCH 1S/C53H68N8O12/c1-30(62)45(51(69)61-24-8-12-43(61)50(68)57-41(11-6-7-23-54)48(66)60-46(31(2)63)53(72)73)59-49(67)42(29-35-17-22-44(64)38(26-35)25-32-9-4-3-5-10-32)58-47(65)39(55)27-33-13-18-36(19-14-33)37-20-15-34(16-21-37)28-40(56)52(70)71/h3-5,9-10,13-22,26,30-31,39-43,45-46,62-64H,6-8,11-12,23-25,27-29,54-56H2,1-2H3,(H,57,68)(H,58,65)(H,59,67)(H,60,66)(H,70,71)(H,72,73)/t30-,31-,39+,40+,41+,42+,43+,45+,46+/m1/s1 D01DNN DRUGINKE VGTTXQUWJIRLOZ-PMDNFMOISA-N D01DNN DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC2=CC(=C(C=C2)O)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)C5=CC=C(C=C5)CC(C(=O)O)N)N)O D01DNN HIGHSTAT Investigative D01DOV DRUG__ID D01DOV D01DOV DRUGCLAS Investigative Drug(s) D01DOV DRUGINCH 1S/C12H24N2OS/c13-11(8-2-1-5-9-16)12(15)14-10-6-3-4-7-10/h10-11,16H,1-9,13H2,(H,14,15)/t11-/m0/s1 D01DOV DRUGINKE BNEXTTBMNDFSSZ-NSHDSACASA-N D01DOV DRUGSMIL C1CCC(C1)NC(=O)C(CCCCCS)N D01DOV DRUGTYPE Small molecular drug D01DOV HIGHSTAT Investigative D01DOW DRUG__ID D01DOW D01DOW DRUGCLAS Investigative Drug(s) D01DOW DRUGINCH 1S/3Na.H3O4P/c;;;1-5(2,3)4/h;;;(H3,1,2,3,4)/q3*+1;/p-3 D01DOW DRUGINKE RYFMWSXOAZQYPI-UHFFFAOYSA-K D01DOW DRUGSMIL [O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+] D01DOW DRUGTYPE Small molecular drug D01DOW HIGHSTAT Investigative D01DOY DRUG__ID D01DOY D01DOY DRUGCLAS Discontinued Drug(s) D01DOY DRUGCOMP Glaxo Group Research Ltd D01DOY HIGHSTAT Discontinued in Phase 1 D01DPC DRUG__ID D01DPC D01DPC DRUGCLAS Investigative Agents D01DPC DRUGTYPE Combination drug D01DPC HIGHSTAT Investigative D01DPC THERCLAS Antiviral Agents D01DPD DRUG__ID D01DPD D01DPD DRUGCLAS Discontinued Drug(s) D01DPD DRUGINCH 1S/C16H17N3O3/c1-2-5-16(20)18-14-8-7-12(15(11-14)19(21)22)10-13-6-3-4-9-17-13/h3-4,6-9,11H,2,5,10H2,1H3,(H,18,20) D01DPD DRUGINKE CZKQVCYQBJJAGG-UHFFFAOYSA-N D01DPD DRUGSMIL CCCC(=O)NC1=CC(=C(C=C1)CC2=CC=CC=N2)[N+](=O)[O-] D01DPD DRUGTYPE Small molecular drug D01DPD HIGHSTAT Discontinued in Phase 1 D01DPF DRUG__ID D01DPF D01DPF DRUGCLAS Investigative Drug(s) D01DPF DRUGINCH 1S/C23H28ClNO3S/c1-5-12-28-22(26)20-17(7-3)19(23(27)29-13-6-2)18(8-4)25-21(20)15-10-9-11-16(24)14-15/h9-11,14H,5-8,12-13H2,1-4H3 D01DPF DRUGINKE RPTCJTNYKDJGHU-UHFFFAOYSA-N D01DPF DRUGSMIL CCCOC(=O)C1=C(N=C(C(=C1CC)C(=O)SCCC)CC)C2=CC(=CC=C2)Cl D01DPF DRUGTYPE Small molecular drug D01DPF HIGHSTAT Investigative D01DPN DRUG__ID D01DPN D01DPN DRUGCLAS Investigative Drug(s) D01DPN DRUGINCH 1S/C13H12N2S/c1-3-13-12(15-10(2)16-13)7-6-11-5-4-8-14-9-11/h4-5,8-9H,3H2,1-2H3 D01DPN DRUGINKE SJJSHLRFCBWELS-UHFFFAOYSA-N D01DPN DRUGSMIL CCC1=C(N=C(S1)C)C#CC2=CN=CC=C2 D01DPN DRUGTYPE Small molecular drug D01DPN HIGHSTAT Investigative D01DQI DRUG__ID D01DQI D01DQI DRUGCLAS Investigative Drug(s) D01DQI DRUGCOMP Oryx GmbH D01DQI HIGHSTAT Investigative D01DQR DRUG__ID D01DQR D01DQR DRUGCLAS Discontinued Drug(s) D01DQR DRUGCOMP Alkermes D01DQR HIGHSTAT Discontinued in Phase 1 D01DQT DRUG__ID D01DQT D01DQT DRUGCLAS Investigative Drug(s) D01DQT DRUGINCH 1S/C70H101N21O18S2/c1-8-34(4)57(69(108)109-7)91-66(105)51(31-111)89-68(107)56(33(2)3)90-64(103)47(23-38-27-78-43-17-12-10-15-41(38)43)85-60(99)45(19-20-52(71)93)84-63(102)49(25-54(95)96)87-62(101)46(22-37-26-77-42-16-11-9-14-40(37)42)82-53(94)29-79-58(97)35(5)81-61(100)48(24-39-28-75-32-80-39)86-59(98)44(18-13-21-76-70(73)74)83-65(104)50(30-110)88-67(106)55(72)36(6)92/h9-12,14-17,26-28,32-36,44-51,55-57,77-78,92,110-111H,8,13,18-25,29-31,72H2,1-7H3,(H2,71,93)(H,75,80)(H,79,97)(H,81,100)(H,82,94)(H,83,104)(H,84,102)(H,85,99)(H,86,98)(H,87,101)(H,88,106)(H,89,107)(H,90,103)(H,91,105)(H,95,96)(H4,73,74,76)/t34?,35-,36+,44-,45-,46-,47-,48-,49-,50-,51-,55-,56-,57-/m0/s1 D01DQT DRUGINKE UQCBIVMMKZHRCG-CREZQNEJSA-N D01DQT DRUGSMIL CCC(C)C(C(=O)OC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CNC(=O)C(C)NC(=O)C(CC5=CNC=N5)NC(=O)C(CCCN=C(N)N)NC(=O)C(CS)NC(=O)C(C(C)O)N D01DQT HIGHSTAT Investigative D01DRE DRUG__ID D01DRE D01DRE DRUGCLAS Investigative Drug(s) D01DRE DRUGCOMP SOM Biotech SL D01DRE HIGHSTAT Investigative D01DRL DRUG__ID D01DRL D01DRL DRUGCLAS Discontinued Drug(s) D01DRL DRUGCOMP Gedeon Richter Ltd D01DRL HIGHSTAT Terminated D01DSB DRUG__ID D01DSB D01DSB DRUGCLAS Investigative Drug(s) D01DSB DRUGCOMP VentiRx Pharmaceuticals Inc D01DSB HIGHSTAT Investigative D01DSL DRUG__ID D01DSL D01DSL COMPCLAS Triptolidenol analogs D01DSL DRUGCLAS Patented Agent(s) D01DSL DRUGCOMP Institute of Materia Medica, Chinese Academy of Medical Sciences, Peop. Rep. China D01DSL DRUGINCH 1S/C29H29FO8/c1-25(2,33)28-21(37-28)22-29(38-22)26(3)11-10-16-17(13-34-23(16)32)18(26)12-19-27(29,36-19)24(28)35-20(31)9-6-14-4-7-15(30)8-5-14/h4-9,18-19,21-22,24,33H,10-13H2,1-3H3/b9-6+/t18-,19-,21-,22-,24-,26-,27+,28-,29+/m0/s1 D01DSL DRUGINKE FVQHGGQECDTHSW-YZAYWNIQSA-N D01DSL DRUGSMIL CC12CCC3=C(C1CC4C5(C26C(O6)C7C(C5OC(=O)C=CC8=CC=C(C=C8)F)(O7)C(C)(C)O)O4)COC3=O D01DSL DRUGTYPE Small molecular drug D01DSL HIGHSTAT Patented D01DSP DRUG__ID D01DSP D01DSP DRUGCLAS Approved Drug(s) D01DSP DRUGINCH 1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1 D01DSP DRUGINKE UQLLWWBDSUHNEB-CZUORRHYSA-N D01DSP DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O D01DSP DRUGTYPE Small molecular drug D01DSP HIGHSTAT Approved D01DSP THERCLAS Antibiotics D01DTE DRUG__ID D01DTE D01DTE DRUGCLAS Investigative Drug(s) D01DTE DRUGINCH 1S/C12H8Cl2O3/c13-7-1-3-12(10(16)5-7)17-11-4-2-8(15)6-9(11)14/h1-6,15-16H D01DTE DRUGINKE JVFMLMMBAJXPOQ-UHFFFAOYSA-N D01DTE DRUGSMIL C1=CC(=C(C=C1O)Cl)OC2=C(C=C(C=C2)Cl)O D01DTE DRUGTYPE Small molecular drug D01DTE HIGHSTAT Investigative D01DTO DRUG__ID D01DTO D01DTO DRUGCLAS Clinical Trial Drug(s) D01DTO DRUGCOMP AOBiome Cambridge, MA D01DTO HIGHSTAT Phase 2 D01DTQ DRUG__ID D01DTQ D01DTQ DRUGCLAS Discontinued Drug(s) D01DTQ DRUGCOMP Pharmaxis Ltd D01DTQ HIGHSTAT Terminated D01DTW DRUG__ID D01DTW D01DTW DRUGCLAS Investigative Drug(s) D01DTW DRUGINCH 1S/C15H26/c1-6-14(4)10-8-12-15(5)11-7-9-13(2)3/h6,9,12H,7-8,10-11H2,1-5H3/b14-6+,15-12+ D01DTW DRUGINKE JXBSHSBNOVLGHF-BUJBXKITSA-N D01DTW DRUGSMIL CC=C(C)CCC=C(C)CCC=C(C)C D01DTW DRUGTYPE Small molecular drug D01DTW HIGHSTAT Investigative D01DVR DRUG__ID D01DVR D01DVR DRUGCLAS Investigative Drug(s) D01DVR DRUGCOMP Neuroscience Technologies D01DVR HIGHSTAT Investigative D01DVS DRUG__ID D01DVS D01DVS DRUGCLAS Investigative Drug(s) D01DVS DRUGCOMP Isis Pharmaceuticals D01DVS DRUGTYPE Antisense drug D01DVS HIGHSTAT Investigative D01DVV DRUG__ID D01DVV D01DVV DRUGCLAS Investigative Drug(s) D01DVV DRUGCOMP Isis Pharmaceuticals D01DVV DRUGTYPE Antisense drug D01DVV HIGHSTAT Investigative D01DVX DRUG__ID D01DVX D01DVX DRUGCLAS Discontinued Drug(s) D01DVX DRUGCOMP Bristol-Myers Squibb Pharma D01DVX DRUGINCH 1S/C27H32N4O4/c1-17(2)14-24(25(32)30-34)31-13-12-27(28,26(31)33)20-8-10-21(11-9-20)35-16-19-15-18(3)29-23-7-5-4-6-22(19)23/h4-11,15,17,24,34H,12-14,16,28H2,1-3H3,(H,30,32)/t24-,27-/m1/s1 D01DVX DRUGINKE QVNZBDLTUKCPGJ-SHQCIBLASA-N D01DVX DRUGSMIL CC1=NC2=CC=CC=C2C(=C1)COC3=CC=C(C=C3)C4(CCN(C4=O)C(CC(C)C)C(=O)NO)N D01DVX DRUGTYPE Small molecular drug D01DVX HIGHSTAT Terminated D01DWN DRUG__ID D01DWN D01DWN DRUGCLAS Patented Agent(s) D01DWN DRUGCOMP Owen D, Wilkins M D01DWN DRUGTYPE Small molecular drug D01DWN HIGHSTAT Patented D01DXB DRUG__ID D01DXB D01DXB DRUGCLAS Patented Agent(s) D01DXB DRUGCOMP DEBRECENI EGYETEM D01DXB DRUGTYPE Carbohydrates D01DXB HIGHSTAT Patented D01DXI DRUG__ID D01DXI D01DXI DRUGCLAS Clinical Trial Drug(s) D01DXI DRUGCOMP Pfizer D01DXI DRUGTYPE Vaccine D01DXI HIGHSTAT Phase 2 D01DYO DRUG__ID D01DYO D01DYO DRUGCLAS Patented Agent(s) D01DYO DRUGINCH 1S/C21H19F5N4O2S/c1-29-11-20(27-12-29)33(31,32)30-9-16(13-2-4-14(22)5-3-13)19(10-30)28-15-6-7-18(23)17(8-15)21(24,25)26/h2-8,11-12,16,19,28H,9-10H2,1H3/t16-,19+/m1/s1 D01DYO DRUGINKE QHYIYIVWHBQJLT-APWZRJJASA-N D01DYO DRUGSMIL CN1C=C(N=C1)S(=O)(=O)N2CC(C(C2)NC3=CC(=C(C=C3)F)C(F)(F)F)C4=CC=C(C=C4)F D01DYO DRUGTYPE Small molecular drug D01DYO HIGHSTAT Patented D01DYZ DRUG__ID D01DYZ D01DYZ DRUGCLAS Investigative Drug(s) D01DYZ DRUGINCH 1S/C23H25NO5/c1-25-19-7-13-6-15(14-8-21(27-3)23(29-5)22(9-14)28-4)17-11-24-12-18(17)16(13)10-20(19)26-2/h6-10,24H,11-12H2,1-5H3 D01DYZ DRUGINKE AECCJUJXNOJGBB-UHFFFAOYSA-N D01DYZ DRUGSMIL COC1=CC2=CC(=C3CNCC3=C2C=C1OC)C4=CC(=C(C(=C4)OC)OC)OC D01DYZ DRUGTYPE Small molecular drug D01DYZ HIGHSTAT Investigative D01DZF DRUG__ID D01DZF D01DZF DRUGCLAS Investigative Drug(s) D01DZF DRUGINCH 1S/C21H20N2O/c24-21(19-11-14-22-15-12-19)23-16-13-20(17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-12,14-15,20H,13,16H2,(H,23,24) D01DZF DRUGINKE FNZXNCPUNGHMCJ-UHFFFAOYSA-N D01DZF DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)C2=CC=NC=C2)C3=CC=CC=C3 D01DZF DRUGTYPE Small molecular drug D01DZF HIGHSTAT Investigative D01EAG DRUG__ID D01EAG D01EAG DRUGCLAS Investigative Drug(s) D01EAG HIGHSTAT Investigative D01EAQ DRUG__ID D01EAQ D01EAQ DRUGCLAS Investigative Drug(s) D01EAQ DRUGINCH 1S/C19H23F3N2O3S/c1-3-6-15(2)27-18-9-4-8-17(11-18)24(13-16-7-5-10-23-12-16)28(25,26)14-19(20,21)22/h4-5,7-12,15H,3,6,13-14H2,1-2H3 D01EAQ DRUGINKE ICFXZBZASBXILF-UHFFFAOYSA-N D01EAQ DRUGSMIL CCCC(C)OC1=CC=CC(=C1)N(CC2=CN=CC=C2)S(=O)(=O)CC(F)(F)F D01EAQ DRUGTYPE Small molecular drug D01EAQ HIGHSTAT Investigative D01EAV DRUG__ID D01EAV D01EAV DRUGCLAS Investigative Drug(s) D01EAV DRUGCOMP Isis Pharmaceuticals D01EAV DRUGTYPE Antisense drug D01EAV HIGHSTAT Investigative D01EBJ DRUG__ID D01EBJ D01EBJ DRUGCLAS Discontinued Drug(s) D01EBJ DRUGCOMP Glaxo Wellcome plc D01EBJ DRUGINCH 1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22)/t12?,13-,14?/m0/s1 D01EBJ DRUGINKE JLDUTSKKXXJGGG-MOKVOYLWSA-N D01EBJ DRUGSMIL CN(C)C1CC(C1)C2=CNC3=C2C=C(C=C3)CC4COC(=O)N4 D01EBJ DRUGTYPE Small molecular drug D01EBJ HIGHSTAT Discontinued in Phase 2 D01EBV DRUG__ID D01EBV D01EBV DRUGCLAS Investigative Drug(s) D01EBV DRUGINCH 1S/C31H50O4/c1-18-11-14-31(26(34)35-8)16-15-29(6)20(24(31)19(18)2)9-10-23-28(5)17-21(32)25(33)27(3,4)22(28)12-13-30(23,29)7/h9,18-19,21-25,32-33H,10-17H2,1-8H3/t18-,19+,21-,22+,23-,24+,25-,28+,29-,30-,31+/m1/s1 D01EBV DRUGINKE BRZWXKGDPAZBLF-ZLSCOBDWSA-N D01EBV DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1C)C)C(=O)OC D01EBV DRUGTYPE Small molecular drug D01EBV HIGHSTAT Investigative D01EBW DRUG__ID D01EBW D01EBW DRUGCLAS Patented Agent(s) D01EBW DRUGCOMP AstraZeneca D01EBW DRUGINCH 1S/C22H28ClN3O3/c1-14-3-2-9-22(29,11-14)13-24-21(28)20-16-4-7-19(26-10-8-15(27)12-26)25-18(16)6-5-17(20)23/h4-7,14-15,27,29H,2-3,8-13H2,1H3,(H,24,28)/t14-,15+,22-/m0/s1 D01EBW DRUGINKE GTFTZKPCYSYNOU-KIMHZCHSSA-N D01EBW DRUGSMIL CC1CCCC(C1)(CNC(=O)C2=C(C=CC3=C2C=CC(=N3)N4CCC(C4)O)Cl)O D01EBW DRUGTYPE Small molecular drug D01EBW HIGHSTAT Patented D01EBY DRUG__ID D01EBY D01EBY DRUGCLAS Investigative Drug(s) D01EBY DRUGINCH 1S/C6H13N3O2S/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1 D01EBY DRUGINKE BKGWACHYAMTLAF-BYPYZUCNSA-N D01EBY DRUGSMIL C(CC(C(=O)O)N)CNC(=S)N D01EBY DRUGTYPE Small molecular drug D01EBY HIGHSTAT Investigative D01ECL DRUG__ID D01ECL D01ECL DRUGCLAS Investigative Drug(s) D01ECL DRUGINCH 1S/C11H8N2S/c1-9-13-11(8-14-9)6-5-10-4-2-3-7-12-10/h2-4,7-8H,1H3 D01ECL DRUGINKE BQDSXKBRSCMFRW-UHFFFAOYSA-N D01ECL DRUGSMIL CC1=NC(=CS1)C#CC2=CC=CC=N2 D01ECL DRUGTYPE Small molecular drug D01ECL HIGHSTAT Investigative D01ECN DRUG__ID D01ECN D01ECN DRUGCLAS Preclinical Drug(s) D01ECN DRUGCOMP Bavarian Nordic A/S D01ECN HIGHSTAT Preclinical D01EDA DRUG__ID D01EDA D01EDA DRUGCLAS Investigative Drug(s) D01EDA DRUGINCH 1S/C46H71N11O12S2/c1-6-26(5)39-45(67)52-29(15-16-35(47)58)41(63)53-32(22-36(48)59)42(64)55-33(24-71-70-19-17-38(61)51-31(43(65)56-39)21-27-11-13-28(14-12-27)69-7-2)46(68)57-18-9-8-10-34(57)44(66)54-30(20-25(3)4)40(62)50-23-37(49)60/h11-14,25-26,29-34,39H,6-10,15-24H2,1-5H3,(H2,47,58)(H2,48,59)(H2,49,60)(H,50,62)(H,51,61)(H,52,67)(H,53,63)(H,54,66)(H,55,64)(H,56,65)/t26-,29-,30-,31-,32-,33-,34-,39-/m0/s1 D01EDA DRUGINKE NMLWRIDSUBGNGP-IHJZLXGESA-N D01EDA DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D01EDA HIGHSTAT Investigative D01EDB DRUG__ID D01EDB D01EDB DRUGCLAS Investigative Drug(s) D01EDB DRUGINCH 1S/C14H14N4O2/c19-14(16-20)9-8-13-11-18(17-15-13)10-4-7-12-5-2-1-3-6-12/h1-9,11,20H,10H2,(H,16,19)/b7-4+,9-8+ D01EDB DRUGINKE IILXTLMEJJIBSG-NUXDXBQRSA-N D01EDB DRUGSMIL C1=CC=C(C=C1)C=CCN2C=C(N=N2)C=CC(=O)NO D01EDB DRUGTYPE Small molecular drug D01EDB HIGHSTAT Investigative D01EDE DRUG__ID D01EDE D01EDE DRUGCLAS Discontinued Drug(s) D01EDE DRUGINCH 1S/C36H35N3O4/c1-23-17-24(2)19-28(18-23)35(41)39(3)33(20-25-13-15-27(16-14-25)26-9-5-4-6-10-26)34(40)38-32(36(42)43)21-29-22-37-31-12-8-7-11-30(29)31/h4-19,22,32-33,37H,20-21H2,1-3H3,(H,38,40)(H,42,43)/t32-,33+/m0/s1 D01EDE DRUGINKE UZDORQWMYRRLQV-JHOUSYSJSA-N D01EDE DRUGSMIL CC1=CC(=CC(=C1)C(=O)N(C)C(CC2=CC=C(C=C2)C3=CC=CC=C3)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)O)C D01EDE DRUGTYPE Small molecular drug D01EDE HIGHSTAT Terminated D01EDJ DRUG__ID D01EDJ D01EDJ DRUGCLAS Clinical Trial Drug(s) D01EDJ DRUGCOMP Venus remedies D01EDJ HIGHSTAT Phase 3 D01EDO DRUG__ID D01EDO D01EDO DRUGCLAS Discontinued Drug(s) D01EDO DRUGCOMP Glaxo Wellcome plc D01EDO HIGHSTAT Discontinued in Phase 1 D01EDS DRUG__ID D01EDS D01EDS DRUGCLAS Discontinued Drug(s) D01EDS HIGHSTAT Discontinued in Phase 2 D01EEM DRUG__ID D01EEM D01EEM DRUGCLAS Investigative Drug(s) D01EEM DRUGINCH 1S/C13H12N2O3S2/c14-20(17,18)10-7-5-9(6-8-10)15-13(16)11-3-1-2-4-12(11)19/h1-8,19H,(H,15,16)(H2,14,17,18) D01EEM DRUGINKE MRLVIVXGUGNENL-UHFFFAOYSA-N D01EEM DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)N)S D01EEM DRUGTYPE Small molecular drug D01EEM HIGHSTAT Investigative D01EEY DRUG__ID D01EEY D01EEY DRUGCLAS Patented Agent(s) D01EEY DRUGCOMP Takeda Pharmaceutical Co. Ltd D01EEY DRUGTYPE Small molecular drug D01EEY HIGHSTAT Patented D01EFO DRUG__ID D01EFO D01EFO DRUGCLAS Discontinued Drug(s) D01EFO DRUGCOMP Novartis AG D01EFO DRUGINCH 1S/C23H19N5O/c1-16-9-10-19(26-22(29)17-6-3-2-4-7-17)14-21(16)28-23-25-13-11-20(27-23)18-8-5-12-24-15-18/h2-15H,1H3,(H,26,29)(H,25,27,28) D01EFO DRUGINKE UOEJSOXEHKCNAE-UHFFFAOYSA-N D01EFO DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2)NC3=NC=CC(=N3)C4=CN=CC=C4 D01EFO HIGHSTAT Terminated D01EFQ DRUG__ID D01EFQ D01EFQ DRUGCLAS Investigative Drug(s) D01EFQ DRUGINCH 1S/C18H24N2O4/c1-4-5-6-7-8-13-9-10-15(14(21)11-13)24-18-19-16(22-2)12-17(20-18)23-3/h9-12,21H,4-8H2,1-3H3 D01EFQ DRUGINKE YNAUOGCPBHCMDN-UHFFFAOYSA-N D01EFQ DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=NC(=CC(=N2)OC)OC)O D01EFQ DRUGTYPE Small molecular drug D01EFQ HIGHSTAT Investigative D01EGC DRUG__ID D01EGC D01EGC DRUGCLAS Patented Agent(s) D01EGC DRUGCOMP Southwest Res Inst D01EGC DRUGTYPE Small molecular drug D01EGC HIGHSTAT Patented D01EGN DRUG__ID D01EGN D01EGN DRUGCLAS Investigative Drug(s) D01EGN DRUGINCH 1S/C23H17NO/c25-21-13-11-19(12-14-21)23-16-20(17-7-3-1-4-8-17)15-22(24-23)18-9-5-2-6-10-18/h1-16,25H D01EGN DRUGINKE LARDQALKCMOPHD-UHFFFAOYSA-N D01EGN DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CC=C(C=C3)O)C4=CC=CC=C4 D01EGN DRUGTYPE Small molecular drug D01EGN HIGHSTAT Investigative D01EHI DRUG__ID D01EHI D01EHI DRUGCLAS Approved Drug(s) D01EHI DRUGCOMP Medlmmune LLC D01EHI HIGHSTAT Approved D01EHP DRUG__ID D01EHP D01EHP DRUGCLAS Investigative Drug(s) D01EHP DRUGINCH 1S/C11H15N5/c1-16-7-14-9-10(12-6-13-11(9)16)15-8-4-2-3-5-8/h6-8H,2-5H2,1H3,(H,12,13,15) D01EHP DRUGINKE LZMRVYPPUVMKOI-UHFFFAOYSA-N D01EHP DRUGSMIL CN1C=NC2=C(N=CN=C21)NC3CCCC3 D01EHP DRUGTYPE Small molecular drug D01EHP HIGHSTAT Investigative D01EHS DRUG__ID D01EHS D01EHS DRUGCLAS Investigative Drug(s) D01EHS DRUGINCH 1S/C6H12N2S/c1-5-4-6(7)8-2-3-9-5/h5H,2-4H2,1H3,(H2,7,8) D01EHS DRUGINKE JXQWNOBSLLRHKM-UHFFFAOYSA-N D01EHS DRUGSMIL CC1CC(=NCCS1)N D01EHS DRUGTYPE Small molecular drug D01EHS HIGHSTAT Investigative D01EHZ DRUG__ID D01EHZ D01EHZ COMPCLAS Piperazine carbamate/urea derivatives D01EHZ DRUGCLAS Patented Agent(s) D01EHZ DRUGCOMP Novartis AG D01EHZ DRUGINCH 1S/C18H29N5O3/c1-14(2)21-10-12-23(13-11-21)18(25)26-15-6-8-22(9-7-15)16-4-5-17(24)20(3)19-16/h4-5,14-15H,6-13H2,1-3H3 D01EHZ DRUGINKE JXFIKXGRFYNISW-UHFFFAOYSA-N D01EHZ DRUGSMIL CC(C)N1CCN(CC1)C(=O)OC2CCN(CC2)C3=NN(C(=O)C=C3)C D01EHZ DRUGTYPE Small molecular drug D01EHZ HIGHSTAT Patented D01EIS DRUG__ID D01EIS D01EIS DRUGCLAS Investigative Drug(s) D01EIS DRUGINCH 1S/C18H22N2/c1-3-7-16(8-4-1)15-18(17-9-5-2-6-10-17)20-13-11-19-12-14-20/h1-10,18-19H,11-15H2 D01EIS DRUGINKE NIBIYLDNVMUKNB-UHFFFAOYSA-N D01EIS DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2)C3=CC=CC=C3 D01EIS DRUGTYPE Small molecular drug D01EIS HIGHSTAT Investigative D01EIT DRUG__ID D01EIT D01EIT COMPCLAS Pyrrolo-pyrimidine derivatives D01EIT DRUGCLAS Patented Agent(s) D01EIT DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED GLAXOSMITHKLINE (CHINA) R&D COMPANY LIMITED D01EIT DRUGTYPE Small molecular drug D01EIT HIGHSTAT Patented D01EJG DRUG__ID D01EJG D01EJG DRUGCLAS Clinical Trial Drug(s) D01EJG DRUGCOMP AC Immune Lausanne, Switzerland Genentech South San Francisco, CA D01EJG HIGHSTAT Phase 2 D01EJH DRUG__ID D01EJH D01EJH DRUGCLAS Investigative Drug(s) D01EJH DRUGINCH 1S/C20H18O4/c1-20(2)6-5-11-7-14-17(9-16(11)24-20)22-10-15-13-4-3-12(21)8-18(13)23-19(14)15/h3-9,15,19,21H,10H2,1-2H3/t15-,19-/m0/s1 D01EJH DRUGINKE OGFFMQWYZCTXCM-KXBFYZLASA-N D01EJH DRUGSMIL CC1(C=CC2=CC3=C(C=C2O1)OCC4C3OC5=C4C=CC(=C5)O)C D01EJH DRUGTYPE Small molecular drug D01EJH HIGHSTAT Investigative D01EJJ DRUG__ID D01EJJ D01EJJ DRUGCLAS Clinical Trial Drug(s) D01EJJ HIGHSTAT Phase 2 D01EKN DRUG__ID D01EKN D01EKN DRUGCLAS Clinical Trial Drug(s) D01EKN DRUGCOMP Raven Biotechnologies D01EKN HIGHSTAT Phase 2 D01EKO DRUG__ID D01EKO D01EKO DRUADIID CLI-01-ALDR-01086 D01EKO DRUGCLAS Investigative Drug(s) D01EKO HIGHSTAT Investigative D01EKQ DRUG__ID D01EKQ D01EKQ DRUADIID FDA-AP-BF04-00671 D01EKQ DRUGCLAS Approved Drug(s) D01EKQ DRUGCOMP Mallinckrodt Inc D01EKQ DRUGINCH 1S/2C6H8O7.3Fe/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;3*+2/p-6/i;;3*1+3 D01EKQ DRUGINKE PFKAKHILNWLJRT-ZHVHGXCCSA-H D01EKQ DRUGSMIL C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Fe+2].[Fe+2].[Fe+2] D01EKQ DRUGTYPE Small molecular drug D01EKQ HIGHSTAT Approved D01EKS DRUG__ID D01EKS D01EKS COMPCLAS Acyl piperidine derivatives D01EKS DRUGCLAS Patented Agent(s) D01EKS DRUGCOMP ASTON UNIVERSITY D01EKS DRUGINCH 1S/C19H28BrN3O3/c20-11-16(24)21-12-17(25)22-1-3-23(4-2-22)18(26)19-8-13-5-14(9-19)7-15(6-13)10-19/h13-15H,1-12H2,(H,21,24) D01EKS DRUGINKE SCSKGYPISIGLDU-UHFFFAOYSA-N D01EKS DRUGSMIL C1CN(CCN1C(=O)CNC(=O)CBr)C(=O)C23CC4CC(C2)CC(C4)C3 D01EKS DRUGTYPE Small molecular drug D01EKS HIGHSTAT Patented D01ELC DRUG__ID D01ELC D01ELC DRUGCLAS Investigative Drug(s) D01ELC DRUGCOMP NovelMed Therapeutics Inc D01ELC HIGHSTAT Investigative D01ELU DRUG__ID D01ELU D01ELU DRUGCLAS Clinical Trial Drug(s) D01ELU DRUGCOMP Canbex Therapeutics Ltd D01ELU DRUGINCH 1S/C18H26N2O3/c1-14(13-21)19-18(23)16-10-7-9-15(12-16)8-5-4-6-11-17(22)20(2)3/h5,7-10,12,14,21H,4,6,11,13H2,1-3H3,(H,19,23)/b8-5-/t14-/m1/s1 D01ELU DRUGINKE SVYRYFAUQHVGAI-BMWLXYDHSA-N D01ELU DRUGSMIL CC(CO)NC(=O)C1=CC=CC(=C1)C=CCCCC(=O)N(C)C D01ELU DRUGTYPE Small molecular drug D01ELU HIGHSTAT Phase 2 D01EMD DRUG__ID D01EMD D01EMD DRUGCLAS Clinical Trial Drug(s) D01EMD DRUGCOMP Northwest Biotherapeutics D01EMD HIGHSTAT Phase 1/2 D01ENA DRUG__ID D01ENA D01ENA DRUGCLAS Investigative Drug(s) D01ENA DRUGINCH 1S/6CN.Fe/c6*1-2;/q6*-1;+2 D01ENA DRUGINKE UETZVSHORCDDTH-UHFFFAOYSA-N D01ENA DRUGSMIL [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2] D01ENA DRUGTYPE Small molecular drug D01ENA HIGHSTAT Investigative D01ENO DRUG__ID D01ENO D01ENO DRUGCLAS Investigative Drug(s) D01ENO DRUGINCH 1S/C20H38O11P2/c1-16(2)8-7-9-17(3)11-13-30-33(27,28)31-32(25,26)29-12-6-5-10-18(21)14-20(4,24)15-19(22)23/h8,11,18,21,24H,5-7,9-10,12-15H2,1-4H3,(H,22,23)(H,25,26)(H,27,28)/b17-11+ D01ENO DRUGINKE PMUQIJKCGIYWGT-GZTJUZNOSA-N D01ENO DRUGSMIL CC(=CCCC(=CCOP(=O)(O)OP(=O)(O)OCCCCC(CC(C)(CC(=O)O)O)O)C)C D01ENO DRUGTYPE Small molecular drug D01ENO HIGHSTAT Investigative D01ENR DRUG__ID D01ENR D01ENR DRUGCLAS Investigative Drug(s) D01ENR DRUGINCH 1S/C19H23NO2/c1-2-6-17(7-3-1)16-18-8-4-5-9-19(18)22-15-12-20-10-13-21-14-11-20/h1-9H,10-16H2 D01ENR DRUGINKE DQESEABEPUDVEZ-UHFFFAOYSA-N D01ENR DRUGSMIL C1COCCN1CCOC2=CC=CC=C2CC3=CC=CC=C3 D01ENR DRUGTYPE Small molecular drug D01ENR HIGHSTAT Investigative D01ENV DRUG__ID D01ENV D01ENV DRUGCLAS Patented Agent(s) D01ENV DRUGINCH 1S/C14H20N2O2/c1-2-18-14(17)12-5-6-13(15-11-12)7-10-16-8-3-4-9-16/h5-6,11H,2-4,7-10H2,1H3 D01ENV DRUGINKE MBNVMBKJYZXTNI-UHFFFAOYSA-N D01ENV DRUGSMIL CCOC(=O)C1=CN=C(C=C1)CCN2CCCC2 D01ENV DRUGTYPE Small molecular drug D01ENV HIGHSTAT Patented D01EOQ DRUG__ID D01EOQ D01EOQ DRUGCLAS Investigative Drug(s) D01EOQ DRUGINCH 1S/C27H24BrN3O3/c1-18-15-21(16-19-7-6-10-24(17-19)34-2)27(33)31(30-18)25(20-8-4-3-5-9-20)26(32)29-23-13-11-22(28)12-14-23/h3-15,17,25H,16H2,1-2H3,(H,29,32)/t25-/m1/s1 D01EOQ DRUGINKE SPUZCVBKJUVZSD-RUZDIDTESA-N D01EOQ DRUGSMIL CC1=NN(C(=O)C(=C1)CC2=CC(=CC=C2)OC)C(C3=CC=CC=C3)C(=O)NC4=CC=C(C=C4)Br D01EOQ DRUGTYPE Small molecular drug D01EOQ HIGHSTAT Investigative D01EOU DRUG__ID D01EOU D01EOU DRUGCLAS Investigative Drug(s) D01EOU DRUGINCH 1S/C21H24ClNO2/c1-25-21(24)20(17-9-3-2-4-10-17)19-12-5-6-13-23(19)15-16-8-7-11-18(22)14-16/h2-4,7-11,14,19-20H,5-6,12-13,15H2,1H3/t19-,20-/m1/s1 D01EOU DRUGINKE MOEMZDNFRMSDIA-WOJBJXKFSA-N D01EOU DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC(=CC=C2)Cl)C3=CC=CC=C3 D01EOU DRUGTYPE Small molecular drug D01EOU HIGHSTAT Investigative D01EPD DRUG__ID D01EPD D01EPD DRUGCLAS Investigative Drug(s) D01EPD DRUGCOMP Isis Pharmaceuticals D01EPD DRUGTYPE Antisense drug D01EPD HIGHSTAT Investigative D01EPO DRUG__ID D01EPO D01EPO DRUGCLAS Investigative Drug(s) D01EPO DRUGCOMP BTG plc D01EPO HIGHSTAT Investigative D01EPP DRUG__ID D01EPP D01EPP DRUGCLAS Discontinued Drug(s) D01EPP DRUGCOMP Elan Corp plc D01EPP HIGHSTAT Terminated D01EPU DRUG__ID D01EPU D01EPU DRUGCLAS Investigative Drug(s) D01EPU DRUGINCH 1S/C21H29NO/c23-17-8-7-16-12-20-18-6-1-2-9-21(18,19(16)13-17)10-11-22(20)14-15-4-3-5-15/h7-8,13,15,18,20,23H,1-6,9-12,14H2/t18-,20+,21+/m0/s1 D01EPU DRUGINKE YSTAPDGDOHWKQR-CEWLAPEOSA-N D01EPU DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)O)CC5CCC5 D01EPU DRUGTYPE Small molecular drug D01EPU HIGHSTAT Investigative D01EQG DRUG__ID D01EQG D01EQG DRUGCLAS Discontinued Drug(s) D01EQG DRUGINCH 1S/C16H20N4O2/c1-5-6-11-14(21)19-13-9-10(2)7-8-12(13)17-16(18(3)4)20(19)15(11)22/h7-9,11H,5-6H2,1-4H3 D01EQG DRUGINKE MPHPHYZQRGLTBO-UHFFFAOYSA-N D01EQG DRUGSMIL CCCC1C(=O)N2C3=C(C=CC(=C3)C)N=C(N2C1=O)N(C)C D01EQG DRUGTYPE Small molecular drug D01EQG HIGHSTAT Withdrawn from market D01EQU DRUG__ID D01EQU D01EQU DRUGCLAS Investigative Drug(s) D01EQU DRUGINCH 1S/C62H104O30S/c1-23(2)12-11-17-62(10,76)36-14-13-31-30-21-35(33-20-29(92-93(77,78)79)15-18-60(33,8)32(30)16-19-61(31,36)9)86-57-48(75)51(39(66)26(5)83-57)89-59-53(91-56-45(72)42(69)38(65)25(4)82-56)47(74)50(28(7)85-59)88-58-52(90-55-44(71)41(68)37(64)24(3)81-55)46(73)49(27(6)84-58)87-54-43(70)40(67)34(63)22-80-54/h16,23-31,33-59,63-76H,11-15,17-22H2,1-10H3,(H,77,78,79)/t24-,25-,26-,27-,28-,29+,30+,31+,33-,34+,35+,36+,37+,38-,39-,40+,41+,42+,43-,44-,45-,46+,47+,48-,49-,50-,51+,52-,53-,54+,55+,56+,57+,58+,59+,60-,61+,62-/m1/s1 D01EQU DRUGINKE RRDLUYKZNPWVNX-HVARHZHCSA-N D01EQU DRUGSMIL CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(OC(C(C3O)OC4C(C(C(C(O4)C)O)O)O)OC5C(C(OC(C5O)OC6CC7C8CCC(C8(CC=C7C9(C6CC(CC9)OS(=O)(=O)O)C)C)C(C)(CCCC(C)C)O)C)O)C)C)OC1C(C(C(CO1)O)O)O)O)O)O)O D01EQU HIGHSTAT Investigative D01ERB DRUG__ID D01ERB D01ERB DRUGCLAS Investigative Drug(s) D01ERB DRUGINCH 1S/C24H27NO2/c1-24-9-6-20-19-5-3-18(26)13-16(19)2-4-21(20)22(24)14-17(23(24)27)12-15-7-10-25-11-8-15/h3,5,7-8,10-13,20-23,26-27H,2,4,6,9,14H2,1H3/b17-12+/t20?,21?,22?,23-,24-/m0/s1 D01ERB DRUGINKE SOWVSBMETYFGLF-PHKWELIGSA-N D01ERB DRUGSMIL CC12CCC3C(C1CC(=CC4=CC=NC=C4)C2O)CCC5=C3C=CC(=C5)O D01ERB DRUGTYPE Small molecular drug D01ERB HIGHSTAT Investigative D01ERE DRUG__ID D01ERE D01ERE DRUGCLAS Clinical Trial Drug(s) D01ERE DRUGCOMP Astellas Pharma US Northbrook, IL D01ERE HIGHSTAT Phase 2 D01ERV DRUG__ID D01ERV D01ERV DRUGCLAS Patented Agent(s) D01ERV DRUGTYPE Small molecular drug D01ERV HIGHSTAT Patented D01ERW DRUG__ID D01ERW D01ERW DRUGCLAS Investigative Drug(s) D01ERW DRUGINCH 1S/C19H16FN5O/c1-11-17(22-23-25(11)16-3-2-8-21-18(16)20)12-4-7-15-13(9-12)10-24(19(15)26)14-5-6-14/h2-4,7-9,14H,5-6,10H2,1H3 D01ERW DRUGINKE XZBFQWRAIYRPPZ-UHFFFAOYSA-N D01ERW DRUGSMIL CC1=C(N=NN1C2=C(N=CC=C2)F)C3=CC4=C(C=C3)C(=O)N(C4)C5CC5 D01ERW DRUGTYPE Small molecular drug D01ERW HIGHSTAT Investigative D01ESB DRUG__ID D01ESB D01ESB DRUGCLAS Discontinued Drug(s) D01ESB DRUGCOMP Yamanouchi D01ESB DRUGINCH 1S/C14H18FNO2.ClH/c15-13-4-5-14(12-3-1-2-11(12)13)18-9-10-8-16-6-7-17-10;/h4-5,10,16H,1-3,6-9H2;1H/t10-;/m0./s1 D01ESB DRUGINKE HWEMEKZYQCJVEZ-PPHPATTJSA-N D01ESB DRUGSMIL C1CC2=C(C=CC(=C2C1)F)OCC3CNCCO3.Cl D01ESB DRUGTYPE Small molecular drug D01ESB HIGHSTAT Discontinued in Phase 2 D01ESB THERCLAS Psychiatric D01ESC DRUG__ID D01ESC D01ESC DRUGCLAS Investigative Drug(s) D01ESC DRUGCOMP Bolder BioTechnology Inc D01ESC HIGHSTAT Investigative D01ESJ DRUG__ID D01ESJ D01ESJ DRUGCLAS Discontinued Drug(s) D01ESJ DRUGCOMP Endo Pharmaceuticals Solutions Inc D01ESJ DRUGINCH 1S/C19H20N2O/c1-14(22)20-12-11-17-16-9-5-6-10-18(16)21-19(17)13-15-7-3-2-4-8-15/h2-10,21H,11-13H2,1H3,(H,20,22) D01ESJ DRUGINKE WVVXBPKOIZGVNS-UHFFFAOYSA-N D01ESJ DRUGSMIL CC(=O)NCCC1=C(NC2=CC=CC=C21)CC3=CC=CC=C3 D01ESJ DRUGTYPE Small molecular drug D01ESJ HIGHSTAT Terminated D01ESN DRUG__ID D01ESN D01ESN DRUGCLAS Investigative Drug(s) D01ESN DRUGINCH 1S/C64H71N9O10/c65-49(35-45-25-29-47(74)30-26-45)63(82)72-33-13-23-55(72)61(80)70-53(39-44-21-11-4-12-22-44)59(78)68-51(37-42-17-7-2-8-18-42)60(79)71-54(40-46-27-31-48(75)32-28-46)64(83)73-34-14-24-56(73)62(81)69-52(38-43-19-9-3-10-20-43)58(77)67-50(57(66)76)36-41-15-5-1-6-16-41/h1-12,15-22,25-32,49-56,74-75H,13-14,23-24,33-40,65H2,(H2,66,76)(H,67,77)(H,68,78)(H,69,81)(H,70,80)(H,71,79)/t49-,50-,51-,52-,53-,54-,55-,56-/m0/s1 D01ESN DRUGINKE DEEQOLBYTQLJHH-MENCHSDRSA-N D01ESN DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N6CCCC6C(=O)NC(CC7=CC=CC=C7)C(=O)NC(CC8=CC=CC=C8)C(=O)N D01ESN HIGHSTAT Investigative D01EST DRUG__ID D01EST D01EST DRUGCLAS Investigative Drug(s) D01EST DRUGINCH 1S/C15H8Cl3NO2/c16-8-1-2-13-9(6-8)10(15(21)19-13)3-7-4-11(17)14(20)12(18)5-7/h1-6,20H,(H,19,21)/b10-3- D01EST DRUGINKE ZJFMARHFPUZEKI-KMKOMSMNSA-N D01EST DRUGSMIL C1=CC2=C(C=C1Cl)C(=CC3=CC(=C(C(=C3)Cl)O)Cl)C(=O)N2 D01EST DRUGTYPE Small molecular drug D01EST HIGHSTAT Investigative D01ESV DRUG__ID D01ESV D01ESV DRUGCLAS Investigative Drug(s) D01ESV DRUGINCH 1S/C14H10F3NO2/c15-14(16,17)11-5-1-9(2-6-11)10-3-7-12(8-4-10)20-13(18)19/h1-8H,(H2,18,19) D01ESV DRUGINKE ZIARVUIVYFGYIG-UHFFFAOYSA-N D01ESV DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)OC(=O)N)C(F)(F)F D01ESV DRUGTYPE Small molecular drug D01ESV HIGHSTAT Investigative D01ETL DRUG__ID D01ETL D01ETL DRUGCLAS Investigative Drug(s) D01ETL DRUGINCH 1S/C21H19F3N2O4S/c1-29-19-9-2-3-10-20(19)30-18-8-4-7-17(12-18)26(14-16-6-5-11-25-13-16)31(27,28)15-21(22,23)24/h2-13H,14-15H2,1H3 D01ETL DRUGINKE GJWZEUKWBMFOAA-UHFFFAOYSA-N D01ETL DRUGSMIL COC1=CC=CC=C1OC2=CC=CC(=C2)N(CC3=CN=CC=C3)S(=O)(=O)CC(F)(F)F D01ETL DRUGTYPE Small molecular drug D01ETL HIGHSTAT Investigative D01ETZ DRUG__ID D01ETZ D01ETZ DRUGCLAS Investigative Drug(s) D01ETZ DRUGINCH 1S/C19H24O2/c1-18-9-7-15-14-6-4-13(20)11-12(14)3-5-16(15)17(18)8-10-19(18,2)21/h7,9,11,16-17,21H,3-6,8,10H2,1-2H3/t16-,17+,18+,19+/m1/s1 D01ETZ DRUGINKE CCCIJQPRIXGQOE-XWSJACJDSA-N D01ETZ DRUGSMIL CC1(CCC2C1(C=CC3=C4CCC(=O)C=C4CCC23)C)O D01ETZ DRUGTYPE Small molecular drug D01ETZ HIGHSTAT Investigative D01EUF DRUG__ID D01EUF D01EUF DRUGCLAS Discontinued Drug(s) D01EUF DRUGCOMP Bristol Myers Squibb; Celltech Group D01EUF DRUGINCH 1S/C23H41N5O5S/c1-13(2)12-14(17(29)26-19(31)16(24-8)22(3,4)5)25-18(30)15(34)10-11-28-20(32)23(6,7)27(9)21(28)33/h13-16,24,34H,10-12H2,1-9H3,(H,25,30)(H,26,29,31)/t14-,15-,16+/m0/s1 D01EUF DRUGINKE BWLOJMZLTBBDHA-HRCADAONSA-N D01EUF DRUGSMIL CC(C)CC(C(=O)NC(=O)C(C(C)(C)C)NC)NC(=O)C(CCN1C(=O)C(N(C1=O)C)(C)C)S D01EUF DRUGTYPE Small molecular drug D01EUF HIGHSTAT Discontinued in Phase 3 D01EUF THERCLAS Anticancer Agents D01EUO DRUG__ID D01EUO D01EUO DRUGCLAS Clinical Trial Drug(s) D01EUO DRUGCOMP Greer Laboratories Inc D01EUO HIGHSTAT Phase 3 D01EUT DRUG__ID D01EUT D01EUT DRUGCLAS Patented Agent(s) D01EUT DRUGINCH 1S/C24H21F2N7O2/c1-4-35-16-9-19(25)18(20(26)10-16)13-33-14(2)17(11-27)22(32-33)24-29-12-21(34-3)23(31-24)30-15-5-7-28-8-6-15/h5-10,12H,4,13H2,1-3H3,(H,28,29,30,31) D01EUT DRUGINKE VNVLBWOVSDGPGB-UHFFFAOYSA-N D01EUT DRUGSMIL CCOC1=CC(=C(C(=C1)F)CN2C(=C(C(=N2)C3=NC=C(C(=N3)NC4=CC=NC=C4)OC)C#N)C)F D01EUT DRUGTYPE Small molecular drug D01EUT HIGHSTAT Patented D01EVA DRUG__ID D01EVA D01EVA DRUGCLAS Investigative Drug(s) D01EVA DRUGINCH 1S/C13H13NO4/c1-2-17-12(15)13-7-9(13)11(14-16)8-5-3-4-6-10(8)18-13/h3-6,9,16H,2,7H2,1H3/b14-11- D01EVA DRUGINKE FXCTZFMSAHZQTR-KAMYIIQDSA-N D01EVA DRUGSMIL CCOC(=O)C12CC1C(=NO)C3=CC=CC=C3O2 D01EVA DRUGTYPE Small molecular drug D01EVA HIGHSTAT Investigative D01EVE DRUG__ID D01EVE D01EVE DRUGCLAS Investigative Drug(s) D01EVE DRUGINCH 1S/C12H10BrN5O/c1-19-8-3-2-6(13)4-7(8)9-10-11(16-5-15-10)18-12(14)17-9/h2-5H,1H3,(H3,14,15,16,17,18) D01EVE DRUGINKE KDNVOUMYSICLPF-UHFFFAOYSA-N D01EVE DRUGSMIL COC1=C(C=C(C=C1)Br)C2=C3C(=NC(=N2)N)N=CN3 D01EVE DRUGTYPE Small molecular drug D01EVE HIGHSTAT Investigative D01EVI DRUG__ID D01EVI D01EVI DRUGCLAS Investigative Drug(s) D01EVI DRUGINCH 1S/C7H10O7/c1-7(14,6(12)13)3(5(10)11)2-4(8)9/h3,14H,2H2,1H3,(H,8,9)(H,10,11)(H,12,13)/t3-,7-/m1/s1 D01EVI DRUGINKE HHKPKXCSHMJWCF-WVBDSBKLSA-N D01EVI DRUGSMIL CC(C(CC(=O)O)C(=O)O)(C(=O)O)O D01EVI DRUGTYPE Small molecular drug D01EVI HIGHSTAT Investigative D01EVP DRUG__ID D01EVP D01EVP DRUGCLAS Patented Agent(s) D01EVP DRUGINCH 1S/C15H16O2/c1-11(9-12-5-3-2-4-6-12)14-8-7-13(16)10-15(14)17/h2-8,10-11,16-17H,9H2,1H3 D01EVP DRUGINKE NGQMLDWNBTVAAC-UHFFFAOYSA-N D01EVP DRUGSMIL CC(CC1=CC=CC=C1)C2=C(C=C(C=C2)O)O D01EVP DRUGTYPE Small molecular drug D01EVP HIGHSTAT Patented D01EVT DRUG__ID D01EVT D01EVT COMPCLAS Ethinyl-pyrazole derivatives D01EVT DRUGCLAS Patented Agent(s) D01EVT DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. NAKAMURA Toshio SAKAGAMI Kazunari KONISHI Kazuhide YAMAMOTO Kanako MASUDA Seiji D01EVT DRUGTYPE Small molecular drug D01EVT HIGHSTAT Patented D01EVX DRUG__ID D01EVX D01EVX DRUGCLAS Investigative Drug(s) D01EVX DRUGINCH 1S/C9H7ClN2O/c1-5-11-7-4-2-3-6(10)8(7)9(13)12-5/h2-4H,1H3,(H,11,12,13) D01EVX DRUGINKE GKDIFKSYPXLUJS-UHFFFAOYSA-N D01EVX DRUGSMIL CC1=NC2=C(C(=CC=C2)Cl)C(=O)N1 D01EVX DRUGTYPE Small molecular drug D01EVX HIGHSTAT Investigative D01EWC DRUG__ID D01EWC D01EWC DRUGCLAS Discontinued Drug(s) D01EWC DRUGCOMP Rottapharm Madaus D01EWC HIGHSTAT Terminated D01EWD DRUG__ID D01EWD D01EWD DRUGCLAS Investigative Drug(s) D01EWD DRUGINCH 1S/C15H22O2Se/c1-3-4-5-6-9-12-18-15-11-8-7-10-14(15)17-13(2)16/h7-8,10-11H,3-6,9,12H2,1-2H3 D01EWD DRUGINKE FDXGTFIBPBOUCY-UHFFFAOYSA-N D01EWD DRUGSMIL CCCCCCC[Se]C1=CC=CC=C1OC(=O)C D01EWD DRUGTYPE Small molecular drug D01EWD HIGHSTAT Investigative D01EWH DRUG__ID D01EWH D01EWH DRUGCLAS Patented Agent(s) D01EWH DRUGCOMP PFIZER INC. DIDIUK, Mary FILIPSKI, Kevin J. GUZMAN-PEREZ, Angel LEE, Esther C. PFEFFERKORN, Jeffrey A. STEVENS, Benjamin TU, Meihua D01EWH DRUGTYPE Small molecular drug D01EWH HIGHSTAT Patented D01EXG DRUG__ID D01EXG D01EXG DRUGCLAS Clinical Trial Drug(s) D01EXG DRUGCOMP AmgenThousand Oaks, CA D01EXG HIGHSTAT Phase 1 D01EXL DRUG__ID D01EXL D01EXL DRUGCLAS Clinical Trial Drug(s) D01EXL DRUGCOMP Vaccinogen D01EXL HIGHSTAT Phase 2 D01EXY DRUG__ID D01EXY D01EXY DRUGCLAS Preclinical Drug(s) D01EXY DRUGCOMP Bionovo Inc D01EXY HIGHSTAT Preclinical D01EYI DRUG__ID D01EYI D01EYI DRUGCLAS Drugs in Phase 2 Trial D01EYI DRUGTYPE Cell therapy D01EYI HIGHSTAT Phase 2 Trial D01EYI THERCLAS Antiviral Agents D01EYJ DRUG__ID D01EYJ D01EYJ COMPCLAS Ruxolitinib derivatives D01EYJ DRUGCLAS Patented Agent(s) D01EYJ DRUGCOMP JIN, Bohan D01EYJ DRUGTYPE Small molecular drug D01EYJ HIGHSTAT Patented D01EYM DRUG__ID D01EYM D01EYM DRUGCLAS Discontinued Drug(s) D01EYM DRUGCOMP Vernalis plc D01EYM HIGHSTAT Terminated D01EYR DRUG__ID D01EYR D01EYR DRUGCLAS Clinical Trial Drug(s) D01EYR DRUGCOMP BioVex D01EYR HIGHSTAT Phase 1/2 D01EZA DRUG__ID D01EZA D01EZA DRUGCLAS Investigative Drug(s) D01EZA DRUGCOMP Entrechem D01EZA HIGHSTAT Investigative D01EZC DRUG__ID D01EZC D01EZC DRUGCLAS Investigative Drug(s) D01EZC DRUGINCH 1S/C25H25NO3/c1-26(18-19-9-3-2-4-10-19)15-7-8-16-28-20-13-14-22-24(17-20)29-23-12-6-5-11-21(23)25(22)27/h2-6,9-14,17H,7-8,15-16,18H2,1H3 D01EZC DRUGINKE VUBALVZUDJIWHQ-UHFFFAOYSA-N D01EZC DRUGSMIL CN(CCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D01EZC DRUGTYPE Small molecular drug D01EZC HIGHSTAT Investigative D01EZY DRUG__ID D01EZY D01EZY DRUGCLAS Discontinued Drug(s) D01EZY DRUGCOMP Japan Tobacco Inc D01EZY HIGHSTAT Terminated D01FAA DRUG__ID D01FAA D01FAA DRUGCLAS Investigative Drug(s) D01FAA DRUGINCH 1S/C11H10BrN5O2/c12-6-3-5-4(7-10(19)17-11(13)16-7)1-2-14-9(18)8(5)15-6/h3-5H,1-2H2,(H,14,18)(H2,13,17,19) D01FAA DRUGINKE QPCBNXNDVYOBIP-UHFFFAOYSA-N D01FAA DRUGSMIL C1CNC(=O)C2=NC(=CC2C1C3=NC(=NC3=O)N)Br D01FAA DRUGTYPE Small molecular drug D01FAA HIGHSTAT Investigative D01FAR DRUG__ID D01FAR D01FAR DRUGCLAS Investigative Drug(s) D01FAR DRUGINCH 1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)/p-2 D01FAR DRUGINKE MUBZPKHOEPUJKR-UHFFFAOYSA-L D01FAR DRUGSMIL C(=O)(C(=O)[O-])[O-] D01FAR DRUGTYPE Small molecular drug D01FAR HIGHSTAT Investigative D01FBL DRUG__ID D01FBL D01FBL DRUGCLAS Investigative Drug(s) D01FBL DRUGINCH 1S/C22H24O7/c1-24-19-9-14(10-20(25-2)21(19)26-3)7-16-15(11-27-22(16)23)6-13-4-5-17-18(8-13)29-12-28-17/h4-5,8-10,15-16H,6-7,11-12H2,1-3H3/t15-,16+/m0/s1 D01FBL DRUGINKE GMLDZDDTZKXJLU-JKSUJKDBSA-N D01FBL DRUGSMIL COC1=CC(=CC(=C1OC)OC)CC2C(COC2=O)CC3=CC4=C(C=C3)OCO4 D01FBL DRUGTYPE Small molecular drug D01FBL HIGHSTAT Investigative D01FBO DRUG__ID D01FBO D01FBO DRUGCLAS Clinical Trial Drug(s) D01FBO DRUGCOMP Novavax D01FBO HIGHSTAT Phase 1/2 D01FBP DRUG__ID D01FBP D01FBP DRUGCLAS Clinical Trial Drug(s) D01FBP DRUGCOMP Janssen Alzheimer Immunotherapy; Pfizer D01FBP HIGHSTAT Phase 2 D01FBS DRUG__ID D01FBS D01FBS DRUGCLAS Clinical Trial Drug(s) D01FBS DRUGCOMP INSERM D01FBS HIGHSTAT Phase 2 D01FCH DRUG__ID D01FCH D01FCH DRUGCLAS Investigative Drug(s) D01FCH DRUGINCH 1S/C17H20N2O9S/c20-14(21)8-7-12(16(23)24)18-15(22)10-3-5-11(6-4-10)29(27,28)19-9-1-2-13(19)17(25)26/h3-6,12-13H,1-2,7-9H2,(H,18,22)(H,20,21)(H,23,24)(H,25,26)/t12-,13+/m0/s1 D01FCH DRUGINKE NDDOUBGQRWFVQM-QWHCGFSZSA-N D01FCH DRUGSMIL C1CC(N(C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)O D01FCH DRUGTYPE Small molecular drug D01FCH HIGHSTAT Investigative D01FCK DRUG__ID D01FCK D01FCK DRUGCLAS Discontinued Drug(s) D01FCK DRUGCOMP Sigma-Tau SpA D01FCK DRUGINCH 1S/C22H45N3O3/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-23-22(28)24-20(18-21(26)27)19-25(2,3)4/h20H,5-19H2,1-4H3,(H2-,23,24,26,27,28)/t20-/m1/s1 D01FCK DRUGINKE BMZYTDRMCBZVNH-HXUWFJFHSA-N D01FCK DRUGSMIL CCCCCCCCCCCCCCNC(=O)NC(CC(=O)[O-])C[N+](C)(C)C D01FCK DRUGTYPE Small molecular drug D01FCK HIGHSTAT Discontinued in Phase 2 D01FCY DRUG__ID D01FCY D01FCY DRUGCLAS Drugs in Phase 1 Trial D01FCY DRUGTYPE Cell therapy D01FCY HIGHSTAT Phase 1 Trial D01FCY THERCLAS Antiviral Agents D01FDL DRUG__ID D01FDL D01FDL DRUGCLAS Clinical Trial Drug(s) D01FDL DRUGCOMP Servier D01FDL DRUGINCH 1S/C15H22N2O2/c1-17-8-3-5-12-4-2-6-14(15(12)17)19-11-13-10-16-7-9-18-13/h2,4,6,13,16H,3,5,7-11H2,1H3 D01FDL DRUGINKE VXQWMLATWQSCBE-UHFFFAOYSA-N D01FDL DRUGSMIL CN1CCCC2=C1C(=CC=C2)OCC3CNCCO3 D01FDL DRUGTYPE Small molecular drug D01FDL HIGHSTAT Phase 3 D01FDN DRUG__ID D01FDN D01FDN DRUGCLAS Clinical Trial Drug(s) D01FDN DRUGINCH 1S/C18H21N3O4/c19-14(17(23)21-15(18(24)25)7-8-16(20)22)10-11-5-6-12-3-1-2-4-13(12)9-11/h1-6,9,14-15H,7-8,10,19H2,(H2,20,22)(H,21,23)(H,24,25)/t14-,15-/m0/s1 D01FDN DRUGINKE VSZVSSYQFUFEQG-GJZGRUSLSA-N D01FDN DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CC(C(=O)NC(CCC(=O)N)C(=O)O)N D01FDN HIGHSTAT Phase 2/3 D01FDW DRUG__ID D01FDW D01FDW DRUGCLAS Investigative Drug(s) D01FDW DRUGINCH 1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)/t27-,28+,29-,30-,31+,32+,33+,34-/m1/s1 D01FDW DRUGINKE KBZOIRJILGZLEJ-BOXDWKHASA-N D01FDW DRUGSMIL C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N D01FDW HIGHSTAT Investigative D01FEA DRUG__ID D01FEA D01FEA DRUGCLAS Investigative Drug(s) D01FEA DRUGINCH 1S/C23H24O5/c1-12(2)8-10-14-19(25)16(11-9-13(3)4)23-18(20(14)26)21(27)15-6-5-7-17(24)22(15)28-23/h5-9,24-26H,10-11H2,1-4H3 D01FEA DRUGINKE GVQOVMKBYJKZSY-UHFFFAOYSA-N D01FEA DRUGSMIL CC(=CCC1=C(C(=C2C(=C1O)C(=O)C3=C(O2)C(=CC=C3)O)CC=C(C)C)O)C D01FEA DRUGTYPE Small molecular drug D01FEA HIGHSTAT Investigative D01FEC DRUG__ID D01FEC D01FEC DRUGCLAS Discontinued Drug(s) D01FEC DRUGCOMP Capstone Therapeutics D01FEC DRUGINCH 1S/C97H146N28O36S.C2H4O2/c1-48(2)79(96(160)161)123-91(155)60(35-51-15-6-5-7-16-51)119-93(157)66-20-13-33-124(66)73(133)45-104-68(128)40-106-85(149)64(46-126)121-89(153)62(38-77(140)141)114-72(132)44-109-84(148)57(27-29-75(136)137)117-92(156)65(47-162)122-81(145)50(4)110-87(151)61(37-76(138)139)113-71(131)43-107-82(146)54(19-12-32-103-97(101)102)115-86(150)55(17-8-10-30-98)111-69(129)42-108-83(147)56(26-28-74(134)135)116-90(154)63(39-78(142)143)120-94(158)67-21-14-34-125(67)95(159)58(18-9-11-31-99)118-88(152)59(36-52-22-24-53(127)25-23-52)112-70(130)41-105-80(144)49(3)100;1-2(3)4/h5-7,15-16,22-25,48-50,54-67,79,126-127,162H,8-14,17-21,26-47,98-100H2,1-4H3,(H,104,128)(H,105,144)(H,106,149)(H,107,146)(H,108,147)(H,109,148)(H,110,151)(H,111,129)(H,112,130)(H,113,131)(H,114,132)(H,115,150)(H,116,154)(H,117,156)(H,118,152)(H,119,157)(H,120,158)(H,121,153)(H,122,145)(H,123,155)(H,134,135)(H,136,137)(H,138,139)(H,140,141)(H,142,143)(H,160,161)(H4,101,102,103);1H3,(H,3,4)/t49-,50-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,79-;/m0./s1 D01FEC DRUGINKE NYKOSFMXGHDHHF-NJTUGBEZSA-N D01FEC DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2CCCN2C(=O)CNC(=O)CNC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CS)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)CNC(=O)C(C)N.CC(=O)O D01FEC DRUGTYPE Small molecular drug D01FEC HIGHSTAT Discontinued in Phase 2 D01FFA DRUG__ID D01FFA D01FFA DRUGCLAS Approved Drug(s) D01FFA DRUGINCH 1S/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s1 D01FFA DRUGINKE AEQDJSLRWYMAQI-KRWDZBQOSA-N D01FFA DRUGSMIL COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)OC)C=C1)OC D01FFA DRUGTYPE Small molecular drug D01FFA HIGHSTAT Approved D01FFC DRUG__ID D01FFC D01FFC DRUGCLAS Clinical Trial Drug(s) D01FFC DRUGCOMP Otsuka America Pharmaceutical D01FFC HIGHSTAT Phase 1 D01FFG DRUG__ID D01FFG D01FFG DRUGCLAS Clinical Trial Drug(s) D01FFG HIGHSTAT Phase 2 D01FFX DRUG__ID D01FFX D01FFX DRUGCLAS Investigative Drug(s) D01FFX DRUGINCH 1S/C16H19NO/c1-2-4-15-11-16(6-5-14(15)3-1)18-12-13-7-9-17-10-8-13/h1-6,11,13,17H,7-10,12H2 D01FFX DRUGINKE MUOXAGUZMVATIC-UHFFFAOYSA-N D01FFX DRUGSMIL C1CNCCC1COC2=CC3=CC=CC=C3C=C2 D01FFX DRUGTYPE Small molecular drug D01FFX HIGHSTAT Investigative D01FGM DRUG__ID D01FGM D01FGM DRUGCLAS Investigative Drug(s) D01FGM DRUGINCH 1S/C16H12O6/c1-21-14-4-8(2-3-10(14)18)13-7-12(20)16-11(19)5-9(17)6-15(16)22-13/h2-7,17-19H,1H3 D01FGM DRUGINKE SCZVLDHREVKTSH-UHFFFAOYSA-N D01FGM DRUGSMIL COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O D01FGM DRUGTYPE Small molecular drug D01FGM HIGHSTAT Investigative D01FGR DRUG__ID D01FGR D01FGR DRUADIID FDA-AP-BF04-00999 D01FGR DRUGCLAS Approved Drug(s) D01FGR DRUGCOMP Johnson & Johnson D01FGR DRUGINCH 1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3 D01FGR DRUGINKE ZZVUWRFHKOJYTH-UHFFFAOYSA-N D01FGR DRUGSMIL CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2 D01FGR DRUGTYPE Small molecular drug D01FGR HIGHSTAT Approved D01FGR THERCLAS Antiallergic Agents D01FGW DRUG__ID D01FGW D01FGW DRUGCLAS Investigative Drug(s) D01FGW DRUGINCH 1S/C14H9Br2N3/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,(H,17,18,19) D01FGW DRUGINKE GBBRIESLSQOJQX-UHFFFAOYSA-N D01FGW DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=C(C=C3)Br D01FGW DRUGTYPE Small molecular drug D01FGW HIGHSTAT Investigative D01FHK DRUG__ID D01FHK D01FHK DRUGCLAS Investigative Drug(s) D01FHK DRUGINCH 1S/C52H69N9O15S/c1-6-8-18-37(57-48(68)40(61-51(71)75-52(3,4)5)26-32-21-23-34(24-22-32)76-77(72,73)74)46(66)55-30-43(62)56-41(27-33-29-54-36-20-14-13-17-35(33)36)49(69)58-38(19-9-7-2)47(67)60-42(28-44(63)64)50(70)59-39(45(53)65)25-31-15-11-10-12-16-31/h10-17,20-24,29,37-42,54H,6-9,18-19,25-28,30H2,1-5H3,(H2,53,65)(H,55,66)(H,56,62)(H,57,68)(H,58,69)(H,59,70)(H,60,67)(H,61,71)(H,63,64)(H,72,73,74)/t37-,38-,39-,40-,41-,42-/m0/s1 D01FHK DRUGINKE CSXIDZJPJYRGSK-UJKKYYSESA-N D01FHK DRUGSMIL CCCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)OC(C)(C)C D01FHK HIGHSTAT Investigative D01FHL DRUG__ID D01FHL D01FHL DRUGCLAS Clinical Trial Drug(s) D01FHL DRUGCOMP Allergan Inc D01FHL HIGHSTAT Phase 2 D01FIM DRUG__ID D01FIM D01FIM DRUGCLAS Patented Agent(s) D01FIM DRUGCOMP EMORY UNIVERSITY JIANG, Jianxiong GANESH, Thota DU, Yuhong THEPCHATRI, Pahk QUAN, Yi DINGLEDINE, Ray J D01FIM DRUGTYPE Small molecular drug D01FIM HIGHSTAT Patented D01FJA DRUG__ID D01FJA D01FJA DRUGCLAS Investigative Drug(s) D01FJA DRUGCOMP Umecrine AB D01FJA HIGHSTAT Investigative D01FJB DRUG__ID D01FJB D01FJB DRUGCLAS Investigative Drug(s) D01FJB DRUGINCH 1S/C12H15N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h1-2,7-8H,3-6H2,(H3,13,14,15,16,17) D01FJB DRUGINKE RXNXVXFFAAPSTR-UHFFFAOYSA-N D01FJB DRUGSMIL C1CC(CC=C1)COC2=NC(=NC3=C2NC=N3)N D01FJB DRUGTYPE Small molecular drug D01FJB HIGHSTAT Investigative D01FJE DRUG__ID D01FJE D01FJE DRUGCLAS Investigative Drug(s) D01FJE DRUGINCH 1S/C16H14O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-7,14,17-18H,8H2,1H3/t14-/m0/s1 D01FJE DRUGINKE HMUJXQRRKBLVOO-AWEZNQCLSA-N D01FJE DRUGSMIL COC1=CC=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O D01FJE DRUGTYPE Small molecular drug D01FJE HIGHSTAT Investigative D01FJN DRUG__ID D01FJN D01FJN DRUGCLAS Investigative Drug(s) D01FJN DRUGCOMP Bayer HealthCare AG D01FJN HIGHSTAT Investigative D01FJQ DRUG__ID D01FJQ D01FJQ DRUGCLAS Investigative Drug(s) D01FJQ DRUGINCH 1S/C63H75N13O11/c1-38(2)54(61(84)74-52(63(86)87)31-42-22-24-45(77)25-23-42)75-59(82)49(30-41-18-10-5-11-19-41)70-56(79)47(28-39-14-6-3-7-15-39)69-58(81)50(32-43-34-64-36-67-43)71-57(80)48(29-40-16-8-4-9-17-40)72-60(83)53-21-13-27-76(53)62(85)51(33-44-35-65-37-68-44)73-55(78)46-20-12-26-66-46/h3-11,14-19,22-25,34-38,46-54,66,77H,12-13,20-21,26-33H2,1-2H3,(H,64,67)(H,65,68)(H,69,81)(H,70,79)(H,71,80)(H,72,83)(H,73,78)(H,74,84)(H,75,82)(H,86,87)/t46-,47+,48+,49+,50+,51+,52+,53-,54+/m1/s1 D01FJQ DRUGINKE LZANPSMBIHLZRC-UNOFDIFTSA-N D01FJQ DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CN=CN4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C6CCCN6C(=O)C(CC7=CN=CN7)NC(=O)C8CCCN8 D01FJQ HIGHSTAT Investigative D01FJT DRUG__ID D01FJT D01FJT DRUGCLAS Approved Drug(s) D01FJT DRUGINCH 1S/C7H13NO3S2/c1-7(2,13)6(11)8-4(3-12)5(9)10/h4,12-13H,3H2,1-2H3,(H,8,11)(H,9,10)/t4-/m0/s1 D01FJT DRUGINKE VUAFHZCUKUDDBC-BYPYZUCNSA-N D01FJT DRUGSMIL CC(C)(C(=O)NC(CS)C(=O)O)S D01FJT DRUGTYPE Small molecular drug D01FJT HIGHSTAT Approved D01FLN DRUG__ID D01FLN D01FLN DRUGCLAS Discontinued Drug(s) D01FLN DRUGCOMP Lexicon Pharmaceuticals Inc D01FLN DRUGINCH 1S/C10H13N3O5/c14-4-7(15)9(17)8(16)6-3-11-10(12-6)5-1-2-18-13-5/h1-3,7-9,14-17H,4H2,(H,11,12)/t7-,8-,9-/m1/s1 D01FLN DRUGINKE WGDPRIZUIYIENM-IWSPIJDZSA-N D01FLN DRUGSMIL C1=CON=C1C2=NC=C(N2)C(C(C(CO)O)O)O D01FLN DRUGTYPE Small molecular drug D01FLN HIGHSTAT Terminated D01FLQ DRUG__ID D01FLQ D01FLQ DRUGCLAS Investigative Drug(s) D01FLQ DRUGINCH 1S/C7H9BO3/c1-11-7-5-3-2-4-6(7)8(9)10/h2-5,9-10H,1H3 D01FLQ DRUGINKE ROEQGIFOWRQYHD-UHFFFAOYSA-N D01FLQ DRUGSMIL B(C1=CC=CC=C1OC)(O)O D01FLQ DRUGTYPE Small molecular drug D01FLQ HIGHSTAT Investigative D01FME DRUG__ID D01FME D01FME DRUGCLAS Discontinued Drug(s) D01FME DRUGCOMP Acambis Inc D01FME HIGHSTAT Terminated D01FMS DRUG__ID D01FMS D01FMS DRUGCLAS Investigative Drug(s) D01FMS DRUGINCH 1S/C20H30NO3.C13H21NO3.ClH/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;/h4-8,14,16-19,22H,9-13H2,1-3H3;4-6,12,14-17H,7-8H2,1-3H3;1H/q+1;;/p-1/t16-,17+,18?,19?,21?;12-;/m.0./s1 D01FMS DRUGINKE ABSQYTODNZGQMD-ORLLXICISA-M D01FMS DRUGSMIL CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.CC(C)(C)NCC(C1=CC(=C(C=C1)[O-])CO)O.Cl D01FMS DRUGTYPE Small molecular drug D01FMS HIGHSTAT Investigative D01FMW DRUG__ID D01FMW D01FMW DRUGCLAS Patented Agent(s) D01FMW DRUGCOMP Kissei Pharmaceutical Co. Ltd D01FMW DRUGTYPE Small molecular drug D01FMW HIGHSTAT Patented D01FNC DRUG__ID D01FNC D01FNC DRUGCLAS Investigative Drug(s) D01FNC DRUGINCH 1S/C14H9N3O2/c15-9-7-12(18)8-4-5-11(17-13(8)14(9)19)10-3-1-2-6-16-10/h1-7H,15H2 D01FNC DRUGINKE UMMNKCUSQIKSGP-UHFFFAOYSA-N D01FNC DRUGSMIL C1=CC=NC(=C1)C2=NC3=C(C=C2)C(=O)C=C(C3=O)N D01FNC DRUGTYPE Small molecular drug D01FNC HIGHSTAT Investigative D01FNH DRUG__ID D01FNH D01FNH DRUGCLAS Investigative Drug(s) D01FNH DRUGINCH 1S/C20H15NO3S/c1-23-14-10-12-15(13-11-14)24-20(22)21-16-6-2-4-8-18(16)25-19-9-5-3-7-17(19)21/h2-13H,1H3 D01FNH DRUGINKE OFQHJDQONOGHGC-UHFFFAOYSA-N D01FNH DRUGSMIL COC1=CC=C(C=C1)OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D01FNH DRUGTYPE Small molecular drug D01FNH HIGHSTAT Investigative D01FOK DRUG__ID D01FOK D01FOK DRUGCLAS Investigative Drug(s) D01FOK DRUGINCH 1S/C14H14O4/c1-3-10(15)13-11(17-4-2)7-5-9-6-8-12(16)18-14(9)13/h5-8H,3-4H2,1-2H3 D01FOK DRUGINKE LJTVZULEIDSNAK-UHFFFAOYSA-N D01FOK DRUGSMIL CCC(=O)C1=C(C=CC2=C1OC(=O)C=C2)OCC D01FOK DRUGTYPE Small molecular drug D01FOK HIGHSTAT Investigative D01FOM DRUG__ID D01FOM D01FOM DRUGCLAS Investigative Drug(s) D01FOM DRUGINCH 1S/C10H12N4S/c1-6-15-10-8(1)9(12-7-13-10)14-4-2-11-3-5-14/h1,6-7,11H,2-5H2 D01FOM DRUGINKE HFGUINASBGDWLY-UHFFFAOYSA-N D01FOM DRUGSMIL C1CN(CCN1)C2=C3C=CSC3=NC=N2 D01FOM DRUGTYPE Small molecular drug D01FOM HIGHSTAT Investigative D01FPD DRUG__ID D01FPD D01FPD DRUGCLAS Investigative Drug(s) D01FPD DRUGINCH 1S/C24H31FO8/c1-23-6-4-15-22(28)33-18(14-5-8-30-12-14)11-24(15,2)20(23)19(26)17(32-13-31-9-7-25)10-16(23)21(27)29-3/h5,8,12,15-18,20H,4,6-7,9-11,13H2,1-3H3/t15-,16-,17-,18-,20-,23-,24-/m0/s1 D01FPD DRUGINKE BESVDGAGHUYOPY-WFOQEEKOSA-N D01FPD DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCOCCF)C)C4=COC=C4 D01FPD DRUGTYPE Small molecular drug D01FPD HIGHSTAT Investigative D01FPR DRUG__ID D01FPR D01FPR DRUGCLAS Patented Agent(s) D01FPR DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D01FPR DRUGTYPE Small molecular drug D01FPR HIGHSTAT Patented D01FPX DRUG__ID D01FPX D01FPX DRUGCLAS Investigative Drug(s) D01FPX DRUGINCH 1S/C11H11N3O2/c1-6-2-4-7(5-3-6)11-14-8(9(12)15)10(13)16-11/h2-5H,13H2,1H3,(H2,12,15) D01FPX DRUGINKE RSMHDVYJLCPVNY-UHFFFAOYSA-N D01FPX DRUGSMIL CC1=CC=C(C=C1)C2=NC(=C(O2)N)C(=O)N D01FPX DRUGTYPE Small molecular drug D01FPX HIGHSTAT Investigative D01FQR DRUG__ID D01FQR D01FQR DRUGCLAS Clinical Trial Drug(s) D01FQR DRUGCOMP Johnson & Johnson D01FQR DRUGINCH 1S/C24H25FN4O2/c1-15-4-3-10-29-23(15)26-16(2)19(24(29)30)9-13-28-11-7-17(8-12-28)22-20-6-5-18(25)14-21(20)31-27-22/h3-6,10,14,17H,7-9,11-13H2,1-2H3 D01FQR DRUGINKE ZZQNEJILGNNOEP-UHFFFAOYSA-N D01FQR DRUGSMIL CC1=CC=CN2C1=NC(=C(C2=O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F)C D01FQR DRUGTYPE Small molecular drug D01FQR HIGHSTAT Phase 2 D01FQV DRUG__ID D01FQV D01FQV DRUGCLAS Clinical Trial Drug(s) D01FQV DRUGCOMP University of Alberta D01FQV DRUGINCH 1S/C2H2Cl2O2.Na/c3-1(4)2(5)6;/h1H,(H,5,6);/q;+1/p-1 D01FQV DRUGINKE LUPNKHXLFSSUGS-UHFFFAOYSA-M D01FQV DRUGSMIL C(C(=O)[O-])(Cl)Cl.[Na+] D01FQV DRUGTYPE Small molecular drug D01FQV HIGHSTAT Phase 1 D01FQZ DRUG__ID D01FQZ D01FQZ DRUGCLAS Investigative Drug(s) D01FQZ DRUGINCH 1S/C21H18O5/c1-11(2)3-4-14-17(23)6-5-13-16-10-25-19-8-18(24)12(9-22)7-15(19)21(16)26-20(13)14/h3,5-9,23-24H,4,10H2,1-2H3 D01FQZ DRUGINKE AGFXXWXSPAYWMF-UHFFFAOYSA-N D01FQZ DRUGSMIL CC(=CCC1=C(C=CC2=C1OC3=C2COC4=C3C=C(C(=C4)O)C=O)O)C D01FQZ DRUGTYPE Small molecular drug D01FQZ HIGHSTAT Investigative D01FRF DRUG__ID D01FRF D01FRF DRUGCLAS Discontinued Drug(s) D01FRF DRUGINCH 1S/C24H27N3O3/c1-14-9-15(2)23(16(3)10-14)25-22-13-19-18-12-21(30-6)20(29-5)11-17(18)7-8-27(19)24(28)26(22)4/h9-13H,7-8H2,1-6H3 D01FRF DRUGINKE MCMSJVMUSBZUCN-UHFFFAOYSA-N D01FRF DRUGSMIL CC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2C)OC)OC)C D01FRF DRUGTYPE Small molecular drug D01FRF HIGHSTAT Terminated D01FRI DRUG__ID D01FRI D01FRI DRUGCLAS Patented Agent(s) D01FRI DRUGCOMP Centrum Medyczne D01FRI DRUGTYPE Small molecular drug D01FRI HIGHSTAT Patented D01FRK DRUG__ID D01FRK D01FRK DRUGCLAS Investigative Drug(s) D01FRK DRUGCOMP Neose Technologies Inc D01FRK HIGHSTAT Investigative D01FRP DRUG__ID D01FRP D01FRP DRUGCLAS Investigative Drug(s) D01FRP DRUGCOMP Shanghai Ambrosia Pharmaceutical Co Ltd D01FRP HIGHSTAT Investigative D01FSW DRUG__ID D01FSW D01FSW DRUGCLAS Investigative Drug(s) D01FSW HIGHSTAT Investigative D01FSX DRUG__ID D01FSX D01FSX DRUGCLAS Clinical Trial Drug(s) D01FSX DRUGCOMP Regeneron Pharmaceuticals D01FSX DRUGTYPE Antibody D01FSX HIGHSTAT Phase 1 D01FTB DRUG__ID D01FTB D01FTB DRUGCLAS Investigative Drug(s) D01FTB DRUGINCH 1S/C9H9ClN2/c10-8-3-1-7(2-4-8)9-11-5-6-12-9/h1-4H,5-6H2,(H,11,12) D01FTB DRUGINKE XUMWMBLBTZAVLW-UHFFFAOYSA-N D01FTB DRUGSMIL C1CN=C(N1)C2=CC=C(C=C2)Cl D01FTB DRUGTYPE Small molecular drug D01FTB HIGHSTAT Investigative D01FTK DRUG__ID D01FTK D01FTK DRUGCLAS Investigative Drug(s) D01FTK DRUGCOMP Wellstat Therapeutics Corp D01FTK HIGHSTAT Investigative D01FTP DRUG__ID D01FTP D01FTP DRUGCLAS Investigative Drug(s) D01FTP DRUGINCH 1S/C17H15N/c1-12-4-3-5-15(10-12)16-9-8-14-7-6-13(2)18-17(14)11-16/h3-11H,1-2H3 D01FTP DRUGINKE LRWHLTHMQZJGQD-UHFFFAOYSA-N D01FTP DRUGSMIL CC1=CC(=CC=C1)C2=CC3=C(C=CC(=N3)C)C=C2 D01FTP DRUGTYPE Small molecular drug D01FTP HIGHSTAT Investigative D01FTR DRUG__ID D01FTR D01FTR DRUGCLAS Patented Agent(s) D01FTR DRUGCOMP F. HOFFMANN-LA ROCHE AG GONG, Leyi TAN, Yun-chou D01FTR DRUGTYPE Small molecular drug D01FTR HIGHSTAT Patented D01FTU DRUG__ID D01FTU D01FTU DRUGCLAS Investigative Drug(s) D01FTU DRUGCOMP Equispharm Co Ltd D01FTU HIGHSTAT Investigative D01FUB DRUG__ID D01FUB D01FUB DRUGCLAS Discontinued Drug(s) D01FUB DRUGCOMP AstraZeneca D01FUB DRUGINCH 1S/C24H24F3N5O3/c1-15-10-17(22-29-20(30-35-22)14-31-8-6-28-7-9-31)11-18-13-32(23(33)21(15)18)12-16-2-4-19(5-3-16)34-24(25,26)27/h2-5,10-11,28H,6-9,12-14H2,1H3 D01FUB DRUGINKE IPCYZQQFECEHLI-UHFFFAOYSA-N D01FUB DRUGSMIL CC1=CC(=CC2=C1C(=O)N(C2)CC3=CC=C(C=C3)OC(F)(F)F)C4=NC(=NO4)CN5CCNCC5 D01FUB DRUGTYPE Small molecular drug D01FUB HIGHSTAT Discontinued in Phase 2 D01FUC DRUG__ID D01FUC D01FUC DRUGCLAS Clinical Trial Drug(s) D01FUC DRUGCOMP Daiichi Seiyaku Co Ltd D01FUC DRUGINCH 1S/C24H22FN3O4/c1-3-24(31)14-6-18-21-12(8-28(18)22(29)13(14)9-32-23(24)30)19-16(26)5-4-11-10(2)15(25)7-17(27-21)20(11)19/h6-7,16,31H,3-5,8-9,26H2,1-2H3/t16-,24-/m0/s1 D01FUC DRUGINKE ZVYVPGLRVWUPMP-FYSMJZIKSA-N D01FUC DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O D01FUC DRUGTYPE Small molecular drug D01FUC HIGHSTAT Phase 3 D01FUL DRUG__ID D01FUL D01FUL DRUGCLAS Clinical Trial Drug(s) D01FUL DRUGCOMP Roche D01FUL DRUGINCH 1S/C21H30N6O8/c1-10(2)17(28)32-9-21(25-26-23)15(34-19(30)12(5)6)14(33-18(29)11(3)4)16(35-21)27-8-7-13(22)24-20(27)31/h7-8,10-12,14-16H,9H2,1-6H3,(H2,22,24,31)/t14-,15+,16-,21-/m1/s1 D01FUL DRUGINKE VKXWOLCNTHXCLF-DXEZIKHYSA-N D01FUL DRUGSMIL CC(C)C(=O)OCC1(C(C(C(O1)N2C=CC(=NC2=O)N)OC(=O)C(C)C)OC(=O)C(C)C)N=[N+]=[N-] D01FUL DRUGTYPE Small molecular drug D01FUL HIGHSTAT Phase 1 D01FVC DRUG__ID D01FVC D01FVC COMPCLAS Bis-aminopyrimidine derivatives D01FVC DRUGCLAS Patented Agent(s) D01FVC DRUGCOMP CELLZOME LIMITED FREEMAN, Jay READER, Valerie ADDISON, Glynn RAMSDEN, Nigel SCANLON, Jane Elizabeth HARRISON, Richard John D01FVC HIGHSTAT Patented D01FVY DRUG__ID D01FVY D01FVY DRUGCLAS Investigative Drug(s) D01FVY DRUGINCH 1S/C14H16N2O/c1-9(17)15-10-6-7-14-12(8-10)11-4-2-3-5-13(11)16-14/h2-5,10,16H,6-8H2,1H3,(H,15,17) D01FVY DRUGINKE DNJBLXBGYRYOBT-UHFFFAOYSA-N D01FVY DRUGSMIL CC(=O)NC1CCC2=C(C1)C3=CC=CC=C3N2 D01FVY DRUGTYPE Small molecular drug D01FVY HIGHSTAT Investigative D01FWD DRUG__ID D01FWD D01FWD DRUGCLAS Investigative Drug(s) D01FWD DRUGINCH 1S/C13H10N2/c1-2-6-11(7-3-1)15-10-14-12-8-4-5-9-13(12)15/h1-10H D01FWD DRUGINKE XNCMQRWVMWLODV-UHFFFAOYSA-N D01FWD DRUGSMIL C1=CC=C(C=C1)N2C=NC3=CC=CC=C32 D01FWD DRUGTYPE Small molecular drug D01FWD HIGHSTAT Investigative D01FWE DRUG__ID D01FWE D01FWE DRUGCLAS Approved Drug(s) D01FWE DRUGCOMP North American Vaccine Inc D01FWE HIGHSTAT Approved D01FWR DRUG__ID D01FWR D01FWR DRUGCLAS Clinical Trial Drug(s) D01FWR DRUGCOMP Allergy therapeutics D01FWR HIGHSTAT Preregistration D01FXD DRUG__ID D01FXD D01FXD DRUGCLAS Discontinued Drug(s) D01FXD DRUGINCH 1S/C17H10Cl2F3N3O3/c1-28-12-4-2-9(8-3-5-13(17(20,21)22)23-14(8)12)16(26)24-15-10(18)6-25(27)7-11(15)19/h2-7,27H,1H3 D01FXD DRUGINKE NPGREARFJMFTDF-UHFFFAOYSA-N D01FXD DRUGSMIL COC1=C2C(=C(C=C1)C(=O)N=C3C(=CN(C=C3Cl)O)Cl)C=CC(=N2)C(F)(F)F D01FXD DRUGTYPE Small molecular drug D01FXD HIGHSTAT Discontinued in Phase 1 D01FYA DRUG__ID D01FYA D01FYA DRUGCLAS Clinical Trial Drug(s) D01FYA DRUGINCH 1S/C18H21IN6O2S/c1-10(2)21-4-3-5-25-17-15(16(20)22-8-23-17)24-18(25)28-14-7-13-12(6-11(14)19)26-9-27-13/h6-8,10,21H,3-5,9H2,1-2H3,(H2,20,22,23) D01FYA DRUGINKE SUPVGFZUWFMATN-UHFFFAOYSA-N D01FYA DRUGSMIL CC(C)NCCCN1C2=NC=NC(=C2N=C1SC3=C(C=C4C(=C3)OCO4)I)N D01FYA DRUGTYPE Small molecular drug D01FYA HIGHSTAT Phase 1 D01FYB DRUG__ID D01FYB D01FYB DRUGCLAS Investigative Drug(s) D01FYB DRUGINCH 1S/C15H12N4O/c16-11-3-1-2-4-12(11)19-15(20)10-5-6-13-14(9-10)18-8-7-17-13/h1-9H,16H2,(H,19,20) D01FYB DRUGINKE DINRLSVFUAZDMZ-UHFFFAOYSA-N D01FYB DRUGSMIL C1=CC=C(C(=C1)N)NC(=O)C2=CC3=NC=CN=C3C=C2 D01FYB DRUGTYPE Small molecular drug D01FYB HIGHSTAT Investigative D01FYX DRUG__ID D01FYX D01FYX DRUGCLAS Clinical Trial Drug(s) D01FYX DRUGCOMP Andes Biotechnologies Santiago, Chile D01FYX HIGHSTAT Phase 1 D01FYY DRUG__ID D01FYY D01FYY DRUADIID CLI-01-ALDR-09125 D01FYY DRUGCLAS Investigative Drug(s) D01FYY HIGHSTAT Investigative D01FZX DRUG__ID D01FZX D01FZX DRUGCLAS Clinical Trial Drug(s) D01FZX DRUGCOMP LEO Pharma D01FZX HIGHSTAT Phase 2 D01FZZ DRUG__ID D01FZZ D01FZZ DRUGCLAS Clinical Trial Drug(s) D01FZZ DRUGCOMP Genentech South San Francisco, CA Xenon Pharmaceuticals Burnaby, Canada D01FZZ DRUGINCH 1S/C25H25ClF6N2O4S/c1-39(36,37)33-23(35)18-10-17(14-2-3-14)21(11-20(18)27)38-13-24(29)4-6-34(7-5-24)12-15-8-16(25(30,31)32)9-19(26)22(15)28/h8-11,14H,2-7,12-13H2,1H3,(H,33,35) D01FZZ DRUGINKE FCTMRPTVPHVTTN-UHFFFAOYSA-N D01FZZ DRUGSMIL CS(=O)(=O)NC(=O)C1=C(C=C(C(=C1)C2CC2)OCC3(CCN(CC3)CC4=C(C(=CC(=C4)C(F)(F)F)Cl)F)F)F D01FZZ HIGHSTAT Phase 1 D01GAG DRUG__ID D01GAG D01GAG DRUGCLAS Investigative Drug(s) D01GAG DRUGCOMP Wellstat Biologics Corp D01GAG HIGHSTAT Investigative D01GAR DRUG__ID D01GAR D01GAR DRUGCLAS Investigative Drug(s) D01GAR DRUGINCH 1S/C8H21NO6P2/c1-2-3-4-5-6-9-7-8(16(10,11)12)17(13,14)15/h8-9H,2-7H2,1H3,(H2,10,11,12)(H2,13,14,15) D01GAR DRUGINKE QDLXIUDMSHZYCG-UHFFFAOYSA-N D01GAR DRUGSMIL CCCCCCNCC(P(=O)(O)O)P(=O)(O)O D01GAR DRUGTYPE Small molecular drug D01GAR HIGHSTAT Investigative D01GAX DRUG__ID D01GAX D01GAX DRUGCLAS Investigative Drug(s) D01GAX DRUGINCH 1S/C12H15N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-7H,8-10H2,1H3 D01GAX DRUGINKE PLRACCBDVIHHLZ-UHFFFAOYSA-N D01GAX DRUGSMIL CN1CCC(=CC1)C2=CC=CC=C2 D01GAX DRUGTYPE Small molecular drug D01GAX HIGHSTAT Investigative D01GAZ DRUG__ID D01GAZ D01GAZ DRUGCLAS Investigative Drug(s) D01GAZ DRUGCOMP FUJIFILM Corp D01GAZ DRUGINCH 1S/C16H11IN4/c17-13-5-6-16-19-15(10-21(16)9-13)12-3-1-11(2-4-12)14-7-8-18-20-14/h1-10H,(H,18,20)/i17-4 D01GAZ DRUGINKE OLFQWTDIJLVADS-HHRLKWFBSA-N D01GAZ DRUGSMIL C1=CC(=CC=C1C2=CC=NN2)C3=CN4C=C(C=CC4=N3)I D01GAZ DRUGTYPE Small molecular drug D01GAZ HIGHSTAT Investigative D01GBV DRUG__ID D01GBV D01GBV DRUGCLAS Investigative Drug(s) D01GBV DRUGCOMP University of Toledo D01GBV HIGHSTAT Investigative D01GBY DRUG__ID D01GBY D01GBY DRUGCLAS Approved Drug(s) D01GBY DRUGCOMP Schering-Plough D01GBY DRUGINCH 1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2 D01GBY DRUGINKE JAUOIFJMECXRGI-UHFFFAOYSA-N D01GBY DRUGSMIL C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4 D01GBY DRUGTYPE Small molecular drug D01GBY HIGHSTAT Approved D01GBY THERCLAS Antiallergic Agents D01GCI DRUG__ID D01GCI D01GCI DRUGCLAS Patented Agent(s) D01GCI DRUGCOMP Vantia Ltd D01GCI DRUGINCH 1S/C31H38Cl2N6O2/c1-31(2,3)11-14-38-12-9-20(10-13-38)29(40)34-17-22-6-5-21(15-25(22)33)30(41)39-19-23-18-35-37(4)28(23)36-26-16-24(32)7-8-27(26)39/h5-8,15-16,18,20,36H,9-14,17,19H2,1-4H3,(H,34,40) D01GCI DRUGINKE QYCFYRDBJAXOJI-UHFFFAOYSA-N D01GCI DRUGSMIL CC(C)(C)CCN1CCC(CC1)C(=O)NCC2=C(C=C(C=C2)C(=O)N3CC4=C(NC5=C3C=CC(=C5)Cl)N(N=C4)C)Cl D01GCI DRUGTYPE Small molecular drug D01GCI HIGHSTAT Patented D01GCT DRUG__ID D01GCT D01GCT DRUGCLAS Discontinued Drug(s) D01GCT DRUGCOMP Alizyme plc D01GCT HIGHSTAT Terminated D01GCY DRUG__ID D01GCY D01GCY DRUGCLAS Discontinued Drug(s) D01GCY DRUGCOMP Novo Nordisk A/S D01GCY HIGHSTAT Terminated D01GDB DRUG__ID D01GDB D01GDB DRUGCLAS Investigative Drug(s) D01GDB DRUGCOMP Universite de la Mediterranee D01GDB HIGHSTAT Investigative D01GDH DRUG__ID D01GDH D01GDH DRUGCLAS Discontinued Drug(s) D01GDH DRUGCOMP Xenova Ltd D01GDH DRUGINCH 1S/C39H38N4O5/c1-42-34(22-27-8-5-4-6-9-27)38(45)41-33(39(42)46)21-28-10-7-11-30(20-28)37(44)40-32-14-12-26(13-15-32)16-18-43-19-17-29-23-35(47-2)36(48-3)24-31(29)25-43/h4-15,20-24H,16-19,25H2,1-3H3,(H,40,44)(H,41,45)/b33-21-,34-22- D01GDH DRUGINKE RTIZZWMBGKGLFO-YWQXDYITSA-N D01GDH DRUGSMIL CN1C(=CC2=CC=CC=C2)C(=O)NC(=CC3=CC(=CC=C3)C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC)C1=O D01GDH DRUGTYPE Small molecular drug D01GDH HIGHSTAT Discontinued in Phase 1 D01GDO DRUG__ID D01GDO D01GDO DRUGCLAS Preclinical Drug(s) D01GDO DRUGCOMP Helix BioMedix Inc D01GDO HIGHSTAT Preclinical D01GEB DRUG__ID D01GEB D01GEB DRUGCLAS Clinical Trial Drug(s) D01GEB DRUGINCH 1S/C23H26N2O/c26-21-9-10-23-22(16-21)20(17-24-23)8-4-5-13-25-14-11-19(12-15-25)18-6-2-1-3-7-18/h1-3,6-7,9-11,16-17,24,26H,4-5,8,12-15H2 D01GEB DRUGINKE HGEYJZMMUGWEOT-UHFFFAOYSA-N D01GEB DRUGSMIL C1CN(CC=C1C2=CC=CC=C2)CCCCC3=CNC4=C3C=C(C=C4)O D01GEB DRUGTYPE Small molecular drug D01GEB HIGHSTAT Phase 2 D01GEE DRUG__ID D01GEE D01GEE COMPCLAS Piperidinyl pyrazole derivatives D01GEE DRUGCLAS Patented Agent(s) D01GEE DRUGCOMP MERCK SHARP &amDOHME CORP. GRAHAM, Thomas, H. SHEN, Dong-Ming SHU, Min D01GEE DRUGTYPE Small molecular drug D01GEE HIGHSTAT Patented D01GEK DRUG__ID D01GEK D01GEK DRUGCLAS Patented Agent(s) D01GEK DRUGCOMP Sanofi D01GEK DRUGINCH 1S/C24H19F4N5O/c25-18-4-1-3-15(9-18)14-33-20(11-16-10-17(24(26,27)28)12-30-22(16)33)23(34)31-19-5-6-21(29-13-19)32-7-2-8-32/h1,3-6,9-13H,2,7-8,14H2,(H,31,34) D01GEK DRUGINKE DXPFHQMFHSGNDI-UHFFFAOYSA-N D01GEK DRUGSMIL C1CN(C1)C2=NC=C(C=C2)NC(=O)C3=CC4=CC(=CN=C4N3CC5=CC(=CC=C5)F)C(F)(F)F D01GEK DRUGTYPE Small molecular drug D01GEK HIGHSTAT Patented D01GEO DRUG__ID D01GEO D01GEO DRUGCLAS Investigative Drug(s) D01GEO DRUGCOMP Geron Corp D01GEO DRUGINCH 1S/C26H14N8O7S/c1-9-17-24-30-14(6-39-24)21-28-12(4-37-21)19-27-11(3-35-19)20-29-13(5-36-20)22-31-15(7-38-22)26-32-16(8-42-26)23-33-18(10(2)40-23)25(34-17)41-9/h3-7,16H,8H2,1-2H3 D01GEO DRUGINKE YVSQVYZBDXIXCC-UHFFFAOYSA-N D01GEO DRUGSMIL CC1=C2C3=NC(=C(O3)C)C4=NC(=CO4)C5=NC(=CO5)C6=NC(=CO6)C7=NC(=CO7)C8=NC(=CO8)C9=NC(CS9)C(=N2)O1 D01GEO DRUGTYPE Small molecular drug D01GEO HIGHSTAT Investigative D01GFH DRUG__ID D01GFH D01GFH DRUGCLAS Patented Agent(s) D01GFH DRUGINCH 1S/C11H8BrNO2/c12-9-6-10(14)13(11(9)15)7-8-4-2-1-3-5-8/h1-6H,7H2 D01GFH DRUGINKE LLBVECSKMXUDOT-UHFFFAOYSA-N D01GFH DRUGSMIL C1=CC=C(C=C1)CN2C(=O)C=C(C2=O)Br D01GFH DRUGTYPE Small molecular drug D01GFH HIGHSTAT Patented D01GFU DRUG__ID D01GFU D01GFU DRUGCLAS Discontinued Drug(s) D01GFU DRUGCOMP Gliatech Inc D01GFU HIGHSTAT Discontinued in Phase 3 D01GFX DRUG__ID D01GFX D01GFX DRUGCLAS Clinical Trial Drug(s) D01GFX DRUGINCH 1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28) D01GFX DRUGINKE PKCDDUHJAFVJJB-UHFFFAOYSA-N D01GFX DRUGSMIL CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O D01GFX DRUGTYPE Small molecular drug D01GFX HIGHSTAT Phase 3 D01GGB DRUG__ID D01GGB D01GGB DRUGCLAS Investigative Drug(s) D01GGB DRUGCOMP Stemline Therapeutics Inc D01GGB HIGHSTAT Investigative D01GGU DRUG__ID D01GGU D01GGU DRUGCLAS Investigative Drug(s) D01GGU DRUGINCH 1S/C17H21N5O/c1-3-4-8-22-14(10-12-6-5-7-13(9-12)23-2)21-15-16(18)19-11-20-17(15)22/h5-7,9,11H,3-4,8,10H2,1-2H3,(H2,18,19,20) D01GGU DRUGINKE BWLWUGBHOXIUBP-UHFFFAOYSA-N D01GGU DRUGSMIL CCCCN1C(=NC2=C(N=CN=C21)N)CC3=CC(=CC=C3)OC D01GGU DRUGTYPE Small molecular drug D01GGU HIGHSTAT Investigative D01GHV DRUG__ID D01GHV D01GHV DRUGCLAS Preclinical Drug(s) D01GHV DRUGINCH 1S/C21H24FN5O6.ClH/c1-14(28)23-11-17-13-26(21(29)33-17)15-2-4-19(18(22)10-15)25-8-6-24(7-9-25)12-16-3-5-20(32-16)27(30)31;/h2-5,10,17H,6-9,11-13H2,1H3,(H,23,28);1H/t17-;/m0./s1 D01GHV DRUGINKE XYGNKPXLGBABKJ-LMOVPXPDSA-N D01GHV DRUGSMIL CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)CC4=CC=C(O4)[N+](=O)[O-])F.Cl D01GHV DRUGTYPE Small molecular drug D01GHV HIGHSTAT Preclinical D01GIF DRUG__ID D01GIF D01GIF DRUGCLAS Discontinued Drug(s) D01GIF DRUGINCH 1S/C19H28N6O2S/c20-14-22-19(24-16-9-5-2-6-10-16)25-28(26,27)18-13-21-12-11-17(18)23-15-7-3-1-4-8-15/h11-13,15-16H,1-10H2,(H,21,23)(H2,22,24,25) D01GIF DRUGINKE XLBWPHZAHLZGNJ-UHFFFAOYSA-N D01GIF DRUGSMIL C1CCC(CC1)NC2=C(C=NC=C2)S(=O)(=O)NC(=NC3CCCCC3)NC#N D01GIF DRUGTYPE Small molecular drug D01GIF HIGHSTAT Discontinued in Phase 1 D01GIG DRUG__ID D01GIG D01GIG DRUGCLAS Investigative Drug(s) D01GIG DRUGCOMP IntraGene Sciences D01GIG HIGHSTAT Investigative D01GIW DRUG__ID D01GIW D01GIW DRUGCLAS Investigative Drug(s) D01GIW DRUGCOMP EntoPharm Co Ltd D01GIW DRUGINCH 1S/S3/c1-3-2 D01GIW DRUGINKE NVSDADJBGGUCLP-UHFFFAOYSA-N D01GIW DRUGSMIL S=S=S D01GIW DRUGTYPE Small molecular drug D01GIW HIGHSTAT Investigative D01GJI DRUG__ID D01GJI D01GJI DRUADIID CLI-01-ALDR-11064 D01GJI DRUGCLAS Investigative Drug(s) D01GJI HIGHSTAT Investigative D01GLG DRUG__ID D01GLG D01GLG DRUGCLAS Investigative Drug(s) D01GLG DRUGINCH 1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1 D01GLG DRUGINKE IQFYYKKMVGJFEH-XLPZGREQSA-N D01GLG DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O D01GLG DRUGTYPE Small molecular drug D01GLG HIGHSTAT Investigative D01GLR DRUG__ID D01GLR D01GLR DRUGCLAS Investigative Drug(s) D01GLR DRUGCOMP Isis Pharmaceuticals D01GLR DRUGTYPE Antisense drug D01GLR HIGHSTAT Investigative D01GMJ DRUG__ID D01GMJ D01GMJ DRUGCLAS Investigative Drug(s) D01GMJ DRUGINCH 1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2 D01GMJ DRUGINKE VHJLVAABSRFDPM-UHFFFAOYSA-N D01GMJ DRUGSMIL C(C(C(CS)O)O)S D01GMJ DRUGTYPE Small molecular drug D01GMJ HIGHSTAT Investigative D01GNF DRUG__ID D01GNF D01GNF DRUGCLAS Investigative Drug(s) D01GNF DRUGINCH 1S/C16H10I2N2O2/c17-11-3-1-10(2-4-11)9-14-15(21)19-20(16(14)22)13-7-5-12(18)6-8-13/h1-9H,(H,19,21)/b14-9- D01GNF DRUGINKE HOZMXIPMJIGFMB-ZROIWOOFSA-N D01GNF DRUGSMIL C1=CC(=CC=C1C=C2C(=O)NN(C2=O)C3=CC=C(C=C3)I)I D01GNF DRUGTYPE Small molecular drug D01GNF HIGHSTAT Investigative D01GNL DRUG__ID D01GNL D01GNL COMPCLAS Pyrazolopyridine derivatives D01GNL DRUGCLAS Patented Agent(s) D01GNL DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D01GNL DRUGTYPE Small molecular drug D01GNL HIGHSTAT Patented D01GNQ DRUG__ID D01GNQ D01GNQ DRUGCLAS Investigative Drug(s) D01GNQ DRUGINCH 1S/C6H7AsO3/c8-7(9)10-6-4-2-1-3-5-6/h1-5,8-9H D01GNQ DRUGINKE NOJGJOHOYAWLBB-UHFFFAOYSA-N D01GNQ DRUGSMIL C1=CC=C(C=C1)O[As](O)O D01GNQ DRUGTYPE Small molecular drug D01GNQ HIGHSTAT Investigative D01GNW DRUG__ID D01GNW D01GNW DRUGCLAS Investigative Drug(s) D01GNW DRUGCOMP NeuroGeneration Inc D01GNW HIGHSTAT Investigative D01GON DRUG__ID D01GON D01GON DRUGCLAS Patented Agent(s) D01GON DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY D01GON DRUGTYPE Small molecular drug D01GON HIGHSTAT Patented D01GOO DRUG__ID D01GOO D01GOO DRUGCLAS Patented Agent(s) D01GOO DRUGINCH 1S/C19H17ClN6/c1-3-26(2)19-17(18-22-24-25-23-18)16(12-7-5-4-6-8-12)14-11-13(20)9-10-15(14)21-19/h4-11H,3H2,1-2H3,(H,22,23,24,25) D01GOO DRUGINKE DNKGOGCNEVPJAB-UHFFFAOYSA-N D01GOO DRUGSMIL CCN(C)C1=NC2=C(C=C(C=C2)Cl)C(=C1C3=NNN=N3)C4=CC=CC=C4 D01GOO DRUGTYPE Small molecular drug D01GOO HIGHSTAT Patented D01GOY DRUG__ID D01GOY D01GOY DRUGCLAS Clinical Trial Drug(s) D01GOY DRUGCOMP AiVita Biomedical D01GOY DRUGTYPE Vaccine D01GOY HIGHSTAT Phase 2 D01GPA DRUG__ID D01GPA D01GPA DRUGCLAS Approved Drug(s) D01GPA DRUGCOMP Immutic Group D01GPA HIGHSTAT Approved D01GPC DRUG__ID D01GPC D01GPC DRUGCLAS Investigative Drug(s) D01GPC DRUGINCH 1S/C20H25ClN4O3S/c1-29(26,27)17-2-3-19(22-13-17)28-9-6-15-10-18(15)14-4-7-25(8-5-14)20-23-11-16(21)12-24-20/h2-3,11-15,18H,4-10H2,1H3/t15-,18-/m1/s1 D01GPC DRUGINKE XFJBGINZIMNZBW-CRAIPNDOSA-N D01GPC DRUGSMIL CS(=O)(=O)C1=CN=C(C=C1)OCCC2CC2C3CCN(CC3)C4=NC=C(C=N4)Cl D01GPC DRUGTYPE Small molecular drug D01GPC HIGHSTAT Investigative D01GPY DRUG__ID D01GPY D01GPY DRUGCLAS Investigative Drug(s) D01GPY DRUGINCH 1S/C17H14O2/c1-11-8-15(18)6-7-17(11)14-3-2-13-10-16(19)5-4-12(13)9-14/h2-10,18-19H,1H3 D01GPY DRUGINKE YIKDKHNOMWERET-UHFFFAOYSA-N D01GPY DRUGSMIL CC1=C(C=CC(=C1)O)C2=CC3=C(C=C2)C=C(C=C3)O D01GPY DRUGTYPE Small molecular drug D01GPY HIGHSTAT Investigative D01GQD DRUG__ID D01GQD D01GQD DRUGCLAS Clinical Trial Drug(s) D01GQD DRUGCOMP Santaris Pharma A/S D01GQD HIGHSTAT Phase 1 D01GQO DRUG__ID D01GQO D01GQO DRUGCLAS Clinical Trial Drug(s) D01GQO DRUGCOMP Stemedica Cell Technologies San Diego, CA D01GQO HIGHSTAT Phase 1 D01GRB DRUG__ID D01GRB D01GRB DRUGCLAS Investigative Drug(s) D01GRB DRUGINCH 1S/C11H16N5O7PS/c1-25-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(23-10)2-22-24(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1 D01GRB DRUGINKE XVTFTCNRRAQHEQ-KQYNXXCUSA-N D01GRB DRUGSMIL CSC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)O)O)N D01GRB DRUGTYPE Small molecular drug D01GRB HIGHSTAT Investigative D01GSA DRUG__ID D01GSA D01GSA DRUGCLAS Investigative Drug(s) D01GSA DRUGCOMP ChemoCentryx Inc D01GSA HIGHSTAT Investigative D01GSE DRUG__ID D01GSE D01GSE DRUGCLAS Clinical Trial Drug(s) D01GSE DRUGCOMP Archemix Corp D01GSE HIGHSTAT Phase 2 D01GSG DRUG__ID D01GSG D01GSG DRUGCLAS Investigative Drug(s) D01GSG DRUGINCH 1S/C16H16N2O/c17-9-12-1-2-15-8-16(4-3-14(15)7-12)19-11-13-5-6-18-10-13/h1-4,7-8,13,18H,5-6,10-11H2/t13-/m1/s1 D01GSG DRUGINKE PYEILVKGQDUINV-CYBMUJFWSA-N D01GSG DRUGSMIL C1CNCC1COC2=CC3=C(C=C2)C=C(C=C3)C#N D01GSG DRUGTYPE Small molecular drug D01GSG HIGHSTAT Investigative D01GSO DRUG__ID D01GSO D01GSO DRUGCLAS Investigative Drug(s) D01GSO DRUGINCH 1S/C12H16F3O4P/c1-3-17-20(16,18-4-2)19-11(12(13,14)15)10-8-6-5-7-9-10/h5-9,11H,3-4H2,1-2H3 D01GSO DRUGINKE LLGREQYHEQMYRW-UHFFFAOYSA-N D01GSO DRUGSMIL CCOP(=O)(OCC)OC(C1=CC=CC=C1)C(F)(F)F D01GSO DRUGTYPE Small molecular drug D01GSO HIGHSTAT Investigative D01GSU DRUG__ID D01GSU D01GSU DRUGCLAS Patented Agent(s) D01GSU DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D01GSU DRUGTYPE Small molecular drug D01GSU HIGHSTAT Patented D01GSW DRUG__ID D01GSW D01GSW DRUGCLAS Investigative Drug(s) D01GSW DRUGINCH 1S/C20H18N2O4/c1-25-16-10-12(11-17(26-2)18(16)23)9-13-7-8-22-19(13)21-15-6-4-3-5-14(15)20(22)24/h3-6,9-11,23H,7-8H2,1-2H3/b13-9+ D01GSW DRUGINKE UBCUTNIGHUVICE-UKTHLTGXSA-N D01GSW DRUGSMIL COC1=CC(=CC(=C1O)OC)C=C2CCN3C2=NC4=CC=CC=C4C3=O D01GSW DRUGTYPE Small molecular drug D01GSW HIGHSTAT Investigative D01GTB DRUG__ID D01GTB D01GTB DRUGCLAS Discontinued Drug(s) D01GTB DRUGCOMP AstraZeneca plc D01GTB HIGHSTAT Discontinued in Phase 1 D01GTC DRUG__ID D01GTC D01GTC DRUGCLAS Clinical Trial Drug(s) D01GTC DRUGCOMP Takeda Deerfield, IL D01GTC HIGHSTAT Phase 1 D01GTL DRUG__ID D01GTL D01GTL DRUGCLAS Investigative Drug(s) D01GTL DRUGCOMP Isis Pharmaceuticals D01GTL DRUGTYPE Antisense drug D01GTL HIGHSTAT Investigative D01GTU DRUG__ID D01GTU D01GTU DRUGCLAS Patented Agent(s) D01GTU DRUGCOMP REATA PHARMACEUTICALS, INC. ANDERSON, Eric JIANG, Xin VISNICK, Melean BENDER, Christopher, F. LIU, Xiaofeng D01GTU DRUGINCH 1S/C31H41NO4/c1-18-20-8-9-29(5)23(28(20,4)15-19(17-32)25(18)34)14-22(33)24-21-16-27(2,3)10-12-31(21,26(35)36-7)13-11-30(24,29)6/h14-15,18,20-21,24H,8-13,16H2,1-7H3/t18-,20-,21?,24?,28-,29+,30+,31-/m0/s1 D01GTU DRUGINKE MAOZWESYDBKVCY-HZCQYKMZSA-N D01GTU DRUGSMIL CC1C2CCC3(C(=CC(=O)C4C3(CCC5(C4CC(CC5)(C)C)C(=O)OC)C)C2(C=C(C1=O)C#N)C)C D01GTU DRUGTYPE Small molecular drug D01GTU HIGHSTAT Patented D01GUG DRUG__ID D01GUG D01GUG DRUGCLAS Investigative Drug(s) D01GUG DRUGINCH 1S/C25H38O4/c1-22(14-26)9-5-10-23(2)17(22)8-11-24(3)18-7-6-15-16(13-29-21(15)28)25(18,4)20(27)12-19(23)24/h6,16-20,26-27H,5,7-14H2,1-4H3/t16-,17-,18-,19+,20+,22-,23-,24-,25+/m0/s1 D01GUG DRUGINKE LXWMXTKOJPFGPW-NFXGRNOLSA-N D01GUG DRUGSMIL CC1(CCCC2(C1CCC3(C2CC(C4(C3CC=C5C4COC5=O)C)O)C)C)CO D01GUG DRUGTYPE Small molecular drug D01GUG HIGHSTAT Investigative D01GUK DRUG__ID D01GUK D01GUK DRUGCLAS Investigative Drug(s) D01GUK DRUGINCH 1S/C16H17N5/c1-2-8-13(9-3-1)21-11-19-14-15(17-10-18-16(14)21)20-12-6-4-5-7-12/h1-3,8-12H,4-7H2,(H,17,18,20) D01GUK DRUGINKE HMTXZOPPYXBLIU-UHFFFAOYSA-N D01GUK DRUGSMIL C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4=CC=CC=C4 D01GUK DRUGTYPE Small molecular drug D01GUK HIGHSTAT Investigative D01GUS DRUG__ID D01GUS D01GUS DRUGCLAS Approved Drug(s) D01GUS DRUGCOMP Dong-A Pharmaceutical D01GUS DRUGINCH 1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32) D01GUS DRUGINKE IYFNEFQTYQPVOC-UHFFFAOYSA-N D01GUS DRUGSMIL CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C D01GUS DRUGTYPE Small molecular drug D01GUS HIGHSTAT Approved D01GUS THERCLAS Vasodilator Agents D01GVC DRUG__ID D01GVC D01GVC DRUGCLAS Clinical Trial Drug(s) D01GVC DRUGCOMP Metabasis Therapeutics Inc D01GVC HIGHSTAT Phase 1 D01GVM DRUG__ID D01GVM D01GVM DRUGCLAS Clinical Trial Drug(s) D01GVM DRUGCOMP QLT Inc D01GVM HIGHSTAT Phase 2 D01GWH DRUG__ID D01GWH D01GWH DRUGCLAS Investigative Drug(s) D01GWH DRUGINCH 1S/C26H30N2O/c29-26(24-14-13-22-11-4-5-12-23(22)20-24)27-25-15-18-28(19-16-25)17-7-6-10-21-8-2-1-3-9-21/h1-5,8-9,11-14,20,25H,6-7,10,15-19H2,(H,27,29) D01GWH DRUGINKE XYKZGGUQORZZTO-UHFFFAOYSA-N D01GWH DRUGSMIL C1CN(CCC1NC(=O)C2=CC3=CC=CC=C3C=C2)CCCCC4=CC=CC=C4 D01GWH DRUGTYPE Small molecular drug D01GWH HIGHSTAT Investigative D01GWN DRUG__ID D01GWN D01GWN DRUGCLAS Investigative Drug(s) D01GWN DRUGINCH 1S/C29H46O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h8-11,15,19-26,30H,7,12-14,16-18H2,1-6H3/b9-8+/t20-,21-,22?,23+,24+,25-,26+,28+,29-/m1/s1 D01GWN DRUGINKE ZFRLPKWDPDXIMP-BLDYNFBXSA-N D01GWN DRUGSMIL CCC(C=CC(C)C1CCC2C1(CC=C3C2C=CC4C3(CCC(C4)O)C)C)C(C)C D01GWN DRUGTYPE Small molecular drug D01GWN HIGHSTAT Investigative D01GWS DRUG__ID D01GWS D01GWS DRUGCLAS Patented Agent(s) D01GWS DRUGCOMP Asan Foundation D01GWS DRUGINCH 1S/C20H23FIN3O4/c1-20(2,28)10-29-24-18(26)16-12-5-4-6-13(12)19(27)25(3)17(16)23-15-8-7-11(22)9-14(15)21/h7-9,23,28H,4-6,10H2,1-3H3,(H,24,26) D01GWS DRUGINKE WMBPVWDVQRPCQY-UHFFFAOYSA-N D01GWS DRUGSMIL CC(C)(CONC(=O)C1=C(N(C(=O)C2=C1CCC2)C)NC3=C(C=C(C=C3)I)F)O D01GWS DRUGTYPE Small molecular drug D01GWS HIGHSTAT Patented D01GXB DRUG__ID D01GXB D01GXB DRUGCLAS Clinical Trial Drug(s) D01GXB DRUGCOMP Sanofi D01GXB DRUGSMIL failed D01GXB DRUGTYPE Combination drug D01GXB HIGHSTAT Phase 1 D01GXL DRUG__ID D01GXL D01GXL DRUGCLAS Clinical Trial Drug(s) D01GXL DRUGCOMP Replidyne D01GXL DRUGINCH 1S/C20H21BrFN3OS/c1-12-17(27-20(13(2)22)19(12)21)11-23-8-5-9-24-18-10-16(26)14-6-3-4-7-15(14)25-18/h3-4,6-7,10,23H,2,5,8-9,11H2,1H3,(H2,24,25,26) D01GXL DRUGINKE BGJMKHPWCFXMOW-UHFFFAOYSA-N D01GXL DRUGSMIL CC1=C(SC(=C1Br)C(=C)F)CNCCCNC2=CC(=O)C3=CC=CC=C3N2 D01GXL DRUGTYPE Small molecular drug D01GXL HIGHSTAT Phase 1 D01GYK DRUG__ID D01GYK D01GYK DRUGCLAS Approved Drug(s) D01GYK DRUGINCH 1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+ D01GYK DRUGINKE ACTRVOBWPAIOHC-XIXRPRMCSA-N D01GYK DRUGSMIL C(C(C(=O)O)S)(C(=O)O)S D01GYK DRUGTYPE Small molecular drug D01GYK HIGHSTAT Approved D01GYS DRUG__ID D01GYS D01GYS DRUGCLAS Investigative Drug(s) D01GYS DRUGINCH 1S/C58H92N18O13S2/c1-5-33(4)47-55(87)71-38(16-11-23-65-57(61)62)49(81)74-44(54(86)72-40(56(88)89)15-9-10-22-59)31-91-90-30-43(53(85)70-39(50(82)76-47)17-12-24-66-58(63)64)75-51(83)41(25-32(2)3)73-52(84)42(27-34-13-7-6-8-14-34)69-46(79)29-67-45(78)28-68-48(80)37(60)26-35-18-20-36(77)21-19-35/h6-8,13-14,18-21,32-33,37-44,47,77H,5,9-12,15-17,22-31,59-60H2,1-4H3,(H,67,78)(H,68,80)(H,69,79)(H,70,85)(H,71,87)(H,72,86)(H,73,84)(H,74,81)(H,75,83)(H,76,82)(H,88,89)(H4,61,62,65)(H4,63,64,66)/t33-,37-,38-,39-,40-,41-,42-,43-,44-,47+/m0/s1 D01GYS DRUGINKE JYEKWXODJFQZIP-HSIOXNDMSA-N D01GYS DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N)C(=O)NC(CCCCN)C(=O)O)CCCN=C(N)N D01GYS HIGHSTAT Investigative D01GYT DRUG__ID D01GYT D01GYT DRUGCLAS Approved Drug(s) D01GYT DRUGINCH 1S/C3H7O4P/c1-2-3(7-2)8(4,5)6/h2-3H,1H3,(H2,4,5,6)/t2-,3+/m0/s1 D01GYT DRUGINKE YMDXZJFXQJVXBF-STHAYSLISA-N D01GYT DRUGSMIL CC1C(O1)P(=O)(O)O D01GYT DRUGTYPE Small molecular drug D01GYT HIGHSTAT Approved D01GYT THERCLAS Antibiotics D01GZV DRUG__ID D01GZV D01GZV DRUGCLAS Investigative Drug(s) D01GZV DRUGINCH 1S/C22H43NO3/c1-3-5-6-7-8-9-10-11-12-13-14-15-18-21(24)22(25)23-19-16-17-20-26-4-2/h3-20H2,1-2H3,(H,23,25) D01GZV DRUGINKE ADDZROPIKDXVSC-UHFFFAOYSA-N D01GZV DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCCCOCC D01GZV DRUGTYPE Small molecular drug D01GZV HIGHSTAT Investigative D01HAT DRUG__ID D01HAT D01HAT DRUGCLAS Clinical Trial Drug(s) D01HAT DRUGCOMP Baylor College of Medicine D01HAT DRUGTYPE CAR T Cell Therapy D01HAT HIGHSTAT Phase 1 D01HAZ DRUG__ID D01HAZ D01HAZ DRUGCLAS Investigative Drug(s) D01HAZ DRUGINCH 1S/C23H39NO/c1-4-7-10-11-12-21-13-15-22(16-14-21)23(25)17-20-24(18-8-5-2)19-9-6-3/h13-16H,4-12,17-20H2,1-3H3 D01HAZ DRUGINKE UMFRWWULZNWTFF-UHFFFAOYSA-N D01HAZ DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)CCN(CCCC)CCCC D01HAZ DRUGTYPE Small molecular drug D01HAZ HIGHSTAT Investigative D01HBE DRUG__ID D01HBE D01HBE DRUGCLAS Discontinued Drug(s) D01HBE DRUGINCH 1S/C35H47NO9/c1-19(13-25-18-41-23(5)36-25)9-8-10-21(3)32(40-7)22(4)27-17-29(37)35(6)30(45-35)12-11-20(2)26-14-24(16-31(38)42-26)15-28-33(43-28)34(39)44-27/h8-13,18,20,22,24,26-30,32-33,37H,14-17H2,1-7H3/b9-8+,12-11+,19-13+,21-10+/t20-,22+,24+,26-,27+,28+,29+,30-,32+,33-,35-/m1/s1 D01HBE DRUGINKE OWPCHSCAPHNHAV-QIPOKPRISA-N D01HBE DRUGSMIL CC1C=CC2C(O2)(C(CC(OC(=O)C3C(O3)CC4CC1OC(=O)C4)C(C)C(C(=CC=CC(=CC5=COC(=N5)C)C)C)OC)O)C D01HBE DRUGTYPE Small molecular drug D01HBE HIGHSTAT Discontinued in Phase 2 D01HBG DRUG__ID D01HBG D01HBG DRUGCLAS Clinical Trial Drug(s) D01HBG DRUGCOMP Rhone-Poulenc SA D01HBG DRUGINCH 1S/C23H29N3OS/c1-3-12-24-23(27)18-10-11-22-20(15-18)26(17(2)16-25-13-6-7-14-25)19-8-4-5-9-21(19)28-22/h4-5,8-11,15,17H,3,6-7,12-14,16H2,1-2H3,(H,24,27)/t17-/m1/s1 D01HBG DRUGINKE KXMAIWXPZGQNCR-QGZVFWFLSA-N D01HBG DRUGSMIL CCCNC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2C(C)CN4CCCC4 D01HBG DRUGTYPE Small molecular drug D01HBG HIGHSTAT Phase 2 D01HBS DRUG__ID D01HBS D01HBS DRUGCLAS Investigative Drug(s) D01HBS DRUGINCH 1S/C19H21NO2/c21-19(20-17-11-5-2-6-12-17)22-18-13-7-10-16(14-18)15-8-3-1-4-9-15/h1,3-4,7-10,13-14,17H,2,5-6,11-12H2,(H,20,21) D01HBS DRUGINKE KGKDDSYRBQOMLE-UHFFFAOYSA-N D01HBS DRUGSMIL C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D01HBS DRUGTYPE Small molecular drug D01HBS HIGHSTAT Investigative D01HCL DRUG__ID D01HCL D01HCL DRUGCLAS Investigative Drug(s) D01HCL DRUGINCH 1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h15-17,19,21,23H,2-14H2,1H3,(H,24,25)/t15-,16+,17+,19+/m0/s1 D01HCL DRUGINKE DPOINJQWXDTOSF-DODZYUBVSA-N D01HCL DRUGSMIL CCCCCC(CCC1C(CC(=O)C1CCCCCCC(=O)O)O)O D01HCL DRUGTYPE Small molecular drug D01HCL HIGHSTAT Investigative D01HCO DRUG__ID D01HCO D01HCO DRUGCLAS Investigative Drug(s) D01HCO DRUGINCH 1S/C14H15N3O3/c1-2-9-20-14-15-8-7-12(17-14)16-11-6-4-3-5-10(11)13(18)19/h3-8H,2,9H2,1H3,(H,18,19)(H,15,16,17) D01HCO DRUGINKE NZLCVQSIEXQTHO-UHFFFAOYSA-N D01HCO DRUGSMIL CCCOC1=NC=CC(=N1)NC2=CC=CC=C2C(=O)O D01HCO DRUGTYPE Small molecular drug D01HCO HIGHSTAT Investigative D01HCR DRUG__ID D01HCR D01HCR DRUGCLAS Investigative Drug(s) D01HCR DRUGINCH 1S/C22H28N2O3/c1-2-3-4-5-6-10-17-26-21-15-13-20(14-16-21)24-22(25)27-23-18-19-11-8-7-9-12-19/h7-9,11-16,18H,2-6,10,17H2,1H3,(H,24,25)/b23-18+ D01HCR DRUGINKE BALHAPBNIAUXLM-PTGBLXJZSA-N D01HCR DRUGSMIL CCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D01HCR DRUGTYPE Small molecular drug D01HCR HIGHSTAT Investigative D01HDD DRUG__ID D01HDD D01HDD DRUGCLAS Investigative Drug(s) D01HDD DRUGINCH 1S/C15H7Cl4NO2/c16-10-8-9(11(17)13(19)12(10)18)15(22)20(14(8)21)6-7-4-2-1-3-5-7/h1-5H,6H2 D01HDD DRUGINKE MQFQHWBPMPPVNJ-UHFFFAOYSA-N D01HDD DRUGSMIL C1=CC=C(C=C1)CN2C(=O)C3=C(C2=O)C(=C(C(=C3Cl)Cl)Cl)Cl D01HDD DRUGTYPE Small molecular drug D01HDD HIGHSTAT Investigative D01HDP DRUG__ID D01HDP D01HDP DRUGCLAS Clinical Trial Drug(s) D01HDP DRUGCOMP Solvay Pharma D01HDP DRUGINCH 1S/C31H38N2O6/c1-2-39-29(37)24(15-14-22-10-4-3-5-11-22)20-31(18-8-9-19-31)30(38)32-25-17-16-23-12-6-7-13-26(23)33(28(25)36)21-27(34)35/h3-7,10-13,24-25H,2,8-9,14-21H2,1H3,(H,32,38)(H,34,35)/t24-,25+/m1/s1 D01HDP DRUGINKE XMQODGUTLZXUGZ-RPBOFIJWSA-N D01HDP DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)CC2(CCCC2)C(=O)NC3CCC4=CC=CC=C4N(C3=O)CC(=O)O D01HDP DRUGTYPE Small molecular drug D01HDP HIGHSTAT Phase 2 D01HED DRUG__ID D01HED D01HED DRUGCLAS Patented Agent(s) D01HED DRUGCOMP Janssen Pharmaceutica NV D01HED DRUGINCH 1S/C26H26F6N6/c27-25(28,29)17-6-8-18(9-7-17)34-22-19-10-15-37(23-20(26(30,31)32)5-4-12-33-23)16-11-21(19)35-24(36-22)38-13-2-1-3-14-38/h4-9,12H,1-3,10-11,13-16H2,(H,34,35,36) D01HED DRUGINKE MRHHSXHMRZMNIM-UHFFFAOYSA-N D01HED DRUGSMIL C1CCN(CC1)C2=NC3=C(CCN(CC3)C4=C(C=CC=N4)C(F)(F)F)C(=N2)NC5=CC=C(C=C5)C(F)(F)F D01HED DRUGTYPE Small molecular drug D01HED HIGHSTAT Patented D01HEN DRUG__ID D01HEN D01HEN DRUGCLAS Investigative Drug(s) D01HEN DRUGCOMP Scripps Research Institute D01HEN HIGHSTAT Investigative D01HFL DRUG__ID D01HFL D01HFL DRUGCLAS Investigative Drug(s) D01HFL DRUGINCH 1S/C21H18N2/c1-4-10-17(11-5-1)20-22-16-21(23-20,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15H,16H2,(H,22,23) D01HFL DRUGINKE KXSXOHNHKQJMNF-UHFFFAOYSA-N D01HFL DRUGSMIL C1C(NC(=N1)C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D01HFL DRUGTYPE Small molecular drug D01HFL HIGHSTAT Investigative D01HFP DRUG__ID D01HFP D01HFP DRUGCLAS Investigative Drug(s) D01HFP DRUGCOMP HanAll Biopharma Co Ltd D01HFP HIGHSTAT Investigative D01HGI DRUG__ID D01HGI D01HGI DRUGCLAS Investigative Drug(s) D01HGI DRUGCOMP Fabre Kramer Pharmaceuticals Inc D01HGI HIGHSTAT Investigative D01HGT DRUG__ID D01HGT D01HGT DRUGCLAS Clinical Trial Drug(s) D01HGT DRUGCOMP Seattle Genetics; Genentech D01HGT DRUGTYPE Antibody D01HGT HIGHSTAT Phase 1 D01HGV DRUG__ID D01HGV D01HGV DRUGCLAS Investigative Drug(s) D01HGV DRUGINCH 1S/C24H20O6/c25-22(14-23(26)24(27)28)19-11-20(29-15-17-7-3-1-4-8-17)13-21(12-19)30-16-18-9-5-2-6-10-18/h1-13H,14-16H2,(H,27,28) D01HGV DRUGINKE SLRLQBRWUMWEOZ-UHFFFAOYSA-N D01HGV DRUGSMIL C1=CC=C(C=C1)COC2=CC(=CC(=C2)C(=O)CC(=O)C(=O)O)OCC3=CC=CC=C3 D01HGV DRUGTYPE Small molecular drug D01HGV HIGHSTAT Investigative D01HHD DRUG__ID D01HHD D01HHD DRUGCLAS Clinical Trial Drug(s) D01HHD DRUGCOMP Biotest AG D01HHD HIGHSTAT Phase 3 D01HHH DRUG__ID D01HHH D01HHH DRUGCLAS Investigative Drug(s) D01HHH DRUGCOMP Chroma Therapeutics Ltd D01HHH HIGHSTAT Investigative D01HHJ DRUG__ID D01HHJ D01HHJ DRUGCLAS Clinical Trial Drug(s) D01HHJ DRUGCOMP Global Biotech Inc D01HHJ HIGHSTAT Phase 1/2 D01HHL DRUG__ID D01HHL D01HHL DRUGCLAS Investigative Drug(s) D01HHL DRUGTYPE Antibody D01HHL HIGHSTAT Investigative D01HJN DRUG__ID D01HJN D01HJN DRUGCLAS Investigative Drug(s) D01HJN DRUGINCH 1S/C12H10O5/c1-2-16-11(14)9-5-7-3-4-8(13)6-10(7)17-12(9)15/h3-6,13H,2H2,1H3 D01HJN DRUGINKE IETDBZQIWIJQJG-UHFFFAOYSA-N D01HJN DRUGSMIL CCOC(=O)C1=CC2=C(C=C(C=C2)O)OC1=O D01HJN DRUGTYPE Small molecular drug D01HJN HIGHSTAT Investigative D01HJQ DRUG__ID D01HJQ D01HJQ COMPCLAS Aminoazetidine derivatives D01HJQ DRUGCLAS Patented Agent(s) D01HJQ DRUGINCH 1S/C29H27Cl2F2N3O4/c1-2-40-28(39)15-34-26(37)14-27(38)36(24-12-22(32)11-23(33)13-24)25-16-35(17-25)29(18-3-7-20(30)8-4-18)19-5-9-21(31)10-6-19/h3-13,25,29H,2,14-17H2,1H3,(H,34,37) D01HJQ DRUGINKE JLIDBGJVXRJCFP-UHFFFAOYSA-N D01HJQ DRUGSMIL CCOC(=O)CNC(=O)CC(=O)N(C1CN(C1)C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)C4=CC(=CC(=C4)F)F D01HJQ DRUGTYPE Small molecular drug D01HJQ HIGHSTAT Patented D01HJZ DRUG__ID D01HJZ D01HJZ DRUGCLAS Investigative Drug(s) D01HJZ DRUGINCH 1S/C16H19N/c1-17(2)13-16(14-9-5-3-6-10-14)15-11-7-4-8-12-15/h3-12,16H,13H2,1-2H3 D01HJZ DRUGINKE UAUJDKBNVRSJBD-UHFFFAOYSA-N D01HJZ DRUGSMIL CN(C)CC(C1=CC=CC=C1)C2=CC=CC=C2 D01HJZ DRUGTYPE Small molecular drug D01HJZ HIGHSTAT Investigative D01HKL DRUG__ID D01HKL D01HKL DRUGCLAS Approved Drug(s) D01HKL DRUGCOMP Abbott Laboratories D01HKL DRUGINCH 1S/C17H15ClO4.C5H14NO/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11;1-6(2,3)4-5-7/h3-10H,1-2H3,(H,20,21);7H,4-5H2,1-3H3/q;+1/p-1 D01HKL DRUGINKE JWAZHODZSADEHB-UHFFFAOYSA-M D01HKL DRUGSMIL CC(C)(C(=O)[O-])OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl.C[N+](C)(C)CCO D01HKL DRUGTYPE Small molecular drug D01HKL HIGHSTAT Approved D01HKU DRUG__ID D01HKU D01HKU DRUGCLAS Investigative Drug(s) D01HKU DRUGINCH 1S/C25H30N10O6/c1-34(12-14-11-28-21-19(29-14)20(26)31-25(27)32-21)15-6-4-13(5-7-15)22(37)30-16(24(39)40)8-9-18(36)35-10-2-3-17(35)23(38)33-41/h4-7,11,16-17,41H,2-3,8-10,12H2,1H3,(H,30,37)(H,33,38)(H,39,40)(H4,26,27,28,31,32)/t16-,17-/m0/s1 D01HKU DRUGINKE UYVVHTPVCDOQRA-IRXDYDNUSA-N D01HKU DRUGSMIL CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)N4CCCC4C(=O)NO)C(=O)O D01HKU DRUGTYPE Small molecular drug D01HKU HIGHSTAT Investigative D01HKZ DRUG__ID D01HKZ D01HKZ DRUGCLAS Clinical Trial Drug(s) D01HKZ DRUGCOMP Tesaro D01HKZ DRUGINCH 1S/C33H44FN5O3/c1-21(2)35-30(40)24-8-12-27(13-9-24)39-29-19-22(20-38-17-15-25(16-18-38)33(3,4)42)5-14-28(29)36-32(39)37-31(41)23-6-10-26(34)11-7-23/h5-7,10-11,14,19,21,24-25,27,42H,8-9,12-13,15-18,20H2,1-4H3,(H,35,40)(H,36,37,41) D01HKZ DRUGINKE WSTUJEXAPHIEIM-UHFFFAOYSA-N D01HKZ DRUGSMIL CC(C)NC(=O)C1CCC(CC1)N2C3=C(C=CC(=C3)CN4CCC(CC4)C(C)(C)O)N=C2NC(=O)C5=CC=C(C=C5)F D01HKZ HIGHSTAT Phase 1/2 D01HLF DRUG__ID D01HLF D01HLF DRUGCLAS Investigative Drug(s) D01HLF DRUGCOMP University of Arizona D01HLF HIGHSTAT Investigative D01HLO DRUG__ID D01HLO D01HLO DRUGCLAS Clinical Trial Drug(s) D01HLO DRUGCOMP Pfizer Inc D01HLO DRUGINCH 1S/C29H32N6OS/c1-19-11-25(31-18-30-19)22-3-5-24-21(12-22)4-6-26(24)35-16-29(17-35)7-9-33(10-8-29)27(36)13-23-15-34-14-20(2)37-28(34)32-23/h3,5,11-12,14-15,18,26H,4,6-10,13,16-17H2,1-2H3/t26-/m1/s1 D01HLO DRUGINKE ZIUDADZJCKGWKR-AREMUKBSSA-N D01HLO DRUGSMIL CC1=CC(=NC=N1)C2=CC3=C(C=C2)C(CC3)N4CC5(C4)CCN(CC5)C(=O)CC6=CN7C=C(SC7=N6)C D01HLO HIGHSTAT Phase 1 D01HNL DRUG__ID D01HNL D01HNL DRUGCLAS Approved Drug(s) D01HNL DRUGINCH 1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11) D01HNL DRUGINKE POJWUDADGALRAB-UHFFFAOYSA-N D01HNL DRUGSMIL C1(C(=O)NC(=O)N1)NC(=O)N D01HNL DRUGTYPE Small molecular drug D01HNL HIGHSTAT Approved D01HNP DRUG__ID D01HNP D01HNP DRUGCLAS Investigative Drug(s) D01HNP DRUGINCH 1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5) D01HNP DRUGINKE AEMRFAOFKBGASW-UHFFFAOYSA-N D01HNP DRUGSMIL C(C(=O)O)O D01HNP DRUGTYPE Small molecular drug D01HNP HIGHSTAT Investigative D01HOI DRUG__ID D01HOI D01HOI DRUGCLAS Investigative Drug(s) D01HOI DRUGCOMP Cardiff Biologicals D01HOI HIGHSTAT Investigative D01HOL DRUG__ID D01HOL D01HOL DRUGCLAS Clinical Trial Drug(s) D01HOL DRUGCOMP Bayer healthcare pharmaceuticals D01HOL HIGHSTAT Phase 1 D01HOO DRUG__ID D01HOO D01HOO DRUGCLAS Investigative Drug(s) D01HOO DRUGINCH 1S/C11H17NO7/c12-6(9(14)15)2-11(10(16)17)3-8-7(19-11)1-5(13)4-18-8/h5-8,13H,1-4,12H2,(H,14,15)(H,16,17)/p-1/t5-,6-,7?,8?,11+/m0/s1 D01HOO DRUGINKE JVLNPAVKDNEYGY-SCTSMQQKSA-M D01HOO DRUGSMIL C1C(COC2C1OC(C2)(CC(C(=O)[O-])[NH3+])C(=O)[O-])O D01HOO DRUGTYPE Small molecular drug D01HOO HIGHSTAT Investigative D01HOP DRUG__ID D01HOP D01HOP DRUGCLAS Investigative Drug(s) D01HOP DRUGINCH 1S/C30H40N6O7/c1-17(2)12-24(30(42)43)36-29(41)23(15-19-8-5-4-6-9-19)35-25(37)16-33-27(39)18(3)34-28(40)22(31)14-20-10-7-11-21(13-20)26(32)38/h4-11,13,17-18,22-24H,12,14-16,31H2,1-3H3,(H2,32,38)(H,33,39)(H,34,40)(H,35,37)(H,36,41)(H,42,43)/t18-,22-,23-,24-/m0/s1 D01HOP DRUGINKE CPTUJVNVSNEVEH-IMNFJDCFSA-N D01HOP DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(C)NC(=O)C(CC2=CC(=CC=C2)C(=O)N)N D01HOP DRUGTYPE Small molecular drug D01HOP HIGHSTAT Investigative D01HOT DRUG__ID D01HOT D01HOT DRUGCLAS Investigative Drug(s) D01HOT DRUGCOMP XBiotech Inc D01HOT HIGHSTAT Investigative D01HPI DRUG__ID D01HPI D01HPI DRUGCLAS Discontinued Drug(s) D01HPI DRUGCOMP Delex Therapeutics Inc D01HPI HIGHSTAT Terminated D01HPP DRUG__ID D01HPP D01HPP DRUGCLAS Investigative Drug(s) D01HPP DRUGCOMP EndGenitor Technologies Inc D01HPP HIGHSTAT Investigative D01HPY DRUG__ID D01HPY D01HPY DRUGCLAS Approved Drug(s) D01HPY DRUGCOMP Oncopeptides AB D01HPY DRUGINCH 1S/C24H30Cl2FN3O3/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26/h3-10,21-22H,2,11-16,28H2,1H3,(H,29,31)/t21-,22-/m0/s1 D01HPY DRUGINKE YQZNKYXGZSVEHI-VXKWHMMOSA-N D01HPY DRUGSMIL CCOC(=O)C(CC1=CC=C(C=C1)F)NC(=O)C(CC2=CC=C(C=C2)N(CCCl)CCCl)N D01HPY DRUGTYPE Small molecular drug D01HPY HIGHSTAT Approved D01HQJ DRUG__ID D01HQJ D01HQJ DRUGCLAS Drugs in Phase 2 Trial D01HQJ DRUGTYPE Cell therapy D01HQJ HIGHSTAT Phase 2 Trial D01HQJ THERCLAS Antiviral Agents D01HQQ DRUG__ID D01HQQ D01HQQ DRUGCLAS Investigative Drug(s) D01HQQ DRUGCOMP String Therapeutics Inc D01HQQ HIGHSTAT Investigative D01HQU DRUG__ID D01HQU D01HQU DRUGCLAS Clinical Trial Drug(s) D01HQU DRUGCOMP Akeso Biopharma Guangdong, China Merck Kenilworth, NJ D01HQU DRUGINCH 1S/C21H15N5O/c1-3-15(19-22-9-10-23-19)4-2-14(1)18-13-26-21(27-18)17-7-5-16(6-8-17)20-24-11-12-25-20/h1-13H,(H,22,23)(H,24,25) D01HQU DRUGINKE POIOBVFAFSUWGR-UHFFFAOYSA-N D01HQU DRUGSMIL C1=CC(=CC=C1C2=CN=C(O2)C3=CC=C(C=C3)C4=NC=CN4)C5=NC=CN5 D01HQU HIGHSTAT Phase 1 D01HQV DRUG__ID D01HQV D01HQV DRUGCLAS Investigative Drug(s) D01HQV DRUGINCH 1S/C16H12O3/c1-10-2-7-15-12(8-10)9-14(16(18)19-15)11-3-5-13(17)6-4-11/h2-9,17H,1H3 D01HQV DRUGINKE JSHUCMRTLUIFTM-UHFFFAOYSA-N D01HQV DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C(=C2)C3=CC=C(C=C3)O D01HQV DRUGTYPE Small molecular drug D01HQV HIGHSTAT Investigative D01HRG DRUG__ID D01HRG D01HRG DRUGCLAS Investigative Drug(s) D01HRG DRUGINCH 1S/C14H9NO2/c16-13-11-8-4-5-9-12(11)15(14(13)17)10-6-2-1-3-7-10/h1-9H D01HRG DRUGINKE UWCPWBIMRYXUOU-UHFFFAOYSA-N D01HRG DRUGSMIL C1=CC=C(C=C1)N2C3=CC=CC=C3C(=O)C2=O D01HRG DRUGTYPE Small molecular drug D01HRG HIGHSTAT Investigative D01HRJ DRUG__ID D01HRJ D01HRJ DRUGCLAS Approved Drug(s) D01HRJ DRUGCOMP BIKEN D01HRJ HIGHSTAT Approved D01HRR DRUG__ID D01HRR D01HRR DRUGCLAS Discontinued Drug(s) D01HRR DRUGCOMP Shionogi & Co Ltd D01HRR DRUGINCH 1S/C20H27NO4S/c22-19(23)11-7-2-1-6-10-18-15-12-13-16(14-15)20(18)21-26(24,25)17-8-4-3-5-9-17/h1,3-6,8-9,15-16,18,20-21H,2,7,10-14H2,(H,22,23)/b6-1-/t15-,16+,18+,20+/m1/s1 D01HRR DRUGINKE PWTCIBWRMQFJBC-ZEMKZVSASA-N D01HRR DRUGSMIL C1CC2CC1C(C2NS(=O)(=O)C3=CC=CC=C3)CC=CCCCC(=O)O D01HRR DRUGTYPE Small molecular drug D01HRR HIGHSTAT Discontinued in Preregistration D01HRU DRUG__ID D01HRU D01HRU DRUGCLAS Clinical Trial Drug(s) D01HRU DRUGCOMP Sebo GmbH D01HRU HIGHSTAT Phase 3 D01HRV DRUG__ID D01HRV D01HRV DRUGCLAS Investigative Drug(s) D01HRV DRUGINCH 1S/C26H31FN6O/c27-21-5-3-19(4-6-21)26(16-34)31-22-9-12-32(13-10-22)11-1-2-20-15-28-25-8-7-23(14-24(20)25)33-17-29-30-18-33/h3-8,14-15,17-18,22,26,28,31,34H,1-2,9-13,16H2/t26-/m0/s1 D01HRV DRUGINKE HNKDAQNYMJNLCC-SANMLTNESA-N D01HRV DRUGSMIL C1CN(CCC1NC(CO)C2=CC=C(C=C2)F)CCCC3=CNC4=C3C=C(C=C4)N5C=NN=C5 D01HRV DRUGTYPE Small molecular drug D01HRV HIGHSTAT Investigative D01HSA DRUG__ID D01HSA D01HSA DRUGCLAS Investigative Drug(s) D01HSA DRUGCOMP Human Genome Sciences Inc D01HSA HIGHSTAT Investigative D01HST DRUG__ID D01HST D01HST DRUGCLAS Investigative Drug(s) D01HST DRUGINCH 1S/C20H16N4O3S2/c1-12-2-4-13(5-3-12)15-9-28-19-22-23-20(24(15)19)29-10-18(25)21-14-6-7-16-17(8-14)27-11-26-16/h2-9H,10-11H2,1H3,(H,21,25) D01HST DRUGINKE XYXNYQAJSYUYNZ-UHFFFAOYSA-N D01HST DRUGSMIL CC1=CC=C(C=C1)C2=CSC3=NN=C(N23)SCC(=O)NC4=CC5=C(C=C4)OCO5 D01HST DRUGTYPE Small molecular drug D01HST HIGHSTAT Investigative D01HTH DRUG__ID D01HTH D01HTH DRUGCLAS Investigative Drug(s) D01HTH DRUGINCH 1S/C20H21N3.ClH/c1-3-15-8-6-11-17(14-15)23(2)20(21)22-19-13-7-10-16-9-4-5-12-18(16)19;/h4-14H,3H2,1-2H3,(H2,21,22);1H D01HTH DRUGINKE CKAKVKWRMCAYJD-UHFFFAOYSA-N D01HTH DRUGSMIL CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC3=CC=CC=C32)N.Cl D01HTH DRUGTYPE Small molecular drug D01HTH HIGHSTAT Investigative D01HTJ DRUG__ID D01HTJ D01HTJ DRUGCLAS Investigative Drug(s) D01HTJ DRUGCOMP FibroGen Inc D01HTJ HIGHSTAT Investigative D01HTL DRUG__ID D01HTL D01HTL DRUGCLAS Approved Drug(s) D01HTL DRUGCOMP GlaxoSmithKline D01HTL DRUGINCH 1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38+,39+,42+,43+,44-,45-/m0/s1 D01HTL DRUGINKE GBABOYUKABKIAF-IELIFDKJSA-N D01HTL DRUGSMIL CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC D01HTL DRUGTYPE Small molecular drug D01HTL HIGHSTAT Approved D01HTL THERCLAS Anticancer Agents D01HTS DRUG__ID D01HTS D01HTS DRUGCLAS Investigative Drug(s) D01HTS DRUGCOMP Molecular Insight Pharmaceuticals Inc D01HTS HIGHSTAT Investigative D01HTX DRUG__ID D01HTX D01HTX DRUGCLAS Investigative Drug(s) D01HTX DRUGINCH 1S/C43H61N11O7/c1-3-5-16-31-38(57)51-32(17-6-4-2)39(58)53-34(23-26-13-8-7-9-14-26)41(60)52-33(19-12-22-47-43(45)46)40(59)54-35(24-27-25-48-29-18-11-10-15-28(27)29)42(61)50-30(37(44)56)20-21-36(55)49-31/h7-11,13-15,18,25,30-35,48H,3-6,12,16-17,19-24H2,1-2H3,(H2,44,56)(H,49,55)(H,50,61)(H,51,57)(H,52,60)(H,53,58)(H,54,59)(H4,45,46,47)/t30-,31-,32-,33-,34+,35-/m0/s1 D01HTX DRUGINKE WGLOHHGRWPHJBM-MAVCTHMOSA-N D01HTX DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CCCC D01HTX DRUGTYPE Small molecular drug D01HTX HIGHSTAT Investigative D01HUN DRUG__ID D01HUN D01HUN DRUGCLAS Investigative Drug(s) D01HUN DRUGINCH 1S/C19H21F2N7O/c20-15-4-3-12(8-16(15)21)14(18-24-6-7-25-18)9-17(29)28-19(22)26-5-1-2-13-10-23-11-27-13/h3-4,6-8,10-11,14H,1-2,5,9H2,(H,23,27)(H,24,25)(H3,22,26,28,29) D01HUN DRUGINKE DGJMWXIXZSWRLP-UHFFFAOYSA-N D01HUN DRUGSMIL C1=CC(=C(C=C1C(CC(=O)NC(=NCCCC2=CN=CN2)N)C3=NC=CN3)F)F D01HUN DRUGTYPE Small molecular drug D01HUN HIGHSTAT Investigative D01HUO DRUG__ID D01HUO D01HUO DRUGCLAS Investigative Drug(s) D01HUO DRUGINCH 1S/C16H7N3O4/c20-13-8-7-5-3-1-2-4-6(5)17-12(7)11-10(9(8)14(21)18-13)15(22)19-16(11)23/h1-4,17H,(H,18,20,21)(H,19,22,23) D01HUO DRUGINKE IZHSJTMCSHXFHX-UHFFFAOYSA-N D01HUO DRUGSMIL C1=CC=C2C(=C1)C3=C4C(=C5C(=C3N2)C(=O)NC5=O)C(=O)NC4=O D01HUO DRUGTYPE Small molecular drug D01HUO HIGHSTAT Investigative D01HUQ DRUG__ID D01HUQ D01HUQ DRUGCLAS Investigative Drug(s) D01HUQ DRUGINCH 1S/C7H10N2O/c8-7(10)2-1-6-3-4-9-5-6/h3-5,9H,1-2H2,(H2,8,10) D01HUQ DRUGINKE TWGRVIPCCGRSNM-UHFFFAOYSA-N D01HUQ DRUGSMIL C1=CNC=C1CCC(=O)N D01HUQ DRUGTYPE Small molecular drug D01HUQ HIGHSTAT Investigative D01HVC DRUG__ID D01HVC D01HVC DRUGCLAS Investigative Drug(s) D01HVC DRUGCOMP Morvus Technology Ltd D01HVC HIGHSTAT Investigative D01HVE DRUG__ID D01HVE D01HVE DRUGCLAS Discontinued Drug(s) D01HVE DRUGCOMP Zeneca Group plc D01HVE HIGHSTAT Terminated D01HVM DRUG__ID D01HVM D01HVM DRUGCLAS Clinical Trial Drug(s) D01HVM DRUGCOMP Agen biomedical (agenix) D01HVM DRUGINCH 1S/C18H14IN3O3/c1-18(24,11-25-15-6-2-12(9-20)3-7-15)17(23)22-14-5-4-13(10-21)16(19)8-14/h2-8,24H,11H2,1H3,(H,22,23)/t18-/m0/s1 D01HVM DRUGINKE RXSZCFAPSDTELY-SFHVURJKSA-N D01HVM DRUGSMIL CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)I)O D01HVM DRUGTYPE Small molecular drug D01HVM HIGHSTAT Phase 2 D01HVR DRUG__ID D01HVR D01HVR DRUGCLAS Clinical Trial Drug(s) D01HVR DRUGCOMP Sumagen D01HVR HIGHSTAT Phase 1 D01HVT DRUG__ID D01HVT D01HVT DRUGCLAS Approved Drug(s) D01HVT DRUGCOMP Novartis D01HVT DRUGINCH 1S/C23H30N8O.C4H6O4/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30;5-3(6)1-2-4(7)8/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28);1-2H2,(H,5,6)(H,7,8) D01HVT DRUGINKE NHANOMFABJQAAH-UHFFFAOYSA-N D01HVT DRUGSMIL CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5.C(CC(=O)O)C(=O)O D01HVT DRUGTYPE Small molecular drug D01HVT HIGHSTAT Approved D01HVT TRADNAME Kisqali D01HVZ DRUG__ID D01HVZ D01HVZ DRUGCLAS Clinical Trial Drug(s) D01HVZ DRUGCOMP Theravance D01HVZ DRUGINCH 1S/C25H37N5O3/c1-17(2)23-27-21-6-4-5-20(22(21)28-23)24(31)26-15-18-7-11-29(12-8-18)16-19-9-13-30(14-10-19)25(32)33-3/h4-6,17-19H,7-16H2,1-3H3,(H,26,31)(H,27,28) D01HVZ DRUGINKE MZOITCJKGUIQEI-UHFFFAOYSA-N D01HVZ DRUGSMIL CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC4CCN(CC4)C(=O)OC D01HVZ DRUGTYPE Small molecular drug D01HVZ HIGHSTAT Phase 2 D01HWK DRUG__ID D01HWK D01HWK DRUGCLAS Investigative Drug(s) D01HWK DRUGCOMP Arachnova Ltd D01HWK HIGHSTAT Investigative D01HXA DRUG__ID D01HXA D01HXA DRUGCLAS Clinical Trial Drug(s) D01HXA DRUGCOMP Ausio Pharmaceuticals D01HXA DRUGINCH 1S/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m1/s1 D01HXA DRUGINKE ADFCQWZHKCXPAJ-GFCCVEGCSA-N D01HXA DRUGSMIL C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O D01HXA HIGHSTAT Phase 2 D01HXN DRUG__ID D01HXN D01HXN DRUGCLAS Investigative Drug(s) D01HXN DRUGCOMP Toray Industries Inc D01HXN HIGHSTAT Investigative D01HYQ DRUG__ID D01HYQ D01HYQ DRUGCLAS Clinical Trial Drug(s) D01HYQ DRUGCOMP onis Pharmaceuticals Carlsbad, CA D01HYQ HIGHSTAT Phase 2 D01HZE DRUG__ID D01HZE D01HZE DRUGCLAS Investigative Drug(s) D01HZE DRUGINCH 1S/C22H26ClN3O2/c1-28-21-12-20(24)19(23)11-18(21)22(27)25-15-9-16-7-8-17(10-15)26(16)13-14-5-3-2-4-6-14/h2-6,11-12,15-17H,7-10,13,24H2,1H3,(H,25,27) D01HZE DRUGINKE BQHYHGXYIOWFJL-UHFFFAOYSA-N D01HZE DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CC3CCC(C2)N3CC4=CC=CC=C4)Cl)N D01HZE HIGHSTAT Investigative D01HZN DRUG__ID D01HZN D01HZN DRUGCLAS Investigative Drug(s) D01HZN DRUGINCH 1S/C14H6F6O2/c15-7-1-5(2-8(16)11(7)19)13(21)14(22)6-3-9(17)12(20)10(18)4-6/h1-4,13,21H D01HZN DRUGINKE BBOPAMQNZSQMGE-UHFFFAOYSA-N D01HZN DRUGSMIL C1=C(C=C(C(=C1F)F)F)C(C(=O)C2=CC(=C(C(=C2)F)F)F)O D01HZN DRUGTYPE Small molecular drug D01HZN HIGHSTAT Investigative D01HZQ DRUG__ID D01HZQ D01HZQ DRUGCLAS Clinical Trial Drug(s) D01HZQ DRUGCOMP Verrica Pharmaceuticals West Chester, PA D01HZQ HIGHSTAT Phase 3 D01IAT DRUG__ID D01IAT D01IAT DRUGCLAS Investigative Drug(s) D01IAT DRUGINCH 1S/C16H12O2/c17-15-3-1-2-12(9-15)13-5-4-11-6-7-16(18)10-14(11)8-13/h1-10,17-18H D01IAT DRUGINKE VEQWNMMVQWDERW-UHFFFAOYSA-N D01IAT DRUGSMIL C1=CC(=CC(=C1)O)C2=CC3=C(C=C2)C=CC(=C3)O D01IAT HIGHSTAT Investigative D01IBO DRUG__ID D01IBO D01IBO DRUGCLAS Discontinued Drug(s) D01IBO DRUGCOMP BioCryst Pharmaceuticals Inc D01IBO DRUGINCH 1S/C14H10N2O2S2/c15-13(16)12-6-8-3-4-9(7-11(8)20-12)18-14(17)10-2-1-5-19-10/h1-7H,(H3,15,16) D01IBO DRUGINKE OTGQTQBPQCRNRG-UHFFFAOYSA-N D01IBO DRUGSMIL C1=CSC(=C1)C(=O)OC2=CC3=C(C=C2)C=C(S3)C(=N)N D01IBO DRUGTYPE Small molecular drug D01IBO HIGHSTAT Discontinued in Phase 1 D01ICF DRUG__ID D01ICF D01ICF DRUGCLAS Investigative Drug(s) D01ICF DRUGINCH 1S/C16H24N4O2/c1-5-8-9-17-14-12-10-18-20(6-2)15(12)19-11(4)13(14)16(21)22-7-3/h10H,5-9H2,1-4H3,(H,17,19) D01ICF DRUGINKE PCTRYMLLRKWXGF-UHFFFAOYSA-N D01ICF DRUGSMIL CCCCNC1=C2C=NN(C2=NC(=C1C(=O)OCC)C)CC D01ICF DRUGTYPE Small molecular drug D01ICF HIGHSTAT Investigative D01ICI DRUG__ID D01ICI D01ICI DRUGCLAS Approved Drug(s) D01ICI DRUGCOMP Gilead Sciences, Foster City, CA D01ICI DRUGINCH 1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1 D01ICI DRUGINKE RWWYLEGWBNMMLJ-YSOARWBDSA-N D01ICI DRUGSMIL CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4 D01ICI DRUGTYPE Small molecular drug D01ICI HIGHSTAT Approved D01ICU DRUG__ID D01ICU D01ICU DRUGCLAS Approved Drug(s) D01ICU HIGHSTAT Approved D01ICY DRUG__ID D01ICY D01ICY DRUGCLAS Clinical Trial Drug(s) D01ICY DRUGCOMP Sanofi D01ICY HIGHSTAT Phase 2 D01IDD DRUG__ID D01IDD D01IDD DRUGCLAS Investigative Drug(s) D01IDD DRUGINCH 1S/C19H16N4O2S/c1-25-14-8-6-12(7-9-14)18(24)21-19-23-22-17(26-19)10-13-11-20-16-5-3-2-4-15(13)16/h2-9,11,20H,10H2,1H3,(H,21,23,24) D01IDD DRUGINKE AXHAJBIEOINPDH-UHFFFAOYSA-N D01IDD DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=NN=C(S2)CC3=CNC4=CC=CC=C43 D01IDD DRUGTYPE Small molecular drug D01IDD HIGHSTAT Investigative D01IDE DRUG__ID D01IDE D01IDE DRUGCLAS Discontinued Drug(s) D01IDE DRUGCOMP Eisai Co Ltd D01IDE DRUGINCH 1S/C26H34N4O2/c1-4-6-16-27-26(31)29-24-20(3)12-10-15-23(24)32-18-11-17-30-19-28-25(22(30)5-2)21-13-8-7-9-14-21/h7-10,12-15,19H,4-6,11,16-18H2,1-3H3,(H2,27,29,31) D01IDE DRUGINKE NQZTZGNLFLQHKG-UHFFFAOYSA-N D01IDE DRUGSMIL CCCCNC(=O)NC1=C(C=CC=C1OCCCN2C=NC(=C2CC)C3=CC=CC=C3)C D01IDE DRUGTYPE Small molecular drug D01IDE HIGHSTAT Discontinued in Phase 2 D01IDQ DRUG__ID D01IDQ D01IDQ DRUGCLAS Discontinued Drug(s) D01IDQ DRUGCOMP Innate, Pharma D01IDQ HIGHSTAT Discontinued in Phase 2 D01IDW DRUG__ID D01IDW D01IDW DRUGCLAS Clinical Trial Drug(s) D01IDW DRUGCOMP OscotecChonan, South Korea D01IDW HIGHSTAT Phase 1 D01IED DRUG__ID D01IED D01IED DRUGCLAS Clinical Trial Drug(s) D01IED DRUGCOMP Biomed valley discoveries D01IED DRUGINCH 1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29)/t19-/m1/s1 D01IED DRUGINKE KSERXGMCDHOLSS-LJQANCHMSA-N D01IED DRUGSMIL CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl D01IED HIGHSTAT Phase 2 D01IEM DRUG__ID D01IEM D01IEM DRUGCLAS Approved Drug(s) D01IEM DRUGCOMP Merck & Co Inc D01IEM DRUGINCH 1S/C12H6Cl4OS/c13-7-1-3-8(4-2-7)18(17)12-6-10(15)9(14)5-11(12)16/h1-6H D01IEM DRUGINKE IEPUYXNXNXZXRP-UHFFFAOYSA-N D01IEM DRUGSMIL C1=CC(=CC=C1S(=O)C2=CC(=C(C=C2Cl)Cl)Cl)Cl D01IEM DRUGTYPE Small molecular drug D01IEM HIGHSTAT Approved D01IEX DRUG__ID D01IEX D01IEX DRUGCLAS Investigative Drug(s) D01IEX DRUGINCH 1S/C26H19N3O8S2.2Na/c27-24-21(39(35,36)37)13-19(22-23(24)26(31)17-9-5-4-8-16(17)25(22)30)29-15-10-11-18(20(12-15)38(32,33)34)28-14-6-2-1-3-7-14;;/h1-13,28-29H,27H2,(H,32,33,34)(H,35,36,37);;/q;2*+1/p-2 D01IEX DRUGINKE QBLLYXXXOJUNCV-UHFFFAOYSA-L D01IEX DRUGSMIL C1=CC=C(C=C1)NC2=C(C=C(C=C2)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+] D01IEX DRUGTYPE Small molecular drug D01IEX HIGHSTAT Investigative D01IFD DRUG__ID D01IFD D01IFD DRUGCLAS Patented Agent(s) D01IFD DRUGCOMP AFFIBODY AB D01IFD DRUGTYPE Antibody D01IFD HIGHSTAT Patented D01IFO DRUG__ID D01IFO D01IFO DRUGCLAS Investigative Drug(s) D01IFO DRUGINCH 1S/C13H7F3N2/c14-13(15,16)10-4-1-3-9(7-10)12-6-2-5-11(8-17)18-12/h1-7H D01IFO DRUGINKE FYQRYAIHFASLNM-UHFFFAOYSA-N D01IFO DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)C2=CC=CC(=N2)C#N D01IFO DRUGTYPE Small molecular drug D01IFO HIGHSTAT Investigative D01IFR DRUG__ID D01IFR D01IFR DRUGCLAS Investigative Drug(s) D01IFR DRUGINCH 1S/C15H12N2OS/c19-15-17-16-14(18-15)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13H,(H,17,19) D01IFR DRUGINKE YCCKTVQLIQQBMK-UHFFFAOYSA-N D01IFR DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C3=NNC(=S)O3 D01IFR DRUGTYPE Small molecular drug D01IFR HIGHSTAT Investigative D01IGH DRUG__ID D01IGH D01IGH DRUGCLAS Clinical Trial Drug(s) D01IGH DRUGCOMP BIKEN D01IGH HIGHSTAT Phase 1 D01IGL DRUG__ID D01IGL D01IGL DRUGCLAS Investigative Drug(s) D01IGL DRUGINCH 1S/C11H15NO2/c1-3-5-7-10(13)12-8-9(6-4-2)11(12)14/h3-4,9H,1-2,5-8H2 D01IGL DRUGINKE QVTWEMBUZOBMIJ-UHFFFAOYSA-N D01IGL DRUGSMIL C=CCCC(=O)N1CC(C1=O)CC=C D01IGL DRUGTYPE Small molecular drug D01IGL HIGHSTAT Investigative D01IGU DRUG__ID D01IGU D01IGU DRUGCLAS Investigative Drug(s) D01IGU DRUGINCH 1S/C3H10N2O/c4-2-1-3-6-5/h1-5H2 D01IGU DRUGINKE VSZFWDPIWSPZON-UHFFFAOYSA-N D01IGU DRUGSMIL C(CN)CON D01IGU DRUGTYPE Small molecular drug D01IGU HIGHSTAT Investigative D01IGW DRUG__ID D01IGW D01IGW DRUGCLAS Investigative Drug(s) D01IGW DRUGINCH 1S/C10H7ClN2O2/c11-8-7(6-4-2-1-3-5-6)9(14)13-10(15)12-8/h1-5H,(H2,12,13,14,15) D01IGW DRUGINKE ORRYLQRWCPCGJZ-UHFFFAOYSA-N D01IGW DRUGSMIL C1=CC=C(C=C1)C2=C(NC(=O)NC2=O)Cl D01IGW DRUGTYPE Small molecular drug D01IGW HIGHSTAT Investigative D01IGZ DRUG__ID D01IGZ D01IGZ DRUGCLAS Clinical Trial Drug(s) D01IGZ DRUGCOMP Boston Biomedical Cambridge, MA D01IGZ DRUGINCH 1S/C14H8O4/c1-7(15)11-6-10-12(16)8-4-2-3-5-9(8)13(17)14(10)18-11/h2-6H,1H3 D01IGZ DRUGINKE DPHUWDIXHNQOSY-UHFFFAOYSA-N D01IGZ DRUGSMIL CC(=O)C1=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O D01IGZ HIGHSTAT Phase 3 D01IHM DRUG__ID D01IHM D01IHM DRUGCLAS Investigative Drug(s) D01IHM DRUGINCH 1S/C13H9F3N4/c1-8-17-18-12-6-5-11(19-20(8)12)9-3-2-4-10(7-9)13(14,15)16/h2-7H,1H3 D01IHM DRUGINKE GUOQUXNJZHGPQF-UHFFFAOYSA-N D01IHM DRUGSMIL CC1=NN=C2N1N=C(C=C2)C3=CC(=CC=C3)C(F)(F)F D01IHM DRUGTYPE Small molecular drug D01IHM HIGHSTAT Investigative D01IHR DRUG__ID D01IHR D01IHR DRUGCLAS Clinical Trial Drug(s) D01IHR DRUGCOMP Accera D01IHR DRUGINCH 1S/C27H50O6/c1-4-7-10-13-16-19-25(28)31-22-24(33-27(30)21-18-15-12-9-6-3)23-32-26(29)20-17-14-11-8-5-2/h24H,4-23H2,1-3H3 D01IHR DRUGINKE VLPFTAMPNXLGLX-UHFFFAOYSA-N D01IHR DRUGSMIL CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC D01IHR DRUGTYPE Small molecular drug D01IHR HIGHSTAT Phase 2 D01IHU DRUG__ID D01IHU D01IHU DRUGCLAS Investigative Drug(s) D01IHU DRUGCOMP Isis Pharmaceuticals D01IHU DRUGTYPE Antisense drug D01IHU HIGHSTAT Investigative D01IHV DRUG__ID D01IHV D01IHV DRUGCLAS Investigative Drug(s) D01IHV DRUGCOMP AdAlta Pty Ltd D01IHV HIGHSTAT Investigative D01IJA DRUG__ID D01IJA D01IJA COMPCLAS Piperazine carbamate/urea derivatives D01IJA DRUGCLAS Patented Agent(s) D01IJA DRUGCOMP Novartis AG D01IJA DRUGINCH 1S/C19H29N5O3/c1-14(2)22-9-11-24(12-10-22)19(26)27-16-5-7-23(8-6-16)15-3-4-17(18(20)25)21-13-15/h3-4,13-14,16H,5-12H2,1-2H3,(H2,20,25) D01IJA DRUGINKE NJPLXPIWGPHUGQ-UHFFFAOYSA-N D01IJA DRUGSMIL CC(C)N1CCN(CC1)C(=O)OC2CCN(CC2)C3=CN=C(C=C3)C(=O)N D01IJA DRUGTYPE Small molecular drug D01IJA HIGHSTAT Patented D01IJD DRUG__ID D01IJD D01IJD DRUGCLAS Investigative Drug(s) D01IJD DRUGINCH 1S/C24H36O4/c1-2-3-6-10-22(25)19-14-12-18(13-15-19)20-16-17-23(26)21(20)9-7-4-5-8-11-24(27)28/h12-15,20-22,25H,2-11,16-17H2,1H3,(H,27,28) D01IJD DRUGINKE XMQKDOCUWFCMEJ-UHFFFAOYSA-N D01IJD DRUGSMIL CCCCCC(C1=CC=C(C=C1)C2CCC(=O)C2CCCCCCC(=O)O)O D01IJD DRUGTYPE Small molecular drug D01IJD HIGHSTAT Investigative D01IJJ DRUG__ID D01IJJ D01IJJ DRUGCLAS Clinical Trial Drug(s) D01IJJ DRUGCOMP Nisco International Inc D01IJJ DRUGTYPE Oncolytic virus therapy D01IJJ HIGHSTAT Phase 2 D01IJL DRUG__ID D01IJL D01IJL DRUGCLAS Discontinued Drug(s) D01IJL DRUGCOMP Fujisawa Pharmaceutical Co Ltd D01IJL DRUGINCH 1S/C24H32O5/c1-9-7-13-17(21(26)11(3)20(13)25)16-12(9)8-14-18(16)19-22-10(2)15(28-23(19)27)5-6-24(14,4)29-22/h7,10-18,20-21,25-26H,5-6,8H2,1-4H3/t10-,11+,12+,13-,14-,15+,16+,17+,18-,20+,21-,24+/m0/s1 D01IJL DRUGINKE WMRQHSFWMFGIFW-OUNSMTAHSA-N D01IJL DRUGSMIL CC1C(C2C=C(C3CC4C(C3C2C1O)C5=C6C(C(CCC4(O6)C)OC5=O)C)C)O D01IJL DRUGTYPE Small molecular drug D01IJL HIGHSTAT Terminated D01IJM DRUG__ID D01IJM D01IJM DRUGCLAS Clinical Trial Drug(s) D01IJM DRUGCOMP Eli Lilly D01IJM DRUGTYPE Monoclonal antibody D01IJM HIGHSTAT Phase 1 D01IJO DRUG__ID D01IJO D01IJO DRUGCLAS Patented Agent(s) D01IJO DRUGTYPE Small molecular drug D01IJO HIGHSTAT Patented D01IJX DRUG__ID D01IJX D01IJX DRUGCLAS Investigative Drug(s) D01IJX DRUGINCH 1S/C13H12N2S/c1-2-11(4-7-15-8-6-14-10-15)12-5-9-16-13(12)3-1/h1-3,5-6,8-10H,4,7H2 D01IJX DRUGINKE ZEWHOUCPWZPPGK-UHFFFAOYSA-N D01IJX DRUGSMIL C1=CC(=C2C=CSC2=C1)CCN3C=CN=C3 D01IJX DRUGTYPE Small molecular drug D01IJX HIGHSTAT Investigative D01IKM DRUG__ID D01IKM D01IKM DRUGCLAS Drugs in Phase 2 Trial D01IKM DRUGTYPE Cell therapy D01IKM HIGHSTAT Phase 2 Trial D01IKM THERCLAS Antiviral Agents D01ILA DRUG__ID D01ILA D01ILA DRUGCLAS Clinical Trial Drug(s) D01ILA DRUGCOMP GeNeuro SA D01ILA HIGHSTAT Phase 2 D01ILH DRUG__ID D01ILH D01ILH DRUGCLAS Investigative Drug(s) D01ILH DRUGINCH 1S/C14H28O6/c1-2-3-4-5-6-7-8-19-13-12(17)11(16)10(9-15)20-14(13)18/h10-18H,2-9H2,1H3/t10-,11-,12+,13-,14-/m1/s1 D01ILH DRUGINKE BVHPDIWLWHHJPD-RKQHYHRCSA-N D01ILH DRUGSMIL CCCCCCCCOC1C(C(C(OC1O)CO)O)O D01ILH DRUGTYPE Small molecular drug D01ILH HIGHSTAT Investigative D01ILJ DRUG__ID D01ILJ D01ILJ DRUGCLAS Approved Drug(s) D01ILJ DRUGCOMP Baxter International Inc D01ILJ HIGHSTAT Approved D01ILN DRUG__ID D01ILN D01ILN DRUGCLAS Investigative Drug(s) D01ILN DRUGINCH 1S/C18H14N6/c19-16-15-17(24-18(20)23-16)22-14(12-9-5-2-6-10-12)13(21-15)11-7-3-1-4-8-11/h1-10H,(H4,19,20,22,23,24) D01ILN DRUGINKE DDZJPETYMUJLIW-UHFFFAOYSA-N D01ILN DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2C4=CC=CC=C4)N)N D01ILN DRUGTYPE Small molecular drug D01ILN HIGHSTAT Investigative D01ILO DRUG__ID D01ILO D01ILO DRUGCLAS Investigative Drug(s) D01ILO DRUGINCH 1S/C3H6N2S/c4-3-5-1-2-6-3/h1-2H2,(H2,4,5) D01ILO DRUGINKE REGFWZVTTFGQOJ-UHFFFAOYSA-N D01ILO DRUGSMIL C1CSC(=N1)N D01ILO DRUGTYPE Small molecular drug D01ILO HIGHSTAT Investigative D01ILP DRUG__ID D01ILP D01ILP DRUGCLAS Clinical Trial Drug(s) D01ILP DRUGCOMP Janssen biotech D01ILP HIGHSTAT Phase 1 D01ILT DRUG__ID D01ILT D01ILT DRUADIID CLI-01-ALDR-03107 D01ILT DRUGCLAS Investigative Drug(s) D01ILT DRUGINCH 1S/C23H23NO2.CH4O3S/c1-23(14-25,15-26)24-13-17-12-22-18-7-3-2-6-16(18)10-11-21(22)20-9-5-4-8-19(17)20;1-5(2,3)4/h2-12,24-26H,13-15H2,1H3;1H3,(H,2,3,4) D01ILT DRUGINKE NJWBUDCAWGTQAS-UHFFFAOYSA-N D01ILT DRUGSMIL CC(CO)(CO)NCC1=CC2=C(C=CC3=CC=CC=C32)C4=CC=CC=C41.CS(=O)(=O)O D01ILT DRUGTYPE Small molecular drug D01ILT HIGHSTAT Investigative D01IMJ DRUG__ID D01IMJ D01IMJ DRUGCLAS Investigative Drug(s) D01IMJ DRUGINCH 1S/C11H10N2OS/c1-8-7-15-11(12-8)13-10(14)9-5-3-2-4-6-9/h2-7H,1H3,(H,12,13,14) D01IMJ DRUGINKE NEPIZAVYXKHUCD-UHFFFAOYSA-N D01IMJ DRUGSMIL CC1=CSC(=N1)NC(=O)C2=CC=CC=C2 D01IMJ DRUGTYPE Small molecular drug D01IMJ HIGHSTAT Investigative D01IMN DRUG__ID D01IMN D01IMN DRUGCLAS Clinical Trial Drug(s) D01IMN DRUGCOMP Valneva Lyon, France D01IMN HIGHSTAT Phase 1 D01IOH DRUG__ID D01IOH D01IOH DRUGCLAS Patented Agent(s) D01IOH DRUGINCH 1S/C19H18N4O3/c1-26-17-11-14(5-7-20-17)22-18(24)13-4-3-12-9-16-19(25)21-6-2-8-23(16)15(12)10-13/h3-5,7,9-11H,2,6,8H2,1H3,(H,21,25)(H,20,22,24) D01IOH DRUGINKE IGJVUIUYHUKAST-UHFFFAOYSA-N D01IOH DRUGSMIL COC1=NC=CC(=C1)NC(=O)C2=CC3=C(C=C2)C=C4N3CCCNC4=O D01IOH DRUGTYPE Small molecular drug D01IOH HIGHSTAT Patented D01IPF DRUG__ID D01IPF D01IPF DRUGCLAS Investigative Drug(s) D01IPF DRUGINCH 1S/C17H17N3O2/c1-2-4-16(22)18-17-14-8-7-12(10-15(14)19-20-17)11-5-3-6-13(21)9-11/h3,5-10,21H,2,4H2,1H3,(H2,18,19,20,22) D01IPF DRUGINKE UKQRPDHIQLHFNS-UHFFFAOYSA-N D01IPF DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC(=CC=C3)O D01IPF DRUGTYPE Small molecular drug D01IPF HIGHSTAT Investigative D01IPI DRUG__ID D01IPI D01IPI DRUGCLAS Discontinued Drug(s) D01IPI DRUGINCH 1S/C19H26N2O4S/c1-19(2)10-6-9-14(18(25)21(19)12-16(22)23)20-17(24)15(26)11-13-7-4-3-5-8-13/h3-5,7-8,14-15,26H,6,9-12H2,1-2H3,(H,20,24)(H,22,23)/t14-,15-/m0/s1 D01IPI DRUGINKE YRSVDSQRGBYVIY-GJZGRUSLSA-N D01IPI DRUGSMIL CC1(CCCC(C(=O)N1CC(=O)O)NC(=O)C(CC2=CC=CC=C2)S)C D01IPI DRUGTYPE Small molecular drug D01IPI HIGHSTAT Discontinued in Phase 2 D01IPS DRUG__ID D01IPS D01IPS DRUGCLAS Investigative Drug(s) D01IPS DRUGINCH 1S/C10H13N4O9P/c15-5-3(1-22-24(19,20)21)23-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H4,12,13,17,18,19,20,21)/p+1/t3-,5-,6-,9-/m1/s1 D01IPS DRUGINKE XHDARDSMKMUDDI-UUOKFMHZSA-O D01IPS DRUGSMIL C1=[N+](C2=C(N1)C(=O)NC(=O)N2)C3C(C(C(O3)COP(=O)(O)O)O)O D01IPS DRUGTYPE Small molecular drug D01IPS HIGHSTAT Investigative D01IPT DRUG__ID D01IPT D01IPT DRUGCLAS Clinical Trial Drug(s) D01IPT DRUGCOMP ImutexLondon, United Kingdom National Institute of Allergy and Infectious Diseases Bethesda, MD D01IPT HIGHSTAT Phase 1 D01IPU DRUG__ID D01IPU D01IPU COMPCLAS Triazole gold complexes D01IPU DRUGCLAS Patented Agent(s) D01IPU DRUGTYPE Small molecular drug D01IPU HIGHSTAT Patented D01IRA DRUG__ID D01IRA D01IRA COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D01IRA DRUGCLAS Patented Agent(s) D01IRA DRUGCOMP PFIZER INC. HELAL, Christopher J. CHAPPIE, Thomas Allen HUMPHREY, John M D01IRA DRUGTYPE Small molecular drug D01IRA HIGHSTAT Patented D01IRG DRUG__ID D01IRG D01IRG DRUGCLAS Approved Drug(s) D01IRG DRUGCOMP Gilead Sciences D01IRG DRUGINCH 1S/C21H18F3N3O5.C21H29N6O5P.C8H10FN3O3S/c22-9-3-14(23)12(15(24)4-9)6-25-20(30)13-7-26-8-16-27(10-1-2-11(5-10)32-16)21(31)17(26)19(29)18(13)28;1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27;9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h3-4,7,10-11,16,29H,1-2,5-6,8H2,(H,25,30);5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24);1,5-6,13H,2-3H2,(H2,10,11,14)/t10-,11+,16+;15-,16+,33+;5-,6+/m010/s1 D01IRG DRUGINKE GMIGIKGMWTUBHA-UKQLQXPXSA-N D01IRG DRUGSMIL CC(C)OC(=O)C(C)NP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OC3=CC=CC=C3.C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F.C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F D01IRG HIGHSTAT Approved D01IRG TRADNAME Biktarvy D01IRO DRUG__ID D01IRO D01IRO DRUGCLAS Investigative Drug(s) D01IRO DRUGINCH 1S/C17H13NO2/c19-14-8-5-12(6-9-14)16-10-7-13(11-18-20)15-3-1-2-4-17(15)16/h1-11,19-20H/b18-11+ D01IRO DRUGINKE VYQQTWUZKPWPRL-WOJGMQOQSA-N D01IRO DRUGSMIL C1=CC=C2C(=C1)C(=CC=C2C3=CC=C(C=C3)O)C=NO D01IRO DRUGTYPE Small molecular drug D01IRO HIGHSTAT Investigative D01IRW DRUG__ID D01IRW D01IRW DRUGCLAS Discontinued Drug(s) D01IRW DRUGCOMP Dainippon Pharmaceutical Co Ltd D01IRW DRUGINCH 1S/C18H16O4/c1-10-3-5-16-13(7-10)9-15(19)14-8-12(11(2)18(20)21)4-6-17(14)22-16/h3-8,11H,9H2,1-2H3,(H,20,21) D01IRW DRUGINKE REHLODZXMGOGQP-UHFFFAOYSA-N D01IRW DRUGSMIL CC1=CC2=C(C=C1)OC3=C(C=C(C=C3)C(C)C(=O)O)C(=O)C2 D01IRW DRUGTYPE Small molecular drug D01IRW HIGHSTAT Discontinued in Preregistration D01IRX DRUG__ID D01IRX D01IRX DRUGCLAS Investigative Drug(s) D01IRX DRUGCOMP Isis Pharmaceuticals D01IRX DRUGTYPE Antisense drug D01IRX HIGHSTAT Investigative D01ISE DRUG__ID D01ISE D01ISE DRUGCLAS Clinical Trial Drug(s) D01ISE DRUGCOMP Merck KGaA D01ISE DRUGINCH 1S/C17H14N2O2/c1-17(2)10-14(19-8-4-3-5-16(19)20)13-9-12(11-18)6-7-15(13)21-17/h3-10H,1-2H3 D01ISE DRUGINKE JTVSKASWNROQQF-UHFFFAOYSA-N D01ISE DRUGSMIL CC1(C=C(C2=C(O1)C=CC(=C2)C#N)N3C=CC=CC3=O)C D01ISE DRUGTYPE Small molecular drug D01ISE HIGHSTAT Phase 2 D01ISX DRUG__ID D01ISX D01ISX DRUGCLAS Investigative Drug(s) D01ISX DRUGINCH 1S/C14H16N2O3S2/c15-21(18,19)13-5-3-11(4-6-13)7-8-16-14(17)10-12-2-1-9-20-12/h1-6,9H,7-8,10H2,(H,16,17)(H2,15,18,19) D01ISX DRUGINKE DWGJCBRJYFGGNR-UHFFFAOYSA-N D01ISX DRUGSMIL C1=CSC(=C1)CC(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N D01ISX DRUGTYPE Small molecular drug D01ISX HIGHSTAT Investigative D01ITB DRUG__ID D01ITB D01ITB DRUGCLAS Clinical Trial Drug(s) D01ITB DRUGCOMP TheraVasc Cleveland, OH D01ITB HIGHSTAT Phase 2 D01ITP DRUG__ID D01ITP D01ITP COMPCLAS Triazolo-pyridine derivatives D01ITP DRUGCLAS Patented Agent(s) D01ITP DRUGCOMP LUNDBECK & CO AS H [DK] D01ITP DRUGINCH 1S/C17H13ClN4O/c1-10-16-20-21-17(11-6-3-4-7-12(11)18)22(16)15-13(19-10)8-5-9-14(15)23-2/h3-9H,1-2H3 D01ITP DRUGINKE MGVXODADYYKJPQ-UHFFFAOYSA-N D01ITP DRUGSMIL CC1=NC2=C(C(=CC=C2)OC)N3C1=NN=C3C4=CC=CC=C4Cl D01ITP DRUGTYPE Small molecular drug D01ITP HIGHSTAT Patented D01IUB DRUG__ID D01IUB D01IUB DRUGCLAS Investigative Drug(s) D01IUB DRUGINCH 1S/C20H30O5/c1-2-17(21)11-8-5-9-14-18(22)12-6-3-4-7-13-19(23)15-10-16-20(24)25/h3-9,11-13,17-19,21-23H,2,10,14-16H2,1H3,(H,24,25)/b4-3+,9-5-,11-8+,12-6+,13-7-/t17-,18-,19+/m0/s1 D01IUB DRUGINKE AOPOCGPBAIARAV-JJVMZPRHSA-N D01IUB DRUGSMIL CCC(C=CC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O)O D01IUB DRUGTYPE Small molecular drug D01IUB HIGHSTAT Investigative D01IUD DRUG__ID D01IUD D01IUD DRUGCLAS Investigative Drug(s) D01IUD DRUGCOMP Prothelia Inc D01IUD HIGHSTAT Investigative D01IUI DRUG__ID D01IUI D01IUI DRUGCLAS Investigative Drug(s) D01IUI DRUGINCH 1S/C23H27NO2/c1-4-5-8-14-24-17(2)23(20-12-6-7-13-21(20)24)22(25)16-18-10-9-11-19(15-18)26-3/h6-7,9-13,15H,4-5,8,14,16H2,1-3H3 D01IUI DRUGINKE QZLRCHSRCYFMFK-UHFFFAOYSA-N D01IUI DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC(=CC=C3)OC)C D01IUI DRUGTYPE Small molecular drug D01IUI HIGHSTAT Investigative D01IUS DRUG__ID D01IUS D01IUS DRUGCLAS Clinical Trial Drug(s) D01IUS DRUGCOMP Bayer Schering Pharma AG D01IUS DRUGINCH 1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m1/s1 D01IUS DRUGINKE VJGFOYBQOIPQFY-XMMPIXPASA-N D01IUS DRUGSMIL CC1=NC2=C(C=C1)C(=CC=C2)NCC(CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O D01IUS DRUGTYPE Small molecular drug D01IUS HIGHSTAT Phase 3 D01IVE DRUG__ID D01IVE D01IVE DRUGCLAS Clinical Trial Drug(s) D01IVE DRUGINCH 1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21-/m0/s1 D01IVE DRUGINKE MXYUKLILVYORSK-HBMCJLEFSA-N D01IVE DRUGSMIL CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(C3=CC=CC=C3)O D01IVE DRUGTYPE Small molecular drug D01IVE HIGHSTAT Phase 2 D01IVR DRUG__ID D01IVR D01IVR COMPCLAS Piperazinyl methyl quinazolinone derivatives D01IVR DRUGCLAS Patented Agent(s) D01IVR DRUGCOMP WASHINGTON UNIVERSITY D01IVR DRUGINCH 1S/C30H31ClN4O4/c1-3-38-27-11-7-6-10-26(27)35-29(32-25-9-5-4-8-24(25)30(35)37)21(2)33-16-18-34(19-17-33)28(36)20-39-23-14-12-22(31)13-15-23/h4-15,21H,3,16-20H2,1-2H3 D01IVR DRUGINKE BKQFRNYHFIQEKN-UHFFFAOYSA-N D01IVR DRUGSMIL CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl D01IVR DRUGTYPE Small molecular drug D01IVR HIGHSTAT Patented D01IWD DRUG__ID D01IWD D01IWD DRUGCLAS Investigative Drug(s) D01IWD DRUGINCH 1S/C19H22N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,18,20,22H,5-8,10H2 D01IWD DRUGINKE MLWGAEVSWJXOQJ-UHFFFAOYSA-N D01IWD DRUGSMIL C1C2CC3CC(CC1N3CC2O)OC(=O)C4=CNC5=CC=CC=C54 D01IWD DRUGTYPE Small molecular drug D01IWD HIGHSTAT Investigative D01IWJ DRUG__ID D01IWJ D01IWJ DRUGCLAS Clinical Trial Drug(s) D01IWJ DRUGCOMP GlaxoSmithKline D01IWJ DRUGSMIL failed D01IWJ DRUGTYPE Combination drug D01IWJ HIGHSTAT Phase 3 D01IWS DRUG__ID D01IWS D01IWS DRUGCLAS Approved Drug(s) D01IWS DRUGINCH 1S/C228H382O191/c229-1-76-114(268)152(306)153(307)191(381-76)419-228(190(344)151(305)113(38-266)418-228)75-380-227(189(343)150(304)112(37-265)417-227)74-379-226(188(342)149(303)111(36-264)416-226)73-378-225(187(341)148(302)110(35-263)415-225)72-377-224(186(340)147(301)109(34-262)414-224)71-376-223(185(339)146(300)108(33-261)413-223)70-375-222(184(338)145(299)107(32-260)412-222)69-374-221(183(337)144(298)106(31-259)411-221)68-373-220(182(336)143(297)105(30-258)410-220)67-372-219(181(335)142(296)104(29-257)409-219)66-371-218(180(334)141(295)103(28-256)408-218)65-370-217(179(333)140(294)102(27-255)407-217)64-369-216(178(332)139(293)101(26-254)406-216)63-368-215(177(331)138(292)100(25-253)405-215)62-367-214(176(330)137(291)99(24-252)404-214)61-366-213(175(329)136(290)98(23-251)403-213)60-365-212(174(328)135(289)97(22-250)402-212)59-364-211(173(327)134(288)96(21-249)401-211)58-363-210(172(326)133(287)95(20-248)400-210)57-362-209(171(325)132(286)94(19-247)399-209)56-361-208(170(324)131(285)93(18-246)398-208)55-360-207(169(323)130(284)92(17-245)397-207)54-359-206(168(322)129(283)91(16-244)396-206)53-358-205(167(321)128(282)90(15-243)395-205)52-357-204(166(320)127(281)89(14-242)394-204)51-356-203(165(319)126(280)88(13-241)393-203)50-355-202(164(318)125(279)87(12-240)392-202)49-354-201(163(317)124(278)86(11-239)391-201)48-353-200(162(316)123(277)85(10-238)390-200)47-352-199(161(315)122(276)84(9-237)389-199)46-351-198(160(314)121(275)83(8-236)388-198)45-350-197(159(313)120(274)82(7-235)387-197)44-349-196(158(312)119(273)81(6-234)386-196)43-348-195(157(311)118(272)80(5-233)385-195)42-347-194(156(310)117(271)79(4-232)384-194)41-346-193(155(309)116(270)78(3-231)383-193)40-345-192(39-267)154(308)115(269)77(2-230)382-192/h76-191,229-344H,1-75H2/t76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152+,153-,154+,155+,156+,157+,158+,159+,160+,161+,162+,163+,164+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,178+,179+,180+,181+,182+,183+,184+,185+,186+,187+,188+,189+,190+,191-,192-,193-,194-,195-,196-,197-,198-,199-,200-,201-,202-,203-,204-,205-,206-,207-,208-,209-,210-,211-,212-,213-,214-,215-,216-,217-,218-,219-,220-,221-,222-,223-,224-,225-,226-,227-,228+/m1/s1 D01IWS DRUGINKE JYJIGFIDKWBXDU-MNNPPOADSA-N D01IWS DRUGSMIL C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)COC3(C(C(C(O3)CO)O)O)COC4(C(C(C(O4)CO)O)O)COC5(C(C(C(O5)CO)O)O)COC6(C(C(C(O6)CO)O)O)COC7(C(C(C(O7)CO)O)O)COC8(C(C(C(O8)CO)O)O)COC9(C(C(C(O9)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)CO)O)O)O)O D01IWS DRUGTYPE Small molecular drug D01IWS HIGHSTAT Approved D01IWS THERCLAS Hypoglycemic Agents D01IXD DRUG__ID D01IXD D01IXD DRUGCLAS Approved Drug(s) D01IXD DRUGCOMP Alcon D01IXD DRUGINCH 1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1 D01IXD DRUGINKE FYMHQCNFKNMJAV-HOTGVXAUSA-N D01IXD DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4CC5C(C4)OCCN5)F)C(=O)O D01IXD DRUGTYPE Small molecular drug D01IXD HIGHSTAT Approved D01IXT DRUG__ID D01IXT D01IXT DRUGCLAS Patented Agent(s) D01IXT DRUGINCH 1S/C18H17NO6/c1-21-10-5-6-11(14(7-10)22-2)17-19-13-9-16(24-4)15(23-3)8-12(13)18(20)25-17/h5-9H,1-4H3 D01IXT DRUGINKE JCFSQIOFMQLSPV-UHFFFAOYSA-N D01IXT DRUGSMIL COC1=CC(=C(C=C1)C2=NC3=CC(=C(C=C3C(=O)O2)OC)OC)OC D01IXT DRUGTYPE Small molecular drug D01IXT HIGHSTAT Patented D01IYF DRUG__ID D01IYF D01IYF COMPCLAS N-oxalylglycine derivatives D01IYF DRUGCLAS Patented Agent(s) D01IYF DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D01IYF DRUGTYPE Small molecular drug D01IYF HIGHSTAT Patented D01IYQ DRUG__ID D01IYQ D01IYQ DRUGCLAS Discontinued Drug(s) D01IYQ DRUGCOMP Meiji Dairies Corp D01IYQ HIGHSTAT Discontinued in Phase 2 D01IZE DRUG__ID D01IZE D01IZE DRUGCLAS Clinical Trial Drug(s) D01IZE DRUGCOMP Dynport vaccine D01IZE HIGHSTAT Phase 2 D01IZN DRUG__ID D01IZN D01IZN DRUGCLAS Investigative Drug(s) D01IZN DRUGINCH 1S/C49H69N13O10S2/c1-28(64)56-40-47(72)61-35(24-30-18-19-31-14-7-8-15-32(31)22-30)42(67)55-25-39(65)57-37(26-63)45(70)60-36(23-29-12-5-4-6-13-29)44(69)62-38(27-73-74-49(40,2)3)46(71)59-34(16-9-10-20-50)43(68)58-33(41(51)66)17-11-21-54-48(52)53/h4-8,12-15,18-19,22,33-38,40,63H,9-11,16-17,20-21,23-27,50H2,1-3H3,(H2,51,66)(H,55,67)(H,56,64)(H,57,65)(H,58,68)(H,59,71)(H,60,70)(H,61,72)(H,62,69)(H4,52,53,54)/t33-,34-,35-,36+,37-,38+,40-/m0/s1 D01IZN DRUGINKE RLMDVJMHWZVFEI-BQQBDQLKSA-N D01IZN DRUGSMIL CC(=O)NC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSC1(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC2=CC=CC=C2)CO)CC3=CC4=CC=CC=C4C=C3 D01IZN HIGHSTAT Investigative D01JCH DRUG__ID D01JCH D01JCH DRUGCLAS Investigative Drug(s) D01JCH DRUGINCH 1S/C18H34O11P2/c1-14(2)6-5-7-15(3)8-10-27-30(23,24)29-31(25,26)28-11-9-16(19)12-18(4,22)13-17(20)21/h6,8,16,19,22H,5,7,9-13H2,1-4H3,(H,20,21)(H,23,24)(H,25,26)/b15-8+ D01JCH DRUGINKE WJXJJEWDRXZOEO-OVCLIPMQSA-N D01JCH DRUGSMIL CC(=CCCC(=CCOP(=O)(O)OP(=O)(O)OCCC(CC(C)(CC(=O)O)O)O)C)C D01JCH DRUGTYPE Small molecular drug D01JCH HIGHSTAT Investigative D01JCJ DRUG__ID D01JCJ D01JCJ DRUGCLAS Investigative Drug(s) D01JCJ DRUGINCH 1S/C14H18N2O2/c1-2-3-4-5-6-8-11(17)14-16-13-12(18-14)9-7-10-15-13/h7,9-10H,2-6,8H2,1H3 D01JCJ DRUGINKE HTWHWGPGIJSJQP-UHFFFAOYSA-N D01JCJ DRUGSMIL CCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2 D01JCJ DRUGTYPE Small molecular drug D01JCJ HIGHSTAT Investigative D01JCT DRUG__ID D01JCT D01JCT DRUGCLAS Clinical Trial Drug(s) D01JCT DRUGCOMP First Affiliated Hospital of Harbin Medical University D01JCT DRUGTYPE CAR T Cell Therapy D01JCT HIGHSTAT Clinical trial D01JCX DRUG__ID D01JCX D01JCX DRUGCLAS Investigative Drug(s) D01JCX HIGHSTAT Investigative D01JCZ DRUG__ID D01JCZ D01JCZ DRUGCLAS Patented Agent(s) D01JCZ DRUGCOMP Merck Sharp & Dohme Corp D01JCZ DRUGTYPE Small molecular drug D01JCZ HIGHSTAT Patented D01JDK DRUG__ID D01JDK D01JDK DRUGCLAS Patented Agent(s) D01JDK DRUGCOMP NTZ LAB LTD [BG] D01JDK DRUGTYPE Small molecular drug D01JDK HIGHSTAT Patented D01JEH DRUG__ID D01JEH D01JEH DRUGCLAS Patented Agent(s) D01JEH DRUGCOMP ENSEMBLE THERAPEUTICS CORPORATION D01JEH DRUGINCH 1S/C80H96N16O14/c1-45(81-9)69(97)87-67(79(3,4)5)75(103)93-33-31-63-65(93)73(101)83-59(39-49-19-25-51-15-11-13-17-53(51)35-49)71(99)85-61(77(105)106)37-47-23-29-58(30-24-47)110-44-56-42-96(92-90-56)64-32-34-94(76(104)68(80(6,7)8)88-70(98)46(2)82-10)66(64)74(102)84-60(40-50-20-26-52-16-12-14-18-54(52)36-50)72(100)86-62(78(107)108)38-48-21-27-57(28-22-48)109-43-55-41-95(63)91-89-55/h11-30,35-36,41-42,45-46,59-68,81-82H,31-34,37-40,43-44H2,1-10H3,(H,83,101)(H,84,102)(H,85,99)(H,86,100)(H,87,97)(H,88,98)(H,105,106)(H,107,108)/t45-,46-,59-,60-,61-,62-,63+,64+,65-,66-,67+,68+/m0/s1 D01JEH DRUGINKE MBKNBOLIPVRUSC-YZMHPAFASA-N D01JEH DRUGSMIL CC(C(=O)NC(C(=O)N1CCC2C1C(=O)NC(C(=O)NC(CC3=CC=C(C=C3)OCC4=CN(C5CCN(C5C(=O)NC(C(=O)NC(CC6=CC=C(C=C6)OCC7=CN2N=N7)C(=O)O)CC8=CC9=CC=CC=C9C=C8)C(=O)C(C(C)(C)C)NC(=O)C(C)NC)N=N4)C(=O)O)CC1=CC2=CC=CC=C2C=C1)C(C)(C)C)NC D01JEH DRUGTYPE Small molecular drug D01JEH HIGHSTAT Patented D01JEI DRUG__ID D01JEI D01JEI DRUGCLAS Discontinued Drug(s) D01JEI DRUGCOMP Pierre Fabre SA D01JEI HIGHSTAT Terminated D01JEO DRUG__ID D01JEO D01JEO DRUGCLAS Investigative Drug(s) D01JEO DRUGCOMP University of North Carolina D01JEO DRUGINCH 1S/C39H60O8/c1-8-9-10-11-15-33-37(5,42)19-16-30-31(43-33)17-20-38(6)35(44-30)23-32-36(47-38)28(41)24-39(7)34(45-32)22-27(4)29(46-39)14-12-13-25(2)26(3)18-21-40/h8-10,13,18,21,27-36,41-42H,1,11-12,14-17,19-20,22-24H2,2-7H3/b10-9-,25-13+,26-18+/t27-,28-,29-,30+,31-,32+,33+,34+,35-,36-,37+,38+,39+/m0/s1 D01JEO DRUGINKE JPBOABGEVHVPNM-GFIBHCGLSA-N D01JEO DRUGSMIL CC1CC2C(CC(C3C(O2)CC4C(O3)(CCC5C(O4)CCC(C(O5)CCC=CC=C)(C)O)C)O)(OC1CCC=C(C)C(=CC=O)C)C D01JEO DRUGTYPE Small molecular drug D01JEO HIGHSTAT Investigative D01JEU DRUG__ID D01JEU D01JEU DRUGCLAS Approved Drug(s) D01JEU DRUGCOMP Merz & Co GmbH D01JEU DRUGINCH 1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3 D01JEU DRUGINKE BUGYDGFZZOZRHP-UHFFFAOYSA-N D01JEU DRUGSMIL CC12CC3CC(C1)(CC(C3)(C2)N)C D01JEU DRUGTYPE Small molecular drug D01JEU HIGHSTAT Approved D01JEX DRUG__ID D01JEX D01JEX DRUGCLAS Investigative Drug(s) D01JEX DRUGINCH 1S/C19H12N2O/c22-19-15-7-3-1-5-12(15)10-17-18-14(11-21(17)19)9-13-6-2-4-8-16(13)20-18/h1-10H,11H2 D01JEX DRUGINKE JORFMKUBMHCFKA-UHFFFAOYSA-N D01JEX DRUGSMIL C1C2=CC3=CC=CC=C3N=C2C4=CC5=CC=CC=C5C(=O)N41 D01JEX DRUGTYPE Small molecular drug D01JEX HIGHSTAT Investigative D01JFF DRUG__ID D01JFF D01JFF DRUGCLAS Investigative Drug(s) D01JFF DRUGINCH 1S/C13H11ClN2O2/c1-18-12-8-9(5-6-10(12)14)16-13(17)11-4-2-3-7-15-11/h2-8H,1H3,(H,16,17) D01JFF DRUGINKE ARYUXFNGXHNNDM-UHFFFAOYSA-N D01JFF DRUGSMIL COC1=C(C=CC(=C1)NC(=O)C2=CC=CC=N2)Cl D01JFF DRUGTYPE Small molecular drug D01JFF HIGHSTAT Investigative D01JFM DRUG__ID D01JFM D01JFM DRUGCLAS Clinical Trial Drug(s) D01JFM DRUGCOMP Aciex Therapeutics Inc D01JFM DRUGINCH 1S/C6H6BrNO/c7-5-1-2-6(4-9)8-3-5/h1-3,9H,4H2 D01JFM DRUGINKE RUCZFWMEACWFER-UHFFFAOYSA-N D01JFM DRUGSMIL C1=CC(=NC=C1Br)CO D01JFM DRUGTYPE Small molecular drug D01JFM HIGHSTAT Phase 3 D01JFT DRUG__ID D01JFT D01JFT DRUADIID FDA-AP-BF04-01302 D01JFT DRUGCLAS Approved Drug(s) D01JFT DRUGCOMP Allergan Pharmaceutical D01JFT DRUGINCH 1S/C19H29NO5/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6/h8-10,13,20-21H,11H2,1-7H3 D01JFT DRUGINKE OCUJLLGVOUDECM-UHFFFAOYSA-N D01JFT DRUGSMIL CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C D01JFT DRUGTYPE Small molecular drug D01JFT HIGHSTAT Approved D01JFT THERCLAS Ophthalmologicals D01JGB DRUG__ID D01JGB D01JGB DRUGCLAS Investigative Drug(s) D01JGB DRUGINCH 1S/C16H23N3/c1-2-8-14-11-15(19-16(12-17)18-14)13-9-6-4-3-5-7-10-13/h11,13H,2-10H2,1H3 D01JGB DRUGINKE AWOXPJKLDJGFMS-UHFFFAOYSA-N D01JGB DRUGSMIL CCCC1=CC(=NC(=N1)C#N)C2CCCCCCC2 D01JGB DRUGTYPE Small molecular drug D01JGB HIGHSTAT Investigative D01JGE DRUG__ID D01JGE D01JGE DRUGCLAS Clinical Trial Drug(s) D01JGE DRUGCOMP Helsinn Therapeutics D01JGE DRUGINCH 1S/C19H24N2O/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20/h2,4,6,13,15,17H,1,3,5,7-12H2/t15-,17+/m0/s1 D01JGE DRUGINKE CPZBLNMUGSZIPR-DOTOQJQBSA-N D01JGE DRUGSMIL C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5 D01JGE DRUGTYPE Small molecular drug D01JGE HIGHSTAT Phase 3 D01JGG DRUG__ID D01JGG D01JGG DRUGCLAS Discontinued Drug(s) D01JGG DRUGCOMP GlaxoSmithKline D01JGG DRUGINCH 1S/C23H21F4NO3S2/c1-12-9-15(6-8-18(12)31-22(3,4)21(29)30)32-11-19-13(2)28-20(33-19)16-7-5-14(10-17(16)24)23(25,26)27/h5-10H,11H2,1-4H3,(H,29,30) D01JGG DRUGINKE ZUGQWAYOWCBWGM-UHFFFAOYSA-N D01JGG DRUGSMIL CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=C(C=C(C=C3)C(F)(F)F)F)C)OC(C)(C)C(=O)O D01JGG DRUGTYPE Small molecular drug D01JGG HIGHSTAT Discontinued in Phase 2 D01JGV DRUG__ID D01JGV D01JGV DRUGCLAS Approved Drug(s) D01JGV DRUGINCH 1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3/t12-,15-,16+,19-/m0/s1 D01JGV DRUGINKE GRTOGORTSDXSFK-XJTZBENFSA-N D01JGV DRUGSMIL CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 D01JGV DRUGTYPE Small molecular drug D01JGV HIGHSTAT Approved D01JHA DRUG__ID D01JHA D01JHA DRUGCLAS Investigative Drug(s) D01JHA DRUGINCH 1S/C21H29NO/c1-4-5-6-9-14-21(2,3)16-12-13-18(20(23)15-16)17-10-7-8-11-19(17)22/h7-8,10-13,15,23H,4-6,9,14,22H2,1-3H3 D01JHA DRUGINKE QCCUOHALIFFEGL-UHFFFAOYSA-N D01JHA DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2=CC=CC=C2N)O D01JHA DRUGTYPE Small molecular drug D01JHA HIGHSTAT Investigative D01JHN DRUG__ID D01JHN D01JHN DRUGCLAS Discontinued Drug(s) D01JHN DRUGCOMP RottaPharma D01JHN DRUGINCH 1S/C20H22N2O/c1-21-15-8-9-16(21)11-17(10-15)22-12-14-7-6-13-4-2-3-5-18(13)19(14)20(22)23/h2-7,15-17H,8-12H2,1H3/t15-,16+,17? D01JHN DRUGINKE RCJGTDKFZCRBAH-SJPCQFCGSA-N D01JHN DRUGSMIL CN1C2CCC1CC(C2)N3CC4=C(C3=O)C5=CC=CC=C5C=C4 D01JHN DRUGTYPE Small molecular drug D01JHN HIGHSTAT Terminated D01JHR DRUG__ID D01JHR D01JHR DRUGCLAS Investigative Drug(s) D01JHR DRUGINCH 1S/C14H23N3O6/c1-14(2)6-5-9(17(14)10(18)7-15)12(21)16-8(13(22)23)3-4-11(19)20/h8-9H,3-7,15H2,1-2H3,(H,16,21)(H,19,20)(H,22,23)/t8-,9-/m0/s1 D01JHR DRUGINKE KNUZCBVWBGSPRA-IUCAKERBSA-N D01JHR DRUGSMIL CC1(CCC(N1C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O)C D01JHR DRUGTYPE Small molecular drug D01JHR HIGHSTAT Investigative D01JIA DRUG__ID D01JIA D01JIA DRUGCLAS Approved Drug(s) D01JIA DRUGCOMP Nutritional Restart D01JIA DRUGINCH 1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1 D01JIA DRUGINKE ZDXPYRJPNDTMRX-VKHMYHEASA-N D01JIA DRUGSMIL C(CC(=O)N)C(C(=O)O)N D01JIA DRUGTYPE Small molecular drug D01JIA HIGHSTAT Approved D01JID DRUG__ID D01JID D01JID DRUGCLAS Investigative Drug(s) D01JID DRUGINCH 1S/C22H26N4O4/c1-5-25(6-2)10-9-23-13-7-8-14-19-17(13)20(27)18-15(26(19)12-24-14)11-16(29-3)22(30-4)21(18)28/h7-8,11-12,23,27H,5-6,9-10H2,1-4H3 D01JID DRUGINKE GRQHDQZNSRJNRZ-UHFFFAOYSA-N D01JID DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=CC(=C(C(=O)C4=C2O)OC)OC D01JID DRUGTYPE Small molecular drug D01JID HIGHSTAT Investigative D01JIO DRUG__ID D01JIO D01JIO DRUGCLAS Clinical Trial Drug(s) D01JIO DRUGINCH 1S/C25H32O5/c1-23-7-4-14(26)10-13(23)11-16(22(28)29-3)20-17(23)5-8-24(2)21(20)15-12-18(15)25(24)9-6-19(27)30-25/h10,15-18,20-21H,4-9,11-12H2,1-3H3/t15-,16-,17+,18+,20-,21+,23+,24+,25+/m1/s1 D01JIO DRUGINKE YDIQJONNFLVNGD-FPMRONRSSA-N D01JIO DRUGSMIL CC12CCC(=O)C=C1CC(C3C2CCC4(C3C5CC5C46CCC(=O)O6)C)C(=O)OC D01JIO DRUGTYPE Small molecular drug D01JIO HIGHSTAT Phase 2 D01JJH DRUG__ID D01JJH D01JJH DRUGCLAS Investigative Drug(s) D01JJH DRUGINCH 1S/C15H20N2O4S/c1-5-22(19,20)17(4)13-11-8-10(9-16)6-7-12(11)21-15(2,3)14(13)18/h6-8,13-14,18H,5H2,1-4H3/t13-,14+/m0/s1 D01JJH DRUGINKE HVSJHHXUORMCGK-UONOGXRCSA-N D01JJH DRUGSMIL CCS(=O)(=O)N(C)C1C(C(OC2=C1C=C(C=C2)C#N)(C)C)O D01JJH DRUGTYPE Small molecular drug D01JJH HIGHSTAT Investigative D01JJN DRUG__ID D01JJN D01JJN DRUGCLAS Patented Agent(s) D01JJN DRUGCOMP BAYER SCHERING PHARMA AG [DE] D01JJN DRUGTYPE Small molecular drug D01JJN HIGHSTAT Patented D01JJR DRUG__ID D01JJR D01JJR DRUGCLAS Investigative Drug(s) D01JJR DRUGINCH 1S/C35H36FN3O9/c1-21(40)37-29(19-23-13-16-27(26(18-23)32(43)48-2)35(36,33(44)45)34(46)47)30(41)38-28-10-6-7-17-39(31(28)42)20-22-11-14-25(15-12-22)24-8-4-3-5-9-24/h3-5,8-9,11-16,18,28-29H,6-7,10,17,19-20H2,1-2H3,(H,37,40)(H,38,41)(H,44,45)(H,46,47)/t28-,29-/m0/s1 D01JJR DRUGINKE RLLAUERCSKPFGD-VMPREFPWSA-N D01JJR DRUGSMIL CC(=O)NC(CC1=CC(=C(C=C1)C(C(=O)O)(C(=O)O)F)C(=O)OC)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D01JJR DRUGTYPE Small molecular drug D01JJR HIGHSTAT Investigative D01JJV DRUG__ID D01JJV D01JJV DRUGCLAS Investigative Drug(s) D01JJV DRUGINCH 1S/C17H22N2O2/c20-15-3-1-2-14(7-15)18-16(21)19-17-8-11-4-12(9-17)6-13(5-11)10-17/h1-3,7,11-13,20H,4-6,8-10H2,(H2,18,19,21) D01JJV DRUGINKE FBTNUWJYRWKVCD-UHFFFAOYSA-N D01JJV DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC(=CC=C4)O D01JJV DRUGTYPE Small molecular drug D01JJV HIGHSTAT Investigative D01JKV DRUG__ID D01JKV D01JKV DRUGCLAS Clinical Trial Drug(s) D01JKV DRUGCOMP Merck D01JKV HIGHSTAT Phase 1 D01JLH DRUG__ID D01JLH D01JLH DRUGCLAS Investigative Drug(s) D01JLH DRUGCOMP Respiratorius AB D01JLH HIGHSTAT Investigative D01JLO DRUG__ID D01JLO D01JLO DRUGCLAS Clinical Trial Drug(s) D01JLO DRUGCOMP Nono inc D01JLO DRUGINCH 1S/C105H188N42O30/c1-7-55(6)80(98(175)140-69(34-36-77(154)155)92(169)143-72(50-148)95(172)142-71(48-78(156)157)94(171)146-79(54(4)5)99(176)177)147-97(174)74(52-150)145-96(173)73(51-149)144-93(170)70(46-53(2)3)141-90(167)62(22-10-13-39-108)133-85(162)63(24-15-41-124-101(113)114)135-87(164)65(26-17-43-126-103(117)118)136-88(165)66(27-18-44-127-104(119)120)138-91(168)68(33-35-75(110)152)139-89(166)67(28-19-45-128-105(121)122)137-86(163)64(25-16-42-125-102(115)116)134-84(161)61(21-9-12-38-107)132-83(160)60(20-8-11-37-106)131-82(159)59(23-14-40-123-100(111)112)130-76(153)49-129-81(158)58(109)47-56-29-31-57(151)32-30-56/h29-32,53-55,58-74,79-80,148-151H,7-28,33-52,106-109H2,1-6H3,(H2,110,152)(H,129,158)(H,130,153)(H,131,159)(H,132,160)(H,133,162)(H,134,161)(H,135,164)(H,136,165)(H,137,163)(H,138,168)(H,139,166)(H,140,175)(H,141,167)(H,142,172)(H,143,169)(H,144,170)(H,145,173)(H,146,171)(H,147,174)(H,154,155)(H,156,157)(H,176,177)(H4,111,112,123)(H4,113,114,124)(H4,115,116,125)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)/t55-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,79-,80-/m0/s1 D01JLO DRUGINKE XWQVQFBTSBCKLI-FKXNDIMNSA-N D01JLO DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)N D01JLO DRUGTYPE Peptide D01JLO HIGHSTAT Phase 3 D01JMC DRUG__ID D01JMC D01JMC DRUGCLAS Approved Drug(s) D01JMC DRUGCOMP Arena Pharmaceuticals Inc. D01JMC DRUGINCH 1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1 D01JMC DRUGINKE XTTZERNUQAFMOF-QMMMGPOBSA-N D01JMC DRUGSMIL CC1CNCCC2=C1C=C(C=C2)Cl D01JMC DRUGTYPE Small molecular drug D01JMC HIGHSTAT Approved D01JMW DRUG__ID D01JMW D01JMW DRUGCLAS Investigative Drug(s) D01JMW DRUGINCH 1S/C13H18BrN3O2/c14-12-11(3-1-4-15-12)13(18)16-5-2-6-17-7-9-19-10-8-17/h1,3-4H,2,5-10H2,(H,16,18) D01JMW DRUGINKE ZMORGFKKKAMCBI-UHFFFAOYSA-N D01JMW DRUGSMIL C1COCCN1CCCNC(=O)C2=C(N=CC=C2)Br D01JMW DRUGTYPE Small molecular drug D01JMW HIGHSTAT Investigative D01JMX DRUG__ID D01JMX D01JMX DRUGCLAS Clinical Trial Drug(s) D01JMX DRUGCOMP Insmed Inc D01JMX HIGHSTAT Phase 2 D01JNE DRUG__ID D01JNE D01JNE DRUGCLAS Clinical Trial Drug(s) D01JNE DRUGCOMP Cytopia Ltd; Cytopia D01JNE HIGHSTAT Phase 2 D01JOA DRUG__ID D01JOA D01JOA DRUGCLAS Discontinued Drug(s) D01JOA DRUGCOMP Chiroscience R&D Ltd D01JOA HIGHSTAT Discontinued in Phase 1 D01JOJ DRUG__ID D01JOJ D01JOJ DRUGCLAS Discontinued Drug(s) D01JOJ DRUGCOMP Reckitt; Colman plc D01JOJ DRUGINCH 1S/C18H26N6O4/c1-18(2)5-6-24(14(18)15(19)26)17(28)12(7-10-8-20-9-21-10)23-16(27)11-3-4-13(25)22-11/h8-9,11-12,14H,3-7H2,1-2H3,(H2,19,26)(H,20,21)(H,22,25)(H,23,27)/t11-,12-,14+/m0/s1 D01JOJ DRUGINKE ZEQAPQNFHVYDEL-SGMGOOAPSA-N D01JOJ DRUGSMIL CC1(CCN(C1C(=O)N)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C D01JOJ DRUGTYPE Small molecular drug D01JOJ HIGHSTAT Discontinued in Phase 2 D01JPA DRUG__ID D01JPA D01JPA DRUGCLAS Clinical Trial Drug(s) D01JPA DRUGCOMP TRACON Pharmaceuticals D01JPA HIGHSTAT Phase 2 D01JPJ DRUG__ID D01JPJ D01JPJ DRUGCLAS Investigative Drug(s) D01JPJ DRUGCOMP PTC Therapeutics Inc D01JPJ DRUGINCH 1S/C23H18F4N6O2S/c1-3-14-9-20-16(10-18(14)24)17(11-28)21(33(20)22-29-7-4-8-30-22)19-6-5-15(12-31-19)36(34,35)32-13(2)23(25,26)27/h4-10,12-13,32H,3H2,1-2H3/t13-/m0/s1 D01JPJ DRUGINKE OBULGMCFXOTNNK-ZDUSSCGKSA-N D01JPJ DRUGSMIL CCC1=CC2=C(C=C1F)C(=C(N2C3=NC=CC=N3)C4=NC=C(C=C4)S(=O)(=O)NC(C)C(F)(F)F)C#N D01JPJ HIGHSTAT Investigative D01JPM DRUG__ID D01JPM D01JPM DRUGCLAS Patented Agent(s) D01JPM DRUGCOMP KARUS THERAPEUTICS LTD D01JPM DRUGTYPE Small molecular drug D01JPM HIGHSTAT Patented D01JQJ DRUG__ID D01JQJ D01JQJ DRUGCLAS Approved Drug(s) D01JQJ DRUGINCH 1S/C6H11IO3/c1-4(7)6-9-3-5(2-8)10-6/h4-6,8H,2-3H2,1H3 D01JQJ DRUGINKE LTINPJMVDKPJJI-UHFFFAOYSA-N D01JQJ DRUGSMIL CC(C1OCC(O1)CO)I D01JQJ DRUGTYPE Small molecular drug D01JQJ HIGHSTAT Approved D01JQX DRUG__ID D01JQX D01JQX DRUGCLAS Investigative Drug(s) D01JQX DRUGINCH 1S/C21H34O/c1-4-5-6-7-15-21(2,3)19-13-11-17(12-14-19)18-9-8-10-20(22)16-18/h11-14,18,20,22H,4-10,15-16H2,1-3H3/t18-,20-/m0/s1 D01JQX DRUGINKE CICRJVLFNFCUOX-ICSRJNTNSA-N D01JQX DRUGSMIL CCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D01JQX DRUGTYPE Small molecular drug D01JQX HIGHSTAT Investigative D01JRF DRUG__ID D01JRF D01JRF DRUGCLAS Discontinued Drug(s) D01JRF DRUGCOMP Shire plc D01JRF HIGHSTAT Terminated D01JSA DRUG__ID D01JSA D01JSA DRUGCLAS Investigative Drug(s) D01JSA DRUGINCH 1S/C40H54N10O9/c1-25-20-29(51)21-26(2)30(25)23-31(41)36(53)47-33(17-11-19-44-39(43)49-50(57)58)37(54)48-34(22-27-12-5-3-6-13-27)38(55)46-32(35(42)52)16-9-10-18-45-40(56)59-24-28-14-7-4-8-15-28/h3-8,12-15,20-21,31-34,51H,9-11,16-19,22-24,41H2,1-2H3,(H2,42,52)(H,45,56)(H,46,55)(H,47,53)(H,48,54)(H3,43,44,49)/t31?,32-,33+,34-/m0/s1 D01JSA DRUGINKE LMMJRHRZYGSRLK-OPTRWXFLSA-N D01JSA DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC(CCCN=C(N)N[N+](=O)[O-])C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCCNC(=O)OCC3=CC=CC=C3)C(=O)N)N)C)O D01JSA DRUGTYPE Small molecular drug D01JSA HIGHSTAT Investigative D01JSG DRUG__ID D01JSG D01JSG DRUGCLAS Investigative Drug(s) D01JSG DRUGCOMP Crucell NV D01JSG HIGHSTAT Investigative D01JSI DRUG__ID D01JSI D01JSI DRUGCLAS Clinical Trial Drug(s) D01JSI DRUGCOMP Pfizer New York, NY D01JSI HIGHSTAT Phase 1 D01JSO DRUG__ID D01JSO D01JSO DRUGCLAS Investigative Drug(s) D01JSO DRUGCOMP ViroMed Co Ltd D01JSO HIGHSTAT Investigative D01JTI DRUG__ID D01JTI D01JTI DRUGCLAS Investigative Drug(s) D01JTI DRUGINCH 1S/C7H6BrF2NO2S/c8-6-3-1-2-5(4-6)7(9,10)14(11,12)13/h1-4H,(H2,11,12,13) D01JTI DRUGINKE RXNVOIIGCVXUGN-UHFFFAOYSA-N D01JTI DRUGSMIL C1=CC(=CC(=C1)Br)C(F)(F)S(=O)(=O)N D01JTI DRUGTYPE Small molecular drug D01JTI HIGHSTAT Investigative D01JTL DRUG__ID D01JTL D01JTL DRUGCLAS Clinical Trial Drug(s) D01JTL DRUGCOMP Kainos Medicine Inc D01JTL HIGHSTAT Phase 1 D01JTW DRUG__ID D01JTW D01JTW DRUGCLAS Clinical Trial Drug(s) D01JTW HIGHSTAT Phase 2 D01JTY DRUG__ID D01JTY D01JTY DRUGCLAS Investigative Drug(s) D01JTY DRUGINCH 1S/C21H22FNO/c1-2-3-6-13-23-15-19(18-7-4-5-8-20(18)23)21(24)14-16-9-11-17(22)12-10-16/h4-5,7-12,15H,2-3,6,13-14H2,1H3 D01JTY DRUGINKE QGDPTDVGZNHCIR-UHFFFAOYSA-N D01JTY DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)F D01JTY DRUGTYPE Small molecular drug D01JTY HIGHSTAT Investigative D01JUF DRUG__ID D01JUF D01JUF DRUADIID FDA-AP-BF04-01054 D01JUF DRUGCLAS Approved Drug(s) D01JUF DRUGCOMP Bedford Laboratories D01JUF DRUGINCH 1S/C17H19N3O/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15/h2-8,11,21H,9-10,12H2,1H3,(H,18,19) D01JUF DRUGINKE MRBDMNSDAVCSSF-UHFFFAOYSA-N D01JUF DRUGSMIL CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O D01JUF DRUGTYPE Small molecular drug D01JUF HIGHSTAT Approved D01JUF THERCLAS Antihypertensive Agents D01JUI DRUG__ID D01JUI D01JUI DRUGCLAS Investigative Drug(s) D01JUI DRUGINCH 1S/C17H15ClN4/c1-10-2-4-11(5-3-10)12-6-7-13-14(8-12)16(22-17(19)20)21-9-15(13)18/h2-9H,1H3,(H4,19,20,21,22) D01JUI DRUGINKE CHWRGRHMWONZIO-UHFFFAOYSA-N D01JUI DRUGSMIL CC1=CC=C(C=C1)C2=CC3=C(C=C2)C(=CN=C3N=C(N)N)Cl D01JUI DRUGTYPE Small molecular drug D01JUI HIGHSTAT Investigative D01JVG DRUG__ID D01JVG D01JVG DRUGCLAS Investigative Drug(s) D01JVG DRUGINCH 1S/C16H11FO2S/c17-12-7-11(8-14(19)9-12)16-6-5-15(20-16)10-1-3-13(18)4-2-10/h1-9,18-19H D01JVG DRUGINKE OWTLTMXTNPNZPH-UHFFFAOYSA-N D01JVG DRUGSMIL C1=CC(=CC=C1C2=CC=C(S2)C3=CC(=CC(=C3)F)O)O D01JVG DRUGTYPE Small molecular drug D01JVG HIGHSTAT Investigative D01JVP DRUG__ID D01JVP D01JVP DRUGCLAS Investigative Drug(s) D01JVP DRUGINCH 1S/C19H22INO3/c1-2-22-16-5-3-4-6-17(16)24-19(18-13-21-11-12-23-18)14-7-9-15(20)10-8-14/h3-10,18-19,21H,2,11-13H2,1H3/t18-,19-/m1/s1 D01JVP DRUGINKE RVASAZVCHKJYMY-RTBURBONSA-N D01JVP DRUGSMIL CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=C(C=C3)I D01JVP DRUGTYPE Small molecular drug D01JVP HIGHSTAT Investigative D01JWH DRUG__ID D01JWH D01JWH DRUGCLAS Clinical Trial Drug(s) D01JWH DRUGCOMP SANOS Bioscience A/S D01JWH HIGHSTAT Phase 1 D01JWT DRUG__ID D01JWT D01JWT DRUGCLAS Investigative Drug(s) D01JWT DRUGINCH 1S/C21H27N3O2/c25-20-18-11-7-8-12-19(18)21(26)24(20)15-10-6-4-2-1-3-5-9-14-23-16-13-22-17-23/h7-8,11-13,16-17H,1-6,9-10,14-15H2 D01JWT DRUGINKE DOVKNTJKHQSOTE-UHFFFAOYSA-N D01JWT DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)CCCCCCCCCCN3C=CN=C3 D01JWT DRUGTYPE Small molecular drug D01JWT HIGHSTAT Investigative D01JXM DRUG__ID D01JXM D01JXM DRUGCLAS Investigative Drug(s) D01JXM DRUGINCH 1S/C15H20N2S/c1-15(2,3)12-4-6-14(7-5-12)18-9-8-13-10-16-11-17-13/h4-7,10-11H,8-9H2,1-3H3,(H,16,17) D01JXM DRUGINKE PQPVHIHIJVIEQG-UHFFFAOYSA-N D01JXM DRUGSMIL CC(C)(C)C1=CC=C(C=C1)SCCC2=CN=CN2 D01JXM HIGHSTAT Investigative D01JYF DRUG__ID D01JYF D01JYF DRUGCLAS Investigative Drug(s) D01JYF DRUGINCH 1S/C20H22O2/c1-5-7-15-9-11-20(22-4)18(13-15)16-10-12-19(21-3)17(14-16)8-6-2/h5-6,9-14H,1-2,7-8H2,3-4H3 D01JYF DRUGINKE GDCJELDNRAWYTE-UHFFFAOYSA-N D01JYF DRUGSMIL COC1=C(C=C(C=C1)C2=C(C=CC(=C2)CC=C)OC)CC=C D01JYF DRUGTYPE Small molecular drug D01JYF HIGHSTAT Investigative D01JYT DRUG__ID D01JYT D01JYT DRUGCLAS Clinical Trial Drug(s) D01JYT DRUGCOMP IntelGenx Corp D01JYT HIGHSTAT Phase 1 D01JYY DRUG__ID D01JYY D01JYY DRUGCLAS Investigative Drug(s) D01JYY DRUGINCH 1S/C19H24N2O/c1-14(2)13-21(18-9-10-20-12-18)19(22)17-8-7-15-5-3-4-6-16(15)11-17/h3-8,11,14,18,20H,9-10,12-13H2,1-2H3/t18-/m1/s1 D01JYY DRUGINKE CEUJKSVEPJAVKD-GOSISDBHSA-N D01JYY DRUGSMIL CC(C)CN(C1CCNC1)C(=O)C2=CC3=CC=CC=C3C=C2 D01JYY DRUGTYPE Small molecular drug D01JYY HIGHSTAT Investigative D01JZO DRUG__ID D01JZO D01JZO DRUGCLAS Investigative Drug(s) D01JZO DRUGINCH 1S/C10H9ClN2/c11-10-3-1-9(2-4-10)7-13-6-5-12-8-13/h1-6,8H,7H2 D01JZO DRUGINKE RPLWYOLCHGTNSX-UHFFFAOYSA-N D01JZO DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)Cl D01JZO DRUGTYPE Small molecular drug D01JZO HIGHSTAT Investigative D01JZV DRUG__ID D01JZV D01JZV DRUGCLAS Investigative Drug(s) D01JZV DRUGINCH 1S/C21H22Cl2N4OS2/c22-16-3-1-13(9-17(16)23)11-27-7-5-15(6-8-27)25-20(28)12-29-21-26-18-4-2-14(24)10-19(18)30-21/h1-4,9-10,15H,5-8,11-12,24H2,(H,25,28) D01JZV DRUGINKE QOHFBKIKGAINLL-UHFFFAOYSA-N D01JZV DRUGSMIL C1CN(CCC1NC(=O)CSC2=NC3=C(S2)C=C(C=C3)N)CC4=CC(=C(C=C4)Cl)Cl D01JZV DRUGTYPE Small molecular drug D01JZV HIGHSTAT Investigative D01KAH DRUG__ID D01KAH D01KAH DRUGCLAS Investigative Drug(s) D01KAH DRUGINCH 1S/C10H14N2O.ClH/c1-8(11)12-7-9-4-3-5-10(6-9)13-2;/h3-6H,7H2,1-2H3,(H2,11,12);1H D01KAH DRUGINKE KAHXLIVOQBJXSB-UHFFFAOYSA-N D01KAH DRUGSMIL CC(=NCC1=CC(=CC=C1)OC)N.Cl D01KAH DRUGTYPE Small molecular drug D01KAH HIGHSTAT Investigative D01KAM DRUG__ID D01KAM D01KAM DRUGCLAS Investigative Drug(s) D01KAM DRUGINCH 1S/C17H13NO7/c19-13-8-12(23-6-7-24-18(21)22)9-16-17(13)14(20)10-15(25-16)11-4-2-1-3-5-11/h1-5,8-10,19H,6-7H2 D01KAM DRUGINKE NLJRSLKTBHDLMH-UHFFFAOYSA-N D01KAM DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)OCCO[N+](=O)[O-])O D01KAM DRUGTYPE Small molecular drug D01KAM HIGHSTAT Investigative D01KAX DRUG__ID D01KAX D01KAX DRUGCLAS Investigative Drug(s) D01KAX DRUGINCH 1S/C10H13N3O/c1-7(11)6-13-10-4-9(14)3-2-8(10)5-12-13/h2-5,7,14H,6,11H2,1H3/t7-/m0/s1 D01KAX DRUGINKE WBYHTZYHAFNBKW-ZETCQYMHSA-N D01KAX DRUGSMIL CC(CN1C2=C(C=CC(=C2)O)C=N1)N D01KAX DRUGTYPE Small molecular drug D01KAX HIGHSTAT Investigative D01KCA DRUG__ID D01KCA D01KCA DRUGCLAS Patented Agent(s) D01KCA DRUGINCH 1S/C14H32N4/c1-3-15-11-7-13-17-9-5-6-10-18-14-8-12-16-4-2/h5-6,15-18H,3-4,7-14H2,1-2H3/b6-5- D01KCA DRUGINKE XFWLTFZLLXVKDY-WAYWQWQTSA-N D01KCA DRUGSMIL CCNCCCNCC=CCNCCCNCC D01KCA DRUGTYPE Small molecular drug D01KCA HIGHSTAT Patented D01KCE DRUG__ID D01KCE D01KCE DRUGCLAS Approved Drug(s) D01KCE DRUGCOMP Baxter; Takeda D01KCE HIGHSTAT Registered D01KCM DRUG__ID D01KCM D01KCM DRUGCLAS Investigative Drug(s) D01KCM DRUGCOMP Isis Pharmaceuticals D01KCM DRUGTYPE Antisense drug D01KCM HIGHSTAT Investigative D01KDM DRUG__ID D01KDM D01KDM DRUGCLAS Clinical Trial Drug(s) D01KDM DRUGCOMP GT Biopharma Washington, DC D01KDM HIGHSTAT Phase 1 D01KDQ DRUG__ID D01KDQ D01KDQ DRUGCLAS Investigative Drug(s) D01KDQ DRUGINCH 1S/C8H20NO/c1-4-9(5-2,6-3)7-8-10/h10H,4-8H2,1-3H3/q+1 D01KDQ DRUGINKE GZBUMTPCIKCWFW-UHFFFAOYSA-N D01KDQ DRUGSMIL CC[N+](CC)(CC)CCO D01KDQ DRUGTYPE Small molecular drug D01KDQ HIGHSTAT Investigative D01KEE DRUG__ID D01KEE D01KEE DRUGCLAS Investigative Drug(s) D01KEE DRUGINCH 1S/CH2O/c1-2/h1H2 D01KEE DRUGINKE WSFSSNUMVMOOMR-UHFFFAOYSA-N D01KEE DRUGSMIL C=O D01KEE DRUGTYPE Small molecular drug D01KEE HIGHSTAT Investigative D01KEF DRUG__ID D01KEF D01KEF DRUGCLAS Investigative Drug(s) D01KEF DRUGCOMP Isis Pharmaceuticals D01KEF DRUGTYPE Antisense drug D01KEF HIGHSTAT Investigative D01KEH DRUG__ID D01KEH D01KEH DRUGCLAS Investigative Drug(s) D01KEH DRUGINCH 1S/C15H21NO6/c1-8(4-3-5-9(2)14(19)20)11-7-16-13(15(21)22)10(11)6-12(17)18/h3-5,9-11,13,16H,6-7H2,1-2H3,(H,17,18)(H,19,20)(H,21,22)/b5-3+,8-4+/t9-,10+,11-,13+/m1/s1 D01KEH DRUGINKE VZFRNCSOCOPNDB-JIUSADRUSA-N D01KEH DRUGSMIL CC(C=CC=C(C)C1CNC(C1CC(=O)O)C(=O)O)C(=O)O D01KEH DRUGTYPE Small molecular drug D01KEH HIGHSTAT Investigative D01KER DRUG__ID D01KER D01KER DRUGCLAS Investigative Drug(s) D01KER DRUGCOMP AlphaRx Inc D01KER HIGHSTAT Investigative D01KFW DRUG__ID D01KFW D01KFW COMPCLAS 3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives D01KFW DRUGCLAS Patented Agent(s) D01KFW DRUGCOMP Nerviano Medical Sciences S.r.l D01KFW DRUGTYPE Small molecular drug D01KFW HIGHSTAT Patented D01KGP DRUG__ID D01KGP D01KGP DRUGCLAS Clinical Trial Drug(s) D01KGP DRUGCOMP Inflazyme Pharmaceuticals D01KGP HIGHSTAT Phase 1 D01KHH DRUG__ID D01KHH D01KHH DRUADIID FDA-AP-BF04-00096 D01KHH DRUGCLAS Approved Drug(s) D01KHH DRUGCOMP Janssen Research And Development Llc D01KHH DRUGINCH 1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3 D01KHH DRUGINKE JURKNVYFZMSNLP-UHFFFAOYSA-N D01KHH DRUGSMIL CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31 D01KHH DRUGTYPE Small molecular drug D01KHH HIGHSTAT Approved D01KHH THERCLAS Antidepressants D01KHW DRUG__ID D01KHW D01KHW DRUGCLAS Clinical Trial Drug(s) D01KHW DRUGINCH 1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1 D01KHW DRUGINKE WHNFPRLDDSXQCL-UAZQEYIDSA-N D01KHW DRUGSMIL CC(C)C(C(=O)N)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CNC=N5)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C D01KHW DRUGTYPE Small molecular drug D01KHW HIGHSTAT Phase 2 D01KHX DRUG__ID D01KHX D01KHX DRUGCLAS Discontinued Drug(s) D01KHX DRUGCOMP Hoechst AG D01KHX DRUGINCH 1S/C21H23NO5S/c1-21(2)20(24)19(22-12-6-9-18(22)23)16-13-15(10-11-17(16)27-21)28(25,26)14-7-4-3-5-8-14/h3-5,7-8,10-11,13,19-20,24H,6,9,12H2,1-2H3/t19-,20+/m1/s1 D01KHX DRUGINKE LKAQWOWWTKFLNX-UXHICEINSA-N D01KHX DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)S(=O)(=O)C3=CC=CC=C3)N4CCCC4=O)O)C D01KHX DRUGTYPE Small molecular drug D01KHX HIGHSTAT Discontinued in Phase 1 D01KIC DRUG__ID D01KIC D01KIC DRUGCLAS Clinical Trial Drug(s) D01KIC DRUGCOMP Bharat Biotech International Ltd D01KIC HIGHSTAT Phase 3 D01KIH DRUG__ID D01KIH D01KIH DRUGCLAS Investigative Drug(s) D01KIH DRUGINCH 1S/C18H20N4/c1-2-5-15(6-3-1)13-21-9-11-22(12-10-21)17-8-4-7-16-18(17)20-14-19-16/h1-8,14H,9-13H2,(H,19,20) D01KIH DRUGINKE ZNBOBGDGUIWKPE-UHFFFAOYSA-N D01KIH DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3=CC=CC4=C3N=CN4 D01KIH DRUGTYPE Small molecular drug D01KIH HIGHSTAT Investigative D01KIJ DRUG__ID D01KIJ D01KIJ DRUGCLAS Patented Agent(s) D01KIJ DRUGCOMP NOVARTIS AG DODD, Stephanie Kay FURET, Pascal GROTZFELD, Robert Martin JAHNKE, Wolfgang JONES, Darryl Brynley MANLEY, Paul MARZINZIK, Andreas PELLE, Xavier Francois Andre SALEM, Bahaa SCHOEPFER, Joseph D01KIJ DRUGINCH 1S/C20H17ClF3N5O3/c21-20(23,24)32-14-3-1-12(2-4-14)27-19(31)11-7-15(17-16(22)9-26-28-17)18(25-8-11)29-6-5-13(30)10-29/h1-4,7-9,13,30H,5-6,10H2,(H,26,28)(H,27,31)/t13-/m1/s1 D01KIJ DRUGINKE NAXNSUPRCUTVTP-CYBMUJFWSA-N D01KIJ DRUGSMIL C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=C(C=NN4)F D01KIJ DRUGTYPE Small molecular drug D01KIJ HIGHSTAT Patented D01KIS DRUG__ID D01KIS D01KIS DRUGCLAS Discontinued Drug(s) D01KIS DRUGCOMP Novartis AG D01KIS DRUGINCH 1S/C42H56N4O7/c1-29(2)37(39(49)43-35(27-32-19-13-8-14-20-32)40(50)46-21-23-52-24-22-46)45-38(48)33(25-30-15-9-6-10-16-30)28-36(47)34(26-31-17-11-7-12-18-31)44-41(51)53-42(3,4)5/h6-20,29,33-37,47H,21-28H2,1-5H3,(H,43,49)(H,44,51)(H,45,48)/t33-,34+,35+,36+,37+/m1/s1 D01KIS DRUGINKE NAJDZKGRZBLNON-RKGCBODKSA-N D01KIS DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)N2CCOCC2)NC(=O)C(CC3=CC=CC=C3)CC(C(CC4=CC=CC=C4)NC(=O)OC(C)(C)C)O D01KIS DRUGTYPE Small molecular drug D01KIS HIGHSTAT Discontinued in Phase 1 D01KIU DRUG__ID D01KIU D01KIU DRUGCLAS Discontinued Drug(s) D01KIU DRUGCOMP INSERM D01KIU DRUGINCH 1S/C19H27NO3/c21-18(23-16-13-20-11-14-22-15-12-20)19(9-5-2-6-10-19)17-7-3-1-4-8-17/h1,3-4,7-8H,2,5-6,9-16H2 D01KIU DRUGINKE RQHKZUBCUZVZEF-UHFFFAOYSA-N D01KIU DRUGSMIL C1CCC(CC1)(C2=CC=CC=C2)C(=O)OCCN3CCOCC3 D01KIU DRUGTYPE Small molecular drug D01KIU HIGHSTAT Terminated D01KIY DRUG__ID D01KIY D01KIY DRUGCLAS Investigative Drug(s) D01KIY DRUGCOMP Epitomics Inc D01KIY HIGHSTAT Investigative D01KJM DRUG__ID D01KJM D01KJM DRUGCLAS Investigative Drug(s) D01KJM DRUGCOMP Kent State University D01KJM HIGHSTAT Investigative D01KJU DRUG__ID D01KJU D01KJU DRUGCLAS Investigative Drug(s) D01KJU DRUGINCH 1S/C16H11ClO2/c17-16-14-7-3-11(9-12(14)4-8-15(16)19)10-1-5-13(18)6-2-10/h1-9,18-19H D01KJU DRUGINKE YHEHVRSGKUYDON-UHFFFAOYSA-N D01KJU DRUGSMIL C1=CC(=CC=C1C2=CC3=C(C=C2)C(=C(C=C3)O)Cl)O D01KJU DRUGTYPE Small molecular drug D01KJU HIGHSTAT Investigative D01KJZ DRUG__ID D01KJZ D01KJZ COMPCLAS Pyrazole derivatives D01KJZ DRUGCLAS Patented Agent(s) D01KJZ DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori IMASHIRO, Ritsuo SATO, Atsush D01KJZ DRUGINCH 1S/C25H28Cl2N6O3/c1-2-28-25(35)29-13-16-36-23-21(24(34)31-32-14-5-6-15-32)30-33(20-8-4-3-7-19(20)27)22(23)17-9-11-18(26)12-10-17/h3-4,7-12H,2,5-6,13-16H2,1H3,(H,31,34)(H2,28,29,35) D01KJZ DRUGINKE ZDSBVGULFYUNNF-UHFFFAOYSA-N D01KJZ DRUGSMIL CCNC(=O)NCCOC1=C(N(N=C1C(=O)NN2CCCC2)C3=CC=CC=C3Cl)C4=CC=C(C=C4)Cl D01KJZ DRUGTYPE Small molecular drug D01KJZ HIGHSTAT Patented D01KKB DRUG__ID D01KKB D01KKB DRUGCLAS Discontinued Drug(s) D01KKB DRUGCOMP Penwest Pharmaceuticals D01KKB HIGHSTAT Discontinued in Preregistration D01KKC DRUG__ID D01KKC D01KKC DRUGCLAS Patented Agent(s) D01KKC DRUGINCH 1S/C17H25N3O3/c1-17(2,3)13-6-4-5-7-14(13)19-8-10-20(11-9-19)16(23)18-12-15(21)22/h4-7H,8-12H2,1-3H3,(H,18,23)(H,21,22) D01KKC DRUGINKE BAZIXHMBHKLDIK-UHFFFAOYSA-N D01KKC DRUGSMIL CC(C)(C)C1=CC=CC=C1N2CCN(CC2)C(=O)NCC(=O)O D01KKC DRUGTYPE Small molecular drug D01KKC HIGHSTAT Patented D01KKE DRUG__ID D01KKE D01KKE DRUGCLAS Discontinued Drug(s) D01KKE DRUGCOMP GSK D01KKE DRUGINCH 1S/C22H24N6O2/c1-14-12-16(30-3)4-5-18(14)26-9-6-17-19(13-15(2)24-21(17)26)28-10-7-20(25-28)27-11-8-23-22(27)29/h4-5,7,10,12-13H,6,8-9,11H2,1-3H3,(H,23,29) D01KKE DRUGINKE JFHJGXQFESYQGY-UHFFFAOYSA-N D01KKE DRUGSMIL CC1=CC(=C2CCN(C2=N1)C3=C(C=C(C=C3)OC)C)N4C=CC(=N4)N5CCNC5=O D01KKE DRUGTYPE Small molecular drug D01KKE HIGHSTAT Discontinued in Phase 2 D01KKI DRUG__ID D01KKI D01KKI DRUGCLAS Clinical Trial Drug(s) D01KKI DRUGCOMP Seattle genetics D01KKI DRUGTYPE Antibody D01KKI HIGHSTAT Phase 1/2 D01KKM DRUG__ID D01KKM D01KKM DRUGCLAS Discontinued Drug(s) D01KKM DRUGCOMP Allergenics Inc D01KKM HIGHSTAT Terminated D01KKQ DRUG__ID D01KKQ D01KKQ DRUGCLAS Approved Drug(s) D01KKQ DRUGCOMP AstraZeneca D01KKQ DRUGINCH 1S/C21H22N4O6S/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28)/t15-/m0/s1 D01KKQ DRUGINKE IVTVGDXNLFLDRM-HNNXBMFYSA-N D01KKQ DRUGSMIL CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1 D01KKQ DRUGTYPE Small molecular drug D01KKQ HIGHSTAT Approved D01KKQ THERCLAS Anticancer Agents D01KKU DRUG__ID D01KKU D01KKU DRUGCLAS Investigative Drug(s) D01KKU DRUGINCH 1S/C15H10O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-9,16H D01KKU DRUGINKE MQGPSCMMNJKMHQ-UHFFFAOYSA-N D01KKU DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)O D01KKU DRUGTYPE Small molecular drug D01KKU HIGHSTAT Investigative D01KLI DRUG__ID D01KLI D01KLI DRUGCLAS Investigative Drug(s) D01KLI HIGHSTAT Investigative D01KMI DRUG__ID D01KMI D01KMI DRUGCLAS Investigative Drug(s) D01KMI DRUGINCH 1S/C19H27NO4/c1-2-3-9-20-10-7-15(8-11-20)14-24-19(21)16-5-4-6-17-18(16)23-13-12-22-17/h4-6,15H,2-3,7-14H2,1H3 D01KMI DRUGINKE YGXXLNHVBNARBP-UHFFFAOYSA-N D01KMI DRUGSMIL CCCCN1CCC(CC1)COC(=O)C2=C3C(=CC=C2)OCCO3 D01KMI DRUGTYPE Small molecular drug D01KMI HIGHSTAT Investigative D01KMR DRUG__ID D01KMR D01KMR DRUGCLAS Clinical Trial Drug(s) D01KMR DRUGCOMP Merz Pharmaceuticals GmbH D01KMR DRUGINCH 1S/C11H23N/c1-9(2)6-10(3,4)8-11(5,12)7-9/h6-8,12H2,1-5H3 D01KMR DRUGINKE OGZQTTHDGQBLBT-UHFFFAOYSA-N D01KMR DRUGSMIL CC1(CC(CC(C1)(C)N)(C)C)C D01KMR DRUGTYPE Small molecular drug D01KMR HIGHSTAT Phase 2 D01KMR THERCLAS Analgesics D01KMW DRUG__ID D01KMW D01KMW DRUGCLAS Clinical Trial Drug(s) D01KMW DRUGCOMP Bristol-Myers Squibb D01KMW DRUGINCH 1S/C24H22ClN2O7PS/c1-32-20-10-17(8-9-19(20)33-12-21(14-2-3-14)34-35(29,30)31)27-13-26-18-11-22(36-23(18)24(27)28)15-4-6-16(25)7-5-15/h4-11,13-14,21H,2-3,12H2,1H3,(H2,29,30,31)/t21-/m0/s1 D01KMW DRUGINKE YDTUJCNTIMWHPJ-NRFANRHFSA-N D01KMW DRUGSMIL COC1=C(C=CC(=C1)N2C=NC3=C(C2=O)SC(=C3)C4=CC=C(C=C4)Cl)OCC(C5CC5)OP(=O)(O)O D01KMW HIGHSTAT Phase 1 D01KMY DRUG__ID D01KMY D01KMY DRUGCLAS Clinical Trial Drug(s) D01KMY DRUGCOMP Merck D01KMY HIGHSTAT Phase 2 D01KNA DRUG__ID D01KNA D01KNA DRUGCLAS Clinical Trial Drug(s) D01KNA DRUGCOMP Diamyd medical D01KNA HIGHSTAT Phase 3 D01KNO DRUG__ID D01KNO D01KNO DRUGCLAS Investigative Drug(s) D01KNO DRUGCOMP University of Gothenburg D01KNO HIGHSTAT Investigative D01KNY DRUG__ID D01KNY D01KNY DRUGCLAS Clinical Trial Drug(s) D01KNY DRUGINCH 1S/C9H10N4O2/c1-2-15-5-6-12-8-7(9(14)13-6)10-3-4-11-8/h3-4H,2,5H2,1H3,(H,11,12,13,14) D01KNY DRUGINKE SFWVULIFVPNTOF-UHFFFAOYSA-N D01KNY DRUGSMIL CCOCC1=NC2=NC=CN=C2C(=O)N1 D01KNY HIGHSTAT Phase 2 D01KNZ DRUG__ID D01KNZ D01KNZ DRUGCLAS Investigative Drug(s) D01KNZ DRUGINCH 1S/C23H22IN5O5/c1-2-9-28-22(32)19-21(29(23(28)33)11-13-3-8-17(25)16(24)10-13)27-20(26-19)14-4-6-15(7-5-14)34-12-18(30)31/h3-8,10H,2,9,11-12,25H2,1H3,(H,26,27)(H,30,31)/i24-2 D01KNZ DRUGINKE DKJMGIXWGPEEFF-XXFZXMJFSA-N D01KNZ DRUGSMIL CCCN1C(=O)C2=C(N=C(N2)C3=CC=C(C=C3)OCC(=O)O)N(C1=O)CC4=CC(=C(C=C4)N)I D01KNZ DRUGTYPE Small molecular drug D01KNZ HIGHSTAT Investigative D01KOA DRUG__ID D01KOA D01KOA DRUGCLAS Approved Drug(s) D01KOA DRUGCOMP Loxo Oncology Stamford, CT D01KOA DRUGINCH 1S/C29H34N8O3/c1-19-9-34-37-17-23(40-18-24-11-30-5-6-39-24)8-25(29(19)37)26-12-32-27(13-31-26)35-15-21-7-22(16-35)36(21)14-20-3-4-28(38-2)33-10-20/h3-4,8-10,12-13,17,21-22,24,30H,5-7,11,14-16,18H2,1-2H3/t21?,22?,24-/m0/s1 D01KOA DRUGINKE MFOVQWYFURMVKU-IWAAJCSBSA-N D01KOA DRUGSMIL CC1=C2C(=CC(=CN2N=C1)OCC3CNCCO3)C4=CN=C(C=N4)N5CC6CC(C5)N6CC7=CN=C(C=C7)OC D01KOA HIGHSTAT Approved D01KOI DRUG__ID D01KOI D01KOI DRUGCLAS Investigative Drug(s) D01KOI DRUGINCH 1S/C9H8N2OS/c10-9-11-8(5-13-9)6-1-3-7(12)4-2-6/h1-5,12H,(H2,10,11) D01KOI DRUGINKE QGSJYYIRAFRPIT-UHFFFAOYSA-N D01KOI DRUGSMIL C1=CC(=CC=C1C2=CSC(=N2)N)O D01KOI DRUGTYPE Small molecular drug D01KOI HIGHSTAT Investigative D01KOO DRUG__ID D01KOO D01KOO DRUGCLAS Investigative Drug(s) D01KOO DRUGINCH 1S/C6H13NO5S/c1-6(2)10-3-5(12-6)4-11-13(7,8)9/h5H,3-4H2,1-2H3,(H2,7,8,9) D01KOO DRUGINKE QFFBTRPNKKXQCZ-UHFFFAOYSA-N D01KOO DRUGSMIL CC1(OCC(O1)COS(=O)(=O)N)C D01KOO DRUGTYPE Small molecular drug D01KOO HIGHSTAT Investigative D01KPN DRUG__ID D01KPN D01KPN DRUGCLAS Investigative Drug(s) D01KPN DRUGINCH 1S/C26H33NO4/c1-18(2)20-12-10-19(11-13-20)15-24(28)27-14-6-8-22(17-27)21-7-5-9-23(16-21)31-26(3,4)25(29)30/h5,7,9-13,16,18,22H,6,8,14-15,17H2,1-4H3,(H,29,30)/t22-/m1/s1 D01KPN DRUGINKE OISHBINQIFNIPV-JOCHJYFZSA-N D01KPN DRUGSMIL CC(C)C1=CC=C(C=C1)CC(=O)N2CCCC(C2)C3=CC(=CC=C3)OC(C)(C)C(=O)O D01KPN DRUGTYPE Small molecular drug D01KPN HIGHSTAT Investigative D01KPS DRUG__ID D01KPS D01KPS DRUGCLAS Clinical Trial Drug(s) D01KPS DRUGCOMP Innopharma D01KPS HIGHSTAT Preregistration D01KPV DRUG__ID D01KPV D01KPV DRUGCLAS Approved Drug(s) D01KPV DRUGCOMP Sanofi-Aventis D01KPV DRUGINCH 1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36) D01KPV DRUGINKE RWTNPBWLLIMQHL-UHFFFAOYSA-N D01KPV DRUGSMIL CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O D01KPV DRUGTYPE Small molecular drug D01KPV HIGHSTAT Approved D01KPV THERCLAS Antiallergic Agents D01KPW DRUG__ID D01KPW D01KPW COMPCLAS Isoquinoline carboxamide derivatives D01KPW DRUGCLAS Patented Agent(s) D01KPW DRUGCOMP COCENSYS, INC D01KPW DRUGINCH 1S/C21H21ClN2O/c1-4-14(2)24(3)21(25)19-13-15-9-5-6-10-16(15)20(23-19)17-11-7-8-12-18(17)22/h5-14H,4H2,1-3H3 D01KPW DRUGINKE RAVIZVQZGXBOQO-UHFFFAOYSA-N D01KPW DRUGSMIL CCC(C)N(C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl D01KPW DRUGTYPE Small molecular drug D01KPW HIGHSTAT Patented D01KPX DRUG__ID D01KPX D01KPX DRUGCLAS Investigative Drug(s) D01KPX DRUGINCH 1S/C14H17N3S2/c1-2-12-10-19-14(16-12)17-13(18)15-9-8-11-6-4-3-5-7-11/h3-7,10H,2,8-9H2,1H3,(H2,15,16,17,18) D01KPX DRUGINKE SMLAKAQKPKAWNV-UHFFFAOYSA-N D01KPX DRUGSMIL CCC1=CSC(=N1)NC(=S)NCCC2=CC=CC=C2 D01KPX DRUGTYPE Small molecular drug D01KPX HIGHSTAT Investigative D01KQA DRUG__ID D01KQA D01KQA DRUGCLAS Approved Drug(s) D01KQA DRUGCOMP Endo Pharmaceuticals D01KQA DRUGINCH 1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1 D01KQA DRUGINKE NETZHAKZCGBWSS-CEDHKZHLSA-N D01KQA DRUGSMIL C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O D01KQA DRUGTYPE Small molecular drug D01KQA HIGHSTAT Approved D01KQA THERCLAS Analgesics D01KQW DRUG__ID D01KQW D01KQW DRUGCLAS Clinical Trial Drug(s) D01KQW DRUGCOMP Infectious disease research institute; aeras global tb vaccine foundation D01KQW HIGHSTAT Phase 2 D01KRQ DRUG__ID D01KRQ D01KRQ DRUGCLAS Investigative Drug(s) D01KRQ DRUGCOMP EMC Microcollections GmbH D01KRQ HIGHSTAT Investigative D01KSL DRUG__ID D01KSL D01KSL DRUGCLAS Discontinued Drugs D01KSL DRUGTYPE Combination drug D01KSL HIGHSTAT Discontinue in Phase 1 Trial D01KSL THERCLAS Antiviral Agents D01KSO DRUG__ID D01KSO D01KSO DRUGCLAS Investigative Drug(s) D01KSO DRUGCOMP Susavion Biosciences Inc D01KSO HIGHSTAT Investigative D01KSR DRUG__ID D01KSR D01KSR DRUGCLAS Investigative Drug(s) D01KSR DRUGINCH 1S/C13H8ClNO3/c14-9-5-10-12(6-11(9)17)18-13(15-10)7-1-3-8(16)4-2-7/h1-6,16-17H D01KSR DRUGINKE BXCKDNMAGMSBHF-UHFFFAOYSA-N D01KSR DRUGSMIL C1=CC(=CC=C1C2=NC3=CC(=C(C=C3O2)O)Cl)O D01KSR DRUGTYPE Small molecular drug D01KSR HIGHSTAT Investigative D01KTB DRUG__ID D01KTB D01KTB DRUGCLAS Investigative Drug(s) D01KTB DRUGCOMP Isis Pharmaceuticals D01KTB DRUGTYPE Antisense drug D01KTB HIGHSTAT Investigative D01KTF DRUG__ID D01KTF D01KTF DRUGCLAS Investigative Drug(s) D01KTF DRUGCOMP Isis Pharmaceuticals D01KTF DRUGTYPE Antisense drug D01KTF HIGHSTAT Investigative D01KTG DRUG__ID D01KTG D01KTG DRUGCLAS Clinical Trial Drug(s) D01KTG DRUGCOMP Novartis pharmaceuticals D01KTG DRUGINCH 1S/C26H24Cl2N6O4/c1-13(2)33-21-19(30-22(33)17-11-29-26(38-5)31-23(17)37-4)25(36)34(18-10-16(28)12-32(3)24(18)35)20(21)14-6-8-15(27)9-7-14/h6-13,20H,1-5H3/t20-/m0/s1 D01KTG DRUGINKE AGBSXNCBIWWLHD-FQEVSTJZSA-N D01KTG DRUGSMIL CC(C)N1C2=C(C(=O)N(C2C3=CC=C(C=C3)Cl)C4=CC(=CN(C4=O)C)Cl)N=C1C5=CN=C(N=C5OC)OC D01KTG HIGHSTAT Phase 1 D01KTM DRUG__ID D01KTM D01KTM DRUGCLAS Investigative Drug(s) D01KTM DRUGINCH 1S/C20H22O6/c1-23-17-7-11(3-5-15(17)21)19-13-9-26-20(14(13)10-25-19)12-4-6-16(22)18(8-12)24-2/h3-8,13-14,19-22H,9-10H2,1-2H3/t13-,14-,19+,20+/m1/s1 D01KTM DRUGINKE HGXBRUKMWQGOIE-NSMLZSOPSA-N D01KTM DRUGSMIL COC1=C(C=CC(=C1)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC)O D01KTM DRUGTYPE Small molecular drug D01KTM HIGHSTAT Investigative D01KTN DRUG__ID D01KTN D01KTN DRUGCLAS Approved Drug(s) D01KTN DRUGCOMP Shionogi D01KTN DRUGINCH 1S/C23H29N5O8S2/c1-5-6-12(13-9-38-21(24)26-13)16(29)27-14-17(30)28-15(11(7-34-22(25)33)8-37-18(14)28)19(31)35-10-36-20(32)23(2,3)4/h6,9,14,18H,5,7-8,10H2,1-4H3,(H2,24,26)(H2,25,33)(H,27,29)/b12-6-/t14-,18-/m1/s1 D01KTN DRUGINKE WVPAABNYMHNFJG-QDVBXLKVSA-N D01KTN DRUGSMIL CCC=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C D01KTN DRUGTYPE Small molecular drug D01KTN HIGHSTAT Approved D01KVG DRUG__ID D01KVG D01KVG DRUGCLAS Investigative Drug(s) D01KVG DRUGINCH 1S/C26H30N2O/c29-25-26(16-7-11-22-10-6-12-23(27-25)24(22)26)15-4-5-17-28-18-13-21(14-19-28)20-8-2-1-3-9-20/h1-3,6,8-10,12-13H,4-5,7,11,14-19H2,(H,27,29) D01KVG DRUGINKE JBQOYPLKTTXLSQ-UHFFFAOYSA-N D01KVG DRUGSMIL C1CC2=C3C(=CC=C2)NC(=O)C3(C1)CCCCN4CCC(=CC4)C5=CC=CC=C5 D01KVG DRUGTYPE Small molecular drug D01KVG HIGHSTAT Investigative D01KVT DRUG__ID D01KVT D01KVT DRUGCLAS Investigative Drug(s) D01KVT DRUGINCH 1S/C38H56N4O4/c1-5-41(29-31-19-11-13-21-37(31)45-3)25-17-9-7-15-23-39-33-27-36(44)34(28-35(33)43)40-24-16-8-10-18-26-42(6-2)30-32-20-12-14-22-38(32)46-4/h11-14,19-22,27-28,39-40H,5-10,15-18,23-26,29-30H2,1-4H3 D01KVT DRUGINKE VPXVPJQOPRBXPO-UHFFFAOYSA-N D01KVT DRUGSMIL CCN(CCCCCCNC1=CC(=O)C(=CC1=O)NCCCCCCN(CC)CC2=CC=CC=C2OC)CC3=CC=CC=C3OC D01KVT DRUGTYPE Small molecular drug D01KVT HIGHSTAT Investigative D01KWB DRUG__ID D01KWB D01KWB DRUGCLAS Discontinued Drug(s) D01KWB DRUGCOMP Sosei R&D Ltd D01KWB HIGHSTAT Terminated D01KWJ DRUG__ID D01KWJ D01KWJ DRUGCLAS Clinical Trial Drug(s) D01KWJ DRUGCOMP Vertex Pharmaceuticals Boston, MA D01KWJ HIGHSTAT Phase 2 D01KWK DRUG__ID D01KWK D01KWK DRUGCLAS Drugs in Phase 2 Trial D01KWK DRUGTYPE Combination drug D01KWK HIGHSTAT Phase 2 Trial D01KWK THERCLAS Antiviral Agents D01KWU DRUG__ID D01KWU D01KWU DRUGCLAS Investigative Drug(s) D01KWU DRUGINCH 1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3 D01KWU DRUGINKE GDFGTRDCCWFXTG-UHFFFAOYSA-N D01KWU DRUGSMIL CCCN1CC(CC2C1CC3=C(C2)C(=CC=C3)O)NS(=O)(=O)N(CC)CC D01KWU DRUGTYPE Small molecular drug D01KWU HIGHSTAT Investigative D01KXE DRUG__ID D01KXE D01KXE DRUGCLAS Clinical Trial Drug(s) D01KXE DRUGCOMP OptiNose AS D01KXE HIGHSTAT Phase 1 D01KYG DRUG__ID D01KYG D01KYG DRUGCLAS Investigative Drug(s) D01KYG DRUGCOMP Inagen Aps D01KYG HIGHSTAT Investigative D01KYM DRUG__ID D01KYM D01KYM DRUGCLAS Investigative Drug(s) D01KYM DRUGINCH 1S/C11H20N2O2/c1-11(2,3)10(15)13-8-6-4-5-7-12-9(8)14/h8H,4-7H2,1-3H3,(H,12,14)(H,13,15)/t8-/m0/s1 D01KYM DRUGINKE FAFRIRJGUOTURZ-QMMMGPOBSA-N D01KYM DRUGSMIL CC(C)(C)C(=O)NC1CCCCNC1=O D01KYM DRUGTYPE Small molecular drug D01KYM HIGHSTAT Investigative D01KYP DRUG__ID D01KYP D01KYP DRUGCLAS Clinical Trial Drug(s) D01KYP DRUGCOMP Aquestive Therapeutics Warren, NJ Sunovion Pharmaceuticals Marlborough, MA D01KYP DRUGINCH 1S/2C17H17NO2.2ClH.H2O/c2*1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2*2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t2*13-;;;/m11.../s1 D01KYP DRUGINKE CXWQXGNFZLHLHQ-DPFCLETOSA-N D01KYP DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.O.Cl.Cl D01KYP HIGHSTAT Phase 3 D01KYS DRUG__ID D01KYS D01KYS DRUGCLAS Patented Agent(s) D01KYS DRUGTYPE Small molecular drug D01KYS HIGHSTAT Patented D01KZC DRUG__ID D01KZC D01KZC DRUGCLAS Discontinued Drug(s) D01KZC DRUGCOMP Eisai Co Ltd D01KZC DRUGINCH 1S/C46H72N4O9.ClH/c1-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-24-31-47-44(52)59-39-29-33-49(34-30-39)45(53)57-36-40(55-3)37-58-46(54)50(35-38-26-23-25-32-48(38)6-2)43(51)41-27-21-22-28-42(41)56-4;/h21-23,25-28,32,39-40H,5-20,24,29-31,33-37H2,1-4H3;1H/t40-;/m1./s1 D01KZC DRUGINKE IXRMFSBOHHRXSS-YPMTVOEDSA-N D01KZC DRUGSMIL CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(CC1)C(=O)OCC(COC(=O)N(CC2=CC=CC=[N+]2CC)C(=O)C3=CC=CC=C3OC)OC.[Cl-] D01KZC DRUGTYPE Small molecular drug D01KZC HIGHSTAT Discontinued in Phase 2 D01KZF DRUG__ID D01KZF D01KZF DRUGCLAS Investigative Drug(s) D01KZF DRUGINCH 1S/C16H13FO3/c1-19-12-6-7-13-14(18)9-15(20-16(13)8-12)10-2-4-11(17)5-3-10/h2-8,15H,9H2,1H3/t15-/m0/s1 D01KZF DRUGINKE LIINIWOYEGBFDA-HNNXBMFYSA-N D01KZF DRUGSMIL COC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=C(C=C3)F D01KZF DRUGTYPE Small molecular drug D01KZF HIGHSTAT Investigative D01KZV DRUG__ID D01KZV D01KZV DRUGCLAS Investigative Drug(s) D01KZV DRUGCOMP Meta-IQ Aps D01KZV HIGHSTAT Investigative D01LAC DRUG__ID D01LAC D01LAC DRUGCLAS Discontinued Drug(s) D01LAC DRUGINCH 1S/C11H13F2N/c12-7-10(8-14)2-1-9-3-5-11(13)6-4-9/h3-7H,1-2,8,14H2/b10-7+ D01LAC DRUGINKE VXLBSYHAEKDUSU-JXMROGBWSA-N D01LAC DRUGSMIL C1=CC(=CC=C1CCC(=CF)CN)F D01LAC DRUGTYPE Small molecular drug D01LAC HIGHSTAT Discontinued in Phase 3 D01LAP DRUG__ID D01LAP D01LAP DRUGCLAS Investigative Drug(s) D01LAP DRUGSMIL C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N D01LAP DRUGTYPE Combination drug (Antisense drug) D01LAP HIGHSTAT Investigative D01LAP THERCLAS Antisense D01LAU DRUG__ID D01LAU D01LAU DRUGCLAS Investigative Drug(s) D01LAU DRUGINCH 1S/C14H17N3O3/c1-9(18)15-6-5-10-8-16-13-4-3-11(7-12(10)13)17-14(19)20-2/h3-4,7-8,16H,5-6H2,1-2H3,(H,15,18)(H,17,19) D01LAU DRUGINKE MPZVHKLZCUEJFO-UHFFFAOYSA-N D01LAU DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)NC(=O)OC D01LAU DRUGTYPE Small molecular drug D01LAU HIGHSTAT Investigative D01LAX DRUG__ID D01LAX D01LAX DRUGCLAS Investigative Drug(s) D01LAX DRUGCOMP Maroon Biotech Corp D01LAX HIGHSTAT Investigative D01LBD DRUG__ID D01LBD D01LBD DRUGCLAS Investigative Drug(s) D01LBD DRUGCOMP Hawthorn Pharmaceuticals Inc D01LBD HIGHSTAT Investigative D01LBI DRUG__ID D01LBI D01LBI DRUGCLAS Investigative Drug(s) D01LBI DRUGCOMP LivTech Inc D01LBI HIGHSTAT Investigative D01LCC DRUG__ID D01LCC D01LCC DRUGCLAS Clinical Trial Drug(s) D01LCC DRUGCOMP Pfizer D01LCC DRUGINCH 1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2 D01LCC DRUGINKE PDMUGYOXRHVNMO-UHFFFAOYSA-N D01LCC DRUGSMIL C1=CC2=C(C=CC(=C2)CN3C4=NC(=CN=C4N=N3)C5=CN(N=C5)CCO)N=C1 D01LCC DRUGTYPE Small molecular drug D01LCC HIGHSTAT Phase 1 D01LCS DRUG__ID D01LCS D01LCS DRUGCLAS Investigative Drug(s) D01LCS DRUGINCH 1S/C19H20N4O2/c20-18(21)11-8-9-14-15(10-11)23-19(22-14)13-6-3-7-16(17(13)24)25-12-4-1-2-5-12/h3,6-10,12,24H,1-2,4-5H2,(H3,20,21)(H,22,23) D01LCS DRUGINKE WCFWDBPDMBXMTQ-UHFFFAOYSA-N D01LCS DRUGSMIL C1CCC(C1)OC2=CC=CC(=C2O)C3=NC4=C(N3)C=C(C=C4)C(=N)N D01LCS DRUGTYPE Small molecular drug D01LCS HIGHSTAT Investigative D01LCZ DRUG__ID D01LCZ D01LCZ DRUGCLAS Patented Agent(s) D01LCZ DRUGCOMP KARUS THERAPEUTICS LTD D01LCZ DRUGTYPE Small molecular drug D01LCZ HIGHSTAT Patented D01LDO DRUG__ID D01LDO D01LDO DRUGCLAS Investigative Drug(s) D01LDO DRUGINCH 1S/C7H16NO5P/c8-6(7(9)10)4-2-1-3-5-14(11,12)13/h6H,1-5,8H2,(H,9,10)(H2,11,12,13)/t6-/m1/s1 D01LDO DRUGINKE MYDMWESTDPJANS-ZCFIWIBFSA-N D01LDO DRUGSMIL C(CCC(C(=O)O)N)CCP(=O)(O)O D01LDO DRUGTYPE Small molecular drug D01LDO HIGHSTAT Investigative D01LDP DRUG__ID D01LDP D01LDP COMPCLAS Ampicidin analogs D01LDP DRUGCLAS Patented Agent(s) D01LDP DRUGTYPE Small molecular drug D01LDP HIGHSTAT Patented D01LDQ DRUG__ID D01LDQ D01LDQ DRUGCLAS Investigative Drug(s) D01LDQ DRUGINCH 1S/C17H21NO6/c1-9(5-7-13(19)18-22)4-6-11-15(20)14-12(8-24-17(14)21)10(2)16(11)23-3/h4,20,22H,5-8H2,1-3H3,(H,18,19)/b9-4+ D01LDQ DRUGINKE XUEGRBSFQYYISJ-RUDMXATFSA-N D01LDQ DRUGSMIL CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)NO)O D01LDQ DRUGTYPE Small molecular drug D01LDQ HIGHSTAT Investigative D01LEO DRUG__ID D01LEO D01LEO DRUGCLAS Investigative Drug(s) D01LEO DRUGCOMP China Medical University D01LEO HIGHSTAT Investigative D01LEP DRUG__ID D01LEP D01LEP DRUGCLAS Investigative Drug(s) D01LEP HIGHSTAT Investigative D01LES DRUG__ID D01LES D01LES DRUGCLAS Clinical Trial Drug(s) D01LES DRUGCOMP Genentech D01LES HIGHSTAT Phase 2 D01LEV DRUG__ID D01LEV D01LEV DRUGCLAS Investigative Drug(s) D01LEV DRUGINCH 1S/C13H8BrNOS/c14-10-5-6-17-12(10)7-9-8-3-1-2-4-11(8)15-13(9)16/h1-7H,(H,15,16)/b9-7+ D01LEV DRUGINKE ZGCKMTQNGWQKEN-VQHVLOKHSA-N D01LEV DRUGSMIL C1=CC=C2C(=C1)C(=CC3=C(C=CS3)Br)C(=O)N2 D01LEV DRUGTYPE Small molecular drug D01LEV HIGHSTAT Investigative D01LFA DRUG__ID D01LFA D01LFA DRUGCLAS Discontinued Drug(s) D01LFA DRUGCOMP Ambrx Inc D01LFA HIGHSTAT Discontinued in Phase 2 D01LFC DRUG__ID D01LFC D01LFC DRUGCLAS Clinical Trial Drug(s) D01LFC DRUGCOMP National Cancer Institute D01LFC DRUGTYPE Vaccine D01LFC HIGHSTAT Phase 2 D01LFH DRUG__ID D01LFH D01LFH DRUGCLAS Clinical Trial Drug(s) D01LFH DRUGCOMP Signpath Pharma D01LFH HIGHSTAT Phase 1 D01LFN DRUG__ID D01LFN D01LFN DRUGCLAS Clinical Trial Drug(s) D01LFN DRUGCOMP Oragenics D01LFN HIGHSTAT Phase 1 D01LFP DRUG__ID D01LFP D01LFP DRUGCLAS Investigative Drug(s) D01LFP DRUGINCH 1S/C17H17ClN2O3/c18-14-8-6-13(7-9-14)11-19-16(21)15(17(22)20-23)10-12-4-2-1-3-5-12/h1-9,15,23H,10-11H2,(H,19,21)(H,20,22) D01LFP DRUGINKE MDFALTKCDXYVEX-UHFFFAOYSA-N D01LFP DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCC2=CC=C(C=C2)Cl)C(=O)NO D01LFP DRUGTYPE Small molecular drug D01LFP HIGHSTAT Investigative D01LFQ DRUG__ID D01LFQ D01LFQ DRUGCLAS Investigative Drug(s) D01LFQ DRUGCOMP Daewoong Pharmaceutical Co Ltd D01LFQ HIGHSTAT Investigative D01LGQ DRUG__ID D01LGQ D01LGQ DRUGCLAS Patented Agent(s) D01LGQ DRUGCOMP PURDUE PHARMA L.P D01LGQ DRUGTYPE Small molecular drug D01LGQ HIGHSTAT Patented D01LKO DRUG__ID D01LKO D01LKO DRUGCLAS Investigative Drug(s) D01LKO DRUGINCH 1S/C35H38N8O5/c36-26(15-22-17-38-27-12-6-4-10-24(22)27)33(46)42-29(14-21-8-2-1-3-9-21)35(48)43-30(34(47)41-20-32(45)40-19-31(37)44)16-23-18-39-28-13-7-5-11-25(23)28/h1-13,17-18,26,29-30,38-39H,14-16,19-20,36H2,(H2,37,44)(H,40,45)(H,41,47)(H,42,46)(H,43,48)/t26-,29+,30-/m1/s1 D01LKO DRUGINKE WIJADCOBFJYNSF-JJZPZGAKSA-N D01LKO DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NCC(=O)NCC(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)N D01LKO DRUGTYPE Small molecular drug D01LKO HIGHSTAT Investigative D01LMH DRUG__ID D01LMH D01LMH DRUGCLAS Investigative Drug(s) D01LMH DRUGINCH 1S/C103H172N24O22/c1-10-11-12-13-14-15-16-17-18-19-20-21-22-41-85(132)110-49-32-28-39-74(93(139)117-72(90(109)136)36-25-29-46-104)119-94(140)73(37-26-30-47-105)118-95(141)75(38-27-31-48-106)120-102(148)83-40-33-50-127(83)88(135)60-113-92(138)76(51-62(2)3)121-96(142)77(52-63(4)5)122-98(144)79(54-67-42-44-69(130)45-43-67)116-87(134)59-112-91(137)65(8)114-101(147)82(61-128)125-99(145)81(56-84(108)131)123-97(143)78(53-64(6)7)124-103(149)89(66(9)129)126-100(146)80(115-86(133)57-107)55-68-58-111-71-35-24-23-34-70(68)71/h23-24,34-35,42-45,58,62-66,72-83,89,111,128-130H,10-22,25-33,36-41,46-57,59-61,104-107H2,1-9H3,(H2,108,131)(H2,109,136)(H,110,132)(H,112,137)(H,113,138)(H,114,147)(H,115,133)(H,116,134)(H,117,139)(H,118,141)(H,119,140)(H,120,148)(H,121,142)(H,122,144)(H,123,143)(H,124,149)(H,125,145)(H,126,146)/t65-,66+,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,89-/m0/s1 D01LMH DRUGINKE FUVBWPLFMCRKPJ-RUUCUJBTSA-N D01LMH DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CN D01LMH HIGHSTAT Investigative D01LMM DRUG__ID D01LMM D01LMM DRUGCLAS Clinical Trial Drug(s) D01LMM DRUGCOMP Novartis pharmaceuticals D01LMM HIGHSTAT Phase 1 D01LMW DRUG__ID D01LMW D01LMW DRUGCLAS Patented Agent(s) D01LMW DRUGCOMP NOVA DECISION [FRAZASYNTH [FR] D01LMW DRUGINCH 1S/C17H14F3N3O2/c1-25-16(24)14-7-11-6-12(9-22-15(11)23-14)21-8-10-4-2-3-5-13(10)17(18,19)20/h2-7,9,21H,8H2,1H3,(H,22,23) D01LMW DRUGINKE MFAPLYWBOUSVJJ-UHFFFAOYSA-N D01LMW DRUGSMIL COC(=O)C1=CC2=CC(=CN=C2N1)NCC3=CC=CC=C3C(F)(F)F D01LMW DRUGTYPE Small molecular drug D01LMW HIGHSTAT Patented D01LNG DRUG__ID D01LNG D01LNG DRUGCLAS Discontinued Drug(s) D01LNG DRUGCOMP Novartis D01LNG DRUGINCH 1S/C23H33N5O2/c1-2-14-27-15-17-28(18-16-27)20-8-6-19(7-9-20)21(29)26-23(10-4-3-5-11-23)22(30)25-13-12-24/h6-9H,2-5,10-11,13-18H2,1H3,(H,25,30)(H,26,29) D01LNG DRUGINKE LLCRBOWRJOUJAE-UHFFFAOYSA-N D01LNG DRUGSMIL CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N D01LNG DRUGTYPE Small molecular drug D01LNG HIGHSTAT Discontinued in Phase 2 D01LNP DRUG__ID D01LNP D01LNP DRUGCLAS Investigative Drug(s) D01LNP DRUGCOMP IsoTherapeutics Group Llc D01LNP HIGHSTAT Investigative D01LOE DRUG__ID D01LOE D01LOE DRUGCLAS Clinical Trial Drug(s) D01LOE DRUGCOMP Boehringer Ingelheim Pharmaceuticals; Eli Lilly D01LOE HIGHSTAT Phase 3 D01LOJ DRUG__ID D01LOJ D01LOJ COMPCLAS Pyrazolopyrimidine acetamide analogs D01LOJ DRUGCLAS Patented Agent(s) D01LOJ DRUGINCH 1S/C21H26N4O2/c1-6-24(7-2)19(26)13-18-20(16-8-10-17(27-5)11-9-16)23-25-15(4)12-14(3)22-21(18)25/h8-12H,6-7,13H2,1-5H3 D01LOJ DRUGINKE ILZWUAWCTNWSFZ-UHFFFAOYSA-N D01LOJ DRUGSMIL CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC=C(C=C3)OC)C)C D01LOJ DRUGTYPE Small molecular drug D01LOJ HIGHSTAT Patented D01LOU DRUG__ID D01LOU D01LOU DRUGCLAS Investigative Drug(s) D01LOU DRUGINCH 1S/C17H11N3O4/c21-16-12-3-1-2-4-14(12)24-17-11(9-19-8-7-18-10-19)5-6-13(15(16)17)20(22)23/h1-8,10H,9H2 D01LOU DRUGINKE JLTNBMDVMUSXHQ-UHFFFAOYSA-N D01LOU DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3O2)CN4C=CN=C4)[N+](=O)[O-] D01LOU DRUGTYPE Small molecular drug D01LOU HIGHSTAT Investigative D01LPG DRUG__ID D01LPG D01LPG DRUGCLAS Investigative Drug(s) D01LPG DRUGINCH 1S/C10H9ClN4O2S/c11-9-5-13-6-10(15-9)14-7-1-3-8(4-2-7)18(12,16)17/h1-6H,(H,14,15)(H2,12,16,17) D01LPG DRUGINKE RSNSGNZRUMHXAY-UHFFFAOYSA-N D01LPG DRUGSMIL C1=CC(=CC=C1NC2=CN=CC(=N2)Cl)S(=O)(=O)N D01LPG DRUGTYPE Small molecular drug D01LPG HIGHSTAT Investigative D01LPK DRUG__ID D01LPK D01LPK DRUGCLAS Discontinued Drug(s) D01LPK DRUGCOMP Victory Pharma Inc D01LPK HIGHSTAT Discontinued in Preregistration D01LPX DRUG__ID D01LPX D01LPX DRUGCLAS Discontinued Drug(s) D01LPX DRUGCOMP Nycomed AS D01LPX DRUGINCH 1S/C14H15NO5S2/c16-13(17)10-20-14-7-6-11(21-14)8-9-15-22(18,19)12-4-2-1-3-5-12/h1-7,15H,8-10H2,(H,16,17) D01LPX DRUGINKE ISSKMEQROMFEHL-UHFFFAOYSA-N D01LPX DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NCCC2=CC=C(S2)OCC(=O)O D01LPX DRUGTYPE Small molecular drug D01LPX HIGHSTAT Discontinued in Phase 2 D01LQC DRUG__ID D01LQC D01LQC DRUGCLAS Discontinued Drug(s) D01LQC DRUGCOMP Phytopharm D01LQC DRUGINCH 1S/C19H14ClN7/c20-15-8-6-13(7-9-15)11-22-18-25-17-14(10-21)12-23-27(17)19(26-18)24-16-4-2-1-3-5-16/h1-9,12H,11H2,(H2,22,24,25,26) D01LQC DRUGINKE QCVULERVJOYHCP-UHFFFAOYSA-N D01LQC DRUGSMIL C1=CC=C(C=C1)NC2=NC(=NC3=C(C=NN32)C#N)NCC4=CC=C(C=C4)Cl D01LQC DRUGTYPE Small molecular drug D01LQC HIGHSTAT Discontinued in Phase 2 D01LQJ DRUG__ID D01LQJ D01LQJ DRUGCLAS Investigative Drug(s) D01LQJ DRUGCOMP Amunix Inc D01LQJ HIGHSTAT Investigative D01LQZ DRUG__ID D01LQZ D01LQZ DRUGCLAS Discontinued Drug(s) D01LQZ DRUGCOMP Transgene SA D01LQZ HIGHSTAT Discontinued in Phase 1 D01LRC DRUG__ID D01LRC D01LRC DRUGCLAS Investigative Drug(s) D01LRC DRUGINCH 1S/C30H50N/c1-5-7-9-11-13-15-17-19-22-28-26(3)29(30-24-21-25-31(30)27(28)4)23-20-18-16-14-12-10-8-6-2/h19-20,22-23H,5-18,21,24-25H2,1-4H3/q+1/b22-19-,23-20- D01LRC DRUGINKE LOTZSYKJMYSNJV-IKJQKJQYSA-N D01LRC DRUGSMIL CCCCCCCCC=CC1=C(C(=C2CCC[N+]2=C1C)C=CCCCCCCCC)C D01LRC DRUGTYPE Small molecular drug D01LRC HIGHSTAT Investigative D01LRH DRUG__ID D01LRH D01LRH DRUGCLAS Discontinued Drug(s) D01LRH DRUGCOMP Bristol-Myers Squibb Pharma Co D01LRH DRUGINCH 1S/C23H18N4/c1-3-19-21(26-9-1)22-20(4-2-10-27-22)23(19,15-17-5-11-24-12-6-17)16-18-7-13-25-14-8-18/h1-14H,15-16H2 D01LRH DRUGINKE FJYRSJDIZKTXKB-UHFFFAOYSA-N D01LRH DRUGSMIL C1=CC2=C(C3=C(C2(CC4=CC=NC=C4)CC5=CC=NC=C5)C=CC=N3)N=C1 D01LRH DRUGTYPE Small molecular drug D01LRH HIGHSTAT Terminated D01LRM DRUG__ID D01LRM D01LRM DRUGCLAS Clinical Trial Drug(s) D01LRM DRUGCOMP Synageva BioPharma Corp D01LRM HIGHSTAT Phase 2 D01LSB DRUG__ID D01LSB D01LSB DRUGCLAS Clinical Trial Drug(s) D01LSB DRUGCOMP Genentech D01LSB HIGHSTAT Phase 2 D01LSP DRUG__ID D01LSP D01LSP DRUGCLAS Patented Agent(s) D01LSP DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D01LSP DRUGTYPE Small molecular drug D01LSP HIGHSTAT Patented D01LSY DRUG__ID D01LSY D01LSY DRUGCLAS Drugs in Phase 2 Trial D01LSY DRUGTYPE Combination drug D01LSY HIGHSTAT Phase 2 Trial D01LSY THERCLAS Antiviral Agents D01LTK DRUG__ID D01LTK D01LTK DRUGCLAS Patented Agent(s) D01LTK DRUGCOMP KOREA OCEAN RESEARCH AND DEVELOPMENT INSITUTE YIM, Joung Han KIM, Il Chan LEE, Sung Gu KIM, Doc Kyu HAN, Se Jong LEE, Hyoung Seok D01LTK HIGHSTAT Patented D01LUB DRUG__ID D01LUB D01LUB DRUGCLAS Investigative Drug(s) D01LUB DRUGINCH 1S/C17H18O4/c1-10-9-16(19)21-17-11(2)14(8-7-12(10)17)20-15-6-4-3-5-13(15)18/h7-9,15H,3-6H2,1-2H3 D01LUB DRUGINKE WRTZCCCOMNOONZ-UHFFFAOYSA-N D01LUB DRUGSMIL CC1=CC(=O)OC2=C1C=CC(=C2C)OC3CCCCC3=O D01LUB DRUGTYPE Small molecular drug D01LUB HIGHSTAT Investigative D01LUH DRUG__ID D01LUH D01LUH DRUGCLAS Investigative Drug(s) D01LUH DRUGCOMP Samaritan Pharmaceuticals Inc D01LUH HIGHSTAT Investigative D01LUJ DRUG__ID D01LUJ D01LUJ DRUGCLAS Patented Agent(s) D01LUJ DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED HENDRICKSON, Thomas, Francis HO, Koc-Kan SAUNDERS, Michael, David STEVENS, Brian, John SWIERCZEK, Krzysztof WRIGHT, Kevin, Bret D01LUJ DRUGINCH 1S/C16H19ClN8O3S/c17-9-1-2-19-16(24-9)20-3-4-29-5-8-11(26)12(27)15(28-8)25-7-23-10-13(18)21-6-22-14(10)25/h1-2,6-8,11-12,15,26-27H,3-5H2,(H2,18,21,22)(H,19,20,24)/t8-,11-,12-,15-/m0/s1 D01LUJ DRUGINKE ZWBSJRQJKXXDKA-REXDEQPNSA-N D01LUJ DRUGSMIL C1=CN=C(N=C1Cl)NCCSCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)O D01LUJ DRUGTYPE Small molecular drug D01LUJ HIGHSTAT Patented D01LUS DRUG__ID D01LUS D01LUS DRUGCLAS Approved Drug(s) D01LUS HIGHSTAT Approved D01LVE DRUG__ID D01LVE D01LVE DRUGCLAS Clinical Trial Drug(s) D01LVE DRUGCOMP Constellation pharmaceuticals D01LVE DRUGINCH 1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9,16H,10H2,1H3,(H2,22,25)/t16-/m0/s1 D01LVE DRUGINKE GCWIQUVXWZWCLE-INIZCTEOSA-N D01LVE DRUGSMIL CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl D01LVE HIGHSTAT Phase 3 D01LVM DRUG__ID D01LVM D01LVM DRUGCLAS Investigative Drug(s) D01LVM DRUGCOMP PharmedArtis GmbH D01LVM HIGHSTAT Investigative D01LVT DRUG__ID D01LVT D01LVT DRUGCLAS Patented Agent(s) D01LVT DRUGCOMP WYETH RAMAMOORTHY, Sivaramakrishnan, P D01LVT DRUGTYPE Small molecular drug D01LVT HIGHSTAT Patented D01LVY DRUG__ID D01LVY D01LVY DRUGCLAS Investigative Drug(s) D01LVY DRUGINCH 1S/C20H15NOS/c1-14-10-12-15(13-11-14)20(22)21-16-6-2-4-8-18(16)23-19-9-5-3-7-17(19)21/h2-13H,1H3 D01LVY DRUGINKE BXCIQPXSBSOIQX-UHFFFAOYSA-N D01LVY DRUGSMIL CC1=CC=C(C=C1)C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D01LVY DRUGTYPE Small molecular drug D01LVY HIGHSTAT Investigative D01LWE DRUG__ID D01LWE D01LWE DRUGCLAS Clinical Trial Drug(s) D01LWE DRUGCOMP Gary Archer Ph.D. D01LWE DRUGTYPE CAR T Cell Therapy D01LWE HIGHSTAT Phase 1 D01LWJ DRUG__ID D01LWJ D01LWJ DRUGCLAS Investigative Drug(s) D01LWJ DRUGINCH 1S/C21H18O11/c22-9-3-1-8(2-4-9)13-7-12(24)15-11(23)5-10(6-14(15)31-13)30-21-18(27)16(25)17(26)19(32-21)20(28)29/h1-7,16-19,21-23,25-27H,(H,28,29)/t16-,17-,18+,19-,21+/m0/s1 D01LWJ DRUGINKE JBFOLLJCGUCDQP-ZFORQUDYSA-N D01LWJ DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O D01LWJ DRUGTYPE Small molecular drug D01LWJ HIGHSTAT Investigative D01LWO DRUG__ID D01LWO D01LWO DRUGCLAS Clinical Trial Drug(s) D01LWO DRUGCOMP TransMolecular Inc D01LWO DRUGINCH 1S/C158H249N53O47S11/c1-77(2)55-96-138(241)205-105(144(247)186-86(125(165)228)28-18-47-173-156(166)167)70-264-262-68-103-131(234)177-63-115(217)176-64-116(218)183-87(25-12-15-44-159)128(231)178-65-117(219)184-88(29-19-48-174-157(168)169)129(232)179-66-118(220)185-89(26-13-16-45-160)133(236)202-107-72-267-269-75-110-149(252)195-98(56-81-23-10-9-11-24-81)143(246)208-124(80(5)213)154(257)209-123(79(4)212)153(256)199-102(61-122(226)227)141(244)196-99(58-83-62-172-76-181-83)139(242)189-92(37-39-113(163)215)136(239)190-94(42-53-260-7)132(235)182-78(3)126(229)187-91(30-20-49-175-158(170)171)134(237)188-90(27-14-17-46-161)135(238)203-108(73-266-265-71-106(146(249)193-96)204-137(240)93(38-40-114(164)216)191-151(254)111-31-21-50-210(111)119(221)67-180-130(233)97(194-147(107)250)57-82-33-35-84(214)36-34-82)148(251)198-100(59-120(222)223)140(243)197-101(60-121(224)225)142(245)206-109(150(253)201-103)74-268-263-69-104(200-127(230)85(162)41-52-259-6)145(248)192-95(43-54-261-8)155(258)211-51-22-32-112(211)152(255)207-110/h9-11,23-24,33-36,62,76-80,85-112,123-124,212-214H,12-22,25-32,37-61,63-75,159-162H2,1-8H3,(H2,163,215)(H2,164,216)(H2,165,228)(H,172,181)(H,176,217)(H,177,234)(H,178,231)(H,179,232)(H,180,233)(H,182,235)(H,183,218)(H,184,219)(H,185,220)(H,186,247)(H,187,229)(H,188,237)(H,189,242)(H,190,239)(H,191,254)(H,192,248)(H,193,249)(H,194,250)(H,195,252)(H,196,244)(H,197,243)(H,198,251)(H,199,256)(H,200,230)(H,201,253)(H,202,236)(H,203,238)(H,204,240)(H,205,241)(H,206,245)(H,207,255)(H,208,246)(H,209,257)(H,222,223)(H,224,225)(H,226,227)(H4,166,167,173)(H4,168,169,174)(H4,170,171,175)/t78-,79+,80+,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,123-,124-/m0/s1 D01LWO DRUGINKE QPAKKWCQMHUHNI-GQIQPHNSSA-N D01LWO DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(CSSCC4C(=O)NCC(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCSC)CCC(=O)N)CC5=CNC=N5)CC(=O)O)C(C)O)C(C)O)CC6=CC=CC=C6)NC(=O)C7CCCN7C(=O)C(NC(=O)C(CSSCC(C(=O)N4)NC(=O)C(NC(=O)C(NC2=O)CC(=O)O)CC(=O)O)NC(=O)C(CCSC)N)CCSC)C(=O)NC(C(=O)NCC(=O)N8CCCC8C(=O)NC(C(=O)N3)CCC(=O)N)CC9=CC=C(C=C9)O)CCCCN)CCCNC(=N)N)CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)N)CC(C)C)CCCCN)CCCNC(=N)N D01LWO HIGHSTAT Phase 2 D01LXD DRUG__ID D01LXD D01LXD DRUGCLAS Clinical Trial Drug(s) D01LXD DRUGCOMP Eli Lilly & Co D01LXD DRUGINCH 1S/C19H27N3O4/c1-11(2)16(23)18(25)20-12(3)17(24)21-15-14-8-6-5-7-13(14)9-10-22(4)19(15)26/h5-8,11-12,15-16,23H,9-10H2,1-4H3,(H,20,25)(H,21,24)/t12-,15-,16-/m0/s1 D01LXD DRUGINKE PKXWXXPNHIWQHW-RCBQFDQVSA-N D01LXD DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O D01LXD DRUGTYPE Small molecular drug D01LXD HIGHSTAT Phase 3 D01LXG DRUG__ID D01LXG D01LXG DRUGCLAS Discontinued Drug(s) D01LXG DRUGCOMP Solvay Pharmaceuticals Inc D01LXG HIGHSTAT Terminated D01LXZ DRUG__ID D01LXZ D01LXZ DRUGCLAS Investigative Drug(s) D01LXZ DRUGCOMP Daewoong Pharmaceutical Co Ltd D01LXZ HIGHSTAT Investigative D01LYK DRUG__ID D01LYK D01LYK DRUGCLAS Investigative Drug(s) D01LYK DRUGCOMP Isis Pharmaceuticals D01LYK DRUGTYPE Antisense drug D01LYK HIGHSTAT Investigative D01LYX DRUG__ID D01LYX D01LYX DRUGCLAS Clinical Trial Drug(s) D01LYX DRUGCOMP Consiglio Nazionale delle Ricerche D01LYX DRUGINCH 1S/C21H33N3O2/c1-5-6-7-8-9-13-22-20(25)26-16-10-11-18-17(15-16)21(2)12-14-23(3)19(21)24(18)4/h10-11,15,19H,5-9,12-14H2,1-4H3,(H,22,25)/t19-,21+/m1/s1 D01LYX DRUGINKE RRGMXBQMCUKRLH-CTNGQTDRSA-N D01LYX DRUGSMIL CCCCCCCNC(=O)OC1=CC2=C(C=C1)N(C3C2(CCN3C)C)C D01LYX DRUGTYPE Small molecular drug D01LYX HIGHSTAT Phase 3 D01LZB DRUG__ID D01LZB D01LZB DRUGCLAS Investigative Drug(s) D01LZB DRUGCOMP Chugai Pharmaceutical D01LZB HIGHSTAT Investigative D01LZC DRUG__ID D01LZC D01LZC DRUGCLAS Discontinued Drug(s) D01LZC DRUGCOMP Genetic Therapy Inc D01LZC HIGHSTAT Terminated D01LZL DRUG__ID D01LZL D01LZL DRUGCLAS Investigative Drug(s) D01LZL HIGHSTAT Investigative D01MAC DRUG__ID D01MAC D01MAC DRUGCLAS Investigative Drug(s) D01MAC DRUGINCH 1S/C11H18N2O7/c1-2-3-4-12-11(14)19-7-5-17-10-8(20-13(15)16)6-18-9(7)10/h7-10H,2-6H2,1H3,(H,12,14)/t7-,8+,9+,10+/m0/s1 D01MAC DRUGINKE ZRPGNSMQMBUVBC-SGIHWFKDSA-N D01MAC DRUGSMIL CCCCNC(=O)OC1COC2C1OCC2O[N+](=O)[O-] D01MAC DRUGTYPE Small molecular drug D01MAC HIGHSTAT Investigative D01MAN DRUG__ID D01MAN D01MAN DRUGCLAS Investigative Drug(s) D01MAN DRUGINCH 1S/C24H18N2O/c1-17-7-8-19-9-10-21(14-23(19)26-17)20-11-12-24(22(13-20)15-25)27-16-18-5-3-2-4-6-18/h2-14H,16H2,1H3 D01MAN DRUGINKE INOCIGKWKFGOCI-UHFFFAOYSA-N D01MAN DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=C(C=C3)OCC4=CC=CC=C4)C#N D01MAN DRUGTYPE Small molecular drug D01MAN HIGHSTAT Investigative D01MAU DRUG__ID D01MAU D01MAU DRUGCLAS Clinical Trial Drug(s) D01MAU DRUGCOMP Targacept Inc D01MAU DRUGINCH 1S/C11H13ClN2O2/c12-10-2-1-9(16-10)11(15)14-5-7-3-13-4-8(7)6-14/h1-2,7-8,13H,3-6H2/t7-,8+ D01MAU DRUGINKE GTUIQNHJSXQMKW-OCAPTIKFSA-N D01MAU DRUGSMIL C1C2CN(CC2CN1)C(=O)C3=CC=C(O3)Cl D01MAU DRUGTYPE Small molecular drug D01MAU HIGHSTAT Phase 2 D01MBF DRUG__ID D01MBF D01MBF DRUGCLAS Investigative Drug(s) D01MBF DRUGINCH 1S/C17H17F2NO/c18-13-4-6-14(7-5-13)21-16-3-1-2-15(19)17(16)12-8-10-20-11-9-12/h1-7,12,20H,8-11H2 D01MBF DRUGINKE WPYMMOOTBZOFOZ-UHFFFAOYSA-N D01MBF DRUGSMIL C1CNCCC1C2=C(C=CC=C2F)OC3=CC=C(C=C3)F D01MBF DRUGTYPE Small molecular drug D01MBF HIGHSTAT Investigative D01MBG DRUG__ID D01MBG D01MBG DRUGCLAS Investigative Drug(s) D01MBG DRUGINCH 1S/C21H30N4O5S2/c1-32-10-8-15(19(22)28)24-20(29)17-3-2-9-25(17)21(30)16(23-18(27)12-31)11-13-4-6-14(26)7-5-13/h4-7,15-17,26,31H,2-3,8-12H2,1H3,(H2,22,28)(H,23,27)(H,24,29)/t15-,16-,17-/m0/s1 D01MBG DRUGINKE LNLWXWOYQHAKTD-ULQDDVLXSA-N D01MBG DRUGSMIL CSCCC(C(=O)N)NC(=O)C1CCCN1C(=O)C(CC2=CC=C(C=C2)O)NC(=O)CS D01MBG DRUGTYPE Small molecular drug D01MBG HIGHSTAT Investigative D01MBM DRUG__ID D01MBM D01MBM DRUGCLAS Investigative Drug(s) D01MBM DRUGCOMP Laila Pharmaceuticals Pvt Ltd D01MBM HIGHSTAT Investigative D01MBR DRUG__ID D01MBR D01MBR DRUGCLAS Investigative Drug(s) D01MBR DRUGINCH 1S/C33H41N7O5/c1-22-28(31(41)44-4)30(29(23(2)37-22)32(42)45-5)24-9-6-10-25(19-24)38-33(36-21-34)35-13-8-14-39-15-17-40(18-16-39)26-11-7-12-27(20-26)43-3/h6-7,9-12,19-20,30,37H,8,13-18H2,1-5H3,(H2,35,36,38) D01MBR DRUGINKE HDRYBCLMRKGHSG-UHFFFAOYSA-N D01MBR DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=CC=C2)NC(=NCCCN3CCN(CC3)C4=CC(=CC=C4)OC)NC#N)C(=O)OC D01MBR DRUGTYPE Small molecular drug D01MBR HIGHSTAT Investigative D01MBV DRUG__ID D01MBV D01MBV DRUGCLAS Clinical Trial Drug(s) D01MBV DRUGINCH 1S/C22H31N3O2.ClH/c1-2-3-11-24-13-9-17(10-14-24)16-23-21(26)20-18-7-4-5-8-19(18)25-12-6-15-27-22(20)25;/h4-5,7-8,17H,2-3,6,9-16H2,1H3,(H,23,26);1H D01MBV DRUGINKE UABVCZHWRUGYSR-UHFFFAOYSA-N D01MBV DRUGSMIL CCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42.Cl D01MBV DRUGTYPE Small molecular drug D01MBV HIGHSTAT Phase 2 D01MCB DRUG__ID D01MCB D01MCB DRUGCLAS Clinical Trial Drug(s) D01MCB DRUGCOMP Merck; Vical D01MCB HIGHSTAT Phase 1 D01MCD DRUG__ID D01MCD D01MCD DRUGCLAS Investigative Drug(s) D01MCD DRUGINCH 1S/C25H23Cl3N2O3/c1-13(31)23(32)29-21-12-25(2,3)33-24-19(21)11-18(14-4-6-15(26)7-5-14)22(30-24)17-9-8-16(27)10-20(17)28/h4-11,13,21,31H,12H2,1-3H3,(H,29,32)/t13-,21?/m1/s1 D01MCD DRUGINKE XCFWDLWOCXSJOK-ILRUXTBWSA-N D01MCD DRUGSMIL CC(C(=O)NC1CC(OC2=C1C=C(C(=N2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)(C)C)O D01MCD DRUGTYPE Small molecular drug D01MCD HIGHSTAT Investigative D01MCF DRUG__ID D01MCF D01MCF DRUGCLAS Investigative Drug(s) D01MCF DRUGCOMP Isis Pharmaceuticals D01MCF DRUGTYPE Antisense drug D01MCF HIGHSTAT Investigative D01MDE DRUG__ID D01MDE D01MDE DRUGCLAS Investigative Drug(s) D01MDE DRUGINCH 1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/p-2/b2-1+ D01MDE DRUGINKE VZCYOOQTPOCHFL-OWOJBTEDSA-L D01MDE DRUGSMIL C(=CC(=O)[O-])C(=O)[O-] D01MDE DRUGTYPE Small molecular drug D01MDE HIGHSTAT Investigative D01MDH DRUG__ID D01MDH D01MDH DRUGCLAS Investigative Drug(s) D01MDH DRUGCOMP CoLucid Pharmaceuticals Inc D01MDH HIGHSTAT Investigative D01MDT DRUG__ID D01MDT D01MDT DRUADIID FDA-AP-BF04-00396 D01MDT DRUGCLAS Approved Drug(s) D01MDT DRUGCOMP Elan Pharmaceuticals D01MDT DRUGINCH 1S/C9H8ClN5S/c10-5-1-2-6-8(15-16-14-6)7(5)13-9-11-3-4-12-9/h1-2H,3-4H2,(H2,11,12,13) D01MDT DRUGINKE XFYDIVBRZNQMJC-UHFFFAOYSA-N D01MDT DRUGSMIL C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl D01MDT DRUGTYPE Small molecular drug D01MDT HIGHSTAT Approved D01MDT THERCLAS Analgesics D01MDX DRUG__ID D01MDX D01MDX DRUGCLAS Clinical Trial Drug(s) D01MDX DRUGCOMP Autolus Limited D01MDX DRUGTYPE CAR T Cell Therapy D01MDX HIGHSTAT Phase 1/2 D01MEA DRUG__ID D01MEA D01MEA DRUGCLAS Investigative Drug(s) D01MEA DRUGINCH 1S/C9H18N2S/c1-2-3-4-8-7-12-6-5-9(10)11-8/h8H,2-7H2,1H3,(H2,10,11) D01MEA DRUGINKE FGUKFZPUKNZRSR-UHFFFAOYSA-N D01MEA DRUGSMIL CCCCC1CSCCC(=N1)N D01MEA DRUGTYPE Small molecular drug D01MEA HIGHSTAT Investigative D01MEP DRUG__ID D01MEP D01MEP DRUGCLAS Investigative Drug(s) D01MEP DRUGINCH 1S/C14H10IN3OS/c15-12-3-1-2-10(8-12)9-20-14-18-17-13(19-14)11-4-6-16-7-5-11/h1-8H,9H2 D01MEP DRUGINKE ZRHRPGSSSVYBRG-UHFFFAOYSA-N D01MEP DRUGSMIL C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3 D01MEP DRUGTYPE Small molecular drug D01MEP HIGHSTAT Investigative D01MFA DRUG__ID D01MFA D01MFA DRUGCLAS Discontinued Drug(s) D01MFA DRUGCOMP Cypress Bioscience Inc D01MFA HIGHSTAT Discontinued in Phase 2 D01MFG DRUG__ID D01MFG D01MFG DRUGCLAS Investigative Drug(s) D01MFG DRUGCOMP Axis Genetics plc D01MFG HIGHSTAT Investigative D01MFK DRUG__ID D01MFK D01MFK DRUGCLAS Investigative Drug(s) D01MFK DRUGINCH 1S/C19H17FO4S/c1-19(2)17(12-7-9-15(10-8-12)25(3,22)23)16(18(21)24-19)13-5-4-6-14(20)11-13/h4-11H,1-3H3 D01MFK DRUGINKE NXERGIJHYVUXHM-UHFFFAOYSA-N D01MFK DRUGSMIL CC1(C(=C(C(=O)O1)C2=CC(=CC=C2)F)C3=CC=C(C=C3)S(=O)(=O)C)C D01MFK DRUGTYPE Small molecular drug D01MFK HIGHSTAT Investigative D01MFK THERCLAS Analgesics D01MFM DRUG__ID D01MFM D01MFM DRUGCLAS Investigative Drug(s) D01MFM DRUGINCH 1S/C40H53N9O10/c1-25-20-29(50)21-26(2)30(25)23-31(41)35(51)45-32(17-11-19-43-39(42)48-49(57)58)36(52)47-34(22-27-12-5-3-6-13-27)37(53)46-33(38(54)55)16-9-10-18-44-40(56)59-24-28-14-7-4-8-15-28/h3-8,12-15,20-21,31-34,50H,9-11,16-19,22-24,41H2,1-2H3,(H,44,56)(H,45,51)(H,46,53)(H,47,52)(H,54,55)(H3,42,43,48)/t31?,32-,33+,34+/m1/s1 D01MFM DRUGINKE DTKHPEUFGZLWTF-OYKWTTPJSA-N D01MFM DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC(CCCN=C(N)N[N+](=O)[O-])C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCCNC(=O)OCC3=CC=CC=C3)C(=O)O)N)C)O D01MFM DRUGTYPE Small molecular drug D01MFM HIGHSTAT Investigative D01MFT DRUG__ID D01MFT D01MFT DRUGCLAS Investigative Drug(s) D01MFT DRUGINCH 1S/C10H6Cl8/c11-3-1-2-4(5(3)12)9(16)7(14)6(13)8(2,15)10(9,17)18/h2-5H,1H2 D01MFT DRUGINKE BIWJNBZANLAXMG-UHFFFAOYSA-N D01MFT DRUGSMIL C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl D01MFT DRUGTYPE Small molecular drug D01MFT HIGHSTAT Investigative D01MFV DRUG__ID D01MFV D01MFV DRUGCLAS Investigative Drug(s) D01MFV DRUGINCH 1S/C12H16N2O2S/c15-11(13-8-9-17)6-7-12(16)14-10-4-2-1-3-5-10/h1-5,17H,6-9H2,(H,13,15)(H,14,16) D01MFV DRUGINKE DQJPTXLXOUGDMC-UHFFFAOYSA-N D01MFV DRUGSMIL C1=CC=C(C=C1)NC(=O)CCC(=O)NCCS D01MFV DRUGTYPE Small molecular drug D01MFV HIGHSTAT Investigative D01MGA DRUG__ID D01MGA D01MGA DRUGCLAS Approved Drug(s) D01MGA DRUGCOMP Pfizer Inc D01MGA DRUGINCH 1S/C26H25F3N6O5.CH4O3S/c1-10(30)24(37)31-11(2)25(38)32-20-14-7-34(8-15(14)20)23-18(29)6-13-21(36)16(26(39)40)9-35(22(13)33-23)19-4-3-12(27)5-17(19)28;1-5(2,3)4/h3-6,9-11,14-15,20H,7-8,30H2,1-2H3,(H,31,37)(H,32,38)(H,39,40);1H3,(H,2,3,4)/t10-,11-,14-,15+,20?;/m0./s1 D01MGA DRUGINKE CYETUYYEVKNSHZ-RSUMCGCKSA-N D01MGA DRUGSMIL CC(C(=O)NC(C)C(=O)NC1C2C1CN(C2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F)N.CS(=O)(=O)O D01MGA DRUGTYPE Small molecular drug D01MGA HIGHSTAT Approved D01MGI DRUG__ID D01MGI D01MGI DRUGCLAS Investigative Drug(s) D01MGI DRUGINCH 1S/C18H29N7O6/c19-18(20)21-5-1-2-11-16(30)22-8-13(26)24-12(7-14(27)28)17(31)23-10-4-3-9(6-10)15(29)25-11/h9-12H,1-8H2,(H,22,30)(H,23,31)(H,24,26)(H,25,29)(H,27,28)(H4,19,20,21)/t9-,10-,11+,12+/m1/s1 D01MGI DRUGINKE SLTMEZLQPRTTBL-WYUUTHIRSA-N D01MGI DRUGSMIL C1CC2CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D01MGI DRUGTYPE Small molecular drug D01MGI HIGHSTAT Investigative D01MGV DRUG__ID D01MGV D01MGV DRUGCLAS Clinical Trial Drug(s) D01MGV DRUGCOMP Warner Chilcott plc D01MGV HIGHSTAT Phase 3 D01MHI DRUG__ID D01MHI D01MHI DRUGCLAS Clinical Trial Drug(s) D01MHI DRUGCOMP Mitsubishi Pharma Corp D01MHI DRUGINCH 1S/C19H23N3O3/c1-11-12(2)25-19-17(11)18(13-6-3-4-7-14(13)20-19)21-15(23)10-22-9-5-8-16(22)24/h3-10H2,1-2H3,(H,20,21,23) D01MHI DRUGINKE PSPGQHXMUKWNDI-UHFFFAOYSA-N D01MHI DRUGSMIL CC1=C(OC2=NC3=C(CCCC3)C(=C12)NC(=O)CN4CCCC4=O)C D01MHI DRUGTYPE Small molecular drug D01MHI HIGHSTAT Phase 2 D01MHL DRUG__ID D01MHL D01MHL DRUGCLAS Clinical Trial Drug(s) D01MHL DRUGCOMP Fujifilm pharmaceuticals; toyama chemical D01MHL DRUGINCH 1S/C25H35N5O2/c26-24(27)20-4-8-22(9-5-20)31-17-1-3-19-12-15-30(16-13-19)14-2-18-32-23-10-6-21(7-11-23)25(28)29/h4-11,19H,1-3,12-18H2,(H3,26,27)(H3,28,29) D01MHL DRUGINKE KUNDLEJVAIBADY-UHFFFAOYSA-N D01MHL DRUGSMIL C1CN(CCC1CCCOC2=CC=C(C=C2)C(=N)N)CCCOC3=CC=C(C=C3)C(=N)N D01MHL DRUGTYPE Small molecular drug D01MHL HIGHSTAT Phase 1 D01MHO DRUG__ID D01MHO D01MHO DRUGCLAS Investigative Drug(s) D01MHO DRUGINCH 1S/C18H23NO6S/c1-19-8-7-18-11-4-6-14(25-26(20,21)22)17(18)24-16-13(23-2)5-3-10(15(16)18)9-12(11)19/h3,5,11-12,14,17H,4,6-9H2,1-2H3,(H,20,21,22)/t11-,12+,14-,17-,18-/m0/s1 D01MHO DRUGINKE UFGYWOICNCSHBB-XSSYPUMDSA-N D01MHO DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(CC4)OS(=O)(=O)O D01MHO DRUGTYPE Small molecular drug D01MHO HIGHSTAT Investigative D01MHP DRUG__ID D01MHP D01MHP DRUGCLAS Investigative Drug(s) D01MHP DRUGINCH 1S/C35H44N2O12/c1-19(2)32(43)26(48-25(39)22-12-9-15-36-22)33(44)28(4)18-31(42)29(32,5)35(33,45)34(49-31)24(20(3)13-14-30(28,34)41)47-23(38)16-37-27(40)46-17-21-10-7-6-8-11-21/h6-12,15,19-20,24,26,36,41-45H,13-14,16-18H2,1-5H3,(H,37,40)/t20?,24-,26-,28+,29?,30?,31?,32?,33?,34?,35?/m1/s1 D01MHP DRUGINKE ZJAWJJNLZWLOIL-JIVHGXQSSA-N D01MHP DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CNC(=O)OCC6=CC=CC=C6)O4)O)O)OC(=O)C7=CC=CN7)(C(C)C)O)C)O)C)O D01MHP DRUGTYPE Small molecular drug D01MHP HIGHSTAT Investigative D01MHT DRUG__ID D01MHT D01MHT DRUGCLAS Investigative Drug(s) D01MHT DRUGCOMP Bolder BioTechnology Inc D01MHT HIGHSTAT Investigative D01MIP DRUG__ID D01MIP D01MIP DRUGCLAS Discontinued Drug(s) D01MIP DRUGCOMP Sugen Pharmaceuticals D01MIP DRUGINCH 1S/C15H13ClN2O/c1-8-5-9(2)17-14(8)7-12-11-6-10(16)3-4-13(11)18-15(12)19/h3-7,17H,1-2H3,(H,18,19)/b12-7- D01MIP DRUGINKE XLBQNZICMYZIQT-GHXNOFRVSA-N D01MIP DRUGSMIL CC1=CC(=C(N1)C=C2C3=C(C=CC(=C3)Cl)NC2=O)C D01MIP DRUGTYPE Small molecular drug D01MIP HIGHSTAT Terminated D01MJF DRUG__ID D01MJF D01MJF DRUGCLAS Investigative Drug(s) D01MJF DRUGINCH 1S/C22H36O/c1-4-5-6-7-8-16-22(2,3)20-14-12-18(13-15-20)19-10-9-11-21(23)17-19/h12-15,19,21,23H,4-11,16-17H2,1-3H3/t19-,21+/m0/s1 D01MJF DRUGINKE SHSCKELICBAALI-PZJWPPBQSA-N D01MJF DRUGSMIL CCCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D01MJF DRUGTYPE Small molecular drug D01MJF HIGHSTAT Investigative D01MJT DRUG__ID D01MJT D01MJT DRUGCLAS Investigative Drug(s) D01MJT DRUGCOMP MiRagen Therapeutics Inc D01MJT HIGHSTAT Investigative D01MKD DRUG__ID D01MKD D01MKD COMPCLAS Phenylalanine derivatives D01MKD DRUGCLAS Patented Agent(s) D01MKD DRUGTYPE Small molecular drug D01MKD HIGHSTAT Patented D01MKM DRUG__ID D01MKM D01MKM DRUGCLAS Investigative Drug(s) D01MKM DRUGINCH 1S/C33H39N5O5/c34-26(20-24-13-16-25(39)17-14-24)33(43)38-19-7-12-29(38)32(42)36-27(18-15-22-8-3-1-4-9-22)31(41)37-28(30(35)40)21-23-10-5-2-6-11-23/h1-6,8-11,13-14,16-17,26-29,39H,7,12,15,18-21,34H2,(H2,35,40)(H,36,42)(H,37,41)/t26-,27-,28-,29-/m0/s1 D01MKM DRUGINKE FNDQFOCGSSQYSF-DZUOILHNSA-N D01MKM DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CCC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)N D01MKM DRUGTYPE Small molecular drug D01MKM HIGHSTAT Investigative D01MLQ DRUG__ID D01MLQ D01MLQ DRUGCLAS Investigative Drug(s) D01MLQ DRUGINCH 1S/C19H20FNO/c20-18-9-5-4-8-17(18)19(22)21-12-10-16(11-13-21)14-15-6-2-1-3-7-15/h1-9,16H,10-14H2 D01MLQ DRUGINKE LEVTWCPGXIVKEH-UHFFFAOYSA-N D01MLQ DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC=CC=C3F D01MLQ DRUGTYPE Small molecular drug D01MLQ HIGHSTAT Investigative D01MMB DRUG__ID D01MMB D01MMB DRUGCLAS Approved Drug(s) D01MMB HIGHSTAT Approved D01MMG DRUG__ID D01MMG D01MMG DRUGCLAS Investigative Drug(s) D01MMG DRUGCOMP Bolder BioTechnology Inc D01MMG HIGHSTAT Investigative D01MML DRUG__ID D01MML D01MML DRUGCLAS Approved Drug(s) D01MML DRUGCOMP Millennium Pharmaceuticals D01MML DRUGINCH 1S/C20H23BCl2N2O9/c1-10(2)5-14(21-33-17(29)8-20(34-21,19(31)32)7-16(27)28)25-15(26)9-24-18(30)12-6-11(22)3-4-13(12)23/h3-4,6,10,14H,5,7-9H2,1-2H3,(H,24,30)(H,25,26)(H,27,28)(H,31,32)/t14-,20?/m0/s1 D01MML DRUGINKE YTXSYWAKVMZICI-PVCZSOGJSA-N D01MML DRUGSMIL B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl D01MML DRUGTYPE Small molecular drug D01MML HIGHSTAT Approved D01MMM DRUG__ID D01MMM D01MMM DRUGCLAS Investigative Drug(s) D01MMM DRUGINCH 1S/C25H30O7/c1-14(2)6-7-16-8-9-19(27)18(12-26)22(16)24(30)17-10-15(3)11-20(23(17)29)32-13-21(28)25(4,5)31/h6,8-12,21,27-29,31H,7,13H2,1-5H3 D01MMM DRUGINKE AXMCRMUBMNEKLN-UHFFFAOYSA-N D01MMM DRUGSMIL CC1=CC(=C(C(=C1)OCC(C(C)(C)O)O)O)C(=O)C2=C(C=CC(=C2C=O)O)CC=C(C)C D01MMM DRUGTYPE Small molecular drug D01MMM HIGHSTAT Investigative D01MMT DRUG__ID D01MMT D01MMT DRUGCLAS Patented Agent(s) D01MMT DRUGCOMP MSN LABORATORIES LIMITED THIRUMALAI RAJAN, Srinivasan ESWARAIAH, Sajja VENKAT REDDY, Ghojala D01MMT DRUGINCH 1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15?,17?,18?/m1/s1 D01MMT DRUGINKE QGJUIPDUBHWZPV-UGTKGIOISA-N D01MMT DRUGSMIL C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N D01MMT DRUGTYPE Small molecular drug D01MMT HIGHSTAT Patented D01MMU DRUG__ID D01MMU D01MMU DRUGCLAS Investigative Drug(s) D01MMU DRUGINCH 1S/C16H15NO2/c1-17-13-5-3-11(4-6-13)16-10-12-9-14(18-2)7-8-15(12)19-16/h3-10,17H,1-2H3 D01MMU DRUGINKE UPVZXZTUTQNNFR-UHFFFAOYSA-N D01MMU DRUGSMIL CNC1=CC=C(C=C1)C2=CC3=C(O2)C=CC(=C3)OC D01MMU DRUGTYPE Small molecular drug D01MMU HIGHSTAT Investigative D01MND DRUG__ID D01MND D01MND DRUGCLAS Investigative Drug(s) D01MND DRUGCOMP James Cook University of North Queensland D01MND HIGHSTAT Investigative D01MNK DRUG__ID D01MNK D01MNK DRUGCLAS Investigative Drug(s) D01MNK DRUGCOMP Imperial College London D01MNK DRUGINCH 1S/C20H27N5O3/c1-13(2)15-10-22-25-19(21-9-14-6-4-3-5-7-14)8-18(24-20(15)25)23-16(11-26)17(28)12-27/h3-8,10,13,16-17,21,26-28H,9,11-12H2,1-2H3,(H,23,24)/t16-,17+/m0/s1 D01MNK DRUGINKE KRIWIRSMQRQYJG-DLBZAZTESA-N D01MNK DRUGSMIL CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC(CO)C(CO)O D01MNK DRUGTYPE Small molecular drug D01MNK HIGHSTAT Investigative D01MNV DRUG__ID D01MNV D01MNV DRUGCLAS Discontinued Drug(s) D01MNV DRUGCOMP Ohio State University D01MNV HIGHSTAT Discontinued in Phase 1 D01MOQ DRUG__ID D01MOQ D01MOQ DRUGCLAS Investigative Drug(s) D01MOQ DRUGINCH 1S/C12H14N2O/c1-3-4-9-7-11(15)10-6-5-8(2)13-12(10)14-9/h5-7H,3-4H2,1-2H3,(H,13,14,15) D01MOQ DRUGINKE JAFFZYFREVCDTP-UHFFFAOYSA-N D01MOQ DRUGSMIL CCCC1=CC(=O)C2=C(N1)N=C(C=C2)C D01MOQ DRUGTYPE Small molecular drug D01MOQ HIGHSTAT Investigative D01MPC DRUG__ID D01MPC D01MPC DRUGCLAS Patented Agent(s) D01MPC DRUGINCH 1S/C24H30FN3O5S/c1-3-24(4-2,23(32)28-12-6-5-7-20(29)30)14-16-9-11-19(34-16)22(31)33-18-10-8-15(21(26)27)13-17(18)25/h8-11,13H,3-7,12,14H2,1-2H3,(H3,26,27)(H,28,32)(H,29,30) D01MPC DRUGINKE JBHHRVQRHSBNTN-UHFFFAOYSA-N D01MPC DRUGSMIL CCC(CC)(CC1=CC=C(S1)C(=O)OC2=C(C=C(C=C2)C(=N)N)F)C(=O)NCCCCC(=O)O D01MPC DRUGTYPE Small molecular drug D01MPC HIGHSTAT Patented D01MPE DRUG__ID D01MPE D01MPE DRUGCLAS Clinical Trial Drug(s) D01MPE DRUGINCH 1S/C3H6N4/c1-2-5-3(4)7-6-2/h1H3,(H3,4,5,6,7) D01MPE DRUGINKE FJRZOOICEHBAED-UHFFFAOYSA-N D01MPE DRUGSMIL CC1=NC(=NN1)N D01MPE HIGHSTAT Phase 2 D01MPK DRUG__ID D01MPK D01MPK DRUGCLAS Investigative Drug(s) D01MPK DRUGINCH 1S/C11H12N2O2/c1-13-10(14)6-9(11(13)15)7-2-4-8(12)5-3-7/h2-5,9H,6,12H2,1H3 D01MPK DRUGINKE QMQMEAAIWVAXHW-UHFFFAOYSA-N D01MPK DRUGSMIL CN1C(=O)CC(C1=O)C2=CC=C(C=C2)N D01MPK DRUGTYPE Small molecular drug D01MPK HIGHSTAT Investigative D01MPX DRUG__ID D01MPX D01MPX DRUGCLAS Investigative Drug(s) D01MPX DRUGCOMP Prolysis Ltd D01MPX DRUGINCH 1S/C14H8ClF2N3O2S/c15-6-3-8-14(19-4-6)23-10(20-8)5-22-9-2-1-7(16)11(12(9)17)13(18)21/h1-4H,5H2,(H2,18,21) D01MPX DRUGINKE INYJNSBDHOVLAH-UHFFFAOYSA-N D01MPX DRUGSMIL C1=CC(=C(C(=C1OCC2=NC3=C(S2)N=CC(=C3)Cl)F)C(=O)N)F D01MPX DRUGTYPE Small molecular drug D01MPX HIGHSTAT Investigative D01MQH DRUG__ID D01MQH D01MQH DRUGCLAS Discontinued Drug(s) D01MQH DRUGCOMP BioTie Therapies Corp D01MQH DRUGTYPE Monoclonal antibody D01MQH HIGHSTAT Discontinued in Phase 1/2 D01MQP DRUG__ID D01MQP D01MQP DRUGCLAS Clinical Trial Drug(s) D01MQP DRUGCOMP Inovio D01MQP HIGHSTAT Phase 1/2 D01MSB DRUG__ID D01MSB D01MSB DRUGCLAS Drugs in Phase 2 Trial D01MSB DRUGTYPE Combination drug D01MSB HIGHSTAT Phase 2/3 Trial D01MSB THERCLAS Antiviral Agents D01MSJ DRUG__ID D01MSJ D01MSJ DRUGCLAS Discontinued Drug(s) D01MSJ DRUGCOMP Inhibitex D01MSJ HIGHSTAT Discontinued in Phase 3 D01MSM DRUG__ID D01MSM D01MSM DRUGCLAS Investigative Drug(s) D01MSM DRUGINCH 1S/C10H6N2O5/c13-8-4-9(14)10(15)11-7-2-1-5(12(16)17)3-6(7)8/h1-4,13H,(H,11,14,15) D01MSM DRUGINKE QIUGYFFOPLNZSP-UHFFFAOYSA-N D01MSM DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])C(=CC(=O)C(=O)N2)O D01MSM DRUGTYPE Small molecular drug D01MSM HIGHSTAT Investigative D01MSP DRUG__ID D01MSP D01MSP DRUGCLAS Patented Agent(s) D01MSP DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D01MSP DRUGINCH 1S/C35H34N2O7/c1-22-13-28(18-37-30(19-38)35(39)40)33(43-20-25-6-3-5-24(14-25)17-36)16-32(22)44-21-27-7-4-8-29(23(27)2)26-9-10-31-34(15-26)42-12-11-41-31/h3-10,13-16,30,37-38H,11-12,18-21H2,1-2H3,(H,39,40) D01MSP DRUGINKE UWNXGZKSIKQKAH-UHFFFAOYSA-N D01MSP DRUGSMIL CC1=CC(=C(C=C1OCC2=C(C(=CC=C2)C3=CC4=C(C=C3)OCCO4)C)OCC5=CC(=CC=C5)C#N)CNC(CO)C(=O)O D01MSP DRUGTYPE Small molecule immunotherapy D01MSP HIGHSTAT Patented D01MSZ DRUG__ID D01MSZ D01MSZ DRUGCLAS Investigative Drug(s) D01MSZ DRUGCOMP Romark Laboratories LC D01MSZ DRUGINCH 1S/C13H11ClN2O3S/c1-7-3-4-8(12(18)19-2)9(5-7)11(17)16-13-15-10(14)6-20-13/h3-6H,1-2H3,(H,15,16,17) D01MSZ DRUGINKE YVTXSJMDCBNRHS-UHFFFAOYSA-N D01MSZ DRUGSMIL CC1=CC(=C(C=C1)C(=O)OC)C(=O)NC2=NC(=CS2)Cl D01MSZ HIGHSTAT Investigative D01MTY DRUG__ID D01MTY D01MTY DRUGCLAS Drugs in Phase 2 Trial D01MTY DRUGTYPE Combination drug D01MTY HIGHSTAT Phase 2/3 Trial D01MTY THERCLAS Antiviral Agents D01MUN DRUG__ID D01MUN D01MUN DRUGCLAS Investigative Drug(s) D01MUN DRUGINCH 1S/C13H11N3/c14-10-5-7-11(8-6-10)16-9-15-12-3-1-2-4-13(12)16/h1-9H,14H2 D01MUN DRUGINKE DWYMPMWWYZEKLQ-UHFFFAOYSA-N D01MUN DRUGSMIL C1=CC=C2C(=C1)N=CN2C3=CC=C(C=C3)N D01MUN DRUGTYPE Small molecular drug D01MUN HIGHSTAT Investigative D01MUR DRUG__ID D01MUR D01MUR DRUGCLAS Approved Drug(s) D01MUR DRUGCOMP Alcon Laboratories D01MUR DRUGINCH 1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1 D01MUR DRUGINKE HCRKCZRJWPKOAR-JTQLQIEISA-N D01MUR DRUGSMIL CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC D01MUR DRUGTYPE Small molecular drug D01MUR HIGHSTAT Approved D01MUR THERCLAS Antiglaucomic Agents D01MUU DRUG__ID D01MUU D01MUU DRUGCLAS Clinical Trial Drug(s) D01MUU DRUGINCH 1S/C22H31N5O4/c23-20(24)16-8-6-14(7-9-16)12-26-21(30)17-10-11-27(17)22(31)19(25-13-18(28)29)15-4-2-1-3-5-15/h6-9,15,17,19,25H,1-5,10-13H2,(H3,23,24)(H,26,30)(H,28,29)/t17-,19+/m0/s1 D01MUU DRUGINKE DKWNMCUOEDMMIN-PKOBYXMFSA-N D01MUU DRUGSMIL C1CCC(CC1)C(C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=N)N)NCC(=O)O D01MUU DRUGTYPE Small molecular drug D01MUU HIGHSTAT Phase 3 D01MUV DRUG__ID D01MUV D01MUV DRUGCLAS Investigative Drug(s) D01MUV DRUGINCH 1S/C22H29NO/c1-21(2,3)22(24)14-16-23(17-15-22)20(18-10-6-4-7-11-18)19-12-8-5-9-13-19/h4-13,20,24H,14-17H2,1-3H3 D01MUV DRUGINKE CSHMHUZYEYOBPL-UHFFFAOYSA-N D01MUV DRUGSMIL CC(C)(C)C1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)O D01MUV DRUGTYPE Small molecular drug D01MUV HIGHSTAT Investigative D01MUW DRUG__ID D01MUW D01MUW DRUGCLAS Clinical Trial Drug(s) D01MUW DRUGCOMP Burzynski research institute D01MUW HIGHSTAT Phase 2 D01MVK DRUG__ID D01MVK D01MVK DRUGCLAS Discontinued Drug(s) D01MVK DRUGCOMP Calydon Inc; Cell Genesys D01MVK HIGHSTAT Discontinued in Phase 2 D01MVO DRUG__ID D01MVO D01MVO DRUGCLAS Clinical Trial Drug(s) D01MVO DRUGCOMP ArGentis Pharmaceuticals D01MVO HIGHSTAT Phase 2 D01MVX DRUG__ID D01MVX D01MVX DRUGCLAS Investigative Drug(s) D01MVX DRUGINCH 1S/C30H36N4/c1(3-11-20-31-27-19-22-32-26-16-8-5-13-23(26)27)2-4-12-21-33-30-24-14-6-9-17-28(24)34-29-18-10-7-15-25(29)30/h5-6,8-9,13-14,16-17,19,22H,1-4,7,10-12,15,18,20-21H2,(H,31,32)(H,33,34) D01MVX DRUGINKE UNVOAAWEEGAXTN-UHFFFAOYSA-N D01MVX DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCCCCCCNC4=CC=NC5=CC=CC=C54 D01MVX DRUGTYPE Small molecular drug D01MVX HIGHSTAT Investigative D01MWF DRUG__ID D01MWF D01MWF DRUGCLAS Investigative Drug(s) D01MWF DRUGCOMP GTx Inc D01MWF HIGHSTAT Investigative D01MWX DRUG__ID D01MWX D01MWX DRUGCLAS Investigative Drug(s) D01MWX DRUGINCH 1S/C22H18N2O4/c25-19-15-7-5-13(23-21(27)11-1-2-11)9-17(15)20(26)18-10-14(6-8-16(18)19)24-22(28)12-3-4-12/h5-12H,1-4H2,(H,23,27)(H,24,28) D01MWX DRUGINKE SCYQIQINYUMLPD-UHFFFAOYSA-N D01MWX DRUGSMIL C1CC1C(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)C5CC5 D01MWX DRUGTYPE Small molecular drug D01MWX HIGHSTAT Investigative D01MXG DRUG__ID D01MXG D01MXG DRUGCLAS Investigative Drug(s) D01MXG DRUGCOMP Addex Pharmaceuticals SA D01MXG HIGHSTAT Investigative D01MXK DRUG__ID D01MXK D01MXK DRUGCLAS Clinical Trial Drug(s) D01MXK DRUGCOMP SantoSolve AS D01MXK DRUGINCH 1S/C26H31N5O/c1-17-6-7-25-22(12-17)19(15-29-25)16-31-10-8-20(9-11-31)30-26(32)23(27)13-18-14-28-24-5-3-2-4-21(18)24/h2-7,12,14-15,20,23,28-29H,8-11,13,16,27H2,1H3,(H,30,32)/t23-/m0/s1 D01MXK DRUGINKE HAGXHOXTZOWANA-QHCPKHFHSA-N D01MXK DRUGSMIL CC1=CC2=C(C=C1)NC=C2CN3CCC(CC3)NC(=O)C(CC4=CNC5=CC=CC=C54)N D01MXK DRUGTYPE Small molecular drug D01MXK HIGHSTAT Phase 3 D01MXN DRUG__ID D01MXN D01MXN DRUGCLAS Investigative Drug(s) D01MXN DRUGINCH 1S/C21H18N2O3/c24-19-13-20(23-8-10-25-11-9-23)26-21-16(2-1-3-17(19)21)14-4-5-18-15(12-14)6-7-22-18/h1-7,12-13,22H,8-11H2 D01MXN DRUGINKE LXMAOXUZAUDVCG-UHFFFAOYSA-N D01MXN DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC5=C(C=C4)NC=C5 D01MXN DRUGTYPE Small molecular drug D01MXN HIGHSTAT Investigative D01MXV DRUG__ID D01MXV D01MXV DRUGCLAS Discontinued Drug(s) D01MXV DRUGINCH 1S/C10H15NO2/c1-2-11-7-10(13)8-4-3-5-9(12)6-8/h3-6,10-13H,2,7H2,1H3 D01MXV DRUGINKE SQVIAVUSQAWMKL-UHFFFAOYSA-N D01MXV DRUGSMIL CCNCC(C1=CC(=CC=C1)O)O D01MXV DRUGTYPE Small molecular drug D01MXV HIGHSTAT Withdrawn from market D01MYJ DRUG__ID D01MYJ D01MYJ DRUGCLAS Clinical Trial Drug(s) D01MYJ DRUGCOMP Chugai Pharmaceutical Co Ltd D01MYJ HIGHSTAT Phase 1/2 D01MYN DRUG__ID D01MYN D01MYN DRUGCLAS Discontinued Drug(s) D01MYN DRUGCOMP Eli Lilly & Co D01MYN HIGHSTAT Discontinued in Phase 2 D01MYO DRUG__ID D01MYO D01MYO DRUGCLAS Investigative Drug(s) D01MYO DRUGINCH 1S/C32H36N2O3/c1-33(2)29-19-17-27(18-20-29)26-15-12-25(13-16-26)23-34(32(36)28-9-5-4-6-10-28)30-11-7-8-24(22-30)14-21-31(35)37-3/h7-8,11-22,28H,4-6,9-10,23H2,1-3H3/b21-14+ D01MYO DRUGINKE VLQTUNDJHLEFEQ-KGENOOAVSA-N D01MYO DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC=C(C=C2)CN(C3=CC=CC(=C3)C=CC(=O)OC)C(=O)C4CCCCC4 D01MYO DRUGTYPE Small molecular drug D01MYO HIGHSTAT Investigative D01MZI DRUG__ID D01MZI D01MZI COMPCLAS Pyrazino[2,1-a]isoquinolin derivatives D01MZI DRUGCLAS Patented Agent(s) D01MZI DRUGCOMP China Pharmaceutical University D01MZI DRUGTYPE Small molecular drug D01MZI HIGHSTAT Patented D01MZJ DRUG__ID D01MZJ D01MZJ DRUGCLAS Clinical Trial Drug(s) D01MZJ DRUGCOMP Genta D01MZJ DRUGTYPE Antisense drug D01MZJ HIGHSTAT Phase 2 D01MZJ THERCLAS Anticancer Agents D01MZT DRUG__ID D01MZT D01MZT DRUGCLAS Preclinical Drug(s) D01MZT HIGHSTAT Preclinical D01NAM DRUG__ID D01NAM D01NAM DRUGCLAS Discontinued Drug(s) D01NAM DRUGCOMP Elbion AG; 4AZA Bioscience D01NAM DRUGINCH 1S/C14H16ClN3O/c15-11-4-6-12(7-5-11)18-10-13(16-14(18)19)17-8-2-1-3-9-17/h4-7H,1-3,8-10H2 D01NAM DRUGINKE YGXIELIREXEJQN-UHFFFAOYSA-N D01NAM DRUGSMIL C1CCN(CC1)C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl D01NAM DRUGTYPE Small molecular drug D01NAM HIGHSTAT Discontinued in Phase 2 D01NAM THERCLAS Psychiatric D01NAP DRUG__ID D01NAP D01NAP DRUGCLAS Clinical Trial Drug(s) D01NAP DRUGCOMP Merrimack Pharmaceuticals D01NAP HIGHSTAT Phase 1 D01NBF DRUG__ID D01NBF D01NBF DRUGCLAS Investigative Drug(s) D01NBF DRUGINCH 1S/C28H38O5/c1-18(17-26(30)31)5-12-22-19(2)6-14-24-23(22)13-15-25(28(24,3)4)33-27(32)16-9-20-7-10-21(29)11-8-20/h6-11,16,18,22-25,29H,5,12-15,17H2,1-4H3,(H,30,31)/b16-9+/t18-,22-,23+,24+,25-/m0/s1 D01NBF DRUGINKE ZSKLTPLHCIUPKA-LOWUFNJHSA-N D01NBF DRUGSMIL CC1=CCC2C(C1CCC(C)CC(=O)O)CCC(C2(C)C)OC(=O)C=CC3=CC=C(C=C3)O D01NBF DRUGTYPE Small molecular drug D01NBF HIGHSTAT Investigative D01NBK DRUG__ID D01NBK D01NBK DRUGCLAS Investigative Drug(s) D01NBK DRUGINCH 1S/C8H13N2O5P/c1-5-8(11)7(2-9)6(3-10-5)4-15-16(12,13)14/h3,11H,2,4,9H2,1H3,(H2,12,13,14) D01NBK DRUGINKE ZMJGSOSNSPKHNH-UHFFFAOYSA-N D01NBK DRUGSMIL CC1=NC=C(C(=C1O)CN)COP(=O)(O)O D01NBK DRUGTYPE Small molecular drug D01NBK HIGHSTAT Investigative D01NBW DRUG__ID D01NBW D01NBW DRUGCLAS Patented Agent(s) D01NBW DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D01NBW DRUGINCH 1S/C18H20N4/c1-3-7-13(8-4-1)16-21-17-15(11-12-19-17)18(22-16)20-14-9-5-2-6-10-14/h1,3-4,7-8,11-12,14H,2,5-6,9-10H2,(H2,19,20,21,22) D01NBW DRUGINKE QWRCXRFAIZINSM-UHFFFAOYSA-N D01NBW DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2C=CN3)C4=CC=CC=C4 D01NBW DRUGTYPE Small molecular drug D01NBW HIGHSTAT Patented D01NBX DRUG__ID D01NBX D01NBX DRUGCLAS Discontinued Drug(s) D01NBX DRUGCOMP Sankyo Co Ltd D01NBX DRUGINCH 1S/C18H20N2O2.ClH/c19-12-8-11-17-13(5-2-6-14(17)21)20-15(22)7-9-3-1-4-10(12)16(9)18(11)20;/h2,5-6,9-10,12,16,21H,1,3-4,7-8,19H2;1H/t9-,10+,12-,16+;/m1./s1 D01NBX DRUGINKE MTSROZWZVOQAQW-PECACPRSSA-N D01NBX DRUGSMIL C1CC2CC(=O)N3C4=C(C5=C3C2C(C1)C(C5)N)C(=CC=C4)O.Cl D01NBX DRUGTYPE Small molecular drug D01NBX HIGHSTAT Terminated D01NCC DRUG__ID D01NCC D01NCC DRUGCLAS Investigative Drug(s) D01NCC DRUGCOMP Amunix Inc D01NCC HIGHSTAT Investigative D01NCH DRUG__ID D01NCH D01NCH DRUGCLAS Clinical Trial Drug(s) D01NCH DRUGCOMP Hoechst AG D01NCH DRUGINCH 1S/C13H19N3O4/c1-19-7-5-15-12(17)10-3-4-14-11(9-10)13(18)16-6-8-20-2/h3-4,9H,5-8H2,1-2H3,(H,15,17)(H,16,18) D01NCH DRUGINKE JUCNGMPTCXPMNB-UHFFFAOYSA-N D01NCH DRUGSMIL COCCNC(=O)C1=CC(=NC=C1)C(=O)NCCOC D01NCH DRUGTYPE Small molecular drug D01NCH HIGHSTAT Phase 2 D01NCJ DRUG__ID D01NCJ D01NCJ DRUGCLAS Patented Agent(s) D01NCJ DRUGCOMP ONYX THERAPEUTICS, INC D01NCJ DRUGTYPE Small molecular drug D01NCJ HIGHSTAT Patented D01NCS DRUG__ID D01NCS D01NCS DRUGCLAS Clinical Trial Drug(s) D01NCS DRUGCOMP Toltec Pharmaceuticals Llc D01NCS HIGHSTAT Phase 2 D01NCW DRUG__ID D01NCW D01NCW DRUGCLAS Investigative Drug(s) D01NCW DRUGINCH 1S/C34H48N4O7S/c1-7-24(4)30(38-34(42)45-22-27-16-12-9-13-17-27)33(41)37-29(21-26-14-10-8-11-15-26)32(40)35-25(5)31(39)36-28(20-23(2)3)18-19-46(6,43)44/h8-19,23-25,28-30H,7,20-22H2,1-6H3,(H,35,40)(H,36,39)(H,37,41)(H,38,42)/b19-18+/t24-,25-,28+,29-,30-/m0/s1 D01NCW DRUGINKE NDQAQUAWHJQVGE-HZPWIFGKSA-N D01NCW DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC2=CC=CC=C2 D01NCW DRUGTYPE Small molecular drug D01NCW HIGHSTAT Investigative D01NDE DRUG__ID D01NDE D01NDE DRUGCLAS Investigative Drug(s) D01NDE DRUGINCH 1S/C15H27F3OS/c1-2-3-4-5-6-7-8-9-10-11-12-20-13-14(19)15(16,17)18/h2-13H2,1H3 D01NDE DRUGINKE NACMLRDTSWENRZ-UHFFFAOYSA-N D01NDE DRUGSMIL CCCCCCCCCCCCSCC(=O)C(F)(F)F D01NDE DRUGTYPE Small molecular drug D01NDE HIGHSTAT Investigative D01NDF DRUG__ID D01NDF D01NDF DRUGCLAS Clinical Trial Drug(s) D01NDF DRUGCOMP Avineuro Pharmaceuticals D01NDF HIGHSTAT Phase 2 D01NDN DRUG__ID D01NDN D01NDN DRUGCLAS Investigative Drug(s) D01NDN DRUGCOMP Shenogen Pharma Group Ltd D01NDN HIGHSTAT Investigative D01NEC DRUG__ID D01NEC D01NEC DRUGCLAS Clinical Trial Drug(s) D01NEC DRUGCOMP GlaxoSmithKline D01NEC DRUGINCH 1S/C18H16Cl2F2N4O2/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1 D01NEC DRUGINKE AXTAPYRUEKNRBA-JTQLQIEISA-N D01NEC DRUGSMIL CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl D01NEC DRUGTYPE Small molecular drug D01NEC HIGHSTAT Phase 2 D01NEZ DRUG__ID D01NEZ D01NEZ DRUGCLAS Investigative Drug(s) D01NEZ DRUGINCH 1S/C26H43ClN6O10S/c1-13(2)21(27)22(31-24(37)20(42-3)12-43-44(39,40)41)25(38)33-16-10-19(35)18(34)9-15(16)8-17(33)23(36)30-6-4-14-5-7-32(11-14)26(28)29/h5,13,15-22,34-35H,4,6-12H2,1-3H3,(H6,28,29,30,31,36,37,39,40,41)/t15-,16+,17+,18+,19+,20-,21-,22-/m1/s1 D01NEZ DRUGINKE DLWZHBAKINZMIF-WNZJUFNWSA-N D01NEZ DRUGSMIL CC(C)C(C(C(=O)N1C2CC(C(CC2CC1C(=O)NCCC3=CC[N+](=C(N)N)C3)O)O)NC(=O)C(COS(=O)(=O)[O-])OC)Cl D01NEZ DRUGTYPE Small molecular drug D01NEZ HIGHSTAT Investigative D01NFH DRUG__ID D01NFH D01NFH DRUGCLAS Investigative Drug(s) D01NFH DRUGINCH 1S/C15H27N3O2/c1-2-14(19)18-10-8-13(9-11-18)17-15(20)16-12-6-4-3-5-7-12/h12-13H,2-11H2,1H3,(H2,16,17,20) D01NFH DRUGINKE VZLSZVQSSZTJPS-UHFFFAOYSA-N D01NFH DRUGSMIL CCC(=O)N1CCC(CC1)NC(=O)NC2CCCCC2 D01NFH DRUGTYPE Small molecular drug D01NFH HIGHSTAT Investigative D01NFK DRUG__ID D01NFK D01NFK DRUGCLAS Investigative Drug(s) D01NFK DRUGCOMP FivePrime Therapeutics Inc D01NFK HIGHSTAT Investigative D01NGB DRUG__ID D01NGB D01NGB DRUGCLAS Investigative Drug(s) D01NGB DRUGCOMP Alligator Bioscience AB D01NGB HIGHSTAT Investigative D01NGF DRUG__ID D01NGF D01NGF DRUGCLAS Investigative Drug(s) D01NGF DRUGCOMP BIOO Therapeutics D01NGF HIGHSTAT Investigative D01NGH DRUG__ID D01NGH D01NGH DRUGCLAS Clinical Trial Drug(s) D01NGH DRUGCOMP St Jude Children's Research Hospital D01NGH DRUGTYPE Vaccine D01NGH HIGHSTAT Phase 1 D01NGT DRUG__ID D01NGT D01NGT DRUGCLAS Discontinued Drug(s) D01NGT DRUGCOMP Roche Holding AG D01NGT HIGHSTAT Discontinued in Phase 1 D01NHH DRUG__ID D01NHH D01NHH DRUGCLAS Investigative Drug(s) D01NHH DRUGINCH 1S/C22H21N3/c1-22(2,3)21-24-19-17(15-10-6-4-7-11-15)14-18(23-20(19)25-21)16-12-8-5-9-13-16/h4-14H,1-3H3,(H,23,24,25) D01NHH DRUGINKE LYZUCUIUVUYBJL-UHFFFAOYSA-N D01NHH DRUGSMIL CC(C)(C)C1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D01NHH DRUGTYPE Small molecular drug D01NHH HIGHSTAT Investigative D01NID DRUG__ID D01NID D01NID DRUGCLAS Investigative Drug(s) D01NID DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)39-60-72(99)88-65(46(3)92)75(102)86-61(38-50-23-13-8-14-24-50)73(100)89-66(47(4)93)76(103)90(5)64(42-91)74(101)87-63(77(104)105)44-107-106-43-56(79)67(94)81-57(27-17-18-34-78)68(95)82-58(36-48-19-9-6-10-20-48)69(96)83-59(37-49-21-11-7-12-22-49)70(97)85-62(71(98)84-60)40-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,94)(H,82,95)(H,83,96)(H,84,98)(H,85,97)(H,86,102)(H,87,101)(H,88,99)(H,89,100)(H,104,105)/t46-,47-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1 D01NID DRUGINKE XJZZHUHCSZMQGG-PCKPOTSRSA-N D01NID DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C)C(C)O)CC7=CC=CC=C7)C(C)O D01NID HIGHSTAT Investigative D01NIJ DRUG__ID D01NIJ D01NIJ DRUGCLAS Investigative Drug(s) D01NIJ HIGHSTAT Investigative D01NIR DRUG__ID D01NIR D01NIR DRUGCLAS Clinical Trial Drug(s) D01NIR DRUGCOMP Il-Yang Pharmaceutical Co D01NIR DRUGINCH 1S/C27H21F3N8O/c1-16-3-4-18(9-23(16)37-26-33-6-5-22(36-26)24-13-31-7-8-32-24)25(39)35-20-10-19(27(28,29)30)11-21(12-20)38-14-17(2)34-15-38/h3-15H,1-2H3,(H,35,39)(H,33,36,37) D01NIR DRUGINKE DUPWHXBITIZIKZ-UHFFFAOYSA-N D01NIR DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=NC=CN=C5 D01NIR DRUGTYPE Small molecular drug D01NIR HIGHSTAT Phase 3 D01NJE DRUG__ID D01NJE D01NJE DRUGCLAS Investigative Drug(s) D01NJE DRUGTYPE Aptamer D01NJE HIGHSTAT Investigative D01NJI DRUG__ID D01NJI D01NJI DRUGCLAS Approved Drug(s) D01NJI DRUGINCH 1S/C17H23N3O.C4H4O4/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15;5-3(6)1-2-4(7)8/h4-11H,12-14H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1- D01NJI DRUGINKE JXYWFNAQESKDNC-BTJKTKAUSA-N D01NJI DRUGSMIL CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O D01NJI DRUGTYPE Small molecular drug D01NJI HIGHSTAT Approved D01NJI THERCLAS Antiasthmatic Agents D01NJT DRUG__ID D01NJT D01NJT DRUGCLAS Discontinued Drug(s) D01NJT DRUGCOMP Pfizer D01NJT DRUGINCH 1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1 D01NJT DRUGINKE CBQGYUDMJHNJBX-OALUTQOASA-N D01NJT DRUGSMIL CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3 D01NJT DRUGTYPE Small molecular drug D01NJT HIGHSTAT Discontinued in Phase 2 D01NJW DRUG__ID D01NJW D01NJW DRUGCLAS Patented Agent(s) D01NJW DRUGINCH 1S/C11H14O2S/c12-9-1-2-10(11(13)7-9)8-3-5-14-6-4-8/h1-2,7-8,12-13H,3-6H2 D01NJW DRUGINKE OLWFCALCIRMVMM-UHFFFAOYSA-N D01NJW DRUGSMIL C1CSCCC1C2=C(C=C(C=C2)O)O D01NJW DRUGTYPE Small molecular drug D01NJW HIGHSTAT Patented D01NKF DRUG__ID D01NKF D01NKF DRUGCLAS Investigative Drug(s) D01NKF DRUGCOMP University of Tennessee D01NKF HIGHSTAT Investigative D01NKS DRUG__ID D01NKS D01NKS DRUGCLAS Drugs in Phase 2 Trial D01NKS DRUGTYPE Combination drug D01NKS HIGHSTAT Phase 2/3 Trial D01NKS THERCLAS Antiviral Agents D01NKW DRUG__ID D01NKW D01NKW DRUGCLAS Clinical Trial Drug(s) D01NKW DRUGCOMP Pharma Two B Ltd D01NKW HIGHSTAT Phase 3 D01NLB DRUG__ID D01NLB D01NLB DRUGCLAS Approved Drug(s) D01NLB DRUGCOMP Neurox/Parke Davis D01NLB DRUGINCH 1S/C102H172N36O32S7/c1-50(2)34-63-91(161)127-62(26-33-171-5)90(160)129-64(35-53-22-24-54(143)25-23-53)92(162)130-65(36-78(148)149)93(163)135-72-48-175-173-45-69(80(108)150)133-86(156)58(18-8-12-29-105)121-76(146)39-117-85(155)66(41-139)131-88(158)61(21-15-32-114-102(111)112)126-96(166)70-46-176-177-47-71(97(167)132-68(43-141)95(165)125-60(87(157)128-63)20-14-31-113-101(109)110)134-89(159)59(19-9-13-30-106)123-81(151)51(3)119-74(144)37-115-83(153)56(16-6-10-27-103)120-75(145)38-116-84(154)57(17-7-11-28-104)124-82(152)55(107)44-172-174-49-73(137-98(72)168)99(169)138-79(52(4)142)100(170)118-40-77(147)122-67(42-140)94(164)136-70/h22-25,50-52,55-73,79,139-143H,6-21,26-49,103-107H2,1-5H3,(H2,108,150)(H,115,153)(H,116,154)(H,117,155)(H,118,170)(H,119,144)(H,120,145)(H,121,146)(H,122,147)(H,123,151)(H,124,152)(H,125,165)(H,126,166)(H,127,161)(H,128,157)(H,129,160)(H,130,162)(H,131,158)(H,132,167)(H,133,156)(H,134,159)(H,135,163)(H,136,164)(H,137,168)(H,138,169)(H,148,149)(H4,109,110,113)(H4,111,112,114)/t51-,52+,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,79-/m0/s1 D01NLB DRUGINKE BPKIMPVREBSLAJ-QTBYCLKRSA-N D01NLB DRUGSMIL CC1C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)NC(C(=O)NCC(=O)NC(C(=O)N3)CO)C(C)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN D01NLB DRUGTYPE Small molecular drug D01NLB HIGHSTAT Approved D01NLB THERCLAS Analgesics D01NMN DRUG__ID D01NMN D01NMN DRUGCLAS Discontinued Drug(s) D01NMN DRUGINCH 1S/C11H16N2O2/c1-8-6-11(7-14)9(2)13(8)5-4-12-10(3)15/h6-7H,4-5H2,1-3H3,(H,12,15) D01NMN DRUGINKE ZUQSGZULKDDMEW-UHFFFAOYSA-N D01NMN DRUGSMIL CC1=CC(=C(N1CCNC(=O)C)C)C=O D01NMN DRUGTYPE Small molecular drug D01NMN HIGHSTAT Discontinued in Phase 2 D01NNL DRUG__ID D01NNL D01NNL DRUGCLAS Discontinued Drug(s) D01NNL DRUGCOMP Inflazyme Pharmaceuticals D01NNL DRUGINCH 1S/HO3P/c1-4(2)3/h(H,1,2,3)/p-1 D01NNL DRUGINKE UEZVMMHDMIWARA-UHFFFAOYSA-M D01NNL DRUGSMIL [O-]P(=O)=O D01NNL DRUGTYPE Small molecular drug D01NNL HIGHSTAT Terminated D01NOI DRUG__ID D01NOI D01NOI DRUGCLAS Investigative Drug(s) D01NOI DRUGCOMP Innate Pharma SA D01NOI HIGHSTAT Investigative D01NOZ DRUG__ID D01NOZ D01NOZ DRUGCLAS Investigative Drug(s) D01NOZ DRUGINCH 1S/C22H26F3N5O2/c1-28(2)11-12-29(3)21-27-18-10-7-16(13-19(18)30(21)4)26-20(31)14-32-17-8-5-15(6-9-17)22(23,24)25/h5-10,13H,11-12,14H2,1-4H3,(H,26,31) D01NOZ DRUGINKE KMPCTCXLXOJTGD-UHFFFAOYSA-N D01NOZ DRUGSMIL CN1C2=C(C=CC(=C2)NC(=O)COC3=CC=C(C=C3)C(F)(F)F)N=C1N(C)CCN(C)C D01NOZ DRUGTYPE Small molecular drug D01NOZ HIGHSTAT Investigative D01NPA DRUG__ID D01NPA D01NPA DRUGCLAS Investigative Drug(s) D01NPA DRUGINCH 1S/C50H80N14O14S/c1-26(2)18-34(45(73)58-32(42(53)70)15-17-79-6)57-38(67)23-55-49(77)40(27(3)4)63-47(75)35(19-29-12-8-7-9-13-29)60-48(76)37(24-65)62-46(74)36(21-39(68)69)61-50(78)41(28(5)66)64-44(72)33(14-10-11-16-51)59-43(71)31(52)20-30-22-54-25-56-30/h7-9,12-13,22,25-28,31-37,40-41,65-66H,10-11,14-21,23-24,51-52H2,1-6H3,(H2,53,70)(H,54,56)(H,55,77)(H,57,67)(H,58,73)(H,59,71)(H,60,76)(H,61,78)(H,62,74)(H,63,75)(H,64,72)(H,68,69)/t28-,31+,32+,33+,34+,35+,36+,37+,40+,41+/m1/s1 D01NPA DRUGINKE HEAUFJZALFKPBA-JPQUDPSNSA-N D01NPA DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(CC2=CN=CN2)N D01NPA DRUGTYPE Small molecular drug D01NPA HIGHSTAT Investigative D01NPK DRUG__ID D01NPK D01NPK DRUGCLAS Investigative Drug(s) D01NPK DRUGCOMP University of Arkansas D01NPK HIGHSTAT Investigative D01NQM DRUG__ID D01NQM D01NQM DRUGCLAS Approved Drug(s) D01NQM DRUGCOMP Colucid pharmaceuticals D01NQM DRUGINCH 1S/C19H18F3N3O2/c1-25-7-5-11(6-8-25)18(26)15-3-2-4-16(23-15)24-19(27)17-13(21)9-12(20)10-14(17)22/h2-4,9-11H,5-8H2,1H3,(H,23,24,27) D01NQM DRUGINKE XEDHVZKDSYZQBF-UHFFFAOYSA-N D01NQM DRUGSMIL CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F D01NQM DRUGTYPE Small molecular drug D01NQM HIGHSTAT Approved D01NSM DRUG__ID D01NSM D01NSM DRUGCLAS Clinical Trial Drug(s) D01NSM DRUGCOMP Cangene Winnipeg, Canada D01NSM HIGHSTAT Phase 1 D01NSO DRUG__ID D01NSO D01NSO DRUGCLAS Investigative Drug(s) D01NSO DRUGCOMP Isis Pharmaceuticals D01NSO DRUGTYPE Antisense drug D01NSO HIGHSTAT Investigative D01NST DRUG__ID D01NST D01NST COMPCLAS Monofluorine derivatives D01NST DRUGCLAS Patented Agent(s) D01NST DRUGCOMP MERCK PATENT GMBH SHERER, Brian A D01NST DRUGINCH 1S/C18H19F3N2O/c19-14-3-1-2-13-16-9-22-10-23(16)15(17(13)14)8-18(20,21)11-4-6-12(24)7-5-11/h1-3,9-12,15,24H,4-8H2 D01NST DRUGINKE UNSORNINUVZBRF-UHFFFAOYSA-N D01NST DRUGSMIL C1CC(CCC1C(CC2C3=C(C=CC=C3F)C4=CN=CN24)(F)F)O D01NST DRUGTYPE Small molecular drug D01NST HIGHSTAT Patented D01NTH DRUG__ID D01NTH D01NTH DRUGCLAS Clinical Trial Drug(s) D01NTH DRUGCOMP University of Edinburgh D01NTH HIGHSTAT Phase 2 D01NTI DRUG__ID D01NTI D01NTI DRUGCLAS Investigative Drug(s) D01NTI DRUGINCH 1S/C18H22N6/c1-3-7-13(8-4-1)11-19-18-23-16-15(20-12-21-16)17(24-18)22-14-9-5-2-6-10-14/h1,3-4,7-8,12,14H,2,5-6,9-11H2,(H3,19,20,21,22,23,24) D01NTI DRUGINKE NPPHTZNKBUCRPG-UHFFFAOYSA-N D01NTI DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)NCC4=CC=CC=C4 D01NTI DRUGTYPE Small molecular drug D01NTI HIGHSTAT Investigative D01NTM DRUG__ID D01NTM D01NTM DRUGCLAS Investigative Drug(s) D01NTM DRUGINCH 1S/C12H17FN2S/c1-8(14)7-15-4-3-9-5-10(13)12(16-2)6-11(9)15/h5-6,8H,3-4,7,14H2,1-2H3/t8-/m0/s1 D01NTM DRUGINKE IGAAICGMRRWZJW-QMMMGPOBSA-N D01NTM DRUGSMIL CC(CN1CCC2=CC(=C(C=C21)SC)F)N D01NTM DRUGTYPE Small molecular drug D01NTM HIGHSTAT Investigative D01NTN DRUG__ID D01NTN D01NTN DRUGCLAS Investigative Drug(s) D01NTN DRUGINCH 1S/C15H20Br2O3/c1-2-3-4-5-8-20-15-12(16)9-11(10-13(15)17)6-7-14(18)19/h9-10H,2-8H2,1H3,(H,18,19) D01NTN DRUGINKE FVDRTJXVCUAOCA-UHFFFAOYSA-N D01NTN DRUGSMIL CCCCCCOC1=C(C=C(C=C1Br)CCC(=O)O)Br D01NTN DRUGTYPE Small molecular drug D01NTN HIGHSTAT Investigative D01NTO DRUG__ID D01NTO D01NTO DRUGCLAS Approved Drug(s) D01NTO DRUGCOMP Finlay Institute D01NTO HIGHSTAT Approved D01NTQ DRUG__ID D01NTQ D01NTQ DRUGCLAS Clinical Trial Drug(s) D01NTQ DRUGCOMP Sanofi D01NTQ HIGHSTAT Phase 1 D01NTR DRUG__ID D01NTR D01NTR DRUGCLAS Investigative Drug(s) D01NTR DRUGCOMP University of California San Diego D01NTR HIGHSTAT Investigative D01NTW DRUG__ID D01NTW D01NTW DRUGCLAS Investigative Drug(s) D01NTW DRUGINCH 1S/C10H8N2O3/c11-5-7(10(12)15)3-6-1-2-8(13)9(14)4-6/h1-4,13-14H,(H2,12,15)/b7-3+ D01NTW DRUGINKE USOXQZNJFMKTKJ-XVNBXDOJSA-N D01NTW DRUGSMIL C1=CC(=C(C=C1C=C(C#N)C(=O)N)O)O D01NTW DRUGTYPE Small molecular drug D01NTW HIGHSTAT Investigative D01NTX DRUG__ID D01NTX D01NTX DRUGCLAS Approved Drug(s) D01NTX DRUGCOMP Millennium Pharmaceuticals D01NTX DRUGINCH 1S/C59H109N6O19P/c1-7-9-11-13-15-17-19-21-23-25-27-29-31-33-50(69)79-40-46(83-51(70)34-32-30-28-26-24-22-20-18-16-14-12-10-8-2)41-81-85(77,78)80-38-37-61-56(73)42(3)62-49(68)36-35-47(55(60)72)65-57(74)43(4)63-58(75)44(5)82-54-52(64-45(6)67)59(76)84-48(39-66)53(54)71/h42-44,46-48,52-54,59,66,71,76H,7-41H2,1-6H3,(H2,60,72)(H,61,73)(H,62,68)(H,63,75)(H,64,67)(H,65,74)(H,77,78)/t42-,43-,44+,46+,47+,48+,52+,53+,54+,59?/m0/s1 D01NTX DRUGINKE JMUHBNWAORSSBD-WKYWBUFDSA-N D01NTX DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)C(C)NC(=O)CCC(C(=O)N)NC(=O)C(C)NC(=O)C(C)OC1C(C(OC(C1O)CO)O)NC(=O)C)OC(=O)CCCCCCCCCCCCCCC D01NTX DRUGTYPE Small molecular drug D01NTX HIGHSTAT Approved D01NTY DRUG__ID D01NTY D01NTY DRUGCLAS Investigative Drug(s) D01NTY DRUGINCH 1S/C5H4IN5O/c6-4-8-1-2(9-4)10-5(7)11-3(1)12/h(H4,7,8,9,10,11,12) D01NTY DRUGINKE SXGFECRAKVVEJT-UHFFFAOYSA-N D01NTY DRUGSMIL C12=C(N=C(NC1=O)N)N=C(N2)I D01NTY DRUGTYPE Small molecular drug D01NTY HIGHSTAT Investigative D01NUG DRUG__ID D01NUG D01NUG DRUGCLAS Discontinued Drug(s) D01NUG DRUGCOMP GlaxoSmithKline D01NUG HIGHSTAT Discontinued in Phase 2 D01NUR DRUG__ID D01NUR D01NUR DRUGCLAS Clinical Trial Drug(s) D01NUR DRUGCOMP Astex Pharmaceuticals Pleasanton, CA D01NUR DRUGINCH 1S/C30H42FN5O3/c1-20-14-35(25(13-32-20)15-34-9-10-39-18-21(34)2)16-28(38)36-19-30(3,4)29-27(36)12-23(26(17-37)33-29)11-22-5-7-24(31)8-6-22/h5-8,12,20-21,25,32,37H,9-11,13-19H2,1-4H3/t20-,21-,25-/m1/s1 D01NUR DRUGINKE YCXOHEXZVKOGEV-DNRQZRRGSA-N D01NUR DRUGSMIL CC1CN(C(CN1)CN2CCOCC2C)CC(=O)N3CC(C4=C3C=C(C(=N4)CO)CC5=CC=C(C=C5)F)(C)C D01NUR HIGHSTAT Phase 2 D01NUT DRUG__ID D01NUT D01NUT DRUGCLAS Investigative Drug(s) D01NUT DRUGINCH 1S/C29H34O4/c1-18(2)7-6-8-20(5)10-13-24-26(31)14-11-21-15-28(33-29(21)24)25-16-22(30)17-27(32)23(25)12-9-19(3)4/h7,9-11,14-17,30-32H,6,8,12-13H2,1-5H3/b20-10+ D01NUT DRUGINKE WCJPAQJEARHLGS-KEBDBYFISA-N D01NUT DRUGSMIL CC(=CCCC(=CCC1=C(C=CC2=C1OC(=C2)C3=C(C(=CC(=C3)O)O)CC=C(C)C)O)C)C D01NUT DRUGTYPE Small molecular drug D01NUT HIGHSTAT Investigative D01NVD DRUG__ID D01NVD D01NVD DRUGCLAS Investigative Drug(s) D01NVD DRUGINCH 1S/C21H20ClN5O2/c1-11-18-19(22)16(10-23-20(18)27(4)25-11)21(28)24-9-14-5-7-15(8-6-14)17-12(2)26-29-13(17)3/h5-8,10H,9H2,1-4H3,(H,24,28) D01NVD DRUGINKE QWZQPWUWGYGVOC-UHFFFAOYSA-N D01NVD DRUGSMIL CC1=C(C(=NO1)C)C2=CC=C(C=C2)CNC(=O)C3=CN=C4C(=C3Cl)C(=NN4C)C D01NVD DRUGTYPE Small molecular drug D01NVD HIGHSTAT Investigative D01NVL DRUG__ID D01NVL D01NVL DRUGCLAS Investigative Drug(s) D01NVL DRUGINCH 1S/C15H9ClN2O2S/c16-10-4-6-13-12(8-10)11-5-3-9-2-1-7-17-14(9)15(11)18-21(13,19)20/h1-8,18H D01NVL DRUGINKE JVPPTVNJBXFSPQ-UHFFFAOYSA-N D01NVL DRUGSMIL C1=CC2=C(C3=C(C=C2)C4=C(C=CC(=C4)Cl)S(=O)(=O)N3)N=C1 D01NVL DRUGTYPE Small molecular drug D01NVL HIGHSTAT Investigative D01NVM DRUG__ID D01NVM D01NVM DRUGCLAS Patented Agent(s) D01NVM DRUGINCH 1S/C23H28N6O/c1-15-13-16(9-12-24-15)19-17-7-3-2-4-8-18(17)25-21(20(19)22-26-28-29-27-22)23(14-30)10-5-6-11-23/h9,12-13,30H,2-8,10-11,14H2,1H3,(H,26,27,28,29) D01NVM DRUGINKE JDONBBWFRSZVOY-UHFFFAOYSA-N D01NVM DRUGSMIL CC1=NC=CC(=C1)C2=C(C(=NC3=C2CCCCC3)C4(CCCC4)CO)C5=NNN=N5 D01NVM DRUGTYPE Small molecular drug D01NVM HIGHSTAT Patented D01NWQ DRUG__ID D01NWQ D01NWQ DRUGCLAS Investigative Drug(s) D01NWQ DRUGINCH 1S/C18H14BrNO/c1-12-10-16(19)8-9-17(12)20-18(21)15-7-6-13-4-2-3-5-14(13)11-15/h2-11H,1H3,(H,20,21) D01NWQ DRUGINKE QDOYRUBXBHREAH-UHFFFAOYSA-N D01NWQ DRUGSMIL CC1=C(C=CC(=C1)Br)NC(=O)C2=CC3=CC=CC=C3C=C2 D01NWQ DRUGTYPE Small molecular drug D01NWQ HIGHSTAT Investigative D01NWS DRUG__ID D01NWS D01NWS DRUGCLAS Investigative Drug(s) D01NWS DRUGINCH 1S/C18H15NO2/c20-17(18-19-12-13-21-18)11-8-14-6-9-16(10-7-14)15-4-2-1-3-5-15/h1-7,9-10,12-13H,8,11H2 D01NWS DRUGINKE RKXYRLSZCAAEPX-UHFFFAOYSA-N D01NWS DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(=O)C3=NC=CO3 D01NWS DRUGTYPE Small molecular drug D01NWS HIGHSTAT Investigative D01NWU DRUG__ID D01NWU D01NWU COMPCLAS 1,2-diamino cyclopentane-based derivatives D01NWU DRUGCLAS Patented Agent(s) D01NWU DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D01NWU DRUGINCH 1S/C21H22FN3O3S/c1-27-16-7-4-8-17(28-2)19(16)20(26)23-13-5-3-6-14(13)24-21-25-15-10-9-12(22)11-18(15)29-21/h4,7-11,13-14H,3,5-6H2,1-2H3,(H,23,26)(H,24,25)/t13-,14-/m0/s1 D01NWU DRUGINKE FFLQAHCLFLUGAV-KBPBESRZSA-N D01NWU DRUGSMIL COC1=C(C(=CC=C1)OC)C(=O)NC2CCCC2NC3=NC4=C(S3)C=C(C=C4)F D01NWU DRUGTYPE Small molecular drug D01NWU HIGHSTAT Patented D01NWV DRUG__ID D01NWV D01NWV DRUGCLAS Clinical Trial Drug(s) D01NWV DRUGCOMP FirstString Research D01NWV HIGHSTAT Phase 3 D01NXF DRUG__ID D01NXF D01NXF DRUGCLAS Clinical Trial Drug(s) D01NXF DRUGCOMP Celladon; Targeted Genetics D01NXF HIGHSTAT Phase 2 D01NXX DRUG__ID D01NXX D01NXX DRUGCLAS Clinical Trial Drug(s) D01NXX DRUGCOMP Sanofi D01NXX HIGHSTAT Phase 1 D01NYQ DRUG__ID D01NYQ D01NYQ DRUGCLAS Clinical Trial Drug(s) D01NYQ HIGHSTAT Phase 2 D01NZH DRUG__ID D01NZH D01NZH DRUGCLAS Clinical Trial Drug(s) D01NZH DRUGCOMP AbbVieNorth Chicago, IL D01NZH HIGHSTAT Phase 1 D01NZS DRUG__ID D01NZS D01NZS DRUGCLAS Investigative Drug(s) D01NZS DRUGINCH 1S/C17H19N3O2/c21-16-14-7-3-4-8-15(14)17(22)20(16)11-6-2-1-5-10-19-12-9-18-13-19/h3-4,7-9,12-13H,1-2,5-6,10-11H2 D01NZS DRUGINKE CGDDIOSGLRENCV-UHFFFAOYSA-N D01NZS DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)CCCCCCN3C=CN=C3 D01NZS DRUGTYPE Small molecular drug D01NZS HIGHSTAT Investigative D01NZT DRUG__ID D01NZT D01NZT DRUGCLAS Clinical Trial Drug(s) D01NZT DRUGCOMP MD Anderson Cancer Center D01NZT HIGHSTAT Phase 1 D01OAG DRUG__ID D01OAG D01OAG DRUGCLAS Investigative Drug(s) D01OAG DRUGINCH 1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13- D01OAG DRUGINKE NCYCYZXNIZJOKI-HWCYFHEPSA-N D01OAG DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=O)C)C D01OAG DRUGTYPE Small molecular drug D01OAG HIGHSTAT Investigative D01OBB DRUG__ID D01OBB D01OBB DRUGCLAS Patented Agent(s) D01OBB DRUGCOMP PROTEOLIX, INC. BENNETT, Mark, K. BUCHHOLZ, Tonia, J. DEMO, Susan LAIDIG, Guy, J. LEWIS, Evan, R. SMYTH, Mark, S D01OBB DRUGTYPE Small molecular drug D01OBB HIGHSTAT Patented D01OBJ DRUG__ID D01OBJ D01OBJ DRUGCLAS Investigative Drug(s) D01OBJ DRUGINCH 1S/C12H9BrN2O/c1-16-10-3-2-8-11(12(10)13)7-4-5-14-6-9(7)15-8/h2-6,15H,1H3 D01OBJ DRUGINKE NXKWYFQQPHBFII-UHFFFAOYSA-N D01OBJ DRUGSMIL COC1=C(C2=C(C=C1)NC3=C2C=CN=C3)Br D01OBJ DRUGTYPE Small molecular drug D01OBJ HIGHSTAT Investigative D01OBM DRUG__ID D01OBM D01OBM DRUGCLAS Clinical Trial Drug(s) D01OBM DRUGCOMP Astrazeneca; medimmune D01OBM HIGHSTAT Phase 1/2 D01OCR DRUG__ID D01OCR D01OCR DRUGCLAS Investigative Drug(s) D01OCR DRUGINCH 1S/C12H18O3S2/c1-3-11(8-9-16)17(13,14)12-6-4-10(15-2)5-7-12/h4-7,11,16H,3,8-9H2,1-2H3 D01OCR DRUGINKE PKYBEORBMGUOOP-UHFFFAOYSA-N D01OCR DRUGSMIL CCC(CCS)S(=O)(=O)C1=CC=C(C=C1)OC D01OCR DRUGTYPE Small molecular drug D01OCR HIGHSTAT Investigative D01OCZ DRUG__ID D01OCZ D01OCZ DRUGCLAS Investigative Drug(s) D01OCZ DRUGINCH 1S/C22H28O2/c1-13(2)10-15-12-20-19-6-4-14-11-16(23)5-7-17(14)18(19)8-9-22(20,3)21(15)24/h5,7,10-11,13,18-20,23H,4,6,8-9,12H2,1-3H3/b15-10+/t18-,19-,20+,22+/m1/s1 D01OCZ DRUGINKE PTANBYHUNIXKEU-HDLVZFDGSA-N D01OCZ DRUGSMIL CC(C)C=C1CC2C3CCC4=C(C3CCC2(C1=O)C)C=CC(=C4)O D01OCZ DRUGTYPE Small molecular drug D01OCZ HIGHSTAT Investigative D01ODC DRUG__ID D01ODC D01ODC DRUGCLAS Investigative Drug(s) D01ODC DRUGCOMP Taligen Therapeutics Inc D01ODC DRUGTYPE Antibody D01ODC HIGHSTAT Investigative D01ODR DRUG__ID D01ODR D01ODR DRUGCLAS Investigative Drug(s) D01ODR DRUGINCH 1S/C14H13BrN2O/c1-14(2,3)11-5-9(4-10(7-16)8-17)6-12(15)13(11)18/h4-6,18H,1-3H3 D01ODR DRUGINKE ABBADGFSRBWENF-UHFFFAOYSA-N D01ODR DRUGSMIL CC(C)(C)C1=C(C(=CC(=C1)C=C(C#N)C#N)Br)O D01ODR DRUGTYPE Small molecular drug D01ODR HIGHSTAT Investigative D01ODT DRUG__ID D01ODT D01ODT DRUGCLAS Investigative Drug(s) D01ODT DRUGCOMP Biomedica Management Corporation D01ODT HIGHSTAT Investigative D01ODU DRUG__ID D01ODU D01ODU DRUGCLAS Clinical Trial Drug(s) D01ODU DRUGCOMP Bayer AG D01ODU DRUGINCH 1S/C20H19FN4O4.ClH/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15;/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28);1H/t15-,16-;/m0./s1 D01ODU DRUGINKE CQMSQUOHWYYEKM-MOGJOVFKSA-N D01ODU DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4CC5C(C4)OCCN5)F)C(=O)O.Cl D01ODU DRUGTYPE Small molecular drug D01ODU HIGHSTAT Phase 3 D01OEF DRUG__ID D01OEF D01OEF DRUGCLAS Patented Agent(s) D01OEF DRUGCOMP MethylGene Inc D01OEF DRUGINCH 1S/C31H25N5O4S/c1-38-21-7-5-20(6-8-21)34-31-35-24-15-22(9-11-26(24)40-31)39-27-12-13-32-25-16-28(41-30(25)27)23-10-4-19(17-33-23)18-36-14-2-3-29(36)37/h4-13,15-17H,2-3,14,18H2,1H3,(H,34,35) D01OEF DRUGINKE NMDJVUTXFINSAW-UHFFFAOYSA-N D01OEF DRUGSMIL COC1=CC=C(C=C1)NC2=NC3=C(O2)C=CC(=C3)OC4=C5C(=NC=C4)C=C(S5)C6=NC=C(C=C6)CN7CCCC7=O D01OEF DRUGTYPE Small molecular drug D01OEF HIGHSTAT Patented D01OFD DRUG__ID D01OFD D01OFD DRUGCLAS Investigative Drug(s) D01OFD DRUGINCH 1S/C51H80O16/c1-9-39(25-36(7)49(59)60)43(52)21-19-38-24-33(4)22-32(3)23-35(6)48(58)34(5)17-20-42(67-47(57)29-41(51(63)64)27-45(55)65-30-38)15-13-11-10-12-14-31(2)16-18-37(8)66-46(56)28-40(50(61)62)26-44(53)54/h12,14,23-24,31,33-37,39-42,48,58H,9-11,13,15-22,25-30H2,1-8H3,(H,53,54)(H,59,60)(H,61,62)(H,63,64)/b14-12+,32-23+,38-24- D01OFD DRUGINKE ZJCPEIGQYKMZFE-PXQKRTIOSA-N D01OFD DRUGSMIL CCC(CC(C)C(=O)O)C(=O)CCC1=CC(CC(=CC(C(C(CCC(OC(=O)CC(CC(=O)OC1)C(=O)O)CCCCC=CC(C)CCC(C)OC(=O)CC(CC(=O)O)C(=O)O)C)O)C)C)C D01OFD DRUGTYPE Small molecular drug D01OFD HIGHSTAT Investigative D01OFH DRUG__ID D01OFH D01OFH DRUGCLAS Investigative Drug(s) D01OFH DRUGINCH 1S/C19H20O2/c1-4-6-14-8-10-18(20)17(12-14)15-9-11-19(21-3)16(13-15)7-5-2/h4-5,8-13,20H,1-2,6-7H2,3H3 D01OFH DRUGINKE OQFHJKZVOALSPV-UHFFFAOYSA-N D01OFH DRUGSMIL COC1=C(C=C(C=C1)C2=C(C=CC(=C2)CC=C)O)CC=C D01OFH DRUGTYPE Small molecular drug D01OFH HIGHSTAT Investigative D01OFO DRUG__ID D01OFO D01OFO DRUGCLAS Patented Agent(s) D01OFO DRUGINCH 1S/C16H21N5O2/c17-15-2-1-11(8-19-15)7-13(16(22)23)14-9-21(10-20-14)12-3-5-18-6-4-12/h1-2,8-10,12-13,18H,3-7H2,(H2,17,19)(H,22,23) D01OFO DRUGINKE ZPMPWZIJWOLMHZ-UHFFFAOYSA-N D01OFO DRUGSMIL C1CNCCC1N2C=C(N=C2)C(CC3=CN=C(C=C3)N)C(=O)O D01OFO DRUGTYPE Small molecular drug D01OFO HIGHSTAT Patented D01OFY DRUG__ID D01OFY D01OFY DRUGCLAS Discontinued Drug(s) D01OFY DRUGCOMP Almirall Prodesfarma SA D01OFY DRUGINCH 1S/C11H12N2O3S/c1-13-7-9(12-17(2,15)16)11(14)8-5-3-4-6-10(8)13/h3-7,12H,1-2H3 D01OFY DRUGINKE LSIYNVMXGMDGMG-UHFFFAOYSA-N D01OFY DRUGSMIL CN1C=C(C(=O)C2=CC=CC=C21)NS(=O)(=O)C D01OFY DRUGTYPE Small molecular drug D01OFY HIGHSTAT Terminated D01OGL DRUG__ID D01OGL D01OGL DRUADIID FDA-AP-BF04-00877 D01OGL DRUGCLAS Approved Drug(s) D01OGL DRUGCOMP Mallinckrodt Medical Inc D01OGL HIGHSTAT Approved D01OGR DRUG__ID D01OGR D01OGR DRUGCLAS Patented Agent(s) D01OGR DRUGCOMP University Zhejiang Technology D01OGR DRUGTYPE Small molecular drug D01OGR HIGHSTAT Patented D01OGV DRUG__ID D01OGV D01OGV DRUGCLAS Clinical Trial Drug(s) D01OGV DRUGCOMP Polyphor Ltd D01OGV HIGHSTAT Phase 1 D01OGZ DRUG__ID D01OGZ D01OGZ DRUGCLAS Investigative Drug(s) D01OGZ DRUGINCH 1S/C22H24F4N2O/c23-17-4-1-15(2-5-17)19-14-21(28-9-7-27(8-10-28)11-12-29)20-13-16(22(24,25)26)3-6-18(19)20/h1-6,13,19,21,29H,7-12,14H2/t19-,21+/m0/s1 D01OGZ DRUGINKE JSBWGXQXCRYYTG-PZJWPPBQSA-N D01OGZ DRUGSMIL C1CN(CCN1CCO)C2CC(C3=C2C=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)F D01OGZ DRUGTYPE Small molecular drug D01OGZ HIGHSTAT Investigative D01OHD DRUG__ID D01OHD D01OHD DRUGCLAS Investigative Drug(s) D01OHD DRUGCOMP MediQuest Therapeutics Inc D01OHD HIGHSTAT Investigative D01OHV DRUG__ID D01OHV D01OHV DRUGCLAS Investigative Drug(s) D01OHV DRUGINCH 1S/C4H4N6O/c5-4-6-2-1(3(11)7-4)8-10-9-2/h(H4,5,6,7,8,9,10,11) D01OHV DRUGINKE LPXQRXLUHJKZIE-UHFFFAOYSA-N D01OHV DRUGSMIL C12=NNN=C1N=C(NC2=O)N D01OHV DRUGTYPE Small molecular drug D01OHV HIGHSTAT Investigative D01OIJ DRUG__ID D01OIJ D01OIJ DRUGCLAS Investigative Drug(s) D01OIJ DRUGINCH 1S/C24H28N6O3/c1-15-20(22(31)29-18(23(32)33)13-8-14-27-24(25)26)30-21(28-15)19(16-9-4-2-5-10-16)17-11-6-3-7-12-17/h2-7,9-12,18-19H,8,13-14H2,1H3,(H,28,30)(H,29,31)(H,32,33)(H4,25,26,27)/t18-/m0/s1 D01OIJ DRUGINKE RFBOIZXPIAOMAX-SFHVURJKSA-N D01OIJ DRUGSMIL CC1=C(N=C(N1)C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NC(CCCN=C(N)N)C(=O)O D01OIJ DRUGTYPE Small molecular drug D01OIJ HIGHSTAT Investigative D01OIK DRUG__ID D01OIK D01OIK DRUGCLAS Investigative Drug(s) D01OIK DRUGINCH 1S/C16H25N3O5/c20-13-1-3-15(4-2-13)24-12-14(21)11-17-5-6-18-16(22)19-7-9-23-10-8-19/h1-4,14,17,20-21H,5-12H2,(H,18,22) D01OIK DRUGINKE DXPOSRCHIDYWHW-UHFFFAOYSA-N D01OIK DRUGSMIL C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O D01OIK DRUGTYPE Small molecular drug D01OIK HIGHSTAT Investigative D01OIL DRUG__ID D01OIL D01OIL DRUGCLAS Approved Drug(s) D01OIL DRUGINCH 1S/C22H31N3O11.2C7H17NO5.Gd/c26-18(27)10-23(6-7-24(11-19(28)29)12-20(30)31)8-9-25(13-21(32)33)17(22(34)35)15-36-14-16-4-2-1-3-5-16;2*1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-5,17H,6-15H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,34,35);2*4-13H,2-3H2,1H3;/q;;;+3/p-3/t;2*4-,5+,6+,7+;/m.00./s1 D01OIL DRUGINKE OCDAWJYGVOLXGZ-VPVMAENOSA-K D01OIL DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)O.[Gd+3] D01OIL DRUGTYPE Small molecular drug D01OIL HIGHSTAT Approved D01OIL THERCLAS Contrast Media D01OIQ DRUG__ID D01OIQ D01OIQ DRUGCLAS Patented Agent(s) D01OIQ DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D01OIQ DRUGTYPE Small molecular drug D01OIQ HIGHSTAT Patented D01OIR DRUG__ID D01OIR D01OIR DRUGCLAS Clinical Trial Drug(s) D01OIR HIGHSTAT Phase 2 D01OIV DRUG__ID D01OIV D01OIV DRUGCLAS Investigative Drug(s) D01OIV DRUGINCH 1S/C18H23NO5/c1-23-17-6-3-12(9-18(17)24-2)7-8-19-11-16(22)13-4-5-14(20)15(21)10-13/h3-6,9-10,16,19-22H,7-8,11H2,1-2H3 D01OIV DRUGINKE DIPGFXJERHNAQQ-UHFFFAOYSA-N D01OIV DRUGSMIL COC1=C(C=C(C=C1)CCNCC(C2=CC(=C(C=C2)O)O)O)OC D01OIV DRUGTYPE Small molecular drug D01OIV HIGHSTAT Investigative D01OJG DRUG__ID D01OJG D01OJG DRUGCLAS Investigative Drug(s) D01OJG DRUGINCH 1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20) D01OJG DRUGINKE ACQZMAJVOPRMQJ-UHFFFAOYSA-N D01OJG DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)NC2=O)NC3=CC=CC=C3 D01OJG DRUGTYPE Small molecular drug D01OJG HIGHSTAT Investigative D01OKF DRUG__ID D01OKF D01OKF DRUGCLAS Investigative Drug(s) D01OKF DRUGINCH 1S/C18H20Cl2N2O/c1-14-2-6-16(7-3-14)21-18(23)15-4-8-17(9-5-15)22(12-10-19)13-11-20/h2-9H,10-13H2,1H3,(H,21,23) D01OKF DRUGINKE YUHSPIYJWBBMHU-UHFFFAOYSA-N D01OKF DRUGSMIL CC1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)N(CCCl)CCCl D01OKF DRUGTYPE Small molecular drug D01OKF HIGHSTAT Investigative D01OKS DRUG__ID D01OKS D01OKS DRUGCLAS Discontinued Drug(s) D01OKS HIGHSTAT Discontinued in Phase 3 D01OLO DRUG__ID D01OLO D01OLO DRUGCLAS Discontinued Drug(s) D01OLO DRUGCOMP Merck D01OLO DRUGINCH 1S/C18H14N4O3S/c1-10-9-14(23)22(18(10)24)21-17-15-11(5-3-6-12(15)25-2)19-16(20-17)13-7-4-8-26-13/h3-9H,1-2H3,(H,19,20,21) D01OLO DRUGINKE GZGLPBNOIFLLRE-UHFFFAOYSA-N D01OLO DRUGSMIL CC1=CC(=O)N(C1=O)NC2=NC(=NC3=C2C(=CC=C3)OC)C4=CC=CS4 D01OLO DRUGTYPE Small molecular drug D01OLO HIGHSTAT Discontinued in Phase 1 D01OMG DRUG__ID D01OMG D01OMG DRUGCLAS Investigative Drug(s) D01OMG DRUGINCH 1S/C14H8N4O/c15-8-10-3-1-4-11(7-10)14-17-13(18-19-14)12-5-2-6-16-9-12/h1-7,9H D01OMG DRUGINKE HGFXDSQLRSWUBO-UHFFFAOYSA-N D01OMG DRUGSMIL C1=CC(=CC(=C1)C2=NC(=NO2)C3=CN=CC=C3)C#N D01OMG DRUGTYPE Small molecular drug D01OMG HIGHSTAT Investigative D01OML DRUG__ID D01OML D01OML DRUGCLAS Discontinued Drug(s) D01OML DRUGCOMP Symbollon Pharmaceuticals D01OML HIGHSTAT Discontinued in Phase 3 D01OMM DRUG__ID D01OMM D01OMM DRUGCLAS Clinical Trial Drug(s) D01OMM DRUGCOMP Vivaldi Biosciences Fort Collins, CO D01OMM HIGHSTAT Phase 2 D01OMO DRUG__ID D01OMO D01OMO DRUGCLAS Investigative Drug(s) D01OMO DRUGCOMP GenVec Inc D01OMO HIGHSTAT Investigative D01OMY DRUG__ID D01OMY D01OMY DRUGCLAS Investigative Drug(s) D01OMY DRUGCOMP Bayhill Therapeutics Inc D01OMY HIGHSTAT Investigative D01OND DRUG__ID D01OND D01OND DRUGCLAS Investigative Drug(s) D01OND DRUGINCH 1S/C15H16N2O2/c1-17(2)13-9-6-10-14(11-13)19-15(18)16-12-7-4-3-5-8-12/h3-11H,1-2H3,(H,16,18) D01OND DRUGINKE YNGSTYODGGYXSA-UHFFFAOYSA-N D01OND DRUGSMIL CN(C)C1=CC(=CC=C1)OC(=O)NC2=CC=CC=C2 D01OND DRUGTYPE Small molecular drug D01OND HIGHSTAT Investigative D01OOI DRUG__ID D01OOI D01OOI DRUGCLAS Investigative Drug(s) D01OOI DRUGCOMP Isis Pharmaceuticals D01OOI DRUGTYPE Antisense drug D01OOI HIGHSTAT Investigative D01OOO DRUG__ID D01OOO D01OOO DRUGCLAS Patented Agent(s) D01OOO DRUGCOMP PROTEOLIX, INC. BENNETT, Mark, K. BUCHHOLZ, Tonia, J. DEMO, Susan LAIDIG, Guy, J. LEWIS, Evan, R. SMYTH, Mark, S D01OOO DRUGTYPE Small molecular drug D01OOO HIGHSTAT Patented D01OOQ DRUG__ID D01OOQ D01OOQ DRUGCLAS Clinical Trial Drug(s) D01OOQ DRUGCOMP Pnp therapeutics D01OOQ HIGHSTAT Phase 1 D01OPV DRUG__ID D01OPV D01OPV DRUADIID FDA-AP-BF04-01319 D01OPV DRUGCLAS Approved Drug(s) D01OPV DRUGCOMP Ge Healthcare D01OPV DRUGINCH 1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1/i9-4 D01OPV DRUGINKE RJFAYQIBOAGBLC-ZEMBQCNESA-N D01OPV DRUGSMIL C[Se]CCC(C(=O)O)N D01OPV DRUGTYPE Small molecular drug D01OPV HIGHSTAT Approved D01OQQ DRUG__ID D01OQQ D01OQQ DRUGCLAS Patented Agent(s) D01OQQ DRUGCOMP INCYTE CORPORATION D01OQQ DRUGINCH 1S/C25H24N4O5/c1-29-15-16(14-27-7-8-30)11-19(25(29)32)24(31)28-21-4-2-3-18(20(21)13-26)17-5-6-22-23(12-17)34-10-9-33-22/h2-6,11-12,15,27,30H,7-10,14H2,1H3,(H,28,31) D01OQQ DRUGINKE CAWQORGXRONNAU-UHFFFAOYSA-N D01OQQ DRUGSMIL CN1C=C(C=C(C1=O)C(=O)NC2=CC=CC(=C2C#N)C3=CC4=C(C=C3)OCCO4)CNCCO D01OQQ DRUGTYPE Small molecule immunotherapy D01OQQ HIGHSTAT Patented D01OQW DRUG__ID D01OQW D01OQW DRUGCLAS Investigative Drug(s) D01OQW DRUGINCH 1S/C34H26O8/c1-16-8-23-22-6-4-21(37)15-30(22)41-34(25-7-5-19(35)13-26(25)38)33(23)24(9-16)32-27(39)10-18(12-31(32)42-34)28-11-17-2-3-20(36)14-29(17)40-28/h2-7,9-15,23-24,33,35-39H,8H2,1H3/t23-,24-,33-,34+/m0/s1 D01OQW DRUGINKE MJJWBJFYYRAYKU-OPKNDJPNSA-N D01OQW DRUGSMIL CC1=CC2C3C(C1)C4=C(C=C(C=C4)O)OC3(OC5=CC(=CC(=C25)O)C6=CC7=C(O6)C=C(C=C7)O)C8=C(C=C(C=C8)O)O D01OQW DRUGTYPE Small molecular drug D01OQW HIGHSTAT Investigative D01ORL DRUG__ID D01ORL D01ORL DRUGCLAS Investigative Drug(s) D01ORL DRUGINCH 1S/C21H24N2O/c24-20-7-6-18-13-19(22-21(18)14-20)15-23-10-8-17(9-11-23)12-16-4-2-1-3-5-16/h1-7,13-14,17,22,24H,8-12,15H2 D01ORL DRUGINKE XCBFDMFJYYJHAL-UHFFFAOYSA-N D01ORL DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CC3=CC4=C(N3)C=C(C=C4)O D01ORL DRUGTYPE Small molecular drug D01ORL HIGHSTAT Investigative D01ORM DRUG__ID D01ORM D01ORM DRUGCLAS Discontinued Drug(s) D01ORM DRUGINCH 1S/C16H15N3O4/c1-17(2)6-7-18-15(20)12-5-3-4-10-8-11(19(22)23)9-13(14(10)12)16(18)21/h3-5,8-9H,6-7H2,1-2H3 D01ORM DRUGINKE XXVLKDRPHSFIIB-UHFFFAOYSA-N D01ORM DRUGSMIL CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)[N+](=O)[O-] D01ORM DRUGTYPE Small molecular drug D01ORM HIGHSTAT Discontinued in Phase 2 D01OSN DRUG__ID D01OSN D01OSN DRUGCLAS Discontinued Drug(s) D01OSN DRUGCOMP Sanofi-aventis D01OSN HIGHSTAT Discontinued in Phase 3 D01OTW DRUG__ID D01OTW D01OTW DRUGCLAS Investigative Drug(s) D01OTW DRUGINCH 1S/C7H7N3O2S2/c8-2-4-13-6-1-3-10-5-7(6)14(9,11)12/h1,3,5H,4H2,(H2,9,11,12) D01OTW DRUGINKE JOIYJNZMYUXKRS-UHFFFAOYSA-N D01OTW DRUGSMIL C1=CN=CC(=C1SCC#N)S(=O)(=O)N D01OTW DRUGTYPE Small molecular drug D01OTW HIGHSTAT Investigative D01OUA DRUG__ID D01OUA D01OUA DRUGCLAS Discontinued Drug(s) D01OUA DRUGCOMP Tsumura & Co D01OUA HIGHSTAT Terminated D01OUE DRUG__ID D01OUE D01OUE DRUADIID FDA-AP-BF04-00698 D01OUE DRUGCLAS Approved Drug(s) D01OUE DRUGCOMP Eli Lilly And Co D01OUE DRUGINCH 1S/C5H9N3/c6-3-1-5-2-4-7-8-5/h2,4H,1,3,6H2,(H,7,8) D01OUE DRUGINKE JXDFEQONERDKSS-UHFFFAOYSA-N D01OUE DRUGSMIL C1=C(NN=C1)CCN D01OUE DRUGTYPE Small molecular drug D01OUE HIGHSTAT Approved D01OUE THERCLAS Antihistamines D01OUJ DRUG__ID D01OUJ D01OUJ DRUGCLAS Investigative Drug(s) D01OUJ DRUGINCH 1S/C9H19BN2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8,14-15H,3-5,11H2,1-2H3/p+1/t7-,8+/m0/s1 D01OUJ DRUGINKE FKCMADOPPWWGNZ-JGVFFNPUSA-O D01OUJ DRUGSMIL B(C1CCCN1C(=O)C(C(C)C)[NH3+])(O)O D01OUJ DRUGTYPE Small molecular drug D01OUJ HIGHSTAT Investigative D01OVV DRUG__ID D01OVV D01OVV DRUGCLAS Investigative Drug(s) D01OVV DRUGCOMP OncoVista Innovative Therapies Inc D01OVV HIGHSTAT Investigative D01OWB DRUG__ID D01OWB D01OWB DRUGCLAS Approved Drug(s) D01OWB HIGHSTAT Approved D01OWJ DRUG__ID D01OWJ D01OWJ DRUGCLAS Discontinued Drug(s) D01OWJ DRUGCOMP Transgene SA; Transgene D01OWJ HIGHSTAT Discontinued in Phase 1 D01OXH DRUG__ID D01OXH D01OXH DRUGCLAS Clinical Trial Drug(s) D01OXH DRUGCOMP Astellas Pharma Inc D01OXH DRUGINCH 1S/C25H23F7N2O4/c1-14(26)13-38-16-3-4-17(20(11-16)25(30,31)32)23(37)34-8-6-24(28,29)19(12-22(36)33-7-9-35)18-10-15(27)2-5-21(18)34/h2-5,10-12,14,35H,6-9,13H2,1H3,(H,33,36)/b19-12-/t14-/m1/s1 D01OXH DRUGINKE VSXSHTIGQAUGMW-VCRXTVNUSA-N D01OXH DRUGSMIL CC(COC1=CC(=C(C=C1)C(=O)N2CCC(C(=CC(=O)NCCO)C3=C2C=CC(=C3)F)(F)F)C(F)(F)F)F D01OXH HIGHSTAT Phase 2 D01OXI DRUG__ID D01OXI D01OXI DRUGCLAS Approved Drug(s) D01OXI DRUGCOMP Direct Therapeutics Inc D01OXI DRUGINCH 1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11) D01OXI DRUGINKE DLGOEMSEDOSKAD-UHFFFAOYSA-N D01OXI DRUGSMIL C(CCl)NC(=O)N(CCCl)N=O D01OXI DRUGTYPE Small molecular drug D01OXI HIGHSTAT Approved D01OXV DRUG__ID D01OXV D01OXV DRUGCLAS Investigative Drug(s) D01OXV DRUGINCH 1S/C17H20ClF4N7O/c1-23-15-10(17(20,21)22)4-24-16(27-15)26-12-5-25-29(14(12)18)13-2-3-28(6-11(13)19)9-7-30-8-9/h4-5,9,11,13H,2-3,6-8H2,1H3,(H2,23,24,26,27)/t11-,13-/m0/s1 D01OXV DRUGINKE PUXPEQJKNAWNQA-AAEUAGOBSA-N D01OXV DRUGSMIL CNC1=NC(=NC=C1C(F)(F)F)NC2=C(N(N=C2)C3CCN(CC3F)C4COC4)Cl D01OXV DRUGTYPE Small molecular drug D01OXV HIGHSTAT Investigative D01OYC DRUG__ID D01OYC D01OYC DRUGCLAS Investigative Drug(s) D01OYC DRUGINCH 1S/C13H16N2O/c1-3-9(2)16-11-6-4-5-10-7-8-12(14)15-13(10)11/h4-9H,3H2,1-2H3,(H2,14,15) D01OYC DRUGINKE RDHSHZSWPBWALB-UHFFFAOYSA-N D01OYC DRUGSMIL CCC(C)OC1=CC=CC2=C1N=C(C=C2)N D01OYC DRUGTYPE Small molecular drug D01OYC HIGHSTAT Investigative D01OYE DRUG__ID D01OYE D01OYE DRUGCLAS Patented Agent(s) D01OYE DRUGTYPE Small molecular drug D01OYE HIGHSTAT Patented D01OYG DRUG__ID D01OYG D01OYG DRUADIID CLI-01-ALDR-02504 D01OYG DRUGCLAS Investigative Drug(s) D01OYG DRUGINCH 1S/C35H37NO3/c1-33-20-30-28-9-7-24(23-5-3-22(21-36)4-6-23)17-25(28)19-34-14-11-27(38)18-26(34)8-10-29(32(30)34)31(33)12-15-35(33,39)13-2-16-37/h2-7,9,13,17-18,29-32,37,39H,8,10-12,14-16,19-20H2,1H3/b13-2+/t29-,30-,31+,32-,33+,34-,35+/m1/s1 D01OYG DRUGINKE QHTHVOAGHYSJSF-DVNFVMEUSA-N D01OYG DRUGSMIL CC12CC3C4C(C1CCC2(C=CCO)O)CCC5=CC(=O)CCC45CC6=C3C=CC(=C6)C7=CC=C(C=C7)C#N D01OYG HIGHSTAT Investigative D01OYR DRUG__ID D01OYR D01OYR DRUGCLAS Discontinued Drug(s) D01OYR DRUGCOMP AstraZeneca plc D01OYR HIGHSTAT Discontinued in Phase 1 D01OYS DRUG__ID D01OYS D01OYS DRUGCLAS Clinical Trial Drug(s) D01OYS DRUGCOMP Karolinska Institute D01OYS HIGHSTAT Phase 1 D01OYX DRUG__ID D01OYX D01OYX DRUGCLAS Drugs in Phase 2 Trial D01OYX DRUGTYPE Combination drug D01OYX HIGHSTAT Phase 2 Trial D01OYX THERCLAS Antiviral Agents D01OYY DRUG__ID D01OYY D01OYY DRUGCLAS Patented Agent(s) D01OYY DRUGCOMP NATCO PHARMA LIMITED KOMPELLA, Amala, Kishan RACHAKONDA, Sreenivas ADIBHATLA KALISATYA, Bhujanga, Rao VENKAIAH CHOWDARY, Nannapanen D01OYY DRUGINCH 1S/C25H17F6N5O/c1-14-4-5-19(12-21(14)36-23-33-8-6-20(35-23)15-3-2-7-32-13-15)34-22(37)16-9-17(24(26,27)28)11-18(10-16)25(29,30)31/h2-13H,1H3,(H,34,37)(H,33,35,36) D01OYY DRUGINKE LCPGCGAJBOWMIP-UHFFFAOYSA-N D01OYY DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)NC3=NC=CC(=N3)C4=CN=CC=C4 D01OYY DRUGTYPE Small molecular drug D01OYY HIGHSTAT Patented D01OZF DRUG__ID D01OZF D01OZF DRUGCLAS Investigative Drug(s) D01OZF DRUGINCH 1S/C20H25N3O3/c24-20(21-17-5-2-1-3-6-17)22-18-7-9-19(10-8-18)26-14-4-11-23-12-15-25-16-13-23/h1-3,5-10H,4,11-16H2,(H2,21,22,24) D01OZF DRUGINKE HTAZKQMMJVVVSK-UHFFFAOYSA-N D01OZF DRUGSMIL C1COCCN1CCCOC2=CC=C(C=C2)NC(=O)NC3=CC=CC=C3 D01OZF DRUGTYPE Small molecular drug D01OZF HIGHSTAT Investigative D01OZL DRUG__ID D01OZL D01OZL DRUGCLAS Investigative Drug(s) D01OZL DRUGINCH 1S/C14H18N2O/c1-3-10(2)9-17-12-6-4-5-11-7-8-13(15)16-14(11)12/h4-8,10H,3,9H2,1-2H3,(H2,15,16) D01OZL DRUGINKE YLIRVLXATQGNTR-UHFFFAOYSA-N D01OZL DRUGSMIL CCC(C)COC1=CC=CC2=C1N=C(C=C2)N D01OZL DRUGTYPE Small molecular drug D01OZL HIGHSTAT Investigative D01OZO DRUG__ID D01OZO D01OZO DRUGCLAS Patented Agent(s) D01OZO DRUGINCH 1S/C26H31N5O3S/c1-29-16-26(27-18-29)35(32,33)28-20-14-31(15-20)21-8-9-25-23(13-21)22(12-19-6-3-2-4-7-19)24(17-34-25)30-10-5-11-30/h2-4,6-9,13,16,18,20,22,24,28H,5,10-12,14-15,17H2,1H3 D01OZO DRUGINKE LMBGMNQXZDWDDD-UHFFFAOYSA-N D01OZO DRUGSMIL CN1C=C(N=C1)S(=O)(=O)NC2CN(C2)C3=CC4=C(C=C3)OCC(C4CC5=CC=CC=C5)N6CCC6 D01OZO DRUGTYPE Small molecular drug D01OZO HIGHSTAT Patented D01OZS DRUG__ID D01OZS D01OZS DRUGCLAS Investigative Drug(s) D01OZS DRUGINCH 1S/C10H18O2/c1-7(2)10(8(3)4)5-6-12-9(10)11/h7-8H,5-6H2,1-4H3 D01OZS DRUGINKE HBNIKFYZKDWFNE-UHFFFAOYSA-N D01OZS DRUGSMIL CC(C)C1(CCOC1=O)C(C)C D01OZS DRUGTYPE Small molecular drug D01OZS HIGHSTAT Investigative D01PAC DRUG__ID D01PAC D01PAC DRUGCLAS Investigative Drug(s) D01PAC DRUGINCH 1S/C27H29IN2/c28-24-14-8-7-13-23(24)19-29-26-22-15-17-30(18-16-22)27(26)25(20-9-3-1-4-10-20)21-11-5-2-6-12-21/h1-14,22,25-27,29H,15-19H2/t26-,27-/m1/s1/i28-2 D01PAC DRUGINKE WSLTYZVXORBNLB-BRXFWFLGSA-N D01PAC DRUGSMIL C1CN2CCC1C(C2C(C3=CC=CC=C3)C4=CC=CC=C4)NCC5=CC=CC=C5I D01PAC DRUGTYPE Small molecular drug D01PAC HIGHSTAT Investigative D01PAP DRUG__ID D01PAP D01PAP DRUGCLAS Patented Agent(s) D01PAP DRUGCOMP Apotex Pharmachem IncTeva Pharmaceutical Industries LtdSynthon Ip IncU & I Pharmaceuticals, LtdGeneva Pharmaceuticals, IncEli Lilly and CompanLilly Industries LimitedKRKA, Tovarna Zdravil, D.D D01PAP DRUGTYPE Small molecular drug D01PAP HIGHSTAT Patented D01PAR DRUG__ID D01PAR D01PAR DRUGCLAS Approved Drug(s) D01PAR HIGHSTAT Approved D01PBO DRUG__ID D01PBO D01PBO DRUGCLAS Investigative Drug(s) D01PBO DRUGINCH 1S/C18H20O7/c19-7-11-12(17(24)9-1-3-13(20)15(22)5-9)8-25-18(11)10-2-4-14(21)16(23)6-10/h1-6,11-12,17-24H,7-8H2/t11-,12+,17-,18-/m1/s1 D01PBO DRUGINKE XRDXBFUYROIFCX-FVEFGIFQSA-N D01PBO DRUGSMIL C1C(C(C(O1)C2=CC(=C(C=C2)O)O)CO)C(C3=CC(=C(C=C3)O)O)O D01PBO DRUGTYPE Small molecular drug D01PBO HIGHSTAT Investigative D01PBW DRUG__ID D01PBW D01PBW DRUGCLAS Clinical Trial Drug(s) D01PBW DRUGINCH 1S/C26H24F3N7O3S/c27-26(28,29)39-20-9-5-6-17(14-20)15-22(37)31-21-12-11-18(33-34-21)7-1-2-10-24-35-36-25(40-24)32-23(38)16-19-8-3-4-13-30-19/h3-6,8-9,11-14H,1-2,7,10,15-16H2,(H,31,34,37)(H,32,36,38) D01PBW DRUGINKE PRAAPINBUWJLGA-UHFFFAOYSA-N D01PBW DRUGSMIL C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F D01PBW HIGHSTAT Phase 2 D01PBX DRUG__ID D01PBX D01PBX COMPCLAS Biphenyl mannoside derivatives D01PBX DRUGCLAS Patented Agent(s) D01PBX DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D01PBX DRUGTYPE Carbohydrates D01PBX HIGHSTAT Patented D01PCB DRUG__ID D01PCB D01PCB DRUGCLAS Clinical Trial Drug(s) D01PCB DRUGCOMP National Biopreparations Center D01PCB HIGHSTAT Phase 1 D01PCE DRUG__ID D01PCE D01PCE DRUGCLAS Discontinued Drug(s) D01PCE DRUGCOMP Shire BioChem Inc D01PCE HIGHSTAT Discontinued in Phase 2 D01PCI DRUG__ID D01PCI D01PCI DRUGCLAS Patented Agent(s) D01PCI DRUGCOMP NTZ LAB LTD [BG] D01PCI DRUGTYPE Small molecular drug D01PCI HIGHSTAT Patented D01PEC DRUG__ID D01PEC D01PEC DRUGCLAS Investigative Drug(s) D01PEC DRUGINCH 1S/C28H28Cl2N2O3/c1-17(33)26(34)31-24-16-28(13-5-2-6-14-28)35-27-22(24)15-21(18-9-11-19(29)12-10-18)25(32-27)20-7-3-4-8-23(20)30/h3-4,7-12,15,17,24,33H,2,5-6,13-14,16H2,1H3,(H,31,34)/t17-,24?/m1/s1 D01PEC DRUGINKE CBNQOXMUNJAOJO-BPNWFJGMSA-N D01PEC DRUGSMIL CC(C(=O)NC1CC2(CCCCC2)OC3=C1C=C(C(=N3)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl)O D01PEC DRUGTYPE Small molecular drug D01PEC HIGHSTAT Investigative D01PEF DRUG__ID D01PEF D01PEF DRUGCLAS Investigative Drug(s) D01PEF DRUGINCH 1S/C12H11N5O/c1-17-6-7(8-2-4-15-12(13)16-8)10-9(18)3-5-14-11(10)17/h2-6H,1H3,(H,14,18)(H2,13,15,16) D01PEF DRUGINKE PYDJIICXCHAWOI-UHFFFAOYSA-N D01PEF DRUGSMIL CN1C=C(C2=C1NC=CC2=O)C3=NC(=NC=C3)N D01PEF DRUGTYPE Small molecular drug D01PEF HIGHSTAT Investigative D01PES DRUG__ID D01PES D01PES DRUGCLAS Investigative Drug(s) D01PES DRUGINCH 1S/C15H14N2/c1-2-7-13(8-3-1)16-11-14-10-12-6-4-5-9-15(12)17-14/h1-10,16-17H,11H2 D01PES DRUGINKE SSQTZURIXXHEKY-UHFFFAOYSA-N D01PES DRUGSMIL C1=CC=C(C=C1)NCC2=CC3=CC=CC=C3N2 D01PES DRUGTYPE Small molecular drug D01PES HIGHSTAT Investigative D01PFN DRUG__ID D01PFN D01PFN DRUGCLAS Investigative Drug(s) D01PFN DRUGINCH 1S/C14H16N2O/c15-13-8-7-11-5-2-6-12(14(11)16-13)17-9-10-3-1-4-10/h2,5-8,10H,1,3-4,9H2,(H2,15,16) D01PFN DRUGINKE LOSCSSHHWRUJGD-UHFFFAOYSA-N D01PFN DRUGSMIL C1CC(C1)COC2=CC=CC3=C2N=C(C=C3)N D01PFN DRUGTYPE Small molecular drug D01PFN HIGHSTAT Investigative D01PFX DRUG__ID D01PFX D01PFX DRUGCLAS Investigative Drug(s) D01PFX DRUGCOMP ALS Therapy Development Foundation Inc D01PFX HIGHSTAT Investigative D01PFZ DRUG__ID D01PFZ D01PFZ COMPCLAS Pyridopyrimidinone derivatives D01PFZ DRUGCLAS Patented Agent(s) D01PFZ DRUGCOMP Oscotec, Inc., S. Korea. assignee D01PFZ DRUGTYPE Small molecular drug D01PFZ HIGHSTAT Patented D01PGJ DRUG__ID D01PGJ D01PGJ DRUGCLAS Clinical Trial Drug(s) D01PGJ DRUGINCH 1S/C11H13N3O3.2BrH/c12-11(7-14-4-2-1-3-5-14)6-8(9(15)16)13-10(11)17;;/h1-5,8H,6-7,12H2,(H-,13,15,16,17);2*1H/t8-,11+;;/m1../s1 D01PGJ DRUGINKE GIZKBHWITTWBAP-IEQXMABBSA-N D01PGJ DRUGSMIL C1C(NC(=O)C1(C[N+]2=CC=CC=C2)N)C(=O)O.Br.[Br-] D01PGJ HIGHSTAT Phase 1 D01PGO DRUG__ID D01PGO D01PGO DRUGCLAS Investigative Drug(s) D01PGO DRUGINCH 1S/C17H27NO4/c1-8-9-21-16(20)14-10(2)13(11(3)18-14)15(19)22-12(4)17(5,6)7/h12,18H,8-9H2,1-7H3/t12-/m0/s1 D01PGO DRUGINKE DOYZAIRDDZPMQZ-LBPRGKRZSA-N D01PGO DRUGSMIL CCCOC(=O)C1=C(C(=C(N1)C)C(=O)OC(C)C(C)(C)C)C D01PGO DRUGTYPE Small molecular drug D01PGO HIGHSTAT Investigative D01PGR DRUG__ID D01PGR D01PGR DRUGCLAS Clinical Trial Drug(s) D01PGR DRUGCOMP Sanofi; Exelixis D01PGR DRUGINCH 1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17) D01PGR DRUGINKE RGHYDLZMTYDBDT-UHFFFAOYSA-N D01PGR DRUGSMIL CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N D01PGR DRUGTYPE Small molecular drug D01PGR HIGHSTAT Phase 2 D01PGU DRUG__ID D01PGU D01PGU DRUGCLAS Investigative Drug(s) D01PGU DRUGINCH 1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7-,10-6+,18-13+/t17-/m0/s1 D01PGU DRUGINKE VHRUMKCAEVRUBK-GODQJPCRSA-N D01PGU DRUGSMIL CCCCCC=CC=C1C(C=CC1=O)CC=CCCCC(=O)O D01PGU DRUGTYPE Small molecular drug D01PGU HIGHSTAT Investigative D01PGY DRUG__ID D01PGY D01PGY DRUGCLAS Investigative Drug(s) D01PGY DRUGINCH 1S/C17H23N5O5/c1-3-4-5-6-7-11-19-15(21-26-2)12-16(20-11)22(9-18-12)17-14(25)13(24)10(8-23)27-17/h9-10,13-14,17,23-25H,3-5,8H2,1-2H3,(H,19,20,21)/t10-,13-,14-,17-/m1/s1 D01PGY DRUGINKE NIZLYCJGSQRCLN-IWCJZZDYSA-N D01PGY DRUGSMIL CCCCC#CC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NOC D01PGY DRUGTYPE Small molecular drug D01PGY HIGHSTAT Investigative D01PHK DRUG__ID D01PHK D01PHK DRUGCLAS Clinical Trial Drug(s) D01PHK DRUGCOMP Novactyl D01PHK HIGHSTAT Phase 2 D01PIL DRUG__ID D01PIL D01PIL DRUGCLAS Discontinued Drug(s) D01PIL DRUGINCH 1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1 D01PIL DRUGINKE GUJRSXAPGDDABA-NSHDSACASA-N D01PIL DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C=CC(=C2OC)Br)OC D01PIL DRUGTYPE Small molecular drug D01PIL HIGHSTAT Withdrawn from market D01PIL THERCLAS Antipsychotic Agents D01PIU DRUG__ID D01PIU D01PIU DRUGCLAS Investigative Drug(s) D01PIU DRUGINCH 1S/C16H13ClFN/c1-2-11-10-19(14-6-4-13(18)5-7-14)16-8-3-12(17)9-15(11)16/h3-10H,2H2,1H3 D01PIU DRUGINKE APVXBLPJSJGGAJ-UHFFFAOYSA-N D01PIU DRUGSMIL CCC1=CN(C2=C1C=C(C=C2)Cl)C3=CC=C(C=C3)F D01PIU DRUGTYPE Small molecular drug D01PIU HIGHSTAT Investigative D01PJR DRUG__ID D01PJR D01PJR DRUGCLAS Approved Drug(s) D01PJR DRUGINCH 1S/C11H16N2O/c1-7-5-4-6-8(2)10(7)13-11(14)9(3)12/h4-6,9H,12H2,1-3H3,(H,13,14) D01PJR DRUGINKE BUJAGSGYPOAWEI-UHFFFAOYSA-N D01PJR DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C(C)N D01PJR DRUGTYPE Small molecular drug D01PJR HIGHSTAT Approved D01PJR THERCLAS Antiarrhythmic Agents D01PJZ DRUG__ID D01PJZ D01PJZ COMPCLAS Cyclic peptidomimetic derivatives D01PJZ DRUGCLAS Patented Agent(s) D01PJZ DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D01PJZ DRUGTYPE Small molecule immunotherapy D01PJZ HIGHSTAT Patented D01PKC DRUG__ID D01PKC D01PKC DRUGCLAS Investigative Drug(s) D01PKC DRUGINCH 1S/C22H27Cl2N5S2/c1-15-13-30-21-20(15)25-14-26-22(21)27-16(2)12-28-7-9-29(10-8-28)31(3,4)17-5-6-18(23)19(24)11-17/h5-6,11,13-14,16H,3-4,7-10,12H2,1-2H3,(H,25,26,27)/t16-/m0/s1 D01PKC DRUGINKE WBVRCGUUZYPAGR-INIZCTEOSA-N D01PKC DRUGSMIL CC1=CSC2=C1N=CN=C2NC(C)CN3CCN(CC3)S(=C)(=C)C4=CC(=C(C=C4)Cl)Cl D01PKC DRUGTYPE Small molecular drug D01PKC HIGHSTAT Investigative D01PKG DRUG__ID D01PKG D01PKG DRUGCLAS Clinical Trial Drug(s) D01PKG DRUGCOMP Abbott Laboratories Abbott D01PKG DRUGSMIL failed D01PKG DRUGTYPE Combination drug D01PKG HIGHSTAT Phase 3 D01PKX DRUG__ID D01PKX D01PKX DRUGCLAS Investigative Drug(s) D01PKX DRUGCOMP Isis Pharmaceuticals D01PKX DRUGTYPE Antisense drug D01PKX HIGHSTAT Investigative D01PKZ DRUG__ID D01PKZ D01PKZ DRUGCLAS Patented Agent(s) D01PKZ DRUGCOMP FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO DE LA PRINCESA UNIVERSIDAD AUTONOMA DE MADRID DNS NEUROSCIENCE D01PKZ DRUGINCH 1S/C21H19FN2O3/c1-14(25)23-11-10-16-13-24-20-8-7-18(12-19(16)20)27-21(26)9-4-15-2-5-17(22)6-3-15/h2-9,12-13,24H,10-11H2,1H3,(H,23,25)/b9-4+ D01PKZ DRUGINKE SAMHXGDYEAOVQC-RUDMXATFSA-N D01PKZ DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC(=O)C=CC3=CC=C(C=C3)F D01PKZ DRUGTYPE Small molecular drug D01PKZ HIGHSTAT Patented D01PLH DRUG__ID D01PLH D01PLH DRUGCLAS Discontinued Drug(s) D01PLH DRUGCOMP Burroughs Wellcome Inc D01PLH DRUGINCH 1S/C22H24N2O2/c1-22(13-25,14-26)23-12-15-7-9-19-18(11-15)21-17-6-4-3-5-16(17)8-10-20(21)24(19)2/h3-11,23,25-26H,12-14H2,1-2H3 D01PLH DRUGINKE JVMISFXHWOKYOX-UHFFFAOYSA-N D01PLH DRUGSMIL CC(CO)(CO)NCC1=CC2=C(C=C1)N(C3=C2C4=CC=CC=C4C=C3)C D01PLH HIGHSTAT Discontinued in Phase 1 D01PLJ DRUG__ID D01PLJ D01PLJ DRUGCLAS Patented Agent(s) D01PLJ DRUGCOMP GRUENENTHAL GMBH [DE] D01PLJ DRUGTYPE Small molecular drug D01PLJ HIGHSTAT Patented D01PLN DRUG__ID D01PLN D01PLN DRUGCLAS Approved Drug(s) D01PLN DRUGCOMP Eli Lilly D01PLN DRUGINCH 1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1 D01PLN DRUGINKE XIURVHNZVLADCM-IUODEOHRSA-N D01PLN DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O D01PLN DRUGTYPE Small molecular drug D01PLN HIGHSTAT Approved D01PLN THERCLAS Antibiotics D01PLP DRUG__ID D01PLP D01PLP DRUGCLAS Investigative Drug(s) D01PLP DRUGINCH 1S/C11H8O4/c12-8-2-1-6-5-10(13)9(11(14)15)4-7(6)3-8/h1-5,12-13H,(H,14,15) D01PLP DRUGINKE QMWOUSYSNFCKAZ-UHFFFAOYSA-N D01PLP DRUGSMIL C1=CC(=CC2=CC(=C(C=C21)O)C(=O)O)O D01PLP DRUGTYPE Small molecular drug D01PLP HIGHSTAT Investigative D01PLR DRUG__ID D01PLR D01PLR DRUGCLAS Clinical Trial Drug(s) D01PLR DRUGCOMP Pfizer New York, NY D01PLR DRUGINCH 1S/C29H30F3N2O5P/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(29(30,31)32,39-40(36,37)38)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23H,9,11,13-14,17-18H2,1H3,(H,34,35)(H2,36,37,38)/t23-,27+,28-/m1/s1 D01PLR DRUGINKE BVXLAHSJXXSWFF-KEKPKEOLSA-N D01PLR DRUGSMIL CC1=C(C=CC=N1)NC(=O)C2=CC3=C(C=C2)C4(CCC(CC4CC3)(C(F)(F)F)OP(=O)(O)O)CC5=CC=CC=C5 D01PLR DRUGTYPE Small molecular drug D01PLR HIGHSTAT Phase 2 D01PNM DRUG__ID D01PNM D01PNM DRUGCLAS Investigative Drug(s) D01PNM DRUGINCH 1S/C26H30O6/c1-14(2)6-7-16(15(3)4)10-19-21(29)12-24(31-5)25-22(30)13-23(32-26(19)25)18-9-8-17(27)11-20(18)28/h6,8-9,11-12,16,23,27-29H,3,7,10,13H2,1-2,4-5H3/t16-,23+/m1/s1 D01PNM DRUGINKE LTTQKYMNTNISSZ-MWTRTKDXSA-N D01PNM DRUGSMIL CC(=CCC(CC1=C2C(=C(C=C1O)OC)C(=O)CC(O2)C3=C(C=C(C=C3)O)O)C(=C)C)C D01PNM DRUGTYPE Small molecular drug D01PNM HIGHSTAT Investigative D01PNR DRUG__ID D01PNR D01PNR DRUGCLAS Investigative Drug(s) D01PNR DRUGCOMP Aster Biopharmaceuticals Ltd D01PNR HIGHSTAT Investigative D01POG DRUG__ID D01POG D01POG DRUADIID CLI-01-ALDR-01103 D01POG DRUGCLAS Investigative Drug(s) D01POG DRUGINCH 1S/C27H36F2N2O4/c1-4-6-7-8-9-17-31(26(34)30-24-15-12-21(28)19-23(24)29)18-16-20-10-13-22(14-11-20)35-27(3,5-2)25(32)33/h10-15,19H,4-9,16-18H2,1-3H3,(H,30,34)(H,32,33)/t27-/m0/s1 D01POG DRUGINKE VGSJXSLGVQINOL-MHZLTWQESA-N D01POG DRUGSMIL CCCCCCCN(CCC1=CC=C(C=C1)OC(C)(CC)C(=O)O)C(=O)NC2=C(C=C(C=C2)F)F D01POG DRUGTYPE Small molecular drug D01POG HIGHSTAT Investigative D01PPR DRUG__ID D01PPR D01PPR DRUGCLAS Patented Agent(s) D01PPR DRUGINCH 1S/C20H26N2O2/c1-15-7-9-18(10-8-15)21-13-17-11-12-22(20(24)19(17)23)14-16-5-3-2-4-6-16/h2-6,11-12,15,18,21,23H,7-10,13-14H2,1H3 D01PPR DRUGINKE VJHCNYYTYSQTGD-UHFFFAOYSA-N D01PPR DRUGSMIL CC1CCC(CC1)NCC2=C(C(=O)N(C=C2)CC3=CC=CC=C3)O D01PPR DRUGTYPE Small molecular drug D01PPR HIGHSTAT Patented D01PPZ DRUG__ID D01PPZ D01PPZ DRUGCLAS Investigative Drug(s) D01PPZ DRUGINCH 1S/C16H24N4O2/c1-5-10(3)7-8-20-15-12(9-18-20)14(17)13(11(4)19-15)16(21)22-6-2/h9-10H,5-8H2,1-4H3,(H2,17,19) D01PPZ DRUGINKE YWSGZSUSPFMIIN-UHFFFAOYSA-N D01PPZ DRUGSMIL CCC(C)CCN1C2=NC(=C(C(=C2C=N1)N)C(=O)OCC)C D01PPZ DRUGTYPE Small molecular drug D01PPZ HIGHSTAT Investigative D01PQK DRUG__ID D01PQK D01PQK DRUGCLAS Drugs in Phase 2 Trial D01PQK DRUGTYPE Combination drug D01PQK HIGHSTAT Phase 2 Trial D01PQK THERCLAS Antiviral Agents D01PQM DRUG__ID D01PQM D01PQM DRUGCLAS Approved Drug(s) D01PQM DRUGCOMP DynPort Vaccine Company LLC D01PQM HIGHSTAT Approved D01PRH DRUG__ID D01PRH D01PRH DRUGCLAS Investigative Drug(s) D01PRH DRUGCOMP Epitomics Inc D01PRH HIGHSTAT Investigative D01PSI DRUG__ID D01PSI D01PSI DRUGCLAS Discontinued Drug(s) D01PSI DRUGCOMP Meiji Seika Kaisha Ltd D01PSI HIGHSTAT Discontinued in Phase 2 D01PSK DRUG__ID D01PSK D01PSK DRUGCLAS Patented Agent(s) D01PSK DRUGCOMP Janssen Pharmaceutica NV D01PSK DRUGINCH 1S/C23H24N4O3/c1-23(13-24,12-19-26-20(29-2)11-21(27-19)30-3)14-8-9-16-15-6-4-5-7-17(15)22(28)25-18(16)10-14/h8-11H,4-7,12H2,1-3H3,(H,25,28) D01PSK DRUGINKE FITDTEZFVLDGBX-UHFFFAOYSA-N D01PSK DRUGSMIL CC(CC1=NC(=CC(=N1)OC)OC)(C#N)C2=CC3=C(C=C2)C4=C(CCCC4)C(=O)N3 D01PSK DRUGTYPE Small molecular drug D01PSK HIGHSTAT Patented D01PSS DRUG__ID D01PSS D01PSS DRUGCLAS Investigative Drug(s) D01PSS DRUGINCH 1S/C9H15N2O14P3/c12-5-3-8(11-2-1-7(13)10-9(11)14)23-6(5)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,20,21)(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1 D01PSS DRUGINKE AHCYMLUZIRLXAA-SHYZEUOFSA-N D01PSS DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O D01PSS DRUGTYPE Small molecular drug D01PSS HIGHSTAT Investigative D01PSU DRUG__ID D01PSU D01PSU DRUGCLAS Investigative Drug(s) D01PSU DRUGSMIL C1=CC2=C(C=C1Cl)C(=C(N2)C3=C4C=C(C=CC4=NC3=O)Cl)NO D01PSU DRUGTYPE Small molecular drug D01PSU HIGHSTAT Investigative D01PSY DRUG__ID D01PSY D01PSY DRUGCLAS Investigative Drug(s) D01PSY DRUGCOMP Florida A & M University D01PSY HIGHSTAT Investigative D01PTE DRUG__ID D01PTE D01PTE DRUGCLAS Investigative Drug(s) D01PTE DRUGINCH 1S/C16H15NO2/c18-15-8-4-7-14-13(15)9-10-16(17-14)19-11-12-5-2-1-3-6-12/h1-3,5-6,9-10H,4,7-8,11H2 D01PTE DRUGINKE VGMBEUFDLPGOMH-UHFFFAOYSA-N D01PTE DRUGSMIL C1CC2=C(C=CC(=N2)OCC3=CC=CC=C3)C(=O)C1 D01PTE DRUGTYPE Small molecular drug D01PTE HIGHSTAT Investigative D01PTS DRUG__ID D01PTS D01PTS DRUGCLAS Clinical Trial Drug(s) D01PTS DRUGCOMP Bionovo Inc D01PTS HIGHSTAT Phase 1/2 D01PUS DRUG__ID D01PUS D01PUS DRUGCLAS Patented Agent(s) D01PUS DRUGCOMP C4T S.C. A.R.L D01PUS DRUGINCH 1S/C24H23NO5S2/c26-23-20-12-11-19(30-32(27,28)22-10-7-15-31-22)16-21(20)29-24(13-5-2-6-14-24)25(23)17-18-8-3-1-4-9-18/h1,3-4,7-12,15-16H,2,5-6,13-14,17H2 D01PUS DRUGINKE XBCSLRKNSRBEMJ-UHFFFAOYSA-N D01PUS DRUGSMIL C1CCC2(CC1)N(C(=O)C3=C(O2)C=C(C=C3)OS(=O)(=O)C4=CC=CS4)CC5=CC=CC=C5 D01PUS DRUGTYPE Small molecular drug D01PUS HIGHSTAT Patented D01PVV DRUG__ID D01PVV D01PVV DRUGCLAS Clinical Trial Drug(s) D01PVV DRUGCOMP Kalypsys D01PVV HIGHSTAT Phase 1 D01PWK DRUG__ID D01PWK D01PWK DRUGCLAS Discontinued Drug(s) D01PWK DRUGINCH 1S/C15H11BrCl2N2O4S/c16-9-3-1-2-8(4-9)7-20-14(15(21)22)19-12-6-10(17)5-11(18)13(12)25(20,23)24/h1-6,14,19H,7H2,(H,21,22) D01PWK DRUGINKE HNXXFIJGNAGRFN-UHFFFAOYSA-N D01PWK DRUGSMIL C1=CC(=CC(=C1)Br)CN2C(NC3=C(S2(=O)=O)C(=CC(=C3)Cl)Cl)C(=O)O D01PWK DRUGTYPE Small molecular drug D01PWK HIGHSTAT Terminated D01PWM DRUG__ID D01PWM D01PWM DRUGCLAS Investigative Drug(s) D01PWM DRUGINCH 1S/C45H44O11/c1-21(2)6-10-27-33(48)15-14-29(41(27)53)42(54)38-31(26-12-8-24(46)18-34(26)49)16-23(5)17-32(38)39-36(51)20-37(52)40-43(55)30(11-7-22(3)4)44(56-45(39)40)28-13-9-25(47)19-35(28)50/h6-9,12-15,17-20,31-32,38,46-53H,10-11,16H2,1-5H3/t31-,32-,38-/m0/s1 D01PWM DRUGINKE DKBPTKFKCCNXNH-QXGWMLRCSA-N D01PWM DRUGSMIL CC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C(=C(C=C3)O)CC=C(C)C)O)C4=C(C=C(C5=C4OC(=C(C5=O)CC=C(C)C)C6=C(C=C(C=C6)O)O)O)O D01PWM DRUGTYPE Small molecular drug D01PWM HIGHSTAT Investigative D01PWO DRUG__ID D01PWO D01PWO DRUGCLAS Investigative Drug(s) D01PWO DRUGINCH 1S/C11H14N2O4S/c12-9(11(14)15)5-6-18-7-8-3-1-2-4-10(8)13(16)17/h1-4,9H,5-7,12H2,(H,14,15) D01PWO DRUGINKE QZOGSZKBBMQKMN-UHFFFAOYSA-N D01PWO DRUGSMIL C1=CC=C(C(=C1)CSCCC(C(=O)O)N)[N+](=O)[O-] D01PWO DRUGTYPE Small molecular drug D01PWO HIGHSTAT Investigative D01PXH DRUG__ID D01PXH D01PXH DRUGCLAS Clinical Trial Drug(s) D01PXH DRUGCOMP Gamida Cell Jerusalem, Israel D01PXH HIGHSTAT Phase 1 D01PXI DRUG__ID D01PXI D01PXI DRUGCLAS Patented Agent(s) D01PXI DRUGCOMP GE HEALTHCARE LIMITED D01PXI DRUGTYPE Small molecular drug D01PXI HIGHSTAT Patented D01PYH DRUG__ID D01PYH D01PYH DRUGCLAS Clinical Trial Drug(s) D01PYH DRUGCOMP The Institute of Virology and Immunoprophylaxis D01PYH HIGHSTAT Phase 1 D01PYM DRUG__ID D01PYM D01PYM DRUGCLAS Patented Agent(s) D01PYM DRUGCOMP RIGAS, Basil D01PYM DRUGINCH 1S/C20H32O12P2/c1-6-26-33(23,27-7-2)30-15-17(32-34(24,28-8-3)29-9-4)14-25-20(22)18-12-10-11-13-19(18)31-16(5)21/h10-13,17H,6-9,14-15H2,1-5H3 D01PYM DRUGINKE UISLTGPOZYGIOG-UHFFFAOYSA-N D01PYM DRUGSMIL CCOP(=O)(OCC)OCC(COC(=O)C1=CC=CC=C1OC(=O)C)OP(=O)(OCC)OCC D01PYM DRUGTYPE Small molecular drug D01PYM HIGHSTAT Patented D01PYO DRUG__ID D01PYO D01PYO COMPCLAS Benzimidazole carboxamide derivatives D01PYO DRUGCLAS Patented Agent(s) D01PYO DRUGCOMP Angion Biomedica Corp D01PYO DRUGTYPE Small molecular drug D01PYO HIGHSTAT Patented D01PYU DRUG__ID D01PYU D01PYU DRUGCLAS Investigative Drug(s) D01PYU DRUGINCH 1S/C27H28N2/c1-3-10-21(11-4-1)17-19-29-18-9-14-23(20-29)26-24-15-7-8-16-25(24)28-27(26)22-12-5-2-6-13-22/h1-8,10-13,15-16,23,28H,9,14,17-20H2 D01PYU DRUGINKE HQXCPXHVSRWLFR-UHFFFAOYSA-N D01PYU DRUGSMIL C1CC(CN(C1)CCC2=CC=CC=C2)C3=C(NC4=CC=CC=C43)C5=CC=CC=C5 D01PYU DRUGTYPE Small molecular drug D01PYU HIGHSTAT Investigative D01PZD DRUG__ID D01PZD D01PZD DRUGCLAS Approved Drug(s) D01PZD DRUGCOMP Amgen D01PZD DRUGINCH 1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8- D01PZD DRUGINKE WUWDLXZGHZSWQZ-WQLSENKSSA-N D01PZD DRUGSMIL CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C D01PZD DRUGTYPE Small molecular drug D01PZD HIGHSTAT Approved D01PZJ DRUG__ID D01PZJ D01PZJ DRUGCLAS Investigative Drug(s) D01PZJ DRUGCOMP BigDNA Ltd D01PZJ HIGHSTAT Investigative D01PZP DRUG__ID D01PZP D01PZP DRUGCLAS Investigative Drug(s) D01PZP DRUGINCH 1S/C10H20O2/c1-9(6-8-11)5-4-7-10(2,3)12/h8-9,12H,4-7H2,1-3H3 D01PZP DRUGINKE WPFVBOQKRVRMJB-UHFFFAOYSA-N D01PZP DRUGSMIL CC(CCCC(C)(C)O)CC=O D01PZP DRUGTYPE Small molecular drug D01PZP HIGHSTAT Investigative D01PZU DRUG__ID D01PZU D01PZU DRUGCLAS Investigative Drug(s) D01PZU DRUGINCH 1S/C21H21N3O/c1-4-22-21(25)18-13-23-19(16-9-5-14(2)6-10-16)20(24-18)17-11-7-15(3)8-12-17/h5-13H,4H2,1-3H3,(H,22,25) D01PZU DRUGINKE BAXIFQMQEGUGGQ-UHFFFAOYSA-N D01PZU DRUGSMIL CCNC(=O)C1=CN=C(C(=N1)C2=CC=C(C=C2)C)C3=CC=C(C=C3)C D01PZU DRUGTYPE Small molecular drug D01PZU HIGHSTAT Investigative D01PZZ DRUG__ID D01PZZ D01PZZ DRUGCLAS Patented Agent(s) D01PZZ DRUGCOMP ELI LILLY AND COMPANY D01PZZ DRUGTYPE Small molecular drug D01PZZ HIGHSTAT Patented D01QAR DRUG__ID D01QAR D01QAR DRUGCLAS Discontinued Drug(s) D01QAR DRUGCOMP Eli Lilly & Co D01QAR DRUGINCH 1S/C20H30N2O2S/c1-19(2,3)14-9-13(10-15(17(14)23)20(4,5)6)11-16-18(24)22(12-25-16)21(7)8/h9-11,23H,12H2,1-8H3/b16-11- D01QAR DRUGINKE DNXBQWAKVPAADQ-WJDWOHSUSA-N D01QAR DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N(CS2)N(C)C D01QAR DRUGTYPE Small molecular drug D01QAR HIGHSTAT Terminated D01QBK DRUG__ID D01QBK D01QBK DRUGCLAS Investigative Drug(s) D01QBK DRUGINCH 1S/C11H14BrN5/c12-11-16-8-9(13)14-6-15-10(8)17(11)7-4-2-1-3-5-7/h6-7H,1-5H2,(H2,13,14,15) D01QBK DRUGINKE IVKXIMVGTFMPDF-UHFFFAOYSA-N D01QBK DRUGSMIL C1CCC(CC1)N2C3=NC=NC(=C3N=C2Br)N D01QBK DRUGTYPE Small molecular drug D01QBK HIGHSTAT Investigative D01QCJ DRUG__ID D01QCJ D01QCJ DRUGCLAS Investigative Drug(s) D01QCJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=C3C=CC(=O)C=C3)NC(=C2)C4=CC=C(C=C4)O D01QCJ DRUGTYPE Small molecular drug D01QCJ HIGHSTAT Investigative D01QCY DRUG__ID D01QCY D01QCY DRUGCLAS Investigative Drug(s) D01QCY DRUGCOMP Oncolys BioPharma Inc D01QCY HIGHSTAT Investigative D01QDB DRUG__ID D01QDB D01QDB DRUGCLAS Investigative Drug(s) D01QDB HIGHSTAT Investigative D01QDG DRUG__ID D01QDG D01QDG DRUGCLAS Investigative Drug(s) D01QDG DRUGINCH 1S/C15H12O3/c1-18-14-7-3-5-10-12(14)8-11-9(15(10)17)4-2-6-13(11)16/h2-7,16H,8H2,1H3 D01QDG DRUGINKE ZLLAABQSJKWBDB-UHFFFAOYSA-N D01QDG DRUGSMIL COC1=CC=CC2=C1CC3=C(C2=O)C=CC=C3O D01QDG DRUGTYPE Small molecular drug D01QDG HIGHSTAT Investigative D01QGX DRUG__ID D01QGX D01QGX DRUGCLAS Approved Drug(s) D01QGX DRUGCOMP Sumitomo D01QGX DRUGINCH 1S/C28H36N4O2S.ClH/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26;/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2;1H/t18-,19+,20-,21-,24+,25-;/m0./s1 D01QGX DRUGINKE NEKCRUIRPWNMLK-SCIYSFAVSA-N D01QGX DRUGSMIL C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O.Cl D01QGX DRUGTYPE Small molecular drug D01QGX HIGHSTAT Approved D01QIA DRUG__ID D01QIA D01QIA DRUGCLAS Discontinued Drug(s) D01QIA DRUGCOMP Bioglan Pharmaceuticals Co D01QIA HIGHSTAT Terminated D01QIN DRUG__ID D01QIN D01QIN DRUADIID FDA-AP-BF04-00037 D01QIN DRUGCLAS Approved Drug(s) D01QIN DRUGCOMP Pfizer Pharmaceuticals D01QIN DRUGINCH 1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1 D01QIN DRUGINKE XUKUURHRXDUEBC-KAYWLYCHSA-N D01QIN DRUGSMIL CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4 D01QIN DRUGTYPE Small molecular drug D01QIN HIGHSTAT Approved D01QIN THERCLAS Anticholesteremic Agents D01QIV DRUG__ID D01QIV D01QIV DRUGCLAS Investigative Drug(s) D01QIV DRUGCOMP Northwest Biotherapeutics Inc D01QIV HIGHSTAT Investigative D01QIX DRUG__ID D01QIX D01QIX DRUGCLAS Clinical Trial Drug(s) D01QIX HIGHSTAT Phase 2 D01QJT DRUG__ID D01QJT D01QJT DRUGCLAS Investigative Drug(s) D01QJT DRUGINCH 1S/C21H19ClN2O3S/c1-12-11-24-21(28-12)18(10-20(26)27)16-7-15(8-17(22)9-16)14-4-2-3-13(5-14)6-19(23)25/h2-5,7-9,11,18H,6,10H2,1H3,(H2,23,25)(H,26,27) D01QJT DRUGINKE SRVXSISGYBMIHR-UHFFFAOYSA-N D01QJT DRUGSMIL CC1=CN=C(S1)C(CC(=O)O)C2=CC(=CC(=C2)C3=CC=CC(=C3)CC(=O)N)Cl D01QJT DRUGTYPE Small molecular drug D01QJT HIGHSTAT Investigative D01QKD DRUG__ID D01QKD D01QKD DRUGCLAS Preclinical Drug(s) D01QKD DRUGCOMP Antisense Therapeutics D01QKD DRUGTYPE Antisense drug D01QKD HIGHSTAT Preclinical D01QKK DRUG__ID D01QKK D01QKK DRUGCLAS Investigative Drug(s) D01QKK DRUGINCH 1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37) D01QKK DRUGINKE BDUHCSBCVGXTJM-UHFFFAOYSA-N D01QKK DRUGSMIL CC(C)OC1=C(C=CC(=C1)OC)C2=NC(C(N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl D01QKK DRUGTYPE Small molecular drug D01QKK HIGHSTAT Investigative D01QKR DRUG__ID D01QKR D01QKR DRUGCLAS Discontinued Drug(s) D01QKR DRUGINCH 1S/C26H38N2O4/c1-3-13-27(20-16-21-22(31-2)9-8-10-23(21)32-19-20)14-6-7-15-28-24(29)17-26(18-25(28)30)11-4-5-12-26/h8-10,20H,3-7,11-19H2,1-2H3/t20-/m0/s1 D01QKR DRUGINKE DLLULNTXJPATBC-FQEVSTJZSA-N D01QKR DRUGSMIL CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C3CC4=C(C=CC=C4OC)OC3 D01QKR DRUGTYPE Small molecular drug D01QKR HIGHSTAT Discontinued in Phase 2 D01QKX DRUG__ID D01QKX D01QKX DRUGCLAS Investigative Drug(s) D01QKX DRUGINCH 1S/C27H50O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27(28)29/h18-19,22-23H,2-17,20-21,24-26H2,1H3,(H,28,29)/b19-18-,23-22- D01QKX DRUGINKE QHCUSXRHMXVISV-ZCIBKELESA-N D01QKX DRUGSMIL CCCCCCCCCCCCCCCCCC=CCCC=CCCCC(=O)O D01QKX DRUGTYPE Small molecular drug D01QKX HIGHSTAT Investigative D01QKZ DRUG__ID D01QKZ D01QKZ DRUGCLAS Clinical Trial Drug(s) D01QKZ DRUGTYPE Antibody D01QKZ HIGHSTAT Phase 1 D01QLH DRUG__ID D01QLH D01QLH DRUGCLAS Approved Drug(s) D01QLH DRUGINCH 1S/C5H11NO2/c1-2-3-4-5-8-6-7/h2-5H2,1H3 D01QLH DRUGINKE CSDTZUBPSYWZDX-UHFFFAOYSA-N D01QLH DRUGSMIL CCCCCON=O D01QLH DRUGTYPE Small molecular drug D01QLH HIGHSTAT Approved D01QLM DRUG__ID D01QLM D01QLM DRUGCLAS Preclinical Drug(s) D01QLM DRUGCOMP Janssen Alzheimer Immunotherapy; Pfizer D01QLM HIGHSTAT Phase 0 D01QLP DRUG__ID D01QLP D01QLP DRUGCLAS Clinical Trial Drug(s) D01QLP DRUGCOMP Oncomed pharmaceuticals D01QLP DRUGTYPE Monoclonal antibody D01QLP HIGHSTAT Phase 2 D01QMC DRUG__ID D01QMC D01QMC DRUGCLAS Clinical Trial Drug(s) D01QMC HIGHSTAT Phase 2 D01QMK DRUG__ID D01QMK D01QMK DRUGCLAS Clinical Trial Drug(s) D01QMK DRUGCOMP Seattle GeneticsBothell, WA D01QMK HIGHSTAT Phase 2 D01QML DRUG__ID D01QML D01QML DRUADIID FDA-AP-BF04-00510 D01QML DRUGCLAS Approved Drug(s) D01QML DRUGCOMP Wyeth Ayerst Laboratories D01QML DRUGINCH 1S/C24H31N3O2S/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28/h3-4,6-9,18,28H,2,5,10-17H2,1H3 D01QML DRUGINKE XZSMZRXAEFNJCU-UHFFFAOYSA-N D01QML DRUGSMIL CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO D01QML DRUGTYPE Small molecular drug D01QML HIGHSTAT Approved D01QML THERCLAS Antipsychotic Agents D01QNF DRUG__ID D01QNF D01QNF DRUGCLAS Investigative Drug(s) D01QNF DRUGCOMP Isis Pharmaceuticals D01QNF DRUGTYPE Antisense drug D01QNF HIGHSTAT Investigative D01QNJ DRUG__ID D01QNJ D01QNJ DRUGCLAS Investigative Drug(s) D01QNJ DRUGCOMP Kwang Dong Pharmaceutical Co Ltd D01QNJ HIGHSTAT Investigative D01QNO DRUG__ID D01QNO D01QNO DRUGCLAS Investigative Drug(s) D01QNO DRUGCOMP L M College of Pharmacy D01QNO HIGHSTAT Investigative D01QNR DRUG__ID D01QNR D01QNR DRUGCLAS Clinical Trial Drug(s) D01QNR DRUGCOMP Novartis Oncology East Hanover, NJ D01QNR DRUGINCH 1S/C24H23F3N4O/c1-13-9-14(11-15(28)10-13)16-7-8-29-12-21(16)31-24(32)20-6-5-19(27)23(30-20)22-17(25)3-2-4-18(22)26/h2-8,12-15H,9-11,28H2,1H3,(H,31,32)/t13-,14+,15-/m0/s1 D01QNR DRUGINKE VRQXRVAKPDCRCI-ZNMIVQPWSA-N D01QNR DRUGSMIL CC1CC(CC(C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F D01QNR HIGHSTAT Phase 1 D01QNX DRUG__ID D01QNX D01QNX DRUGCLAS Patented Agent(s) D01QNX DRUGCOMP ENANTA PHARMACEUTICALS, INC D01QNX DRUGTYPE Small molecular drug D01QNX HIGHSTAT Patented D01QOB DRUG__ID D01QOB D01QOB DRUGCLAS Investigative Drug(s) D01QOB DRUGINCH 1S/C13H18N2O4/c1-2-3-8-19-11-6-4-10(5-7-11)13(17)14-9-12(16)15-18/h4-7,18H,2-3,8-9H2,1H3,(H,14,17)(H,15,16) D01QOB DRUGINKE BFVCLRFRELSADQ-UHFFFAOYSA-N D01QOB DRUGSMIL CCCCOC1=CC=C(C=C1)C(=O)NCC(=O)NO D01QOB DRUGTYPE Small molecular drug D01QOB HIGHSTAT Investigative D01QOU DRUG__ID D01QOU D01QOU DRUGCLAS Investigative Drug(s) D01QOU DRUGINCH 1S/C16H15NO2.Na/c1-12(16(18)19)9-13-4-6-14(7-5-13)10-15-3-2-8-17-11-15;/h2-9,11H,10H2,1H3,(H,18,19);/q;+1/p-1/b12-9+; D01QOU DRUGINKE ZAPOSLLMEZKFQS-NBYYMMLRSA-M D01QOU DRUGSMIL CC(=CC1=CC=C(C=C1)CC2=CN=CC=C2)C(=O)[O-].[Na+] D01QOU DRUGTYPE Small molecular drug D01QOU HIGHSTAT Investigative D01QPX DRUG__ID D01QPX D01QPX DRUGCLAS Patented Agent(s) D01QPX DRUGINCH 1S/C18H14N10/c1-27-15-5-4-11(6-13(15)14(8-20)25-27)23-18-24-16(22-10-2-3-10)17-21-9-12(7-19)28(17)26-18/h4-6,9-10H,2-3H2,1H3,(H2,22,23,24,26) D01QPX DRUGINKE JAQNOWSPKHFMOW-UHFFFAOYSA-N D01QPX DRUGSMIL CN1C2=C(C=C(C=C2)NC3=NN4C(=CN=C4C(=N3)NC5CC5)C#N)C(=N1)C#N D01QPX DRUGTYPE Small molecular drug D01QPX HIGHSTAT Patented D01QQC DRUG__ID D01QQC D01QQC DRUGCLAS Clinical Trial Drug(s) D01QQC DRUGCOMP Advantagene D01QQC HIGHSTAT Phase 1/2 D01QQD DRUG__ID D01QQD D01QQD DRUGCLAS Investigative Drug(s) D01QQD DRUGINCH 1S/C22H28N4O3S/c23-22(24)25-13-7-12-19(21(28)29)26-20(27)15-30-14-18(16-8-3-1-4-9-16)17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2,(H,26,27)(H,28,29)(H4,23,24,25)/t19-/m0/s1 D01QQD DRUGINKE OVJFQPIFXZBDKN-IBGZPJMESA-N D01QQD DRUGSMIL C1=CC=C(C=C1)C(CSCC(=O)NC(CCCN=C(N)N)C(=O)O)C2=CC=CC=C2 D01QQD DRUGTYPE Small molecular drug D01QQD HIGHSTAT Investigative D01QQM DRUG__ID D01QQM D01QQM DRUGCLAS Discontinued Drug(s) D01QQM DRUGINCH 1S/C24H28N4O6/c25-22(26)16-3-5-17(6-4-16)23(32)27-20(13-15-1-7-18(29)8-2-15)24(33)28-11-9-19(10-12-28)34-14-21(30)31/h1-8,19-20,29H,9-14H2,(H3,25,26)(H,27,32)(H,30,31)/t20-/m0/s1 D01QQM DRUGINKE FPKOGTAFKSLZLD-FQEVSTJZSA-N D01QQM DRUGSMIL C1CN(CCC1OCC(=O)O)C(=O)C(CC2=CC=C(C=C2)O)NC(=O)C3=CC=C(C=C3)C(=N)N D01QQM DRUGTYPE Small molecular drug D01QQM HIGHSTAT Discontinued in Phase 3 D01QRF DRUG__ID D01QRF D01QRF DRUGCLAS Investigative Drug(s) D01QRF DRUGCOMP Ikerchem D01QRF HIGHSTAT Investigative D01QRG DRUG__ID D01QRG D01QRG DRUGCLAS Discontinued Drug(s) D01QRG DRUGCOMP Aventis D01QRG DRUGINCH 1S/C24H25FN4O4/c1-24(23(30)29-10-12-31-13-11-29)14-32-22(33-15-24)21-27-19(16-2-4-18(25)5-3-16)20(28-21)17-6-8-26-9-7-17/h2-9,22H,10-15H2,1H3,(H,27,28) D01QRG DRUGINKE YEQUJOKCSZTBFS-UHFFFAOYSA-N D01QRG DRUGSMIL CC1(COC(OC1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)C(=O)N5CCOCC5 D01QRG DRUGTYPE Small molecular drug D01QRG HIGHSTAT Terminated D01QRR DRUG__ID D01QRR D01QRR DRUGCLAS Investigative Drug(s) D01QRR DRUGINCH 1S/C20H25NO6/c22-19(14-8-4-5-9-14)26-15-11-24-18-16(12-25-17(15)18)27-20(23)21-10-13-6-2-1-3-7-13/h1-3,6-7,14-18H,4-5,8-12H2,(H,21,23)/t15-,16+,17-,18-/m1/s1 D01QRR DRUGINKE UPLFPBDRBGHRQW-XMTFNYHQSA-N D01QRR DRUGSMIL C1CCC(C1)C(=O)OC2COC3C2OCC3OC(=O)NCC4=CC=CC=C4 D01QRR DRUGTYPE Small molecular drug D01QRR HIGHSTAT Investigative D01QSG DRUG__ID D01QSG D01QSG DRUGCLAS Clinical Trial Drug(s) D01QSG DRUGCOMP Vitae Pharmaceuticals D01QSG DRUGINCH 1S/C26H41ClN4O5/c1-28-23(14-19-6-5-12-35-18-19)16-30-25(32)31-11-4-8-21(17-31)24(20-7-3-9-22(27)15-20)36-13-10-29-26(33)34-2/h3,7,9,15,19,21,23-24,28H,4-6,8,10-14,16-18H2,1-2H3,(H,29,33)(H,30,32)/t19-,21-,23+,24+/m1/s1 D01QSG DRUGINKE NXWASIVXQMMPLM-ZXMXYHOLSA-N D01QSG DRUGSMIL CNC(CC1CCCOC1)CNC(=O)N2CCCC(C2)C(C3=CC(=CC=C3)Cl)OCCNC(=O)OC D01QSG DRUGTYPE Small molecular drug D01QSG HIGHSTAT Phase 1 D01QSO DRUG__ID D01QSO D01QSO DRUGCLAS Clinical Trial Drug(s) D01QSO DRUGCOMP Novartis D01QSO DRUGINCH 1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23) D01QSO DRUGINKE CWHUFRVAEUJCEF-UHFFFAOYSA-N D01QSO DRUGSMIL C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4 D01QSO DRUGTYPE Small molecular drug D01QSO HIGHSTAT Phase 3 D01QSU DRUG__ID D01QSU D01QSU DRUADIID CLI-01-ALDR-01308 D01QSU DRUGCLAS Investigative Drug(s) D01QSU DRUGINCH 1S/C31H47N3O7/c1-19(2)15-23(33)27(39)30(18-35,34(7)29(41)25(37)17-21(5)6)31(26(38)13-14-32,22-11-9-8-10-12-22)28(40)24(36)16-20(3)4/h8-12,18-20,23-25,36-37H,5,13-17,32-33H2,1-4,6-7H3/t23-,24?,25-,30-,31?/m0/s1 D01QSU DRUGINKE ZPYMSTAWPQJBRU-DJQJIUKYSA-N D01QSU DRUGSMIL CC(C)CC(C(=O)C(C=O)(C(C1=CC=CC=C1)(C(=O)CCN)C(=O)C(CC(C)C)O)N(C)C(=O)C(CC(=C)C)O)N D01QSU DRUGTYPE Small molecular drug D01QSU HIGHSTAT Investigative D01QTD DRUG__ID D01QTD D01QTD DRUGCLAS Investigative Drug(s) D01QTD DRUGCOMP Genable Technologies Ltd D01QTD HIGHSTAT Investigative D01QTJ DRUG__ID D01QTJ D01QTJ DRUGCLAS Clinical Trial Drug(s) D01QTJ DRUGCOMP Xenon D01QTJ HIGHSTAT Phase 1 D01QUF DRUG__ID D01QUF D01QUF DRUGCLAS Discontinued Drug(s) D01QUF DRUGCOMP GlaxoSmithKline Inc D01QUF DRUGINCH 1S/C21H29NO5/c1-14(23)21(2)13-22(20(24)26-4)12-17(21)15-9-10-18(25-3)19(11-15)27-16-7-5-6-8-16/h9-11,16-17H,5-8,12-13H2,1-4H3/t17-,21-/m0/s1 D01QUF DRUGINKE YTFBNFMILWHYAP-UWJYYQICSA-N D01QUF DRUGSMIL CC(=O)C1(CN(CC1C2=CC(=C(C=C2)OC)OC3CCCC3)C(=O)OC)C D01QUF HIGHSTAT Terminated D01QUS DRUG__ID D01QUS D01QUS DRUGCLAS Approved Drug(s) D01QUS DRUGCOMP LEO Pharma Inc D01QUS DRUGINCH 1S/C27H40O3/c1-17(6-13-25(29)20-8-9-20)23-11-12-24-19(5-4-14-27(23,24)3)7-10-21-15-22(28)16-26(30)18(21)2/h6-7,10,13,17,20,22-26,28-30H,2,4-5,8-9,11-12,14-16H2,1,3H3/b13-6+,19-7+,21-10-/t17-,22-,23-,24+,25-,26+,27-/m1/s1 D01QUS DRUGINKE LWQQLNNNIPYSNX-UROSTWAQSA-N D01QUS DRUGSMIL CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C D01QUS DRUGTYPE Small molecular drug D01QUS HIGHSTAT Approved D01QUS THERCLAS Antipsoriatic Agents D01QWL DRUG__ID D01QWL D01QWL DRUGCLAS Investigative Drug(s) D01QWL DRUGINCH 1S/C25H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-25(29)26-21-22-18-19-23(27)24(28)20-22/h9-10,18-20,27-28H,2-8,11-17,21H2,1H3,(H,26,29)/b10-9- D01QWL DRUGINKE DMFNZWDAFAVBIA-KTKRTIGZSA-N D01QWL DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCC1=CC(=C(C=C1)O)O D01QWL DRUGTYPE Small molecular drug D01QWL HIGHSTAT Investigative D01QWO DRUG__ID D01QWO D01QWO DRUGCLAS Investigative Drug(s) D01QWO DRUGINCH 1S/C16H18O3/c1-2-3-12-18-14-8-10-16(11-9-14)19-15-6-4-13(17)5-7-15/h4-11,17H,2-3,12H2,1H3 D01QWO DRUGINKE WZNRRCAQHKVCHJ-UHFFFAOYSA-N D01QWO DRUGSMIL CCCCOC1=CC=C(C=C1)OC2=CC=C(C=C2)O D01QWO DRUGTYPE Small molecular drug D01QWO HIGHSTAT Investigative D01QWS DRUG__ID D01QWS D01QWS DRUGCLAS Clinical Trial Drug(s) D01QWS DRUGCOMP Galectin Therapeutics D01QWS HIGHSTAT Phase 1 D01QWT DRUG__ID D01QWT D01QWT DRUGCLAS Clinical Trial Drug(s) D01QWT DRUGCOMP Eli LillyIndianapolis, IN D01QWT HIGHSTAT Phase 3 D01QXL DRUG__ID D01QXL D01QXL DRUGCLAS Investigative Drug(s) D01QXL DRUGINCH 1S/C17H11NO3/c19-11-4-6-13-10(8-11)2-1-3-14(13)17-18-15-9-12(20)5-7-16(15)21-17/h1-9,19-20H D01QXL DRUGINKE GLVGKXBQPYTMGJ-UHFFFAOYSA-N D01QXL DRUGSMIL C1=CC2=C(C=CC(=C2)O)C(=C1)C3=NC4=C(O3)C=CC(=C4)O D01QXL DRUGTYPE Small molecular drug D01QXL HIGHSTAT Investigative D01QXS DRUG__ID D01QXS D01QXS DRUGCLAS Investigative Drug(s) D01QXS DRUGCOMP Rexahn Pharmaceuticals Inc D01QXS HIGHSTAT Investigative D01QXW DRUG__ID D01QXW D01QXW DRUGCLAS Investigative Drug(s) D01QXW DRUGCOMP MuriGen Therapeutics D01QXW DRUGTYPE Antibody D01QXW HIGHSTAT Investigative D01QXY DRUG__ID D01QXY D01QXY DRUGCLAS Clinical Trial Drug(s) D01QXY DRUGCOMP NuVax Therapeutics D01QXY DRUGINCH 1S/C20H24O4/c1-12(2)17-9-15(5-6-19(17)21)10-18-13(3)7-16(8-14(18)4)24-11-20(22)23/h5-9,12,21H,10-11H2,1-4H3,(H,22,23) D01QXY DRUGINKE QNAZTOHXCZPOSA-UHFFFAOYSA-N D01QXY DRUGSMIL CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)C(C)C)C)OCC(=O)O D01QXY DRUGTYPE Small molecular drug D01QXY HIGHSTAT Phase 1 D01QYA DRUG__ID D01QYA D01QYA DRUGCLAS Patented Agent(s) D01QYA DRUGINCH 1S/C19H26N2/c1-17-9-11-19(12-10-17)16-21(14-13-20(2)3)15-18-7-5-4-6-8-18/h4-12H,13-16H2,1-3H3 D01QYA DRUGINKE FAKZYZYSFVGBEY-UHFFFAOYSA-N D01QYA DRUGSMIL CC1=CC=C(C=C1)CN(CCN(C)C)CC2=CC=CC=C2 D01QYA DRUGTYPE Small molecular drug D01QYA HIGHSTAT Patented D01QYQ DRUG__ID D01QYQ D01QYQ DRUGCLAS Investigative Drug(s) D01QYQ DRUGCOMP University of Virginia D01QYQ DRUGINCH 1S/C26H26N6O4/c1-3-13-31-24-22(25(34)32(14-4-2)26(31)35)29-23(30-24)18-7-11-20(12-8-18)36-16-21(33)28-19-9-5-17(15-27)6-10-19/h5-12H,3-4,13-14,16H2,1-2H3,(H,28,33)(H,29,30) D01QYQ DRUGINKE AJBBEYXFRYFVNM-UHFFFAOYSA-N D01QYQ DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C#N D01QYQ DRUGTYPE Small molecular drug D01QYQ HIGHSTAT Investigative D01RAD DRUG__ID D01RAD D01RAD DRUGCLAS Investigative Drug(s) D01RAD DRUGINCH 1S/C16H15F3N2O4/c1-8-12(15(22)25-3)13(14(21(23)24)9(2)20-8)10-6-4-5-7-11(10)16(17,18)19/h4-7,13,20H,1-3H3 D01RAD DRUGINKE ZFLWDHHVRRZMEI-UHFFFAOYSA-N D01RAD DRUGSMIL CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC=CC=C2C(F)(F)F)C(=O)OC D01RAD DRUGTYPE Small molecular drug D01RAD HIGHSTAT Investigative D01RAE DRUG__ID D01RAE D01RAE DRUGCLAS Discontinued Drug(s) D01RAE DRUGCOMP Pfizer D01RAE DRUGINCH 1S/C21H27N3O3S/c22-28(25,26)19-7-5-18(6-8-19)24-14-12-23(13-15-24)11-9-21-20-4-2-1-3-17(20)10-16-27-21/h1-8,21H,9-16H2,(H2,22,25,26)/t21-/m0/s1 D01RAE DRUGINKE WNUQCGWXPNGORO-NRFANRHFSA-N D01RAE DRUGSMIL C1COC(C2=CC=CC=C21)CCN3CCN(CC3)C4=CC=C(C=C4)S(=O)(=O)N D01RAE DRUGTYPE Small molecular drug D01RAE HIGHSTAT Terminated D01RAN DRUG__ID D01RAN D01RAN DRUGCLAS Clinical Trial Drug(s) D01RAN DRUGCOMP Lacer SA D01RAN DRUGINCH 1S/C8H11NO6S/c1-4(10)16-6-3-14-7-5(15-9(11)12)2-13-8(6)7/h5-8H,2-3H2,1H3/t5-,6+,7-,8-/m1/s1 D01RAN DRUGINKE BXZDULYKEZVEEK-ULAWRXDQSA-N D01RAN DRUGSMIL CC(=O)SC1COC2C1OCC2O[N+](=O)[O-] D01RAN DRUGTYPE Small molecular drug D01RAN HIGHSTAT Phase 2 D01RBE DRUG__ID D01RBE D01RBE COMPCLAS Pyrrolidine carboxamide derivatives D01RBE DRUGCLAS Patented Agent(s) D01RBE DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, Cangming D01RBE DRUGINCH 1S/C30H34ClF3N4O/c1-18-13-28(38(35-18)21-6-8-26(33)25(31)15-21)19-9-11-36(12-10-19)29(39)24-17-37(30(2,3)4)16-23(24)22-7-5-20(32)14-27(22)34/h5-8,13-15,19,23-24H,9-12,16-17H2,1-4H3/t23-,24+/m0/s1 D01RBE DRUGINKE UGINLDOCQNRWSG-BJKOFHAPSA-N D01RBE DRUGSMIL CC1=NN(C(=C1)C2CCN(CC2)C(=O)C3CN(CC3C4=C(C=C(C=C4)F)F)C(C)(C)C)C5=CC(=C(C=C5)F)Cl D01RBE DRUGTYPE Small molecular drug D01RBE HIGHSTAT Patented D01RBK DRUG__ID D01RBK D01RBK DRUGCLAS Discontinued Drug(s) D01RBK DRUGCOMP AFG Biosolutions Inc D01RBK DRUGINCH 1S/C143H230N42O37S7/c1-24-69(11)105(148)135(213)162-82(27-4)118(196)174-94-58-225-59-95(175-123(201)89(48-67(7)8)169-115(193)74(16)158-138(216)107(70(12)25-2)180-132(94)210)133(211)184-112-79(21)229-61-96(160-104(190)56-152-134(212)100-38-34-44-185(100)142(112)220)128(206)164-84(36-29-32-42-145)120(198)182-109-76(18)226-60-97(161-103(189)55-151-117(195)85(39-45-223-22)165-122(200)88(47-66(5)6)168-113(191)72(14)156-102(188)54-153-136(109)214)129(207)171-92(51-101(147)187)125(203)166-86(40-46-224-23)119(197)163-83(35-28-31-41-144)121(199)183-110-77(19)228-63-99-130(208)170-90(49-80-52-149-64-154-80)124(202)176-98(62-227-78(20)111(141(219)177-99)181-116(194)75(17)159-140(110)218)131(209)173-93(57-186)127(205)179-108(71(13)26-3)139(217)172-91(50-81-53-150-65-155-81)126(204)178-106(68(9)10)137(215)157-73(15)114(192)167-87(143(221)222)37-30-33-43-146/h27,52-53,64-72,75-79,83-100,105-112,186H,15-16,24-26,28-51,54-63,144-146,148H2,1-14,17-23H3,(H2,147,187)(H,149,154)(H,150,155)(H,151,195)(H,152,212)(H,153,214)(H,156,188)(H,157,215)(H,158,216)(H,159,218)(H,160,190)(H,161,189)(H,162,213)(H,163,197)(H,164,206)(H,165,200)(H,166,203)(H,167,192)(H,168,191)(H,169,193)(H,170,208)(H,171,207)(H,172,217)(H,173,209)(H,174,196)(H,175,201)(H,176,202)(H,177,219)(H,178,204)(H,179,205)(H,180,210)(H,181,194)(H,182,198)(H,183,199)(H,184,211)(H,221,222)/b82-27- D01RBK DRUGINKE NVNLLIYOARQCIX-GSJOZIGCSA-N D01RBK DRUGSMIL CCC(C)C1C(=O)NC(=C)C(=O)NC(C(=O)NC(CSCC(C(=O)N1)NC(=O)C(=CC)NC(=O)C(C(C)CC)N)C(=O)NC2C(SCC(NC(=O)CNC(=O)C3CCCN3C2=O)C(=O)NC(CCCCN)C(=O)NC4C(SCC(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC4=O)C)CC(C)C)CCSC)C(=O)NC(CC(=O)N)C(=O)NC(CCSC)C(=O)NC(CCCCN)C(=O)NC5C(SCC6C(=O)NC(C(=O)NC(CSC(C(C(=O)N6)NC(=O)C(NC5=O)C)C)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC7=CN=CN7)C(=O)NC(C(C)C)C(=O)NC(=C)C(=O)NC(CCCCN)C(=O)O)CC8=CN=CN8)C)C)C)CC(C)C D01RBK HIGHSTAT Terminated D01RBP DRUG__ID D01RBP D01RBP DRUGCLAS Clinical Trial Drug(s) D01RBP DRUGCOMP Retrophin San Diego, CA D01RBP DRUGINCH 1S/C20H31N2O9P/c1-14(19(26)29-5)22-32(27,31-15-9-7-6-8-10-15)30-13-20(2,3)17(24)18(25)21-12-11-16(23)28-4/h6-10,14,17,24H,11-13H2,1-5H3,(H,21,25)(H,22,27)/t14-,17-,32?/m0/s1 D01RBP DRUGINKE HUWUHKIPYXWUPN-YVRVQSMLSA-N D01RBP DRUGSMIL CC(C(=O)OC)NP(=O)(OCC(C)(C)C(C(=O)NCCC(=O)OC)O)OC1=CC=CC=C1 D01RBP HIGHSTAT Phase 3 D01RBR DRUG__ID D01RBR D01RBR DRUGCLAS Clinical Trial Drug(s) D01RBR DRUGCOMP Saegis Pharmaceuticals D01RBR DRUGINCH 1S/C7H18NO2P/c1-2-3-6-11(9,10)7-4-5-8/h2-8H2,1H3,(H,9,10) D01RBR DRUGINKE ONNMDRQRSGKZCN-UHFFFAOYSA-N D01RBR DRUGSMIL CCCCP(=O)(CCCN)O D01RBR DRUGTYPE Small molecular drug D01RBR HIGHSTAT Phase 2 D01RCC DRUG__ID D01RCC D01RCC DRUGCLAS Discontinued Drug(s) D01RCC DRUGCOMP Bristol-Myers Squibb Co D01RCC DRUGINCH 1S/C36H54N4O9/c1-35(2,3)48-33(44)38-28(20-25-10-8-7-9-11-25)30(41)22-37-23-31(42)29(39-34(45)49-36(4,5)6)21-26-12-14-27(15-13-26)47-24-32(43)40-16-18-46-19-17-40/h7-15,28-31,37,41-42H,16-24H2,1-6H3,(H,38,44)(H,39,45)/t28-,29-,30+,31+/m0/s1 D01RCC DRUGINKE OQHZMGOXOOOFEE-SYQUUIDJSA-N D01RCC DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(CNCC(C(CC2=CC=C(C=C2)OCC(=O)N3CCOCC3)NC(=O)OC(C)(C)C)O)O D01RCC DRUGTYPE Small molecular drug D01RCC HIGHSTAT Terminated D01RCM DRUG__ID D01RCM D01RCM DRUGCLAS Clinical Trial Drug(s) D01RCM HIGHSTAT Phase 1 D01RCS DRUG__ID D01RCS D01RCS DRUGCLAS Discontinued Drug(s) D01RCS DRUGINCH 1S/C24H32N4O2S/c29-21-17-24(9-3-4-10-24)18-22(30)28(21)12-6-5-11-26-13-15-27(16-14-26)23-19-7-1-2-8-20(19)31-25-23/h1-2,7-8H,3-6,9-18H2 D01RCS DRUGINKE ZFZPJDFBJFHYIV-UHFFFAOYSA-N D01RCS DRUGSMIL C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54 D01RCS DRUGTYPE Small molecular drug D01RCS HIGHSTAT Discontinued in Phase 3 D01RDB DRUG__ID D01RDB D01RDB DRUGCLAS Investigative Drug(s) D01RDB DRUGINCH 1S/C15H13N5O/c16-15(17)20-14(21)10-6-2-1-5-9(10)13-18-11-7-3-4-8-12(11)19-13/h1-8H,(H,18,19)(H4,16,17,20,21) D01RDB DRUGINKE FJRZRURKRDCIKZ-UHFFFAOYSA-N D01RDB DRUGSMIL C1=CC=C(C(=C1)C2=NC3=CC=CC=C3N2)C(=O)N=C(N)N D01RDB DRUGTYPE Small molecular drug D01RDB HIGHSTAT Investigative D01RDR DRUG__ID D01RDR D01RDR DRUGCLAS Clinical Trial Drug(s) D01RDR DRUGCOMP Arch Biopartners Toronto, Canada D01RDR HIGHSTAT Phase 1 D01REE DRUG__ID D01REE D01REE DRUGCLAS Clinical Trial Drug(s) D01REE DRUGCOMP Dong-A Pharmaceutical Co Ltd D01REE DRUGINCH 1S/C8H15NO2.C2H4/c1-7(2)8(10)11-6-5-9(3)4;1-2/h1,5-6H2,2-4H3;1-2H2 D01REE DRUGINKE PNMYDOBPCBCQIA-UHFFFAOYSA-N D01REE DRUGSMIL CC(=C)C(=O)OCCN(C)C.C=C D01REE DRUGTYPE Small molecular drug D01REE HIGHSTAT Phase 3 D01REI DRUG__ID D01REI D01REI DRUGCLAS Investigative Drug(s) D01REI DRUGINCH 1S/C18H15NO2/c20-17-6-5-16(12-18(17)21)15-3-1-13(2-4-15)11-14-7-9-19-10-8-14/h1-10,12,20-21H,11H2 D01REI DRUGINKE KOYRCBKCALKGKO-UHFFFAOYSA-N D01REI DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC(=C(C=C3)O)O D01REI DRUGTYPE Small molecular drug D01REI HIGHSTAT Investigative D01REJ DRUG__ID D01REJ D01REJ DRUGCLAS Clinical Trial Drug(s) D01REJ DRUGCOMP Virobay Inc D01REJ HIGHSTAT Phase 1 D01RFF DRUG__ID D01RFF D01RFF DRUGCLAS Investigative Drug(s) D01RFF DRUGINCH 1S/C21H23F2NO2/c1-5-25-18-11-13(21(2,3)4)9-10-14(18)17-12-26-20(24-17)19-15(22)7-6-8-16(19)23/h6-11,17H,5,12H2,1-4H3 D01RFF DRUGINKE IXSZQYVWNJNRAL-UHFFFAOYSA-N D01RFF DRUGSMIL CCOC1=C(C=CC(=C1)C(C)(C)C)C2COC(=N2)C3=C(C=CC=C3F)F D01RFF DRUGTYPE Small molecular drug D01RFF HIGHSTAT Investigative D01RFG DRUG__ID D01RFG D01RFG DRUGCLAS Investigative Drug(s) D01RFG DRUGINCH 1S/C19H26N2O/c1-12-17-10-14-5-6-15(18(20)22)9-16(14)19(12,2)7-8-21(17)11-13-3-4-13/h5-6,9,12-13,17H,3-4,7-8,10-11H2,1-2H3,(H2,20,22)/t12-,17?,19-/m0/s1 D01RFG DRUGINKE FAVQVALXVLMHLE-BKBNBNODSA-N D01RFG DRUGSMIL CC1C2CC3=C(C1(CCN2CC4CC4)C)C=C(C=C3)C(=O)N D01RFG DRUGTYPE Small molecular drug D01RFG HIGHSTAT Investigative D01RFI DRUG__ID D01RFI D01RFI DRUGCLAS Discontinued Drug(s) D01RFI DRUGINCH 1S/C27H36N2O2/c1-4-5-6-13-24(25-16-18-26(31-3)19-17-25)14-8-15-27(30)29-22(2)10-7-11-23-12-9-20-28-21-23/h8-9,12,14-22H,4-7,10-11,13H2,1-3H3,(H,29,30)/b15-8+,24-14+/t22-/m1/s1 D01RFI DRUGINKE HLCHRSFXEXAMLU-YDQNRGGDSA-N D01RFI DRUGSMIL CCCCCC(=CC=CC(=O)NC(C)CCCC1=CN=CC=C1)C2=CC=C(C=C2)OC D01RFI DRUGTYPE Small molecular drug D01RFI HIGHSTAT Terminated D01RGG DRUG__ID D01RGG D01RGG DRUGCLAS Investigative Drug(s) D01RGG DRUGINCH 1S/C15H17N3S/c1-15(2,3)13-9-19-14(18-13)17-12-6-4-5-11-10(12)7-8-16-11/h4-9,16H,1-3H3,(H,17,18) D01RGG DRUGINKE ITGYBDHDFLFUCN-UHFFFAOYSA-N D01RGG DRUGSMIL CC(C)(C)C1=CSC(=N1)NC2=CC=CC3=C2C=CN3 D01RGG DRUGTYPE Small molecular drug D01RGG HIGHSTAT Investigative D01RGM DRUG__ID D01RGM D01RGM DRUGCLAS Investigative Drug(s) D01RGM DRUGINCH 1S/C10H11F3N2S/c1-2-16-9(14)15-8-5-3-7(4-6-8)10(11,12)13/h3-6H,2H2,1H3,(H2,14,15) D01RGM DRUGINKE LCMOXIFARISMOH-UHFFFAOYSA-N D01RGM DRUGSMIL CCSC(=NC1=CC=C(C=C1)C(F)(F)F)N D01RGM DRUGTYPE Small molecular drug D01RGM HIGHSTAT Investigative D01RHK DRUG__ID D01RHK D01RHK DRUGCLAS Patented Agent(s) D01RHK DRUGCOMP WASHINGTON UNIVERSITY D01RHK DRUGTYPE Carbohydrates D01RHK HIGHSTAT Patented D01RHR DRUG__ID D01RHR D01RHR DRUGCLAS Investigative Drug(s) D01RHR DRUGINCH 1S/C29H23F3N6O3/c1-3-25(39)35-20-8-5-9-21(13-20)38-28-33-15-23(16-34-28)37-27(41)24-14-22(11-10-17(24)2)36-26(40)18-6-4-7-19(12-18)29(30,31)32/h3-16H,1H2,2H3,(H,35,39)(H,36,40)(H,37,41)(H,33,34,38) D01RHR DRUGINKE BTWVWABAWDKQNJ-UHFFFAOYSA-N D01RHR DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)C(=O)NC3=CN=C(N=C3)NC4=CC(=CC=C4)NC(=O)C=C D01RHR DRUGTYPE Small molecular drug D01RHR HIGHSTAT Investigative D01RIP DRUG__ID D01RIP D01RIP DRUGCLAS Investigative Drug(s) D01RIP DRUGINCH 1S/C33H35F2N3O6S/c1-33(2)30(31(42)37-27-21-12-7-6-11-20(21)16-25(27)39)38(18-45-33)32(43)28(41)24(15-19-9-4-3-5-10-19)36-26(40)17-44-29-22(34)13-8-14-23(29)35/h3-14,24-25,27-28,30,39,41H,15-18H2,1-2H3,(H,36,40)(H,37,42)/t24-,25+,27-,28-,30+/m0/s1 D01RIP DRUGINKE KCNWMHBIZSWXTB-UPZHSWQNSA-N D01RIP DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=C(C=CC=C3F)F)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D01RIP DRUGTYPE Small molecular drug D01RIP HIGHSTAT Investigative D01RIT DRUG__ID D01RIT D01RIT COMPCLAS Pyrazole derivatives D01RIT DRUGCLAS Patented Agent(s) D01RIT DRUGINCH 1S/C25H28Cl2N4OS/c1-3-4-6-9-19-11-13-22(33-19)24-17(2)23(25(32)29-30-14-7-5-8-15-30)28-31(24)21-12-10-18(26)16-20(21)27/h6,9-13,16H,3-5,7-8,14-15H2,1-2H3,(H,29,32)/b9-6+ D01RIT DRUGINKE IHFQVFSRVQQXSC-RMKNXTFCSA-N D01RIT DRUGSMIL CCCC=CC1=CC=C(S1)C2=C(C(=NN2C3=C(C=C(C=C3)Cl)Cl)C(=O)NN4CCCCC4)C D01RIT DRUGTYPE Small molecular drug D01RIT HIGHSTAT Patented D01RJL DRUG__ID D01RJL D01RJL COMPCLAS Cyclopropyl-spiro piperidine derivatives D01RJL DRUGCLAS Patented Agent(s) D01RJL DRUGCOMP MERCK SHARP & DOHME CORP. HO, Ginny, D. TULSHIAN, Deen HEAP, Charles, R D01RJL DRUGTYPE Small molecular drug D01RJL HIGHSTAT Patented D01RJV DRUG__ID D01RJV D01RJV DRUGCLAS Investigative Drug(s) D01RJV DRUGINCH 1S/C8H13N3/c1-6-7(2-3-10-6)8-4-9-5-11-8/h4-7,10H,2-3H2,1H3,(H,9,11)/t6-,7+/m0/s1 D01RJV DRUGINKE FLOJCNYYPGNYBP-NKWVEPMBSA-N D01RJV DRUGSMIL CC1C(CCN1)C2=CN=CN2 D01RJV DRUGTYPE Small molecular drug D01RJV HIGHSTAT Investigative D01RJY DRUG__ID D01RJY D01RJY DRUGCLAS Investigative Drug(s) D01RJY DRUGINCH 1S/C19H23NO2/c21-19(20-22)11-7-2-1-4-8-16-12-14-18(15-13-16)17-9-5-3-6-10-17/h3,5-6,9-10,12-15,22H,1-2,4,7-8,11H2,(H,20,21) D01RJY DRUGINKE UDSUAIGMNDAMBQ-UHFFFAOYSA-N D01RJY DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCCCCCC(=O)NO D01RJY DRUGTYPE Small molecular drug D01RJY HIGHSTAT Investigative D01RKI DRUG__ID D01RKI D01RKI DRUGCLAS Investigative Drug(s) D01RKI DRUGINCH 1S/C42H47BrN4O5S/c43-28-12-16-31(17-13-28)53(50,51)52-36-11-7-10-32-33-18-21-44-38(39(33)45-37(32)36)34-26-42(49)20-5-3-1-2-4-6-22-46-24-19-35(34)41(27-46)25-29-14-15-30(48)9-8-23-47(29)40(41)42/h1,3,7,10-13,16-18,21,26,29,35,40,45,49H,2,4-6,8-9,14-15,19-20,22-25,27H2/b3-1-/t29-,35?,40+,41-,42-/m0/s1 D01RKI DRUGINKE WYQZODVBTOVVOF-WXPZYUJUSA-N D01RKI DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC5N4CCCC(=O)CC5)O)C6=NC=CC7=C6NC8=C7C=CC=C8OS(=O)(=O)C9=CC=C(C=C9)Br D01RKI DRUGTYPE Small molecular drug D01RKI HIGHSTAT Investigative D01RKQ DRUG__ID D01RKQ D01RKQ DRUGCLAS Discontinued Drug(s) D01RKQ DRUGCOMP Novartis AG D01RKQ DRUGINCH 1S/C61H99N9O14/c1-21-37(9)50-52(73)62-33-45(71)66(16)48(35(5)6)53(74)63-42(31-40-26-28-41(82-20)29-27-40)60(81)83-39(11)55(76)70-30-24-23-25-43(70)56(77)67(17)49(36(7)8)54(75)64-47(34(3)4)58(79)65(15)44(32-46(72)84-61(12,13)14)57(78)69(19)51(38(10)22-2)59(80)68(50)18/h26-29,34-39,42-44,47-51H,21-25,30-33H2,1-20H3,(H,62,73)(H,63,74)(H,64,75)/t37-,38-,39+,42-,43-,44-,47-,48-,49-,50-,51-/m0/s1 D01RKQ DRUGINKE UGWMRFXIOXUDPM-OUABENRGSA-N D01RKQ DRUGSMIL CCC(C)C1C(=O)NCC(=O)N(C(C(=O)NC(C(=O)OC(C(=O)N2CCCCC2C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)CC)C)CC(=O)OC(C)(C)C)C)C(C)C)C(C)C)C)C)CC3=CC=C(C=C3)OC)C(C)C)C D01RKQ HIGHSTAT Terminated D01RKY DRUG__ID D01RKY D01RKY DRUGCLAS Discontinued Drug(s) D01RKY DRUGCOMP Novartis AG D01RKY HIGHSTAT Discontinued in Phase 1 D01RLA DRUG__ID D01RLA D01RLA DRUGCLAS Investigative Drug(s) D01RLA DRUGCOMP Cyclacel Pharmaceuticals Inc D01RLA HIGHSTAT Investigative D01RLF DRUG__ID D01RLF D01RLF DRUGCLAS Investigative Drug(s) D01RLF DRUGINCH 1S/C14H12N2O2/c1-2-18-14(17)12-7-10-9-5-3-4-6-11(9)16-13(10)8-15-12/h3-8,16H,2H2,1H3 D01RLF DRUGINKE KOVRZNUMIKACTB-UHFFFAOYSA-N D01RLF DRUGSMIL CCOC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D01RLF DRUGTYPE Small molecular drug D01RLF HIGHSTAT Investigative D01RLG DRUG__ID D01RLG D01RLG DRUGCLAS Approved Drug(s) D01RLG DRUGCOMP Astellas Pharma Inc D01RLG HIGHSTAT Approved D01RLS DRUG__ID D01RLS D01RLS DRUGCLAS Clinical Trial Drug(s) D01RLS DRUGCOMP Stematix Inc D01RLS HIGHSTAT Phase 1/2 D01RLU DRUG__ID D01RLU D01RLU DRUGCLAS Discontinued Drug(s) D01RLU DRUGCOMP Ark Therapeutics Group plc D01RLU HIGHSTAT Discontinued in Phase 1/2 D01RNA DRUG__ID D01RNA D01RNA DRUGCLAS Investigative Drug(s) D01RNA DRUGINCH 1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9,19,21-25,28H,6,8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1 D01RNA DRUGINKE AVSXSVCZWQODGV-DPAQBDIFSA-N D01RNA DRUGSMIL CC(CCC=C(C)C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C D01RNA DRUGTYPE Small molecular drug D01RNA HIGHSTAT Investigative D01RNF DRUG__ID D01RNF D01RNF DRUGCLAS Investigative Drug(s) D01RNF DRUGCOMP ZGene A/S D01RNF HIGHSTAT Investigative D01RNL DRUG__ID D01RNL D01RNL DRUGCLAS Discontinued Drug(s) D01RNL DRUGCOMP PDL BioPharma Inc; Seattle Genetics D01RNL DRUGTYPE Antibody D01RNL HIGHSTAT Discontinued in Phase 2 D01RNV DRUG__ID D01RNV D01RNV DRUGCLAS Clinical Trial Drug(s) D01RNV DRUGCOMP Amsterdam Molecular Therapeutics D01RNV HIGHSTAT Phase 3 D01RPD DRUG__ID D01RPD D01RPD DRUGCLAS Investigative Drug(s) D01RPD DRUGINCH 1S/C18H18N4O2/c1-20-14(12-8-7-11-13-9-5-4-6-10-13)19-16-15(20)17(23)22(3)18(24)21(16)2/h4-12H,1-3H3/b11-7+,12-8+ D01RPD DRUGINKE NDTZOLIJIQKCRC-MKICQXMISA-N D01RPD DRUGSMIL CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)C=CC=CC3=CC=CC=C3 D01RPD DRUGTYPE Small molecular drug D01RPD HIGHSTAT Investigative D01RPM DRUG__ID D01RPM D01RPM DRUGCLAS Investigative Drug(s) D01RPM DRUGINCH 1S/C18H33NO4/c1-2-3-4-5-6-8-11-14-17(19(22)23)15-12-9-7-10-13-16-18(20)21/h14H,2-13,15-16H2,1H3,(H,20,21)/b17-14+ D01RPM DRUGINKE CQOAKBVRRVHWKV-SAPNQHFASA-N D01RPM DRUGSMIL CCCCCCCCC=C(CCCCCCCC(=O)O)[N+](=O)[O-] D01RPM DRUGTYPE Small molecular drug D01RPM HIGHSTAT Investigative D01RQE DRUG__ID D01RQE D01RQE DRUGCLAS Patented Agent(s) D01RQE DRUGINCH 1S/C28H35N5O2S/c1-21(34)29-24-7-4-6-23(20-24)22-10-14-31(15-11-22)12-5-13-33-28(35)26-9-3-2-8-25(26)27(30-33)32-16-18-36-19-17-32/h2-4,6-9,20,22H,5,10-19H2,1H3,(H,29,34) D01RQE DRUGINKE XXBGKRFICBGOCH-UHFFFAOYSA-N D01RQE DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2CCN(CC2)CCCN3C(=O)C4=CC=CC=C4C(=N3)N5CCSCC5 D01RQE DRUGTYPE Small molecular drug D01RQE HIGHSTAT Patented D01RQK DRUG__ID D01RQK D01RQK DRUGCLAS Investigative Drug(s) D01RQK DRUGINCH 1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7-,10-6-,18-13+/t17-/m0/s1 D01RQK DRUGINKE VHRUMKCAEVRUBK-WKELIDJCSA-N D01RQK DRUGSMIL CCCCCC=CC=C1C(C=CC1=O)CC=CCCCC(=O)O D01RQK DRUGTYPE Small molecular drug D01RQK HIGHSTAT Investigative D01RQN DRUG__ID D01RQN D01RQN DRUGCLAS Clinical Trial Drug(s) D01RQN DRUGINCH 1S/C17H23NO5/c1-17(2,3)23-16(21)18-9-13(14(10-18)15(19)20)11-5-7-12(22-4)8-6-11/h5-8,13-14H,9-10H2,1-4H3,(H,19,20) D01RQN DRUGINKE ISEHHCOIDMZBSU-UHFFFAOYSA-N D01RQN DRUGSMIL CC(C)(C)OC(=O)N1CC(C(C1)C(=O)O)C2=CC=C(C=C2)OC D01RQN HIGHSTAT Phase 1 D01RQP DRUG__ID D01RQP D01RQP DRUGCLAS Clinical Trial Drug(s) D01RQP DRUGCOMP ImmunGeneCamarillo, CA D01RQP HIGHSTAT Phase 1 D01RQV DRUG__ID D01RQV D01RQV DRUGCLAS Approved Drug(s) D01RQV DRUGCOMP Alexion Pharmaceuticals Inc D01RQV DRUGTYPE Monoclonal antibody D01RQV HIGHSTAT Approved D01RRF DRUG__ID D01RRF D01RRF DRUGCLAS Clinical Trial Drug(s) D01RRF DRUGINCH 1S/C22H16N4O2S/c1-14-10-20(29-25-14)24-22(28)21(27)18-12-17(26-9-3-2-4-19(18)26)11-15-5-7-16(13-23)8-6-15/h2-10,12H,11H2,1H3,(H,24,28) D01RRF DRUGINKE IZZYUABKZYIINT-UHFFFAOYSA-N D01RRF DRUGSMIL CC1=NSC(=C1)NC(=O)C(=O)C2=C3C=CC=CN3C(=C2)CC4=CC=C(C=C4)C#N D01RRF DRUGTYPE Small molecular drug D01RRF HIGHSTAT Phase 1 D01RSH DRUG__ID D01RSH D01RSH DRUGCLAS Investigative Drug(s) D01RSH DRUGINCH 1S/C14H9BrClNO3/c15-9-3-1-2-8(6-9)13(18)17-12-7-10(16)4-5-11(12)14(19)20/h1-7H,(H,17,18)(H,19,20) D01RSH DRUGINKE NKUSVNRZDILGSG-UHFFFAOYSA-N D01RSH DRUGSMIL C1=CC(=CC(=C1)Br)C(=O)NC2=C(C=CC(=C2)Cl)C(=O)O D01RSH DRUGTYPE Small molecular drug D01RSH HIGHSTAT Investigative D01RSK DRUG__ID D01RSK D01RSK DRUGCLAS Investigative Drug(s) D01RSK DRUGCOMP UCB Celltech D01RSK HIGHSTAT Investigative D01RSW DRUG__ID D01RSW D01RSW DRUGCLAS Investigative Drug(s) D01RSW DRUGCOMP Tactical Therapeutics Inc D01RSW HIGHSTAT Investigative D01RTO DRUG__ID D01RTO D01RTO COMPCLAS Polyhydroxy benzamide derivatives D01RTO DRUGCLAS Patented Agent(s) D01RTO DRUGINCH 1S/C24H27NO4/c26-19-3-1-18(22(28)9-19)13-25-23(29)17-2-4-21(27)20(8-17)24-10-14-5-15(11-24)7-16(6-14)12-24/h1-4,8-9,14-16,26-28H,5-7,10-13H2,(H,25,29) D01RTO DRUGINKE FXWMRZHJFYXBFU-UHFFFAOYSA-N D01RTO DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C(=O)NCC5=C(C=C(C=C5)O)O)O D01RTO DRUGTYPE Small molecular drug D01RTO HIGHSTAT Patented D01RTR DRUG__ID D01RTR D01RTR DRUGCLAS Investigative Drug(s) D01RTR DRUGINCH 1S/C12H18N2/c1-11-4-3-8-14(11)9-6-12-5-2-7-13-10-12/h2,5,7,10-11H,3-4,6,8-9H2,1H3/t11-/m1/s1 D01RTR DRUGINKE WJLLZUXQRCOTAJ-LLVKDONJSA-N D01RTR DRUGSMIL CC1CCCN1CCC2=CN=CC=C2 D01RTR DRUGTYPE Small molecular drug D01RTR HIGHSTAT Investigative D01RTU DRUG__ID D01RTU D01RTU DRUGCLAS Investigative Drug(s) D01RTU DRUGINCH 1S/C22H34N4O2/c1-24-19(14-16-6-3-2-4-7-16)22(28)26-13-5-8-20(26)21(27)25-15-17-9-11-18(23)12-10-17/h2-4,6-7,17-20,24H,5,8-15,23H2,1H3,(H,25,27)/t17?,18?,19-,20+/m1/s1 D01RTU DRUGINKE MDSVGJAUFNXYRR-TUNPWDSISA-N D01RTU DRUGSMIL CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NCC3CCC(CC3)N D01RTU DRUGTYPE Small molecular drug D01RTU HIGHSTAT Investigative D01RUH DRUG__ID D01RUH D01RUH DRUGCLAS Investigative Drug(s) D01RUH DRUGINCH 1S/C18H13NO3/c1-21-13-9-10-7-8-19-16-14(10)15(18(13)22-2)11-5-3-4-6-12(11)17(16)20/h3-9H,1-2H3 D01RUH DRUGINKE DPBMWJXWUINLQT-UHFFFAOYSA-N D01RUH DRUGSMIL COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=CC=CC=C42)OC D01RUH DRUGTYPE Small molecular drug D01RUH HIGHSTAT Investigative D01RUI DRUG__ID D01RUI D01RUI DRUGCLAS Patented Agent(s) D01RUI DRUGCOMP CORNELL UNIVERSITY ITHACA COLLEGE D01RUI DRUGTYPE Small molecular drug D01RUI HIGHSTAT Patented D01RUK DRUG__ID D01RUK D01RUK DRUGCLAS Patented Agent(s) D01RUK DRUGCOMP Purdue Pharma L.P D01RUK DRUGINCH 1S/C20H20ClF4N3O3/c21-15-9-12(16(30)11-29)10-26-17(15)19(22)5-7-28(8-6-19)18(31)27-14-3-1-13(2-4-14)20(23,24)25/h1-4,9-10,16,29-30H,5-8,11H2,(H,27,31)/t16-/m1/s1 D01RUK DRUGINKE DSVBUDHKIZVCPH-MRXNPFEDSA-N D01RUK DRUGSMIL C1CN(CCC1(C2=C(C=C(C=N2)C(CO)O)Cl)F)C(=O)NC3=CC=C(C=C3)C(F)(F)F D01RUK DRUGTYPE Small molecular drug D01RUK HIGHSTAT Patented D01RUN DRUG__ID D01RUN D01RUN DRUGCLAS Investigative Drug(s) D01RUN DRUGINCH 1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)/t12-/m0/s1 D01RUN DRUGINKE HJORMJIFDVBMOB-LBPRGKRZSA-N D01RUN DRUGSMIL COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3 D01RUN DRUGTYPE Small molecular drug D01RUN HIGHSTAT Investigative D01RUO DRUG__ID D01RUO D01RUO DRUGCLAS Investigative Drug(s) D01RUO DRUGINCH 1S/C14H11N/c1-2-7-13-10-15-14-8-4-3-6-12(14)9-11(13)5-1/h1-8,10H,9H2 D01RUO DRUGINKE IDWNSAXOQLJYOF-UHFFFAOYSA-N D01RUO DRUGSMIL C1C2=CC=CC=C2C=NC3=CC=CC=C31 D01RUO DRUGTYPE Small molecular drug D01RUO HIGHSTAT Investigative D01RVA DRUG__ID D01RVA D01RVA DRUGCLAS Clinical Trial Drug(s) D01RVA DRUGCOMP Adria Laboratories Inc D01RVA DRUGINCH 1S/C14H18ClN3O2.ClH/c15-11-6-10(13-9(12(11)16)3-5-20-13)14(19)18-7-8-2-1-4-17-8;/h6,8,17H,1-5,7,16H2,(H,18,19);1H/t8-;/m0./s1 D01RVA DRUGINKE PCBGZTCWZUGEJX-QRPNPIFTSA-N D01RVA DRUGSMIL C1CC(NC1)CNC(=O)C2=CC(=C(C3=C2OCC3)N)Cl.Cl D01RVA DRUGTYPE Small molecular drug D01RVA HIGHSTAT Phase 1 D01RVF DRUG__ID D01RVF D01RVF DRUGCLAS Investigative Drug(s) D01RVF DRUGINCH 1S/C18H22N2O/c1-2-5-15(6-3-1)13-20-16-8-10-18(11-9-16)21-14-17-7-4-12-19-17/h1-3,5-6,8-11,17,19-20H,4,7,12-14H2/t17-/m1/s1 D01RVF DRUGINKE HITMFLNAOQIZSN-QGZVFWFLSA-N D01RVF DRUGSMIL C1CC(NC1)COC2=CC=C(C=C2)NCC3=CC=CC=C3 D01RVF DRUGTYPE Small molecular drug D01RVF HIGHSTAT Investigative D01RVS DRUG__ID D01RVS D01RVS DRUGCLAS Discontinued Drug(s) D01RVS DRUGCOMP AstraZeneca D01RVS DRUGINCH 1S/C22H28N6O3S.C16H15Cl2N3O2/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20;1-3-9-6-12(16(22)20-8(9)2)19-7-13-21-14-10(17)4-5-11(18)15(14)23-13/h4-8,13-15,24-26H,9-12H2,1-3H3;4-6,19H,3,7H2,1-2H3,(H,20,22) D01RVS DRUGINKE XOJHGEHJHFRZRW-UHFFFAOYSA-N D01RVS DRUGSMIL CCC1=C(NC(=O)C(=C1)NCC2=NC3=C(C=CC(=C3O2)Cl)Cl)C.CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C D01RVS DRUGTYPE Small molecular drug D01RVS HIGHSTAT Discontinued in Phase 1 D01RWS DRUG__ID D01RWS D01RWS DRUGCLAS Investigative Drug(s) D01RWS DRUGINCH 1S/C20H20O2/c1-13(2)17-10-9-14(3)19-18(17)12-16(20(21)22-19)11-15-7-5-4-6-8-15/h4-10,12-13H,11H2,1-3H3 D01RWS DRUGINKE PFSLDHWSUPFZPK-UHFFFAOYSA-N D01RWS DRUGSMIL CC1=C2C(=C(C=C1)C(C)C)C=C(C(=O)O2)CC3=CC=CC=C3 D01RWS DRUGTYPE Small molecular drug D01RWS HIGHSTAT Investigative D01RWY DRUG__ID D01RWY D01RWY DRUGCLAS Investigative Drug(s) D01RWY DRUGINCH 1S/C17H26ClNO/c1-5-6-7-11-15(19-17(2,3)4)16(20)13-9-8-10-14(18)12-13/h8-10,12,15,19H,5-7,11H2,1-4H3 D01RWY DRUGINKE OROOSQVGDDDAFY-UHFFFAOYSA-N D01RWY DRUGSMIL CCCCCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C D01RWY DRUGTYPE Small molecular drug D01RWY HIGHSTAT Investigative D01RXM DRUG__ID D01RXM D01RXM DRUGCLAS Investigative Drug(s) D01RXM DRUGINCH 1S/C9H9NO/c1-11-8-2-3-9-7(6-8)4-5-10-9/h2-6,10H,1H3 D01RXM DRUGINKE DWAQDRSOVMLGRQ-UHFFFAOYSA-N D01RXM DRUGSMIL COC1=CC2=C(C=C1)NC=C2 D01RXM DRUGTYPE Small molecular drug D01RXM HIGHSTAT Investigative D01RXV DRUG__ID D01RXV D01RXV DRUGCLAS Patented Agent(s) D01RXV DRUGINCH 1S/C24H21N7/c1-2-4-22-20(3-1)19(7-8-26-22)21-15-29-31-16-18(14-28-24(21)31)17-5-6-23(27-13-17)30-11-9-25-10-12-30/h1-8,13-16,25H,9-12H2 D01RXV DRUGINKE YTUZELSDHUVEFM-UHFFFAOYSA-N D01RXV DRUGSMIL C1CN(CCN1)C2=NC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3 D01RXV DRUGTYPE Small molecular drug D01RXV HIGHSTAT Patented D01RXW DRUG__ID D01RXW D01RXW DRUGCLAS Clinical Trial Drug(s) D01RXW DRUGCOMP Merck D01RXW DRUGINCH 1S/C38H55N5O9S/c1-7-25-18-38(25,33(46)41-53(49,50)27-14-15-27)40-31(44)29-17-26-20-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)16-9-8-11-23-12-10-13-24-19-42(21-28(23)24)35(48)52-26/h10,12-13,25-27,29-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,26-,29+,30-,38-/m1/s1 D01RXW DRUGINKE KUQWGLQLLVFLSM-ONAXAZCASA-N D01RXW DRUGSMIL CCC1CC1(C(=O)NS(=O)(=O)C2CC2)NC(=O)C3CC4CN3C(=O)C(NC(=O)OCC(CCCCC5=C6CN(CC6=CC=C5)C(=O)O4)(C)C)C(C)(C)C D01RXW DRUGTYPE Small molecular drug D01RXW HIGHSTAT Phase 2 D01RYJ DRUG__ID D01RYJ D01RYJ DRUGCLAS Investigative Drug(s) D01RYJ DRUGCOMP Onco-Pharmakon Inc D01RYJ HIGHSTAT Investigative D01RZG DRUG__ID D01RZG D01RZG COMPCLAS Amidine oxime derivatives D01RZG DRUGCLAS Patented Agent(s) D01RZG DRUGCOMP HUMAN BIOMOLECULAR RESEARCH INSTITUTE CASHMAN, John, R. KALISIAK, Jaroslaw D01RZG DRUGTYPE Small molecular drug D01RZG HIGHSTAT Patented D01RZP DRUG__ID D01RZP D01RZP DRUGCLAS Investigative Drug(s) D01RZP DRUGINCH 1S/C17H14O2S/c1-11-7-12(5-6-16(11)19)14-9-17(20-10-14)13-3-2-4-15(18)8-13/h2-10,18-19H,1H3 D01RZP DRUGINKE STFVOGWUKNAWOF-UHFFFAOYSA-N D01RZP DRUGSMIL CC1=C(C=CC(=C1)C2=CSC(=C2)C3=CC(=CC=C3)O)O D01RZP DRUGTYPE Small molecular drug D01RZP HIGHSTAT Investigative D01SAD DRUG__ID D01SAD D01SAD DRUGCLAS Investigative Drug(s) D01SAD DRUGCOMP Thrombotargets Corp D01SAD HIGHSTAT Investigative D01SAK DRUG__ID D01SAK D01SAK DRUGCLAS Investigative Drug(s) D01SAK DRUGCOMP TetraLogic Pharmaceuticals Corp D01SAK HIGHSTAT Investigative D01SAT DRUG__ID D01SAT D01SAT DRUGCLAS Approved Drug(s) D01SAT DRUGINCH 1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3 D01SAT DRUGINKE HXLAFSUPPDYFEO-UHFFFAOYSA-N D01SAT DRUGSMIL CC1=CC(=CC=C1)OCC(CNCCC2=CC(=C(C=C2)OC)OC)O D01SAT DRUGTYPE Small molecular drug D01SAT HIGHSTAT Approved D01SAT THERCLAS Antihypertensive Agents D01SAV DRUG__ID D01SAV D01SAV DRUGCLAS Clinical Trial Drug(s) D01SAV DRUGCOMP Oshadi Drug Administration Ltd D01SAV HIGHSTAT Phase 2 D01SAX DRUG__ID D01SAX D01SAX DRUGCLAS Investigative Drug(s) D01SAX DRUGINCH 1S/C22H27N3O3S/c1-25(14-12-17-10-11-19(26-2)20(16-17)27-3)13-7-15-28-22-23-21(29-24-22)18-8-5-4-6-9-18/h4-6,8-11,16H,7,12-15H2,1-3H3 D01SAX DRUGINKE RHJGWXNLFGHPHA-UHFFFAOYSA-N D01SAX DRUGSMIL CN(CCCOC1=NSC(=N1)C2=CC=CC=C2)CCC3=CC(=C(C=C3)OC)OC D01SAX DRUGTYPE Small molecular drug D01SAX HIGHSTAT Investigative D01SAY DRUG__ID D01SAY D01SAY DRUGCLAS Approved Drug(s) D01SAY DRUGCOMP Dendreon D01SAY HIGHSTAT Approved D01SAY TRADNAME Provenge D01SBC DRUG__ID D01SBC D01SBC DRUGCLAS Investigative Drug(s) D01SBC DRUGCOMP Scripps Research Institute D01SBC DRUGINCH 1S/C42H46F6N6O12/c43-41(44,45)29-14-10-25(11-15-29)23-65-39(63)53-31(37(59)60)8-1-3-18-49-33(55)21-51-35(57)27-6-5-7-28(20-27)36(58)52-22-34(56)50-19-4-2-9-32(38(61)62)54-40(64)66-24-26-12-16-30(17-13-26)42(46,47)48/h5-7,10-17,20,31-32H,1-4,8-9,18-19,21-24H2,(H,49,55)(H,50,56)(H,51,57)(H,52,58)(H,53,63)(H,54,64)(H,59,60)(H,61,62)/t31-,32-/m0/s1 D01SBC DRUGINKE QRURLAHCTNYZLV-ACHIHNKUSA-N D01SBC DRUGSMIL C1=CC(=CC(=C1)C(=O)NCC(=O)NCCCCC(C(=O)O)NC(=O)OCC2=CC=C(C=C2)C(F)(F)F)C(=O)NCC(=O)NCCCCC(C(=O)O)NC(=O)OCC3=CC=C(C=C3)C(F)(F)F D01SBC HIGHSTAT Investigative D01SBP DRUG__ID D01SBP D01SBP DRUGCLAS Discontinued Drug(s) D01SBP DRUGCOMP Purdue Neuroscience Corp D01SBP DRUGINCH 1S/C31H40O3/c1-20(32)23-7-5-22(6-8-23)13-16-31(34)18-17-29(3)24(19-31)9-10-25-27-12-11-26(21(2)33)30(27,4)15-14-28(25)29/h5-8,24-28,34H,9-12,14-15,17-19H2,1-4H3/t24-,25-,26+,27-,28-,29-,30+,31+/m0/s1 D01SBP DRUGINKE ZPPSBQVNGSDAFI-KWJNIICQSA-N D01SBP DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C#CC5=CC=C(C=C5)C(=O)C)O)C)C D01SBP HIGHSTAT Terminated D01SBZ DRUG__ID D01SBZ D01SBZ DRUGCLAS Investigative Drug(s) D01SBZ DRUGINCH 1S/C16H19NO/c1-13(17)11-14-7-9-16(10-8-14)18-12-15-5-3-2-4-6-15/h2-10,13H,11-12,17H2,1H3 D01SBZ DRUGINKE ZDZASCUBDMUTSR-UHFFFAOYSA-N D01SBZ DRUGSMIL CC(CC1=CC=C(C=C1)OCC2=CC=CC=C2)N D01SBZ DRUGTYPE Small molecular drug D01SBZ HIGHSTAT Investigative D01SCR DRUG__ID D01SCR D01SCR DRUGCLAS Clinical Trial Drug(s) D01SCR DRUGCOMP Piramal Healthcare Ltd D01SCR HIGHSTAT Phase 1/2 D01SDX DRUG__ID D01SDX D01SDX DRUGCLAS Investigative Drug(s) D01SDX DRUGINCH 1S/C29H37N7O6S2/c1-16(33-26(39)19(30)12-18-8-9-20-23(14-18)44-29(31)36-20)25(38)32-15-24(37)34-22(13-17-6-4-3-5-7-17)27(40)35-21(28(41)42)10-11-43-2/h3-9,14,16,19,21-22H,10-13,15,30H2,1-2H3,(H2,31,36)(H,32,38)(H,33,39)(H,34,37)(H,35,40)(H,41,42)/t16-,19-,21-,22-/m0/s1 D01SDX DRUGINKE NQZMBRNFTRPOCP-PWZKMPOXSA-N D01SDX DRUGSMIL CC(C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCSC)C(=O)O)NC(=O)C(CC2=CC3=C(C=C2)N=C(S3)N)N D01SDX DRUGTYPE Small molecular drug D01SDX HIGHSTAT Investigative D01SEO DRUG__ID D01SEO D01SEO DRUGCLAS Discontinued Drug(s) D01SEO DRUGCOMP Zeneca Group plc D01SEO DRUGINCH 1S/C24H34N2O4/c1-16(26(5)6)24(28,18-10-8-9-11-21(18)30-15-22(25)27)19-14-17(23(2,3)4)12-13-20(19)29-7/h8-14,16,28H,15H2,1-7H3,(H2,25,27)/t16-,24-/m1/s1 D01SEO DRUGINKE DLGGQRFVOGBFAX-VOIUYBSRSA-N D01SEO DRUGSMIL CC(C(C1=CC=CC=C1OCC(=O)N)(C2=C(C=CC(=C2)C(C)(C)C)OC)O)N(C)C D01SEO DRUGTYPE Small molecular drug D01SEO HIGHSTAT Terminated D01SFN DRUG__ID D01SFN D01SFN DRUGCLAS Clinical Trial Drug(s) D01SFN DRUGCOMP Baylor College of Medicine D01SFN DRUGTYPE CAR T Cell Therapy D01SFN HIGHSTAT Phase 1 D01SGC DRUG__ID D01SGC D01SGC DRUGCLAS Investigative Drug(s) D01SGC DRUGINCH 1S/C33H35FN2O6/c1-20(2)31-30(33(42)35-24-12-14-25(37)15-13-24)29(21-6-4-3-5-7-21)32(22-8-10-23(34)11-9-22)36(31)17-16-26(38)18-27(39)19-28(40)41/h3-15,20,26-27,37-39H,16-19H2,1-2H3,(H,35,42)(H,40,41)/t26-,27-/m1/s1 D01SGC DRUGINKE SOZOATLLFFVAPM-KAYWLYCHSA-N D01SGC DRUGSMIL CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=C(C=C4)O D01SGC DRUGTYPE Small molecular drug D01SGC HIGHSTAT Investigative D01SGK DRUG__ID D01SGK D01SGK DRUGCLAS Approved Drug(s) D01SGK DRUGCOMP Portela & Ca SA D01SGK DRUGINCH 1S/C15H10Cl2N4O6/c1-5-10(13(17)20(24)6(2)11(5)16)14-18-15(27-19-14)7-3-8(21(25)26)12(23)9(22)4-7/h3-4,22-23H,1-2H3 D01SGK DRUGINKE ASOADIZOVZTJSR-UHFFFAOYSA-N D01SGK DRUGSMIL CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-] D01SGK HIGHSTAT Approved D01SGM DRUG__ID D01SGM D01SGM DRUGCLAS Discontinued Drug(s) D01SGM DRUGCOMP Fujisawa Pharmaceutical Co Ltd D01SGM DRUGINCH 1S/C40H63N7O7.ClH/c1-29(2)16-17-35(48)33(24-30-12-8-6-9-13-30)43-37(49)34(26-32-27-41-28-42-32)46(5)38(50)36(25-31-14-10-7-11-15-31)54-40(52)45(4)19-18-44(3)39(51)47-20-22-53-23-21-47;/h7,10-11,14-15,27-30,33-36,48H,6,8-9,12-13,16-26H2,1-5H3,(H,41,42)(H,43,49);1H/t33-,34-,35-,36-;/m0./s1 D01SGM DRUGINKE MBTHCNKHNNGZGE-GIOOZNHKSA-N D01SGM DRUGSMIL CC(C)CCC(C(CC1CCCCC1)NC(=O)C(CC2=CN=CN2)N(C)C(=O)C(CC3=CC=CC=C3)OC(=O)N(C)CCN(C)C(=O)N4CCOCC4)O.Cl D01SGM DRUGTYPE Small molecular drug D01SGM HIGHSTAT Discontinued in Phase 2 D01SGP DRUG__ID D01SGP D01SGP DRUGCLAS Investigative Drug(s) D01SGP DRUGINCH 1S/C21H27NO3/c1-21-8-7-16-15-6-4-14(23)9-12(15)3-5-17(16)18(21)10-13(20(21)25)11-19(24)22-2/h4,6,9,13,16-18,23H,3,5,7-8,10-11H2,1-2H3,(H,22,24)/t13?,16?,17?,18?,21-/m0/s1 D01SGP DRUGINKE VGAXMSUTCOBBFZ-XMTGCZIPSA-N D01SGP DRUGSMIL CC12CCC3C(C1CC(C2=O)CC(=O)NC)CCC4=C3C=CC(=C4)O D01SGP DRUGTYPE Small molecular drug D01SGP HIGHSTAT Investigative D01SHB DRUG__ID D01SHB D01SHB DRUGCLAS Investigative Drug(s) D01SHB DRUGINCH 1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14) D01SHB DRUGINKE HCZHHEIFKROPDY-UHFFFAOYSA-N D01SHB DRUGSMIL C1=CC=C2C(=C1)C(=O)C=C(N2)C(=O)O D01SHB DRUGTYPE Small molecular drug D01SHB HIGHSTAT Investigative D01SHJ DRUG__ID D01SHJ D01SHJ DRUGCLAS Clinical Trial Drug(s) D01SHJ DRUGCOMP Adlai Nortye Hangzhou, China D01SHJ DRUGINCH 1S/C22H18F5N3O4/c1-11(12-6-8-13(9-7-12)21(32)33)28-19(31)16-17(18(23)24)29-30(2)20(16)34-15-5-3-4-14(10-15)22(25,26)27/h3-11,18H,1-2H3,(H,28,31)(H,32,33)/t11-/m0/s1 D01SHJ DRUGINKE MKLKAQMPKHNQPR-NSHDSACASA-N D01SHJ DRUGSMIL CC(C1=CC=C(C=C1)C(=O)O)NC(=O)C2=C(N(N=C2C(F)F)C)OC3=CC=CC(=C3)C(F)(F)F D01SHJ HIGHSTAT Phase 1 D01SHR DRUG__ID D01SHR D01SHR DRUGCLAS Investigative Drug(s) D01SHR DRUGINCH 1S/C17H19NO2/c1-12-6-2-4-8-15(12)20-17-13(10-18)11-19-16-9-5-3-7-14(16)17/h2-9,13,17H,10-11,18H2,1H3/t13-,17-/m1/s1 D01SHR DRUGINKE RQRGTZIPGLRQOJ-CXAGYDPISA-N D01SHR DRUGSMIL CC1=CC=CC=C1OC2C(COC3=CC=CC=C23)CN D01SHR DRUGTYPE Small molecular drug D01SHR HIGHSTAT Investigative D01SHZ DRUG__ID D01SHZ D01SHZ DRUGCLAS Approved Drug(s) D01SHZ DRUGCOMP Clovis Oncology D01SHZ DRUGINCH 1S/C19H18FN3O/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24) D01SHZ DRUGINKE HMABYWSNWIZPAG-UHFFFAOYSA-N D01SHZ DRUGSMIL CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2 D01SHZ DRUGTYPE Small molecular drug D01SHZ HIGHSTAT Approved D01SIB DRUG__ID D01SIB D01SIB DRUGCLAS Clinical Trial Drug(s) D01SIB DRUGCOMP Merck & Co Inc D01SIB HIGHSTAT Phase 1 D01SJC DRUG__ID D01SJC D01SJC DRUGCLAS Discontinued Drug(s) D01SJC DRUGCOMP Durect D01SJC DRUGINCH 1S/C22H30N2O2S.C6H8O7/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-10,17H,3,11-16,18H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D01SJC DRUGINKE OJCZPLDERGDQRJ-UHFFFAOYSA-N D01SJC DRUGSMIL CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D01SJC DRUGTYPE Small molecular drug D01SJC HIGHSTAT Discontinued in Phase 2 D01SJL DRUG__ID D01SJL D01SJL DRUGCLAS Investigative Drug(s) D01SJL DRUGINCH 1S/C10H12ClN3O/c1-6(12)5-14-10-7(4-13-14)2-3-8(15)9(10)11/h2-4,6,15H,5,12H2,1H3/t6-/m0/s1 D01SJL DRUGINKE VCXUEWRCJZWCJB-LURJTMIESA-N D01SJL DRUGSMIL CC(CN1C2=C(C=CC(=C2Cl)O)C=N1)N D01SJL DRUGTYPE Small molecular drug D01SJL HIGHSTAT Investigative D01SJS DRUG__ID D01SJS D01SJS DRUGCLAS Clinical Trial Drug(s) D01SJS DRUGCOMP Axelar AB D01SJS DRUGINCH 1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19+,20-/m0/s1 D01SJS DRUGINKE YJGVMLPVUAXIQN-HAEOHBJNSA-N D01SJS DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O D01SJS DRUGTYPE Small molecular drug D01SJS HIGHSTAT Phase 2 D01SJT DRUG__ID D01SJT D01SJT DRUGCLAS Clinical Trial Drug(s) D01SJT DRUGCOMP Pfizer D01SJT DRUGINCH 1S/C21H20F3N7O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30) D01SJT DRUGINKE MZDKLVOWGIOKTN-UHFFFAOYSA-N D01SJT DRUGSMIL CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C D01SJT DRUGTYPE Small molecular drug D01SJT HIGHSTAT Phase 1 D01SKR DRUG__ID D01SKR D01SKR DRUGCLAS Clinical Trial Drug(s) D01SKR DRUGCOMP GlaxoSmithKline D01SKR DRUGSMIL failed D01SKR DRUGTYPE Combination drug D01SKR HIGHSTAT Phase 2 D01SKT DRUG__ID D01SKT D01SKT DRUGCLAS Clinical Trial Drug(s) D01SKT DRUGCOMP Biogen, Cambridge, MA Ionis Pharmaceuticals Carlsbad, CA D01SKT HIGHSTAT Phase 2 D01SLA DRUG__ID D01SLA D01SLA DRUGCLAS Investigative Drug(s) D01SLA DRUGINCH 1S/C21H28O2/c1-4-21(23)12-9-18-16-6-5-14-13-15(22)7-10-19(14,2)17(16)8-11-20(18,21)3/h1,13,16-18,23H,5-12H2,2-3H3/t16-,17+,18+,19+,20+,21+/m1/s1 D01SLA DRUGINKE CHNXZKVNWQUJIB-CEGNMAFCSA-N D01SLA DRUGSMIL CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C#C)O)C D01SLA DRUGTYPE Small molecular drug D01SLA HIGHSTAT Investigative D01SLG DRUG__ID D01SLG D01SLG DRUGCLAS Investigative Drug(s) D01SLG DRUGINCH 1S/C44H68O13/c1-25-21-34(55-44(23-25)35(46)12-11-31(54-44)24-41(6,50)40(48)49)26(2)9-10-30-14-18-43(53-30)19-15-33-39(57-43)36(47)29(5)38(52-33)32(45)22-28(4)37-27(3)13-17-42(56-37)16-7-8-20-51-42/h9-10,23,26-28,30-39,45-47,50H,5,7-8,11-22,24H2,1-4,6H3,(H,48,49)/b10-9+/t26-,27-,28+,30+,31+,32+,33-,34+,35-,36-,37+,38+,39-,41-,42+,43-,44-/m1/s1 D01SLG DRUGINKE QNDVLZJODHBUFM-WFXQOWMNSA-N D01SLG DRUGSMIL CC1CCC2(CCCCO2)OC1C(C)CC(C3C(=C)C(C4C(O3)CCC5(O4)CCC(O5)C=CC(C)C6CC(=CC7(O6)C(CCC(O7)CC(C)(C(=O)O)O)O)C)O)O D01SLG DRUGTYPE Small molecular drug D01SLG HIGHSTAT Investigative D01SLS DRUG__ID D01SLS D01SLS DRUGCLAS Investigative Drug(s) D01SLS DRUGINCH 1S/C15H17ClN2O2S/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18/h1-2,4-7,17H,3,8-11H2 D01SLS DRUGINKE OZSMSRIUUDGTEP-UHFFFAOYSA-N D01SLS DRUGSMIL C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3Cl D01SLS DRUGTYPE Small molecular drug D01SLS HIGHSTAT Investigative D01SLZ DRUG__ID D01SLZ D01SLZ DRUGCLAS Investigative Drug(s) D01SLZ DRUGINCH 1S/C27H24N2O3/c30-25-18-20-29(26(31)28-25)19-10-11-21-32-27(22-12-4-1-5-13-22,23-14-6-2-7-15-23)24-16-8-3-9-17-24/h1-18,20H,19,21H2,(H,28,30,31)/b11-10- D01SLZ DRUGINKE ISRBLVQOVMVNRK-KHPPLWFESA-N D01SLZ DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)OCC=CCN4C=CC(=O)NC4=O D01SLZ DRUGTYPE Small molecular drug D01SLZ HIGHSTAT Investigative D01SNR DRUG__ID D01SNR D01SNR DRUGCLAS Investigative Drug(s) D01SNR DRUGINCH 1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3 D01SNR DRUGINKE FULAPETWGIGNMT-UHFFFAOYSA-N D01SNR DRUGSMIL CC1(C(=C(C(=O)O1)OCC2CC2)C3=CC=C(C=C3)S(=O)(=O)C)C D01SNR DRUGTYPE Small molecular drug D01SNR HIGHSTAT Investigative D01SNS DRUG__ID D01SNS D01SNS DRUGCLAS Investigative Drug(s) D01SNS DRUGINCH 1S/C22H24N2O2/c1-3-6-21(25)23-12-11-18-19-13-16(26-2)9-10-20(19)24-14-15-7-4-5-8-17(15)22(18)24/h4-5,7-10,13H,3,6,11-12,14H2,1-2H3,(H,23,25) D01SNS DRUGINKE RQYIUGOJQFWLAZ-UHFFFAOYSA-N D01SNS DRUGSMIL CCCC(=O)NCCC1=C2C3=CC=CC=C3CN2C4=C1C=C(C=C4)OC D01SNS DRUGTYPE Small molecular drug D01SNS HIGHSTAT Investigative D01SNU DRUG__ID D01SNU D01SNU DRUGCLAS Preclinical Drug(s) D01SNU DRUGCOMP Poseida Therapeutics D01SNU DRUGTYPE CAR T Cell Therapy D01SNU HIGHSTAT Preclinical D01SNV DRUG__ID D01SNV D01SNV DRUGCLAS Clinical Trial Drug(s) D01SNV DRUGCOMP Dompe, Milan, Italy D01SNV HIGHSTAT Phase 2 D01SNZ DRUG__ID D01SNZ D01SNZ DRUGCLAS Clinical Trial Drug(s) D01SNZ DRUGCOMP Mallinckrodt Pharma D01SNZ DRUGINCH 1S/C63H112O42/c1-22(64)8-85-15-29-50-36(71)43(78)57(92-29)100-51-30(16-86-9-23(2)65)94-59(45(80)38(51)73)102-53-32(18-88-11-25(4)67)96-61(47(82)40(53)75)104-55-34(20-90-13-27(6)69)98-63(49(84)42(55)77)105-56-35(21-91-14-28(7)70)97-62(48(83)41(56)76)103-54-33(19-89-12-26(5)68)95-60(46(81)39(54)74)101-52-31(17-87-10-24(3)66)93-58(99-50)44(79)37(52)72/h22-84H,8-21H2,1-7H3 D01SNZ DRUGINKE ODLHGICHYURWBS-UHFFFAOYSA-N D01SNZ DRUGSMIL CC(COCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)O)O)O D01SNZ DRUGTYPE Small molecular drug D01SNZ HIGHSTAT Phase 3 D01SPD DRUG__ID D01SPD D01SPD DRUGCLAS Clinical Trial Drug(s) D01SPD DRUGCOMP Bayer HealthCare Pharmaceuticals D01SPD DRUGINCH 1S/C13H14N8O2.Na/c22-13-10(20-2-1-16-18-20)8-17-21(13)12-7-11(14-9-15-12)19-3-5-23-6-4-19;/h1-2,7-9,22H,3-6H2;/q;+1/p-1 D01SPD DRUGINKE VYRQLKYGGSWDNH-UHFFFAOYSA-M D01SPD DRUGSMIL C1COCCN1C2=NC=NC(=C2)N3C(=C(C=N3)N4C=CN=N4)[O-].[Na+] D01SPD DRUGTYPE Small molecular drug D01SPD HIGHSTAT Phase 2 D01SPH DRUG__ID D01SPH D01SPH DRUGCLAS Investigative Drug(s) D01SPH DRUGINCH 1S/C7H15NO10P2/c9-5(10)4-2-1-3-8(4)6(11)7(12,19(13,14)15)20(16,17)18/h4,6,11-12H,1-3H2,(H,9,10)(H2,13,14,15)(H2,16,17,18) D01SPH DRUGINKE CDFDGXYBANXCPC-UHFFFAOYSA-N D01SPH DRUGSMIL C1CC(N(C1)C(C(O)(P(=O)(O)O)P(=O)(O)O)O)C(=O)O D01SPH DRUGTYPE Small molecular drug D01SPH HIGHSTAT Investigative D01SPI DRUG__ID D01SPI D01SPI DRUGCLAS Discontinued Drug(s) D01SPI DRUGCOMP Akela Pharma D01SPI DRUGINCH 1S/C163H273N51O49S2/c1-73(2)52-97(186-116(226)65-179-131(233)82(18)183-139(241)98(53-74(3)4)193-137(239)94(44-35-49-176-162(171)172)188-142(244)101(57-91-62-175-72-182-91)199-159(261)128(88(24)221)213-156(258)123(79(13)14)207-151(253)110(71-265)204-160(262)126(86(22)219)210-133(235)84(20)185-157(259)125(85(21)218)211-147(249)105(61-119(229)230)198-150(252)109(70-264)203-130(232)81(17)166)140(242)194-99(54-75(5)6)141(243)202-108(69-217)149(251)190-95(45-36-50-177-163(173)174)138(240)201-106(67-215)134(236)180-63-115(225)178-64-118(228)205-121(77(9)10)155(257)208-122(78(11)12)154(256)191-93(43-32-34-48-165)136(238)196-102(58-112(167)222)144(246)197-103(59-113(168)223)143(245)195-100(56-90-40-29-26-30-41-90)145(247)209-124(80(15)16)161(263)214-51-37-46-111(214)152(254)212-127(87(23)220)158(260)200-104(60-114(169)224)146(248)206-120(76(7)8)153(255)181-66-117(227)187-107(68-216)148(250)189-92(42-31-33-47-164)135(237)184-83(19)132(234)192-96(129(170)231)55-89-38-27-25-28-39-89/h25-30,38-41,73-88,91-111,120-128,175,182,215-221,264-265H,31-37,42-72,164-166H2,1-24H3,(H2,167,222)(H2,168,223)(H2,169,224)(H2,170,231)(H,178,225)(H,179,233)(H,180,236)(H,181,255)(H,183,241)(H,184,237)(H,185,259)(H,186,226)(H,187,227)(H,188,244)(H,189,250)(H,190,251)(H,191,256)(H,192,234)(H,193,239)(H,194,242)(H,195,245)(H,196,238)(H,197,246)(H,198,252)(H,199,261)(H,200,260)(H,201,240)(H,202,243)(H,203,232)(H,204,262)(H,205,228)(H,206,248)(H,207,253)(H,208,257)(H,209,247)(H,210,235)(H,211,249)(H,212,254)(H,213,258)(H,229,230)(H4,171,172,176)(H4,173,174,177) D01SPI DRUGINKE JAPBQZADVRUIIO-UHFFFAOYSA-N D01SPI DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4CNCN4)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(CS)NC(=O)C(C)N D01SPI DRUGTYPE Small molecular drug D01SPI HIGHSTAT Discontinued in Phase 2 D01SPJ DRUG__ID D01SPJ D01SPJ DRUGCLAS Clinical Trial Drug(s) D01SPJ DRUGCOMP Oligovax SAS D01SPJ DRUGINCH 1S/C256H322N95O129P25S25/c1-101-44-330(248(371)317-227(101)354)166-18-110(353)137(431-166)54-405-481(380,506)468-123-31-179(339-88-292-192-205(261)274-79-283-214(192)339)444-150(123)67-418-483(382,508)457-112-20-167(326-14-10-162(257)305-244(326)367)432-138(112)55-407-487(386,512)461-116-24-172(332-46-103(3)229(356)319-250(332)373)440-146(116)63-415-499(398,524)477-132-40-188(348-97-301-201-223(348)309-240(270)313-236(201)363)452-158(132)75-426-484(383,509)460-115-23-170(329-17-13-165(260)308-247(329)370)435-141(115)58-410-496(395,521)471-127-35-183(343-92-296-196-209(265)278-83-287-218(196)343)451-157(127)74-425-505(404,530)480-135-43-191(351-100-304-204-226(351)312-243(273)316-239(204)366)455-161(135)78-429-493(392,518)467-122-30-178(338-52-109(9)235(362)325-256(338)379)439-145(122)62-414-498(397,523)473-129-37-185(345-94-298-198-211(267)280-85-289-220(198)345)446-152(129)69-420-491(390,516)465-120-28-176(336-50-107(7)233(360)323-254(336)377)437-143(120)60-412-489(388,514)463-118-26-174(334-48-105(5)231(358)321-252(334)375)442-148(118)65-417-500(399,525)478-133-41-189(349-98-302-202-224(349)310-241(271)314-237(202)364)453-159(133)76-427-485(384,510)458-113-21-168(327-15-11-163(258)306-245(327)368)433-139(113)56-408-494(393,519)469-125-33-181(341-90-294-194-207(263)276-81-285-216(194)341)448-154(125)71-423-503(402,528)475-130-38-186(346-95-299-199-212(268)281-86-290-221(199)346)447-153(130)70-421-492(391,517)466-121-29-177(337-51-108(8)234(361)324-255(337)378)438-144(121)61-413-497(396,522)472-128-36-184(344-93-297-197-210(266)279-84-288-219(197)344)445-151(128)68-419-490(389,515)464-119-27-175(335-49-106(6)232(359)322-253(335)376)436-142(119)59-411-488(387,513)462-117-25-173(333-47-104(4)230(357)320-251(333)374)441-147(117)64-416-501(400,526)479-134-42-190(350-99-303-203-225(350)311-242(272)315-238(203)365)454-160(134)77-428-486(385,511)459-114-22-169(328-16-12-164(259)307-246(328)369)434-140(114)57-409-495(394,520)470-126-34-182(342-91-295-195-208(264)277-82-286-217(195)342)449-155(126)72-424-504(403,529)476-131-39-187(347-96-300-200-213(269)282-87-291-222(200)347)450-156(131)73-422-502(401,527)474-124-32-180(340-89-293-193-206(262)275-80-284-215(193)340)443-149(124)66-406-482(381,507)456-111-19-171(430-136(111)53-352)331-45-102(2)228(355)318-249(331)372/h10-17,44-52,79-100,110-161,166-191,352-353H,18-43,53-78H2,1-9H3,(H,380,506)(H,381,507)(H,382,508)(H,383,509)(H,384,510)(H,385,511)(H,386,512)(H,387,513)(H,388,514)(H,389,515)(H,390,516)(H,391,517)(H,392,518)(H,393,519)(H,394,520)(H,395,521)(H,396,522)(H,397,523)(H,398,524)(H,399,525)(H,400,526)(H,401,527)(H,402,528)(H,403,529)(H,404,530)(H2,257,305,367)(H2,258,306,368)(H2,259,307,369)(H2,260,308,370)(H2,261,274,283)(H2,262,275,284)(H2,263,276,285)(H2,264,277,286)(H2,265,278,287)(H2,266,279,288)(H2,267,280,289)(H2,268,281,290)(H2,269,282,291)(H,317,354,371)(H,318,355,372)(H,319,356,373)(H,320,357,374)(H,321,358,375)(H,322,359,376)(H,323,360,377)(H,324,361,378)(H,325,362,379)(H3,270,309,313,363)(H3,271,310,314,364)(H3,272,311,315,365)(H3,273,312,316,366) D01SPJ DRUGINKE CJZRVARTODENJN-UHFFFAOYSA-N D01SPJ DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)O D01SPJ HIGHSTAT Phase 1 D01SPW DRUG__ID D01SPW D01SPW DRUGCLAS Clinical Trial Drug(s) D01SPW HIGHSTAT Phase 3 D01SQI DRUG__ID D01SQI D01SQI DRUGCLAS Clinical Trial Drug(s) D01SQI DRUGCOMP University of Pennsylvania D01SQI HIGHSTAT Phase 2 D01SQO DRUG__ID D01SQO D01SQO COMPCLAS Quinazoline alkaloid derivatives D01SQO DRUGCLAS Patented Agent(s) D01SQO DRUGINCH 1S/C11H12N2O/c14-10-5-6-13-7-8-3-1-2-4-9(8)12-11(10)13/h1-4,10,14H,5-7H2/t10-/m1/s1 D01SQO DRUGINKE YIICVSCAKJMMDJ-SNVBAGLBSA-N D01SQO DRUGSMIL C1CN2CC3=CC=CC=C3N=C2C1O D01SQO DRUGTYPE Small molecular drug D01SQO HIGHSTAT Patented D01SQP DRUG__ID D01SQP D01SQP DRUGCLAS Investigative Drug(s) D01SQP DRUGCOMP Hanmi Pharmaceutical Co Ltd D01SQP HIGHSTAT Investigative D01SQY DRUG__ID D01SQY D01SQY DRUGCLAS Investigative Drug(s) D01SQY DRUGINCH 1S/C18H19NO2/c1-10-7-13(8-11(2)18(10)20)17-12(3)15-9-14(21-4)5-6-16(15)19-17/h5-9,19-20H,1-4H3 D01SQY DRUGINKE OZFHUMGEWVYBRM-UHFFFAOYSA-N D01SQY DRUGSMIL CC1=CC(=CC(=C1O)C)C2=C(C3=C(N2)C=CC(=C3)OC)C D01SQY DRUGTYPE Small molecular drug D01SQY HIGHSTAT Investigative D01SRB DRUG__ID D01SRB D01SRB DRUGCLAS Clinical Trial Drug(s) D01SRB DRUGCOMP Childrens Hospital of Philadelphia D01SRB HIGHSTAT Phase 3 D01SRL DRUG__ID D01SRL D01SRL DRUGCLAS Investigative Drug(s) D01SRL DRUGINCH 1S/C9H10N2O2/c12-11(13)9-2-1-7-3-4-10-6-8(7)5-9/h1-2,5,10H,3-4,6H2 D01SRL DRUGINKE YPRWYZSUBZXORL-UHFFFAOYSA-N D01SRL DRUGSMIL C1CNCC2=C1C=CC(=C2)[N+](=O)[O-] D01SRL DRUGTYPE Small molecular drug D01SRL HIGHSTAT Investigative D01SRS DRUG__ID D01SRS D01SRS DRUGCLAS Investigative Drug(s) D01SRS DRUGINCH 1S/C10H12N2O2/c1-7-4-8-2-3-10(12(13)14)5-9(8)6-11-7/h2-3,5,7,11H,4,6H2,1H3 D01SRS DRUGINKE OTVSEAHLIUCIKT-UHFFFAOYSA-N D01SRS DRUGSMIL CC1CC2=C(CN1)C=C(C=C2)[N+](=O)[O-] D01SRS DRUGTYPE Small molecular drug D01SRS HIGHSTAT Investigative D01SSI DRUG__ID D01SSI D01SSI DRUGCLAS Investigative Drug(s) D01SSI DRUGINCH 1S/C27H31FN6OS/c28-21-3-4-22-20(5-6-29-22)24(21)26-30-23-15-19(17-33-9-7-32(8-10-33)16-18-1-2-18)36-25(23)27(31-26)34-11-13-35-14-12-34/h3-6,15,18,29H,1-2,7-14,16-17H2 D01SSI DRUGINKE YDNOHCOYQVZOMC-UHFFFAOYSA-N D01SSI DRUGSMIL C1CC1CN2CCN(CC2)CC3=CC4=C(S3)C(=NC(=N4)C5=C(C=CC6=C5C=CN6)F)N7CCOCC7 D01SSI DRUGTYPE Small molecular drug D01SSI HIGHSTAT Investigative D01SSK DRUG__ID D01SSK D01SSK DRUGCLAS Clinical Trial Drug(s) D01SSK DRUGCOMP Spectrum Pharmaceuticals D01SSK HIGHSTAT Phase 1 D01SSL DRUG__ID D01SSL D01SSL DRUGCLAS Investigative Drug(s) D01SSL DRUGCOMP Armour Therapeutics Inc D01SSL HIGHSTAT Investigative D01STB DRUG__ID D01STB D01STB DRUGCLAS Approved Drug(s) D01STB DRUGCOMP Sanofi-Aventis D01STB DRUGINCH 1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1 D01STB DRUGINKE HDACQVRGBOVJII-JBDAPHQKSA-N D01STB DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O D01STB DRUGTYPE Small molecular drug D01STB HIGHSTAT Approved D01STB THERCLAS Antihypertensive Agents D01STE DRUG__ID D01STE D01STE DRUGCLAS Investigative Drug(s) D01STE DRUGINCH 1S/C21H45O6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-26-19-21(22)20-27-28(23,24)25/h21-22H,2-20H2,1H3,(H2,23,24,25)/t21-/m0/s1 D01STE DRUGINKE HUUYDUFSUADEJQ-NRFANRHFSA-N D01STE DRUGSMIL CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O D01STE DRUGTYPE Small molecular drug D01STE HIGHSTAT Investigative D01STY DRUG__ID D01STY D01STY DRUGCLAS Investigative Drug(s) D01STY DRUGINCH 1S/C6H7IN2O2S/c7-5-3-4(12(9,10)11)1-2-6(5)8/h1-3H,8H2,(H2,9,10,11) D01STY DRUGINKE HCODCRHNVCTCTR-UHFFFAOYSA-N D01STY DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)I)N D01STY HIGHSTAT Investigative D01SUE DRUG__ID D01SUE D01SUE DRUGCLAS Investigative Drug(s) D01SUE DRUGINCH 1S/C15H13N/c1-2-6-15-13(5-1)7-8-14(15)10-12-4-3-9-16-11-12/h1-6,9-11H,7-8H2/b14-10+ D01SUE DRUGINKE WDSJJUYCBHIJRT-GXDHUFHOSA-N D01SUE DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=CC=CC=C31 D01SUE DRUGTYPE Small molecular drug D01SUE HIGHSTAT Investigative D01SUF DRUG__ID D01SUF D01SUF DRUGCLAS Investigative Drug(s) D01SUF DRUGCOMP GP Pharm SA D01SUF HIGHSTAT Investigative D01SUL DRUG__ID D01SUL D01SUL DRUGCLAS Investigative Drug(s) D01SUL DRUGCOMP Johnson & Johnson D01SUL DRUGINCH 1S/C19H20Br2N2O3/c1-19(2)25-11-16(17(26-19)12-6-4-3-5-7-12)23-18(24)22-15-9-8-13(20)10-14(15)21/h3-10,16-17H,11H2,1-2H3,(H2,22,23,24)/t16-,17-/m0/s1 D01SUL DRUGINKE RBKIJGLHFFQHBE-IRXDYDNUSA-N D01SUL DRUGSMIL CC1(OCC(C(O1)C2=CC=CC=C2)NC(=O)NC3=C(C=C(C=C3)Br)Br)C D01SUL DRUGTYPE Small molecular drug D01SUL HIGHSTAT Investigative D01SUO DRUG__ID D01SUO D01SUO DRUGCLAS Investigative Drug(s) D01SUO DRUGCOMP EcoBiotics Ltd D01SUO DRUGINCH 1S/C30H42O10/c1-9-13(3)23(33)38-21-16(6)28(36)17-11-15(5)20(32)29(17,37)25(35)27(12-31)22(39-27)18(28)19-26(7,8)30(19,21)40-24(34)14(4)10-2/h9,11,14,16-19,21-22,25,31,35-37H,10,12H2,1-8H3/b13-9+/t14-,16+,17-,18+,19+,21+,22-,25+,27-,28-,29+,30+/m0/s1 D01SUO DRUGINKE YLQZMOUMDYVSQR-FOWZUWBHSA-N D01SUO DRUGSMIL CCC(C)C(=O)OC12C(C1(C)C)C3C4C(O4)(C(C5(C(C3(C(C2OC(=O)C(=CC)C)C)O)C=C(C5=O)C)O)O)CO D01SUO DRUGTYPE Small molecular drug D01SUO HIGHSTAT Investigative D01SUY DRUG__ID D01SUY D01SUY DRUGCLAS Investigative Drug(s) D01SUY DRUGCOMP FoldLess Srl D01SUY HIGHSTAT Investigative D01SVG DRUG__ID D01SVG D01SVG DRUGCLAS Investigative Drug(s) D01SVG DRUGCOMP Wuhan Katygen Pharmaceuticals Inc D01SVG HIGHSTAT Investigative D01SVO DRUG__ID D01SVO D01SVO DRUGCLAS Investigative Agents D01SVO DRUGINCH 1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1 D01SVO DRUGINKE XCUAIINAJCDIPM-XVFCMESISA-N D01SVO DRUGSMIL C1=CN(C(=O)N=C1NO)C2C(C(C(O2)CO)O)O D01SVO DRUGTYPE Small molecular drug D01SVO HIGHSTAT Investigative D01SVO THERCLAS Antiviral Agents D01SWJ DRUG__ID D01SWJ D01SWJ DRUGCLAS Investigative Drug(s) D01SWJ HIGHSTAT Investigative D01SWK DRUG__ID D01SWK D01SWK DRUGCLAS Discontinued Drug(s) D01SWK DRUGCOMP Dainippon Pharmaceutical Co Ltd D01SWK DRUGINCH 1S/C21H23ClN2O4/c1-13(23-11-18(25)14-4-2-5-16(22)9-14)8-15-10-24-21-17(15)6-3-7-19(21)28-12-20(26)27/h2-7,9-10,13,18,23-25H,8,11-12H2,1H3,(H,26,27)/t13-,18+/m1/s1 D01SWK DRUGINKE FHEYFIGWYQJVDR-ACJLOTCBSA-N D01SWK DRUGSMIL CC(CC1=CNC2=C1C=CC=C2OCC(=O)O)NCC(C3=CC(=CC=C3)Cl)O D01SWK DRUGTYPE Small molecular drug D01SWK HIGHSTAT Discontinued in Phase 2 D01SWO DRUG__ID D01SWO D01SWO DRUGCLAS Investigative Drug(s) D01SWO DRUGINCH 1S/C23H18O2/c24-19-7-3-6-15(10-19)22-12-18-11-20(25)8-9-21(18)23(22)13-16-4-1-2-5-17(16)14-23/h1-12,24-25H,13-14H2 D01SWO DRUGINKE NBNSBPOETAKHET-UHFFFAOYSA-N D01SWO DRUGSMIL C1C2=CC=CC=C2CC13C4=C(C=C(C=C4)O)C=C3C5=CC(=CC=C5)O D01SWO DRUGTYPE Small molecular drug D01SWO HIGHSTAT Investigative D01SXB DRUG__ID D01SXB D01SXB DRUGCLAS Investigative Drug(s) D01SXB DRUGINCH 1S/C16H15NO4/c18-11-12-2-1-3-13(8-12)15-9-14(19)10-16(21-15)17-4-6-20-7-5-17/h1-3,8-11H,4-7H2 D01SXB DRUGINKE JXTKUJIDCHLXDV-UHFFFAOYSA-N D01SXB DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC(=C3)C=O D01SXB DRUGTYPE Small molecular drug D01SXB HIGHSTAT Investigative D01SXE DRUG__ID D01SXE D01SXE DRUGCLAS Investigative Drug(s) D01SXE DRUGCOMP Siemens medical solutions D01SXE HIGHSTAT Investigative D01SXG DRUG__ID D01SXG D01SXG DRUGCLAS Investigative Drug(s) D01SXG DRUGCOMP BioRestorative Therapies Inc D01SXG HIGHSTAT Investigative D01SXH DRUG__ID D01SXH D01SXH DRUGCLAS Clinical Trial Drug(s) D01SXH DRUGCOMP Xin Wang D01SXH DRUGTYPE CAR T Cell Therapy D01SXH HIGHSTAT Phase 1 D01SXY DRUG__ID D01SXY D01SXY DRUGCLAS Clinical Trial Drug(s) D01SXY DRUGCOMP Novacta Biosystems Ltd D01SXY DRUGTYPE Peptide D01SXY HIGHSTAT Phase 1 D01SYN DRUG__ID D01SYN D01SYN DRUGCLAS Patented Agent(s) D01SYN DRUGCOMP MERCK SHARP & DOHME CORP. MSD K.K. LIN, Linus, S. SUZUKI, Takao D01SYN DRUGTYPE Small molecular drug D01SYN HIGHSTAT Patented D01SYO DRUG__ID D01SYO D01SYO DRUGCLAS Investigative Drug(s) D01SYO DRUGINCH 1S/C11H8N2S/c1-9-13-11(8-14-9)3-2-10-4-6-12-7-5-10/h4-8H,1H3 D01SYO DRUGINKE WWKCHJLBBNNNCI-UHFFFAOYSA-N D01SYO DRUGSMIL CC1=NC(=CS1)C#CC2=CC=NC=C2 D01SYO DRUGTYPE Small molecular drug D01SYO HIGHSTAT Investigative D01SYU DRUG__ID D01SYU D01SYU DRUGCLAS Clinical Trial Drug(s) D01SYU DRUGCOMP Pfizer New York, NY D01SYU DRUGINCH 1S/C25H24F2N2O3/c1-14(2)32-24(31)17-12-29(23(30)15-9-10-18(26)19(27)11-15)13-25(3,4)21-16-7-5-6-8-20(16)28-22(17)21/h5-12,14,28H,13H2,1-4H3 D01SYU DRUGINKE INASOKQDNHHMRE-UHFFFAOYSA-N D01SYU DRUGSMIL CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F D01SYU DRUGTYPE Small molecular drug D01SYU HIGHSTAT Phase 1 D01SZA DRUG__ID D01SZA D01SZA DRUGCLAS Clinical Trial Drug(s) D01SZA DRUGCOMP Mochida Pharmaceutical Co Ltd D01SZA HIGHSTAT Phase 1 D01SZX DRUG__ID D01SZX D01SZX DRUGCLAS Investigative Drug(s) D01SZX DRUGINCH 1S/C17H12N2O2/c20-17-13-5-1-2-6-14(13)21-15-7-3-4-12(16(15)17)10-19-9-8-18-11-19/h1-9,11H,10H2 D01SZX DRUGINKE FJYGKMHQKKRCON-UHFFFAOYSA-N D01SZX DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC=C3O2)CN4C=CN=C4 D01SZX DRUGTYPE Small molecular drug D01SZX HIGHSTAT Investigative D01TAJ DRUG__ID D01TAJ D01TAJ DRUGCLAS Investigative Drug(s) D01TAJ DRUGCOMP Isis Pharmaceuticals D01TAJ DRUGTYPE Antisense drug D01TAJ HIGHSTAT Investigative D01TAQ DRUG__ID D01TAQ D01TAQ DRUGCLAS Investigative Drug(s) D01TAQ DRUGCOMP NovaLead Pharma D01TAQ HIGHSTAT Investigative D01TBJ DRUG__ID D01TBJ D01TBJ DRUGCLAS Clinical Trial Drug(s) D01TBJ DRUGCOMP Ischemix D01TBJ DRUGINCH 1S/C16H26N2O6S2/c1-10(16(23)24)17-15(22)12(6-7-14(20)21)18-13(19)5-3-2-4-11-8-9-25-26-11/h10-12H,2-9H2,1H3,(H,17,22)(H,18,19)(H,20,21)(H,23,24)/t10-,11+,12-/m0/s1 D01TBJ DRUGINKE MQXRTCVZPIHBLD-TUAOUCFPSA-N D01TBJ DRUGSMIL CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CCCCC1CCSS1 D01TBJ HIGHSTAT Phase 2 D01TBL DRUG__ID D01TBL D01TBL DRUGCLAS Investigative Drug(s) D01TBL DRUGCOMP Innoventus Project AB D01TBL DRUGINCH 1S/C12H9N3O/c16-12-10(5-8-6-13-7-14-8)9-3-1-2-4-11(9)15-12/h1-7H,(H,13,14)(H,15,16)/b10-5+ D01TBL DRUGINKE VEEGZPWAAPPXRB-BJMVGYQFSA-N D01TBL DRUGSMIL C1=CC=C2C(=C1)C(=CC3=CN=CN3)C(=O)N2 D01TBL DRUGTYPE Small molecular drug D01TBL HIGHSTAT Investigative D01TBN DRUG__ID D01TBN D01TBN DRUGCLAS Discontinued Drug(s) D01TBN DRUGCOMP Pfizer D01TBN DRUGINCH 1S/C31H38N2O/c1-22(2)26-14-15-28(34-3)27(20-26)21-32-30-25-16-18-33(19-17-25)31(30)29(23-10-6-4-7-11-23)24-12-8-5-9-13-24/h4-15,20,22,25,29-32H,16-19,21H2,1-3H3/t30-,31-/m0/s1 D01TBN DRUGINKE XPNMCDYOYIKVGB-CONSDPRKSA-N D01TBN DRUGSMIL CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3 D01TBN DRUGTYPE Small molecular drug D01TBN HIGHSTAT Discontinued in Phase 2 D01TCM DRUG__ID D01TCM D01TCM DRUGCLAS Discontinued Drug(s) D01TCM DRUGCOMP Novo Nordisk A/S D01TCM HIGHSTAT Terminated D01TDC DRUG__ID D01TDC D01TDC DRUGCLAS Investigative Drug(s) D01TDC DRUGINCH 1S/C5H10N2S/c1-4-2-3-7-5(6)8-4/h4H,2-3H2,1H3,(H2,6,7) D01TDC DRUGINKE BATVOUKHGLKDGQ-UHFFFAOYSA-N D01TDC DRUGSMIL CC1CCN=C(S1)N D01TDC DRUGTYPE Small molecular drug D01TDC HIGHSTAT Investigative D01TDG DRUG__ID D01TDG D01TDG DRUGCLAS Investigative Drug(s) D01TDG DRUGINCH 1S/C9H12N2S/c1-2-12-9(10)11-8-6-4-3-5-7-8/h3-7H,2H2,1H3,(H2,10,11) D01TDG DRUGINKE LAXNJIWNBHHMDO-UHFFFAOYSA-N D01TDG DRUGSMIL CCSC(=NC1=CC=CC=C1)N D01TDG DRUGTYPE Small molecular drug D01TDG HIGHSTAT Investigative D01TDT DRUG__ID D01TDT D01TDT COMPCLAS Aryl pyrimidine derivatives D01TDT DRUGCLAS Patented Agent(s) D01TDT DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D01TDT DRUGTYPE Small molecular drug D01TDT HIGHSTAT Patented D01TDV DRUG__ID D01TDV D01TDV DRUGCLAS Investigative Drug(s) D01TDV DRUGINCH 1S/C25H28N6O2/c1-29-12-14-30(15-13-29)22-10-5-19(16-23(22)33-3)27-24-11-4-18-17-26-31(25(18)28-24)20-6-8-21(32-2)9-7-20/h4-11,16-17H,12-15H2,1-3H3,(H,27,28) D01TDV DRUGINKE LZQFMCFJCXQTTG-UHFFFAOYSA-N D01TDV DRUGSMIL CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=C3)C=NN4C5=CC=C(C=C5)OC)OC D01TDV DRUGTYPE Small molecular drug D01TDV HIGHSTAT Investigative D01TDY DRUG__ID D01TDY D01TDY DRUGCLAS Clinical Trial Drug(s) D01TDY DRUGCOMP Theratechnologies Inc D01TDY HIGHSTAT Phase 1 D01TEA DRUG__ID D01TEA D01TEA DRUGCLAS Clinical Trial Drug(s) D01TEA DRUGCOMP Derma Sciences D01TEA DRUGINCH 1S/C42H64N12O11/c1-4-6-9-28(50-36(59)29(10-7-16-47-42(44)45)49-35(58)27(43)20-33(56)57)37(60)51-30(18-24-12-14-26(55)15-13-24)38(61)53-34(23(3)5-2)39(62)52-31(19-25-21-46-22-48-25)40(63)54-17-8-11-32(54)41(64)65/h12-15,21-23,27-32,34,55H,4-11,16-20,43H2,1-3H3,(H,46,48)(H,49,58)(H,50,59)(H,51,60)(H,52,62)(H,53,61)(H,56,57)(H,64,65)(H4,44,45,47)/t23-,27-,28-,29-,30-,31-,32-,34-/m0/s1 D01TEA DRUGINKE RUBMHAHMIJSMHA-LBWFYSSPSA-N D01TEA DRUGSMIL CCCCC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)CC)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N D01TEA DRUGTYPE Small molecular drug D01TEA HIGHSTAT Phase 3 D01TFO DRUG__ID D01TFO D01TFO DRUGCLAS Investigative Drug(s) D01TFO DRUGINCH 1S/C36H59N7O9/c1-11-22(7)28(32(46)39-27(21(5)6)34(48)51-10)41-35(49)43-42-33(47)29(23(8)12-2)40-31(45)26(18-20(3)4)38-30(44)24(9)37-36(50)52-19-25-16-14-13-15-17-25/h13-17,20-24,26-29H,11-12,18-19H2,1-10H3,(H,37,50)(H,38,44)(H,39,46)(H,40,45)(H,42,47)(H2,41,43,49) D01TFO DRUGINKE HGMOIJOFHZHWKH-UHFFFAOYSA-N D01TFO DRUGSMIL CCC(C)C(C(=O)NNC(=O)NC(C(C)CC)C(=O)NC(C(C)C)C(=O)OC)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC1=CC=CC=C1 D01TFO DRUGTYPE Small molecular drug D01TFO HIGHSTAT Investigative D01TFQ DRUG__ID D01TFQ D01TFQ DRUGCLAS Investigative Drug(s) D01TFQ DRUGINCH 1S/C34H39N3O7S/c1-34(2)31(32(42)36-29-25-14-7-6-12-23(25)17-27(29)39)37(20-45-34)33(43)30(41)26(16-21-9-4-3-5-10-21)35-28(40)19-44-24-13-8-11-22(15-24)18-38/h3-15,26-27,29-31,38-39,41H,16-20H2,1-2H3,(H,35,40)(H,36,42)/t26-,27+,29-,30-,31+/m0/s1 D01TFQ DRUGINKE NRLFBLHYKZDHHW-VFCPCCRCSA-N D01TFQ DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC(=C3)CO)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D01TFQ DRUGTYPE Small molecular drug D01TFQ HIGHSTAT Investigative D01TGE DRUG__ID D01TGE D01TGE DRUGCLAS Patented Agent(s) D01TGE DRUGCOMP PFIZER INC. ASPNES, Gary, Erik DIDIUK, Mary, Theresa FILIPSKI, Kevin, James GUZMAN-PEREZ, Angel PFEFFERKORN, Jeffrey, Allen STEVENS, Benjamin, Dawson TU, Meihua, Mik D01TGE DRUGINCH 1S/C28H28F3NO4/c1-18(2)17-25(21-3-5-22(6-4-21)27(35)32-16-15-26(33)34)36-24-13-9-20(10-14-24)19-7-11-23(12-8-19)28(29,30)31/h3-14,18,25H,15-17H2,1-2H3,(H,32,35)(H,33,34) D01TGE DRUGINKE KVQXZASOMKRHSG-UHFFFAOYSA-N D01TGE DRUGSMIL CC(C)CC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)OC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F D01TGE DRUGTYPE Small molecular drug D01TGE HIGHSTAT Patented D01TGF DRUG__ID D01TGF D01TGF COMPCLAS Cyclic peptidomimetic derivatives D01TGF DRUGCLAS Investigative Drug(s) D01TGF DRUGTYPE Small molecule immunotherapy D01TGF HIGHSTAT Investigative D01TGH DRUG__ID D01TGH D01TGH DRUGCLAS Discontinued Drug(s) D01TGH DRUGCOMP Pfizer Inc D01TGH HIGHSTAT Terminated D01TGI DRUG__ID D01TGI D01TGI DRUGCLAS Investigative Drug(s) D01TGI DRUGINCH 1S/C18H12Cl2O2/c19-14-7-9-17(15(20)11-14)22-18-8-6-13(10-16(18)21)12-4-2-1-3-5-12/h1-11,21H D01TGI DRUGINKE NOKHJANPMHROFU-UHFFFAOYSA-N D01TGI DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D01TGI DRUGTYPE Small molecular drug D01TGI HIGHSTAT Investigative D01THA DRUG__ID D01THA D01THA COMPCLAS Ethylaminopyrimidine derivatives D01THA DRUGCLAS Patented Agent(s) D01THA DRUGCOMP JANSSEN PHARMACEUTICA N.V. APODACA, Richard BREITENBUCHER, J., Guy CHAMBERS, Alison, L. DENG, Xiaohu HAWRYLUK, Natalie, A. KEITH, John, M. MANI, Neelakandha, S. MERIT, Jeffrey, E. PIERCE, Joan, M. SEIERSTAD, Mark XIAO, Wei D01THA DRUGINCH 1S/C20H20ClN3O2/c1-2-26-19-9-8-15(10-16(19)21)17-11-20(24-13-23-17)22-12-18(25)14-6-4-3-5-7-14/h3-11,13,18,25H,2,12H2,1H3,(H,22,23,24)/t18-/m0/s1 D01THA DRUGINKE MOEQPDYTFQLEOK-SFHVURJKSA-N D01THA DRUGSMIL CCOC1=C(C=C(C=C1)C2=CC(=NC=N2)NCC(C3=CC=CC=C3)O)Cl D01THA DRUGTYPE Small molecular drug D01THA HIGHSTAT Patented D01THF DRUG__ID D01THF D01THF DRUGCLAS Investigative Drug(s) D01THF DRUGINCH 1S/C17H17NOS/c1-11-7-12(2)17(13(3)8-11)20-15-6-5-14(10-18)16(9-15)19-4/h5-9H,1-4H3 D01THF DRUGINKE YPJRESPHGOONFU-UHFFFAOYSA-N D01THF DRUGSMIL CC1=CC(=C(C(=C1)C)SC2=CC(=C(C=C2)C#N)OC)C D01THF DRUGTYPE Small molecular drug D01THF HIGHSTAT Investigative D01THG DRUG__ID D01THG D01THG DRUGCLAS Investigative Drug(s) D01THG DRUGINCH 1S/C5H8O2/c1-3-4(2)5(6)7/h3H,1-2H3,(H,6,7)/b4-3+ D01THG DRUGINKE UIERETOOQGIECD-ONEGZZNKSA-N D01THG DRUGSMIL CC=C(C)C(=O)O D01THG DRUGTYPE Small molecular drug D01THG HIGHSTAT Investigative D01THN DRUG__ID D01THN D01THN DRUGCLAS Clinical Trial Drug(s) D01THN DRUGCOMP Japan Tobacco Inc D01THN HIGHSTAT Phase 2 D01THX DRUG__ID D01THX D01THX DRUGCLAS Approved Drug(s) D01THX HIGHSTAT Approved D01TIN DRUG__ID D01TIN D01TIN DRUGCLAS Discontinued Drug(s) D01TIN DRUGCOMP Roche Holding AG D01TIN HIGHSTAT Terminated D01TJM DRUG__ID D01TJM D01TJM DRUGCLAS Clinical Trial Drug(s) D01TJM DRUGCOMP Chemokine Therapeutics Corp; Chemokine Therapeutics D01TJM DRUGINCH 1S/C86H147N27O23/c1-45(2)35-58(104-81(133)64(43-116)110-83(135)68(47(5)6)112-66(120)39-99-71(123)53(89)17-9-12-30-87)75(127)108-62(41-114)79(131)106-60(37-49-22-26-51(118)27-23-49)77(129)102-56(20-15-33-97-85(92)93)73(125)96-32-14-11-19-55(70(91)122)101-74(126)57(21-16-34-98-86(94)95)103-78(130)61(38-50-24-28-52(119)29-25-50)107-80(132)63(42-115)109-76(128)59(36-46(3)4)105-82(134)65(44-117)111-84(136)69(48(7)8)113-67(121)40-100-72(124)54(90)18-10-13-31-88/h22-29,45-48,53-65,68-69,114-119H,9-21,30-44,87-90H2,1-8H3,(H2,91,122)(H,96,125)(H,99,123)(H,100,124)(H,101,126)(H,102,129)(H,103,130)(H,104,133)(H,105,134)(H,106,131)(H,107,132)(H,108,127)(H,109,128)(H,110,135)(H,111,136)(H,112,120)(H,113,121)(H4,92,93,97)(H4,94,95,98)/t53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,68-,69-/m0/s1 D01TJM DRUGINKE VUYRSKROGTWHDC-HZGLMRDYSA-N D01TJM DRUGSMIL CC(C)CC(C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCNC(=N)N)C(=O)NCCCCC(C(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CCCCN)N)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CCCCN)N D01TJM HIGHSTAT Phase 1/2 D01TJV DRUG__ID D01TJV D01TJV DRUGCLAS Investigative Drug(s) D01TJV DRUGCOMP Kowa Co Ltd D01TJV HIGHSTAT Investigative D01TJW DRUG__ID D01TJW D01TJW DRUGCLAS Patented Agent(s) D01TJW DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D01TJW DRUGINCH 1S/C19H18Cl2N2O3/c20-13-10-14(21)16(12-6-2-1-3-7-12)15(11-13)22-18(26)23-19(17(24)25)8-4-5-9-19/h1-3,6-7,10-11H,4-5,8-9H2,(H,24,25)(H2,22,23,26) D01TJW DRUGINKE XKZSVPIUPDFCIQ-UHFFFAOYSA-N D01TJW DRUGSMIL C1CCC(C1)(C(=O)O)NC(=O)NC2=C(C(=CC(=C2)Cl)Cl)C3=CC=CC=C3 D01TJW DRUGTYPE Small molecular drug D01TJW HIGHSTAT Patented D01TJY DRUG__ID D01TJY D01TJY DRUGCLAS Clinical Trial Drug(s) D01TJY DRUGCOMP ProStrakan Group plc D01TJY DRUGINCH 1S/C29H37N7O5S/c1-18-26(31-17-25(29(37)38)35-42(39,40)23-9-7-22(41-3)8-10-23)32-19(2)33-28(18)36-15-12-20(13-16-36)24-11-6-21-5-4-14-30-27(21)34-24/h6-11,20,25,35H,4-5,12-17H2,1-3H3,(H,30,34)(H,37,38)(H,31,32,33)/t25-/m0/s1 D01TJY DRUGINKE CXHCNOMGODVIKB-VWLOTQADSA-N D01TJY DRUGSMIL CC1=C(N=C(N=C1N2CCC(CC2)C3=NC4=C(CCCN4)C=C3)C)NCC(C(=O)O)NS(=O)(=O)C5=CC=C(C=C5)OC D01TJY HIGHSTAT Phase 1 D01TKS DRUG__ID D01TKS D01TKS DRUGCLAS Investigative Drug(s) D01TKS DRUGINCH 1S/C28H38N6O6S/c1-17(32-27(39)21(29)14-19-8-10-20(35)11-9-19)26(38)31-16-24(36)33-23(15-18-6-4-3-5-7-18)28(40)34-22(25(30)37)12-13-41-2/h3-11,17,21-23,35H,12-16,29H2,1-2H3,(H2,30,37)(H,31,38)(H,32,39)(H,33,36)(H,34,40)/t17-,21+,22+,23+/m1/s1 D01TKS DRUGINKE ANZXICRKKYOVMY-SZOBAZRNSA-N D01TKS DRUGSMIL CC(C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N D01TKS DRUGTYPE Small molecular drug D01TKS HIGHSTAT Investigative D01TLN DRUG__ID D01TLN D01TLN DRUGCLAS Investigative Drug(s) D01TLN DRUGINCH 1S/C29H28NO5/c1-31-26-10-9-20-15-25-23-17-28-27(34-19-35-28)16-21(23)11-12-30(25)18-24(20)29(26)33-14-6-5-13-32-22-7-3-2-4-8-22/h2-4,7-10,15-18H,5-6,11-14,19H2,1H3/q+1 D01TLN DRUGINKE BKMOSBYJXKOCTP-UHFFFAOYSA-N D01TLN DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCOC6=CC=CC=C6 D01TLN DRUGTYPE Small molecular drug D01TLN HIGHSTAT Investigative D01TLV DRUG__ID D01TLV D01TLV DRUGCLAS Clinical Trial Drug(s) D01TLV DRUGCOMP Evotec D01TLV HIGHSTAT Phase 1 D01TMC DRUG__ID D01TMC D01TMC DRUGCLAS Investigative Drug(s) D01TMC DRUGINCH 1S/C17H15N5O2/c1-2-22-20-17(19-21-22)18-16(23)15-11-7-3-5-9-13(11)24-14-10-6-4-8-12(14)15/h3-10,15H,2H2,1H3,(H,18,20,23) D01TMC DRUGINKE HVTLYEBQNBWUIT-UHFFFAOYSA-N D01TMC DRUGSMIL CCN1N=C(N=N1)NC(=O)C2C3=CC=CC=C3OC4=CC=CC=C24 D01TMC DRUGTYPE Small molecular drug D01TMC HIGHSTAT Investigative D01TMF DRUG__ID D01TMF D01TMF DRUGCLAS Approved Drug(s) D01TMF HIGHSTAT Approved D01TMK DRUG__ID D01TMK D01TMK DRUGCLAS Investigative Drug(s) D01TMK DRUGCOMP Genexine Co Ltd D01TMK DRUGTYPE Antibody D01TMK HIGHSTAT Investigative D01TMQ DRUG__ID D01TMQ D01TMQ DRUGCLAS Clinical Trial Drug(s) D01TMQ DRUGCOMP Orexigen Therapeutics D01TMQ DRUGINCH 1S/C20H23NO4.C13H18ClNO/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h3-4,11,15,18,22,24H,1-2,5-10H2;5-9,15H,1-4H3/t15-,18+,19+,20-;/m1./s1 D01TMQ DRUGINKE KVNBDVQGENTICK-ITLPAZOVSA-N D01TMQ DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O D01TMQ DRUGTYPE Small molecular drug D01TMQ HIGHSTAT Phase 3 D01TMW DRUG__ID D01TMW D01TMW DRUGCLAS Clinical Trial Drug(s) D01TMW DRUGCOMP Boehringer Ingelheim Pharmaceuticals type 2 diabetes (pediatric) Bridgewater, NJ Eli Lilly Indianapolis, IN D01TMW HIGHSTAT Phase 2 D01TNK DRUG__ID D01TNK D01TNK DRUGCLAS Clinical Trial Drug(s) D01TNK DRUGCOMP Jian-Kun Hu D01TNK DRUGTYPE CAR T Cell Therapy D01TNK HIGHSTAT Phase 1 D01TNT DRUG__ID D01TNT D01TNT DRUGCLAS Investigative Drug(s) D01TNT DRUGINCH 1S/C40H38O11/c1-19(2)4-3-5-20-12-27(24-9-6-21(41)14-29(24)44)36(39(49)26-11-8-23(43)16-31(26)46)28(13-20)37-32(47)18-35-38(40(37)50)33(48)17-34(51-35)25-10-7-22(42)15-30(25)45/h4,6-11,13-16,18,27-28,34,36,41-47,50H,3,5,12,17H2,1-2H3/t27-,28?,34?,36-/m1/s1 D01TNT DRUGINKE VYCKCQBOVSSJSK-CFQOWUBYSA-N D01TNT DRUGSMIL CC(=CCCC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C=C(C=C3)O)O)C4=C(C5=C(C=C4O)OC(CC5=O)C6=C(C=C(C=C6)O)O)O)C D01TNT DRUGTYPE Small molecular drug D01TNT HIGHSTAT Investigative D01TNW DRUG__ID D01TNW D01TNW DRUGCLAS Approved Drug(s) D01TNW DRUGCOMP AstraZeneca D01TNW DRUGINCH 1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1 D01TNW DRUGINKE JVHXJTBJCFBINQ-ADAARDCZSA-N D01TNW DRUGSMIL CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl D01TNW DRUGTYPE Small molecular drug D01TNW HIGHSTAT Approved D01TOR DRUG__ID D01TOR D01TOR DRUGCLAS Investigative Drug(s) D01TOR DRUGINCH 1S/C20H16N4/c1-2-7-15(8-3-1)13-22-20-17-10-4-5-11-18(17)23-19(24-20)16-9-6-12-21-14-16/h1-12,14H,13H2,(H,22,23,24) D01TOR DRUGINKE AELMNLIYFALJIR-UHFFFAOYSA-N D01TOR DRUGSMIL C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)C4=CN=CC=C4 D01TOR DRUGTYPE Small molecular drug D01TOR HIGHSTAT Investigative D01TOU DRUG__ID D01TOU D01TOU DRUGCLAS Investigative Drug(s) D01TOU DRUGINCH 1S/C21H25FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11H,4,6,12-16H2,1H3 D01TOU DRUGINKE IRYFCWPNDIUQOW-UHFFFAOYSA-N D01TOU DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F D01TOU DRUGTYPE Small molecular drug D01TOU HIGHSTAT Investigative D01TPU DRUG__ID D01TPU D01TPU DRUGCLAS Discontinued Drug(s) D01TPU DRUGCOMP ASTA Medica AG D01TPU HIGHSTAT Terminated D01TPW DRUG__ID D01TPW D01TPW DRUGCLAS Investigative Drug(s) D01TPW DRUGINCH 1S/C4H6O3.Na/c5-3-1-2-4(6)7;/h1-2,5H,3H2,(H,6,7);/q;+1/p-1/b2-1+; D01TPW DRUGINKE PUAFPEZXZZJTBR-TYYBGVCCSA-M D01TPW DRUGSMIL C(C=CC(=O)[O-])O.[Na+] D01TPW DRUGTYPE Small molecular drug D01TPW HIGHSTAT Investigative D01TQD DRUG__ID D01TQD D01TQD DRUGCLAS Investigative Drug(s) D01TQD DRUGINCH 1S/C19H19FN2O2/c1-13(19(2,3)24)22-18(23)17-10-9-15(12-21-17)8-7-14-5-4-6-16(20)11-14/h4-6,9-13,24H,1-3H3,(H,22,23)/t13-/m1/s1 D01TQD DRUGINKE ZPKZAFDYFVJULO-CYBMUJFWSA-N D01TQD DRUGSMIL CC(C(C)(C)O)NC(=O)C1=NC=C(C=C1)C#CC2=CC(=CC=C2)F D01TQD DRUGTYPE Small molecular drug D01TQD HIGHSTAT Investigative D01TQR DRUG__ID D01TQR D01TQR DRUGCLAS Approved Drug(s) D01TQR DRUGINCH 1S/C33H60O10/c1-2-3-4-5-6-7-8-9-32-10-12-33(13-11-32)43-31-30-42-29-28-41-27-26-40-25-24-39-23-22-38-21-20-37-19-18-36-17-16-35-15-14-34/h10-13,34H,2-9,14-31H2,1H3 D01TQR DRUGINKE FBWNMEQMRUMQSO-UHFFFAOYSA-N D01TQR DRUGSMIL CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO D01TQR DRUGTYPE Small molecular drug D01TQR HIGHSTAT Approved D01TRI DRUG__ID D01TRI D01TRI DRUGCLAS Investigative Drug(s) D01TRI DRUGINCH 1S/C30H22N2O4/c33-27(15-19-7-3-1-4-8-19)31-21-11-13-23-25(17-21)30(36)26-18-22(12-14-24(26)29(23)35)32-28(34)16-20-9-5-2-6-10-20/h1-14,17-18H,15-16H2,(H,31,33)(H,32,34) D01TRI DRUGINKE YFLLPGICLQVMIU-UHFFFAOYSA-N D01TRI DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CC5=CC=CC=C5 D01TRI DRUGTYPE Small molecular drug D01TRI HIGHSTAT Investigative D01TRN DRUG__ID D01TRN D01TRN DRUGCLAS Investigative Drug(s) D01TRN DRUGINCH 1S/C29H28N2O5/c1-18-7-12-27-26(13-18)30(3)16-23(36-27)17-35-22-10-8-20(9-11-22)29(34)31-19(2)14-24-21(15-28(32)33)5-4-6-25(24)31/h4-14,23H,15-17H2,1-3H3,(H,32,33)/t23-/m0/s1 D01TRN DRUGINKE PDLHJVXUGHZZQP-QHCPKHFHSA-N D01TRN DRUGSMIL CC1=CC2=C(C=C1)OC(CN2C)COC3=CC=C(C=C3)C(=O)N4C(=CC5=C(C=CC=C54)CC(=O)O)C D01TRN DRUGTYPE Small molecular drug D01TRN HIGHSTAT Investigative D01TRU DRUG__ID D01TRU D01TRU DRUGCLAS Investigative Drug(s) D01TRU DRUGCOMP NanoForm Cardiovascular Therapeutics Ltd D01TRU HIGHSTAT Investigative D01TSI DRUG__ID D01TSI D01TSI DRUGCLAS Approved Drug(s) D01TSI DRUGCOMP Eli Lilly D01TSI DRUGINCH 1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1 D01TSI DRUGINKE XCGSFFUVFURLIX-VFGNJEKYSA-N D01TSI DRUGSMIL CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C D01TSI DRUGTYPE Small molecular drug D01TSI HIGHSTAT Approved D01TSI THERCLAS Analgesics D01TSM DRUG__ID D01TSM D01TSM DRUGCLAS Investigative Drug(s) D01TSM DRUGINCH 1S/C21H18N2O2/c1-14(24)15-7-9-16(10-8-15)18-11-12-19(22)20(13-18)23-21(25)17-5-3-2-4-6-17/h2-13H,22H2,1H3,(H,23,25) D01TSM DRUGINKE NWHQDZJUELCUHQ-UHFFFAOYSA-N D01TSM DRUGSMIL CC(=O)C1=CC=C(C=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CC=CC=C3 D01TSM DRUGTYPE Small molecular drug D01TSM HIGHSTAT Investigative D01TSN DRUG__ID D01TSN D01TSN DRUGCLAS Discontinued Drug(s) D01TSN DRUGINCH 1S/C11H15N3S/c1-14-6-2-3-7-8(14)4-5-9-10(7)13-11(12)15-9/h3,8H,2,4-6H2,1H3,(H2,12,13) D01TSN DRUGINKE XFJSSDHKIXXJLM-UHFFFAOYSA-N D01TSN DRUGSMIL CN1CCC=C2C1CCC3=C2N=C(S3)N D01TSN DRUGTYPE Small molecular drug D01TSN HIGHSTAT Terminated D01TSX DRUG__ID D01TSX D01TSX DRUGCLAS Investigative Drug(s) D01TSX DRUGINCH 1S/C11H16INO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3/t7-/m1/s1 D01TSX DRUGINKE BGMZUEKZENQUJY-SSDOTTSWSA-N D01TSX DRUGSMIL CC(CC1=CC(=C(C=C1OC)I)OC)N D01TSX DRUGTYPE Small molecular drug D01TSX HIGHSTAT Investigative D01TUB DRUG__ID D01TUB D01TUB DRUGCLAS Investigative Drug(s) D01TUB DRUGINCH 1S/C15H10ClNO2/c16-13-8-15(9-1-3-10(18)4-2-9)17-14-6-5-11(19)7-12(13)14/h1-8,18-19H D01TUB DRUGINKE MJJDANHWHHWHME-UHFFFAOYSA-N D01TUB DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=C(C=C3)O)C(=C2)Cl)O D01TUB HIGHSTAT Investigative D01TVQ DRUG__ID D01TVQ D01TVQ DRUGCLAS Approved Drug(s) D01TVQ DRUGCOMP Bayer Pharmaceuticals Corporation D01TVQ DRUGTYPE Antibody D01TVQ HIGHSTAT Approved D01TVQ THERCLAS Anticancer Agents D01TVR DRUG__ID D01TVR D01TVR DRUGCLAS Discontinued Drug(s) D01TVR DRUGCOMP Spherix D01TVR DRUGINCH 1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4+,5+,6?/m1/s1 D01TVR DRUGINKE LKDRXBCSQODPBY-OEXCPVAWSA-N D01TVR DRUGSMIL C1C(C(C(C(O1)(CO)O)O)O)O D01TVR DRUGTYPE Small molecular drug D01TVR HIGHSTAT Discontinued in Phase 3 D01TVT DRUG__ID D01TVT D01TVT DRUGCLAS Investigative Drug(s) D01TVT DRUGCOMP Johns Hopkins University D01TVT HIGHSTAT Investigative D01TWD DRUG__ID D01TWD D01TWD DRUGCLAS Investigative Drug(s) D01TWD DRUGINCH 1S/C22H28N4O3S/c1-16-8-10-19(11-9-16)30(28,29)25-20(22(27)26-12-3-2-4-13-26)15-17-6-5-7-18(14-17)21(23)24/h5-11,14,20,25H,2-4,12-13,15H2,1H3,(H3,23,24) D01TWD DRUGINKE RNNMXTSTLVYYQG-UHFFFAOYSA-N D01TWD DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(CC2=CC(=CC=C2)C(=N)N)C(=O)N3CCCCC3 D01TWD DRUGTYPE Small molecular drug D01TWD HIGHSTAT Investigative D01TWG DRUG__ID D01TWG D01TWG DRUGCLAS Clinical Trial Drug(s) D01TWG DRUGCOMP UCB Smyrna, GA D01TWG HIGHSTAT Phase 2 D01TYB DRUG__ID D01TYB D01TYB DRUGCLAS Discontinued Drug(s) D01TYB DRUGCOMP Flamel Technologies D01TYB HIGHSTAT Discontinued in Phase 1 D01TYJ DRUG__ID D01TYJ D01TYJ DRUGCLAS Investigative Drug(s) D01TYJ DRUGINCH 1S/C14H10N4O6S/c15-9-1-3-11(4-2-9)25(23,24)16-6-5-12-13(16)7-10(17(19)20)8-14(12)18(21)22/h1-8H,15H2 D01TYJ DRUGINKE NMGNRDGVTLTPFO-UHFFFAOYSA-N D01TYJ DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)N2C=CC3=C2C=C(C=C3[N+](=O)[O-])[N+](=O)[O-] D01TYJ DRUGTYPE Small molecular drug D01TYJ HIGHSTAT Investigative D01TYO DRUG__ID D01TYO D01TYO DRUGCLAS Investigative Drug(s) D01TYO DRUGSMIL CC=C(C)C1CCC2CC(CC(C2C1C(=O)C3=C(C(NC3=O)CC(C)(C(=O)O)O)O)C)C D01TYO DRUGTYPE Small molecular drug D01TYO HIGHSTAT Investigative D01TZT DRUG__ID D01TZT D01TZT DRUGCLAS Investigative Drug(s) D01TZT DRUGINCH 1S/C13H11NO5/c15-10-6-3-7-11(16)12(10)13(17)8-4-1-2-5-9(8)14(18)19/h1-2,4-5,12H,3,6-7H2 D01TZT DRUGINKE ZZJZBPYZTKGWTD-UHFFFAOYSA-N D01TZT DRUGSMIL C1CC(=O)C(C(=O)C1)C(=O)C2=CC=CC=C2[N+](=O)[O-] D01TZT DRUGTYPE Small molecular drug D01TZT HIGHSTAT Investigative D01UAD DRUG__ID D01UAD D01UAD DRUGCLAS Clinical Trial Drug(s) D01UAD DRUGCOMP Palvella Therapeutics Wayne, PA D01UAD HIGHSTAT Phase 2 D01UAL DRUG__ID D01UAL D01UAL DRUGCLAS Patented Agent(s) D01UAL DRUGCOMP GEORGETOWN UNIVERSITY YENUGONDA, Venkata, Mahidhar BROWN, Milton, L D01UAL DRUGINCH 1S/C34H42ClN9O4S/c1-20(2)27(18-45)40-34-41-31(30-32(42-34)44(19-37-30)21(3)4)39-22-13-14-25(26(35)17-22)33(46)36-15-16-38-49(47,48)29-12-8-9-23-24(29)10-7-11-28(23)43(5)6/h7-14,17,19-21,27,38,45H,15-16,18H2,1-6H3,(H,36,46)(H2,39,40,41,42)/t27-/m0/s1 D01UAL DRUGINKE NJNQGMFCZFMREY-MHZLTWQESA-N D01UAL DRUGSMIL CC(C)C(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=C(C=C3)C(=O)NCCNS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C)Cl D01UAL DRUGTYPE Small molecular drug D01UAL HIGHSTAT Patented D01UAM DRUG__ID D01UAM D01UAM DRUGCLAS Clinical Trial Drug(s) D01UAM DRUGCOMP Memorial Sloan-Kettering Cancer Center D01UAM HIGHSTAT Phase 1 D01UAO DRUG__ID D01UAO D01UAO DRUGCLAS Investigative Drug(s) D01UAO DRUGINCH 1S/C13H10ClNO3/c14-12-11(8-1-4-10(16)5-2-8)6-3-9(7-15-18)13(12)17/h1-6,16-17H,7H2 D01UAO DRUGINKE CIYDFCOZUPKHFA-UHFFFAOYSA-N D01UAO DRUGSMIL C1=CC(=CC=C1C2=C(C(=C(C=C2)CN=O)O)Cl)O D01UAO DRUGTYPE Small molecular drug D01UAO HIGHSTAT Investigative D01UAS DRUG__ID D01UAS D01UAS DRUGCLAS Investigative Drug(s) D01UAS DRUGINCH 1S/C12H10BrNO3/c1-2-17-12(16)9-6-14-10-4-3-7(13)5-8(10)11(9)15/h3-6H,2H2,1H3,(H,14,15) D01UAS DRUGINKE IVZIOBTVAJBBAS-UHFFFAOYSA-N D01UAS DRUGSMIL CCOC(=O)C1=CNC2=C(C1=O)C=C(C=C2)Br D01UAS DRUGTYPE Small molecular drug D01UAS HIGHSTAT Investigative D01UAU DRUG__ID D01UAU D01UAU DRUGCLAS Clinical Trial Drug(s) D01UAU DRUGCOMP Concert Pharmaceuticals Lexington, MA D01UAU HIGHSTAT Phase 2 D01UBA DRUG__ID D01UBA D01UBA DRUGCLAS Patented Agent(s) D01UBA DRUGCOMP PIRAMAL HEALTHCARE LIMITED SIVAKUMAR, Meenakshi JOSHI, Kalpana Sanjay AWARE, Valmik Sopan SARDE, Ankush Gangaram BAGUL, Sandeep Mukunda MANOHAR, Sonal Mohan D01UBA DRUGINCH 1S/C13H14N2O3/c1-2-3-12-14-13(18-15-12)7-5-9-4-6-10(16)11(17)8-9/h4-8,16-17H,2-3H2,1H3/b7-5+ D01UBA DRUGINKE MAWOOXDYMFRJNN-FNORWQNLSA-N D01UBA DRUGSMIL CCCC1=NOC(=N1)C=CC2=CC(=C(C=C2)O)O D01UBA DRUGTYPE Small molecular drug D01UBA HIGHSTAT Patented D01UBV DRUG__ID D01UBV D01UBV DRUGCLAS Investigative Drug(s) D01UBV DRUGCOMP InNexus Biotechnology Inc D01UBV HIGHSTAT Investigative D01UBX DRUG__ID D01UBX D01UBX DRUGCLAS Approved Drug(s) D01UBX DRUGINCH 1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1 D01UBX DRUGINKE USZYSDMBJDPRIF-SVEJIMAYSA-N D01UBX DRUGSMIL CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O D01UBX DRUGTYPE Small molecular drug D01UBX HIGHSTAT Approved D01UBX THERCLAS Anticancer Agents D01UBY DRUG__ID D01UBY D01UBY DRUGCLAS Clinical Trial Drug(s) D01UBY DRUGCOMP Janssen Research & Development D01UBY DRUGINCH 1S/C22H25F3N4O3S/c23-22(24,25)15-3-1-2-14(8-15)20(31)27-10-19(30)28-16-11-29(12-16)17-4-6-21(32,7-5-17)18-9-26-13-33-18/h1-3,8-9,13,16-17,32H,4-7,10-12H2,(H,27,31)(H,28,30) D01UBY DRUGINKE CFKBNYUHQSQBSX-UHFFFAOYSA-N D01UBY DRUGSMIL C1CC(CCC1N2CC(C2)NC(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)(C4=CN=CS4)O D01UBY DRUGTYPE Small molecular drug D01UBY HIGHSTAT Phase 2 D01UDC DRUG__ID D01UDC D01UDC DRUGCLAS Investigative Drug(s) D01UDC DRUGINCH 1S/C9H15NO2/c1-6(11)12-9-5-7-3-2-4-8(9)10-7/h7-10H,2-5H2,1H3 D01UDC DRUGINKE HHXDJDWQQPSWHW-UHFFFAOYSA-N D01UDC DRUGSMIL CC(=O)OC1CC2CCCC1N2 D01UDC DRUGTYPE Small molecular drug D01UDC HIGHSTAT Investigative D01UDR DRUG__ID D01UDR D01UDR DRUGCLAS Discontinued Drug(s) D01UDR DRUGCOMP Roche Holding AG D01UDR HIGHSTAT Terminated D01UDS DRUG__ID D01UDS D01UDS DRUGCLAS Clinical Trial Drug(s) D01UDS DRUGCOMP GlaxoSmithKline plc D01UDS DRUGINCH 1S/C19H20F3N3O3S/c1-13-12-24(10-11-25(13)18(26)17-4-3-9-23-14(17)2)29(27,28)16-7-5-15(6-8-16)19(20,21)22/h3-9,13H,10-12H2,1-2H3/t13-/m0/s1 D01UDS DRUGINKE BLFJGFDZMABYMY-ZDUSSCGKSA-N D01UDS DRUGSMIL CC1CN(CCN1C(=O)C2=C(N=CC=C2)C)S(=O)(=O)C3=CC=C(C=C3)C(F)(F)F D01UDS HIGHSTAT Phase 2 D01UDU DRUG__ID D01UDU D01UDU DRUGCLAS Investigative Drug(s) D01UDU DRUGINCH 1S/C6H8ClN3O2S/c7-5-3-4(13(9,11)12)1-2-6(5)10-8/h1-3,10H,8H2,(H2,9,11,12) D01UDU DRUGINKE MIIRMBFCBFPOKU-UHFFFAOYSA-N D01UDU DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)Cl)NN D01UDU DRUGTYPE Small molecular drug D01UDU HIGHSTAT Investigative D01UFF DRUG__ID D01UFF D01UFF DRUGCLAS Investigative Drug(s) D01UFF DRUGINCH 1S/C22H32O3/c1-3-13-11-19-18-6-4-14-10-15(24)5-7-16(14)17(18)8-9-22(19,2)21(13)20(25)12-23/h10,13,16-19,21,23H,3-9,11-12H2,1-2H3/t13-,16+,17-,18-,19+,21-,22+/m1/s1 D01UFF DRUGINKE IJLXLZGJDSJGIQ-BILPMHSYSA-N D01UFF DRUGSMIL CCC1CC2C3CCC4=CC(=O)CCC4C3CCC2(C1C(=O)CO)C D01UFF DRUGTYPE Small molecular drug D01UFF HIGHSTAT Investigative D01UFK DRUG__ID D01UFK D01UFK DRUGCLAS Clinical Trial Drug(s) D01UFK DRUGCOMP Apitope Technology (Bristol) Ltd D01UFK DRUGTYPE Vaccine D01UFK HIGHSTAT Phase 2 D01UFM DRUG__ID D01UFM D01UFM DRUGCLAS Investigative Drug(s) D01UFM DRUGINCH 1S/C16H17NO3/c18-15(17-12-7-2-1-3-8-12)13-10-11-6-4-5-9-14(11)20-16(13)19/h4-6,9-10,12H,1-3,7-8H2,(H,17,18) D01UFM DRUGINKE KUWSPPXPGQEHSQ-UHFFFAOYSA-N D01UFM DRUGSMIL C1CCC(CC1)NC(=O)C2=CC3=CC=CC=C3OC2=O D01UFM DRUGTYPE Small molecular drug D01UFM HIGHSTAT Investigative D01UFN DRUG__ID D01UFN D01UFN DRUGCLAS Approved Drug(s) D01UFN DRUGINCH 1S/C27H38F6O3/c1-16(6-4-13-25(36,26(28,29)30)27(31,32)33)21-10-11-22-18(7-5-12-24(21,22)3)8-9-19-14-20(34)15-23(35)17(19)2/h8-9,16,20-23,34-36H,2,4-7,10-15H2,1,3H3/b18-8+,19-9-/t16-,20-,21-,22+,23+,24-/m1/s1 D01UFN DRUGINKE XPYGGHVSFMUHLH-UUSULHAXSA-N D01UFN DRUGSMIL CC(CCCC(C(F)(F)F)(C(F)(F)F)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C D01UFN DRUGTYPE Small molecular drug D01UFN HIGHSTAT Approved D01UFZ DRUG__ID D01UFZ D01UFZ DRUGCLAS Clinical Trial Drug(s) D01UFZ DRUGCOMP Relmada Therapeutics New York, NY D01UFZ HIGHSTAT Phase 1 D01UGG DRUG__ID D01UGG D01UGG DRUGCLAS Clinical Trial Drug(s) D01UGG DRUGCOMP The Menarini Group D01UGG DRUGINCH 1S/C32H37NO13/c1-12-26(37)17(33)7-21(43-12)46-31-13(2)44-22(8-18(31)35)45-19-10-32(42,20(36)11-34)9-16-23(19)30(41)25-24(29(16)40)27(38)14-5-3-4-6-15(14)28(25)39/h3-6,12-13,17-19,21-22,26,31,34-35,37,40-42H,7-11,33H2,1-2H3/t12-,13-,17-,18-,19-,21-,22-,26+,31+,32-/m0/s1 D01UGG DRUGINKE VQHRZZISQVWPLK-UIRGBLDSSA-N D01UGG DRUGSMIL CC1C(C(CC(O1)OC2C(OC(CC2O)OC3CC(CC4=C3C(=C5C(=C4O)C(=O)C6=CC=CC=C6C5=O)O)(C(=O)CO)O)C)N)O D01UGG DRUGTYPE Small molecular drug D01UGG HIGHSTAT Phase 2 D01UHA DRUG__ID D01UHA D01UHA DRUGCLAS Clinical Trial Drug(s) D01UHA DRUGCOMP Innate Therapeutics Ltd D01UHA HIGHSTAT Phase 2 D01UHU DRUG__ID D01UHU D01UHU DRUGCLAS Investigative Drug(s) D01UHU DRUGCOMP Massachusetts Institute of Technology D01UHU DRUGINCH 1S/C5H5N.2ClH.2H3N.Pt/c1-2-4-6-5-3-1;;;;;/h1-5H;2*1H;2*1H3;/q;;;;;+2/p-2 D01UHU DRUGINKE JDWBOMGRVMIMAU-UHFFFAOYSA-L D01UHU DRUGSMIL C1=CC=NC=C1.N.N.[Cl-].Cl[Pt+] D01UHU DRUGTYPE Small molecular drug D01UHU HIGHSTAT Investigative D01UIJ DRUG__ID D01UIJ D01UIJ DRUGCLAS Patented Agent(s) D01UIJ DRUGINCH 1S/C29H30N6O5/c1-16-32-22-9-7-17(13-24(22)39-16)20-15-31-26-25(20)28(40-19-5-3-4-6-19)35-29(34-26)33-21-10-8-18(14-23(21)38-2)27(37)30-11-12-36/h7-10,13-15,19,36H,3-6,11-12H2,1-2H3,(H,30,37)(H2,31,33,34,35) D01UIJ DRUGINKE DUZMKFLMNMTYDM-UHFFFAOYSA-N D01UIJ DRUGSMIL CC1=NC2=C(O1)C=C(C=C2)C3=CNC4=C3C(=NC(=N4)NC5=C(C=C(C=C5)C(=O)NCCO)OC)OC6CCCC6 D01UIJ DRUGTYPE Small molecular drug D01UIJ HIGHSTAT Patented D01UIY DRUG__ID D01UIY D01UIY DRUGCLAS Investigative Drug(s) D01UIY DRUGINCH 1S/C14H21NO3/c1-4-18-14-8-7-13(17-3)10-12(14)6-5-9-15-11(2)16/h7-8,10H,4-6,9H2,1-3H3,(H,15,16) D01UIY DRUGINKE GTXCCVOUHCBPES-UHFFFAOYSA-N D01UIY DRUGSMIL CCOC1=C(C=C(C=C1)OC)CCCNC(=O)C D01UIY DRUGTYPE Small molecular drug D01UIY HIGHSTAT Investigative D01UJK DRUG__ID D01UJK D01UJK DRUGCLAS Clinical Trial Drug(s) D01UJK DRUGCOMP Sanofi-Aventis D01UJK HIGHSTAT Phase 1 D01UJL DRUG__ID D01UJL D01UJL DRUGCLAS Investigative Drug(s) D01UJL DRUGINCH 1S/C9H20N2O2/c1-11(2,3)7-5-4-6-8(10)9(12)13/h8H,4-7,10H2,1-3H3/p+1/t8-/m0/s1 D01UJL DRUGINKE MXNRLFUSFKVQSK-QMMMGPOBSA-O D01UJL DRUGSMIL C[N+](C)(C)CCCCC(C(=O)O)N D01UJL DRUGTYPE Small molecular drug D01UJL HIGHSTAT Investigative D01UJS DRUG__ID D01UJS D01UJS DRUGCLAS Investigative Drug(s) D01UJS DRUGCOMP ZaBeCor Pharmaceutical Co D01UJS HIGHSTAT Investigative D01UKK DRUG__ID D01UKK D01UKK DRUGCLAS Clinical Trial Drug(s) D01UKK DRUGCOMP Pfizer New York, NY D01UKK HIGHSTAT Phase 2 D01UKL DRUG__ID D01UKL D01UKL DRUGCLAS Investigative Drug(s) D01UKL DRUGINCH 1S/C18H32N4O8S/c1-2-3-4-5-6-9-22(30)18(29)31-11-13(16(26)20-10-15(24)25)21-14(23)8-7-12(19)17(27)28/h12-13,30H,2-11,19H2,1H3,(H,20,26)(H,21,23)(H,24,25)(H,27,28)/t12-,13-/m0/s1 D01UKL DRUGINKE BRCVFVPDJZMQPO-STQMWFEESA-N D01UKL DRUGSMIL CCCCCCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D01UKL DRUGTYPE Small molecular drug D01UKL HIGHSTAT Investigative D01UKV DRUG__ID D01UKV D01UKV DRUGCLAS Investigative Drug(s) D01UKV DRUGINCH 1S/C20H21NO/c1-2-4-16(5-3-1)15-22-19-8-6-17(7-9-19)20-14-21-12-10-18(20)11-13-21/h1-9,14,18H,10-13,15H2 D01UKV DRUGINKE OKNMXSHKBLYYKN-UHFFFAOYSA-N D01UKV DRUGSMIL C1CN2CCC1C(=C2)C3=CC=C(C=C3)OCC4=CC=CC=C4 D01UKV DRUGTYPE Small molecular drug D01UKV HIGHSTAT Investigative D01ULE DRUG__ID D01ULE D01ULE DRUGCLAS Investigative Drug(s) D01ULE DRUGINCH 1S/C7H9O3PS/c8-11(9,10)7(12)6-4-2-1-3-5-6/h1-5,7,12H,(H2,8,9,10) D01ULE DRUGINKE FSPBPXVXCWHRHO-UHFFFAOYSA-N D01ULE DRUGSMIL C1=CC=C(C=C1)C(P(=O)(O)O)S D01ULE DRUGTYPE Small molecular drug D01ULE HIGHSTAT Investigative D01ULX DRUG__ID D01ULX D01ULX DRUGCLAS Investigative Drug(s) D01ULX DRUGCOMP Celgene Corp D01ULX DRUGINCH 1S/C20H21Cl2NO6/c1-29-10-17(24)23-16(18(25)19(26)20(27)28)6-11-2-4-12(5-3-11)13-7-14(21)9-15(22)8-13/h2-5,7-9,16,18-19,25-26H,6,10H2,1H3,(H,23,24)(H,27,28)/t16-,18-,19+/m0/s1 D01ULX DRUGINKE NTCBTNCWNRCBGX-YTQUADARSA-N D01ULX DRUGSMIL COCC(=O)NC(CC1=CC=C(C=C1)C2=CC(=CC(=C2)Cl)Cl)C(C(C(=O)O)O)O D01ULX HIGHSTAT Investigative D01UMT DRUG__ID D01UMT D01UMT DRUGCLAS Clinical Trial Drug(s) D01UMT DRUGCOMP Hoffmann La Roche D01UMT DRUGINCH 1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28) D01UMT DRUGINKE OVSKGTONMLKNPZ-UHFFFAOYSA-N D01UMT DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=C4C=CC(=C5)[N+](=O)[O-])C D01UMT DRUGTYPE Small molecular drug D01UMT HIGHSTAT Phase 2 D01UMT THERCLAS Anticancer Agents D01UNC DRUG__ID D01UNC D01UNC DRUGCLAS Investigative Drug(s) D01UNC DRUGINCH 1S/C8H10N2O4S/c9-6-1-3-7(4-2-6)15(13,14)10-5-8(11)12/h1-4,10H,5,9H2,(H,11,12) D01UNC DRUGINKE BPJUMYMTQYMSFZ-UHFFFAOYSA-N D01UNC DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)NCC(=O)O D01UNC DRUGTYPE Small molecular drug D01UNC HIGHSTAT Investigative D01UNE DRUG__ID D01UNE D01UNE DRUGCLAS Investigative Drug(s) D01UNE DRUGINCH 1S/C38H41N4O7PS/c1-48-33-18-10-11-19-34(33)51-25-29(37(44)41-32(36(39)43)21-28-22-40-31-17-9-8-16-30(28)31)24-50(46,47)35(20-26-12-4-2-5-13-26)42-38(45)49-23-27-14-6-3-7-15-27/h2-19,22,29,32,35,40H,20-21,23-25H2,1H3,(H2,39,43)(H,41,44)(H,42,45)(H,46,47)/t29-,32-,35+/m0/s1 D01UNE DRUGINKE YDDMVPLLJTZTQL-LAABSITASA-N D01UNE DRUGSMIL COC1=CC=CC=C1SCC(CP(=O)(C(CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3)O)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)N D01UNE DRUGTYPE Small molecular drug D01UNE HIGHSTAT Investigative D01UNF DRUG__ID D01UNF D01UNF DRUGCLAS Preclinical Drug(s) D01UNF DRUGCOMP NAEJA Pharmaceuticals Inc D01UNF HIGHSTAT Preclinical D01UNS DRUG__ID D01UNS D01UNS DRUGCLAS Drugs in Phase 2 Trial D01UNS DRUGTYPE Combination drug D01UNS HIGHSTAT Phase 2 Trial D01UNS THERCLAS Antiviral Agents D01UNT DRUG__ID D01UNT D01UNT DRUGCLAS Investigative Drug(s) D01UNT DRUGINCH 1S/C30H34ClF3N4O7S/c1-16(2)23(29(43)36-28(42)22-6-5-15-38(22)24(17(3)4)25(39)30(32,33)34)35-26(40)18-7-9-19(10-8-18)27(41)37-46(44,45)21-13-11-20(31)12-14-21/h7-14,16-17,22-24H,5-6,15H2,1-4H3,(H,35,40)(H,37,41)(H,36,42,43)/t22-,23-,24?/m0/s1 D01UNT DRUGINKE SMCMGLCPSSSOQE-NTZARQNWSA-N D01UNT DRUGSMIL CC(C)C(C(=O)NC(=O)C1CCCN1C(C(C)C)C(=O)C(F)(F)F)NC(=O)C2=CC=C(C=C2)C(=O)NS(=O)(=O)C3=CC=C(C=C3)Cl D01UNT DRUGTYPE Small molecular drug D01UNT HIGHSTAT Investigative D01UOK DRUG__ID D01UOK D01UOK DRUGCLAS Investigative Drug(s) D01UOK DRUGCOMP Isis Pharmaceuticals D01UOK DRUGTYPE Antisense drug D01UOK HIGHSTAT Investigative D01UOO DRUG__ID D01UOO D01UOO DRUGCLAS Investigative Drug(s) D01UOO DRUGINCH 1S/C17H15N3O3S/c1-2-24-17-18-15-9-8-13(20(22)23)10-14(15)16(21)19(17)11-12-6-4-3-5-7-12/h3-10H,2,11H2,1H3 D01UOO DRUGINKE XLPYZVKSRJZTGS-UHFFFAOYSA-N D01UOO DRUGSMIL CCSC1=NC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)N1CC3=CC=CC=C3 D01UOO DRUGTYPE Small molecular drug D01UOO HIGHSTAT Investigative D01UPA DRUG__ID D01UPA D01UPA DRUGCLAS